1	2	3	4	5	6	7	8
laterality-lesion	Other testing : OCT - Macula : Dme [s1] OU [e1] Assessment Assessment and Plan : 1 .	[s2] Proliferative diabetic retinopathy [e2] ( 362.02 ) 2 .	laterality	lesion	T9	T3	note_4453
laterality-lesion	OCT , Posterior Segment - OU - Both Eyes OD : Drusen , no SRF [s1] OS [e1] : Geo atrophy , Drusen .	No [s2] SRF [e2] Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T5	T2	note_1142
NonRel	POW # ID [s1] OD [e1] from PPV for VH , vitritis , TRD from secondary complications .	Hx of previous [s2] exudative [e2] RD OU .	laterality	lesion	T4	T2	2748168_note_9227
NonRel	Hx of previous exudative RD [s1] OU [e1] .	POW # ID OD from PPV for [s2] VH [e2] , vitritis , TRD from secondary complications .	laterality	lesion	T5	T1	2748168_note_9227
NonRel	Hx of [s1] previous [e1] exudative RD OU .	POW # ID OD from PPV for [s2] VH [e2] , vitritis , TRD from secondary complications .	severity	lesion	T6	T1	2748168_note_9227
NonRel	[s1] Mild [e1] nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 2 .	Mild [s2] nonproliferative diabetic retinopathy [e2] of left eye without macular edema associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	severity	lesion	T8	T3	2559086_note_8081
NonRel	[s1] Mild [e1] nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 2 .	Mild nonproliferative diabetic retinopathy of left eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	severity	lesion	T8	T4	2559086_note_8081
NonRel	[s1] Mild [e1] nonproliferative diabetic retinopathy of left eye without macular edema associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	Mild [s2] nonproliferative diabetic retinopathy [e2] of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 2 .	severity	lesion	T9	T1	2559086_note_8081
NonRel	[s1] Mild [e1] nonproliferative diabetic retinopathy of left eye without macular edema associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	Mild nonproliferative diabetic retinopathy of right eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 2 .	severity	lesion	T9	T2	2559086_note_8081
NonRel	Mild nonproliferative diabetic retinopathy of [s1] right eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 2 .	Mild [s2] nonproliferative diabetic retinopathy [e2] of left eye without macular edema associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	laterality	lesion	T10	T3	2559086_note_8081
NonRel	Mild nonproliferative diabetic retinopathy of [s1] right eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 2 .	Mild nonproliferative diabetic retinopathy of left eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	laterality	lesion	T10	T4	2559086_note_8081
NonRel	Mild nonproliferative diabetic retinopathy of [s1] left eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	Mild [s2] nonproliferative diabetic retinopathy [e2] of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 2 .	laterality	lesion	T11	T1	2559086_note_8081
NonRel	Mild nonproliferative diabetic retinopathy of [s1] left eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	Mild nonproliferative diabetic retinopathy of right eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 2 .	laterality	lesion	T11	T2	2559086_note_8081
NonRel	Allergies : Allergies Allergen Reactions • Metformin Diarrhea ROS Positive for : Endocrine ( DM ) , Cardiovascular ( HTN ) , Eyes ( glaucoma ) Negative for : Constitutional , Gastrointestinal , Neurological , Skin , Genitourinary , Musculoskeletal , HENT , Respiratory , Psychiatric , Allergic / Imm , Heme / Lymph Objective : Base Eye Exam Visual Acuity Right Left Dist sc 20 / 150 20 / 30 - 2 Dist ph sc NI Method : Snellen - Linear Tonometry Right Left Pressure 38 17 Method : icare Time : 1 : 38 PM Tonometry # 2 Right Left Pressure 36 Method : Applanation Time : 1 : 41 PM Tonometry # 3 Right Left Pressure 35 16 Method : Applanation ( kane ) Time : 3 : 06 PM Pachymetry Right Left Thickness 690 626 Date : DATE Pupils Pupils Light React APD Right PERRL irreg 1 - Left PERRL 3 2 - Visual Fields Right Left Restrictions Partial superior temporal , inferior temporal , superior nasal , inferior nasal deficiencies Extraocular Movement Right Left Result Full Full Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Dilation Both eyes : 1.0 % Mydriacyl @ 2 : 02 PM Slit Lamp and Fundus Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Dermatochalasis - upper lid , Ptosis Ptosis , Dermatochalasis - upper lid Conjunctiva / Sclera Superior nasal conjunctival sutures intact , seidel - Subconjunctival hemorrhage , Injection Cornea mild corneal edema , Punctate epithelial erosions Punctate epithelial erosions Anterior Chamber Deep and quiet Deep and quiet Iris irregular reactive pupil , few vessels visible , patent pi Round and reactive , no NVI Lens Posterior chamber intraocular lens Posterior chamber intraocular lens Vitreous PVD clear Fundus Exam Right Left Disc Normal , no NVD Normal , no NVD C / D Ratio 0.4 0.2 Macula flat , [s1] few [e1] DBH ERM with wrinkling , few intraretinal heme Vessels attenuation attenuation Periphery PRP scars , flat few dbh PRP scars , flat few dbh No annotated images are attached to the encounter .	Other testing : OCT - RNFL : OD : Avg 99 , full wnl OS : borderline STQ and ITQ , Avg 84 , WNL MAC OCT OD : ERM with surface wrinkling , mild IRF OS : ERM , with mild surface wrinkling , no IRF / [s2] SRF [e2] Assessment and Plan : ICD - 9 - CM 1 .	severity	lesion	T12	T8	2260561_note_6253
NonRel	Allergies : Allergies Allergen Reactions • Metformin Diarrhea ROS Positive for : Endocrine ( DM ) , Cardiovascular ( HTN ) , Eyes ( glaucoma ) Negative for : Constitutional , Gastrointestinal , Neurological , Skin , Genitourinary , Musculoskeletal , HENT , Respiratory , Psychiatric , Allergic / Imm , Heme / Lymph Objective : Base Eye Exam Visual Acuity Right Left Dist sc 20 / 150 20 / 30 - 2 Dist ph sc NI Method : Snellen - Linear Tonometry Right Left Pressure 38 17 Method : icare Time : 1 : 38 PM Tonometry # 2 Right Left Pressure 36 Method : Applanation Time : 1 : 41 PM Tonometry # 3 Right Left Pressure 35 16 Method : Applanation ( kane ) Time : 3 : 06 PM Pachymetry Right Left Thickness 690 626 Date : DATE Pupils Pupils Light React APD Right PERRL irreg 1 - Left PERRL 3 2 - Visual Fields Right Left Restrictions Partial superior temporal , inferior temporal , superior nasal , inferior nasal deficiencies Extraocular Movement Right Left Result Full Full Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Dilation Both eyes : 1.0 % Mydriacyl @ 2 : 02 PM Slit Lamp and Fundus Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Dermatochalasis - upper lid , Ptosis Ptosis , Dermatochalasis - upper lid Conjunctiva / Sclera Superior nasal conjunctival sutures intact , seidel - Subconjunctival hemorrhage , Injection Cornea mild corneal edema , Punctate epithelial erosions Punctate epithelial erosions Anterior Chamber Deep and quiet Deep and quiet Iris irregular reactive pupil , few vessels visible , patent pi Round and reactive , no NVI Lens Posterior chamber intraocular lens Posterior chamber intraocular lens Vitreous PVD clear Fundus Exam Right Left Disc Normal , no NVD Normal , no NVD C / D Ratio 0.4 0.2 Macula flat , few DBH ERM with wrinkling , [s1] few [e1] intraretinal heme Vessels attenuation attenuation Periphery PRP scars , flat few dbh PRP scars , flat few dbh No annotated images are attached to the encounter .	Other testing : OCT - RNFL : OD : Avg 99 , full wnl OS : borderline STQ and ITQ , Avg 84 , WNL MAC OCT OD : ERM with surface wrinkling , mild IRF OS : ERM , with mild surface wrinkling , no IRF / [s2] SRF [e2] Assessment and Plan : ICD - 9 - CM 1 .	severity	lesion	T13	T8	2260561_note_6253
NonRel	Allergies : Allergies Allergen Reactions • Metformin Diarrhea ROS Positive for : Endocrine ( DM ) , Cardiovascular ( HTN ) , Eyes ( glaucoma ) Negative for : Constitutional , Gastrointestinal , Neurological , Skin , Genitourinary , Musculoskeletal , HENT , Respiratory , Psychiatric , Allergic / Imm , Heme / Lymph Objective : Base Eye Exam Visual Acuity Right Left Dist sc 20 / 150 20 / 30 - 2 Dist ph sc NI Method : Snellen - Linear Tonometry Right Left Pressure 38 17 Method : icare Time : 1 : 38 PM Tonometry # 2 Right Left Pressure 36 Method : Applanation Time : 1 : 41 PM Tonometry # 3 Right Left Pressure 35 16 Method : Applanation ( kane ) Time : 3 : 06 PM Pachymetry Right Left Thickness 690 626 Date : DATE Pupils Pupils Light React APD Right PERRL irreg 1 - Left PERRL 3 2 - Visual Fields Right Left Restrictions Partial superior temporal , inferior temporal , superior nasal , inferior nasal deficiencies Extraocular Movement Right Left Result Full Full Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Dilation Both eyes : 1.0 % Mydriacyl @ 2 : 02 PM Slit Lamp and Fundus Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Dermatochalasis - upper lid , Ptosis Ptosis , Dermatochalasis - upper lid Conjunctiva / Sclera Superior nasal conjunctival sutures intact , seidel - Subconjunctival hemorrhage , Injection Cornea mild corneal edema , Punctate epithelial erosions Punctate epithelial erosions Anterior Chamber Deep and quiet Deep and quiet Iris irregular reactive pupil , few vessels visible , patent pi Round and reactive , no NVI Lens Posterior chamber intraocular lens Posterior chamber intraocular lens Vitreous PVD clear Fundus Exam Right Left Disc Normal , no NVD Normal , no NVD C / D Ratio 0.4 0.2 Macula flat , few DBH ERM with wrinkling , few intraretinal heme Vessels attenuation attenuation Periphery PRP scars , flat [s1] few [e1] dbh PRP scars , flat few dbh No annotated images are attached to the encounter .	Other testing : OCT - RNFL : OD : Avg 99 , full wnl OS : borderline STQ and ITQ , Avg 84 , WNL MAC OCT OD : ERM with surface wrinkling , mild IRF OS : ERM , with mild surface wrinkling , no IRF / [s2] SRF [e2] Assessment and Plan : ICD - 9 - CM 1 .	severity	lesion	T14	T8	2260561_note_6253
NonRel	Allergies : Allergies Allergen Reactions • Metformin Diarrhea ROS Positive for : Endocrine ( DM ) , Cardiovascular ( HTN ) , Eyes ( glaucoma ) Negative for : Constitutional , Gastrointestinal , Neurological , Skin , Genitourinary , Musculoskeletal , HENT , Respiratory , Psychiatric , Allergic / Imm , Heme / Lymph Objective : Base Eye Exam Visual Acuity Right Left Dist sc 20 / 150 20 / 30 - 2 Dist ph sc NI Method : Snellen - Linear Tonometry Right Left Pressure 38 17 Method : icare Time : 1 : 38 PM Tonometry # 2 Right Left Pressure 36 Method : Applanation Time : 1 : 41 PM Tonometry # 3 Right Left Pressure 35 16 Method : Applanation ( kane ) Time : 3 : 06 PM Pachymetry Right Left Thickness 690 626 Date : DATE Pupils Pupils Light React APD Right PERRL irreg 1 - Left PERRL 3 2 - Visual Fields Right Left Restrictions Partial superior temporal , inferior temporal , superior nasal , inferior nasal deficiencies Extraocular Movement Right Left Result Full Full Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Dilation Both eyes : 1.0 % Mydriacyl @ 2 : 02 PM Slit Lamp and Fundus Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Dermatochalasis - upper lid , Ptosis Ptosis , Dermatochalasis - upper lid Conjunctiva / Sclera Superior nasal conjunctival sutures intact , seidel - Subconjunctival hemorrhage , Injection Cornea mild corneal edema , Punctate epithelial erosions Punctate epithelial erosions Anterior Chamber Deep and quiet Deep and quiet Iris irregular reactive pupil , few vessels visible , patent pi Round and reactive , no NVI Lens Posterior chamber intraocular lens Posterior chamber intraocular lens Vitreous PVD clear Fundus Exam Right Left Disc Normal , no NVD Normal , no NVD C / D Ratio 0.4 0.2 Macula flat , few DBH ERM with wrinkling , few intraretinal heme Vessels attenuation attenuation Periphery PRP scars , flat few dbh PRP scars , flat [s1] few [e1] dbh No annotated images are attached to the encounter .	Other testing : OCT - RNFL : OD : Avg 99 , full wnl OS : borderline STQ and ITQ , Avg 84 , WNL MAC OCT OD : ERM with surface wrinkling , mild IRF OS : ERM , with mild surface wrinkling , no IRF / [s2] SRF [e2] Assessment and Plan : ICD - 9 - CM 1 .	severity	lesion	T15	T8	2260561_note_6253
NonRel	Mac OCT [s1] OD [e1] shows atrophy and IRF .	Mac OCT OS shows laser scarring with no [s2] IRF [e2] .	laterality	lesion	T11	T14	note_3955
NonRel	Mac OCT [s1] OS [e1] shows laser scarring with no IRF .	Mac OCT OD shows atrophy and [s2] IRF [e2] .	laterality	lesion	T13	T12	note_3955
NonRel	OCT , Retina - OU - Both Eyes OD : microcystic change only [s1] OS [e1] : CSME nasally Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	[s2] Nonproliferative diabetic retinopathy [e2] of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 Appt req Internal Medicine 362.05 2 .	laterality	lesion	T1	T3	note_1085
NonRel	OCT , Retina - OU - Both Eyes OD : microcystic change only [s1] OS [e1] : CSME nasally Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Nonproliferative diabetic retinopathy of right eye , with [s2] macular edema [e2] , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 Appt req Internal Medicine 362.05 2 .	laterality	lesion	T1	T5	note_1085
NonRel	OCT , Retina - OU - Both Eyes OD : microcystic change only [s1] OS [e1] : CSME nasally Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate [s2] nonproliferative retinopathy [e2] E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 Appt req Internal Medicine 362.05 2 .	laterality	lesion	T1	T7	note_1085
NonRel	Nonproliferative diabetic retinopathy of [s1] right eye [e1] , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 Appt req Internal Medicine 362.05 2 .	OCT , Retina - OU - Both Eyes OD : microcystic change only OS : [s2] CSME [e2] nasally Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T4	T2	note_1085
NonRel	Nonproliferative diabetic retinopathy of [s1] right eye [e1] , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 Appt req Internal Medicine 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 Appt req Internal Medicine 362.05 Mr. Chaffin is a 59 year old male with a 15 year history of diabetes .	laterality	lesion	T4	T9	note_1085
NonRel	Nonproliferative diabetic retinopathy of [s1] right eye [e1] , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 Appt req Internal Medicine 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 Appt req Internal Medicine 362.05 Mr. Chaffin is a 59 year old male with a 15 year history of diabetes .	laterality	lesion	T4	T11	note_1085
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with [s1] moderate [e1] nonproliferative retinopathy E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 Appt req Internal Medicine 362.05 2 .	OCT , Retina - OU - Both Eyes OD : microcystic change only OS : [s2] CSME [e2] nasally Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	severity	lesion	T6	T2	note_1085
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with [s1] moderate [e1] nonproliferative retinopathy E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 Appt req Internal Medicine 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 Appt req Internal Medicine 362.05 Mr. Chaffin is a 59 year old male with a 15 year history of diabetes .	severity	lesion	T6	T9	note_1085
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with [s1] moderate [e1] nonproliferative retinopathy E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 Appt req Internal Medicine 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 Appt req Internal Medicine 362.05 Mr. Chaffin is a 59 year old male with a 15 year history of diabetes .	severity	lesion	T6	T11	note_1085
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 Appt req Internal Medicine 362.05 Mr. Chaffin is a 59 year old male with a 15 year history of diabetes .	[s2] Nonproliferative diabetic retinopathy [e2] of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 Appt req Internal Medicine 362.05 2 .	severity	lesion	T8	T3	note_1085
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 Appt req Internal Medicine 362.05 Mr. Chaffin is a 59 year old male with a 15 year history of diabetes .	Nonproliferative diabetic retinopathy of right eye , with [s2] macular edema [e2] , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 Appt req Internal Medicine 362.05 2 .	severity	lesion	T8	T5	note_1085
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 Appt req Internal Medicine 362.05 Mr. Chaffin is a 59 year old male with a 15 year history of diabetes .	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate [s2] nonproliferative retinopathy [e2] E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 Appt req Internal Medicine 362.05 2 .	severity	lesion	T8	T7	note_1085
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 Appt req Internal Medicine 362.05 Mr. Chaffin is a 59 year old male with a 15 year history of diabetes .	[s2] Nonproliferative diabetic retinopathy [e2] of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 Appt req Internal Medicine 362.05 2 .	laterality	lesion	T10	T3	note_1085
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 Appt req Internal Medicine 362.05 Mr. Chaffin is a 59 year old male with a 15 year history of diabetes .	Nonproliferative diabetic retinopathy of right eye , with [s2] macular edema [e2] , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 Appt req Internal Medicine 362.05 2 .	laterality	lesion	T10	T5	note_1085
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 Appt req Internal Medicine 362.05 Mr. Chaffin is a 59 year old male with a 15 year history of diabetes .	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate [s2] nonproliferative retinopathy [e2] E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 Appt req Internal Medicine 362.05 2 .	laterality	lesion	T10	T7	note_1085
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Retina - [s1] OU [e1] - Both Eyes 362.07 Appt req Internal Medicine 362.05 2 .	OCT , Retina - OU - Both Eyes OD : microcystic change only OS : [s2] CSME [e2] nasally Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T15	T2	note_1085
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Retina - [s1] OU [e1] - Both Eyes 362.07 Appt req Internal Medicine 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 Appt req Internal Medicine 362.05 Mr. Chaffin is a 59 year old male with a 15 year history of diabetes .	laterality	lesion	T15	T9	note_1085
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Retina - [s1] OU [e1] - Both Eyes 362.07 Appt req Internal Medicine 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 Appt req Internal Medicine 362.05 Mr. Chaffin is a 59 year old male with a 15 year history of diabetes .	laterality	lesion	T15	T11	note_1085
NonRel	Pt is Family Medicine physician in Crystal River 1 ) Maculopathy ( w / RPE loss ) - evidence of prior SRF , [s1] mild [e1] RPE attenuation .	Macular atrophy , retinal - Left Eye H35.89 362.51 OCT , Retina - OU - Both Eyes No significant [s2] PMH [e2] , no hx of steroid usage .	severity	lesion	T3	T1	note_5103
NonRel	Pt is Family Medicine physician in Crystal River 1 ) Maculopathy ( w / RPE loss ) - evidence of prior SRF , [s1] mild [e1] RPE attenuation .	Today without [s2] SRF [e2] .	severity	lesion	T3	T4	note_5103
NonRel	Macular atrophy , retinal - Left Eye H35.89 362.51 OCT , Retina - OU - Both Eyes No [s1] significant [e1] PMH , no hx of steroid usage .	Pt is Family Medicine physician in Crystal River 1 ) Maculopathy ( w / RPE loss ) - evidence of prior [s2] SRF [e2] , mild RPE attenuation .	severity	lesion	T5	T2	note_5103
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] associated with type 2 diabetes mellitus E11.3592 250.50 Pan Retinal Photocoagulation - OS - Left Eye 362.02 OPH - OS Intravitreal Injection , Pharmacologic Agent 3 .	[s2] Proliferative diabetic retinopathy [e2] of right eye associated with type 2 diabetes mellitus E11.3591 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 2 .	laterality	lesion	T13	T4	note_7661
NonRel	IDDM , + 81 mg ASA Treatment Hx : IVFA ( 6 / 15 / 17 ) : Active PDR [s1] OD [e1] , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	+ [s2] NVI [e2] .	laterality	lesion	T16	T7	note_7661
NonRel	IDDM , + 81 mg ASA Treatment Hx : IVFA ( 6 / 15 / 17 ) : Active PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR [s1] OU [e1] ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	+ [s2] NVI [e2] .	laterality	lesion	T18	T7	note_7661
NonRel	IDDM , + 81 mg ASA Treatment Hx : IVFA ( 6 / 15 / 17 ) : [s1] Active [e1] PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	+ [s2] NVI [e2] .	severity	lesion	T20	T7	note_7661
NonRel	IDDM , + 81 mg ASA Treatment Hx : IVFA ( 6 / 15 / 17 ) : Active PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - [s1] Active [e1] PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	+ [s2] NVI [e2] .	severity	lesion	T21	T7	note_7661
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	laterality	lesion	T1	T7	note_2433
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	laterality	lesion	T1	T8	note_2433
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with [s2] ciCSME [e2] being treated with IVA OS .	laterality	lesion	T1	T9	note_2433
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	severity	lesion	T2	T7	note_2433
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	severity	lesion	T2	T8	note_2433
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with [s2] ciCSME [e2] being treated with IVA OS .	severity	lesion	T2	T9	note_2433
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	laterality	lesion	T5	T3	note_2433
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	laterality	lesion	T5	T4	note_2433
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	severity	lesion	T6	T3	note_2433
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	severity	lesion	T6	T4	note_2433
NonRel	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA [s1] OS [e1] .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	laterality	lesion	T10	T3	note_2433
NonRel	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA [s1] OS [e1] .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	laterality	lesion	T10	T4	note_2433
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 362.07 2 .	S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 by Dr. Iyer Z98.890 V45.69 IVA OD - 12 / 8 / 17 ( today ) IVA OD - 11 / 2 / 17 IVA OD - 10 / 3 / 17 GDD OS - 7 / 19 / 17 PPV / PVR / Retinectomy / SO OS - 7 / 10 / 17 IVA OS - 7 / 7 / 17 IVA OD - 6 / 30 / 17 PRP OD - 6 / 30 / 17 IVFA ( 6 / 8 / 17 ) : [s2] NVE [e2] , NVD throughout OD with multiple areas of peripheral capillary nonperfusion and enlarged macular FAZ GDD OS - Blake - 5 / 5 / 17 PPV / TRD / PPL / SO OS - Kay / Roseman - week of 4 / 24 / 17 per patient PPV / TRD OS - Kay - 4 / 21 / 17 PRP OU - Kay PRP / IVA OD - 6 / 30 / 17 S / P GDD Tube ( OS ) w / Dr. Blake 7 / 19 / 17 S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 Dr Iyer 1 ) S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 Dr Iyer - patient reports persistent signficant pain but no exam finding to explain this .	laterality	lesion	T2	T4	note_8234
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 362.07 2 .	S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 by Dr. Iyer Z98.890 V45.69 IVA OD - 12 / 8 / 17 ( today ) IVA OD - 11 / 2 / 17 IVA OD - 10 / 3 / 17 GDD OS - 7 / 19 / 17 PPV / PVR / Retinectomy / SO OS - 7 / 10 / 17 IVA OS - 7 / 7 / 17 IVA OD - 6 / 30 / 17 PRP OD - 6 / 30 / 17 IVFA ( 6 / 8 / 17 ) : NVE , [s2] NVD [e2] throughout OD with multiple areas of peripheral capillary nonperfusion and enlarged macular FAZ GDD OS - Blake - 5 / 5 / 17 PPV / TRD / PPL / SO OS - Kay / Roseman - week of 4 / 24 / 17 per patient PPV / TRD OS - Kay - 4 / 21 / 17 PRP OU - Kay PRP / IVA OD - 6 / 30 / 17 S / P GDD Tube ( OS ) w / Dr. Blake 7 / 19 / 17 S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 Dr Iyer 1 ) S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 Dr Iyer - patient reports persistent signficant pain but no exam finding to explain this .	laterality	lesion	T2	T5	note_8234
NonRel	S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 by Dr. Iyer Z98.890 V45.69 IVA OD - 12 / 8 / 17 ( today ) IVA OD - 11 / 2 / 17 IVA OD - 10 / 3 / 17 GDD OS - 7 / 19 / 17 PPV / PVR / Retinectomy / SO OS - 7 / 10 / 17 IVA OS - 7 / 7 / 17 IVA OD - 6 / 30 / 17 PRP OD - 6 / 30 / 17 IVFA ( 6 / 8 / 17 ) : NVE , NVD throughout [s1] OD [e1] with multiple areas of peripheral capillary nonperfusion and enlarged macular FAZ GDD OS - Blake - 5 / 5 / 17 PPV / TRD / PPL / SO OS - Kay / Roseman - week of 4 / 24 / 17 per patient PPV / TRD OS - Kay - 4 / 21 / 17 PRP OU - Kay PRP / IVA OD - 6 / 30 / 17 S / P GDD Tube ( OS ) w / Dr. Blake 7 / 19 / 17 S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 Dr Iyer 1 ) S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 Dr Iyer - patient reports persistent signficant pain but no exam finding to explain this .	Type 1 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema E10.3511 250.51 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 362.07 2 .	laterality	lesion	T6	T1	note_8234
NonRel	S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 by Dr. Iyer Z98.890 V45.69 IVA OD - 12 / 8 / 17 ( today ) IVA OD - 11 / 2 / 17 IVA OD - 10 / 3 / 17 GDD OS - 7 / 19 / 17 PPV / PVR / Retinectomy / SO OS - 7 / 10 / 17 IVA OS - 7 / 7 / 17 IVA OD - 6 / 30 / 17 PRP OD - 6 / 30 / 17 IVFA ( 6 / 8 / 17 ) : NVE , NVD throughout [s1] OD [e1] with multiple areas of peripheral capillary nonperfusion and enlarged macular FAZ GDD OS - Blake - 5 / 5 / 17 PPV / TRD / PPL / SO OS - Kay / Roseman - week of 4 / 24 / 17 per patient PPV / TRD OS - Kay - 4 / 21 / 17 PRP OU - Kay PRP / IVA OD - 6 / 30 / 17 S / P GDD Tube ( OS ) w / Dr. Blake 7 / 19 / 17 S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 Dr Iyer 1 ) S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 Dr Iyer - patient reports persistent signficant pain but no exam finding to explain this .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] E10.3511 250.51 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 362.07 2 .	laterality	lesion	T6	T3	note_8234
NonRel	S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 by Dr. Iyer Z98.890 V45.69 IVA OD - 12 / 8 / 17 ( today ) IVA OD - 11 / 2 / 17 IVA OD - 10 / 3 / 17 GDD OS - 7 / 19 / 17 PPV / PVR / Retinectomy / SO OS - 7 / 10 / 17 IVA OS - 7 / 7 / 17 IVA OD - 6 / 30 / 17 PRP OD - 6 / 30 / 17 IVFA ( 6 / 8 / 17 ) : NVE , NVD throughout [s1] OD [e1] with multiple areas of peripheral capillary nonperfusion and enlarged macular FAZ GDD OS - Blake - 5 / 5 / 17 PPV / TRD / PPL / SO OS - Kay / Roseman - week of 4 / 24 / 17 per patient PPV / TRD OS - Kay - 4 / 21 / 17 PRP OU - Kay PRP / IVA OD - 6 / 30 / 17 S / P GDD Tube ( OS ) w / Dr. Blake 7 / 19 / 17 S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 Dr Iyer 1 ) S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 Dr Iyer - patient reports persistent signficant pain but no exam finding to explain this .	Unsure if functional - IOP 10 today on no IOP meds - Total hyphema but good blebs inferiorly 2 ) IDDM - Active [s2] PDR [e2] OU OD - Active PDR s / p PRP . + ME on exam .	laterality	lesion	T6	T8	note_8234
NonRel	S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 by Dr. Iyer Z98.890 V45.69 IVA OD - 12 / 8 / 17 ( today ) IVA OD - 11 / 2 / 17 IVA OD - 10 / 3 / 17 GDD OS - 7 / 19 / 17 PPV / PVR / Retinectomy / SO OS - 7 / 10 / 17 IVA OS - 7 / 7 / 17 IVA OD - 6 / 30 / 17 PRP OD - 6 / 30 / 17 IVFA ( 6 / 8 / 17 ) : NVE , NVD throughout [s1] OD [e1] with multiple areas of peripheral capillary nonperfusion and enlarged macular FAZ GDD OS - Blake - 5 / 5 / 17 PPV / TRD / PPL / SO OS - Kay / Roseman - week of 4 / 24 / 17 per patient PPV / TRD OS - Kay - 4 / 21 / 17 PRP OU - Kay PRP / IVA OD - 6 / 30 / 17 S / P GDD Tube ( OS ) w / Dr. Blake 7 / 19 / 17 S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 Dr Iyer 1 ) S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 Dr Iyer - patient reports persistent signficant pain but no exam finding to explain this .	Unsure if functional - IOP 10 today on no IOP meds - Total hyphema but good blebs inferiorly 2 ) IDDM - Active PDR OU OD - Active [s2] PDR [e2] s / p PRP . + ME on exam .	laterality	lesion	T6	T12	note_8234
NonRel	S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 by Dr. Iyer Z98.890 V45.69 IVA OD - 12 / 8 / 17 ( today ) IVA OD - 11 / 2 / 17 IVA OD - 10 / 3 / 17 GDD OS - 7 / 19 / 17 PPV / PVR / Retinectomy / SO OS - 7 / 10 / 17 IVA OS - 7 / 7 / 17 IVA OD - 6 / 30 / 17 PRP OD - 6 / 30 / 17 IVFA ( 6 / 8 / 17 ) : NVE , NVD throughout [s1] OD [e1] with multiple areas of peripheral capillary nonperfusion and enlarged macular FAZ GDD OS - Blake - 5 / 5 / 17 PPV / TRD / PPL / SO OS - Kay / Roseman - week of 4 / 24 / 17 per patient PPV / TRD OS - Kay - 4 / 21 / 17 PRP OU - Kay PRP / IVA OD - 6 / 30 / 17 S / P GDD Tube ( OS ) w / Dr. Blake 7 / 19 / 17 S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 Dr Iyer 1 ) S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 Dr Iyer - patient reports persistent signficant pain but no exam finding to explain this .	Unsure if functional - IOP 10 today on no IOP meds - Total hyphema but good blebs inferiorly 2 ) IDDM - Active PDR OU OD - Active PDR s / p PRP . + [s2] ME [e2] on exam .	laterality	lesion	T6	T13	note_8234
NonRel	Unsure if functional - IOP 10 today on no IOP meds - Total hyphema but good blebs inferiorly 2 ) IDDM - [s1] Active [e1] PDR OU OD - Active PDR s / p PRP . + ME on exam .	S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 by Dr. Iyer Z98.890 V45.69 IVA OD - 12 / 8 / 17 ( today ) IVA OD - 11 / 2 / 17 IVA OD - 10 / 3 / 17 GDD OS - 7 / 19 / 17 PPV / PVR / Retinectomy / SO OS - 7 / 10 / 17 IVA OS - 7 / 7 / 17 IVA OD - 6 / 30 / 17 PRP OD - 6 / 30 / 17 IVFA ( 6 / 8 / 17 ) : [s2] NVE [e2] , NVD throughout OD with multiple areas of peripheral capillary nonperfusion and enlarged macular FAZ GDD OS - Blake - 5 / 5 / 17 PPV / TRD / PPL / SO OS - Kay / Roseman - week of 4 / 24 / 17 per patient PPV / TRD OS - Kay - 4 / 21 / 17 PRP OU - Kay PRP / IVA OD - 6 / 30 / 17 S / P GDD Tube ( OS ) w / Dr. Blake 7 / 19 / 17 S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 Dr Iyer 1 ) S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 Dr Iyer - patient reports persistent signficant pain but no exam finding to explain this .	severity	lesion	T7	T4	note_8234
NonRel	Unsure if functional - IOP 10 today on no IOP meds - Total hyphema but good blebs inferiorly 2 ) IDDM - [s1] Active [e1] PDR OU OD - Active PDR s / p PRP . + ME on exam .	S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 by Dr. Iyer Z98.890 V45.69 IVA OD - 12 / 8 / 17 ( today ) IVA OD - 11 / 2 / 17 IVA OD - 10 / 3 / 17 GDD OS - 7 / 19 / 17 PPV / PVR / Retinectomy / SO OS - 7 / 10 / 17 IVA OS - 7 / 7 / 17 IVA OD - 6 / 30 / 17 PRP OD - 6 / 30 / 17 IVFA ( 6 / 8 / 17 ) : NVE , [s2] NVD [e2] throughout OD with multiple areas of peripheral capillary nonperfusion and enlarged macular FAZ GDD OS - Blake - 5 / 5 / 17 PPV / TRD / PPL / SO OS - Kay / Roseman - week of 4 / 24 / 17 per patient PPV / TRD OS - Kay - 4 / 21 / 17 PRP OU - Kay PRP / IVA OD - 6 / 30 / 17 S / P GDD Tube ( OS ) w / Dr. Blake 7 / 19 / 17 S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 Dr Iyer 1 ) S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 Dr Iyer - patient reports persistent signficant pain but no exam finding to explain this .	severity	lesion	T7	T5	note_8234
NonRel	Unsure if functional - IOP 10 today on no IOP meds - Total hyphema but good blebs inferiorly 2 ) IDDM - Active PDR [s1] OU [e1] OD - Active PDR s / p PRP . + ME on exam .	S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 by Dr. Iyer Z98.890 V45.69 IVA OD - 12 / 8 / 17 ( today ) IVA OD - 11 / 2 / 17 IVA OD - 10 / 3 / 17 GDD OS - 7 / 19 / 17 PPV / PVR / Retinectomy / SO OS - 7 / 10 / 17 IVA OS - 7 / 7 / 17 IVA OD - 6 / 30 / 17 PRP OD - 6 / 30 / 17 IVFA ( 6 / 8 / 17 ) : [s2] NVE [e2] , NVD throughout OD with multiple areas of peripheral capillary nonperfusion and enlarged macular FAZ GDD OS - Blake - 5 / 5 / 17 PPV / TRD / PPL / SO OS - Kay / Roseman - week of 4 / 24 / 17 per patient PPV / TRD OS - Kay - 4 / 21 / 17 PRP OU - Kay PRP / IVA OD - 6 / 30 / 17 S / P GDD Tube ( OS ) w / Dr. Blake 7 / 19 / 17 S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 Dr Iyer 1 ) S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 Dr Iyer - patient reports persistent signficant pain but no exam finding to explain this .	laterality	lesion	T9	T4	note_8234
NonRel	Unsure if functional - IOP 10 today on no IOP meds - Total hyphema but good blebs inferiorly 2 ) IDDM - Active PDR [s1] OU [e1] OD - Active PDR s / p PRP . + ME on exam .	S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 by Dr. Iyer Z98.890 V45.69 IVA OD - 12 / 8 / 17 ( today ) IVA OD - 11 / 2 / 17 IVA OD - 10 / 3 / 17 GDD OS - 7 / 19 / 17 PPV / PVR / Retinectomy / SO OS - 7 / 10 / 17 IVA OS - 7 / 7 / 17 IVA OD - 6 / 30 / 17 PRP OD - 6 / 30 / 17 IVFA ( 6 / 8 / 17 ) : NVE , [s2] NVD [e2] throughout OD with multiple areas of peripheral capillary nonperfusion and enlarged macular FAZ GDD OS - Blake - 5 / 5 / 17 PPV / TRD / PPL / SO OS - Kay / Roseman - week of 4 / 24 / 17 per patient PPV / TRD OS - Kay - 4 / 21 / 17 PRP OU - Kay PRP / IVA OD - 6 / 30 / 17 S / P GDD Tube ( OS ) w / Dr. Blake 7 / 19 / 17 S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 Dr Iyer 1 ) S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 Dr Iyer - patient reports persistent signficant pain but no exam finding to explain this .	laterality	lesion	T9	T5	note_8234
NonRel	Unsure if functional - IOP 10 today on no IOP meds - Total hyphema but good blebs inferiorly 2 ) IDDM - Active PDR OU [s1] OD [e1] - Active PDR s / p PRP . + ME on exam .	S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 by Dr. Iyer Z98.890 V45.69 IVA OD - 12 / 8 / 17 ( today ) IVA OD - 11 / 2 / 17 IVA OD - 10 / 3 / 17 GDD OS - 7 / 19 / 17 PPV / PVR / Retinectomy / SO OS - 7 / 10 / 17 IVA OS - 7 / 7 / 17 IVA OD - 6 / 30 / 17 PRP OD - 6 / 30 / 17 IVFA ( 6 / 8 / 17 ) : [s2] NVE [e2] , NVD throughout OD with multiple areas of peripheral capillary nonperfusion and enlarged macular FAZ GDD OS - Blake - 5 / 5 / 17 PPV / TRD / PPL / SO OS - Kay / Roseman - week of 4 / 24 / 17 per patient PPV / TRD OS - Kay - 4 / 21 / 17 PRP OU - Kay PRP / IVA OD - 6 / 30 / 17 S / P GDD Tube ( OS ) w / Dr. Blake 7 / 19 / 17 S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 Dr Iyer 1 ) S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 Dr Iyer - patient reports persistent signficant pain but no exam finding to explain this .	laterality	lesion	T10	T4	note_8234
NonRel	Unsure if functional - IOP 10 today on no IOP meds - Total hyphema but good blebs inferiorly 2 ) IDDM - Active PDR OU [s1] OD [e1] - Active PDR s / p PRP . + ME on exam .	S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 by Dr. Iyer Z98.890 V45.69 IVA OD - 12 / 8 / 17 ( today ) IVA OD - 11 / 2 / 17 IVA OD - 10 / 3 / 17 GDD OS - 7 / 19 / 17 PPV / PVR / Retinectomy / SO OS - 7 / 10 / 17 IVA OS - 7 / 7 / 17 IVA OD - 6 / 30 / 17 PRP OD - 6 / 30 / 17 IVFA ( 6 / 8 / 17 ) : NVE , [s2] NVD [e2] throughout OD with multiple areas of peripheral capillary nonperfusion and enlarged macular FAZ GDD OS - Blake - 5 / 5 / 17 PPV / TRD / PPL / SO OS - Kay / Roseman - week of 4 / 24 / 17 per patient PPV / TRD OS - Kay - 4 / 21 / 17 PRP OU - Kay PRP / IVA OD - 6 / 30 / 17 S / P GDD Tube ( OS ) w / Dr. Blake 7 / 19 / 17 S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 Dr Iyer 1 ) S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 Dr Iyer - patient reports persistent signficant pain but no exam finding to explain this .	laterality	lesion	T10	T5	note_8234
NonRel	Unsure if functional - IOP 10 today on no IOP meds - Total hyphema but good blebs inferiorly 2 ) IDDM - Active PDR OU OD - [s1] Active [e1] PDR s / p PRP . + ME on exam .	S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 by Dr. Iyer Z98.890 V45.69 IVA OD - 12 / 8 / 17 ( today ) IVA OD - 11 / 2 / 17 IVA OD - 10 / 3 / 17 GDD OS - 7 / 19 / 17 PPV / PVR / Retinectomy / SO OS - 7 / 10 / 17 IVA OS - 7 / 7 / 17 IVA OD - 6 / 30 / 17 PRP OD - 6 / 30 / 17 IVFA ( 6 / 8 / 17 ) : [s2] NVE [e2] , NVD throughout OD with multiple areas of peripheral capillary nonperfusion and enlarged macular FAZ GDD OS - Blake - 5 / 5 / 17 PPV / TRD / PPL / SO OS - Kay / Roseman - week of 4 / 24 / 17 per patient PPV / TRD OS - Kay - 4 / 21 / 17 PRP OU - Kay PRP / IVA OD - 6 / 30 / 17 S / P GDD Tube ( OS ) w / Dr. Blake 7 / 19 / 17 S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 Dr Iyer 1 ) S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 Dr Iyer - patient reports persistent signficant pain but no exam finding to explain this .	severity	lesion	T11	T4	note_8234
NonRel	Unsure if functional - IOP 10 today on no IOP meds - Total hyphema but good blebs inferiorly 2 ) IDDM - Active PDR OU OD - [s1] Active [e1] PDR s / p PRP . + ME on exam .	S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 by Dr. Iyer Z98.890 V45.69 IVA OD - 12 / 8 / 17 ( today ) IVA OD - 11 / 2 / 17 IVA OD - 10 / 3 / 17 GDD OS - 7 / 19 / 17 PPV / PVR / Retinectomy / SO OS - 7 / 10 / 17 IVA OS - 7 / 7 / 17 IVA OD - 6 / 30 / 17 PRP OD - 6 / 30 / 17 IVFA ( 6 / 8 / 17 ) : NVE , [s2] NVD [e2] throughout OD with multiple areas of peripheral capillary nonperfusion and enlarged macular FAZ GDD OS - Blake - 5 / 5 / 17 PPV / TRD / PPL / SO OS - Kay / Roseman - week of 4 / 24 / 17 per patient PPV / TRD OS - Kay - 4 / 21 / 17 PRP OU - Kay PRP / IVA OD - 6 / 30 / 17 S / P GDD Tube ( OS ) w / Dr. Blake 7 / 19 / 17 S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 Dr Iyer 1 ) S / p PPV / ROSO / AC washout ( OS ) 11 / 30 / 17 Dr Iyer - patient reports persistent signficant pain but no exam finding to explain this .	severity	lesion	T11	T5	note_8234
NonRel	Nonproliferative diabetic retinopathy of [s1] right eye [e1] , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OS - DATE ( today ) IVA OU - Kay ( DATE ) Intravitreal injection OU ( with Dr. NAME , April 2017 ) 1 .	laterality	lesion	T19	T8	460233_note_1091
NonRel	Nonproliferative diabetic retinopathy of [s1] right eye [e1] , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OS - DATE ( today ) IVA OU - Kay ( DATE ) Intravitreal injection OU ( with Dr. NAME , April 2017 ) 1 .	laterality	lesion	T19	T9	460233_note_1091
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with [s1] moderate [e1] nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OS - DATE ( today ) IVA OU - Kay ( DATE ) Intravitreal injection OU ( with Dr. NAME , April 2017 ) 1 .	severity	lesion	T20	T8	460233_note_1091
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with [s1] moderate [e1] nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OS - DATE ( today ) IVA OU - Kay ( DATE ) Intravitreal injection OU ( with Dr. NAME , April 2017 ) 1 .	severity	lesion	T20	T9	460233_note_1091
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OS - DATE ( today ) IVA OU - Kay ( DATE ) Intravitreal injection OU ( with Dr. NAME , April 2017 ) 1 .	[s2] Nonproliferative diabetic retinopathy [e2] of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	severity	lesion	T21	T5	460233_note_1091
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OS - DATE ( today ) IVA OU - Kay ( DATE ) Intravitreal injection OU ( with Dr. NAME , April 2017 ) 1 .	Nonproliferative diabetic retinopathy of right eye , with [s2] macular edema [e2] , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	severity	lesion	T21	T6	460233_note_1091
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OS - DATE ( today ) IVA OU - Kay ( DATE ) Intravitreal injection OU ( with Dr. NAME , April 2017 ) 1 .	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate [s2] nonproliferative retinopathy [e2] E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	severity	lesion	T21	T7	460233_note_1091
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OS - DATE ( today ) IVA OU - Kay ( DATE ) Intravitreal injection OU ( with Dr. NAME , April 2017 ) 1 .	[s2] Nonproliferative diabetic retinopathy [e2] of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	laterality	lesion	T22	T5	460233_note_1091
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OS - DATE ( today ) IVA OU - Kay ( DATE ) Intravitreal injection OU ( with Dr. NAME , April 2017 ) 1 .	Nonproliferative diabetic retinopathy of right eye , with [s2] macular edema [e2] , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	laterality	lesion	T22	T6	460233_note_1091
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OS - DATE ( today ) IVA OU - Kay ( DATE ) Intravitreal injection OU ( with Dr. NAME , April 2017 ) 1 .	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate [s2] nonproliferative retinopathy [e2] E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	laterality	lesion	T22	T7	460233_note_1091
NonRel	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD [s1] Moderate [e1] NPDR with mild DME OS Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	Plan IVA OS today OCT : interval increase in [s2] ME [e2] NAME , MD participated in the care of this patient .	severity	lesion	T23	T28	460233_note_1091
NonRel	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with [s1] mild [e1] DME OS Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	Plan IVA OS today OCT : interval increase in [s2] ME [e2] NAME , MD participated in the care of this patient .	severity	lesion	T24	T28	460233_note_1091
NonRel	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with mild DME OS [s1] Moderate [e1] NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	Plan IVA OS today OCT : interval increase in [s2] ME [e2] NAME , MD participated in the care of this patient .	severity	lesion	T25	T28	460233_note_1091
NonRel	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) [s1] OD [e1] Moderate NPDR with mild DME OS Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	Plan IVA OS today OCT : interval increase in [s2] ME [e2] NAME , MD participated in the care of this patient .	laterality	lesion	T26	T28	460233_note_1091
NonRel	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with mild DME [s1] OS [e1] Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	Plan IVA OS today OCT : interval increase in [s2] ME [e2] NAME , MD participated in the care of this patient .	laterality	lesion	T27	T28	460233_note_1091
NonRel	Central retinal vein occlusion of left eye H34.8122 362.35 OCT , Posterior Segment - OU - Both Eyes OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OU - 10 / 12 / 18 IVA OU - 8 / 31 / 18 IVA OU - 7 / 13 / 18 Missed appointments IVA OU - 4 / 20 / 18 IVA OU - 3 / 16 / 18 IVA OU - 1 / 26 / 18 IVA OU - 12 / 22 / 17 ( missed appointments 3 months ) IVA OU - 9 / 29 / 17 ( missed appointments 3 months ) IVA OU - 6 / 30 / 2017 IVA OU - 5 / 19 / 2017 IVA OU - 4 / 14 / 2017 IVA OU - 3 / 10 / 2017 IVFA - 2 / 7 / 2017 - diffuse vascular leakage , mas , NVE nasally [s1] OS [e1] Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( 2 / 2018 ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with Macular Edema OU Lack of regular treatments due to patient visit ( 3 month gap ) .	Persistent [s2] ME [e2] OU sig today .	laterality	lesion	T6	T9	note_2372
NonRel	Central retinal vein occlusion of left eye H34.8122 362.35 OCT , Posterior Segment - OU - Both Eyes OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OU - 10 / 12 / 18 IVA OU - 8 / 31 / 18 IVA OU - 7 / 13 / 18 Missed appointments IVA OU - 4 / 20 / 18 IVA OU - 3 / 16 / 18 IVA OU - 1 / 26 / 18 IVA OU - 12 / 22 / 17 ( missed appointments 3 months ) IVA OU - 9 / 29 / 17 ( missed appointments 3 months ) IVA OU - 6 / 30 / 2017 IVA OU - 5 / 19 / 2017 IVA OU - 4 / 14 / 2017 IVA OU - 3 / 10 / 2017 IVFA - 2 / 7 / 2017 - diffuse vascular leakage , mas , NVE nasally OS Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( 2 / 2018 ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with Macular Edema [s1] OU [e1] Lack of regular treatments due to patient visit ( 3 month gap ) .	Persistent [s2] ME [e2] OU sig today .	laterality	lesion	T8	T9	note_2372
NonRel	Persistent ME [s1] OU [e1] sig today .	Central retinal vein occlusion of left eye H34.8122 362.35 OCT , Posterior Segment - OU - Both Eyes OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OU - 10 / 12 / 18 IVA OU - 8 / 31 / 18 IVA OU - 7 / 13 / 18 Missed appointments IVA OU - 4 / 20 / 18 IVA OU - 3 / 16 / 18 IVA OU - 1 / 26 / 18 IVA OU - 12 / 22 / 17 ( missed appointments 3 months ) IVA OU - 9 / 29 / 17 ( missed appointments 3 months ) IVA OU - 6 / 30 / 2017 IVA OU - 5 / 19 / 2017 IVA OU - 4 / 14 / 2017 IVA OU - 3 / 10 / 2017 IVFA - 2 / 7 / 2017 - diffuse vascular leakage , mas , [s2] NVE [e2] nasally OS Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( 2 / 2018 ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with Macular Edema OU Lack of regular treatments due to patient visit ( 3 month gap ) .	laterality	lesion	T10	T5	note_2372
NonRel	Persistent ME [s1] OU [e1] sig today .	Central retinal vein occlusion of left eye H34.8122 362.35 OCT , Posterior Segment - OU - Both Eyes OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OU - 10 / 12 / 18 IVA OU - 8 / 31 / 18 IVA OU - 7 / 13 / 18 Missed appointments IVA OU - 4 / 20 / 18 IVA OU - 3 / 16 / 18 IVA OU - 1 / 26 / 18 IVA OU - 12 / 22 / 17 ( missed appointments 3 months ) IVA OU - 9 / 29 / 17 ( missed appointments 3 months ) IVA OU - 6 / 30 / 2017 IVA OU - 5 / 19 / 2017 IVA OU - 4 / 14 / 2017 IVA OU - 3 / 10 / 2017 IVFA - 2 / 7 / 2017 - diffuse vascular leakage , mas , NVE nasally OS Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( 2 / 2018 ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with [s2] Macular Edema [e2] OU Lack of regular treatments due to patient visit ( 3 month gap ) .	laterality	lesion	T10	T7	note_2372
NonRel	Persistent ME [s1] OU [e1] sig today .	Central retinal vein occlusion of left eye H34.8122 362.35 OCT , Posterior Segment - OU - Both Eyes OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OU - 10 / 12 / 18 IVA OU - 8 / 31 / 18 IVA OU - 7 / 13 / 18 Missed appointments IVA OU - 4 / 20 / 18 IVA OU - 3 / 16 / 18 IVA OU - 1 / 26 / 18 IVA OU - 12 / 22 / 17 ( missed appointments 3 months ) IVA OU - 9 / 29 / 17 ( missed appointments 3 months ) IVA OU - 6 / 30 / 2017 IVA OU - 5 / 19 / 2017 IVA OU - 4 / 14 / 2017 IVA OU - 3 / 10 / 2017 IVFA - 2 / 7 / 2017 - diffuse vascular leakage , [s2] mas [e2] , NVE nasally OS Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( 2 / 2018 ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with Macular Edema OU Lack of regular treatments due to patient visit ( 3 month gap ) .	laterality	lesion	T10	T15	note_2372
NonRel	[s1] Persistent [e1] ME OU sig today .	Central retinal vein occlusion of left eye H34.8122 362.35 OCT , Posterior Segment - OU - Both Eyes OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OU - 10 / 12 / 18 IVA OU - 8 / 31 / 18 IVA OU - 7 / 13 / 18 Missed appointments IVA OU - 4 / 20 / 18 IVA OU - 3 / 16 / 18 IVA OU - 1 / 26 / 18 IVA OU - 12 / 22 / 17 ( missed appointments 3 months ) IVA OU - 9 / 29 / 17 ( missed appointments 3 months ) IVA OU - 6 / 30 / 2017 IVA OU - 5 / 19 / 2017 IVA OU - 4 / 14 / 2017 IVA OU - 3 / 10 / 2017 IVFA - 2 / 7 / 2017 - diffuse vascular leakage , mas , [s2] NVE [e2] nasally OS Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( 2 / 2018 ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with Macular Edema OU Lack of regular treatments due to patient visit ( 3 month gap ) .	severity	lesion	T11	T5	note_2372
NonRel	[s1] Persistent [e1] ME OU sig today .	Central retinal vein occlusion of left eye H34.8122 362.35 OCT , Posterior Segment - OU - Both Eyes OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OU - 10 / 12 / 18 IVA OU - 8 / 31 / 18 IVA OU - 7 / 13 / 18 Missed appointments IVA OU - 4 / 20 / 18 IVA OU - 3 / 16 / 18 IVA OU - 1 / 26 / 18 IVA OU - 12 / 22 / 17 ( missed appointments 3 months ) IVA OU - 9 / 29 / 17 ( missed appointments 3 months ) IVA OU - 6 / 30 / 2017 IVA OU - 5 / 19 / 2017 IVA OU - 4 / 14 / 2017 IVA OU - 3 / 10 / 2017 IVFA - 2 / 7 / 2017 - diffuse vascular leakage , mas , NVE nasally OS Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( 2 / 2018 ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with [s2] Macular Edema [e2] OU Lack of regular treatments due to patient visit ( 3 month gap ) .	severity	lesion	T11	T7	note_2372
NonRel	[s1] Persistent [e1] ME OU sig today .	Central retinal vein occlusion of left eye H34.8122 362.35 OCT , Posterior Segment - OU - Both Eyes OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OU - 10 / 12 / 18 IVA OU - 8 / 31 / 18 IVA OU - 7 / 13 / 18 Missed appointments IVA OU - 4 / 20 / 18 IVA OU - 3 / 16 / 18 IVA OU - 1 / 26 / 18 IVA OU - 12 / 22 / 17 ( missed appointments 3 months ) IVA OU - 9 / 29 / 17 ( missed appointments 3 months ) IVA OU - 6 / 30 / 2017 IVA OU - 5 / 19 / 2017 IVA OU - 4 / 14 / 2017 IVA OU - 3 / 10 / 2017 IVFA - 2 / 7 / 2017 - diffuse vascular leakage , [s2] mas [e2] , NVE nasally OS Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( 2 / 2018 ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with Macular Edema OU Lack of regular treatments due to patient visit ( 3 month gap ) .	severity	lesion	T11	T15	note_2372
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 362.02 2 .	[s2] Vitreous hemorrhage [e2] , left H43.12 379.23 Treatment Hx : PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] .	laterality	lesion	T2	T4	note_5880
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 362.02 2 .	Vitreous hemorrhage , left H43.12 379.23 Treatment Hx : PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active [s2] PDR [e2] OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] .	laterality	lesion	T2	T6	note_5880
NonRel	Vitreous hemorrhage , [s1] left [e1] H43.12 379.23 Treatment Hx : PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] .	[s2] Proliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 362.02 2 .	laterality	lesion	T5	T1	note_5880
NonRel	Vitreous hemorrhage , [s1] left [e1] H43.12 379.23 Treatment Hx : PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] .	Proliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3513 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 362.02 2 .	laterality	lesion	T5	T3	note_5880
NonRel	Vitreous hemorrhage , [s1] left [e1] H43.12 379.23 Treatment Hx : PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] .	Severe [s2] PDR [e2] OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T5	T10	note_5880
NonRel	Vitreous hemorrhage , [s1] left [e1] H43.12 379.23 Treatment Hx : PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] .	Severe PDR OU , [s2] VH [e2] OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T5	T11	note_5880
NonRel	Vitreous hemorrhage , left H43.12 379.23 Treatment Hx : PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR [s1] OD [e1] , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] .	[s2] Proliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 362.02 2 .	laterality	lesion	T7	T1	note_5880
NonRel	Vitreous hemorrhage , left H43.12 379.23 Treatment Hx : PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR [s1] OD [e1] , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] .	Proliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3513 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 362.02 2 .	laterality	lesion	T7	T3	note_5880
NonRel	Vitreous hemorrhage , left H43.12 379.23 Treatment Hx : PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR [s1] OD [e1] , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] .	Severe [s2] PDR [e2] OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T7	T10	note_5880
NonRel	Vitreous hemorrhage , left H43.12 379.23 Treatment Hx : PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR [s1] OD [e1] , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] .	Severe PDR OU , [s2] VH [e2] OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T7	T11	note_5880
NonRel	[s1] Severe [e1] PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	[s2] Vitreous hemorrhage [e2] , left H43.12 379.23 Treatment Hx : PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] .	severity	lesion	T8	T4	note_5880
NonRel	[s1] Severe [e1] PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Vitreous hemorrhage , left H43.12 379.23 Treatment Hx : PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active [s2] PDR [e2] OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] .	severity	lesion	T8	T6	note_5880
NonRel	Severe PDR [s1] OU [e1] , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	[s2] Vitreous hemorrhage [e2] , left H43.12 379.23 Treatment Hx : PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] .	laterality	lesion	T9	T4	note_5880
NonRel	Severe PDR [s1] OU [e1] , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Vitreous hemorrhage , left H43.12 379.23 Treatment Hx : PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active [s2] PDR [e2] OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] .	laterality	lesion	T9	T6	note_5880
NonRel	Severe PDR OU , VH [s1] OS [e1] OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	[s2] Vitreous hemorrhage [e2] , left H43.12 379.23 Treatment Hx : PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] .	laterality	lesion	T12	T4	note_5880
NonRel	Severe PDR OU , VH [s1] OS [e1] OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Vitreous hemorrhage , left H43.12 379.23 Treatment Hx : PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active [s2] PDR [e2] OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] .	laterality	lesion	T12	T6	note_5880
NonRel	Vitreous hemorrhage , left H43.12 379.23 Treatment Hx : PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - [s1] Active [e1] PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] .	[s2] Proliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 362.02 2 .	severity	lesion	T13	T1	note_5880
NonRel	Vitreous hemorrhage , left H43.12 379.23 Treatment Hx : PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - [s1] Active [e1] PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] .	Proliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3513 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 362.02 2 .	severity	lesion	T13	T3	note_5880
NonRel	Vitreous hemorrhage , left H43.12 379.23 Treatment Hx : PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - [s1] Active [e1] PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] .	Severe [s2] PDR [e2] OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	severity	lesion	T13	T10	note_5880
NonRel	Vitreous hemorrhage , left H43.12 379.23 Treatment Hx : PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - [s1] Active [e1] PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] .	Severe PDR OU , [s2] VH [e2] OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	severity	lesion	T13	T11	note_5880
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No [s2] NVI [e2] or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T11	T3	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or [s2] NVD [e2] or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T11	T4	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or [s2] NVA [e2] Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T11	T5	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without [s2] Edema [e2] , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T11	T6	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms [s2] NVE [e2] temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T11	T7	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No [s2] Neovascularization [e2] .	laterality	lesion	T11	T8	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	[s2] Proliferative diabetic retinopathy [e2] of right eye associated with type 1 diabetes mellitus E10.3591 250.51 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OU - Both Eyes 2 .	laterality	lesion	T11	T15	39541_note_166
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : [s2] PDR [e2] OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	severity	lesion	T13	T1	39541_note_166
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New [s2] NVE [e2] temporally .	severity	lesion	T13	T2	39541_note_166
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	Mild [s2] NPDR [e2] now .	severity	lesion	T13	T9	39541_note_166
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	[s2] Nonproliferative diabetic retinopathy [e2] associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	severity	lesion	T13	T17	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	No [s2] NVI [e2] or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T12	T3	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	No NVI or [s2] NVD [e2] or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T12	T4	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	No NVI or NVD or [s2] NVA [e2] Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T12	T5	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	No NVI or NVD or NVA Mac OCT without [s2] Edema [e2] , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T12	T6	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms [s2] NVE [e2] temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T12	T7	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No [s2] Neovascularization [e2] .	severity	lesion	T12	T8	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	[s2] Proliferative diabetic retinopathy [e2] of right eye associated with type 1 diabetes mellitus E10.3591 250.51 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OU - Both Eyes 2 .	severity	lesion	T12	T15	39541_note_166
NonRel	[s1] Mild [e1] NPDR now .	No [s2] NVI [e2] or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T14	T3	39541_note_166
NonRel	[s1] Mild [e1] NPDR now .	No NVI or [s2] NVD [e2] or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T14	T4	39541_note_166
NonRel	[s1] Mild [e1] NPDR now .	No NVI or NVD or [s2] NVA [e2] Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T14	T5	39541_note_166
NonRel	[s1] Mild [e1] NPDR now .	No NVI or NVD or NVA Mac OCT without [s2] Edema [e2] , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T14	T6	39541_note_166
NonRel	[s1] Mild [e1] NPDR now .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms [s2] NVE [e2] temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T14	T7	39541_note_166
NonRel	[s1] Mild [e1] NPDR now .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No [s2] Neovascularization [e2] .	severity	lesion	T14	T8	39541_note_166
NonRel	[s1] Mild [e1] NPDR now .	Mac OCT without [s2] Edema [e2] , mild ERM , no posterior hyloid IVFA with shallow ITQ tractional RD with leakage Plan : Tomorrow 11 : 45 AM PRP right eye focusing in temporal mid - periphery and temporal far periphery PRP left eye mid periphery x 360 NAME , MD participated in the care of this patient .	severity	lesion	T14	T10	39541_note_166
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] associated with type 1 diabetes mellitus E10.3591 250.51 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OU - Both Eyes 2 .	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : [s2] PDR [e2] OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	laterality	lesion	T16	T1	39541_note_166
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] associated with type 1 diabetes mellitus E10.3591 250.51 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OU - Both Eyes 2 .	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New [s2] NVE [e2] temporally .	laterality	lesion	T16	T2	39541_note_166
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] associated with type 1 diabetes mellitus E10.3591 250.51 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OU - Both Eyes 2 .	[s2] Nonproliferative diabetic retinopathy [e2] associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	laterality	lesion	T16	T17	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No [s2] NVI [e2] or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T18	T3	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or [s2] NVD [e2] or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T18	T4	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or [s2] NVA [e2] Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T18	T5	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without [s2] Edema [e2] , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T18	T6	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms [s2] NVE [e2] temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T18	T7	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No [s2] Neovascularization [e2] .	laterality	lesion	T18	T8	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	[s2] Proliferative diabetic retinopathy [e2] of right eye associated with type 1 diabetes mellitus E10.3591 250.51 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OU - Both Eyes 2 .	laterality	lesion	T18	T15	39541_note_166
NonRel	Central retinal vein occlusion of left eye H34.8122 362.35 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OU - 4 / 14 / 2017 ( today ) IVA OU - 3 / 10 / 2017 IVFA - 2 / 7 / 2017 - diffuse vascular leakage , mas , NVE nasally [s1] OS [e1] Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Pending Protein S - Pending PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Pending RPR - Non - reactive FTA - abs - Pending Ace - Negative Lysozyme - Pending A1c - 13.6 Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU - Past Medical History of DMII , HTN , Hyperlipidemia - IVFA showed diffuse vascular leakage OU .	Original exam shows likely [s2] NVI [e2] OU that resolved with IVA .	laterality	lesion	T6	T7	note_2321
NonRel	Original exam shows likely NVI [s1] OU [e1] that resolved with IVA .	Central retinal vein occlusion of left eye H34.8122 362.35 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OU - 4 / 14 / 2017 ( today ) IVA OU - 3 / 10 / 2017 IVFA - 2 / 7 / 2017 - diffuse vascular leakage , [s2] mas [e2] , NVE nasally OS Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Pending Protein S - Pending PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Pending RPR - Non - reactive FTA - abs - Pending Ace - Negative Lysozyme - Pending A1c - 13.6 Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU - Past Medical History of DMII , HTN , Hyperlipidemia - IVFA showed diffuse vascular leakage OU .	laterality	lesion	T8	T4	note_2321
NonRel	Original exam shows likely NVI [s1] OU [e1] that resolved with IVA .	Central retinal vein occlusion of left eye H34.8122 362.35 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OU - 4 / 14 / 2017 ( today ) IVA OU - 3 / 10 / 2017 IVFA - 2 / 7 / 2017 - diffuse vascular leakage , mas , [s2] NVE [e2] nasally OS Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Pending Protein S - Pending PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Pending RPR - Non - reactive FTA - abs - Pending Ace - Negative Lysozyme - Pending A1c - 13.6 Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU - Past Medical History of DMII , HTN , Hyperlipidemia - IVFA showed diffuse vascular leakage OU .	laterality	lesion	T8	T5	note_2321
NonRel	Original exam shows likely NVI [s1] OU [e1] that resolved with IVA .	No [s2] NVA [e2] on exam .	laterality	lesion	T8	T9	note_2321
NonRel	2 ) LD [s1] OS [e1] - temporally with PVD present but given the hx of HST + SRF OD will likely consider laser prophylaxis OS at later date .	Today will enhance ( still with [s2] VH [e2] ) and recheck in 6 weeks .	laterality	lesion	T5	T6	994046_note_1743
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	laterality	lesion	T12	T3	1162635_note_2414
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	laterality	lesion	T12	T4	1162635_note_2414
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for [s2] non proliferative diabetic retinopathy [e2] eval OU 1 ) T2DM - on insulin .	laterality	lesion	T12	T5	1162635_note_2414
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	severity	lesion	T13	T3	1162635_note_2414
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	severity	lesion	T13	T4	1162635_note_2414
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for [s2] non proliferative diabetic retinopathy [e2] eval OU 1 ) T2DM - on insulin .	severity	lesion	T13	T5	1162635_note_2414
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T14	T1	1162635_note_2414
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T14	T2	1162635_note_2414
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Last A1C 6.2 ( DATE ) OD - Severe [s2] NPDR [e2] without ME .	laterality	lesion	T14	T23	1162635_note_2414
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Last A1C 6.2 ( DATE ) OD - Severe NPDR without [s2] ME [e2] .	laterality	lesion	T14	T24	1162635_note_2414
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	severity	lesion	T15	T1	1162635_note_2414
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	severity	lesion	T15	T2	1162635_note_2414
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Last A1C 6.2 ( DATE ) OD - Severe [s2] NPDR [e2] without ME .	severity	lesion	T15	T23	1162635_note_2414
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Last A1C 6.2 ( DATE ) OD - Severe NPDR without [s2] ME [e2] .	severity	lesion	T15	T24	1162635_note_2414
NonRel	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval [s1] OU [e1] 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T16	T1	1162635_note_2414
NonRel	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval [s1] OU [e1] 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T16	T2	1162635_note_2414
NonRel	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval [s1] OU [e1] 1 ) T2DM - on insulin .	Last A1C 6.2 ( DATE ) OD - Severe [s2] NPDR [e2] without ME .	laterality	lesion	T16	T23	1162635_note_2414
NonRel	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval [s1] OU [e1] 1 ) T2DM - on insulin .	Last A1C 6.2 ( DATE ) OD - Severe NPDR without [s2] ME [e2] .	laterality	lesion	T16	T24	1162635_note_2414
NonRel	OS - [s1] Severe [e1] NPDR with ME .	Last A1C 6.2 ( DATE ) OD - Severe [s2] NPDR [e2] without ME .	severity	lesion	T17	T23	1162635_note_2414
NonRel	OS - [s1] Severe [e1] NPDR with ME .	Last A1C 6.2 ( DATE ) OD - Severe NPDR without [s2] ME [e2] .	severity	lesion	T17	T24	1162635_note_2414
NonRel	[s1] OS [e1] - Severe NPDR with ME .	Last A1C 6.2 ( DATE ) OD - Severe [s2] NPDR [e2] without ME .	laterality	lesion	T18	T23	1162635_note_2414
NonRel	[s1] OS [e1] - Severe NPDR with ME .	Last A1C 6.2 ( DATE ) OD - Severe NPDR without [s2] ME [e2] .	laterality	lesion	T18	T24	1162635_note_2414
NonRel	Last A1C 6.2 ( DATE ) OD - [s1] Severe [e1] NPDR without ME .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	severity	lesion	T22	T3	1162635_note_2414
NonRel	Last A1C 6.2 ( DATE ) OD - [s1] Severe [e1] NPDR without ME .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	severity	lesion	T22	T4	1162635_note_2414
NonRel	Last A1C 6.2 ( DATE ) OD - [s1] Severe [e1] NPDR without ME .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for [s2] non proliferative diabetic retinopathy [e2] eval OU 1 ) T2DM - on insulin .	severity	lesion	T22	T5	1162635_note_2414
NonRel	Last A1C 6.2 ( DATE ) OD - [s1] Severe [e1] NPDR without ME .	OS - Severe [s2] NPDR [e2] with ME .	severity	lesion	T22	T6	1162635_note_2414
NonRel	Last A1C 6.2 ( DATE ) OD - [s1] Severe [e1] NPDR without ME .	OS - Severe NPDR with [s2] ME [e2] .	severity	lesion	T22	T7	1162635_note_2414
NonRel	Last A1C 6.2 ( DATE ) [s1] OD [e1] - Severe NPDR without ME .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	laterality	lesion	T25	T3	1162635_note_2414
NonRel	Last A1C 6.2 ( DATE ) [s1] OD [e1] - Severe NPDR without ME .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	laterality	lesion	T25	T4	1162635_note_2414
NonRel	Last A1C 6.2 ( DATE ) [s1] OD [e1] - Severe NPDR without ME .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for [s2] non proliferative diabetic retinopathy [e2] eval OU 1 ) T2DM - on insulin .	laterality	lesion	T25	T5	1162635_note_2414
NonRel	Last A1C 6.2 ( DATE ) [s1] OD [e1] - Severe NPDR without ME .	OS - Severe [s2] NPDR [e2] with ME .	laterality	lesion	T25	T6	1162635_note_2414
NonRel	Last A1C 6.2 ( DATE ) [s1] OD [e1] - Severe NPDR without ME .	OS - Severe NPDR with [s2] ME [e2] .	laterality	lesion	T25	T7	1162635_note_2414
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] associated with type 2 diabetes mellitus E11.3591 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye associated with type 2 diabetes mellitus E11.3592 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 3 .	laterality	lesion	T2	T3	note_7667
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] associated with type 2 diabetes mellitus E11.3592 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 3 .	[s2] Proliferative diabetic retinopathy [e2] of right eye associated with type 2 diabetes mellitus E11.3591 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 2 .	laterality	lesion	T4	T1	note_7667
NonRel	IDDM , + 81 mg ASA Treatment Hx : PRP OD - 8 / 4 / 17 ( inadequate ) IVA OU - 6 / 30 / 17 PRP OS - 6 / 30 / 17 IVFA ( 6 / 15 / 17 ) : [s1] Active [e1] PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	+ [s2] NVI [e2] , no NV in angle .	severity	lesion	T5	T11	note_7667
NonRel	IDDM , + 81 mg ASA Treatment Hx : PRP OD - 8 / 4 / 17 ( inadequate ) IVA OU - 6 / 30 / 17 PRP OS - 6 / 30 / 17 IVFA ( 6 / 15 / 17 ) : Active PDR [s1] OD [e1] , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	+ [s2] NVI [e2] , no NV in angle .	laterality	lesion	T7	T11	note_7667
NonRel	IDDM , + 81 mg ASA Treatment Hx : PRP OD - 8 / 4 / 17 ( inadequate ) IVA OU - 6 / 30 / 17 PRP OS - 6 / 30 / 17 IVFA ( 6 / 15 / 17 ) : Active PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - [s1] Active [e1] PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	+ [s2] NVI [e2] , no NV in angle .	severity	lesion	T8	T11	note_7667
NonRel	IDDM , + 81 mg ASA Treatment Hx : PRP OD - 8 / 4 / 17 ( inadequate ) IVA OU - 6 / 30 / 17 PRP OS - 6 / 30 / 17 IVFA ( 6 / 15 / 17 ) : Active PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR [s1] OU [e1] ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	+ [s2] NVI [e2] , no NV in angle .	laterality	lesion	T10	T11	note_7667
NonRel	[s1] OS [e1] - no NVI on exam today , angle open on gonio .	Hx of + [s2] NVD [e2] , + NVE , vast ischemia nasally s / p IVA and PRP .	laterality	lesion	T12	T14	note_7667
NonRel	[s1] OS [e1] - no NVI on exam today , angle open on gonio .	Hx of + NVD , + [s2] NVE [e2] , vast ischemia nasally s / p IVA and PRP .	laterality	lesion	T12	T15	note_7667
NonRel	Nonproliferative diabetic retinopathy of [s1] right eye [e1] , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 3 .	laterality	lesion	T2	T7	note_1942
NonRel	Nonproliferative diabetic retinopathy of [s1] right eye [e1] , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 3 .	laterality	lesion	T2	T9	note_1942
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with [s1] moderate [e1] nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 3 .	severity	lesion	T4	T7	note_1942
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with [s1] moderate [e1] nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 3 .	severity	lesion	T4	T9	note_1942
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 3 .	[s2] Nonproliferative diabetic retinopathy [e2] of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T6	T1	note_1942
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 3 .	Nonproliferative diabetic retinopathy of right eye , with [s2] macular edema [e2] , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T6	T3	note_1942
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 3 .	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate [s2] nonproliferative retinopathy [e2] E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T6	T5	note_1942
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 3 .	Type 2 diabetes mellitus with [s2] macular edema [e2] E11.311 250.50 362.07 362.01 4 .	severity	lesion	T6	T10	note_1942
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 3 .	[s2] Nonproliferative diabetic retinopathy [e2] of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T8	T1	note_1942
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 3 .	Nonproliferative diabetic retinopathy of right eye , with [s2] macular edema [e2] , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T8	T3	note_1942
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 3 .	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate [s2] nonproliferative retinopathy [e2] E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T8	T5	note_1942
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 3 .	Type 2 diabetes mellitus with [s2] macular edema [e2] E11.311 250.50 362.07 362.01 4 .	laterality	lesion	T8	T10	note_1942
NonRel	Type 2 diabetes mellitus with [s1] both eyes [e1] affected by moderate nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3393 250.50 Z79.4 362.05 V58.67 Treatment History IVL OS - 10 / 27 / 17 ( today ) IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) DM II - Seeing endocrinology outside UF .	Type 2 diabetes mellitus with [s2] macular edema [e2] E11.311 250.50 362.07 362.01 4 .	laterality	lesion	T11	T10	note_1942
NonRel	Type 2 diabetes mellitus with [s1] both eyes [e1] affected by moderate nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3393 250.50 Z79.4 362.05 V58.67 Treatment History IVL OS - 10 / 27 / 17 ( today ) IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) DM II - Seeing endocrinology outside UF .	Per patient , A1C now aroun 7 % D - Moderate [s2] NPDR [e2] , H / O PRP and focal laser .	laterality	lesion	T11	T20	note_1942
NonRel	Type 2 diabetes mellitus with both eyes affected by [s1] moderate [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3393 250.50 Z79.4 362.05 V58.67 Treatment History IVL OS - 10 / 27 / 17 ( today ) IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) DM II - Seeing endocrinology outside UF .	Type 2 diabetes mellitus with [s2] macular edema [e2] E11.311 250.50 362.07 362.01 4 .	severity	lesion	T12	T10	note_1942
NonRel	Type 2 diabetes mellitus with both eyes affected by [s1] moderate [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3393 250.50 Z79.4 362.05 V58.67 Treatment History IVL OS - 10 / 27 / 17 ( today ) IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) DM II - Seeing endocrinology outside UF .	Per patient , A1C now aroun 7 % D - Moderate [s2] NPDR [e2] , H / O PRP and focal laser .	severity	lesion	T12	T20	note_1942
NonRel	Type 2 diabetes mellitus with both eyes affected by moderate nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3393 250.50 Z79.4 362.05 V58.67 Treatment History IVL OS - 10 / 27 / 17 ( today ) IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - [s1] OD [e1] : Moderate NPDR OU 1 ) DM II - Seeing endocrinology outside UF .	Type 2 diabetes mellitus with [s2] macular edema [e2] E11.311 250.50 362.07 362.01 4 .	laterality	lesion	T15	T10	note_1942
NonRel	Type 2 diabetes mellitus with both eyes affected by moderate nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3393 250.50 Z79.4 362.05 V58.67 Treatment History IVL OS - 10 / 27 / 17 ( today ) IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - [s1] OD [e1] : Moderate NPDR OU 1 ) DM II - Seeing endocrinology outside UF .	Per patient , A1C now aroun 7 % D - Moderate [s2] NPDR [e2] , H / O PRP and focal laser .	laterality	lesion	T15	T20	note_1942
NonRel	Type 2 diabetes mellitus with both eyes affected by moderate nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3393 250.50 Z79.4 362.05 V58.67 Treatment History IVL OS - 10 / 27 / 17 ( today ) IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : [s1] Moderate [e1] NPDR OU 1 ) DM II - Seeing endocrinology outside UF .	Type 2 diabetes mellitus with [s2] macular edema [e2] E11.311 250.50 362.07 362.01 4 .	severity	lesion	T16	T10	note_1942
NonRel	Type 2 diabetes mellitus with both eyes affected by moderate nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3393 250.50 Z79.4 362.05 V58.67 Treatment History IVL OS - 10 / 27 / 17 ( today ) IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : [s1] Moderate [e1] NPDR OU 1 ) DM II - Seeing endocrinology outside UF .	Per patient , A1C now aroun 7 % D - Moderate [s2] NPDR [e2] , H / O PRP and focal laser .	severity	lesion	T16	T20	note_1942
NonRel	Per patient , A1C now aroun 7 % D - [s1] Moderate [e1] NPDR , H / O PRP and focal laser .	Type 2 diabetes mellitus with both eyes affected by moderate [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin E11.3393 250.50 Z79.4 362.05 V58.67 Treatment History IVL OS - 10 / 27 / 17 ( today ) IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) DM II - Seeing endocrinology outside UF .	severity	lesion	T19	T13	note_1942
NonRel	Per patient , A1C now aroun 7 % D - [s1] Moderate [e1] NPDR , H / O PRP and focal laser .	Type 2 diabetes mellitus with both eyes affected by moderate nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin E11.3393 250.50 Z79.4 362.05 V58.67 Treatment History IVL OS - 10 / 27 / 17 ( today ) IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) DM II - Seeing endocrinology outside UF .	severity	lesion	T19	T14	note_1942
NonRel	Per patient , A1C now aroun 7 % D - [s1] Moderate [e1] NPDR , H / O PRP and focal laser .	Type 2 diabetes mellitus with both eyes affected by moderate nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3393 250.50 Z79.4 362.05 V58.67 Treatment History IVL OS - 10 / 27 / 17 ( today ) IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate [s2] NPDR [e2] OU 1 ) DM II - Seeing endocrinology outside UF .	severity	lesion	T19	T17	note_1942
NonRel	Per patient , A1C now aroun 7 % D - [s1] Moderate [e1] NPDR , H / O PRP and focal laser .	OS - Moderate [s2] NPDR [e2] , H / O Scant PRP and focal laser .	severity	lesion	T19	T23	note_1942
NonRel	[s1] OS [e1] - Moderate NPDR , H / O Scant PRP and focal laser .	Per patient , A1C now aroun 7 % D - Moderate [s2] NPDR [e2] , H / O PRP and focal laser .	laterality	lesion	T21	T20	note_1942
NonRel	[s1] OS [e1] - Moderate NPDR , H / O Scant PRP and focal laser .	[s2] CSME [e2] that is refractory to treatment with IVA and refractory to treatment with intravitreal injection of Lucentis as well .	laterality	lesion	T21	T24	note_1942
NonRel	OS - [s1] Moderate [e1] NPDR , H / O Scant PRP and focal laser .	Per patient , A1C now aroun 7 % D - Moderate [s2] NPDR [e2] , H / O PRP and focal laser .	severity	lesion	T22	T20	note_1942
NonRel	OS - [s1] Moderate [e1] NPDR , H / O Scant PRP and focal laser .	[s2] CSME [e2] that is refractory to treatment with IVA and refractory to treatment with intravitreal injection of Lucentis as well .	severity	lesion	T22	T24	note_1942
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 3 .	laterality	lesion	T25	T7	note_1942
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 3 .	laterality	lesion	T25	T9	note_1942
NonRel	CME ( cystoid macular edema ) , [s1] left [e1] - Left Eye 362.53 4 .	[s2] Neovascularization of optic disc [e2] of left eye - Left Eye 362.16 5 .	laterality	lesion	T2	T4	note_5937
NonRel	Neovascularization of optic disc of [s1] left eye [e1] - Left Eye 362.16 5 .	[s2] CME [e2] ( cystoid macular edema ) , left - Left Eye 362.53 4 .	laterality	lesion	T5	T1	note_5937
NonRel	Neovascularization of optic disc of [s1] left eye [e1] - Left Eye 362.16 5 .	CME ( [s2] cystoid macular edema [e2] ) , left - Left Eye 362.53 4 .	laterality	lesion	T5	T3	note_5937
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 1 diabetes mellitus E10.3513 250.51 OCT , Retina - OU - Both Eyes 362.07 362.02 Treatment Hx : PPV / TRD OS - 12 / 27 / 17 IVA OS - 12 / 22 / 17 ( preop ) IVFA ( 9 / 26 / 17 ) - Active PDR OS PPV x 2 / SO OD - 2015 / 2016 ( Outside UF ) IVA OD x 3 1 ) IDDM - Hx of PDR OU OD - s / p PPV x 2 and now with dense cataract with no view to the posterior segment .	AC shallow , no [s2] NVI [e2] today .	laterality	lesion	T2	T9	note_1830
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus E10.3513 250.51 OCT , Retina - OU - Both Eyes 362.07 362.02 Treatment Hx : PPV / TRD OS - 12 / 27 / 17 IVA OS - 12 / 22 / 17 ( preop ) IVFA ( 9 / 26 / 17 ) - [s1] Active [e1] PDR OS PPV x 2 / SO OD - 2015 / 2016 ( Outside UF ) IVA OD x 3 1 ) IDDM - Hx of PDR OU OD - s / p PPV x 2 and now with dense cataract with no view to the posterior segment .	AC shallow , no [s2] NVI [e2] today .	severity	lesion	T4	T9	note_1830
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus E10.3513 250.51 OCT , Retina - OU - Both Eyes 362.07 362.02 Treatment Hx : PPV / TRD OS - 12 / 27 / 17 IVA OS - 12 / 22 / 17 ( preop ) IVFA ( 9 / 26 / 17 ) - Active PDR [s1] OS [e1] PPV x 2 / SO OD - 2015 / 2016 ( Outside UF ) IVA OD x 3 1 ) IDDM - Hx of PDR OU OD - s / p PPV x 2 and now with dense cataract with no view to the posterior segment .	AC shallow , no [s2] NVI [e2] today .	laterality	lesion	T6	T9	note_1830
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus E10.3513 250.51 OCT , Retina - OU - Both Eyes 362.07 362.02 Treatment Hx : PPV / TRD OS - 12 / 27 / 17 IVA OS - 12 / 22 / 17 ( preop ) IVFA ( 9 / 26 / 17 ) - Active PDR OS PPV x 2 / SO OD - 2015 / 2016 ( Outside UF ) IVA OD x 3 1 ) IDDM - Hx of PDR [s1] OU [e1] OD - s / p PPV x 2 and now with dense cataract with no view to the posterior segment .	AC shallow , no [s2] NVI [e2] today .	laterality	lesion	T8	T9	note_1830
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 Appt req Opthalmology 362.07 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	Central retinal vein occlusion , left eye , with [s2] macular edema [e2] H34.8120 362.35 Appt req Opthalmology 362.83 3 .	severity	lesion	T1	T6	note_1069
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 Appt req Opthalmology 362.07 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	Central retinal vein occlusion , left eye , with [s2] macular edema [e2] H34.8120 362.35 Appt req Opthalmology 362.83 3 .	laterality	lesion	T3	T6	note_1069
NonRel	Central retinal vein occlusion , [s1] left eye [e1] , with macular edema H34.8120 362.35 Appt req Opthalmology 362.83 3 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 Appt req Opthalmology 362.07 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	laterality	lesion	T5	T2	note_1069
NonRel	Central retinal vein occlusion , [s1] left eye [e1] , with macular edema H34.8120 362.35 Appt req Opthalmology 362.83 3 .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3311 250.50 Appt req Opthalmology 362.07 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	laterality	lesion	T5	T4	note_1069
NonRel	Central retinal vein occlusion , [s1] left eye [e1] , with macular edema H34.8120 362.35 Appt req Opthalmology 362.83 3 .	Anterior subcapsular polar cataract , nonsenile H26.9 366.01 Appt req Opthalmology Attending Note : Treatment History IVA OD - 8 / 22 / 17 IVFA ( 3 / 9 / 2017 ) - Moderate [s2] NPDR [e2] OD , Ischemic CRVO OS 1 ) IDDM [ Type 2 , Duration 12 years , A1c 10.2 ] OD - Moderate NDPR with CSME .	laterality	lesion	T5	T8	note_1069
NonRel	Central retinal vein occlusion , [s1] left eye [e1] , with macular edema H34.8120 362.35 Appt req Opthalmology 362.83 3 .	Anterior subcapsular polar cataract , nonsenile H26.9 366.01 Appt req Opthalmology Attending Note : Treatment History IVA OD - 8 / 22 / 17 IVFA ( 3 / 9 / 2017 ) - Moderate NPDR OD , Ischemic CRVO OS 1 ) IDDM [ Type 2 , Duration 12 years , A1c 10.2 ] OD - Moderate [s2] NDPR [e2] with CSME .	laterality	lesion	T5	T12	note_1069
NonRel	Central retinal vein occlusion , [s1] left eye [e1] , with macular edema H34.8120 362.35 Appt req Opthalmology 362.83 3 .	Anterior subcapsular polar cataract , nonsenile H26.9 366.01 Appt req Opthalmology Attending Note : Treatment History IVA OD - 8 / 22 / 17 IVFA ( 3 / 9 / 2017 ) - Moderate NPDR OD , Ischemic CRVO OS 1 ) IDDM [ Type 2 , Duration 12 years , A1c 10.2 ] OD - Moderate NDPR with [s2] CSME [e2] .	laterality	lesion	T5	T13	note_1069
NonRel	Anterior subcapsular polar cataract , nonsenile H26.9 366.01 Appt req Opthalmology Attending Note : Treatment History IVA OD - 8 / 22 / 17 IVFA ( 3 / 9 / 2017 ) - [s1] Moderate [e1] NPDR OD , Ischemic CRVO OS 1 ) IDDM [ Type 2 , Duration 12 years , A1c 10.2 ] OD - Moderate NDPR with CSME .	Central retinal vein occlusion , left eye , with [s2] macular edema [e2] H34.8120 362.35 Appt req Opthalmology 362.83 3 .	severity	lesion	T7	T6	note_1069
NonRel	Anterior subcapsular polar cataract , nonsenile H26.9 366.01 Appt req Opthalmology Attending Note : Treatment History IVA OD - 8 / 22 / 17 IVFA ( 3 / 9 / 2017 ) - [s1] Moderate [e1] NPDR OD , Ischemic CRVO OS 1 ) IDDM [ Type 2 , Duration 12 years , A1c 10.2 ] OD - Moderate NDPR with CSME .	No [s2] NVE [e2] .	severity	lesion	T7	T14	note_1069
NonRel	Anterior subcapsular polar cataract , nonsenile H26.9 366.01 Appt req Opthalmology Attending Note : Treatment History IVA OD - 8 / 22 / 17 IVFA ( 3 / 9 / 2017 ) - Moderate NPDR [s1] OD [e1] , Ischemic CRVO OS 1 ) IDDM [ Type 2 , Duration 12 years , A1c 10.2 ] OD - Moderate NDPR with CSME .	Central retinal vein occlusion , left eye , with [s2] macular edema [e2] H34.8120 362.35 Appt req Opthalmology 362.83 3 .	laterality	lesion	T9	T6	note_1069
NonRel	Anterior subcapsular polar cataract , nonsenile H26.9 366.01 Appt req Opthalmology Attending Note : Treatment History IVA OD - 8 / 22 / 17 IVFA ( 3 / 9 / 2017 ) - Moderate NPDR [s1] OD [e1] , Ischemic CRVO OS 1 ) IDDM [ Type 2 , Duration 12 years , A1c 10.2 ] OD - Moderate NDPR with CSME .	No [s2] NVE [e2] .	laterality	lesion	T9	T14	note_1069
NonRel	Anterior subcapsular polar cataract , nonsenile H26.9 366.01 Appt req Opthalmology Attending Note : Treatment History IVA OD - 8 / 22 / 17 IVFA ( 3 / 9 / 2017 ) - Moderate NPDR OD , Ischemic CRVO OS 1 ) IDDM [ Type 2 , Duration 12 years , A1c 10.2 ] [s1] OD [e1] - Moderate NDPR with CSME .	Central retinal vein occlusion , left eye , with [s2] macular edema [e2] H34.8120 362.35 Appt req Opthalmology 362.83 3 .	laterality	lesion	T10	T6	note_1069
NonRel	Anterior subcapsular polar cataract , nonsenile H26.9 366.01 Appt req Opthalmology Attending Note : Treatment History IVA OD - 8 / 22 / 17 IVFA ( 3 / 9 / 2017 ) - Moderate NPDR OD , Ischemic CRVO OS 1 ) IDDM [ Type 2 , Duration 12 years , A1c 10.2 ] [s1] OD [e1] - Moderate NDPR with CSME .	No [s2] NVE [e2] .	laterality	lesion	T10	T14	note_1069
NonRel	Anterior subcapsular polar cataract , nonsenile H26.9 366.01 Appt req Opthalmology Attending Note : Treatment History IVA OD - 8 / 22 / 17 IVFA ( 3 / 9 / 2017 ) - Moderate NPDR OD , Ischemic CRVO OS 1 ) IDDM [ Type 2 , Duration 12 years , A1c 10.2 ] OD - [s1] Moderate [e1] NDPR with CSME .	Central retinal vein occlusion , left eye , with [s2] macular edema [e2] H34.8120 362.35 Appt req Opthalmology 362.83 3 .	severity	lesion	T11	T6	note_1069
NonRel	Anterior subcapsular polar cataract , nonsenile H26.9 366.01 Appt req Opthalmology Attending Note : Treatment History IVA OD - 8 / 22 / 17 IVFA ( 3 / 9 / 2017 ) - Moderate NPDR OD , Ischemic CRVO OS 1 ) IDDM [ Type 2 , Duration 12 years , A1c 10.2 ] OD - [s1] Moderate [e1] NDPR with CSME .	No [s2] NVE [e2] .	severity	lesion	T11	T14	note_1069
NonRel	OS - Unable to grade due to CRVO . 2 ) CRVO [s1] OS [e1] ( Ischemic with ME ) - Onset 2007 but with subsequent event .	[s2] ME [e2] resolved on furosemide .	laterality	lesion	T20	T16	note_1069
NonRel	Vitreous hemorrhage , [s1] right [e1] H43.11 379.23 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 6 .	[s2] Proliferative diabetic retinopathy [e2] of right eye determined by examination associated with type 2 diabetes mellitus E11.3591 250.50 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 362.02 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 Treatment Hx : IVFA ( DATE ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - Active PDR .	laterality	lesion	T8	T4	2660331_note_8739
NonRel	Vitreous hemorrhage , [s1] right [e1] H43.11 379.23 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 6 .	Proliferative diabetic retinopathy of right eye determined by examination associated with type 2 diabetes mellitus E11.3591 250.50 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 362.02 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 Treatment Hx : IVFA ( DATE ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of [s2] PDR [e2] OU OD - Active PDR .	laterality	lesion	T8	T14	2660331_note_8739
NonRel	Vitreous hemorrhage , [s1] right [e1] H43.11 379.23 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 6 .	Proliferative diabetic retinopathy of right eye determined by examination associated with type 2 diabetes mellitus E11.3591 250.50 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 362.02 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 Treatment Hx : IVFA ( DATE ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - Active [s2] PDR [e2] .	laterality	lesion	T8	T15	2660331_note_8739
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] determined by examination associated with type 2 diabetes mellitus E11.3591 250.50 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 362.02 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 Treatment Hx : IVFA ( DATE ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - Active PDR .	[s2] Vitreous hemorrhage [e2] , right H43.11 379.23 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 6 .	laterality	lesion	T9	T3	2660331_note_8739
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] determined by examination associated with type 2 diabetes mellitus E11.3591 250.50 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 362.02 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 Treatment Hx : IVFA ( DATE ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - Active PDR .	[s2] VH [e2] with SHH for duration of one month .	laterality	lesion	T9	T5	2660331_note_8739
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] determined by examination associated with type 2 diabetes mellitus E11.3591 250.50 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 362.02 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 Treatment Hx : IVFA ( DATE ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - Active PDR .	VH with [s2] SHH [e2] for duration of one month .	laterality	lesion	T9	T19	2660331_note_8739
NonRel	Proliferative diabetic retinopathy of right eye determined by examination associated with type 2 diabetes mellitus E11.3591 250.50 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 362.02 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 Treatment Hx : IVFA ( DATE ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - [s1] Active [e1] PDR .	[s2] Vitreous hemorrhage [e2] , right H43.11 379.23 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 6 .	severity	lesion	T16	T3	2660331_note_8739
NonRel	Proliferative diabetic retinopathy of right eye determined by examination associated with type 2 diabetes mellitus E11.3591 250.50 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 362.02 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 Treatment Hx : IVFA ( DATE ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - [s1] Active [e1] PDR .	[s2] VH [e2] with SHH for duration of one month .	severity	lesion	T16	T5	2660331_note_8739
NonRel	Proliferative diabetic retinopathy of right eye determined by examination associated with type 2 diabetes mellitus E11.3591 250.50 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 362.02 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 Treatment Hx : IVFA ( DATE ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - [s1] Active [e1] PDR .	VH with [s2] SHH [e2] for duration of one month .	severity	lesion	T16	T19	2660331_note_8739
NonRel	Proliferative diabetic retinopathy of right eye determined by examination associated with type 2 diabetes mellitus E11.3591 250.50 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 362.02 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 Treatment Hx : IVFA ( DATE ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR [s1] OU [e1] OD - Active PDR .	[s2] Vitreous hemorrhage [e2] , right H43.11 379.23 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 6 .	laterality	lesion	T17	T3	2660331_note_8739
NonRel	Proliferative diabetic retinopathy of right eye determined by examination associated with type 2 diabetes mellitus E11.3591 250.50 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 362.02 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 Treatment Hx : IVFA ( DATE ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR [s1] OU [e1] OD - Active PDR .	[s2] VH [e2] with SHH for duration of one month .	laterality	lesion	T17	T5	2660331_note_8739
NonRel	Proliferative diabetic retinopathy of right eye determined by examination associated with type 2 diabetes mellitus E11.3591 250.50 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 362.02 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 Treatment Hx : IVFA ( DATE ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR [s1] OU [e1] OD - Active PDR .	VH with [s2] SHH [e2] for duration of one month .	laterality	lesion	T17	T19	2660331_note_8739
NonRel	Proliferative diabetic retinopathy of right eye determined by examination associated with type 2 diabetes mellitus E11.3591 250.50 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 362.02 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 Treatment Hx : IVFA ( DATE ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU [s1] OD [e1] - Active PDR .	[s2] Vitreous hemorrhage [e2] , right H43.11 379.23 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 6 .	laterality	lesion	T18	T3	2660331_note_8739
NonRel	Proliferative diabetic retinopathy of right eye determined by examination associated with type 2 diabetes mellitus E11.3591 250.50 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 362.02 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 Treatment Hx : IVFA ( DATE ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU [s1] OD [e1] - Active PDR .	[s2] VH [e2] with SHH for duration of one month .	laterality	lesion	T18	T5	2660331_note_8739
NonRel	Proliferative diabetic retinopathy of right eye determined by examination associated with type 2 diabetes mellitus E11.3591 250.50 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 362.02 Surgical Case Request : VITRECTOMY PARS PLANA W / ENDOLASER PANRETINAL PHOTOCOAG - DX 250.50 , 362.02 , 379.23 Treatment Hx : IVFA ( DATE ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU [s1] OD [e1] - Active PDR .	VH with [s2] SHH [e2] for duration of one month .	laterality	lesion	T18	T19	2660331_note_8739
NonRel	OS : Diffuse [s1] CSME [e1] Fluorescein Angiography - OU - Both Eyes OD : Moderate NPDR , Mild peripheral non - perfusion .	DFE / OCT OU OCT , Posterior Segment - OU - Both Eyes OD : CSME Temporal and superotemporal to the [s2] fovea [e2] .	lesion	eye_part	T13	T28	note_5696
NonRel	OS : Diffuse CSME Fluorescein Angiography - OU - Both Eyes OD : Moderate [s1] NPDR [e1] , Mild peripheral non - perfusion .	DFE / OCT OU OCT , Posterior Segment - OU - Both Eyes OD : CSME Temporal and superotemporal to the [s2] fovea [e2] .	lesion	eye_part	T14	T28	note_5696
NonRel	Nonproliferative diabetic retinopathy of [s1] right eye [e1] , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.05 Mr. Crawford is re - referred for diabetic eye exam .	laterality	lesion	T16	T4	note_5696
NonRel	Nonproliferative diabetic retinopathy of [s1] right eye [e1] , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.05 Mr. Crawford is re - referred for diabetic eye exam .	laterality	lesion	T16	T5	note_5696
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with [s1] moderate [e1] nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.05 Mr. Crawford is re - referred for diabetic eye exam .	severity	lesion	T17	T4	note_5696
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with [s1] moderate [e1] nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.05 Mr. Crawford is re - referred for diabetic eye exam .	severity	lesion	T17	T5	note_5696
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.05 Mr. Crawford is re - referred for diabetic eye exam .	[s2] Nonproliferative diabetic retinopathy [e2] of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.05 2 .	severity	lesion	T18	T1	note_5696
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.05 Mr. Crawford is re - referred for diabetic eye exam .	Nonproliferative diabetic retinopathy of right eye , with [s2] macular edema [e2] , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.05 2 .	severity	lesion	T18	T2	note_5696
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.05 Mr. Crawford is re - referred for diabetic eye exam .	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate [s2] nonproliferative retinopathy [e2] E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.05 2 .	severity	lesion	T18	T3	note_5696
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.05 Mr. Crawford is re - referred for diabetic eye exam .	Treatment History ? ? ? * * * IVL OS Today ? ? IVFA 1 / 31 / 2017 - Moderate [s2] NPDR [e2] OU with CSME OS > OD 1 .	severity	lesion	T18	T6	note_5696
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.05 Mr. Crawford is re - referred for diabetic eye exam .	Treatment History ? ? ? * * * IVL OS Today ? ? IVFA 1 / 31 / 2017 - Moderate NPDR OU with [s2] CSME [e2] OS > OD 1 .	severity	lesion	T18	T7	note_5696
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.05 Mr. Crawford is re - referred for diabetic eye exam .	[s2] Nonproliferative diabetic retinopathy [e2] of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.05 2 .	laterality	lesion	T19	T1	note_5696
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.05 Mr. Crawford is re - referred for diabetic eye exam .	Nonproliferative diabetic retinopathy of right eye , with [s2] macular edema [e2] , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.05 2 .	laterality	lesion	T19	T2	note_5696
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.05 Mr. Crawford is re - referred for diabetic eye exam .	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate [s2] nonproliferative retinopathy [e2] E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.05 2 .	laterality	lesion	T19	T3	note_5696
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.05 Mr. Crawford is re - referred for diabetic eye exam .	Treatment History ? ? ? * * * IVL OS Today ? ? IVFA 1 / 31 / 2017 - Moderate [s2] NPDR [e2] OU with CSME OS > OD 1 .	laterality	lesion	T19	T6	note_5696
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.05 Mr. Crawford is re - referred for diabetic eye exam .	Treatment History ? ? ? * * * IVL OS Today ? ? IVFA 1 / 31 / 2017 - Moderate NPDR OU with [s2] CSME [e2] OS > OD 1 .	laterality	lesion	T19	T7	note_5696
NonRel	Treatment History ? ? ? * * * IVL OS Today ? ? IVFA 1 / 31 / 2017 - [s1] Moderate [e1] NPDR OU with CSME OS > OD 1 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.05 Mr. Crawford is re - referred for diabetic eye exam .	severity	lesion	T20	T4	note_5696
NonRel	Treatment History ? ? ? * * * IVL OS Today ? ? IVFA 1 / 31 / 2017 - [s1] Moderate [e1] NPDR OU with CSME OS > OD 1 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.05 Mr. Crawford is re - referred for diabetic eye exam .	severity	lesion	T20	T5	note_5696
NonRel	Treatment History ? ? ? * * * IVL OS Today ? ? IVFA 1 / 31 / 2017 - Moderate NPDR [s1] OU [e1] with CSME OS > OD 1 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.05 Mr. Crawford is re - referred for diabetic eye exam .	laterality	lesion	T21	T4	note_5696
NonRel	Treatment History ? ? ? * * * IVL OS Today ? ? IVFA 1 / 31 / 2017 - Moderate NPDR [s1] OU [e1] with CSME OS > OD 1 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.05 Mr. Crawford is re - referred for diabetic eye exam .	laterality	lesion	T21	T5	note_5696
NonRel	Treatment History ? ? ? * * * IVL OS Today ? ? IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME [s1] OS [e1] > OD 1 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.05 Mr. Crawford is re - referred for diabetic eye exam .	laterality	lesion	T22	T4	note_5696
NonRel	Treatment History ? ? ? * * * IVL OS Today ? ? IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME [s1] OS [e1] > OD 1 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.05 Mr. Crawford is re - referred for diabetic eye exam .	laterality	lesion	T22	T5	note_5696
NonRel	Poor Control OD : [s1] Moderate [e1] NPDR with + CSME .	VA 20 / 30 OS : Moderate [s2] NPDR [e2] with + + CSME 2 .	severity	lesion	T23	T10	note_5696
NonRel	Poor Control OD : [s1] Moderate [e1] NPDR with + CSME .	VA 20 / 30 OS : Moderate NPDR with + + [s2] CSME [e2] 2 .	severity	lesion	T23	T11	note_5696
NonRel	Poor Control [s1] OD [e1] : Moderate NPDR with + CSME .	VA 20 / 30 OS : Moderate [s2] NPDR [e2] with + + CSME 2 .	laterality	lesion	T24	T10	note_5696
NonRel	Poor Control [s1] OD [e1] : Moderate NPDR with + CSME .	VA 20 / 30 OS : Moderate NPDR with + + [s2] CSME [e2] 2 .	laterality	lesion	T24	T11	note_5696
NonRel	VA 20 / 30 OS : [s1] Moderate [e1] NPDR with + + CSME 2 .	Poor Control OD : Moderate [s2] NPDR [e2] with + CSME .	severity	lesion	T25	T8	note_5696
NonRel	VA 20 / 30 OS : [s1] Moderate [e1] NPDR with + + CSME 2 .	Poor Control OD : Moderate NPDR with + [s2] CSME [e2] .	severity	lesion	T25	T9	note_5696
NonRel	VA 20 / 30 [s1] OS [e1] : Moderate NPDR with + + CSME 2 .	Poor Control OD : Moderate [s2] NPDR [e2] with + CSME .	laterality	lesion	T26	T8	note_5696
NonRel	VA 20 / 30 [s1] OS [e1] : Moderate NPDR with + + CSME 2 .	Poor Control OD : Moderate NPDR with + [s2] CSME [e2] .	laterality	lesion	T26	T9	note_5696
NonRel	DFE / OCT OU OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : CSME Temporal and superotemporal to the fovea .	OS : Diffuse [s2] CSME [e2] Fluorescein Angiography - OU - Both Eyes OD : Moderate NPDR , Mild peripheral non - perfusion .	laterality	lesion	T27	T13	note_5696
NonRel	DFE / OCT OU OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : CSME Temporal and superotemporal to the fovea .	OS : Diffuse CSME Fluorescein Angiography - OU - Both Eyes OD : Moderate [s2] NPDR [e2] , Mild peripheral non - perfusion .	laterality	lesion	T27	T14	note_5696
NonRel	[s1] OS [e1] : Diffuse CSME Fluorescein Angiography - OU - Both Eyes OD : Moderate NPDR , Mild peripheral non - perfusion .	DFE / OCT OU OCT , Posterior Segment - OU - Both Eyes OD : [s2] CSME [e2] Temporal and superotemporal to the fovea .	laterality	lesion	T29	T12	note_5696
NonRel	[s1] OS [e1] : Diffuse CSME Fluorescein Angiography - OU - Both Eyes OD : Moderate NPDR , Mild peripheral non - perfusion .	+ Macular leakage OS : Moderate [s2] NPDR [e2] , Mild peripheral non - perfusion .	laterality	lesion	T29	T15	note_5696
NonRel	OS : Diffuse CSME Fluorescein Angiography - OU - Both Eyes [s1] OD [e1] : Moderate NPDR , Mild peripheral non - perfusion .	DFE / OCT OU OCT , Posterior Segment - OU - Both Eyes OD : [s2] CSME [e2] Temporal and superotemporal to the fovea .	laterality	lesion	T30	T12	note_5696
NonRel	OS : Diffuse CSME Fluorescein Angiography - OU - Both Eyes [s1] OD [e1] : Moderate NPDR , Mild peripheral non - perfusion .	+ Macular leakage OS : Moderate [s2] NPDR [e2] , Mild peripheral non - perfusion .	laterality	lesion	T30	T15	note_5696
NonRel	OS : Diffuse CSME Fluorescein Angiography - OU - Both Eyes OD : [s1] Moderate [e1] NPDR , Mild peripheral non - perfusion .	DFE / OCT OU OCT , Posterior Segment - OU - Both Eyes OD : [s2] CSME [e2] Temporal and superotemporal to the fovea .	severity	lesion	T31	T12	note_5696
NonRel	OS : Diffuse CSME Fluorescein Angiography - OU - Both Eyes OD : [s1] Moderate [e1] NPDR , Mild peripheral non - perfusion .	+ Macular leakage OS : Moderate [s2] NPDR [e2] , Mild peripheral non - perfusion .	severity	lesion	T31	T15	note_5696
NonRel	+ Macular leakage [s1] OS [e1] : Moderate NPDR , Mild peripheral non - perfusion .	OS : Diffuse [s2] CSME [e2] Fluorescein Angiography - OU - Both Eyes OD : Moderate NPDR , Mild peripheral non - perfusion .	laterality	lesion	T32	T13	note_5696
NonRel	+ Macular leakage [s1] OS [e1] : Moderate NPDR , Mild peripheral non - perfusion .	OS : Diffuse CSME Fluorescein Angiography - OU - Both Eyes OD : Moderate [s2] NPDR [e2] , Mild peripheral non - perfusion .	laterality	lesion	T32	T14	note_5696
NonRel	+ Macular leakage OS : [s1] Moderate [e1] NPDR , Mild peripheral non - perfusion .	OS : Diffuse [s2] CSME [e2] Fluorescein Angiography - OU - Both Eyes OD : Moderate NPDR , Mild peripheral non - perfusion .	severity	lesion	T33	T13	note_5696
NonRel	+ Macular leakage OS : [s1] Moderate [e1] NPDR , Mild peripheral non - perfusion .	OS : Diffuse CSME Fluorescein Angiography - OU - Both Eyes OD : Moderate [s2] NPDR [e2] , Mild peripheral non - perfusion .	severity	lesion	T33	T14	note_5696
NonRel	Central retinal vein occlusion of left eye H34.8122 362.35 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OU - 4 / 14 / 2017 IVA OU - 3 / 10 / 2017 IVFA - 2 / 7 / 2017 - diffuse vascular leakage , mas , NVE nasally [s1] OS [e1] 1 .	Bilateral CRVOs versus OIS versus [s2] PDR [e2] - Past Medical History of DMII , HTN , Hyperlipidemia - IVFA shows diffuse vascular leakage OU .	laterality	lesion	T3	T4	note_2320
NonRel	Original exam shows likely NVI [s1] OU [e1] , Not seen today .	Bilateral CRVOs versus OIS versus [s2] PDR [e2] - Past Medical History of DMII , HTN , Hyperlipidemia - IVFA shows diffuse vascular leakage OU .	laterality	lesion	T6	T4	note_2320
NonRel	Original exam shows likely NVI [s1] OU [e1] , Not seen today .	No [s2] NVA [e2] on exam .	laterality	lesion	T6	T7	note_2320
NonRel	Proliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] Right Eye [e1] E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	laterality	lesion	T16	T5	1158336_note_2399
NonRel	Proliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] Right Eye [e1] E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	Moderate nonproliferative diabetic retinopathy without [s2] macular edema [e2] associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	laterality	lesion	T16	T6	1158336_note_2399
NonRel	Proliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] Right Eye [e1] E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical [s2] PDR [e2] without CSME ( + NVE , - NVI ) .	laterality	lesion	T16	T7	1158336_note_2399
NonRel	Proliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] Right Eye [e1] E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without [s2] CSME [e2] ( + NVE , - NVI ) .	laterality	lesion	T16	T8	1158336_note_2399
NonRel	Proliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] Right Eye [e1] E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - [s2] NVI [e2] ) .	laterality	lesion	T16	T9	1158336_note_2399
NonRel	Proliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] Right Eye [e1] E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + [s2] NVE [e2] , - NVI ) .	laterality	lesion	T16	T10	1158336_note_2399
NonRel	Proliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] Right Eye [e1] E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active [s2] PDR [e2] OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	laterality	lesion	T16	T27	1158336_note_2399
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	[s2] Proliferative diabetic retinopathy [e2] without macular edema associated with type 2 diabetes mellitus - Right Eye E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	severity	lesion	T17	T3	1158336_note_2399
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Proliferative diabetic retinopathy without [s2] macular edema [e2] associated with type 2 diabetes mellitus - Right Eye E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	severity	lesion	T17	T4	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] left eye [e1] E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	[s2] Proliferative diabetic retinopathy [e2] without macular edema associated with type 2 diabetes mellitus - Right Eye E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	laterality	lesion	T18	T3	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] left eye [e1] E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Proliferative diabetic retinopathy without [s2] macular edema [e2] associated with type 2 diabetes mellitus - Right Eye E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	laterality	lesion	T18	T4	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] [s1] OD [e1] - Clinical PDR without CSME ( + NVE , - NVI ) .	[s2] Proliferative diabetic retinopathy [e2] without macular edema associated with type 2 diabetes mellitus - Right Eye E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	laterality	lesion	T19	T3	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] [s1] OD [e1] - Clinical PDR without CSME ( + NVE , - NVI ) .	Proliferative diabetic retinopathy without [s2] macular edema [e2] associated with type 2 diabetes mellitus - Right Eye E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	laterality	lesion	T19	T4	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - [s1] Active [e1] PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	[s2] Proliferative diabetic retinopathy [e2] without macular edema associated with type 2 diabetes mellitus - Right Eye E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	severity	lesion	T28	T3	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - [s1] Active [e1] PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Proliferative diabetic retinopathy without [s2] macular edema [e2] associated with type 2 diabetes mellitus - Right Eye E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	severity	lesion	T28	T4	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR [s1] OU [e1] 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	[s2] Proliferative diabetic retinopathy [e2] without macular edema associated with type 2 diabetes mellitus - Right Eye E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	laterality	lesion	T29	T3	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR [s1] OU [e1] 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Proliferative diabetic retinopathy without [s2] macular edema [e2] associated with type 2 diabetes mellitus - Right Eye E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	laterality	lesion	T29	T4	1158336_note_2399
NonRel	Acute on chronic diastolic heart failure I50.33 428.33 Appt req Opthalmology POH : Monocular with phthisis bulbi OS ( NLP ) Pseudophakic [s1] OD [e1] with NPDR , last seen 2015 Lab Results Component Value Date HGBA 1 C 6.4 ( H ) 06 / 19 / 2017 HGBA 1 C 13.2 ( H ) 05 / 06 / 2014 1 ) DM - Hg A1C 6.4 .	OD - Active [s2] PDR [e2] .	laterality	lesion	T5	T9	note_416
NonRel	[s1] OD [e1] - Active PDR .	Acute on chronic diastolic heart failure I50.33 428.33 Appt req Opthalmology POH : Monocular with phthisis bulbi OS ( NLP ) Pseudophakic OD with [s2] NPDR [e2] , last seen 2015 Lab Results Component Value Date HGBA 1 C 6.4 ( H ) 06 / 19 / 2017 HGBA 1 C 13.2 ( H ) 05 / 06 / 2014 1 ) DM - Hg A1C 6.4 .	laterality	lesion	T7	T6	note_416
NonRel	[s1] OD [e1] - Active PDR .	Seen in hospital with active [s2] VH [e2] .	laterality	lesion	T7	T11	note_416
NonRel	OD - [s1] Active [e1] PDR .	Acute on chronic diastolic heart failure I50.33 428.33 Appt req Opthalmology POH : Monocular with phthisis bulbi OS ( NLP ) Pseudophakic OD with [s2] NPDR [e2] , last seen 2015 Lab Results Component Value Date HGBA 1 C 6.4 ( H ) 06 / 19 / 2017 HGBA 1 C 13.2 ( H ) 05 / 06 / 2014 1 ) DM - Hg A1C 6.4 .	severity	lesion	T8	T6	note_416
NonRel	OD - [s1] Active [e1] PDR .	Seen in hospital with active [s2] VH [e2] .	severity	lesion	T8	T11	note_416
NonRel	Seen in hospital with [s1] active [e1] VH .	OD - Active [s2] PDR [e2] .	severity	lesion	T10	T9	note_416
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] associated with type 2 diabetes mellitus , macular edema presence unspecified E11.3493 250.50 362.06 2 .	[s2] Vitreous hemorrhage [e2] , left H43.12 379.23 New retina patient for diabetic retinopathy , poor vision left eye for months .	laterality	lesion	T6	T4	2060252_note_5874
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , macular edema presence unspecified E11.3493 250.50 362.06 2 .	[s2] Vitreous hemorrhage [e2] , left H43.12 379.23 New retina patient for diabetic retinopathy , poor vision left eye for months .	severity	lesion	T7	T4	2060252_note_5874
NonRel	Vitreous hemorrhage , [s1] left [e1] H43.12 379.23 New retina patient for diabetic retinopathy , poor vision left eye for months .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes associated with type 2 diabetes mellitus , macular edema presence unspecified E11.3493 250.50 362.06 2 .	laterality	lesion	T8	T1	2060252_note_5874
NonRel	Vitreous hemorrhage , [s1] left [e1] H43.12 379.23 New retina patient for diabetic retinopathy , poor vision left eye for months .	Severe nonproliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , [s2] macular edema [e2] presence unspecified E11.3493 250.50 362.06 2 .	laterality	lesion	T8	T2	2060252_note_5874
NonRel	Vitreous hemorrhage , [s1] left [e1] H43.12 379.23 New retina patient for diabetic retinopathy , poor vision left eye for months .	1 ) DM - Severe Active PDR OU , [s2] vitreous hemorrhage [e2] OS - New patient to clinic , no previous ophthalmology care or treatment , hx of poorly controlled diabetes and HTN with unknown A1c. - presented to ER DATE with new vit heme , has not resolved - IVFA today with significant NVE and retinal ischemia OD Large C / d OD - mother and sister with glaucoma - IOP wnl today - will refer for eval wtih Dr. NAME Plan : OD - IVA next visit , laser at later visit OS - IVA at next visit , consider washout RTC Thursday IVA OU Referral to Dr. NAME for Glaucoma evaluation NAME , MD participated in the care of this patient .	laterality	lesion	T8	T5	2060252_note_5874
NonRel	Vitreous hemorrhage , [s1] left [e1] H43.12 379.23 New retina patient for diabetic retinopathy , poor vision left eye for months .	1 ) DM - Severe Active [s2] PDR [e2] OU , vitreous hemorrhage OS - New patient to clinic , no previous ophthalmology care or treatment , hx of poorly controlled diabetes and HTN with unknown A1c. - presented to ER DATE with new vit heme , has not resolved - IVFA today with significant NVE and retinal ischemia OD Large C / d OD - mother and sister with glaucoma - IOP wnl today - will refer for eval wtih Dr. NAME Plan : OD - IVA next visit , laser at later visit OS - IVA at next visit , consider washout RTC Thursday IVA OU Referral to Dr. NAME for Glaucoma evaluation NAME , MD participated in the care of this patient .	laterality	lesion	T8	T13	2060252_note_5874
NonRel	Vitreous hemorrhage , [s1] left [e1] H43.12 379.23 New retina patient for diabetic retinopathy , poor vision left eye for months .	1 ) DM - Severe Active PDR OU , vitreous hemorrhage OS - New patient to clinic , no previous ophthalmology care or treatment , hx of poorly controlled diabetes and HTN with unknown A1c. - presented to ER DATE with new [s2] vit heme [e2] , has not resolved - IVFA today with significant NVE and retinal ischemia OD Large C / d OD - mother and sister with glaucoma - IOP wnl today - will refer for eval wtih Dr. NAME Plan : OD - IVA next visit , laser at later visit OS - IVA at next visit , consider washout RTC Thursday IVA OU Referral to Dr. NAME for Glaucoma evaluation NAME , MD participated in the care of this patient .	laterality	lesion	T8	T15	2060252_note_5874
NonRel	Vitreous hemorrhage , [s1] left [e1] H43.12 379.23 New retina patient for diabetic retinopathy , poor vision left eye for months .	1 ) DM - Severe Active PDR OU , vitreous hemorrhage OS - New patient to clinic , no previous ophthalmology care or treatment , hx of poorly controlled diabetes and HTN with unknown A1c. - presented to ER DATE with new vit heme , has not resolved - IVFA today with significant [s2] NVE [e2] and retinal ischemia OD Large C / d OD - mother and sister with glaucoma - IOP wnl today - will refer for eval wtih Dr. NAME Plan : OD - IVA next visit , laser at later visit OS - IVA at next visit , consider washout RTC Thursday IVA OU Referral to Dr. NAME for Glaucoma evaluation NAME , MD participated in the care of this patient .	laterality	lesion	T8	T17	2060252_note_5874
NonRel	1 ) DM - Severe Active PDR OU , vitreous hemorrhage [s1] OS [e1] - New patient to clinic , no previous ophthalmology care or treatment , hx of poorly controlled diabetes and HTN with unknown A1c. - presented to ER DATE with new vit heme , has not resolved - IVFA today with significant NVE and retinal ischemia OD Large C / d OD - mother and sister with glaucoma - IOP wnl today - will refer for eval wtih Dr. NAME Plan : OD - IVA next visit , laser at later visit OS - IVA at next visit , consider washout RTC Thursday IVA OU Referral to Dr. NAME for Glaucoma evaluation NAME , MD participated in the care of this patient .	[s2] Vitreous hemorrhage [e2] , left H43.12 379.23 New retina patient for diabetic retinopathy , poor vision left eye for months .	laterality	lesion	T9	T4	2060252_note_5874
NonRel	1 ) DM - [s1] Severe [e1] Active PDR OU , vitreous hemorrhage OS - New patient to clinic , no previous ophthalmology care or treatment , hx of poorly controlled diabetes and HTN with unknown A1c. - presented to ER DATE with new vit heme , has not resolved - IVFA today with significant NVE and retinal ischemia OD Large C / d OD - mother and sister with glaucoma - IOP wnl today - will refer for eval wtih Dr. NAME Plan : OD - IVA next visit , laser at later visit OS - IVA at next visit , consider washout RTC Thursday IVA OU Referral to Dr. NAME for Glaucoma evaluation NAME , MD participated in the care of this patient .	[s2] Vitreous hemorrhage [e2] , left H43.12 379.23 New retina patient for diabetic retinopathy , poor vision left eye for months .	severity	lesion	T11	T4	2060252_note_5874
NonRel	1 ) DM - Severe [s1] Active [e1] PDR OU , vitreous hemorrhage OS - New patient to clinic , no previous ophthalmology care or treatment , hx of poorly controlled diabetes and HTN with unknown A1c. - presented to ER DATE with new vit heme , has not resolved - IVFA today with significant NVE and retinal ischemia OD Large C / d OD - mother and sister with glaucoma - IOP wnl today - will refer for eval wtih Dr. NAME Plan : OD - IVA next visit , laser at later visit OS - IVA at next visit , consider washout RTC Thursday IVA OU Referral to Dr. NAME for Glaucoma evaluation NAME , MD participated in the care of this patient .	[s2] Vitreous hemorrhage [e2] , left H43.12 379.23 New retina patient for diabetic retinopathy , poor vision left eye for months .	severity	lesion	T12	T4	2060252_note_5874
NonRel	1 ) DM - Severe Active PDR [s1] OU [e1] , vitreous hemorrhage OS - New patient to clinic , no previous ophthalmology care or treatment , hx of poorly controlled diabetes and HTN with unknown A1c. - presented to ER DATE with new vit heme , has not resolved - IVFA today with significant NVE and retinal ischemia OD Large C / d OD - mother and sister with glaucoma - IOP wnl today - will refer for eval wtih Dr. NAME Plan : OD - IVA next visit , laser at later visit OS - IVA at next visit , consider washout RTC Thursday IVA OU Referral to Dr. NAME for Glaucoma evaluation NAME , MD participated in the care of this patient .	[s2] Vitreous hemorrhage [e2] , left H43.12 379.23 New retina patient for diabetic retinopathy , poor vision left eye for months .	laterality	lesion	T14	T4	2060252_note_5874
NonRel	1 ) DM - Severe Active PDR OU , vitreous hemorrhage OS - New patient to clinic , no previous ophthalmology care or treatment , hx of poorly controlled diabetes and HTN with unknown A1c. - presented to ER DATE with new vit heme , has not resolved - IVFA today with [s1] significant [e1] NVE and retinal ischemia OD Large C / d OD - mother and sister with glaucoma - IOP wnl today - will refer for eval wtih Dr. NAME Plan : OD - IVA next visit , laser at later visit OS - IVA at next visit , consider washout RTC Thursday IVA OU Referral to Dr. NAME for Glaucoma evaluation NAME , MD participated in the care of this patient .	[s2] Vitreous hemorrhage [e2] , left H43.12 379.23 New retina patient for diabetic retinopathy , poor vision left eye for months .	severity	lesion	T16	T4	2060252_note_5874
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 362.07 362.05 2 .	OCT , Retina - OU - Both Eyes OD - retinal thickening , IFR cyst sup to COM and inf temporally , CMT 281 OS - inferior ERM , retinal thickening , few [s2] IRF [e2] cysts CMT 271 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	severity	lesion	T2	T1	note_2908
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 362.07 362.05 2 .	OCT , Retina - OU - Both Eyes OD - retinal thickening , IFR cyst sup to COM and inf temporally , CMT 281 OS - inferior ERM , retinal thickening , few [s2] IRF [e2] cysts CMT 271 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T4	T1	note_2908
NonRel	Hx of PDR [s1] OU [e1] , s / p PRP OU .	Quiescent [s2] PDR [e2] without edema .	laterality	lesion	T7	T4	note_322
NonRel	Hx of PDR [s1] OU [e1] , s / p PRP OU .	Quiescent PDR without [s2] edema [e2] .	laterality	lesion	T7	T5	note_322
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	[s2] Diabetic macular edema [e2] not clinically significant - Both Eyes E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 New retina patient here today for evaluation for DR .	severity	lesion	T1	T5	note_1783
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - [s1] Both Eyes [e1] E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	[s2] Diabetic macular edema [e2] not clinically significant - Both Eyes E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 New retina patient here today for evaluation for DR .	laterality	lesion	T4	T5	note_1783
NonRel	Diabetic macular edema [s1] not clinically significant [e1] - Both Eyes E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 New retina patient here today for evaluation for DR .	Moderate [s2] nonproliferative diabetic retinopathy [e2] without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	severity	lesion	T6	T2	note_1783
NonRel	Diabetic macular edema [s1] not clinically significant [e1] - Both Eyes E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 New retina patient here today for evaluation for DR .	Moderate nonproliferative diabetic retinopathy without [s2] macular edema [e2] associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	severity	lesion	T6	T3	note_1783
NonRel	Diabetic macular edema [s1] not clinically significant [e1] - Both Eyes E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 New retina patient here today for evaluation for DR .	Treatment Hx : IVFA ( 8 / 2 / 18 ) - Severe [s2] NPDR [e2] OU 1 ) OD - Severe NPDR with ciCSME OS - Severe NPDR with nciCSME Recommend BG control , will monitor .	severity	lesion	T6	T9	note_1783
NonRel	Diabetic macular edema [s1] not clinically significant [e1] - Both Eyes E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 New retina patient here today for evaluation for DR .	Treatment Hx : IVFA ( 8 / 2 / 18 ) - Severe NPDR OU 1 ) OD - Severe [s2] NPDR [e2] with ciCSME OS - Severe NPDR with nciCSME Recommend BG control , will monitor .	severity	lesion	T6	T13	note_1783
NonRel	Diabetic macular edema [s1] not clinically significant [e1] - Both Eyes E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 New retina patient here today for evaluation for DR .	Treatment Hx : IVFA ( 8 / 2 / 18 ) - Severe NPDR OU 1 ) OD - Severe NPDR with [s2] ciCSME [e2] OS - Severe NPDR with nciCSME Recommend BG control , will monitor .	severity	lesion	T6	T14	note_1783
NonRel	Diabetic macular edema [s1] not clinically significant [e1] - Both Eyes E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 New retina patient here today for evaluation for DR .	Treatment Hx : IVFA ( 8 / 2 / 18 ) - Severe NPDR OU 1 ) OD - Severe NPDR with ciCSME OS - Severe [s2] NPDR [e2] with nciCSME Recommend BG control , will monitor .	severity	lesion	T6	T17	note_1783
NonRel	Diabetic macular edema [s1] not clinically significant [e1] - Both Eyes E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 New retina patient here today for evaluation for DR .	Treatment Hx : IVFA ( 8 / 2 / 18 ) - Severe NPDR OU 1 ) OD - Severe NPDR with ciCSME OS - Severe NPDR with [s2] nciCSME [e2] Recommend BG control , will monitor .	severity	lesion	T6	T18	note_1783
NonRel	Diabetic macular edema not clinically significant - [s1] Both Eyes [e1] E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 New retina patient here today for evaluation for DR .	Moderate [s2] nonproliferative diabetic retinopathy [e2] without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	laterality	lesion	T7	T2	note_1783
NonRel	Diabetic macular edema not clinically significant - [s1] Both Eyes [e1] E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 New retina patient here today for evaluation for DR .	Moderate nonproliferative diabetic retinopathy without [s2] macular edema [e2] associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	laterality	lesion	T7	T3	note_1783
NonRel	Diabetic macular edema not clinically significant - [s1] Both Eyes [e1] E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 New retina patient here today for evaluation for DR .	Treatment Hx : IVFA ( 8 / 2 / 18 ) - Severe [s2] NPDR [e2] OU 1 ) OD - Severe NPDR with ciCSME OS - Severe NPDR with nciCSME Recommend BG control , will monitor .	laterality	lesion	T7	T9	note_1783
NonRel	Diabetic macular edema not clinically significant - [s1] Both Eyes [e1] E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 New retina patient here today for evaluation for DR .	Treatment Hx : IVFA ( 8 / 2 / 18 ) - Severe NPDR OU 1 ) OD - Severe [s2] NPDR [e2] with ciCSME OS - Severe NPDR with nciCSME Recommend BG control , will monitor .	laterality	lesion	T7	T13	note_1783
NonRel	Diabetic macular edema not clinically significant - [s1] Both Eyes [e1] E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 New retina patient here today for evaluation for DR .	Treatment Hx : IVFA ( 8 / 2 / 18 ) - Severe NPDR OU 1 ) OD - Severe NPDR with [s2] ciCSME [e2] OS - Severe NPDR with nciCSME Recommend BG control , will monitor .	laterality	lesion	T7	T14	note_1783
NonRel	Diabetic macular edema not clinically significant - [s1] Both Eyes [e1] E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 New retina patient here today for evaluation for DR .	Treatment Hx : IVFA ( 8 / 2 / 18 ) - Severe NPDR OU 1 ) OD - Severe NPDR with ciCSME OS - Severe [s2] NPDR [e2] with nciCSME Recommend BG control , will monitor .	laterality	lesion	T7	T17	note_1783
NonRel	Diabetic macular edema not clinically significant - [s1] Both Eyes [e1] E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 New retina patient here today for evaluation for DR .	Treatment Hx : IVFA ( 8 / 2 / 18 ) - Severe NPDR OU 1 ) OD - Severe NPDR with ciCSME OS - Severe NPDR with [s2] nciCSME [e2] Recommend BG control , will monitor .	laterality	lesion	T7	T18	note_1783
NonRel	Treatment Hx : IVFA ( 8 / 2 / 18 ) - [s1] Severe [e1] NPDR OU 1 ) OD - Severe NPDR with ciCSME OS - Severe NPDR with nciCSME Recommend BG control , will monitor .	[s2] Diabetic macular edema [e2] not clinically significant - Both Eyes E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 New retina patient here today for evaluation for DR .	severity	lesion	T8	T5	note_1783
NonRel	Treatment Hx : IVFA ( 8 / 2 / 18 ) - Severe NPDR [s1] OU [e1] 1 ) OD - Severe NPDR with ciCSME OS - Severe NPDR with nciCSME Recommend BG control , will monitor .	[s2] Diabetic macular edema [e2] not clinically significant - Both Eyes E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 New retina patient here today for evaluation for DR .	laterality	lesion	T10	T5	note_1783
NonRel	Treatment Hx : IVFA ( 8 / 2 / 18 ) - Severe NPDR OU 1 ) [s1] OD [e1] - Severe NPDR with ciCSME OS - Severe NPDR with nciCSME Recommend BG control , will monitor .	[s2] Diabetic macular edema [e2] not clinically significant - Both Eyes E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 New retina patient here today for evaluation for DR .	laterality	lesion	T11	T5	note_1783
NonRel	Treatment Hx : IVFA ( 8 / 2 / 18 ) - Severe NPDR OU 1 ) OD - [s1] Severe [e1] NPDR with ciCSME OS - Severe NPDR with nciCSME Recommend BG control , will monitor .	[s2] Diabetic macular edema [e2] not clinically significant - Both Eyes E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 New retina patient here today for evaluation for DR .	severity	lesion	T12	T5	note_1783
NonRel	Treatment Hx : IVFA ( 8 / 2 / 18 ) - Severe NPDR OU 1 ) OD - Severe NPDR with ciCSME [s1] OS [e1] - Severe NPDR with nciCSME Recommend BG control , will monitor .	[s2] Diabetic macular edema [e2] not clinically significant - Both Eyes E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 New retina patient here today for evaluation for DR .	laterality	lesion	T15	T5	note_1783
NonRel	Treatment Hx : IVFA ( 8 / 2 / 18 ) - Severe NPDR OU 1 ) OD - Severe NPDR with ciCSME OS - [s1] Severe [e1] NPDR with nciCSME Recommend BG control , will monitor .	[s2] Diabetic macular edema [e2] not clinically significant - Both Eyes E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 New retina patient here today for evaluation for DR .	severity	lesion	T16	T5	note_1783
NonRel	Other testing : OCT MAC OD : thickness : 221 , good foveal contour ( - ) IRF or SRF [s1] OS [e1] : thickness : 217 , good foveal contour ( - ) IRF or SRF Assessment and Plan : ICD - 9 - CM 1 .	Allergies : No Known Allergies ROS Positive for : Endocrine ( borderline DM ) , Eyes ( blurry vision ) , Respiratory ( Asthma ) Negative for : Constitutional , Gastrointestinal , Neurological , Skin , Genitourinary , Musculoskeletal , HENT , Cardiovascular , Psychiatric , Allergic / Imm , Heme / Lymph Objective : Base Eye Exam Visual Acuity Right Left Dist sc 20 / 30 - 1 20 / 30 - 2 Near sc J1 + J1 + Method : Snellen - Linear Tonometry Right Left Pressure 12 12 Method : icare Time : 2 : 57 PM Pupils Pupils Light React APD Right PERRL 3 2 - Left PERRL 3 2 - Visual Fields Right Left Result Full Full Method : Counting fingers Extraocular Movement Right Left Result Full , Ortho Full , Ortho Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 11 PM Slit Lamp and Fundus Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Blepharitis , Meibomian gland dysfunction Blepharitis , Meibomian gland dysfunction Conjunctiva / Sclera scattered melanosis , mild inj scattered melanosis , mild inj Cornea clear , mild oil glands few PEE inf , otherwise clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive ( - ) NVI Round and reactive ( - ) NVI Lens mild Nuclear sclerosis , trace inj cortical trace Nuclear sclerosis Fundus Exam Right Left Vitreous Normal Normal Disc Normal , P & D ( - ) [s2] NVD [e2] Normal , P & D ( - ) NVD C / D Ratio 0.3 0.3 Macula mild mottling ( - ) CSME mild mottling ( - ) CSME Vessels Normal Normal Periphery Normal ( - ) holes or tears ( - ) NVE Normal ( - ) holes or tears ( - ) NVE Refraction Manifest Refraction Sphere Cylinder Axis Dist Add Near Right - 4.25 + 3.50 090 20 / 20 - 2 + 1.50 J1 + Left - 1.75 + 0.75 070 20 / 20 - 2 + 1.50 J1 + Manifest Refraction # 2 ( Retinoscopy ) Sphere Cylinder Axis Dist Add Near Right - 2.00 + 1.50 90 20 / 40 Left - 3.50 + 1.00 90 20 / 30 Comments : Pt reports that eyes are burning No annotated images are attached to the encounter .	laterality	lesion	T15	T2	217884_note_474
NonRel	Other testing : OCT MAC OD : thickness : 221 , good foveal contour ( - ) IRF or SRF [s1] OS [e1] : thickness : 217 , good foveal contour ( - ) IRF or SRF Assessment and Plan : ICD - 9 - CM 1 .	Allergies : No Known Allergies ROS Positive for : Endocrine ( borderline DM ) , Eyes ( blurry vision ) , Respiratory ( Asthma ) Negative for : Constitutional , Gastrointestinal , Neurological , Skin , Genitourinary , Musculoskeletal , HENT , Cardiovascular , Psychiatric , Allergic / Imm , Heme / Lymph Objective : Base Eye Exam Visual Acuity Right Left Dist sc 20 / 30 - 1 20 / 30 - 2 Near sc J1 + J1 + Method : Snellen - Linear Tonometry Right Left Pressure 12 12 Method : icare Time : 2 : 57 PM Pupils Pupils Light React APD Right PERRL 3 2 - Left PERRL 3 2 - Visual Fields Right Left Result Full Full Method : Counting fingers Extraocular Movement Right Left Result Full , Ortho Full , Ortho Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 11 PM Slit Lamp and Fundus Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Blepharitis , Meibomian gland dysfunction Blepharitis , Meibomian gland dysfunction Conjunctiva / Sclera scattered melanosis , mild inj scattered melanosis , mild inj Cornea clear , mild oil glands few PEE inf , otherwise clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive ( - ) NVI Round and reactive ( - ) NVI Lens mild Nuclear sclerosis , trace inj cortical trace Nuclear sclerosis Fundus Exam Right Left Vitreous Normal Normal Disc Normal , P & D ( - ) NVD Normal , P & D ( - ) NVD C / D Ratio 0.3 0.3 Macula mild mottling ( - ) [s2] CSME [e2] mild mottling ( - ) CSME Vessels Normal Normal Periphery Normal ( - ) holes or tears ( - ) NVE Normal ( - ) holes or tears ( - ) NVE Refraction Manifest Refraction Sphere Cylinder Axis Dist Add Near Right - 4.25 + 3.50 090 20 / 20 - 2 + 1.50 J1 + Left - 1.75 + 0.75 070 20 / 20 - 2 + 1.50 J1 + Manifest Refraction # 2 ( Retinoscopy ) Sphere Cylinder Axis Dist Add Near Right - 2.00 + 1.50 90 20 / 40 Left - 3.50 + 1.00 90 20 / 30 Comments : Pt reports that eyes are burning No annotated images are attached to the encounter .	laterality	lesion	T15	T3	217884_note_474
NonRel	Other testing : OCT MAC OD : thickness : 221 , good foveal contour ( - ) IRF or SRF [s1] OS [e1] : thickness : 217 , good foveal contour ( - ) IRF or SRF Assessment and Plan : ICD - 9 - CM 1 .	Allergies : No Known Allergies ROS Positive for : Endocrine ( borderline DM ) , Eyes ( blurry vision ) , Respiratory ( Asthma ) Negative for : Constitutional , Gastrointestinal , Neurological , Skin , Genitourinary , Musculoskeletal , HENT , Cardiovascular , Psychiatric , Allergic / Imm , Heme / Lymph Objective : Base Eye Exam Visual Acuity Right Left Dist sc 20 / 30 - 1 20 / 30 - 2 Near sc J1 + J1 + Method : Snellen - Linear Tonometry Right Left Pressure 12 12 Method : icare Time : 2 : 57 PM Pupils Pupils Light React APD Right PERRL 3 2 - Left PERRL 3 2 - Visual Fields Right Left Result Full Full Method : Counting fingers Extraocular Movement Right Left Result Full , Ortho Full , Ortho Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 11 PM Slit Lamp and Fundus Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Blepharitis , Meibomian gland dysfunction Blepharitis , Meibomian gland dysfunction Conjunctiva / Sclera scattered melanosis , mild inj scattered melanosis , mild inj Cornea clear , mild oil glands few PEE inf , otherwise clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive ( - ) NVI Round and reactive ( - ) NVI Lens mild Nuclear sclerosis , trace inj cortical trace Nuclear sclerosis Fundus Exam Right Left Vitreous Normal Normal Disc Normal , P & D ( - ) NVD Normal , P & D ( - ) NVD C / D Ratio 0.3 0.3 Macula mild mottling ( - ) CSME mild mottling ( - ) [s2] CSME [e2] Vessels Normal Normal Periphery Normal ( - ) holes or tears ( - ) NVE Normal ( - ) holes or tears ( - ) NVE Refraction Manifest Refraction Sphere Cylinder Axis Dist Add Near Right - 4.25 + 3.50 090 20 / 20 - 2 + 1.50 J1 + Left - 1.75 + 0.75 070 20 / 20 - 2 + 1.50 J1 + Manifest Refraction # 2 ( Retinoscopy ) Sphere Cylinder Axis Dist Add Near Right - 2.00 + 1.50 90 20 / 40 Left - 3.50 + 1.00 90 20 / 30 Comments : Pt reports that eyes are burning No annotated images are attached to the encounter .	laterality	lesion	T15	T4	217884_note_474
NonRel	Other testing : OCT MAC OD : thickness : 221 , good foveal contour ( - ) IRF or SRF [s1] OS [e1] : thickness : 217 , good foveal contour ( - ) IRF or SRF Assessment and Plan : ICD - 9 - CM 1 .	Allergies : No Known Allergies ROS Positive for : Endocrine ( borderline DM ) , Eyes ( blurry vision ) , Respiratory ( Asthma ) Negative for : Constitutional , Gastrointestinal , Neurological , Skin , Genitourinary , Musculoskeletal , HENT , Cardiovascular , Psychiatric , Allergic / Imm , Heme / Lymph Objective : Base Eye Exam Visual Acuity Right Left Dist sc 20 / 30 - 1 20 / 30 - 2 Near sc J1 + J1 + Method : Snellen - Linear Tonometry Right Left Pressure 12 12 Method : icare Time : 2 : 57 PM Pupils Pupils Light React APD Right PERRL 3 2 - Left PERRL 3 2 - Visual Fields Right Left Result Full Full Method : Counting fingers Extraocular Movement Right Left Result Full , Ortho Full , Ortho Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 11 PM Slit Lamp and Fundus Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Blepharitis , Meibomian gland dysfunction Blepharitis , Meibomian gland dysfunction Conjunctiva / Sclera scattered melanosis , mild inj scattered melanosis , mild inj Cornea clear , mild oil glands few PEE inf , otherwise clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive ( - ) NVI Round and reactive ( - ) NVI Lens mild Nuclear sclerosis , trace inj cortical trace Nuclear sclerosis Fundus Exam Right Left Vitreous Normal Normal Disc Normal , P & D ( - ) NVD Normal , P & D ( - ) NVD C / D Ratio 0.3 0.3 Macula mild mottling ( - ) CSME mild mottling ( - ) CSME Vessels Normal Normal Periphery Normal ( - ) holes or tears ( - ) [s2] NVE [e2] Normal ( - ) holes or tears ( - ) NVE Refraction Manifest Refraction Sphere Cylinder Axis Dist Add Near Right - 4.25 + 3.50 090 20 / 20 - 2 + 1.50 J1 + Left - 1.75 + 0.75 070 20 / 20 - 2 + 1.50 J1 + Manifest Refraction # 2 ( Retinoscopy ) Sphere Cylinder Axis Dist Add Near Right - 2.00 + 1.50 90 20 / 40 Left - 3.50 + 1.00 90 20 / 30 Comments : Pt reports that eyes are burning No annotated images are attached to the encounter .	laterality	lesion	T15	T5	217884_note_474
NonRel	Other testing : OCT MAC OD : thickness : 221 , good foveal contour ( - ) IRF or SRF [s1] OS [e1] : thickness : 217 , good foveal contour ( - ) IRF or SRF Assessment and Plan : ICD - 9 - CM 1 .	Allergies : No Known Allergies ROS Positive for : Endocrine ( borderline DM ) , Eyes ( blurry vision ) , Respiratory ( Asthma ) Negative for : Constitutional , Gastrointestinal , Neurological , Skin , Genitourinary , Musculoskeletal , HENT , Cardiovascular , Psychiatric , Allergic / Imm , Heme / Lymph Objective : Base Eye Exam Visual Acuity Right Left Dist sc 20 / 30 - 1 20 / 30 - 2 Near sc J1 + J1 + Method : Snellen - Linear Tonometry Right Left Pressure 12 12 Method : icare Time : 2 : 57 PM Pupils Pupils Light React APD Right PERRL 3 2 - Left PERRL 3 2 - Visual Fields Right Left Result Full Full Method : Counting fingers Extraocular Movement Right Left Result Full , Ortho Full , Ortho Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 11 PM Slit Lamp and Fundus Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Blepharitis , Meibomian gland dysfunction Blepharitis , Meibomian gland dysfunction Conjunctiva / Sclera scattered melanosis , mild inj scattered melanosis , mild inj Cornea clear , mild oil glands few PEE inf , otherwise clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive ( - ) NVI Round and reactive ( - ) NVI Lens mild Nuclear sclerosis , trace inj cortical trace Nuclear sclerosis Fundus Exam Right Left Vitreous Normal Normal Disc Normal , P & D ( - ) NVD Normal , P & D ( - ) NVD C / D Ratio 0.3 0.3 Macula mild mottling ( - ) CSME mild mottling ( - ) CSME Vessels Normal Normal Periphery Normal ( - ) holes or tears ( - ) NVE Normal ( - ) holes or tears ( - ) [s2] NVE [e2] Refraction Manifest Refraction Sphere Cylinder Axis Dist Add Near Right - 4.25 + 3.50 090 20 / 20 - 2 + 1.50 J1 + Left - 1.75 + 0.75 070 20 / 20 - 2 + 1.50 J1 + Manifest Refraction # 2 ( Retinoscopy ) Sphere Cylinder Axis Dist Add Near Right - 2.00 + 1.50 90 20 / 40 Left - 3.50 + 1.00 90 20 / 30 Comments : Pt reports that eyes are burning No annotated images are attached to the encounter .	laterality	lesion	T15	T6	217884_note_474
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3591 250.50 362.02 3 .	[s2] Proliferative diabetic retinopathy [e2] of left eye without macular edema associated with type 2 diabetes mellitus E11.3592 250.50 362.02 4 .	laterality	lesion	T7	T3	note_8007
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3591 250.50 362.02 3 .	Proliferative diabetic retinopathy of left eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3592 250.50 362.02 4 .	laterality	lesion	T7	T4	note_8007
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3592 250.50 362.02 4 .	[s2] Proliferative diabetic retinopathy [e2] of right eye without macular edema associated with type 2 diabetes mellitus E11.3591 250.50 362.02 3 .	laterality	lesion	T8	T1	note_8007
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3592 250.50 362.02 4 .	Proliferative diabetic retinopathy of right eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3591 250.50 362.02 3 .	laterality	lesion	T8	T2	note_8007
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 2 .	[s2] Diabetic macular edema [e2] of right eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Here today for IVA OS for PDR / NVD .	laterality	lesion	T2	T4	note_1363
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 2 .	Diabetic macular edema of right eye with [s2] proliferative retinopathy [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Here today for IVA OS for PDR / NVD .	laterality	lesion	T2	T6	note_1363
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 2 .	Diabetic macular edema of right eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Here today for IVA OS for [s2] PDR [e2] / NVD .	laterality	lesion	T2	T23	note_1363
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 2 .	Diabetic macular edema of right eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Here today for IVA OS for PDR / [s2] NVD [e2] .	laterality	lesion	T2	T24	note_1363
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Here today for IVA OS for PDR / NVD .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 2 .	laterality	lesion	T5	T1	note_1363
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Here today for IVA OS for PDR / NVD .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 2 .	laterality	lesion	T5	T3	note_1363
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Here today for IVA OS for PDR / NVD .	Recent leg venous duplex without DVT . Treatment Hx : IVA OS - 3 / 8 / 19 IVA OS - 2 / 1 / 19 IVA OS - 12 / 28 / 18 IVFA ( 3 / 8 / 2018 ) : Quiescent [s2] PDR [e2] OU PRP OS ( session 1 ) - 8 / 4 / 17 - IVFA guided PRP OD ( session 2 ) - 7 / 7 / 17 - IVFA guided PRP OD ( session 1 ) - 6 / 16 / 17 - IVFA guided 1 .	laterality	lesion	T5	T8	note_1363
NonRel	Recent leg venous duplex without DVT . Treatment Hx : IVA OS - 3 / 8 / 19 IVA OS - 2 / 1 / 19 IVA OS - 12 / 28 / 18 IVFA ( 3 / 8 / 2018 ) : [s1] Quiescent [e1] PDR OU PRP OS ( session 1 ) - 8 / 4 / 17 - IVFA guided PRP OD ( session 2 ) - 7 / 7 / 17 - IVFA guided PRP OD ( session 1 ) - 6 / 16 / 17 - IVFA guided 1 .	[s2] Diabetic macular edema [e2] of right eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Here today for IVA OS for PDR / NVD .	severity	lesion	T7	T4	note_1363
NonRel	Recent leg venous duplex without DVT . Treatment Hx : IVA OS - 3 / 8 / 19 IVA OS - 2 / 1 / 19 IVA OS - 12 / 28 / 18 IVFA ( 3 / 8 / 2018 ) : [s1] Quiescent [e1] PDR OU PRP OS ( session 1 ) - 8 / 4 / 17 - IVFA guided PRP OD ( session 2 ) - 7 / 7 / 17 - IVFA guided PRP OD ( session 1 ) - 6 / 16 / 17 - IVFA guided 1 .	Diabetic macular edema of right eye with [s2] proliferative retinopathy [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Here today for IVA OS for PDR / NVD .	severity	lesion	T7	T6	note_1363
NonRel	Recent leg venous duplex without DVT . Treatment Hx : IVA OS - 3 / 8 / 19 IVA OS - 2 / 1 / 19 IVA OS - 12 / 28 / 18 IVFA ( 3 / 8 / 2018 ) : [s1] Quiescent [e1] PDR OU PRP OS ( session 1 ) - 8 / 4 / 17 - IVFA guided PRP OD ( session 2 ) - 7 / 7 / 17 - IVFA guided PRP OD ( session 1 ) - 6 / 16 / 17 - IVFA guided 1 .	Diabetic macular edema of right eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Here today for IVA OS for [s2] PDR [e2] / NVD .	severity	lesion	T7	T23	note_1363
NonRel	Recent leg venous duplex without DVT . Treatment Hx : IVA OS - 3 / 8 / 19 IVA OS - 2 / 1 / 19 IVA OS - 12 / 28 / 18 IVFA ( 3 / 8 / 2018 ) : [s1] Quiescent [e1] PDR OU PRP OS ( session 1 ) - 8 / 4 / 17 - IVFA guided PRP OD ( session 2 ) - 7 / 7 / 17 - IVFA guided PRP OD ( session 1 ) - 6 / 16 / 17 - IVFA guided 1 .	Diabetic macular edema of right eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Here today for IVA OS for PDR / [s2] NVD [e2] .	severity	lesion	T7	T24	note_1363
NonRel	Recent leg venous duplex without DVT . Treatment Hx : IVA OS - 3 / 8 / 19 IVA OS - 2 / 1 / 19 IVA OS - 12 / 28 / 18 IVFA ( 3 / 8 / 2018 ) : Quiescent PDR [s1] OU PRP [e1] OS ( session 1 ) - 8 / 4 / 17 - IVFA guided PRP OD ( session 2 ) - 7 / 7 / 17 - IVFA guided PRP OD ( session 1 ) - 6 / 16 / 17 - IVFA guided 1 .	[s2] Diabetic macular edema [e2] of right eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Here today for IVA OS for PDR / NVD .	laterality	lesion	T9	T4	note_1363
NonRel	Recent leg venous duplex without DVT . Treatment Hx : IVA OS - 3 / 8 / 19 IVA OS - 2 / 1 / 19 IVA OS - 12 / 28 / 18 IVFA ( 3 / 8 / 2018 ) : Quiescent PDR [s1] OU PRP [e1] OS ( session 1 ) - 8 / 4 / 17 - IVFA guided PRP OD ( session 2 ) - 7 / 7 / 17 - IVFA guided PRP OD ( session 1 ) - 6 / 16 / 17 - IVFA guided 1 .	Diabetic macular edema of right eye with [s2] proliferative retinopathy [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Here today for IVA OS for PDR / NVD .	laterality	lesion	T9	T6	note_1363
NonRel	Recent leg venous duplex without DVT . Treatment Hx : IVA OS - 3 / 8 / 19 IVA OS - 2 / 1 / 19 IVA OS - 12 / 28 / 18 IVFA ( 3 / 8 / 2018 ) : Quiescent PDR [s1] OU PRP [e1] OS ( session 1 ) - 8 / 4 / 17 - IVFA guided PRP OD ( session 2 ) - 7 / 7 / 17 - IVFA guided PRP OD ( session 1 ) - 6 / 16 / 17 - IVFA guided 1 .	Diabetic macular edema of right eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Here today for IVA OS for [s2] PDR [e2] / NVD .	laterality	lesion	T9	T23	note_1363
NonRel	Recent leg venous duplex without DVT . Treatment Hx : IVA OS - 3 / 8 / 19 IVA OS - 2 / 1 / 19 IVA OS - 12 / 28 / 18 IVFA ( 3 / 8 / 2018 ) : Quiescent PDR [s1] OU PRP [e1] OS ( session 1 ) - 8 / 4 / 17 - IVFA guided PRP OD ( session 2 ) - 7 / 7 / 17 - IVFA guided PRP OD ( session 1 ) - 6 / 16 / 17 - IVFA guided 1 .	Diabetic macular edema of right eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Here today for IVA OS for PDR / [s2] NVD [e2] .	laterality	lesion	T9	T24	note_1363
NonRel	Hx of PDR OU with new ciCSME [s1] OD [e1] .	OD : [s2] PDR [e2] with CSME that shows interval decrease .	laterality	lesion	T11	T15	note_1363
NonRel	Hx of PDR OU with new ciCSME [s1] OD [e1] .	OD : PDR with [s2] CSME [e2] that shows interval decrease .	laterality	lesion	T11	T16	note_1363
NonRel	Hx of PDR [s1] OU [e1] with new ciCSME OD .	OD : [s2] PDR [e2] with CSME that shows interval decrease .	laterality	lesion	T13	T15	note_1363
NonRel	Hx of PDR [s1] OU [e1] with new ciCSME OD .	OD : PDR with [s2] CSME [e2] that shows interval decrease .	laterality	lesion	T13	T16	note_1363
NonRel	[s1] OD [e1] : PDR with CSME that shows interval decrease .	Hx of PDR OU with new [s2] ciCSME [e2] OD .	laterality	lesion	T14	T10	note_1363
NonRel	[s1] OD [e1] : PDR with CSME that shows interval decrease .	Hx of [s2] PDR [e2] OU with new ciCSME OD .	laterality	lesion	T14	T12	note_1363
NonRel	[s1] OD [e1] : PDR with CSME that shows interval decrease .	S / p IVFA guided PRP x2. OS : [s2] PDR [e2] , + IRF today with VMT now resolved with PVD induction .	laterality	lesion	T14	T18	note_1363
NonRel	S / p IVFA guided PRP x2. [s1] OS [e1] : PDR , + IRF today with VMT now resolved with PVD induction .	OD : [s2] PDR [e2] with CSME that shows interval decrease .	laterality	lesion	T17	T15	note_1363
NonRel	S / p IVFA guided PRP x2. [s1] OS [e1] : PDR , + IRF today with VMT now resolved with PVD induction .	OD : PDR with [s2] CSME [e2] that shows interval decrease .	laterality	lesion	T17	T16	note_1363
NonRel	S / p IVFA guided PRP x2. [s1] OS [e1] : PDR , + IRF today with VMT now resolved with PVD induction .	+ NVD . IVA monthly x 6 months for new [s2] NVD [e2] ( Protocol S ) .	laterality	lesion	T17	T19	note_1363
NonRel	Diabetic macular edema of right eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Here today for IVA [s1] OS [e1] for PDR / NVD .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 2 .	laterality	lesion	T22	T1	note_1363
NonRel	Diabetic macular edema of right eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Here today for IVA [s1] OS [e1] for PDR / NVD .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 2 .	laterality	lesion	T22	T3	note_1363
NonRel	Diabetic macular edema of right eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Here today for IVA [s1] OS [e1] for PDR / NVD .	Recent leg venous duplex without DVT . Treatment Hx : IVA OS - 3 / 8 / 19 IVA OS - 2 / 1 / 19 IVA OS - 12 / 28 / 18 IVFA ( 3 / 8 / 2018 ) : Quiescent [s2] PDR [e2] OU PRP OS ( session 1 ) - 8 / 4 / 17 - IVFA guided PRP OD ( session 2 ) - 7 / 7 / 17 - IVFA guided PRP OD ( session 1 ) - 6 / 16 / 17 - IVFA guided 1 .	laterality	lesion	T22	T8	note_1363
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Pan Retinal Photocoagulation - OD - Right Eye 362.07 2 .	[s2] Diabetic retinopathy [e2] of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	laterality	lesion	T2	T4	note_2235
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Pan Retinal Photocoagulation - OD - Right Eye 362.07 2 .	Diabetic retinopathy of left eye , with [s2] macular edema [e2] , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	laterality	lesion	T2	T6	note_2235
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Pan Retinal Photocoagulation - OD - Right Eye 362.07 2 .	Diabetic retinopathy of left eye , with macular edema , with severe [s2] nonproliferative retinopathy [e2] , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	laterality	lesion	T2	T8	note_2235
NonRel	Diabetic retinopathy of [s1] left eye [e1] , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	Type 1 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema E10.3511 250.51 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Pan Retinal Photocoagulation - OD - Right Eye 362.07 2 .	laterality	lesion	T5	T1	note_2235
NonRel	Diabetic retinopathy of [s1] left eye [e1] , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] E10.3511 250.51 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Pan Retinal Photocoagulation - OD - Right Eye 362.07 2 .	laterality	lesion	T5	T3	note_2235
NonRel	Diabetic retinopathy of [s1] left eye [e1] , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	[s2] Vitreous hemorrhage [e2] of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T5	T9	note_2235
NonRel	Diabetic retinopathy of [s1] left eye [e1] , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe [s2] NPDR [e2] OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T5	T12	note_2235
NonRel	Diabetic retinopathy of [s1] left eye [e1] , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe [s2] NPDR [e2] OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T5	T15	note_2235
NonRel	Diabetic retinopathy of [s1] left eye [e1] , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of [s2] MAs [e2] , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T5	T17	note_2235
NonRel	Diabetic retinopathy of [s1] left eye [e1] , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + [s2] IRMA [e2] superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T5	T18	note_2235
NonRel	Diabetic retinopathy of [s1] left eye [e1] , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior [s2] vitreous heme [e2] , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T5	T24	note_2235
NonRel	Diabetic retinopathy of [s1] left eye [e1] , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , [s2] macular exudates [e2] OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T5	T26	note_2235
NonRel	Diabetic retinopathy of [s1] left eye [e1] , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal [s2] macular exudates [e2] and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T5	T31	note_2235
NonRel	Diabetic retinopathy of [s1] left eye [e1] , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T5	T32	note_2235
NonRel	Diabetic retinopathy of [s1] left eye [e1] , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	laterality	lesion	T5	T34	note_2235
NonRel	Diabetic retinopathy of left eye , with macular edema , with [s1] severe [e1] nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	Type 1 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema E10.3511 250.51 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Pan Retinal Photocoagulation - OD - Right Eye 362.07 2 .	severity	lesion	T7	T1	note_2235
NonRel	Diabetic retinopathy of left eye , with macular edema , with [s1] severe [e1] nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] E10.3511 250.51 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Pan Retinal Photocoagulation - OD - Right Eye 362.07 2 .	severity	lesion	T7	T3	note_2235
NonRel	Diabetic retinopathy of left eye , with macular edema , with [s1] severe [e1] nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	[s2] Vitreous hemorrhage [e2] of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T7	T9	note_2235
NonRel	Diabetic retinopathy of left eye , with macular edema , with [s1] severe [e1] nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe [s2] NPDR [e2] OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T7	T12	note_2235
NonRel	Diabetic retinopathy of left eye , with macular edema , with [s1] severe [e1] nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe [s2] NPDR [e2] OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T7	T15	note_2235
NonRel	Diabetic retinopathy of left eye , with macular edema , with [s1] severe [e1] nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of [s2] MAs [e2] , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T7	T17	note_2235
NonRel	Diabetic retinopathy of left eye , with macular edema , with [s1] severe [e1] nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + [s2] IRMA [e2] superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T7	T18	note_2235
NonRel	Diabetic retinopathy of left eye , with macular edema , with [s1] severe [e1] nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior [s2] vitreous heme [e2] , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T7	T24	note_2235
NonRel	Diabetic retinopathy of left eye , with macular edema , with [s1] severe [e1] nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , [s2] macular exudates [e2] OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T7	T26	note_2235
NonRel	Diabetic retinopathy of left eye , with macular edema , with [s1] severe [e1] nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal [s2] macular exudates [e2] and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T7	T31	note_2235
NonRel	Diabetic retinopathy of left eye , with macular edema , with [s1] severe [e1] nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T7	T32	note_2235
NonRel	Diabetic retinopathy of left eye , with macular edema , with [s1] severe [e1] nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	severity	lesion	T7	T34	note_2235
NonRel	Vitreous hemorrhage of [s1] right eye [e1] H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	[s2] Diabetic retinopathy [e2] of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	laterality	lesion	T10	T4	note_2235
NonRel	Vitreous hemorrhage of [s1] right eye [e1] H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with [s2] macular edema [e2] , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	laterality	lesion	T10	T6	note_2235
NonRel	Vitreous hemorrhage of [s1] right eye [e1] H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with macular edema , with severe [s2] nonproliferative retinopathy [e2] , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	laterality	lesion	T10	T8	note_2235
NonRel	Vitreous hemorrhage of [s1] right eye [e1] H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe [s2] NPDR [e2] OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T10	T36	note_2235
NonRel	Vitreous hemorrhage of [s1] right eye [e1] H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T10	T38	note_2235
NonRel	Vitreous hemorrhage of [s1] right eye [e1] H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Early PDR with temporal ME .	laterality	lesion	T10	T41	note_2235
NonRel	Vitreous hemorrhage of [s1] right eye [e1] H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early [s2] PDR [e2] with temporal ME .	laterality	lesion	T10	T45	note_2235
NonRel	Vitreous hemorrhage of [s1] right eye [e1] H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal [s2] ME [e2] .	laterality	lesion	T10	T47	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : [s1] Severe [e1] NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	[s2] Diabetic retinopathy [e2] of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	severity	lesion	T11	T4	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : [s1] Severe [e1] NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with [s2] macular edema [e2] , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	severity	lesion	T11	T6	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : [s1] Severe [e1] NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with macular edema , with severe [s2] nonproliferative retinopathy [e2] , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	severity	lesion	T11	T8	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : [s1] Severe [e1] NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe [s2] NPDR [e2] OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	severity	lesion	T11	T36	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : [s1] Severe [e1] NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	severity	lesion	T11	T38	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : [s1] Severe [e1] NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Early PDR with temporal ME .	severity	lesion	T11	T41	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : [s1] Severe [e1] NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early [s2] PDR [e2] with temporal ME .	severity	lesion	T11	T45	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : [s1] Severe [e1] NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal [s2] ME [e2] .	severity	lesion	T11	T47	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR [s1] OU [e1] IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	[s2] Diabetic retinopathy [e2] of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	laterality	lesion	T13	T4	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR [s1] OU [e1] IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with [s2] macular edema [e2] , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	laterality	lesion	T13	T6	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR [s1] OU [e1] IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with macular edema , with severe [s2] nonproliferative retinopathy [e2] , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	laterality	lesion	T13	T8	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR [s1] OU [e1] IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe [s2] NPDR [e2] OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T13	T36	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR [s1] OU [e1] IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T13	T38	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR [s1] OU [e1] IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Early PDR with temporal ME .	laterality	lesion	T13	T41	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR [s1] OU [e1] IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early [s2] PDR [e2] with temporal ME .	laterality	lesion	T13	T45	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR [s1] OU [e1] IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal [s2] ME [e2] .	laterality	lesion	T13	T47	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : [s1] Severe [e1] NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	[s2] Diabetic retinopathy [e2] of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	severity	lesion	T14	T4	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : [s1] Severe [e1] NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with [s2] macular edema [e2] , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	severity	lesion	T14	T6	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : [s1] Severe [e1] NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with macular edema , with severe [s2] nonproliferative retinopathy [e2] , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	severity	lesion	T14	T8	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : [s1] Severe [e1] NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe [s2] NPDR [e2] OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	severity	lesion	T14	T36	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : [s1] Severe [e1] NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	severity	lesion	T14	T38	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : [s1] Severe [e1] NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Early PDR with temporal ME .	severity	lesion	T14	T41	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : [s1] Severe [e1] NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early [s2] PDR [e2] with temporal ME .	severity	lesion	T14	T45	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : [s1] Severe [e1] NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal [s2] ME [e2] .	severity	lesion	T14	T47	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR [s1] OS [e1] IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	[s2] Diabetic retinopathy [e2] of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	laterality	lesion	T16	T4	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR [s1] OS [e1] IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with [s2] macular edema [e2] , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	laterality	lesion	T16	T6	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR [s1] OS [e1] IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with macular edema , with severe [s2] nonproliferative retinopathy [e2] , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	laterality	lesion	T16	T8	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR [s1] OS [e1] IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe [s2] NPDR [e2] OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T16	T36	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR [s1] OS [e1] IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T16	T38	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR [s1] OS [e1] IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Early PDR with temporal ME .	laterality	lesion	T16	T41	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR [s1] OS [e1] IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early [s2] PDR [e2] with temporal ME .	laterality	lesion	T16	T45	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR [s1] OS [e1] IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal [s2] ME [e2] .	laterality	lesion	T16	T47	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme [s1] OD [e1] and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	[s2] Diabetic retinopathy [e2] of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	laterality	lesion	T23	T4	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme [s1] OD [e1] and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with [s2] macular edema [e2] , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	laterality	lesion	T23	T6	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme [s1] OD [e1] and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with macular edema , with severe [s2] nonproliferative retinopathy [e2] , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	laterality	lesion	T23	T8	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme [s1] OD [e1] and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe [s2] NPDR [e2] OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T23	T36	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme [s1] OD [e1] and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T23	T38	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme [s1] OD [e1] and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Early PDR with temporal ME .	laterality	lesion	T23	T41	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme [s1] OD [e1] and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early [s2] PDR [e2] with temporal ME .	laterality	lesion	T23	T45	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme [s1] OD [e1] and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal [s2] ME [e2] .	laterality	lesion	T23	T47	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates [s1] OD [e1] , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	[s2] Diabetic retinopathy [e2] of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	laterality	lesion	T27	T4	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates [s1] OD [e1] , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with [s2] macular edema [e2] , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	laterality	lesion	T27	T6	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates [s1] OD [e1] , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with macular edema , with severe [s2] nonproliferative retinopathy [e2] , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	laterality	lesion	T27	T8	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates [s1] OD [e1] , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe [s2] NPDR [e2] OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T27	T36	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates [s1] OD [e1] , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T27	T38	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates [s1] OD [e1] , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Early PDR with temporal ME .	laterality	lesion	T27	T41	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates [s1] OD [e1] , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early [s2] PDR [e2] with temporal ME .	laterality	lesion	T27	T45	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates [s1] OD [e1] , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal [s2] ME [e2] .	laterality	lesion	T27	T47	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , [s1] OS [e1] with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	[s2] Diabetic retinopathy [e2] of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	laterality	lesion	T28	T4	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , [s1] OS [e1] with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with [s2] macular edema [e2] , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	laterality	lesion	T28	T6	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , [s1] OS [e1] with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with macular edema , with severe [s2] nonproliferative retinopathy [e2] , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	laterality	lesion	T28	T8	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , [s1] OS [e1] with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe [s2] NPDR [e2] OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T28	T36	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , [s1] OS [e1] with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T28	T38	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , [s1] OS [e1] with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Early PDR with temporal ME .	laterality	lesion	T28	T41	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , [s1] OS [e1] with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early [s2] PDR [e2] with temporal ME .	laterality	lesion	T28	T45	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , [s1] OS [e1] with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal [s2] ME [e2] .	laterality	lesion	T28	T47	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with [s1] temporal [e1] macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	[s2] Diabetic retinopathy [e2] of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	severity	lesion	T29	T4	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with [s1] temporal [e1] macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with [s2] macular edema [e2] , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	severity	lesion	T29	T6	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with [s1] temporal [e1] macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with macular edema , with severe [s2] nonproliferative retinopathy [e2] , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	severity	lesion	T29	T8	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with [s1] temporal [e1] macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe [s2] NPDR [e2] OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	severity	lesion	T29	T36	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with [s1] temporal [e1] macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	severity	lesion	T29	T38	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with [s1] temporal [e1] macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Early PDR with temporal ME .	severity	lesion	T29	T41	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with [s1] temporal [e1] macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early [s2] PDR [e2] with temporal ME .	severity	lesion	T29	T45	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with [s1] temporal [e1] macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal [s2] ME [e2] .	severity	lesion	T29	T47	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	[s2] Diabetic retinopathy [e2] of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	laterality	lesion	T33	T4	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with [s2] macular edema [e2] , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	laterality	lesion	T33	T6	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with macular edema , with severe [s2] nonproliferative retinopathy [e2] , associated with type 1 diabetes mellitus E10.3412 250.51 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.06 3 .	laterality	lesion	T33	T8	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Severe [s2] NPDR [e2] OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T33	T36	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T33	T38	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Early PDR with temporal ME .	laterality	lesion	T33	T41	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early [s2] PDR [e2] with temporal ME .	laterality	lesion	T33	T45	note_2235
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal [s2] ME [e2] .	laterality	lesion	T33	T47	note_2235
NonRel	[s1] Severe [e1] NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	[s2] Vitreous hemorrhage [e2] of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T35	T9	note_2235
NonRel	[s1] Severe [e1] NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe [s2] NPDR [e2] OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T35	T12	note_2235
NonRel	[s1] Severe [e1] NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe [s2] NPDR [e2] OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T35	T15	note_2235
NonRel	[s1] Severe [e1] NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of [s2] MAs [e2] , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T35	T17	note_2235
NonRel	[s1] Severe [e1] NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + [s2] IRMA [e2] superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T35	T18	note_2235
NonRel	[s1] Severe [e1] NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior [s2] vitreous heme [e2] , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T35	T24	note_2235
NonRel	[s1] Severe [e1] NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , [s2] macular exudates [e2] OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T35	T26	note_2235
NonRel	[s1] Severe [e1] NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal [s2] macular exudates [e2] and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T35	T31	note_2235
NonRel	[s1] Severe [e1] NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T35	T32	note_2235
NonRel	[s1] Severe [e1] NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	severity	lesion	T35	T34	note_2235
NonRel	[s1] Severe [e1] NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	With previous [s2] VH [e2] OD , stable to last visit with observation .	severity	lesion	T35	T48	note_2235
NonRel	Severe NPDR [s1] OS [e1] . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	[s2] Vitreous hemorrhage [e2] of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T37	T9	note_2235
NonRel	Severe NPDR [s1] OS [e1] . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe [s2] NPDR [e2] OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T37	T12	note_2235
NonRel	Severe NPDR [s1] OS [e1] . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe [s2] NPDR [e2] OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T37	T15	note_2235
NonRel	Severe NPDR [s1] OS [e1] . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of [s2] MAs [e2] , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T37	T17	note_2235
NonRel	Severe NPDR [s1] OS [e1] . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + [s2] IRMA [e2] superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T37	T18	note_2235
NonRel	Severe NPDR [s1] OS [e1] . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior [s2] vitreous heme [e2] , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T37	T24	note_2235
NonRel	Severe NPDR [s1] OS [e1] . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , [s2] macular exudates [e2] OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T37	T26	note_2235
NonRel	Severe NPDR [s1] OS [e1] . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal [s2] macular exudates [e2] and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T37	T31	note_2235
NonRel	Severe NPDR [s1] OS [e1] . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T37	T32	note_2235
NonRel	Severe NPDR [s1] OS [e1] . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	laterality	lesion	T37	T34	note_2235
NonRel	Severe NPDR [s1] OS [e1] . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	With previous [s2] VH [e2] OD , stable to last visit with observation .	laterality	lesion	T37	T48	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Early PDR with temporal ME .	[s2] Vitreous hemorrhage [e2] of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T39	T9	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe [s2] NPDR [e2] OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T39	T12	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe [s2] NPDR [e2] OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T39	T15	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of [s2] MAs [e2] , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T39	T17	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + [s2] IRMA [e2] superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T39	T18	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior [s2] vitreous heme [e2] , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T39	T24	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , [s2] macular exudates [e2] OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T39	T26	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal [s2] macular exudates [e2] and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T39	T31	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T39	T32	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	laterality	lesion	T39	T34	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Early PDR with temporal ME .	With previous [s2] VH [e2] OD , stable to last visit with observation .	laterality	lesion	T39	T48	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Early PDR with temporal ME .	[s2] Vitreous hemorrhage [e2] of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T40	T9	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe [s2] NPDR [e2] OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T40	T12	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe [s2] NPDR [e2] OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T40	T15	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of [s2] MAs [e2] , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T40	T17	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + [s2] IRMA [e2] superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T40	T18	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior [s2] vitreous heme [e2] , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T40	T24	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , [s2] macular exudates [e2] OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T40	T26	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal [s2] macular exudates [e2] and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T40	T31	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T40	T32	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	severity	lesion	T40	T34	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Early PDR with temporal ME .	With previous [s2] VH [e2] OD , stable to last visit with observation .	severity	lesion	T40	T48	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Early PDR with temporal ME .	[s2] Vitreous hemorrhage [e2] of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T42	T9	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe [s2] NPDR [e2] OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T42	T12	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe [s2] NPDR [e2] OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T42	T15	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of [s2] MAs [e2] , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T42	T17	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + [s2] IRMA [e2] superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T42	T18	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior [s2] vitreous heme [e2] , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T42	T24	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , [s2] macular exudates [e2] OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T42	T26	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal [s2] macular exudates [e2] and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T42	T31	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T42	T32	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	laterality	lesion	T42	T34	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Early PDR with temporal ME .	With previous [s2] VH [e2] OD , stable to last visit with observation .	laterality	lesion	T42	T48	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) [s1] OD [e1] - Early PDR with temporal ME .	[s2] Vitreous hemorrhage [e2] of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T43	T9	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) [s1] OD [e1] - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe [s2] NPDR [e2] OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T43	T12	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) [s1] OD [e1] - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe [s2] NPDR [e2] OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T43	T15	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) [s1] OD [e1] - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of [s2] MAs [e2] , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T43	T17	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) [s1] OD [e1] - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + [s2] IRMA [e2] superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T43	T18	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) [s1] OD [e1] - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior [s2] vitreous heme [e2] , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T43	T24	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) [s1] OD [e1] - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , [s2] macular exudates [e2] OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T43	T26	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) [s1] OD [e1] - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal [s2] macular exudates [e2] and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T43	T31	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) [s1] OD [e1] - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T43	T32	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) [s1] OD [e1] - Early PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	laterality	lesion	T43	T34	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) [s1] OD [e1] - Early PDR with temporal ME .	With previous [s2] VH [e2] OD , stable to last visit with observation .	laterality	lesion	T43	T48	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Early [e1] PDR with temporal ME .	[s2] Vitreous hemorrhage [e2] of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T44	T9	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Early [e1] PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe [s2] NPDR [e2] OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T44	T12	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Early [e1] PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe [s2] NPDR [e2] OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T44	T15	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Early [e1] PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of [s2] MAs [e2] , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T44	T17	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Early [e1] PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + [s2] IRMA [e2] superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T44	T18	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Early [e1] PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior [s2] vitreous heme [e2] , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T44	T24	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Early [e1] PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , [s2] macular exudates [e2] OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T44	T26	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Early [e1] PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal [s2] macular exudates [e2] and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T44	T31	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Early [e1] PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T44	T32	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Early [e1] PDR with temporal ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	severity	lesion	T44	T34	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Early [e1] PDR with temporal ME .	With previous [s2] VH [e2] OD , stable to last visit with observation .	severity	lesion	T44	T48	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with [s1] temporal [e1] ME .	[s2] Vitreous hemorrhage [e2] of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T46	T9	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with [s1] temporal [e1] ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe [s2] NPDR [e2] OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T46	T12	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with [s1] temporal [e1] ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe [s2] NPDR [e2] OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T46	T15	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with [s1] temporal [e1] ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of [s2] MAs [e2] , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T46	T17	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with [s1] temporal [e1] ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + [s2] IRMA [e2] superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T46	T18	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with [s1] temporal [e1] ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior [s2] vitreous heme [e2] , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T46	T24	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with [s1] temporal [e1] ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , [s2] macular exudates [e2] OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T46	T26	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with [s1] temporal [e1] ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal [s2] macular exudates [e2] and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T46	T31	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with [s1] temporal [e1] ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T46	T32	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with [s1] temporal [e1] ME .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS IVFA - 9 / 13 / 16 : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos 9 / 13 / 2016 : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	severity	lesion	T46	T34	note_2235
NonRel	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with [s1] temporal [e1] ME .	With previous [s2] VH [e2] OD , stable to last visit with observation .	severity	lesion	T46	T48	note_2235
NonRel	With previous VH [s1] OD [e1] , stable to last visit with observation .	Severe [s2] NPDR [e2] OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T49	T36	note_2235
NonRel	With previous VH [s1] OD [e1] , stable to last visit with observation .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T49	T38	note_2235
NonRel	With previous VH [s1] OD [e1] , stable to last visit with observation .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Early PDR with temporal ME .	laterality	lesion	T49	T41	note_2235
NonRel	With previous VH [s1] OD [e1] , stable to last visit with observation .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early [s2] PDR [e2] with temporal ME .	laterality	lesion	T49	T45	note_2235
NonRel	With previous VH [s1] OD [e1] , stable to last visit with observation .	Severe NPDR OS . 12 / 16 / 2016 - Sectoral PRP OD , IVA # 1 OU . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal [s2] ME [e2] .	laterality	lesion	T49	T47	note_2235
NonRel	Repeat of IVFA demonstrated one spot of [s1] mild [e1] NVE .	Clinically still has significant [s2] vitreous hemorrhage [e2] inferiorly He has macular edema .	severity	lesion	T50	T53	note_2235
NonRel	Repeat of IVFA demonstrated one spot of [s1] mild [e1] NVE .	Clinically still has significant vitreous hemorrhage inferiorly He has [s2] macular edema [e2] .	severity	lesion	T50	T54	note_2235
NonRel	Clinically still has [s1] significant [e1] vitreous hemorrhage inferiorly He has macular edema .	Repeat of IVFA demonstrated one spot of mild [s2] NVE [e2] .	severity	lesion	T52	T51	note_2235
NonRel	Clinically still has [s1] significant [e1] vitreous hemorrhage inferiorly He has macular edema .	Today : PRP + IVA # 1 of 3 OS - Severe [s2] NPDR [e2] with CSME .	severity	lesion	T52	T57	note_2235
NonRel	Clinically still has [s1] significant [e1] vitreous hemorrhage inferiorly He has macular edema .	Today : PRP + IVA # 1 of 3 OS - Severe NPDR with [s2] CSME [e2] .	severity	lesion	T52	T58	note_2235
NonRel	Today : PRP + IVA # 1 of 3 [s1] OS [e1] - Severe NPDR with CSME .	Clinically still has significant [s2] vitreous hemorrhage [e2] inferiorly He has macular edema .	laterality	lesion	T55	T53	note_2235
NonRel	Today : PRP + IVA # 1 of 3 [s1] OS [e1] - Severe NPDR with CSME .	Clinically still has significant vitreous hemorrhage inferiorly He has [s2] macular edema [e2] .	laterality	lesion	T55	T54	note_2235
NonRel	Today : PRP + IVA # 1 of 3 OS - [s1] Severe [e1] NPDR with CSME .	Clinically still has significant [s2] vitreous hemorrhage [e2] inferiorly He has macular edema .	severity	lesion	T56	T53	note_2235
NonRel	Today : PRP + IVA # 1 of 3 OS - [s1] Severe [e1] NPDR with CSME .	Clinically still has significant vitreous hemorrhage inferiorly He has [s2] macular edema [e2] .	severity	lesion	T56	T54	note_2235
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T14	T4	note_7563
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T14	T5	note_7563
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T14	T6	note_7563
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T14	T7	note_7563
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	severity	lesion	T14	T8	note_7563
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	severity	lesion	T14	T9	note_7563
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T15	T4	note_7563
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T15	T5	note_7563
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T15	T6	note_7563
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T15	T7	note_7563
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	laterality	lesion	T15	T8	note_7563
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	laterality	lesion	T15	T9	note_7563
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T16	T3	note_7563
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T16	T2	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - [s1] Severe [e1] NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	severity	lesion	T17	T3	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - [s1] Severe [e1] NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	severity	lesion	T17	T2	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR [s1] OS [e1] Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T18	T3	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR [s1] OS [e1] Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T18	T2	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR [s1] OD [e1] , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T19	T3	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR [s1] OD [e1] , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T19	T2	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - [s1] Severe [e1] NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	severity	lesion	T20	T3	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - [s1] Severe [e1] NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	severity	lesion	T20	T2	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] [s1] OD [e1] - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T21	T3	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] [s1] OD [e1] - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T21	T2	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , [s1] Active [e1] PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	severity	lesion	T25	T3	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , [s1] Active [e1] PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	severity	lesion	T25	T2	note_7563
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus - Right Eye E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 CANCELED : OCT , Retina - OU - Both Eyes 362.02 Treatment Hx : IVA OD - 3 / 16 / 18 ( today ) PPV / SDEM / Retinectomy / SO ( OS ) - 1 / 22 / 18 IVA OD - 12 / 28 / 17 PPV / ML / SDEM / AFX / EPC / C3F8 ( OS ) 11 / 6 / 17 IVA OS - 11 / 2 / 17 IVA OD - 10 / 12 / 17 IVA OD - 8 / 4 / 17 PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active PDR OU 1 ) IDDM [ Type II , Dx 2002 ] .	Active [s2] PDR [e2] OU , TRD OS .	laterality	lesion	T1	T5	note_8502
NonRel	Active PDR [s1] OU [e1] , TRD OS .	[s2] Proliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus - Right Eye E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 CANCELED : OCT , Retina - OU - Both Eyes 362.02 Treatment Hx : IVA OD - 3 / 16 / 18 ( today ) PPV / SDEM / Retinectomy / SO ( OS ) - 1 / 22 / 18 IVA OD - 12 / 28 / 17 PPV / ML / SDEM / AFX / EPC / C3F8 ( OS ) 11 / 6 / 17 IVA OS - 11 / 2 / 17 IVA OD - 10 / 12 / 17 IVA OD - 8 / 4 / 17 PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active PDR OU 1 ) IDDM [ Type II , Dx 2002 ] .	laterality	lesion	T9	T3	note_8502
NonRel	Active PDR [s1] OU [e1] , TRD OS .	Proliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus - Right Eye E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 CANCELED : OCT , Retina - OU - Both Eyes 362.02 Treatment Hx : IVA OD - 3 / 16 / 18 ( today ) PPV / SDEM / Retinectomy / SO ( OS ) - 1 / 22 / 18 IVA OD - 12 / 28 / 17 PPV / ML / SDEM / AFX / EPC / C3F8 ( OS ) 11 / 6 / 17 IVA OS - 11 / 2 / 17 IVA OD - 10 / 12 / 17 IVA OD - 8 / 4 / 17 PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active PDR OU 1 ) IDDM [ Type II , Dx 2002 ] .	laterality	lesion	T9	T4	note_8502
NonRel	Active PDR [s1] OU [e1] , TRD OS .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus - Right Eye E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 CANCELED : OCT , Retina - OU - Both Eyes 362.02 Treatment Hx : IVA OD - 3 / 16 / 18 ( today ) PPV / SDEM / Retinectomy / SO ( OS ) - 1 / 22 / 18 IVA OD - 12 / 28 / 17 PPV / ML / SDEM / AFX / EPC / C3F8 ( OS ) 11 / 6 / 17 IVA OS - 11 / 2 / 17 IVA OD - 10 / 12 / 17 IVA OD - 8 / 4 / 17 PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active [s2] PDR [e2] OU 1 ) IDDM [ Type II , Dx 2002 ] .	laterality	lesion	T9	T13	note_8502
NonRel	[s1] Active [e1] PDR OU , TRD OS .	[s2] Proliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus - Right Eye E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 CANCELED : OCT , Retina - OU - Both Eyes 362.02 Treatment Hx : IVA OD - 3 / 16 / 18 ( today ) PPV / SDEM / Retinectomy / SO ( OS ) - 1 / 22 / 18 IVA OD - 12 / 28 / 17 PPV / ML / SDEM / AFX / EPC / C3F8 ( OS ) 11 / 6 / 17 IVA OS - 11 / 2 / 17 IVA OD - 10 / 12 / 17 IVA OD - 8 / 4 / 17 PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active PDR OU 1 ) IDDM [ Type II , Dx 2002 ] .	severity	lesion	T11	T3	note_8502
NonRel	[s1] Active [e1] PDR OU , TRD OS .	Proliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus - Right Eye E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 CANCELED : OCT , Retina - OU - Both Eyes 362.02 Treatment Hx : IVA OD - 3 / 16 / 18 ( today ) PPV / SDEM / Retinectomy / SO ( OS ) - 1 / 22 / 18 IVA OD - 12 / 28 / 17 PPV / ML / SDEM / AFX / EPC / C3F8 ( OS ) 11 / 6 / 17 IVA OS - 11 / 2 / 17 IVA OD - 10 / 12 / 17 IVA OD - 8 / 4 / 17 PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active PDR OU 1 ) IDDM [ Type II , Dx 2002 ] .	severity	lesion	T11	T4	note_8502
NonRel	[s1] Active [e1] PDR OU , TRD OS .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus - Right Eye E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 CANCELED : OCT , Retina - OU - Both Eyes 362.02 Treatment Hx : IVA OD - 3 / 16 / 18 ( today ) PPV / SDEM / Retinectomy / SO ( OS ) - 1 / 22 / 18 IVA OD - 12 / 28 / 17 PPV / ML / SDEM / AFX / EPC / C3F8 ( OS ) 11 / 6 / 17 IVA OS - 11 / 2 / 17 IVA OD - 10 / 12 / 17 IVA OD - 8 / 4 / 17 PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active [s2] PDR [e2] OU 1 ) IDDM [ Type II , Dx 2002 ] .	severity	lesion	T11	T13	note_8502
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus - Right Eye E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 CANCELED : OCT , Retina - OU - Both Eyes 362.02 Treatment Hx : IVA OD - 3 / 16 / 18 ( today ) PPV / SDEM / Retinectomy / SO ( OS ) - 1 / 22 / 18 IVA OD - 12 / 28 / 17 PPV / ML / SDEM / AFX / EPC / C3F8 ( OS ) 11 / 6 / 17 IVA OS - 11 / 2 / 17 IVA OD - 10 / 12 / 17 IVA OD - 8 / 4 / 17 PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active PDR [s1] OU [e1] 1 ) IDDM [ Type II , Dx 2002 ] .	Active [s2] PDR [e2] OU , TRD OS .	laterality	lesion	T12	T5	note_8502
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus - Right Eye E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 CANCELED : OCT , Retina - OU - Both Eyes 362.02 Treatment Hx : IVA OD - 3 / 16 / 18 ( today ) PPV / SDEM / Retinectomy / SO ( OS ) - 1 / 22 / 18 IVA OD - 12 / 28 / 17 PPV / ML / SDEM / AFX / EPC / C3F8 ( OS ) 11 / 6 / 17 IVA OS - 11 / 2 / 17 IVA OD - 10 / 12 / 17 IVA OD - 8 / 4 / 17 PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - [s1] Active [e1] PDR OU 1 ) IDDM [ Type II , Dx 2002 ] .	Active [s2] PDR [e2] OU , TRD OS .	severity	lesion	T14	T5	note_8502
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema ( CMS - HCC code ) E10.3511 250.51 OCT , Posterior Segment - OU - Both Eyes 362.02 362.07 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3512 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02	laterality	lesion	T5	T3	note_2297
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema ( CMS - HCC code ) E10.3511 250.51 OCT , Posterior Segment - OU - Both Eyes 362.02 362.07 2 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3512 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02	laterality	lesion	T5	T4	note_2297
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3512 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02	Type 1 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema ( CMS - HCC code ) E10.3511 250.51 OCT , Posterior Segment - OU - Both Eyes 362.02 362.07 2 .	laterality	lesion	T6	T1	note_2297
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3512 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] ( CMS - HCC code ) E10.3511 250.51 OCT , Posterior Segment - OU - Both Eyes 362.02 362.07 2 .	laterality	lesion	T6	T2	note_2297
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 1 diabetes mellitus - Right Eye E10.3511 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Pan Retinal Photocoagulation - OD - Right Eye 2 .	[s2] Diabetic macular edema [e2] of left eye with proliferative retinopathy associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Mr. Colonair is referred from Dr. Cameron for evaluation of PDR OU . 1 .	laterality	lesion	T2	T4	note_7939
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 1 diabetes mellitus - Right Eye E10.3511 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Pan Retinal Photocoagulation - OD - Right Eye 2 .	Diabetic macular edema of left eye with [s2] proliferative retinopathy [e2] associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Mr. Colonair is referred from Dr. Cameron for evaluation of PDR OU . 1 .	laterality	lesion	T2	T6	note_7939
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 1 diabetes mellitus - Right Eye E10.3511 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Pan Retinal Photocoagulation - OD - Right Eye 2 .	Diabetic macular edema of left eye with proliferative retinopathy associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Mr. Colonair is referred from Dr. Cameron for evaluation of [s2] PDR [e2] OU . 1 .	laterality	lesion	T2	T7	note_7939
NonRel	Diabetic macular edema of [s1] left eye [e1] with proliferative retinopathy associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Mr. Colonair is referred from Dr. Cameron for evaluation of PDR OU . 1 .	[s2] Diabetic macular edema [e2] of right eye with proliferative retinopathy associated with type 1 diabetes mellitus - Right Eye E10.3511 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Pan Retinal Photocoagulation - OD - Right Eye 2 .	laterality	lesion	T5	T1	note_7939
NonRel	Diabetic macular edema of [s1] left eye [e1] with proliferative retinopathy associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Mr. Colonair is referred from Dr. Cameron for evaluation of PDR OU . 1 .	Diabetic macular edema of right eye with [s2] proliferative retinopathy [e2] associated with type 1 diabetes mellitus - Right Eye E10.3511 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Pan Retinal Photocoagulation - OD - Right Eye 2 .	laterality	lesion	T5	T3	note_7939
NonRel	Diabetic macular edema of left eye with proliferative retinopathy associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Mr. Colonair is referred from Dr. Cameron for evaluation of PDR [s1] OU [e1] . 1 .	[s2] Diabetic macular edema [e2] of right eye with proliferative retinopathy associated with type 1 diabetes mellitus - Right Eye E10.3511 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Pan Retinal Photocoagulation - OD - Right Eye 2 .	laterality	lesion	T8	T1	note_7939
NonRel	Diabetic macular edema of left eye with proliferative retinopathy associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Mr. Colonair is referred from Dr. Cameron for evaluation of PDR [s1] OU [e1] . 1 .	Diabetic macular edema of right eye with [s2] proliferative retinopathy [e2] associated with type 1 diabetes mellitus - Right Eye E10.3511 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Pan Retinal Photocoagulation - OD - Right Eye 2 .	laterality	lesion	T8	T3	note_7939
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy [s1] OD [e1] - Active PDR without CSME ( + DME ) on exam .	OS - Active [s2] PDR [e2] with sub - hyaloid hemorrhage .	laterality	lesion	T9	T16	note_7939
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy [s1] OD [e1] - Active PDR without CSME ( + DME ) on exam .	OS - Active PDR with [s2] sub - hyaloid hemorrhage [e2] .	laterality	lesion	T9	T17	note_7939
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy OD - [s1] Active [e1] PDR without CSME ( + DME ) on exam .	OS - Active [s2] PDR [e2] with sub - hyaloid hemorrhage .	severity	lesion	T10	T16	note_7939
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy OD - [s1] Active [e1] PDR without CSME ( + DME ) on exam .	OS - Active PDR with [s2] sub - hyaloid hemorrhage [e2] .	severity	lesion	T10	T17	note_7939
NonRel	[s1] OS [e1] - Active PDR with sub - hyaloid hemorrhage .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy OD - Active [s2] PDR [e2] without CSME ( + DME ) on exam .	laterality	lesion	T14	T11	note_7939
NonRel	[s1] OS [e1] - Active PDR with sub - hyaloid hemorrhage .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy OD - Active PDR without [s2] CSME [e2] ( + DME ) on exam .	laterality	lesion	T14	T12	note_7939
NonRel	[s1] OS [e1] - Active PDR with sub - hyaloid hemorrhage .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy OD - Active PDR without CSME ( + [s2] DME [e2] ) on exam .	laterality	lesion	T14	T13	note_7939
NonRel	[s1] OS [e1] - Active PDR with sub - hyaloid hemorrhage .	Mild temporal [s2] macular edema [e2] Plan IVFA - Guided PRP OU with IVA pre - treatment OS .	laterality	lesion	T14	T20	note_7939
NonRel	OS - [s1] Active [e1] PDR with sub - hyaloid hemorrhage .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy OD - Active [s2] PDR [e2] without CSME ( + DME ) on exam .	severity	lesion	T15	T11	note_7939
NonRel	OS - [s1] Active [e1] PDR with sub - hyaloid hemorrhage .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy OD - Active PDR without [s2] CSME [e2] ( + DME ) on exam .	severity	lesion	T15	T12	note_7939
NonRel	OS - [s1] Active [e1] PDR with sub - hyaloid hemorrhage .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy OD - Active PDR without CSME ( + [s2] DME [e2] ) on exam .	severity	lesion	T15	T13	note_7939
NonRel	OS - [s1] Active [e1] PDR with sub - hyaloid hemorrhage .	Mild temporal [s2] macular edema [e2] Plan IVFA - Guided PRP OU with IVA pre - treatment OS .	severity	lesion	T15	T20	note_7939
NonRel	[s1] Mild [e1] temporal macular edema Plan IVFA - Guided PRP OU with IVA pre - treatment OS .	OS - Active [s2] PDR [e2] with sub - hyaloid hemorrhage .	severity	lesion	T18	T16	note_7939
NonRel	[s1] Mild [e1] temporal macular edema Plan IVFA - Guided PRP OU with IVA pre - treatment OS .	OS - Active PDR with [s2] sub - hyaloid hemorrhage [e2] .	severity	lesion	T18	T17	note_7939
NonRel	Mild [s1] temporal [e1] macular edema Plan IVFA - Guided PRP OU with IVA pre - treatment OS .	OS - Active [s2] PDR [e2] with sub - hyaloid hemorrhage .	severity	lesion	T19	T16	note_7939
NonRel	Mild [s1] temporal [e1] macular edema Plan IVFA - Guided PRP OU with IVA pre - treatment OS .	OS - Active PDR with [s2] sub - hyaloid hemorrhage [e2] .	severity	lesion	T19	T17	note_7939
NonRel	Mild temporal macular edema Plan IVFA - Guided PRP [s1] OU [e1] with IVA pre - treatment OS .	OS - Active [s2] PDR [e2] with sub - hyaloid hemorrhage .	laterality	lesion	T21	T16	note_7939
NonRel	Mild temporal macular edema Plan IVFA - Guided PRP [s1] OU [e1] with IVA pre - treatment OS .	OS - Active PDR with [s2] sub - hyaloid hemorrhage [e2] .	laterality	lesion	T21	T17	note_7939
NonRel	Treatment History IVA OD - DATE ( today ) PRP OS ( IVFA - guided ) - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVFA ( DATE ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) DM - PDR [s1] OU [e1] , SHH OD OD : Active PDR with large VH and now new SHH .	Will need PRP in the future once [s2] SHH [e2] clears .	laterality	lesion	T11	T9	1649489_note_3986
NonRel	Treatment History IVA OD - DATE ( today ) PRP OS ( IVFA - guided ) - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVFA ( DATE ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) DM - PDR OU , SHH OD [s1] OD [e1] : Active PDR with large VH and now new SHH .	Will need PRP in the future once [s2] SHH [e2] clears .	laterality	lesion	T12	T9	1649489_note_3986
NonRel	Treatment History IVA OD - DATE ( today ) PRP OS ( IVFA - guided ) - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVFA ( DATE ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) DM - PDR OU , SHH OD OD : Active PDR with [s1] large [e1] VH and now new SHH .	Will need PRP in the future once [s2] SHH [e2] clears .	severity	lesion	T13	T9	1649489_note_3986
NonRel	Treatment History IVA OD - DATE ( today ) PRP OS ( IVFA - guided ) - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVFA ( DATE ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) DM - PDR OU , SHH OD OD : [s1] Active [e1] PDR with large VH and now new SHH .	Will need PRP in the future once [s2] SHH [e2] clears .	severity	lesion	T17	T9	1649489_note_3986
NonRel	Treatment History IVA OD - DATE ( today ) PRP OS ( IVFA - guided ) - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVFA ( DATE ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) DM - PDR OU , SHH [s1] OD [e1] OD : Active PDR with large VH and now new SHH .	Will need PRP in the future once [s2] SHH [e2] clears .	laterality	lesion	T19	T9	1649489_note_3986
NonRel	OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : good foveal contour , trace IRF improved from 3 / 2018 OS : foveal inversion with significant IRF , slightly worse from 3 / 2018 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU , vision stable per patient , blood sugars improving .	laterality	lesion	T1	T6	note_7745
NonRel	OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : good foveal contour , trace IRF improved from 3 / 2018 OS : foveal inversion with significant IRF , slightly worse from 3 / 2018 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU , vision stable per patient , blood sugars improving .	laterality	lesion	T1	T8	note_7745
NonRel	OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : good foveal contour , trace IRF improved from 3 / 2018 OS : foveal inversion with significant IRF , slightly worse from 3 / 2018 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU , vision stable per patient , blood sugars improving .	laterality	lesion	T1	T10	note_7745
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : good foveal contour , trace IRF improved from 3 / 2018 [s1] OS [e1] : foveal inversion with significant IRF , slightly worse from 3 / 2018 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU , vision stable per patient , blood sugars improving .	laterality	lesion	T2	T6	note_7745
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : good foveal contour , trace IRF improved from 3 / 2018 [s1] OS [e1] : foveal inversion with significant IRF , slightly worse from 3 / 2018 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU , vision stable per patient , blood sugars improving .	laterality	lesion	T2	T8	note_7745
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : good foveal contour , trace IRF improved from 3 / 2018 [s1] OS [e1] : foveal inversion with significant IRF , slightly worse from 3 / 2018 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU , vision stable per patient , blood sugars improving .	laterality	lesion	T2	T10	note_7745
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : good foveal contour , trace IRF improved from 3 / 2018 OS : foveal inversion with [s1] significant [e1] IRF , slightly worse from 3 / 2018 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU , vision stable per patient , blood sugars improving .	severity	lesion	T3	T6	note_7745
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : good foveal contour , trace IRF improved from 3 / 2018 OS : foveal inversion with [s1] significant [e1] IRF , slightly worse from 3 / 2018 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU , vision stable per patient , blood sugars improving .	severity	lesion	T3	T8	note_7745
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : good foveal contour , trace IRF improved from 3 / 2018 OS : foveal inversion with [s1] significant [e1] IRF , slightly worse from 3 / 2018 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU , vision stable per patient , blood sugars improving .	severity	lesion	T3	T10	note_7745
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU , vision stable per patient , blood sugars improving .	OCT , Posterior Segment - OU - Both Eyes OD : good foveal contour , trace IRF improved from 3 / 2018 OS : foveal inversion with significant [s2] IRF [e2] , slightly worse from 3 / 2018 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	severity	lesion	T5	T4	note_7745
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU , vision stable per patient , blood sugars improving .	Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T5	T13	note_7745
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU , vision stable per patient , blood sugars improving .	OCT , Posterior Segment - OU - Both Eyes OD : good foveal contour , trace IRF improved from 3 / 2018 OS : foveal inversion with significant [s2] IRF [e2] , slightly worse from 3 / 2018 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T7	T4	note_7745
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU , vision stable per patient , blood sugars improving .	Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T7	T13	note_7745
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU , vision stable per patient , blood sugars improving .	OCT , Posterior Segment - OU - Both Eyes OD : good foveal contour , trace IRF improved from 3 / 2018 OS : foveal inversion with significant [s2] IRF [e2] , slightly worse from 3 / 2018 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	severity	lesion	T9	T4	note_7745
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU , vision stable per patient , blood sugars improving .	Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T9	T13	note_7745
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] , vision stable per patient , blood sugars improving .	OCT , Posterior Segment - OU - Both Eyes OD : good foveal contour , trace IRF improved from 3 / 2018 OS : foveal inversion with significant [s2] IRF [e2] , slightly worse from 3 / 2018 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T11	T4	note_7745
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] , vision stable per patient , blood sugars improving .	Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T11	T13	note_7745
NonRel	Treatment Hx : IVFA ( 1 / 19 / 18 ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU , vision stable per patient , blood sugars improving .	severity	lesion	T12	T6	note_7745
NonRel	Treatment Hx : IVFA ( 1 / 19 / 18 ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU , vision stable per patient , blood sugars improving .	severity	lesion	T12	T8	note_7745
NonRel	Treatment Hx : IVFA ( 1 / 19 / 18 ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU , vision stable per patient , blood sugars improving .	severity	lesion	T12	T10	note_7745
NonRel	Treatment Hx : IVFA ( 1 / 19 / 18 ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with CSME OU OD - Severe NPDR with CSME .	severity	lesion	T12	T16	note_7745
NonRel	Treatment Hx : IVFA ( 1 / 19 / 18 ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with [s2] CSME [e2] OU OD - Severe NPDR with CSME .	severity	lesion	T12	T18	note_7745
NonRel	Treatment Hx : IVFA ( 1 / 19 / 18 ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with CSME OU OD - Severe [s2] NPDR [e2] with CSME .	severity	lesion	T12	T22	note_7745
NonRel	Treatment Hx : IVFA ( 1 / 19 / 18 ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with CSME OU OD - Severe NPDR with [s2] CSME [e2] .	severity	lesion	T12	T23	note_7745
NonRel	Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU , vision stable per patient , blood sugars improving .	laterality	lesion	T14	T6	note_7745
NonRel	Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU , vision stable per patient , blood sugars improving .	laterality	lesion	T14	T8	note_7745
NonRel	Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU , vision stable per patient , blood sugars improving .	laterality	lesion	T14	T10	note_7745
NonRel	Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with CSME OU OD - Severe NPDR with CSME .	laterality	lesion	T14	T16	note_7745
NonRel	Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with [s2] CSME [e2] OU OD - Severe NPDR with CSME .	laterality	lesion	T14	T18	note_7745
NonRel	Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with CSME OU OD - Severe [s2] NPDR [e2] with CSME .	laterality	lesion	T14	T22	note_7745
NonRel	Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with CSME OU OD - Severe NPDR with [s2] CSME [e2] .	laterality	lesion	T14	T23	note_7745
NonRel	[s1] Severe [e1] NPDR OU with CSME OU OD - Severe NPDR with CSME .	Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T15	T13	note_7745
NonRel	Severe NPDR [s1] OU [e1] with CSME OU OD - Severe NPDR with CSME .	Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T17	T13	note_7745
NonRel	Severe NPDR OU with CSME [s1] OU [e1] OD - Severe NPDR with CSME .	Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T19	T13	note_7745
NonRel	Severe NPDR OU with CSME OU [s1] OD [e1] - Severe NPDR with CSME .	Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T20	T13	note_7745
NonRel	Severe NPDR OU with CSME OU OD - [s1] Severe [e1] NPDR with CSME .	Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T21	T13	note_7745
NonRel	[s1] Right eye [e1] affected by proliferative diabetic retinopathy with traction retinal detachment involving macula , associated with type 2 diabetes mellitus E11.3521 250.50 362.02 361.81 2 .	Left eye affected by [s2] proliferative diabetic retinopathy [e2] with traction retinal detachment not involving macula , associated with type 2 diabetes mellitus E11.3532 250.50 362.02 361.81 3 .	laterality	lesion	T1	T4	note_8850
NonRel	[s1] Left eye [e1] affected by proliferative diabetic retinopathy with traction retinal detachment not involving macula , associated with type 2 diabetes mellitus E11.3532 250.50 362.02 361.81 3 .	Right eye affected by [s2] proliferative diabetic retinopathy [e2] with traction retinal detachment involving macula , associated with type 2 diabetes mellitus E11.3521 250.50 362.02 361.81 2 .	laterality	lesion	T3	T2	note_8850
NonRel	[s1] Refractory [e1] ME to IVA . Treatment Hx : IVE OS - 7 / 27 / 18 ( today ) IVE OS - 6 / 21 / 18 IVA OS 5 / 18 / 18 IVA OS 4 / 13 / 18 IVA OS 3 / 9 / 18 IVA OS 1 / 19 / 18 IVA OS 12 / 12 / 17 IVFA 11 / 16 / 17 - within normal limits OD .	OS with significant macular perivascular leakage and significant nonperfusion in the periphery 1 ) CRVO with [s2] Macular Edema [e2] OS - treated with IVA with refractory IRF then switched to IVE last visit with great improvement in ME and VA ( 20 / 150 to 20 / 80 ) .	severity	lesion	T6	T7	note_3218
NonRel	[s1] Refractory [e1] ME to IVA . Treatment Hx : IVE OS - 7 / 27 / 18 ( today ) IVE OS - 6 / 21 / 18 IVA OS 5 / 18 / 18 IVA OS 4 / 13 / 18 IVA OS 3 / 9 / 18 IVA OS 1 / 19 / 18 IVA OS 12 / 12 / 17 IVFA 11 / 16 / 17 - within normal limits OD .	OS with significant macular perivascular leakage and significant nonperfusion in the periphery 1 ) CRVO with Macular Edema OS - treated with IVA with refractory IRF then switched to IVE last visit with great improvement in [s2] ME [e2] and VA ( 20 / 150 to 20 / 80 ) .	severity	lesion	T6	T9	note_3218
NonRel	OS with significant macular perivascular leakage and significant nonperfusion in the periphery 1 ) CRVO with Macular Edema [s1] OS [e1] - treated with IVA with refractory IRF then switched to IVE last visit with great improvement in ME and VA ( 20 / 150 to 20 / 80 ) .	Refractory [s2] ME [e2] to IVA . Treatment Hx : IVE OS - 7 / 27 / 18 ( today ) IVE OS - 6 / 21 / 18 IVA OS 5 / 18 / 18 IVA OS 4 / 13 / 18 IVA OS 3 / 9 / 18 IVA OS 1 / 19 / 18 IVA OS 12 / 12 / 17 IVFA 11 / 16 / 17 - within normal limits OD .	laterality	lesion	T8	T5	note_3218
NonRel	[s1] OS [e1] with significant macular perivascular leakage and significant nonperfusion in the periphery 1 ) CRVO with Macular Edema OS - treated with IVA with refractory IRF then switched to IVE last visit with great improvement in ME and VA ( 20 / 150 to 20 / 80 ) .	Refractory [s2] ME [e2] to IVA . Treatment Hx : IVE OS - 7 / 27 / 18 ( today ) IVE OS - 6 / 21 / 18 IVA OS 5 / 18 / 18 IVA OS 4 / 13 / 18 IVA OS 3 / 9 / 18 IVA OS 1 / 19 / 18 IVA OS 12 / 12 / 17 IVFA 11 / 16 / 17 - within normal limits OD .	laterality	lesion	T10	T5	note_3218
NonRel	1 ) Subhyaloid Hemorrhage [s1] OD [e1] ( Valsalva ) - First evaluated 2 / 19 / 2018 in ED .	Heme and [s2] SHH [e2] now resolved .	laterality	lesion	T6	T7	note_3180
NonRel	Cystoid macular edema of [s1] left eye [e1] H35.352 362.53 OCT , Posterior Segment - OU - Both Eyes 2 .	[s2] Retinal edema [e2] H35.81 362.83 OCT , Posterior Segment - OU - Both Eyes OD : NS Normal OS : NS VA improved CF 2 ' CRVO with inactive proliferation and macular scar ( congested nerve head syndrome ) S / p PRP + IVA DATE S / p Lucentis DATE with no effect NVD on exam , thought be cause of previous VH Area of retinal edema / elevation along inferior arcade with likely resolved vitreoadhesion OCT with subfoveal scar , IRF RTC : * * * NAME , MD participated in the care of this patient .	laterality	lesion	T6	T1	2118556_note_5964
NonRel	Cystoid macular edema of [s1] left eye [e1] H35.352 362.53 OCT , Posterior Segment - OU - Both Eyes 2 .	Retinal edema H35.81 362.83 OCT , Posterior Segment - OU - Both Eyes OD : NS Normal OS : NS VA improved CF 2 ' CRVO with inactive proliferation and macular scar ( congested nerve head syndrome ) S / p PRP + IVA DATE S / p Lucentis DATE with no effect NVD on exam , thought be cause of previous VH Area of [s2] retinal edema [e2] / elevation along inferior arcade with likely resolved vitreoadhesion OCT with subfoveal scar , IRF RTC : * * * NAME , MD participated in the care of this patient .	laterality	lesion	T6	T2	2118556_note_5964
NonRel	Cystoid macular edema of [s1] left eye [e1] H35.352 362.53 OCT , Posterior Segment - OU - Both Eyes 2 .	Retinal edema H35.81 362.83 OCT , Posterior Segment - OU - Both Eyes OD : NS Normal OS : NS VA improved CF 2 ' CRVO with inactive proliferation and macular scar ( congested nerve head syndrome ) S / p PRP + IVA DATE S / p Lucentis DATE with no effect [s2] NVD [e2] on exam , thought be cause of previous VH Area of retinal edema / elevation along inferior arcade with likely resolved vitreoadhesion OCT with subfoveal scar , IRF RTC : * * * NAME , MD participated in the care of this patient .	laterality	lesion	T6	T4	2118556_note_5964
NonRel	Cystoid macular edema of [s1] left eye [e1] H35.352 362.53 OCT , Posterior Segment - OU - Both Eyes 2 .	Retinal edema H35.81 362.83 OCT , Posterior Segment - OU - Both Eyes OD : NS Normal OS : NS VA improved CF 2 ' CRVO with inactive proliferation and macular scar ( congested nerve head syndrome ) S / p PRP + IVA DATE S / p Lucentis DATE with no effect NVD on exam , thought be cause of previous [s2] VH [e2] Area of retinal edema / elevation along inferior arcade with likely resolved vitreoadhesion OCT with subfoveal scar , IRF RTC : * * * NAME , MD participated in the care of this patient .	laterality	lesion	T6	T5	2118556_note_5964
NonRel	Retinal edema H35.81 362.83 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes OD : NS Normal OS : NS VA improved CF 2 ' CRVO with inactive proliferation and macular scar ( congested nerve head syndrome ) S / p PRP + IVA DATE S / p Lucentis DATE with no effect NVD on exam , thought be cause of previous VH Area of retinal edema / elevation along inferior arcade with likely resolved vitreoadhesion OCT with subfoveal scar , IRF RTC : * * * NAME , MD participated in the care of this patient .	Cystoid [s2] macular edema [e2] of left eye H35.352 362.53 OCT , Posterior Segment - OU - Both Eyes 2 .	laterality	lesion	T7	T3	2118556_note_5964
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 2 .	Type 2 diabetes mellitus with right eye affected by [s2] proliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3511 250.50 Z79.4 362.02 362.07 V58.67 { OPH RESIDENTS / FELLOWS : 21021146 } participated in the care of this patient .	laterality	lesion	T2	T5	note_3719
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 2 .	Type 2 diabetes mellitus with right eye affected by proliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3511 250.50 Z79.4 362.02 362.07 V58.67 { OPH RESIDENTS / FELLOWS : 21021146 } participated in the care of this patient .	laterality	lesion	T2	T6	note_3719
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by proliferative retinopathy and macular edema , with long - term current use of insulin E11.3511 250.50 Z79.4 362.02 362.07 V58.67 { OPH RESIDENTS / FELLOWS : 21021146 } participated in the care of this patient .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 2 .	laterality	lesion	T4	T1	note_3719
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by proliferative retinopathy and macular edema , with long - term current use of insulin E11.3511 250.50 Z79.4 362.02 362.07 V58.67 { OPH RESIDENTS / FELLOWS : 21021146 } participated in the care of this patient .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 2 .	laterality	lesion	T4	T3	note_3719
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	severity	lesion	T14	T3	note_2415
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	severity	lesion	T14	T4	note_2415
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non [s2] proliferative diabetic retinopathy [e2] eval OU 1 ) T2DM - on insulin .	severity	lesion	T14	T5	note_2415
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	laterality	lesion	T15	T3	note_2415
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	laterality	lesion	T15	T4	note_2415
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non [s2] proliferative diabetic retinopathy [e2] eval OU 1 ) T2DM - on insulin .	laterality	lesion	T15	T5	note_2415
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	severity	lesion	T16	T1	note_2415
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	severity	lesion	T16	T2	note_2415
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Last A1C 6.2 ( 06 / 2017 ) OD - Severe [s2] NPDR [e2] without ME .	severity	lesion	T16	T6	note_2415
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Last A1C 6.2 ( 06 / 2017 ) OD - Severe NPDR without [s2] ME [e2] .	severity	lesion	T16	T7	note_2415
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T17	T1	note_2415
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T17	T2	note_2415
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Last A1C 6.2 ( 06 / 2017 ) OD - Severe [s2] NPDR [e2] without ME .	laterality	lesion	T17	T6	note_2415
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Last A1C 6.2 ( 06 / 2017 ) OD - Severe NPDR without [s2] ME [e2] .	laterality	lesion	T17	T7	note_2415
NonRel	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval [s1] OU [e1] 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T18	T1	note_2415
NonRel	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval [s1] OU [e1] 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T18	T2	note_2415
NonRel	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval [s1] OU [e1] 1 ) T2DM - on insulin .	Last A1C 6.2 ( 06 / 2017 ) OD - Severe [s2] NPDR [e2] without ME .	laterality	lesion	T18	T6	note_2415
NonRel	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval [s1] OU [e1] 1 ) T2DM - on insulin .	Last A1C 6.2 ( 06 / 2017 ) OD - Severe NPDR without [s2] ME [e2] .	laterality	lesion	T18	T7	note_2415
NonRel	Last A1C 6.2 ( 06 / 2017 ) [s1] OD [e1] - Severe NPDR without ME .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	laterality	lesion	T19	T3	note_2415
NonRel	Last A1C 6.2 ( 06 / 2017 ) [s1] OD [e1] - Severe NPDR without ME .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	laterality	lesion	T19	T4	note_2415
NonRel	Last A1C 6.2 ( 06 / 2017 ) [s1] OD [e1] - Severe NPDR without ME .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non [s2] proliferative diabetic retinopathy [e2] eval OU 1 ) T2DM - on insulin .	laterality	lesion	T19	T5	note_2415
NonRel	Last A1C 6.2 ( 06 / 2017 ) [s1] OD [e1] - Severe NPDR without ME .	OS - Severe [s2] NPDR [e2] with CSME .	laterality	lesion	T19	T8	note_2415
NonRel	Last A1C 6.2 ( 06 / 2017 ) [s1] OD [e1] - Severe NPDR without ME .	OS - Severe NPDR with [s2] CSME [e2] .	laterality	lesion	T19	T9	note_2415
NonRel	Last A1C 6.2 ( 06 / 2017 ) OD - [s1] Severe [e1] NPDR without ME .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	severity	lesion	T20	T3	note_2415
NonRel	Last A1C 6.2 ( 06 / 2017 ) OD - [s1] Severe [e1] NPDR without ME .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	severity	lesion	T20	T4	note_2415
NonRel	Last A1C 6.2 ( 06 / 2017 ) OD - [s1] Severe [e1] NPDR without ME .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non [s2] proliferative diabetic retinopathy [e2] eval OU 1 ) T2DM - on insulin .	severity	lesion	T20	T5	note_2415
NonRel	Last A1C 6.2 ( 06 / 2017 ) OD - [s1] Severe [e1] NPDR without ME .	OS - Severe [s2] NPDR [e2] with CSME .	severity	lesion	T20	T8	note_2415
NonRel	Last A1C 6.2 ( 06 / 2017 ) OD - [s1] Severe [e1] NPDR without ME .	OS - Severe NPDR with [s2] CSME [e2] .	severity	lesion	T20	T9	note_2415
NonRel	OS - [s1] Severe [e1] NPDR with CSME .	Last A1C 6.2 ( 06 / 2017 ) OD - Severe [s2] NPDR [e2] without ME .	severity	lesion	T21	T6	note_2415
NonRel	OS - [s1] Severe [e1] NPDR with CSME .	Last A1C 6.2 ( 06 / 2017 ) OD - Severe NPDR without [s2] ME [e2] .	severity	lesion	T21	T7	note_2415
NonRel	[s1] OS [e1] - Severe NPDR with CSME .	Last A1C 6.2 ( 06 / 2017 ) OD - Severe [s2] NPDR [e2] without ME .	laterality	lesion	T22	T6	note_2415
NonRel	[s1] OS [e1] - Severe NPDR with CSME .	Last A1C 6.2 ( 06 / 2017 ) OD - Severe NPDR without [s2] ME [e2] .	laterality	lesion	T22	T7	note_2415
NonRel	[s1] OD [e1] - midperipheral ischemia on IVFA with NVE . + ME .	OS - extensive [s2] ME [e2] , ERM , midperipheral ischemia .	laterality	lesion	T3	T2	2485245_note_7318
NonRel	OS - [s1] extensive [e1] ME , ERM , midperipheral ischemia .	OD - midperipheral ischemia on IVFA with [s2] NVE [e2] . + ME .	severity	lesion	T4	T1	2485245_note_7318
NonRel	[s1] OS [e1] - extensive ME , ERM , midperipheral ischemia .	OD - midperipheral ischemia on IVFA with [s2] NVE [e2] . + ME .	laterality	lesion	T5	T1	2485245_note_7318
NonRel	Type 2 diabetes mellitus with [s1] both eyes [e1] affected by proliferative retinopathy and traction retinal detachments involving maculae , unspecified long term insulin use status E11.3523 250.50 OCT , Retina - OU - Both Eyes 362.02 Fluorescein Angiography - OU - Both Eyes 361.81 3 .	Both eyes affected by [s2] proliferative diabetic retinopathy [e2] with traction retinal detachments involving maculae , associated with type 2 diabetes mellitus E11.3523 250.50 362.02 361.81 New patient here today for evaluation of diabetic retinopathy .	laterality	lesion	T5	T2	note_8904
NonRel	[s1] Both eyes [e1] affected by proliferative diabetic retinopathy with traction retinal detachments involving maculae , associated with type 2 diabetes mellitus E11.3523 250.50 362.02 361.81 New patient here today for evaluation of diabetic retinopathy .	Type 2 diabetes mellitus with both eyes affected by [s2] proliferative retinopathy [e2] and traction retinal detachments involving maculae , unspecified long term insulin use status E11.3523 250.50 OCT , Retina - OU - Both Eyes 362.02 Fluorescein Angiography - OU - Both Eyes 361.81 3 .	laterality	lesion	T6	T1	note_8904
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T17	T6	note_7750
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T17	T8	note_7750
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	severity	lesion	T17	T9	note_7750
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	severity	lesion	T17	T10	note_7750
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	severity	lesion	T17	T11	note_7750
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with [s2] nci [e2] DME OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T17	T29	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T18	T6	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T18	T8	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	laterality	lesion	T18	T9	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	laterality	lesion	T18	T10	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	laterality	lesion	T18	T11	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with [s2] nci [e2] DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T18	T29	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T19	T6	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T19	T8	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	severity	lesion	T19	T9	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	severity	lesion	T19	T10	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	severity	lesion	T19	T11	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with [s2] nci [e2] DME OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T19	T29	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T20	T6	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T20	T8	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	laterality	lesion	T20	T9	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	laterality	lesion	T20	T10	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	laterality	lesion	T20	T11	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with [s2] nci [e2] DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T20	T29	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T21	T6	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T21	T8	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	laterality	lesion	T21	T9	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	laterality	lesion	T21	T10	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	laterality	lesion	T21	T11	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with [s2] nci [e2] DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T21	T29	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T22	T6	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T22	T8	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	severity	lesion	T22	T9	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	severity	lesion	T22	T10	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	severity	lesion	T22	T11	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with [s2] nci [e2] DME OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T22	T29	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T23	T6	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T23	T8	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	laterality	lesion	T23	T9	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	laterality	lesion	T23	T10	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	laterality	lesion	T23	T11	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with [s2] nci [e2] DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T23	T29	note_7750
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T24	T1	note_7750
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T24	T2	note_7750
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T24	T3	note_7750
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T24	T4	note_7750
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T24	T5	note_7750
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T25	T1	note_7750
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T25	T2	note_7750
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T25	T3	note_7750
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T25	T4	note_7750
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T25	T5	note_7750
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T7	T1	note_7750
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T7	T2	note_7750
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T7	T3	note_7750
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T7	T4	note_7750
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T7	T5	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T26	T1	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T26	T2	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T26	T3	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T26	T4	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T26	T5	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T27	T1	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T27	T2	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T27	T3	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T27	T4	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T27	T5	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T28	T1	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T28	T2	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T28	T3	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T28	T4	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T28	T5	note_7750
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 2 .	[s2] Diabetic macular edema [e2] of left eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 3 .	laterality	lesion	T19	T3	2525474_note_7919
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 2 .	Diabetic macular edema of left eye with [s2] proliferative retinopathy [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 3 .	laterality	lesion	T19	T4	2525474_note_7919
NonRel	Diabetic macular edema of [s1] left eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 3 .	[s2] Diabetic macular edema [e2] of right eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 2 .	laterality	lesion	T20	T1	2525474_note_7919
NonRel	Diabetic macular edema of [s1] left eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 3 .	Diabetic macular edema of right eye with [s2] proliferative retinopathy [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 2 .	laterality	lesion	T20	T2	2525474_note_7919
NonRel	Diabetic macular edema of [s1] left eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 3 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , VH OS ) , previous cardiac stent placement .	laterality	lesion	T20	T5	2525474_note_7919
NonRel	Diabetic macular edema of [s1] left eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 3 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , VH OS ) , previous cardiac stent placement .	laterality	lesion	T20	T6	2525474_note_7919
NonRel	Diabetic macular edema of [s1] left eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 3 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of [s2] PDR [e2] OU ( ciCSME OD , VH OS ) , previous cardiac stent placement .	laterality	lesion	T20	T35	2525474_note_7919
NonRel	Diabetic macular edema of [s1] left eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 3 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( [s2] ciCSME [e2] OD , VH OS ) , previous cardiac stent placement .	laterality	lesion	T20	T36	2525474_note_7919
NonRel	Diabetic macular edema of [s1] left eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 3 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , [s2] VH [e2] OS ) , previous cardiac stent placement .	laterality	lesion	T20	T39	2525474_note_7919
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , VH OS ) , previous cardiac stent placement .	[s2] Diabetic macular edema [e2] of left eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 3 .	laterality	lesion	T21	T3	2525474_note_7919
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , VH OS ) , previous cardiac stent placement .	Diabetic macular edema of left eye with [s2] proliferative retinopathy [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 3 .	laterality	lesion	T21	T4	2525474_note_7919
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , VH OS ) , previous cardiac stent placement .	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild [s2] NVE [e2] ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	laterality	lesion	T21	T7	2525474_note_7919
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , VH OS ) , previous cardiac stent placement .	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual [s2] NVD [e2] OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	laterality	lesion	T21	T8	2525474_note_7919
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , VH OS ) , previous cardiac stent placement .	Returns today for evaluation of [s2] PDR [e2] with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	laterality	lesion	T21	T9	2525474_note_7919
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , VH OS ) , previous cardiac stent placement .	Returns today for evaluation of PDR with [s2] CSME [e2] . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	laterality	lesion	T21	T10	2525474_note_7919
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , VH OS ) , previous cardiac stent placement .	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active [s2] PDR [e2] OU 1 .	laterality	lesion	T21	T11	2525474_note_7919
NonRel	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - [s1] Mild [e1] NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , VH OS ) , previous cardiac stent placement .	severity	lesion	T22	T5	2525474_note_7919
NonRel	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - [s1] Mild [e1] NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , VH OS ) , previous cardiac stent placement .	severity	lesion	T22	T6	2525474_note_7919
NonRel	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - [s1] Mild [e1] NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	NIDDM - [ Duration 16 yrs , Dx [s2] PDR [e2] OU here , Most recent A1c 8.1 per patient .	severity	lesion	T22	T12	2525474_note_7919
NonRel	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - [s1] Mild [e1] NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of [s2] PDR [e2] OU ( ciCSME OD , VH OS ) , previous cardiac stent placement .	severity	lesion	T22	T35	2525474_note_7919
NonRel	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - [s1] Mild [e1] NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( [s2] ciCSME [e2] OD , VH OS ) , previous cardiac stent placement .	severity	lesion	T22	T36	2525474_note_7919
NonRel	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - [s1] Mild [e1] NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , [s2] VH [e2] OS ) , previous cardiac stent placement .	severity	lesion	T22	T39	2525474_note_7919
NonRel	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , [s1] residual [e1] NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , VH OS ) , previous cardiac stent placement .	severity	lesion	T23	T5	2525474_note_7919
NonRel	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , [s1] residual [e1] NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , VH OS ) , previous cardiac stent placement .	severity	lesion	T23	T6	2525474_note_7919
NonRel	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , [s1] residual [e1] NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	NIDDM - [ Duration 16 yrs , Dx [s2] PDR [e2] OU here , Most recent A1c 8.1 per patient .	severity	lesion	T23	T12	2525474_note_7919
NonRel	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , [s1] residual [e1] NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of [s2] PDR [e2] OU ( ciCSME OD , VH OS ) , previous cardiac stent placement .	severity	lesion	T23	T35	2525474_note_7919
NonRel	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , [s1] residual [e1] NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( [s2] ciCSME [e2] OD , VH OS ) , previous cardiac stent placement .	severity	lesion	T23	T36	2525474_note_7919
NonRel	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , [s1] residual [e1] NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , [s2] VH [e2] OS ) , previous cardiac stent placement .	severity	lesion	T23	T39	2525474_note_7919
NonRel	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD [s1] OS [e1] IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , VH OS ) , previous cardiac stent placement .	laterality	lesion	T24	T5	2525474_note_7919
NonRel	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD [s1] OS [e1] IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , VH OS ) , previous cardiac stent placement .	laterality	lesion	T24	T6	2525474_note_7919
NonRel	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD [s1] OS [e1] IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	NIDDM - [ Duration 16 yrs , Dx [s2] PDR [e2] OU here , Most recent A1c 8.1 per patient .	laterality	lesion	T24	T12	2525474_note_7919
NonRel	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD [s1] OS [e1] IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of [s2] PDR [e2] OU ( ciCSME OD , VH OS ) , previous cardiac stent placement .	laterality	lesion	T24	T35	2525474_note_7919
NonRel	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD [s1] OS [e1] IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( [s2] ciCSME [e2] OD , VH OS ) , previous cardiac stent placement .	laterality	lesion	T24	T36	2525474_note_7919
NonRel	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD [s1] OS [e1] IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , [s2] VH [e2] OS ) , previous cardiac stent placement .	laterality	lesion	T24	T39	2525474_note_7919
NonRel	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - [s1] Active [e1] PDR OU 1 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , VH OS ) , previous cardiac stent placement .	severity	lesion	T25	T5	2525474_note_7919
NonRel	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - [s1] Active [e1] PDR OU 1 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , VH OS ) , previous cardiac stent placement .	severity	lesion	T25	T6	2525474_note_7919
NonRel	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - [s1] Active [e1] PDR OU 1 .	NIDDM - [ Duration 16 yrs , Dx [s2] PDR [e2] OU here , Most recent A1c 8.1 per patient .	severity	lesion	T25	T12	2525474_note_7919
NonRel	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - [s1] Active [e1] PDR OU 1 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of [s2] PDR [e2] OU ( ciCSME OD , VH OS ) , previous cardiac stent placement .	severity	lesion	T25	T35	2525474_note_7919
NonRel	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - [s1] Active [e1] PDR OU 1 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( [s2] ciCSME [e2] OD , VH OS ) , previous cardiac stent placement .	severity	lesion	T25	T36	2525474_note_7919
NonRel	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - [s1] Active [e1] PDR OU 1 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , [s2] VH [e2] OS ) , previous cardiac stent placement .	severity	lesion	T25	T39	2525474_note_7919
NonRel	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR [s1] OU [e1] 1 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , VH OS ) , previous cardiac stent placement .	laterality	lesion	T26	T5	2525474_note_7919
NonRel	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR [s1] OU [e1] 1 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , VH OS ) , previous cardiac stent placement .	laterality	lesion	T26	T6	2525474_note_7919
NonRel	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR [s1] OU [e1] 1 .	NIDDM - [ Duration 16 yrs , Dx [s2] PDR [e2] OU here , Most recent A1c 8.1 per patient .	laterality	lesion	T26	T12	2525474_note_7919
NonRel	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR [s1] OU [e1] 1 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of [s2] PDR [e2] OU ( ciCSME OD , VH OS ) , previous cardiac stent placement .	laterality	lesion	T26	T35	2525474_note_7919
NonRel	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR [s1] OU [e1] 1 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( [s2] ciCSME [e2] OD , VH OS ) , previous cardiac stent placement .	laterality	lesion	T26	T36	2525474_note_7919
NonRel	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR [s1] OU [e1] 1 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , [s2] VH [e2] OS ) , previous cardiac stent placement .	laterality	lesion	T26	T39	2525474_note_7919
NonRel	NIDDM - [ Duration 16 yrs , Dx PDR [s1] OU [e1] here , Most recent A1c 8.1 per patient .	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild [s2] NVE [e2] ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	laterality	lesion	T27	T7	2525474_note_7919
NonRel	NIDDM - [ Duration 16 yrs , Dx PDR [s1] OU [e1] here , Most recent A1c 8.1 per patient .	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual [s2] NVD [e2] OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	laterality	lesion	T27	T8	2525474_note_7919
NonRel	NIDDM - [ Duration 16 yrs , Dx PDR [s1] OU [e1] here , Most recent A1c 8.1 per patient .	Returns today for evaluation of [s2] PDR [e2] with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	laterality	lesion	T27	T9	2525474_note_7919
NonRel	NIDDM - [ Duration 16 yrs , Dx PDR [s1] OU [e1] here , Most recent A1c 8.1 per patient .	Returns today for evaluation of PDR with [s2] CSME [e2] . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	laterality	lesion	T27	T10	2525474_note_7919
NonRel	NIDDM - [ Duration 16 yrs , Dx PDR [s1] OU [e1] here , Most recent A1c 8.1 per patient .	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active [s2] PDR [e2] OU 1 .	laterality	lesion	T27	T11	2525474_note_7919
NonRel	NIDDM - [ Duration 16 yrs , Dx PDR [s1] OU [e1] here , Most recent A1c 8.1 per patient .	BS historically very poorly controlled ] OD - [s2] PDR [e2] with ciCSME now s / p PRP and IVA .	laterality	lesion	T27	T13	2525474_note_7919
NonRel	NIDDM - [ Duration 16 yrs , Dx PDR [s1] OU [e1] here , Most recent A1c 8.1 per patient .	BS historically very poorly controlled ] OD - PDR with [s2] ciCSME [e2] now s / p PRP and IVA .	laterality	lesion	T27	T14	2525474_note_7919
NonRel	BS historically very poorly controlled ] [s1] OD [e1] - PDR with ciCSME now s / p PRP and IVA .	NIDDM - [ Duration 16 yrs , Dx [s2] PDR [e2] OU here , Most recent A1c 8.1 per patient .	laterality	lesion	T28	T12	2525474_note_7919
NonRel	BS historically very poorly controlled ] [s1] OD [e1] - PDR with ciCSME now s / p PRP and IVA .	Significant improvement from presentation with only mild nasal [s2] NVE [e2] remaining .	laterality	lesion	T28	T15	2525474_note_7919
NonRel	Significant improvement from presentation with only [s1] mild [e1] nasal NVE remaining .	BS historically very poorly controlled ] OD - [s2] PDR [e2] with ciCSME now s / p PRP and IVA .	severity	lesion	T29	T13	2525474_note_7919
NonRel	Significant improvement from presentation with only [s1] mild [e1] nasal NVE remaining .	BS historically very poorly controlled ] OD - PDR with [s2] ciCSME [e2] now s / p PRP and IVA .	severity	lesion	T29	T14	2525474_note_7919
NonRel	RTC 1 month PRP OD ( IVFA - guided ) IVFA [s1] OD [e1] with residual NVE nasally and superiorly along major vessel .	OS with possible peripapillary [s2] NVE [e2] , otherwise quiescent There is marked improvement following treatment in this patient .	laterality	lesion	T31	T18	2525474_note_7919
NonRel	RTC 1 month PRP OD ( IVFA - guided ) IVFA OD with [s1] residual [e1] NVE nasally and superiorly along major vessel .	OS with possible peripapillary [s2] NVE [e2] , otherwise quiescent There is marked improvement following treatment in this patient .	severity	lesion	T32	T18	2525474_note_7919
NonRel	[s1] OS [e1] with possible peripapillary NVE , otherwise quiescent There is marked improvement following treatment in this patient .	RTC 1 month PRP OD ( IVFA - guided ) IVFA OD with residual [s2] NVE [e2] nasally and superiorly along major vessel .	laterality	lesion	T33	T17	2525474_note_7919
NonRel	OS with [s1] possible [e1] peripapillary NVE , otherwise quiescent There is marked improvement following treatment in this patient .	RTC 1 month PRP OD ( IVFA - guided ) IVFA OD with residual [s2] NVE [e2] nasally and superiorly along major vessel .	severity	lesion	T34	T17	2525474_note_7919
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR [s1] OU [e1] ( ciCSME OD , VH OS ) , previous cardiac stent placement .	[s2] Diabetic macular edema [e2] of left eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 3 .	laterality	lesion	T37	T3	2525474_note_7919
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR [s1] OU [e1] ( ciCSME OD , VH OS ) , previous cardiac stent placement .	Diabetic macular edema of left eye with [s2] proliferative retinopathy [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 3 .	laterality	lesion	T37	T4	2525474_note_7919
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR [s1] OU [e1] ( ciCSME OD , VH OS ) , previous cardiac stent placement .	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild [s2] NVE [e2] ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	laterality	lesion	T37	T7	2525474_note_7919
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR [s1] OU [e1] ( ciCSME OD , VH OS ) , previous cardiac stent placement .	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual [s2] NVD [e2] OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	laterality	lesion	T37	T8	2525474_note_7919
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR [s1] OU [e1] ( ciCSME OD , VH OS ) , previous cardiac stent placement .	Returns today for evaluation of [s2] PDR [e2] with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	laterality	lesion	T37	T9	2525474_note_7919
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR [s1] OU [e1] ( ciCSME OD , VH OS ) , previous cardiac stent placement .	Returns today for evaluation of PDR with [s2] CSME [e2] . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	laterality	lesion	T37	T10	2525474_note_7919
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR [s1] OU [e1] ( ciCSME OD , VH OS ) , previous cardiac stent placement .	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active [s2] PDR [e2] OU 1 .	laterality	lesion	T37	T11	2525474_note_7919
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME [s1] OD [e1] , VH OS ) , previous cardiac stent placement .	[s2] Diabetic macular edema [e2] of left eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 3 .	laterality	lesion	T38	T3	2525474_note_7919
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME [s1] OD [e1] , VH OS ) , previous cardiac stent placement .	Diabetic macular edema of left eye with [s2] proliferative retinopathy [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 3 .	laterality	lesion	T38	T4	2525474_note_7919
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME [s1] OD [e1] , VH OS ) , previous cardiac stent placement .	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild [s2] NVE [e2] ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	laterality	lesion	T38	T7	2525474_note_7919
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME [s1] OD [e1] , VH OS ) , previous cardiac stent placement .	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual [s2] NVD [e2] OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	laterality	lesion	T38	T8	2525474_note_7919
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME [s1] OD [e1] , VH OS ) , previous cardiac stent placement .	Returns today for evaluation of [s2] PDR [e2] with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	laterality	lesion	T38	T9	2525474_note_7919
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME [s1] OD [e1] , VH OS ) , previous cardiac stent placement .	Returns today for evaluation of PDR with [s2] CSME [e2] . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	laterality	lesion	T38	T10	2525474_note_7919
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME [s1] OD [e1] , VH OS ) , previous cardiac stent placement .	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active [s2] PDR [e2] OU 1 .	laterality	lesion	T38	T11	2525474_note_7919
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , VH [s1] OS [e1] ) , previous cardiac stent placement .	[s2] Diabetic macular edema [e2] of left eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 3 .	laterality	lesion	T40	T3	2525474_note_7919
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , VH [s1] OS [e1] ) , previous cardiac stent placement .	Diabetic macular edema of left eye with [s2] proliferative retinopathy [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 3 .	laterality	lesion	T40	T4	2525474_note_7919
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , VH [s1] OS [e1] ) , previous cardiac stent placement .	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild [s2] NVE [e2] ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	laterality	lesion	T40	T7	2525474_note_7919
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , VH [s1] OS [e1] ) , previous cardiac stent placement .	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual [s2] NVD [e2] OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	laterality	lesion	T40	T8	2525474_note_7919
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , VH [s1] OS [e1] ) , previous cardiac stent placement .	Returns today for evaluation of [s2] PDR [e2] with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	laterality	lesion	T40	T9	2525474_note_7919
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , VH [s1] OS [e1] ) , previous cardiac stent placement .	Returns today for evaluation of PDR with [s2] CSME [e2] . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active PDR OU 1 .	laterality	lesion	T40	T10	2525474_note_7919
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 Hx of PDR OU ( ciCSME OD , VH [s1] OS [e1] ) , previous cardiac stent placement .	Returns today for evaluation of PDR with CSME . Treatment Hx IVFA ( DATE ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OS - DATE PRP OS - DATE IVA OU - DATE PRP OD - DATE IVFA ( DATE ) - Active [s2] PDR [e2] OU 1 .	laterality	lesion	T40	T11	2525474_note_7919
NonRel	Central retinal vein occlusion of left eye H34.8122 362.35 OCT , Retina - OU - Both Eyes Treatment History IVFA ( DATE ) - [s1] Moderate [e1] NPDR OD with CSME superonasal to fovea .	Ischemic CRVO OS IVFA ( DATE ) - Moderate [s2] NPDR [e2] OD with CSME superonasal to fovea .	severity	lesion	T17	T4	392314_note_1008
NonRel	Central retinal vein occlusion of left eye H34.8122 362.35 OCT , Retina - OU - Both Eyes Treatment History IVFA ( DATE ) - [s1] Moderate [e1] NPDR OD with CSME superonasal to fovea .	Ischemic CRVO OS IVFA ( DATE ) - Moderate NPDR OD with [s2] CSME [e2] superonasal to fovea .	severity	lesion	T17	T5	392314_note_1008
NonRel	Central retinal vein occlusion of left eye H34.8122 362.35 OCT , Retina - OU - Both Eyes Treatment History IVFA ( DATE ) - [s1] Moderate [e1] NPDR OD with CSME superonasal to fovea .	[s2] Nonproliferative diabetic retinopathy [e2] of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 2 .	severity	lesion	T17	T27	392314_note_1008
NonRel	Central retinal vein occlusion of left eye H34.8122 362.35 OCT , Retina - OU - Both Eyes Treatment History IVFA ( DATE ) - [s1] Moderate [e1] NPDR OD with CSME superonasal to fovea .	Nonproliferative diabetic retinopathy of right eye , with [s2] macular edema [e2] , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 2 .	severity	lesion	T17	T29	392314_note_1008
NonRel	Central retinal vein occlusion of left eye H34.8122 362.35 OCT , Retina - OU - Both Eyes Treatment History IVFA ( DATE ) - [s1] Moderate [e1] NPDR OD with CSME superonasal to fovea .	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate [s2] nonproliferative retinopathy [e2] E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 2 .	severity	lesion	T17	T31	392314_note_1008
NonRel	Central retinal vein occlusion of left eye H34.8122 362.35 OCT , Retina - OU - Both Eyes Treatment History IVFA ( DATE ) - Moderate NPDR [s1] OD [e1] with CSME superonasal to fovea .	Ischemic CRVO OS IVFA ( DATE ) - Moderate [s2] NPDR [e2] OD with CSME superonasal to fovea .	laterality	lesion	T18	T4	392314_note_1008
NonRel	Central retinal vein occlusion of left eye H34.8122 362.35 OCT , Retina - OU - Both Eyes Treatment History IVFA ( DATE ) - Moderate NPDR [s1] OD [e1] with CSME superonasal to fovea .	Ischemic CRVO OS IVFA ( DATE ) - Moderate NPDR OD with [s2] CSME [e2] superonasal to fovea .	laterality	lesion	T18	T5	392314_note_1008
NonRel	Central retinal vein occlusion of left eye H34.8122 362.35 OCT , Retina - OU - Both Eyes Treatment History IVFA ( DATE ) - Moderate NPDR [s1] OD [e1] with CSME superonasal to fovea .	[s2] Nonproliferative diabetic retinopathy [e2] of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 2 .	laterality	lesion	T18	T27	392314_note_1008
NonRel	Central retinal vein occlusion of left eye H34.8122 362.35 OCT , Retina - OU - Both Eyes Treatment History IVFA ( DATE ) - Moderate NPDR [s1] OD [e1] with CSME superonasal to fovea .	Nonproliferative diabetic retinopathy of right eye , with [s2] macular edema [e2] , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 2 .	laterality	lesion	T18	T29	392314_note_1008
NonRel	Central retinal vein occlusion of left eye H34.8122 362.35 OCT , Retina - OU - Both Eyes Treatment History IVFA ( DATE ) - Moderate NPDR [s1] OD [e1] with CSME superonasal to fovea .	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate [s2] nonproliferative retinopathy [e2] E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 2 .	laterality	lesion	T18	T31	392314_note_1008
NonRel	Ischemic CRVO OS IVFA ( DATE ) - [s1] Moderate [e1] NPDR OD with CSME superonasal to fovea .	Central retinal vein occlusion of left eye H34.8122 362.35 OCT , Retina - OU - Both Eyes Treatment History IVFA ( DATE ) - Moderate [s2] NPDR [e2] OD with CSME superonasal to fovea .	severity	lesion	T19	T2	392314_note_1008
NonRel	Ischemic CRVO OS IVFA ( DATE ) - [s1] Moderate [e1] NPDR OD with CSME superonasal to fovea .	Central retinal vein occlusion of left eye H34.8122 362.35 OCT , Retina - OU - Both Eyes Treatment History IVFA ( DATE ) - Moderate NPDR OD with [s2] CSME [e2] superonasal to fovea .	severity	lesion	T19	T3	392314_note_1008
NonRel	Ischemic CRVO OS IVFA ( DATE ) - Moderate NPDR [s1] OD [e1] with CSME superonasal to fovea .	Central retinal vein occlusion of left eye H34.8122 362.35 OCT , Retina - OU - Both Eyes Treatment History IVFA ( DATE ) - Moderate [s2] NPDR [e2] OD with CSME superonasal to fovea .	laterality	lesion	T20	T2	392314_note_1008
NonRel	Ischemic CRVO OS IVFA ( DATE ) - Moderate NPDR [s1] OD [e1] with CSME superonasal to fovea .	Central retinal vein occlusion of left eye H34.8122 362.35 OCT , Retina - OU - Both Eyes Treatment History IVFA ( DATE ) - Moderate NPDR OD with [s2] CSME [e2] superonasal to fovea .	laterality	lesion	T20	T3	392314_note_1008
NonRel	No NVE [s1] OS [e1] - Difficult to grade due to CRVO .	[s2] ME [e2] improved .	laterality	lesion	T24	T9	392314_note_1008
NonRel	ME [s1] improved [e1] .	No [s2] NVE [e2] OS - Difficult to grade due to CRVO .	severity	lesion	T25	T8	392314_note_1008
NonRel	ME [s1] improved [e1] .	[s2] Macular edema [e2] dramatic improvement thought to be secondary to furosemide Plan : Observe OD CLOSELY ( monocular patient with new medication change ) .	severity	lesion	T25	T10	392314_note_1008
NonRel	3 ) CRVO [s1] OS [e1] ( Ischemic with ME ) - Onset 2007 .	[s2] Macular edema [e2] dramatic improvement thought to be secondary to furosemide Plan : Observe OD CLOSELY ( monocular patient with new medication change ) .	laterality	lesion	T26	T10	392314_note_1008
NonRel	3 ) CRVO [s1] OS [e1] ( Ischemic with ME ) - Onset 2007 .	No [s2] NVI [e2] on exam .	laterality	lesion	T26	T12	392314_note_1008
NonRel	Nonproliferative diabetic retinopathy of [s1] right eye [e1] , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 2 .	Central retinal vein occlusion of left eye H34.8122 362.35 OCT , Retina - OU - Both Eyes Treatment History IVFA ( DATE ) - Moderate [s2] NPDR [e2] OD with CSME superonasal to fovea .	laterality	lesion	T28	T2	392314_note_1008
NonRel	Nonproliferative diabetic retinopathy of [s1] right eye [e1] , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 2 .	Central retinal vein occlusion of left eye H34.8122 362.35 OCT , Retina - OU - Both Eyes Treatment History IVFA ( DATE ) - Moderate NPDR OD with [s2] CSME [e2] superonasal to fovea .	laterality	lesion	T28	T3	392314_note_1008
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with [s1] moderate [e1] nonproliferative retinopathy E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 2 .	Central retinal vein occlusion of left eye H34.8122 362.35 OCT , Retina - OU - Both Eyes Treatment History IVFA ( DATE ) - Moderate [s2] NPDR [e2] OD with CSME superonasal to fovea .	severity	lesion	T30	T2	392314_note_1008
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with [s1] moderate [e1] nonproliferative retinopathy E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 2 .	Central retinal vein occlusion of left eye H34.8122 362.35 OCT , Retina - OU - Both Eyes Treatment History IVFA ( DATE ) - Moderate NPDR OD with [s2] CSME [e2] superonasal to fovea .	severity	lesion	T30	T3	392314_note_1008
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Retina - [s1] OU [e1] - Both Eyes 362.07 362.05 2 .	Central retinal vein occlusion of left eye H34.8122 362.35 OCT , Retina - OU - Both Eyes Treatment History IVFA ( DATE ) - Moderate [s2] NPDR [e2] OD with CSME superonasal to fovea .	laterality	lesion	T32	T2	392314_note_1008
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Retina - [s1] OU [e1] - Both Eyes 362.07 362.05 2 .	Central retinal vein occlusion of left eye H34.8122 362.35 OCT , Retina - OU - Both Eyes Treatment History IVFA ( DATE ) - Moderate NPDR OD with [s2] CSME [e2] superonasal to fovea .	laterality	lesion	T32	T3	392314_note_1008
NonRel	Diabetic macular edema of [s1] right eye [e1] E11.311 250.50 OCT , Retina - OU - Both Eyes 362.07 362.01 2 .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes E11.3493 250.50 362.06 3 .	laterality	lesion	T2	T4	note_7515
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes E11.3493 250.50 362.06 3 .	[s2] Diabetic macular edema [e2] of right eye E11.311 250.50 OCT , Retina - OU - Both Eyes 362.07 362.01 2 .	severity	lesion	T3	T1	note_7515
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] E11.3493 250.50 362.06 3 .	[s2] Diabetic macular edema [e2] of right eye E11.311 250.50 OCT , Retina - OU - Both Eyes 362.07 362.01 2 .	laterality	lesion	T5	T1	note_7515
NonRel	Siva Iyer MD OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : Continued superior and superotemporal edema and exudation OS : Interval improvement of edema compared to last visit OPH - OD Intravitreal Injection , Pharmacologic Agent Avastin # 04 Time out was taken , correct eye was identified and marked , correct dose of medication was confirmed .	INVASIVE PROCEDURE NOTE Pre - op DX : [s2] PDR [e2] with DME Right Post - op DX : same Attending : Siva Iyer , M.D. Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine and 0.5 % povidone iodine was dripped into the conjunctival fornix .	laterality	lesion	T2	T3	note_2248
NonRel	Siva Iyer MD OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : Continued superior and superotemporal edema and exudation OS : Interval improvement of edema compared to last visit OPH - OD Intravitreal Injection , Pharmacologic Agent Avastin # 04 Time out was taken , correct eye was identified and marked , correct dose of medication was confirmed .	INVASIVE PROCEDURE NOTE Pre - op DX : PDR with [s2] DME [e2] Right Post - op DX : same Attending : Siva Iyer , M.D. Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine and 0.5 % povidone iodine was dripped into the conjunctival fornix .	laterality	lesion	T2	T4	note_2248
NonRel	INVASIVE PROCEDURE NOTE Pre - op DX : PDR with DME [s1] Right Post [e1] - op DX : same Attending : Siva Iyer , M.D. Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine and 0.5 % povidone iodine was dripped into the conjunctival fornix .	Siva Iyer MD OCT , Posterior Segment - OU - Both Eyes OD : Continued superior and superotemporal edema and [s2] exudation [e2] OS : Interval improvement of edema compared to last visit OPH - OD Intravitreal Injection , Pharmacologic Agent Avastin # 04 Time out was taken , correct eye was identified and marked , correct dose of medication was confirmed .	laterality	lesion	T5	T1	note_2248
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 Focal Laser - OD - Right Eye 362.02 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	[s2] Diabetic retinopathy [e2] of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T11	T12	note_2248
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 Focal Laser - OD - Right Eye 362.02 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Diabetic retinopathy of left eye , with [s2] macular edema [e2] , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T11	T15	note_2248
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 Focal Laser - OD - Right Eye 362.02 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Diabetic retinopathy of left eye , with macular edema , with severe [s2] nonproliferative retinopathy [e2] , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T11	T16	note_2248
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 Focal Laser - OD - Right Eye 362.02 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Diabetic retinopathy of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T11	T18	note_2248
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 Focal Laser - OD - Right Eye 362.02 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Diabetic retinopathy of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	laterality	lesion	T11	T20	note_2248
NonRel	Diabetic retinopathy of [s1] left eye [e1] , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] E10.3511 250.51 Focal Laser - OD - Right Eye 362.02 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T14	T10	note_2248
NonRel	Diabetic retinopathy of [s1] left eye [e1] , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema E10.3511 250.51 Focal Laser - OD - Right Eye 362.02 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T14	T13	note_2248
NonRel	Diabetic retinopathy of [s1] left eye [e1] , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe [s2] NPDR [e2] OS .	laterality	lesion	T14	T22	note_2248
NonRel	Diabetic retinopathy of left eye , with macular edema , with [s1] severe [e1] nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] E10.3511 250.51 Focal Laser - OD - Right Eye 362.02 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	severity	lesion	T17	T10	note_2248
NonRel	Diabetic retinopathy of left eye , with macular edema , with [s1] severe [e1] nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema E10.3511 250.51 Focal Laser - OD - Right Eye 362.02 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	severity	lesion	T17	T13	note_2248
NonRel	Diabetic retinopathy of left eye , with macular edema , with [s1] severe [e1] nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe [s2] NPDR [e2] OS .	severity	lesion	T17	T22	note_2248
NonRel	Diabetic retinopathy of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] E10.3511 250.51 Focal Laser - OD - Right Eye 362.02 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T19	T10	note_2248
NonRel	Diabetic retinopathy of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema E10.3511 250.51 Focal Laser - OD - Right Eye 362.02 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T19	T13	note_2248
NonRel	Diabetic retinopathy of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Severe [s2] NPDR [e2] OS .	laterality	lesion	T19	T22	note_2248
NonRel	[s1] Severe [e1] NPDR OS .	[s2] Diabetic retinopathy [e2] of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T21	T12	note_2248
NonRel	[s1] Severe [e1] NPDR OS .	Diabetic retinopathy of left eye , with [s2] macular edema [e2] , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T21	T15	note_2248
NonRel	[s1] Severe [e1] NPDR OS .	Diabetic retinopathy of left eye , with macular edema , with severe [s2] nonproliferative retinopathy [e2] , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T21	T16	note_2248
NonRel	[s1] Severe [e1] NPDR OS .	Diabetic retinopathy of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T21	T18	note_2248
NonRel	[s1] Severe [e1] NPDR OS .	Diabetic retinopathy of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	severity	lesion	T21	T20	note_2248
NonRel	[s1] Severe [e1] NPDR OS .	IVFA - 9 / 13 / 16 : Severe [s2] NPDR [e2] OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	severity	lesion	T21	T25	note_2248
NonRel	[s1] Severe [e1] NPDR OS .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe [s2] NPDR [e2] OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	severity	lesion	T21	T28	note_2248
NonRel	[s1] Severe [e1] NPDR OS .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	severity	lesion	T21	T30	note_2248
NonRel	[s1] Severe [e1] NPDR OS .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Active PDR with CSME now s / p PRP as above .	severity	lesion	T21	T33	note_2248
NonRel	[s1] Severe [e1] NPDR OS .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active [s2] PDR [e2] with CSME now s / p PRP as above .	severity	lesion	T21	T37	note_2248
NonRel	[s1] Severe [e1] NPDR OS .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with [s2] CSME [e2] now s / p PRP as above .	severity	lesion	T21	T38	note_2248
NonRel	Severe NPDR [s1] OS [e1] .	[s2] Diabetic retinopathy [e2] of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T23	T12	note_2248
NonRel	Severe NPDR [s1] OS [e1] .	Diabetic retinopathy of left eye , with [s2] macular edema [e2] , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T23	T15	note_2248
NonRel	Severe NPDR [s1] OS [e1] .	Diabetic retinopathy of left eye , with macular edema , with severe [s2] nonproliferative retinopathy [e2] , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T23	T16	note_2248
NonRel	Severe NPDR [s1] OS [e1] .	Diabetic retinopathy of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T23	T18	note_2248
NonRel	Severe NPDR [s1] OS [e1] .	Diabetic retinopathy of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	laterality	lesion	T23	T20	note_2248
NonRel	Severe NPDR [s1] OS [e1] .	IVFA - 9 / 13 / 16 : Severe [s2] NPDR [e2] OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	laterality	lesion	T23	T25	note_2248
NonRel	Severe NPDR [s1] OS [e1] .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe [s2] NPDR [e2] OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	laterality	lesion	T23	T28	note_2248
NonRel	Severe NPDR [s1] OS [e1] .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	laterality	lesion	T23	T30	note_2248
NonRel	Severe NPDR [s1] OS [e1] .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Active PDR with CSME now s / p PRP as above .	laterality	lesion	T23	T33	note_2248
NonRel	Severe NPDR [s1] OS [e1] .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active [s2] PDR [e2] with CSME now s / p PRP as above .	laterality	lesion	T23	T37	note_2248
NonRel	Severe NPDR [s1] OS [e1] .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with [s2] CSME [e2] now s / p PRP as above .	laterality	lesion	T23	T38	note_2248
NonRel	IVFA - 9 / 13 / 16 : [s1] Severe [e1] NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	Severe [s2] NPDR [e2] OS .	severity	lesion	T24	T22	note_2248
NonRel	IVFA - 9 / 13 / 16 : [s1] Severe [e1] NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	Developed [s2] CSME [e2] after PRP .	severity	lesion	T24	T39	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR [s1] OU [e1] IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	Severe [s2] NPDR [e2] OS .	laterality	lesion	T26	T22	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR [s1] OU [e1] IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	Developed [s2] CSME [e2] after PRP .	laterality	lesion	T26	T39	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : [s1] Severe [e1] NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	Severe [s2] NPDR [e2] OS .	severity	lesion	T27	T22	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : [s1] Severe [e1] NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	Developed [s2] CSME [e2] after PRP .	severity	lesion	T27	T39	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR [s1] OS [e1] 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	Severe [s2] NPDR [e2] OS .	laterality	lesion	T29	T22	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR [s1] OS [e1] 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	Developed [s2] CSME [e2] after PRP .	laterality	lesion	T29	T39	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	Severe [s2] NPDR [e2] OS .	laterality	lesion	T31	T22	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	Developed [s2] CSME [e2] after PRP .	laterality	lesion	T31	T39	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	Severe [s2] NPDR [e2] OS .	severity	lesion	T32	T22	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	Developed [s2] CSME [e2] after PRP .	severity	lesion	T32	T39	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Active PDR with CSME now s / p PRP as above .	Severe [s2] NPDR [e2] OS .	laterality	lesion	T34	T22	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Active PDR with CSME now s / p PRP as above .	Developed [s2] CSME [e2] after PRP .	laterality	lesion	T34	T39	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) [s1] OD [e1] - Active PDR with CSME now s / p PRP as above .	Severe [s2] NPDR [e2] OS .	laterality	lesion	T35	T22	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) [s1] OD [e1] - Active PDR with CSME now s / p PRP as above .	Developed [s2] CSME [e2] after PRP .	laterality	lesion	T35	T39	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Active [e1] PDR with CSME now s / p PRP as above .	Severe [s2] NPDR [e2] OS .	severity	lesion	T36	T22	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Active [e1] PDR with CSME now s / p PRP as above .	Developed [s2] CSME [e2] after PRP .	severity	lesion	T36	T39	note_2248
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus E11.3511 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 2 .	[s2] Diabetic macular edema [e2] of left eye with proliferative retinopathy associated with type 2 diabetes mellitus E11.3512 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Mr. Boothe is here for follow - up of PDR OU ( NIDDM ) .	laterality	lesion	T8	T10	note_7872
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus E11.3511 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 2 .	Diabetic macular edema of left eye with [s2] proliferative retinopathy [e2] associated with type 2 diabetes mellitus E11.3512 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Mr. Boothe is here for follow - up of PDR OU ( NIDDM ) .	laterality	lesion	T8	T12	note_7872
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus E11.3511 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 2 .	Diabetic macular edema of left eye with proliferative retinopathy associated with type 2 diabetes mellitus E11.3512 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Mr. Boothe is here for follow - up of [s2] PDR [e2] OU ( NIDDM ) .	laterality	lesion	T8	T13	note_7872
NonRel	Diabetic macular edema of [s1] left eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus E11.3512 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Mr. Boothe is here for follow - up of PDR OU ( NIDDM ) .	[s2] Diabetic macular edema [e2] of right eye with proliferative retinopathy associated with type 2 diabetes mellitus E11.3511 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 2 .	laterality	lesion	T11	T7	note_7872
NonRel	Diabetic macular edema of [s1] left eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus E11.3512 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Mr. Boothe is here for follow - up of PDR OU ( NIDDM ) .	Diabetic macular edema of right eye with [s2] proliferative retinopathy [e2] associated with type 2 diabetes mellitus E11.3511 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 2 .	laterality	lesion	T11	T9	note_7872
NonRel	Diabetic macular edema of [s1] left eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus E11.3512 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Mr. Boothe is here for follow - up of PDR OU ( NIDDM ) .	Treatment History IVA OU - 4 / 14 / 17 ( today ) PRP OD - 4 / 14 / 2017 ( today ) IVFA ( 4 / 6 / 2017 ) - Active [s2] PDR [e2] OU 1 .	laterality	lesion	T11	T16	note_7872
NonRel	Diabetic macular edema of left eye with proliferative retinopathy associated with type 2 diabetes mellitus E11.3512 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Mr. Boothe is here for follow - up of PDR [s1] OU [e1] ( NIDDM ) .	[s2] Diabetic macular edema [e2] of right eye with proliferative retinopathy associated with type 2 diabetes mellitus E11.3511 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 2 .	laterality	lesion	T14	T7	note_7872
NonRel	Diabetic macular edema of left eye with proliferative retinopathy associated with type 2 diabetes mellitus E11.3512 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Mr. Boothe is here for follow - up of PDR [s1] OU [e1] ( NIDDM ) .	Diabetic macular edema of right eye with [s2] proliferative retinopathy [e2] associated with type 2 diabetes mellitus E11.3511 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 2 .	laterality	lesion	T14	T9	note_7872
NonRel	Diabetic macular edema of left eye with proliferative retinopathy associated with type 2 diabetes mellitus E11.3512 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Mr. Boothe is here for follow - up of PDR [s1] OU [e1] ( NIDDM ) .	Treatment History IVA OU - 4 / 14 / 17 ( today ) PRP OD - 4 / 14 / 2017 ( today ) IVFA ( 4 / 6 / 2017 ) - Active [s2] PDR [e2] OU 1 .	laterality	lesion	T14	T16	note_7872
NonRel	Treatment History IVA OU - 4 / 14 / 17 ( today ) PRP OD - 4 / 14 / 2017 ( today ) IVFA ( 4 / 6 / 2017 ) - [s1] Active [e1] PDR OU 1 .	[s2] Diabetic macular edema [e2] of left eye with proliferative retinopathy associated with type 2 diabetes mellitus E11.3512 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Mr. Boothe is here for follow - up of PDR OU ( NIDDM ) .	severity	lesion	T15	T10	note_7872
NonRel	Treatment History IVA OU - 4 / 14 / 17 ( today ) PRP OD - 4 / 14 / 2017 ( today ) IVFA ( 4 / 6 / 2017 ) - [s1] Active [e1] PDR OU 1 .	Diabetic macular edema of left eye with [s2] proliferative retinopathy [e2] associated with type 2 diabetes mellitus E11.3512 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Mr. Boothe is here for follow - up of PDR OU ( NIDDM ) .	severity	lesion	T15	T12	note_7872
NonRel	Treatment History IVA OU - 4 / 14 / 17 ( today ) PRP OD - 4 / 14 / 2017 ( today ) IVFA ( 4 / 6 / 2017 ) - [s1] Active [e1] PDR OU 1 .	Diabetic macular edema of left eye with proliferative retinopathy associated with type 2 diabetes mellitus E11.3512 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Mr. Boothe is here for follow - up of [s2] PDR [e2] OU ( NIDDM ) .	severity	lesion	T15	T13	note_7872
NonRel	Treatment History IVA OU - 4 / 14 / 17 ( today ) PRP OD - 4 / 14 / 2017 ( today ) IVFA ( 4 / 6 / 2017 ) - Active PDR [s1] OU [e1] 1 .	[s2] Diabetic macular edema [e2] of left eye with proliferative retinopathy associated with type 2 diabetes mellitus E11.3512 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Mr. Boothe is here for follow - up of PDR OU ( NIDDM ) .	laterality	lesion	T17	T10	note_7872
NonRel	Treatment History IVA OU - 4 / 14 / 17 ( today ) PRP OD - 4 / 14 / 2017 ( today ) IVFA ( 4 / 6 / 2017 ) - Active PDR [s1] OU [e1] 1 .	Diabetic macular edema of left eye with [s2] proliferative retinopathy [e2] associated with type 2 diabetes mellitus E11.3512 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Mr. Boothe is here for follow - up of PDR OU ( NIDDM ) .	laterality	lesion	T17	T12	note_7872
NonRel	Treatment History IVA OU - 4 / 14 / 17 ( today ) PRP OD - 4 / 14 / 2017 ( today ) IVFA ( 4 / 6 / 2017 ) - Active PDR [s1] OU [e1] 1 .	Diabetic macular edema of left eye with proliferative retinopathy associated with type 2 diabetes mellitus E11.3512 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Mr. Boothe is here for follow - up of [s2] PDR [e2] OU ( NIDDM ) .	laterality	lesion	T17	T13	note_7872
NonRel	Vitreous hemorrhage , [s1] right [e1] - Right Eye H43.11 379.23 OPH - OD Intravitreal Injection , Pharmacologic Agent CANCELED : OCT , Retina - OU - Both Eyes 2 .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus - Right Eye E11.3511 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 362.02 3 .	laterality	lesion	T6	T7	note_2109
NonRel	Vitreous hemorrhage , [s1] right [e1] - Right Eye H43.11 379.23 OPH - OD Intravitreal Injection , Pharmacologic Agent CANCELED : OCT , Retina - OU - Both Eyes 2 .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus - Right Eye E11.3511 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 362.02 3 .	laterality	lesion	T6	T9	note_2109
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus - Right Eye E11.3511 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 362.02 3 .	[s2] Vitreous hemorrhage [e2] , right - Right Eye H43.11 379.23 OPH - OD Intravitreal Injection , Pharmacologic Agent CANCELED : OCT , Retina - OU - Both Eyes 2 .	laterality	lesion	T8	T5	note_2109
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus - Right Eye E11.3511 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 362.02 3 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 29 / 17 ( today ) IVA OD - 11 / 28 / 17 PRP OU - 5 / 19 / 2017 IVFA ( 5 / 4 / 17 ) : No demonstrable NVE OD ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	laterality	lesion	T8	T10	note_2109
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus - Right Eye E11.3511 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 362.02 3 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 29 / 17 ( today ) IVA OD - 11 / 28 / 17 PRP OU - 5 / 19 / 2017 IVFA ( 5 / 4 / 17 ) : No demonstrable NVE OD ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	laterality	lesion	T8	T12	note_2109
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus - Right Eye E11.3511 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 362.02 3 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 29 / 17 ( today ) IVA OD - 11 / 28 / 17 PRP OU - 5 / 19 / 2017 IVFA ( 5 / 4 / 17 ) : No demonstrable [s2] NVE [e2] OD ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	laterality	lesion	T8	T13	note_2109
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus - Right Eye E11.3511 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 362.02 3 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 29 / 17 ( today ) IVA OD - 11 / 28 / 17 PRP OU - 5 / 19 / 2017 IVFA ( 5 / 4 / 17 ) : No demonstrable NVE OD ( IVA masking possible ) , OS with still active areas of [s2] NVE [e2] but with great improvement since prior to first laser .	laterality	lesion	T8	T16	note_2109
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 29 / 17 ( today ) IVA OD - 11 / 28 / 17 PRP OU - 5 / 19 / 2017 IVFA ( 5 / 4 / 17 ) : No demonstrable NVE OD ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus - Right Eye E11.3511 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 362.02 3 .	laterality	lesion	T11	T7	note_2109
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 29 / 17 ( today ) IVA OD - 11 / 28 / 17 PRP OU - 5 / 19 / 2017 IVFA ( 5 / 4 / 17 ) : No demonstrable NVE OD ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus - Right Eye E11.3511 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 362.02 3 .	laterality	lesion	T11	T9	note_2109
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 29 / 17 ( today ) IVA OD - 11 / 28 / 17 PRP OU - 5 / 19 / 2017 IVFA ( 5 / 4 / 17 ) : No demonstrable NVE OD ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	IVA OD - 3 / 24 / 2017 IVA OD - 2 / 10 / 17 PRP OS - 2 / 10 / 17 IVFA ( 2 / 10 / 2017 ) - Only limited peripheral view OD , but [s2] NVE [e2] with peripheral dropout .	laterality	lesion	T11	T18	note_2109
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 29 / 17 ( today ) IVA OD - 11 / 28 / 17 PRP OU - 5 / 19 / 2017 IVFA ( 5 / 4 / 17 ) : No demonstrable NVE [s1] OD [e1] ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus - Right Eye E11.3511 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 362.02 3 .	laterality	lesion	T14	T7	note_2109
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 29 / 17 ( today ) IVA OD - 11 / 28 / 17 PRP OU - 5 / 19 / 2017 IVFA ( 5 / 4 / 17 ) : No demonstrable NVE [s1] OD [e1] ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus - Right Eye E11.3511 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 362.02 3 .	laterality	lesion	T14	T9	note_2109
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 29 / 17 ( today ) IVA OD - 11 / 28 / 17 PRP OU - 5 / 19 / 2017 IVFA ( 5 / 4 / 17 ) : No demonstrable NVE [s1] OD [e1] ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	IVA OD - 3 / 24 / 2017 IVA OD - 2 / 10 / 17 PRP OS - 2 / 10 / 17 IVFA ( 2 / 10 / 2017 ) - Only limited peripheral view OD , but [s2] NVE [e2] with peripheral dropout .	laterality	lesion	T14	T18	note_2109
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 29 / 17 ( today ) IVA OD - 11 / 28 / 17 PRP OU - 5 / 19 / 2017 IVFA ( 5 / 4 / 17 ) : No demonstrable NVE OD ( IVA masking possible ) , [s1] OS [e1] with still active areas of NVE but with great improvement since prior to first laser .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus - Right Eye E11.3511 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 362.02 3 .	laterality	lesion	T15	T7	note_2109
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 29 / 17 ( today ) IVA OD - 11 / 28 / 17 PRP OU - 5 / 19 / 2017 IVFA ( 5 / 4 / 17 ) : No demonstrable NVE OD ( IVA masking possible ) , [s1] OS [e1] with still active areas of NVE but with great improvement since prior to first laser .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus - Right Eye E11.3511 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 362.02 3 .	laterality	lesion	T15	T9	note_2109
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 29 / 17 ( today ) IVA OD - 11 / 28 / 17 PRP OU - 5 / 19 / 2017 IVFA ( 5 / 4 / 17 ) : No demonstrable NVE OD ( IVA masking possible ) , [s1] OS [e1] with still active areas of NVE but with great improvement since prior to first laser .	IVA OD - 3 / 24 / 2017 IVA OD - 2 / 10 / 17 PRP OS - 2 / 10 / 17 IVFA ( 2 / 10 / 2017 ) - Only limited peripheral view OD , but [s2] NVE [e2] with peripheral dropout .	laterality	lesion	T15	T18	note_2109
NonRel	IVA OD - 3 / 24 / 2017 IVA OD - 2 / 10 / 17 PRP OS - 2 / 10 / 17 IVFA ( 2 / 10 / 2017 ) - Only limited peripheral view [s1] OD [e1] , but NVE with peripheral dropout .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 29 / 17 ( today ) IVA OD - 11 / 28 / 17 PRP OU - 5 / 19 / 2017 IVFA ( 5 / 4 / 17 ) : No demonstrable NVE OD ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	laterality	lesion	T17	T10	note_2109
NonRel	IVA OD - 3 / 24 / 2017 IVA OD - 2 / 10 / 17 PRP OS - 2 / 10 / 17 IVFA ( 2 / 10 / 2017 ) - Only limited peripheral view [s1] OD [e1] , but NVE with peripheral dropout .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 29 / 17 ( today ) IVA OD - 11 / 28 / 17 PRP OU - 5 / 19 / 2017 IVFA ( 5 / 4 / 17 ) : No demonstrable NVE OD ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	laterality	lesion	T17	T12	note_2109
NonRel	IVA OD - 3 / 24 / 2017 IVA OD - 2 / 10 / 17 PRP OS - 2 / 10 / 17 IVFA ( 2 / 10 / 2017 ) - Only limited peripheral view [s1] OD [e1] , but NVE with peripheral dropout .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 29 / 17 ( today ) IVA OD - 11 / 28 / 17 PRP OU - 5 / 19 / 2017 IVFA ( 5 / 4 / 17 ) : No demonstrable [s2] NVE [e2] OD ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	laterality	lesion	T17	T13	note_2109
NonRel	IVA OD - 3 / 24 / 2017 IVA OD - 2 / 10 / 17 PRP OS - 2 / 10 / 17 IVFA ( 2 / 10 / 2017 ) - Only limited peripheral view [s1] OD [e1] , but NVE with peripheral dropout .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 29 / 17 ( today ) IVA OD - 11 / 28 / 17 PRP OU - 5 / 19 / 2017 IVFA ( 5 / 4 / 17 ) : No demonstrable NVE OD ( IVA masking possible ) , OS with still active areas of [s2] NVE [e2] but with great improvement since prior to first laser .	laterality	lesion	T17	T16	note_2109
NonRel	IVA OD - 3 / 24 / 2017 IVA OD - 2 / 10 / 17 PRP OS - 2 / 10 / 17 IVFA ( 2 / 10 / 2017 ) - Only limited peripheral view [s1] OD [e1] , but NVE with peripheral dropout .	OS with active [s2] NVE [e2] and peripheral non - perfusion inferonasally .	laterality	lesion	T17	T21	note_2109
NonRel	[s1] OS [e1] with active NVE and peripheral non - perfusion inferonasally .	IVA OD - 3 / 24 / 2017 IVA OD - 2 / 10 / 17 PRP OS - 2 / 10 / 17 IVFA ( 2 / 10 / 2017 ) - Only limited peripheral view OD , but [s2] NVE [e2] with peripheral dropout .	laterality	lesion	T19	T18	note_2109
NonRel	OS with [s1] active [e1] NVE and peripheral non - perfusion inferonasally .	IVA OD - 3 / 24 / 2017 IVA OD - 2 / 10 / 17 PRP OS - 2 / 10 / 17 IVFA ( 2 / 10 / 2017 ) - Only limited peripheral view OD , but [s2] NVE [e2] with peripheral dropout .	severity	lesion	T20	T18	note_2109
NonRel	Type 2 diabetes mellitus with [s1] both eyes [e1] affected by proliferative retinopathy and traction retinal detachments involving maculae , unspecified long term insulin use status E11.3523 250.50 OCT , Retina - OU - Both Eyes 362.02 Fluorescein Angiography - OU - Both Eyes 361.81 3 .	Both eyes affected by [s2] proliferative diabetic retinopathy [e2] with traction retinal detachments involving maculae , associated with type 2 diabetes mellitus E11.3523 250.50 362.02 361.81 Patient does not speak English .	laterality	lesion	T1	T4	note_8903
NonRel	[s1] Both eyes [e1] affected by proliferative diabetic retinopathy with traction retinal detachments involving maculae , associated with type 2 diabetes mellitus E11.3523 250.50 362.02 361.81 Patient does not speak English .	Type 2 diabetes mellitus with both eyes affected by [s2] proliferative retinopathy [e2] and traction retinal detachments involving maculae , unspecified long term insulin use status E11.3523 250.50 OCT , Retina - OU - Both Eyes 362.02 Fluorescein Angiography - OU - Both Eyes 361.81 3 .	laterality	lesion	T3	T2	note_8903
NonRel	OCT , Retina - OU - Both Eyes OD : Normal foveal contour without [s1] IRF [e1] / SRF .	No loss of IS / SO junction OS : Normeal [s2] foveal [e2] contour without IRF / SRF .	lesion	eye_part	T2	T4	916985_note_1493
NonRel	OCT , Retina - OU - Both Eyes OD : Normal foveal contour without IRF / [s1] SRF [e1] .	No loss of IS / SO junction OS : Normeal [s2] foveal [e2] contour without IRF / SRF .	lesion	eye_part	T3	T4	916985_note_1493
NonRel	No loss of IS / SO junction OS : Normeal foveal contour without [s1] IRF [e1] / SRF .	OCT , Retina - OU - Both Eyes OD : Normal [s2] foveal [e2] contour without IRF / SRF .	lesion	eye_part	T5	T1	916985_note_1493
NonRel	No loss of IS / SO junction OS : Normeal foveal contour without IRF / [s1] SRF [e1] .	OCT , Retina - OU - Both Eyes OD : Normal [s2] foveal [e2] contour without IRF / SRF .	lesion	eye_part	T6	T1	916985_note_1493
NonRel	OCT , Retina - OU - Both Eyes [s1] OD [e1] : Normal foveal contour without IRF / SRF .	No loss of IS / SO junction OS : Normeal foveal contour without [s2] IRF [e2] / SRF .	laterality	lesion	T7	T5	916985_note_1493
NonRel	OCT , Retina - OU - Both Eyes [s1] OD [e1] : Normal foveal contour without IRF / SRF .	No loss of IS / SO junction OS : Normeal foveal contour without IRF / [s2] SRF [e2] .	laterality	lesion	T7	T6	916985_note_1493
NonRel	No loss of IS / SO junction [s1] OS [e1] : Normeal foveal contour without IRF / SRF .	OCT , Retina - OU - Both Eyes OD : Normal foveal contour without [s2] IRF [e2] / SRF .	laterality	lesion	T8	T2	916985_note_1493
NonRel	No loss of IS / SO junction [s1] OS [e1] : Normeal foveal contour without IRF / SRF .	OCT , Retina - OU - Both Eyes OD : Normal foveal contour without IRF / [s2] SRF [e2] .	laterality	lesion	T8	T3	916985_note_1493
NonRel	DME [s1] OU [e1] , improved OD on OCT vs last exam s / p IVA .	[s2] Proliferative diabetic retinopathy [e2] ( 362.02 ) PR INJECT INTRAVITREAL PHARMCOLOGIC 1 - 3 ) PDR with recurrent VH - VA good .	laterality	lesion	T31	T5	1810666_note_4397
NonRel	DME [s1] OU [e1] , improved OD on OCT vs last exam s / p IVA .	Proliferative diabetic retinopathy ( 362.02 ) PR INJECT INTRAVITREAL PHARMCOLOGIC 1 - 3 ) PDR with recurrent [s2] VH [e2] - VA good .	laterality	lesion	T31	T22	1810666_note_4397
NonRel	DME [s1] OU [e1] , improved OD on OCT vs last exam s / p IVA .	Proliferative diabetic retinopathy ( 362.02 ) PR INJECT INTRAVITREAL PHARMCOLOGIC 1 - 3 ) [s2] PDR [e2] with recurrent VH - VA good .	laterality	lesion	T31	T35	1810666_note_4397
NonRel	Other testing : OCT - Macula : Dme [s1] OU [e1] Assessment Assessment and Plan : 1 .	Allergies : No Known Allergies ROS Positive for : Eyes Negative for : Cardiovascular , Respiratory Objective Objective : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 40 + 2 20 / 200 Method : Snellen - Linear Correction : Glasses Tonometry Right Left Pressure 19 19 Method : I care Time : 2 : 42 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 49 PM Main Ophthalmology Exam Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris no [s2] NVI [e2] , Iris atrophy at pupil margin Round and reactive Lens Posterior subcapsular cataract Posterior subcapsular cataract Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T9	T1	note_4453
NonRel	PRP limited by [s1] residual [e1] VH .	PDR with [s2] VH [e2] - plan for IVA OU today and PRP OD .	severity	lesion	T12	T5	note_4453
NonRel	PRP limited by [s1] residual [e1] VH .	Consider further PRP as [s2] VH [e2] continues to clear .	severity	lesion	T12	T7	note_4453
NonRel	PRP limited by [s1] residual [e1] VH .	[s2] PDR [e2] with VH - plan for IVA OU today and PRP OD .	severity	lesion	T12	T11	note_4453
NonRel	PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP [s1] OD [e1] Pre - op DX : PDR Post - op DX : PDR Surgeon : Feistmann Assitant : Rocke Power : 250 - 350 mW Duration : 30 - 40 ms Spot Size : 200 Total shots : 672 Description of Procedure : Consent was obtained , time out was performed .	Consider further PRP as [s2] VH [e2] continues to clear .	laterality	lesion	T14	T7	note_4453
NonRel	Treatment Hx : IVFA ( today ) : [s1] Severe [e1] NPDR OU 1 .	IDDM with Severe [s2] NPDR [e2] OU - Diagnosed in early 30 ' s - Significant CWS and fibrovascular pegs OU on exam .	severity	lesion	T12	T2	298406_note_809
NonRel	Treatment Hx : IVFA ( today ) : [s1] Severe [e1] NPDR OU 1 .	IDDM with Severe NPDR OU - Diagnosed in early 30 ' s - Significant [s2] CWS [e2] and fibrovascular pegs OU on exam .	severity	lesion	T12	T3	298406_note_809
NonRel	Treatment Hx : IVFA ( today ) : [s1] Severe [e1] NPDR OU 1 .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes , with macular edema , associated with type 2 diabetes mellitus E11.3413 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.06 Lab Results Component Value Date HGBA 1 C 9.8 DATE HGBA 1 C 12.1 ( H ) DATE New Retina patient here today for eval of diabetic retinopathy .	severity	lesion	T12	T22	298406_note_809
NonRel	Treatment Hx : IVFA ( today ) : [s1] Severe [e1] NPDR OU 1 .	Severe nonproliferative diabetic retinopathy of both eyes , with [s2] macular edema [e2] , associated with type 2 diabetes mellitus E11.3413 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.06 Lab Results Component Value Date HGBA 1 C 9.8 DATE HGBA 1 C 12.1 ( H ) DATE New Retina patient here today for eval of diabetic retinopathy .	severity	lesion	T12	T23	298406_note_809
NonRel	Treatment Hx : IVFA ( today ) : Severe NPDR [s1] OU [e1] 1 .	IDDM with Severe [s2] NPDR [e2] OU - Diagnosed in early 30 ' s - Significant CWS and fibrovascular pegs OU on exam .	laterality	lesion	T13	T2	298406_note_809
NonRel	Treatment Hx : IVFA ( today ) : Severe NPDR [s1] OU [e1] 1 .	IDDM with Severe NPDR OU - Diagnosed in early 30 ' s - Significant [s2] CWS [e2] and fibrovascular pegs OU on exam .	laterality	lesion	T13	T3	298406_note_809
NonRel	Treatment Hx : IVFA ( today ) : Severe NPDR [s1] OU [e1] 1 .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes , with macular edema , associated with type 2 diabetes mellitus E11.3413 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.06 Lab Results Component Value Date HGBA 1 C 9.8 DATE HGBA 1 C 12.1 ( H ) DATE New Retina patient here today for eval of diabetic retinopathy .	laterality	lesion	T13	T22	298406_note_809
NonRel	Treatment Hx : IVFA ( today ) : Severe NPDR [s1] OU [e1] 1 .	Severe nonproliferative diabetic retinopathy of both eyes , with [s2] macular edema [e2] , associated with type 2 diabetes mellitus E11.3413 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.06 Lab Results Component Value Date HGBA 1 C 9.8 DATE HGBA 1 C 12.1 ( H ) DATE New Retina patient here today for eval of diabetic retinopathy .	laterality	lesion	T13	T23	298406_note_809
NonRel	IDDM with [s1] Severe [e1] NPDR OU - Diagnosed in early 30 ' s - Significant CWS and fibrovascular pegs OU on exam .	Treatment Hx : IVFA ( today ) : Severe [s2] NPDR [e2] OU 1 .	severity	lesion	T14	T1	298406_note_809
NonRel	IDDM with [s1] Severe [e1] NPDR OU - Diagnosed in early 30 ' s - Significant CWS and fibrovascular pegs OU on exam .	Scattered [s2] IRMAs [e2] vs early NVE .	severity	lesion	T14	T4	298406_note_809
NonRel	IDDM with [s1] Severe [e1] NPDR OU - Diagnosed in early 30 ' s - Significant CWS and fibrovascular pegs OU on exam .	Scattered IRMAs vs early [s2] NVE [e2] .	severity	lesion	T14	T5	298406_note_809
NonRel	IDDM with Severe NPDR [s1] OU [e1] - Diagnosed in early 30 ' s - Significant CWS and fibrovascular pegs OU on exam .	Treatment Hx : IVFA ( today ) : Severe [s2] NPDR [e2] OU 1 .	laterality	lesion	T15	T1	298406_note_809
NonRel	IDDM with Severe NPDR [s1] OU [e1] - Diagnosed in early 30 ' s - Significant CWS and fibrovascular pegs OU on exam .	Scattered [s2] IRMAs [e2] vs early NVE .	laterality	lesion	T15	T4	298406_note_809
NonRel	IDDM with Severe NPDR [s1] OU [e1] - Diagnosed in early 30 ' s - Significant CWS and fibrovascular pegs OU on exam .	Scattered IRMAs vs early [s2] NVE [e2] .	laterality	lesion	T15	T5	298406_note_809
NonRel	IDDM with Severe NPDR OU - Diagnosed in early 30 ' s - [s1] Significant [e1] CWS and fibrovascular pegs OU on exam .	Treatment Hx : IVFA ( today ) : Severe [s2] NPDR [e2] OU 1 .	severity	lesion	T16	T1	298406_note_809
NonRel	IDDM with Severe NPDR OU - Diagnosed in early 30 ' s - [s1] Significant [e1] CWS and fibrovascular pegs OU on exam .	Scattered [s2] IRMAs [e2] vs early NVE .	severity	lesion	T16	T4	298406_note_809
NonRel	IDDM with Severe NPDR OU - Diagnosed in early 30 ' s - [s1] Significant [e1] CWS and fibrovascular pegs OU on exam .	Scattered IRMAs vs early [s2] NVE [e2] .	severity	lesion	T16	T5	298406_note_809
NonRel	IDDM with Severe NPDR OU - Diagnosed in early 30 ' s - Significant CWS and fibrovascular pegs [s1] OU [e1] on exam .	Treatment Hx : IVFA ( today ) : Severe [s2] NPDR [e2] OU 1 .	laterality	lesion	T17	T1	298406_note_809
NonRel	IDDM with Severe NPDR OU - Diagnosed in early 30 ' s - Significant CWS and fibrovascular pegs [s1] OU [e1] on exam .	Scattered [s2] IRMAs [e2] vs early NVE .	laterality	lesion	T17	T4	298406_note_809
NonRel	IDDM with Severe NPDR OU - Diagnosed in early 30 ' s - Significant CWS and fibrovascular pegs [s1] OU [e1] on exam .	Scattered IRMAs vs early [s2] NVE [e2] .	laterality	lesion	T17	T5	298406_note_809
NonRel	[s1] Scattered [e1] IRMAs vs early NVE .	IDDM with Severe [s2] NPDR [e2] OU - Diagnosed in early 30 ' s - Significant CWS and fibrovascular pegs OU on exam .	severity	lesion	T18	T2	298406_note_809
NonRel	[s1] Scattered [e1] IRMAs vs early NVE .	IDDM with Severe NPDR OU - Diagnosed in early 30 ' s - Significant [s2] CWS [e2] and fibrovascular pegs OU on exam .	severity	lesion	T18	T3	298406_note_809
NonRel	[s1] Scattered [e1] IRMAs vs early NVE .	No [s2] CSME [e2] 2 .	severity	lesion	T18	T6	298406_note_809
NonRel	Scattered IRMAs vs [s1] early [e1] NVE .	IDDM with Severe [s2] NPDR [e2] OU - Diagnosed in early 30 ' s - Significant CWS and fibrovascular pegs OU on exam .	severity	lesion	T19	T2	298406_note_809
NonRel	Scattered IRMAs vs [s1] early [e1] NVE .	IDDM with Severe NPDR OU - Diagnosed in early 30 ' s - Significant [s2] CWS [e2] and fibrovascular pegs OU on exam .	severity	lesion	T19	T3	298406_note_809
NonRel	Scattered IRMAs vs [s1] early [e1] NVE .	No [s2] CSME [e2] 2 .	severity	lesion	T19	T6	298406_note_809
NonRel	NAME MD IVFA ( Today ) : superior IRMA [s1] OD [e1] and peripheral ischemia OU , no NVD or NVE noted .	DATE OCT without [s2] IRF [e2] / SRF , attached hylaoid	laterality	lesion	T20	T10	298406_note_809
NonRel	NAME MD IVFA ( Today ) : superior IRMA [s1] OD [e1] and peripheral ischemia OU , no NVD or NVE noted .	DATE OCT without IRF / [s2] SRF [e2] , attached hylaoid	laterality	lesion	T20	T11	298406_note_809
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes , with macular edema , associated with type 2 diabetes mellitus E11.3413 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.06 Lab Results Component Value Date HGBA 1 C 9.8 DATE HGBA 1 C 12.1 ( H ) DATE New Retina patient here today for eval of diabetic retinopathy .	Treatment Hx : IVFA ( today ) : Severe [s2] NPDR [e2] OU 1 .	severity	lesion	T21	T1	298406_note_809
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] , with macular edema , associated with type 2 diabetes mellitus E11.3413 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.06 Lab Results Component Value Date HGBA 1 C 9.8 DATE HGBA 1 C 12.1 ( H ) DATE New Retina patient here today for eval of diabetic retinopathy .	Treatment Hx : IVFA ( today ) : Severe [s2] NPDR [e2] OU 1 .	laterality	lesion	T24	T1	298406_note_809
NonRel	Treatment History IVA OD - 11 / 16 / 18 ( today ) IVA OD - 10 / 12 / 18 IVA OD - 9 / 7 / 18 IVA OD - 8 / 3 / 18 PRP OS ( IVFA - guided ) - 5 / 18 / 18 IVA OU - 5 / 18 / 18 IVA OU - 3 / 9 / 18 IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - [s1] Active [e1] PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) DM - PDR OU , SHH OD OD : Active PDR with large VH and now new SHH .	Will need PRP in the future once [s2] SHH [e2] clears .	severity	lesion	T6	T19	note_3992
NonRel	Treatment History IVA OD - 11 / 16 / 18 ( today ) IVA OD - 10 / 12 / 18 IVA OD - 9 / 7 / 18 IVA OD - 8 / 3 / 18 PRP OS ( IVFA - guided ) - 5 / 18 / 18 IVA OU - 5 / 18 / 18 IVA OU - 3 / 9 / 18 IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR [s1] OU [e1] Outside Retina : Multiple IVA OU PRP OU 1 ) DM - PDR OU , SHH OD OD : Active PDR with large VH and now new SHH .	Will need PRP in the future once [s2] SHH [e2] clears .	laterality	lesion	T8	T19	note_3992
NonRel	Treatment History IVA OD - 11 / 16 / 18 ( today ) IVA OD - 10 / 12 / 18 IVA OD - 9 / 7 / 18 IVA OD - 8 / 3 / 18 PRP OS ( IVFA - guided ) - 5 / 18 / 18 IVA OU - 5 / 18 / 18 IVA OU - 3 / 9 / 18 IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) DM - PDR [s1] OU [e1] , SHH OD OD : Active PDR with large VH and now new SHH .	Will need PRP in the future once [s2] SHH [e2] clears .	laterality	lesion	T10	T19	note_3992
NonRel	Treatment History IVA OD - 11 / 16 / 18 ( today ) IVA OD - 10 / 12 / 18 IVA OD - 9 / 7 / 18 IVA OD - 8 / 3 / 18 PRP OS ( IVFA - guided ) - 5 / 18 / 18 IVA OU - 5 / 18 / 18 IVA OU - 3 / 9 / 18 IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) DM - PDR OU , SHH [s1] OD [e1] OD : Active PDR with large VH and now new SHH .	Will need PRP in the future once [s2] SHH [e2] clears .	laterality	lesion	T12	T19	note_3992
NonRel	Treatment History IVA OD - 11 / 16 / 18 ( today ) IVA OD - 10 / 12 / 18 IVA OD - 9 / 7 / 18 IVA OD - 8 / 3 / 18 PRP OS ( IVFA - guided ) - 5 / 18 / 18 IVA OU - 5 / 18 / 18 IVA OU - 3 / 9 / 18 IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) DM - PDR OU , SHH OD [s1] OD [e1] : Active PDR with large VH and now new SHH .	Will need PRP in the future once [s2] SHH [e2] clears .	laterality	lesion	T13	T19	note_3992
NonRel	Treatment History IVA OD - 11 / 16 / 18 ( today ) IVA OD - 10 / 12 / 18 IVA OD - 9 / 7 / 18 IVA OD - 8 / 3 / 18 PRP OS ( IVFA - guided ) - 5 / 18 / 18 IVA OU - 5 / 18 / 18 IVA OU - 3 / 9 / 18 IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) DM - PDR OU , SHH OD OD : [s1] Active [e1] PDR with large VH and now new SHH .	Will need PRP in the future once [s2] SHH [e2] clears .	severity	lesion	T14	T19	note_3992
NonRel	Treatment History IVA OD - 11 / 16 / 18 ( today ) IVA OD - 10 / 12 / 18 IVA OD - 9 / 7 / 18 IVA OD - 8 / 3 / 18 PRP OS ( IVFA - guided ) - 5 / 18 / 18 IVA OU - 5 / 18 / 18 IVA OU - 3 / 9 / 18 IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) DM - PDR OU , SHH OD OD : Active PDR with [s1] large [e1] VH and now new SHH .	Will need PRP in the future once [s2] SHH [e2] clears .	severity	lesion	T16	T19	note_3992
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Hx of PDR OU , s / p PPV OS , and PRP OD .	laterality	lesion	T2	T4	note_4017
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Hx of PDR OU , s / p PPV OS , and PRP OD .	laterality	lesion	T2	T6	note_4017
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Hx of [s2] PDR [e2] OU , s / p PPV OS , and PRP OD .	laterality	lesion	T2	T12	note_4017
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Hx of PDR OU , s / p PPV OS , and PRP OD .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	laterality	lesion	T5	T1	note_4017
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Hx of PDR OU , s / p PPV OS , and PRP OD .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	laterality	lesion	T5	T3	note_4017
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Hx of PDR [s1] OU [e1] , s / p PPV OS , and PRP OD .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	laterality	lesion	T13	T1	note_4017
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Hx of PDR [s1] OU [e1] , s / p PPV OS , and PRP OD .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	laterality	lesion	T13	T3	note_4017
NonRel	+ NVE OU on IVFA today OD - Mild [s1] NVE [e1] in mid - periphery , but well - lasered .	S / P Focal OS - Mild NVE in [s2] mid periphery [e2] .	lesion	eye_part	T5	T17	174109_note_438
NonRel	S / P Focal OS - Mild [s1] NVE [e1] in mid periphery .	+ NVE OU on IVFA today OD - Mild NVE in [s2] mid - periphery [e2] , but well - lasered .	lesion	eye_part	T6	T12	174109_note_438
NonRel	Diabetes mellitus due to underlying condition with chronic kidney disease on chronic dialysis , with long - term current use of insulin E08 . 22 249.40 N18.6 585.9 Z79.4 V45.11 Z99.2 V58.67 Mr. NAME is a 72 year old male with a h / o PDR [s1] OU [e1] s / p PRP OU Referred from Dr. NAME for evaluation of possible NVE seen clinically .	Treatment Hx IVFA - PRP and focal laser scars with [s2] NVE [e2] OU .	laterality	lesion	T8	T13	174109_note_438
NonRel	Diabetes mellitus due to underlying condition with chronic kidney disease on chronic dialysis , with long - term current use of insulin E08 . 22 249.40 N18.6 585.9 Z79.4 V45.11 Z99.2 V58.67 Mr. NAME is a 72 year old male with a h / o PDR OU s / p PRP OU Referred from Dr. NAME for evaluation of [s1] possible [e1] NVE seen clinically .	Treatment Hx IVFA - PRP and focal laser scars with [s2] NVE [e2] OU .	severity	lesion	T9	T13	174109_note_438
NonRel	+ NVE OU on IVFA today OD - [s1] Mild [e1] NVE in mid - periphery , but well - lasered .	S / P Focal OS - Mild [s2] NVE [e2] in mid periphery .	severity	lesion	T10	T6	174109_note_438
NonRel	+ NVE OU on IVFA today [s1] OD [e1] - Mild NVE in mid - periphery , but well - lasered .	S / P Focal OS - Mild [s2] NVE [e2] in mid periphery .	laterality	lesion	T11	T6	174109_note_438
NonRel	Treatment Hx IVFA - PRP and focal laser scars with NVE [s1] OU [e1] .	Diabetes mellitus due to underlying condition with chronic kidney disease on chronic dialysis , with long - term current use of insulin E08 . 22 249.40 N18.6 585.9 Z79.4 V45.11 Z99.2 V58.67 Mr. NAME is a 72 year old male with a h / o PDR OU s / p PRP OU Referred from Dr. NAME for evaluation of possible [s2] NVE [e2] seen clinically .	laterality	lesion	T14	T3	174109_note_438
NonRel	Treatment Hx IVFA - PRP and focal laser scars with NVE [s1] OU [e1] .	Diabetes mellitus due to underlying condition with chronic kidney disease on chronic dialysis , with long - term current use of insulin E08 . 22 249.40 N18.6 585.9 Z79.4 V45.11 Z99.2 V58.67 Mr. NAME is a 72 year old male with a h / o [s2] PDR [e2] OU s / p PRP OU Referred from Dr. NAME for evaluation of possible NVE seen clinically .	laterality	lesion	T14	T4	174109_note_438
NonRel	S / P Focal OS - [s1] Mild [e1] NVE in mid periphery .	+ NVE OU on IVFA today OD - Mild [s2] NVE [e2] in mid - periphery , but well - lasered .	severity	lesion	T15	T5	174109_note_438
NonRel	S / P Focal [s1] OS [e1] - Mild NVE in mid periphery .	+ NVE OU on IVFA today OD - Mild [s2] NVE [e2] in mid - periphery , but well - lasered .	laterality	lesion	T16	T5	174109_note_438
NonRel	PDR ( proliferative diabetic retinopathy ) - [s1] OU [e1] ( 250.50 ) 2 .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 30 - 20 / 30 Method : Snellen - Linear Correction : Glasses Tonometry Right Left Pressure 12 13 Method : Applanation Time : 1 : 57 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 1 : 57 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Blepharitis Blepharitis Conjunctiva / Sclera White and quiet White and quiet Cornea PEK PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Nuclear sclerosis , 1 + Cortical cataract , 1 + Posterior subcapsular cataract 2 + Nuclear sclerosis , 1 + Cortical cataract , 1 + Posterior subcapsular cataract Vitreous Normal , no heme Posterior vitreous detachment , no heme Fundus Exam Right Left Disc Normal Normal Macula No [s2] CSME [e2] , + ERM No CSME , + ERM Vessels Vascular attenuation , beading , narrowing Vascular attenuation , Tortuous , Arteriolar narrowing , beading Periphery extensing PRP , sup - temp neo extensive PRP , dbh , inferior preretinal heme extending inf - temp Neuro / Psych Oriented x3 : Yes Other testing : { : 21027038 } Assessment and Plan : 1 .	laterality	lesion	T6	T1	note_209
NonRel	PDR ( proliferative diabetic retinopathy ) - [s1] OU [e1] ( 250.50 ) 2 .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 30 - 20 / 30 Method : Snellen - Linear Correction : Glasses Tonometry Right Left Pressure 12 13 Method : Applanation Time : 1 : 57 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 1 : 57 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Blepharitis Blepharitis Conjunctiva / Sclera White and quiet White and quiet Cornea PEK PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Nuclear sclerosis , 1 + Cortical cataract , 1 + Posterior subcapsular cataract 2 + Nuclear sclerosis , 1 + Cortical cataract , 1 + Posterior subcapsular cataract Vitreous Normal , no heme Posterior vitreous detachment , no heme Fundus Exam Right Left Disc Normal Normal Macula No CSME , + ERM No [s2] CSME [e2] , + ERM Vessels Vascular attenuation , beading , narrowing Vascular attenuation , Tortuous , Arteriolar narrowing , beading Periphery extensing PRP , sup - temp neo extensive PRP , dbh , inferior preretinal heme extending inf - temp Neuro / Psych Oriented x3 : Yes Other testing : { : 21027038 } Assessment and Plan : 1 .	laterality	lesion	T6	T2	note_209
NonRel	PDR ( proliferative diabetic retinopathy ) - [s1] OU [e1] ( 250.50 ) 2 .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 30 - 20 / 30 Method : Snellen - Linear Correction : Glasses Tonometry Right Left Pressure 12 13 Method : Applanation Time : 1 : 57 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 1 : 57 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Blepharitis Blepharitis Conjunctiva / Sclera White and quiet White and quiet Cornea PEK PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Nuclear sclerosis , 1 + Cortical cataract , 1 + Posterior subcapsular cataract 2 + Nuclear sclerosis , 1 + Cortical cataract , 1 + Posterior subcapsular cataract Vitreous Normal , no heme Posterior vitreous detachment , no heme Fundus Exam Right Left Disc Normal Normal Macula No CSME , + ERM No CSME , + ERM Vessels Vascular attenuation , beading , narrowing Vascular attenuation , Tortuous , Arteriolar narrowing , beading Periphery extensing PRP , sup - temp neo extensive PRP , [s2] dbh [e2] , inferior preretinal heme extending inf - temp Neuro / Psych Oriented x3 : Yes Other testing : { : 21027038 } Assessment and Plan : 1 .	laterality	lesion	T6	T3	note_209
NonRel	Visit Date : 2 / 21 / 2012 Referring Physician : Dr. None Chief Complaint Patient presents with • Eye Problem IDDM x1965 with PDR [s1] OU [e1] with regressed NV and stable preretinal heme OS s / p PRP last visit 9 / 28 / 11 .	Subjective : History of Present Illness : Anthony Demott is a 47 y.o. male who is here today for IDDM x1965 with [s2] PDR [e2] OU with regressed NV and stable preretinal heme OS s / p PRP last visit 9 / 28 / 11 .	laterality	lesion	T9	T8	note_209
NonRel	Subjective : History of Present Illness : Anthony Demott is a 47 y.o. male who is here today for IDDM x1965 with PDR [s1] OU [e1] with regressed NV and stable preretinal heme OS s / p PRP last visit 9 / 28 / 11 .	Visit Date : 2 / 21 / 2012 Referring Physician : Dr. None Chief Complaint Patient presents with • Eye Problem IDDM x1965 with [s2] PDR [e2] OU with regressed NV and stable preretinal heme OS s / p PRP last visit 9 / 28 / 11 .	laterality	lesion	T10	T7	note_209
NonRel	Acute on chronic diastolic heart failure I50.33 428.33 Hx of PDR , VH [s1] OD [e1] with hospitalization DATE .	Attending Note : 1 ) IDDM 2 [ Hg A1C 6.4 ] OD - Active PDR with significant improvement in [s2] VH [e2] from the last visit .	laterality	lesion	T9	T3	157996_note_418
NonRel	Acute on chronic diastolic heart failure I50.33 428.33 Hx of PDR , VH [s1] OD [e1] with hospitalization DATE .	Attending Note : 1 ) IDDM 2 [ Hg A1C 6.4 ] OD - Active [s2] PDR [e2] with significant improvement in VH from the last visit .	laterality	lesion	T9	T4	157996_note_418
NonRel	Attending Note : 1 ) IDDM 2 [ Hg A1C 6.4 ] [s1] OD [e1] - Active PDR with significant improvement in VH from the last visit .	Acute on chronic diastolic heart failure I50.33 428.33 Hx of [s2] PDR [e2] , VH OD with hospitalization DATE .	laterality	lesion	T10	T6	157996_note_418
NonRel	Attending Note : 1 ) IDDM 2 [ Hg A1C 6.4 ] [s1] OD [e1] - Active PDR with significant improvement in VH from the last visit .	Acute on chronic diastolic heart failure I50.33 428.33 Hx of PDR , [s2] VH [e2] OD with hospitalization DATE .	laterality	lesion	T10	T7	157996_note_418
NonRel	Attending Note : 1 ) IDDM 2 [ Hg A1C 6.4 ] [s1] OD [e1] - Active PDR with significant improvement in VH from the last visit .	Inferior arcade with tractional band ( + [s2] NVE [e2] ) .	laterality	lesion	T10	T11	157996_note_418
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 362.02 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with VH that has responded to treatment with IVA .	laterality	lesion	T3	T2	note_4008
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 362.02 2 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with VH that has responded to treatment with IVA .	laterality	lesion	T3	T6	note_4008
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 362.02 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - [s2] PDR [e2] with VH that has responded to treatment with IVA .	laterality	lesion	T3	T7	note_4008
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 362.02 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with [s2] VH [e2] that has responded to treatment with IVA .	laterality	lesion	T3	T8	note_4008
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with VH that has responded to treatment with IVA .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 362.02 2 .	laterality	lesion	T5	T1	note_4008
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with VH that has responded to treatment with IVA .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 362.02 2 .	laterality	lesion	T5	T4	note_4008
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] [s1] OD [e1] - PDR with VH that has responded to treatment with IVA .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 362.02 2 .	laterality	lesion	T9	T1	note_4008
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] [s1] OD [e1] - PDR with VH that has responded to treatment with IVA .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 362.02 2 .	laterality	lesion	T9	T4	note_4008
NonRel	S / P 25 g PPV / ML / DEM / AFX / EL / SO OS 11 / 13 / 17 Z98.890 V45.69 Treatment History IVA OS - 11 / 9 / 17 ( preop ) PRP OD - 6 / 30 / 2017 IVA OD - 6 / 15 / 17 IVFA ( 6 / 15 / 17 ) - [s1] Active [e1] PDR OU 1 ) DM - Active Proliferative Diabetic retinopathy OU . Diagnosed in the 90 s , A1c 10.0 OD PDR s / p PRP as above .	Recently in ED for mild [s2] VH [e2] , but clearing and will await laser maturation .	severity	lesion	T1	T8	note_2200
NonRel	S / P 25 g PPV / ML / DEM / AFX / EL / SO OS 11 / 13 / 17 Z98.890 V45.69 Treatment History IVA OS - 11 / 9 / 17 ( preop ) PRP OD - 6 / 30 / 2017 IVA OD - 6 / 15 / 17 IVFA ( 6 / 15 / 17 ) - Active PDR [s1] OU [e1] 1 ) DM - Active Proliferative Diabetic retinopathy OU . Diagnosed in the 90 s , A1c 10.0 OD PDR s / p PRP as above .	Recently in ED for mild [s2] VH [e2] , but clearing and will await laser maturation .	laterality	lesion	T3	T8	note_2200
NonRel	S / P 25 g PPV / ML / DEM / AFX / EL / SO OS 11 / 13 / 17 Z98.890 V45.69 Treatment History IVA OS - 11 / 9 / 17 ( preop ) PRP OD - 6 / 30 / 2017 IVA OD - 6 / 15 / 17 IVFA ( 6 / 15 / 17 ) - Active PDR OU 1 ) DM - [s1] Active [e1] Proliferative Diabetic retinopathy OU . Diagnosed in the 90 s , A1c 10.0 OD PDR s / p PRP as above .	Recently in ED for mild [s2] VH [e2] , but clearing and will await laser maturation .	severity	lesion	T4	T8	note_2200
NonRel	S / P 25 g PPV / ML / DEM / AFX / EL / SO OS 11 / 13 / 17 Z98.890 V45.69 Treatment History IVA OS - 11 / 9 / 17 ( preop ) PRP OD - 6 / 30 / 2017 IVA OD - 6 / 15 / 17 IVFA ( 6 / 15 / 17 ) - Active PDR OU 1 ) DM - Active Proliferative Diabetic retinopathy [s1] OU [e1] . Diagnosed in the 90 s , A1c 10.0 OD PDR s / p PRP as above .	Recently in ED for mild [s2] VH [e2] , but clearing and will await laser maturation .	laterality	lesion	T6	T8	note_2200
NonRel	Recently in ED for [s1] mild [e1] VH , but clearing and will await laser maturation .	S / P 25 g PPV / ML / DEM / AFX / EL / SO OS 11 / 13 / 17 Z98.890 V45.69 Treatment History IVA OS - 11 / 9 / 17 ( preop ) PRP OD - 6 / 30 / 2017 IVA OD - 6 / 15 / 17 IVFA ( 6 / 15 / 17 ) - Active [s2] PDR [e2] OU 1 ) DM - Active Proliferative Diabetic retinopathy OU . Diagnosed in the 90 s , A1c 10.0 OD PDR s / p PRP as above .	severity	lesion	T7	T2	note_2200
NonRel	Recently in ED for [s1] mild [e1] VH , but clearing and will await laser maturation .	S / P 25 g PPV / ML / DEM / AFX / EL / SO OS 11 / 13 / 17 Z98.890 V45.69 Treatment History IVA OS - 11 / 9 / 17 ( preop ) PRP OD - 6 / 30 / 2017 IVA OD - 6 / 15 / 17 IVFA ( 6 / 15 / 17 ) - Active PDR OU 1 ) DM - Active [s2] Proliferative Diabetic retinopathy [e2] OU . Diagnosed in the 90 s , A1c 10.0 OD PDR s / p PRP as above .	severity	lesion	T7	T5	note_2200
NonRel	Recently in ED for [s1] mild [e1] VH , but clearing and will await laser maturation .	S / P 25 g PPV / ML / DEM / AFX / EL / SO OS 11 / 13 / 17 Z98.890 V45.69 Treatment History IVA OS - 11 / 9 / 17 ( preop ) PRP OD - 6 / 30 / 2017 IVA OD - 6 / 15 / 17 IVFA ( 6 / 15 / 17 ) - Active PDR OU 1 ) DM - Active Proliferative Diabetic retinopathy OU . Diagnosed in the 90 s , A1c 10.0 OD [s2] PDR [e2] s / p PRP as above .	severity	lesion	T7	T9	note_2200
NonRel	S / P 25 g PPV / ML / DEM / AFX / EL / SO OS 11 / 13 / 17 Z98.890 V45.69 Treatment History IVA OS - 11 / 9 / 17 ( preop ) PRP OD - 6 / 30 / 2017 IVA OD - 6 / 15 / 17 IVFA ( 6 / 15 / 17 ) - Active PDR OU 1 ) DM - Active Proliferative Diabetic retinopathy OU . Diagnosed in the 90 s , A1c 10.0 [s1] OD [e1] PDR s / p PRP as above .	Recently in ED for mild [s2] VH [e2] , but clearing and will await laser maturation .	laterality	lesion	T10	T8	note_2200
NonRel	Vitreous hemorrhage , [s1] right [e1] - Right Eye H43.11 379.23 OCT , Posterior Segment - OU - Both Eyes OPH - OU Fluorescein Angiography 2 .	[s2] Proliferative diabetic retinopathy [e2] with macular edema associated with type 2 diabetes mellitus - Right Eye E11.3519 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 3 .	laterality	lesion	T13	T2	note_2085
NonRel	Vitreous hemorrhage , [s1] right [e1] - Right Eye H43.11 379.23 OCT , Posterior Segment - OU - Both Eyes OPH - OU Fluorescein Angiography 2 .	Proliferative diabetic retinopathy with [s2] macular edema [e2] associated with type 2 diabetes mellitus - Right Eye E11.3519 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 3 .	laterality	lesion	T13	T3	note_2085
NonRel	Diabetic macular edema of [s1] right eye [e1] E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.01 Attending Note : Treatment Hx IVFA ( 5 / 4 / 17 ) : No demonstrable NVE OD ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	[s2] Proliferative diabetic retinopathy [e2] with macular edema associated with type 2 diabetes mellitus - Right Eye E11.3519 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 3 .	laterality	lesion	T14	T2	note_2085
NonRel	Diabetic macular edema of [s1] right eye [e1] E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.01 Attending Note : Treatment Hx IVFA ( 5 / 4 / 17 ) : No demonstrable NVE OD ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	Proliferative diabetic retinopathy with [s2] macular edema [e2] associated with type 2 diabetes mellitus - Right Eye E11.3519 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 3 .	laterality	lesion	T14	T3	note_2085
NonRel	Diabetic macular edema of [s1] right eye [e1] E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.01 Attending Note : Treatment Hx IVFA ( 5 / 4 / 17 ) : No demonstrable NVE OD ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	IVA OD - 3 / 24 / 2017 IVA OD - 2 / 10 / 17 PRP OS - 2 / 10 / 17 IVFA ( 2 / 10 / 2017 ) - Only limited peripheral view OD , but [s2] NVE [e2] with peripheral dropout .	laterality	lesion	T14	T7	note_2085
NonRel	Diabetic macular edema of right eye E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.01 Attending Note : Treatment Hx IVFA ( 5 / 4 / 17 ) : No demonstrable NVE [s1] OD [e1] ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	[s2] Proliferative diabetic retinopathy [e2] with macular edema associated with type 2 diabetes mellitus - Right Eye E11.3519 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 3 .	laterality	lesion	T15	T2	note_2085
NonRel	Diabetic macular edema of right eye E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.01 Attending Note : Treatment Hx IVFA ( 5 / 4 / 17 ) : No demonstrable NVE [s1] OD [e1] ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	Proliferative diabetic retinopathy with [s2] macular edema [e2] associated with type 2 diabetes mellitus - Right Eye E11.3519 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 3 .	laterality	lesion	T15	T3	note_2085
NonRel	Diabetic macular edema of right eye E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.01 Attending Note : Treatment Hx IVFA ( 5 / 4 / 17 ) : No demonstrable NVE [s1] OD [e1] ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	IVA OD - 3 / 24 / 2017 IVA OD - 2 / 10 / 17 PRP OS - 2 / 10 / 17 IVFA ( 2 / 10 / 2017 ) - Only limited peripheral view OD , but [s2] NVE [e2] with peripheral dropout .	laterality	lesion	T15	T7	note_2085
NonRel	OS with [s1] active [e1] NVE and peripheral non - perfusion inferonasally .	IVA OD - 3 / 24 / 2017 IVA OD - 2 / 10 / 17 PRP OS - 2 / 10 / 17 IVFA ( 2 / 10 / 2017 ) - Only limited peripheral view OD , but [s2] NVE [e2] with peripheral dropout .	severity	lesion	T16	T7	note_2085
NonRel	[s1] OS [e1] with active NVE and peripheral non - perfusion inferonasally .	IVA OD - 3 / 24 / 2017 IVA OD - 2 / 10 / 17 PRP OS - 2 / 10 / 17 IVFA ( 2 / 10 / 2017 ) - Only limited peripheral view OD , but [s2] NVE [e2] with peripheral dropout .	laterality	lesion	T17	T7	note_2085
NonRel	IVA OD - 3 / 24 / 2017 IVA OD - 2 / 10 / 17 PRP OS - 2 / 10 / 17 IVFA ( 2 / 10 / 2017 ) - Only limited peripheral view [s1] OD [e1] , but NVE with peripheral dropout .	[s2] Diabetic macular edema [e2] of right eye E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.01 Attending Note : Treatment Hx IVFA ( 5 / 4 / 17 ) : No demonstrable NVE OD ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	laterality	lesion	T20	T4	note_2085
NonRel	IVA OD - 3 / 24 / 2017 IVA OD - 2 / 10 / 17 PRP OS - 2 / 10 / 17 IVFA ( 2 / 10 / 2017 ) - Only limited peripheral view [s1] OD [e1] , but NVE with peripheral dropout .	Diabetic macular edema of right eye E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.01 Attending Note : Treatment Hx IVFA ( 5 / 4 / 17 ) : No demonstrable [s2] NVE [e2] OD ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	laterality	lesion	T20	T5	note_2085
NonRel	IVA OD - 3 / 24 / 2017 IVA OD - 2 / 10 / 17 PRP OS - 2 / 10 / 17 IVFA ( 2 / 10 / 2017 ) - Only limited peripheral view [s1] OD [e1] , but NVE with peripheral dropout .	Diabetic macular edema of right eye E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.01 Attending Note : Treatment Hx IVFA ( 5 / 4 / 17 ) : No demonstrable NVE OD ( IVA masking possible ) , OS with still active areas of [s2] NVE [e2] but with great improvement since prior to first laser .	laterality	lesion	T20	T6	note_2085
NonRel	IVA OD - 3 / 24 / 2017 IVA OD - 2 / 10 / 17 PRP OS - 2 / 10 / 17 IVFA ( 2 / 10 / 2017 ) - Only limited peripheral view [s1] OD [e1] , but NVE with peripheral dropout .	OS with active [s2] NVE [e2] and peripheral non - perfusion inferonasally .	laterality	lesion	T20	T8	note_2085
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 1 diabetes mellitus - Right Eye E10.3511 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 362.07 362.02 3 .	laterality	lesion	T15	T5	note_8139
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 1 diabetes mellitus - Right Eye E10.3511 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 2 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 362.07 362.02 3 .	laterality	lesion	T15	T6	note_8139
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 362.07 362.02 3 .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 1 diabetes mellitus - Right Eye E10.3511 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 2 .	laterality	lesion	T16	T3	note_8139
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 362.07 362.02 3 .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 1 diabetes mellitus - Right Eye E10.3511 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 2 .	laterality	lesion	T16	T4	note_8139
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 362.07 362.02 3 .	Posterior proliferative vitreoretinopathy , left H35.22 362.29 H / o [s2] PDR [e2] with TRD OS s / p repair with Dr. Kay followed by emergent repeat surgery for elevated IOP 2 weeks later then sent to shands for GDD surgery .	laterality	lesion	T16	T7	note_8139
NonRel	Posterior proliferative vitreoretinopathy , left H35.22 362.29 H / o PDR with TRD [s1] OS [e1] s / p repair with Dr. Kay followed by emergent repeat surgery for elevated IOP 2 weeks later then sent to shands for GDD surgery .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 362.07 362.02 3 .	laterality	lesion	T17	T5	note_8139
NonRel	Posterior proliferative vitreoretinopathy , left H35.22 362.29 H / o PDR with TRD [s1] OS [e1] s / p repair with Dr. Kay followed by emergent repeat surgery for elevated IOP 2 weeks later then sent to shands for GDD surgery .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 362.07 362.02 3 .	laterality	lesion	T17	T6	note_8139
NonRel	Posterior proliferative vitreoretinopathy , left H35.22 362.29 H / o PDR with TRD [s1] OS [e1] s / p repair with Dr. Kay followed by emergent repeat surgery for elevated IOP 2 weeks later then sent to shands for GDD surgery .	Treatment Hx : IVA OD - 6 / 30 / 17 ( today ) PRP OD - 6 / 30 / 17 ( today ) IVFA ( 6 / 8 / 17 ) : [s2] NVE [e2] , NVD throughout OD with multiple areas of peripheral capillary nonperfusion and enlarged macular FAZ GDD OS - Blake - 5 / 5 / 17 PPV / TRD / PPL / SO OS - Kay / Roseman - week of 4 / 24 / 17 per patient PPV / TRD OS - Kay - 4 / 21 / 17 PRP OU - Kay PRP / IVA OD - 6 / 30 / 17 1 ) IDDM - Active PDR OU OD - Active PDR s / p PRP , but inadequate and IVFA confirms today active PDR that requires extensive PRP enhancement .	laterality	lesion	T17	T8	note_8139
NonRel	Posterior proliferative vitreoretinopathy , left H35.22 362.29 H / o PDR with TRD [s1] OS [e1] s / p repair with Dr. Kay followed by emergent repeat surgery for elevated IOP 2 weeks later then sent to shands for GDD surgery .	Treatment Hx : IVA OD - 6 / 30 / 17 ( today ) PRP OD - 6 / 30 / 17 ( today ) IVFA ( 6 / 8 / 17 ) : NVE , [s2] NVD [e2] throughout OD with multiple areas of peripheral capillary nonperfusion and enlarged macular FAZ GDD OS - Blake - 5 / 5 / 17 PPV / TRD / PPL / SO OS - Kay / Roseman - week of 4 / 24 / 17 per patient PPV / TRD OS - Kay - 4 / 21 / 17 PRP OU - Kay PRP / IVA OD - 6 / 30 / 17 1 ) IDDM - Active PDR OU OD - Active PDR s / p PRP , but inadequate and IVFA confirms today active PDR that requires extensive PRP enhancement .	laterality	lesion	T17	T9	note_8139
NonRel	Posterior proliferative vitreoretinopathy , left H35.22 362.29 H / o PDR with TRD [s1] OS [e1] s / p repair with Dr. Kay followed by emergent repeat surgery for elevated IOP 2 weeks later then sent to shands for GDD surgery .	Treatment Hx : IVA OD - 6 / 30 / 17 ( today ) PRP OD - 6 / 30 / 17 ( today ) IVFA ( 6 / 8 / 17 ) : NVE , NVD throughout OD with multiple areas of peripheral capillary nonperfusion and enlarged macular FAZ GDD OS - Blake - 5 / 5 / 17 PPV / TRD / PPL / SO OS - Kay / Roseman - week of 4 / 24 / 17 per patient PPV / TRD OS - Kay - 4 / 21 / 17 PRP OU - Kay PRP / IVA OD - 6 / 30 / 17 1 ) IDDM - Active PDR OU OD - Active [s2] PDR [e2] s / p PRP , but inadequate and IVFA confirms today active PDR that requires extensive PRP enhancement .	laterality	lesion	T17	T11	note_8139
NonRel	Posterior proliferative vitreoretinopathy , left H35.22 362.29 H / o PDR with TRD [s1] OS [e1] s / p repair with Dr. Kay followed by emergent repeat surgery for elevated IOP 2 weeks later then sent to shands for GDD surgery .	Treatment Hx : IVA OD - 6 / 30 / 17 ( today ) PRP OD - 6 / 30 / 17 ( today ) IVFA ( 6 / 8 / 17 ) : NVE , NVD throughout OD with multiple areas of peripheral capillary nonperfusion and enlarged macular FAZ GDD OS - Blake - 5 / 5 / 17 PPV / TRD / PPL / SO OS - Kay / Roseman - week of 4 / 24 / 17 per patient PPV / TRD OS - Kay - 4 / 21 / 17 PRP OU - Kay PRP / IVA OD - 6 / 30 / 17 1 ) IDDM - Active PDR OU OD - Active PDR s / p PRP , but inadequate and IVFA confirms today active [s2] PDR [e2] that requires extensive PRP enhancement .	laterality	lesion	T17	T12	note_8139
NonRel	Posterior proliferative vitreoretinopathy , left H35.22 362.29 H / o PDR with TRD [s1] OS [e1] s / p repair with Dr. Kay followed by emergent repeat surgery for elevated IOP 2 weeks later then sent to shands for GDD surgery .	Treatment Hx : IVA OD - 6 / 30 / 17 ( today ) PRP OD - 6 / 30 / 17 ( today ) IVFA ( 6 / 8 / 17 ) : NVE , NVD throughout OD with multiple areas of peripheral capillary nonperfusion and enlarged macular FAZ GDD OS - Blake - 5 / 5 / 17 PPV / TRD / PPL / SO OS - Kay / Roseman - week of 4 / 24 / 17 per patient PPV / TRD OS - Kay - 4 / 21 / 17 PRP OU - Kay PRP / IVA OD - 6 / 30 / 17 1 ) IDDM - Active [s2] PDR [e2] OU OD - Active PDR s / p PRP , but inadequate and IVFA confirms today active PDR that requires extensive PRP enhancement .	laterality	lesion	T17	T10	note_8139
NonRel	Treatment Hx : IVA OD - 6 / 30 / 17 ( today ) PRP [s1] OD [e1] - 6 / 30 / 17 ( today ) IVFA ( 6 / 8 / 17 ) : NVE , NVD throughout OD with multiple areas of peripheral capillary nonperfusion and enlarged macular FAZ GDD OS - Blake - 5 / 5 / 17 PPV / TRD / PPL / SO OS - Kay / Roseman - week of 4 / 24 / 17 per patient PPV / TRD OS - Kay - 4 / 21 / 17 PRP OU - Kay PRP / IVA OD - 6 / 30 / 17 1 ) IDDM - Active PDR OU OD - Active PDR s / p PRP , but inadequate and IVFA confirms today active PDR that requires extensive PRP enhancement .	Posterior proliferative vitreoretinopathy , left H35.22 362.29 H / o [s2] PDR [e2] with TRD OS s / p repair with Dr. Kay followed by emergent repeat surgery for elevated IOP 2 weeks later then sent to shands for GDD surgery .	laterality	lesion	T18	T7	note_8139
NonRel	Treatment Hx : IVA OD - 6 / 30 / 17 ( today ) PRP OD - 6 / 30 / 17 ( today ) IVFA ( 6 / 8 / 17 ) : NVE , NVD throughout OD with multiple areas of peripheral capillary nonperfusion and enlarged macular FAZ GDD OS - Blake - 5 / 5 / 17 PPV / TRD / PPL / SO OS - Kay / Roseman - week of 4 / 24 / 17 per patient PPV / TRD OS - Kay - 4 / 21 / 17 PRP OU - Kay PRP / IVA OD - 6 / 30 / 17 1 ) IDDM - Active PDR [s1] OU [e1] OD - Active PDR s / p PRP , but inadequate and IVFA confirms today active PDR that requires extensive PRP enhancement .	Posterior proliferative vitreoretinopathy , left H35.22 362.29 H / o [s2] PDR [e2] with TRD OS s / p repair with Dr. Kay followed by emergent repeat surgery for elevated IOP 2 weeks later then sent to shands for GDD surgery .	laterality	lesion	T19	T7	note_8139
NonRel	Treatment Hx : IVA OD - 6 / 30 / 17 ( today ) PRP OD - 6 / 30 / 17 ( today ) IVFA ( 6 / 8 / 17 ) : NVE , NVD throughout OD with multiple areas of peripheral capillary nonperfusion and enlarged macular FAZ GDD OS - Blake - 5 / 5 / 17 PPV / TRD / PPL / SO OS - Kay / Roseman - week of 4 / 24 / 17 per patient PPV / TRD OS - Kay - 4 / 21 / 17 PRP OU - Kay PRP / IVA OD - 6 / 30 / 17 1 ) IDDM - Active PDR OU [s1] OD [e1] - Active PDR s / p PRP , but inadequate and IVFA confirms today active PDR that requires extensive PRP enhancement .	Posterior proliferative vitreoretinopathy , left H35.22 362.29 H / o [s2] PDR [e2] with TRD OS s / p repair with Dr. Kay followed by emergent repeat surgery for elevated IOP 2 weeks later then sent to shands for GDD surgery .	laterality	lesion	T20	T7	note_8139
NonRel	Treatment Hx : IVA OD - 6 / 30 / 17 ( today ) PRP OD - 6 / 30 / 17 ( today ) IVFA ( 6 / 8 / 17 ) : NVE , NVD throughout OD with multiple areas of peripheral capillary nonperfusion and enlarged macular FAZ GDD OS - Blake - 5 / 5 / 17 PPV / TRD / PPL / SO OS - Kay / Roseman - week of 4 / 24 / 17 per patient PPV / TRD OS - Kay - 4 / 21 / 17 PRP OU - Kay PRP / IVA OD - 6 / 30 / 17 1 ) IDDM - [s1] Active [e1] PDR OU OD - Active PDR s / p PRP , but inadequate and IVFA confirms today active PDR that requires extensive PRP enhancement .	Posterior proliferative vitreoretinopathy , left H35.22 362.29 H / o [s2] PDR [e2] with TRD OS s / p repair with Dr. Kay followed by emergent repeat surgery for elevated IOP 2 weeks later then sent to shands for GDD surgery .	severity	lesion	T21	T7	note_8139
NonRel	Treatment Hx : IVA OD - 6 / 30 / 17 ( today ) PRP OD - 6 / 30 / 17 ( today ) IVFA ( 6 / 8 / 17 ) : NVE , NVD throughout OD with multiple areas of peripheral capillary nonperfusion and enlarged macular FAZ GDD OS - Blake - 5 / 5 / 17 PPV / TRD / PPL / SO OS - Kay / Roseman - week of 4 / 24 / 17 per patient PPV / TRD OS - Kay - 4 / 21 / 17 PRP OU - Kay PRP / IVA OD - 6 / 30 / 17 1 ) IDDM - Active PDR OU OD - [s1] Active [e1] PDR s / p PRP , but inadequate and IVFA confirms today active PDR that requires extensive PRP enhancement .	Posterior proliferative vitreoretinopathy , left H35.22 362.29 H / o [s2] PDR [e2] with TRD OS s / p repair with Dr. Kay followed by emergent repeat surgery for elevated IOP 2 weeks later then sent to shands for GDD surgery .	severity	lesion	T22	T7	note_8139
NonRel	Treatment Hx : IVA OD - 6 / 30 / 17 ( today ) PRP OD - 6 / 30 / 17 ( today ) IVFA ( 6 / 8 / 17 ) : NVE , NVD throughout OD with multiple areas of peripheral capillary nonperfusion and enlarged macular FAZ GDD OS - Blake - 5 / 5 / 17 PPV / TRD / PPL / SO OS - Kay / Roseman - week of 4 / 24 / 17 per patient PPV / TRD OS - Kay - 4 / 21 / 17 PRP OU - Kay PRP / IVA OD - 6 / 30 / 17 1 ) IDDM - Active PDR OU OD - Active PDR s / p PRP , but inadequate and IVFA confirms today [s1] active [e1] PDR that requires extensive PRP enhancement .	Posterior proliferative vitreoretinopathy , left H35.22 362.29 H / o [s2] PDR [e2] with TRD OS s / p repair with Dr. Kay followed by emergent repeat surgery for elevated IOP 2 weeks later then sent to shands for GDD surgery .	severity	lesion	T23	T7	note_8139
NonRel	Type 2 diabetes mellitus with [s1] both eyes [e1] affected by moderate nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3313 250.50 OCT , Retina - OU - Both Eyes Z79.4 362.05 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent V58.67 Hx of ciCSME OU being treated with IVA OU with good response and now stability .	Recent renal function decline , and lung mass being evaluated for possible CA . Treatment History IVA OU - 8 / 31 / 18 ( today ) IVA OU - 7 / 22 / 18 IVA OU - 6 / 15 / 18 IVA OU - 5 / 11 / 18 IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 , A1C 6.9 ] Moderate [s2] NPDR [e2] with ciCSME OU OD - ciCSME has responded to IVA but now plateau / stable OS - ciCSME has responded to IVA , but now plateau / stable Plateau response to IVA , would like to switch to Lucentis but not covered by FAP , will continue IVA . 2 ) NSC OU - 20 / 50 and 20 / 40 .	laterality	lesion	T1	T6	note_1135
NonRel	Type 2 diabetes mellitus with [s1] both eyes [e1] affected by moderate nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3313 250.50 OCT , Retina - OU - Both Eyes Z79.4 362.05 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent V58.67 Hx of ciCSME OU being treated with IVA OU with good response and now stability .	Recent renal function decline , and lung mass being evaluated for possible CA . Treatment History IVA OU - 8 / 31 / 18 ( today ) IVA OU - 7 / 22 / 18 IVA OU - 6 / 15 / 18 IVA OU - 5 / 11 / 18 IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 , A1C 6.9 ] Moderate NPDR with [s2] ciCSME [e2] OU OD - ciCSME has responded to IVA but now plateau / stable OS - ciCSME has responded to IVA , but now plateau / stable Plateau response to IVA , would like to switch to Lucentis but not covered by FAP , will continue IVA . 2 ) NSC OU - 20 / 50 and 20 / 40 .	laterality	lesion	T1	T7	note_1135
NonRel	Type 2 diabetes mellitus with [s1] both eyes [e1] affected by moderate nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3313 250.50 OCT , Retina - OU - Both Eyes Z79.4 362.05 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent V58.67 Hx of ciCSME OU being treated with IVA OU with good response and now stability .	Recent renal function decline , and lung mass being evaluated for possible CA . Treatment History IVA OU - 8 / 31 / 18 ( today ) IVA OU - 7 / 22 / 18 IVA OU - 6 / 15 / 18 IVA OU - 5 / 11 / 18 IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 , A1C 6.9 ] Moderate NPDR with ciCSME OU OD - [s2] ciCSME [e2] has responded to IVA but now plateau / stable OS - ciCSME has responded to IVA , but now plateau / stable Plateau response to IVA , would like to switch to Lucentis but not covered by FAP , will continue IVA . 2 ) NSC OU - 20 / 50 and 20 / 40 .	laterality	lesion	T1	T10	note_1135
NonRel	Type 2 diabetes mellitus with [s1] both eyes [e1] affected by moderate nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3313 250.50 OCT , Retina - OU - Both Eyes Z79.4 362.05 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent V58.67 Hx of ciCSME OU being treated with IVA OU with good response and now stability .	Recent renal function decline , and lung mass being evaluated for possible CA . Treatment History IVA OU - 8 / 31 / 18 ( today ) IVA OU - 7 / 22 / 18 IVA OU - 6 / 15 / 18 IVA OU - 5 / 11 / 18 IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 , A1C 6.9 ] Moderate NPDR with ciCSME OU OD - ciCSME has responded to IVA but now plateau / stable OS - [s2] ciCSME [e2] has responded to IVA , but now plateau / stable Plateau response to IVA , would like to switch to Lucentis but not covered by FAP , will continue IVA . 2 ) NSC OU - 20 / 50 and 20 / 40 .	laterality	lesion	T1	T12	note_1135
NonRel	Type 2 diabetes mellitus with both eyes affected by [s1] moderate [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3313 250.50 OCT , Retina - OU - Both Eyes Z79.4 362.05 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent V58.67 Hx of ciCSME OU being treated with IVA OU with good response and now stability .	Recent renal function decline , and lung mass being evaluated for possible CA . Treatment History IVA OU - 8 / 31 / 18 ( today ) IVA OU - 7 / 22 / 18 IVA OU - 6 / 15 / 18 IVA OU - 5 / 11 / 18 IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 , A1C 6.9 ] Moderate [s2] NPDR [e2] with ciCSME OU OD - ciCSME has responded to IVA but now plateau / stable OS - ciCSME has responded to IVA , but now plateau / stable Plateau response to IVA , would like to switch to Lucentis but not covered by FAP , will continue IVA . 2 ) NSC OU - 20 / 50 and 20 / 40 .	severity	lesion	T2	T6	note_1135
NonRel	Type 2 diabetes mellitus with both eyes affected by [s1] moderate [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3313 250.50 OCT , Retina - OU - Both Eyes Z79.4 362.05 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent V58.67 Hx of ciCSME OU being treated with IVA OU with good response and now stability .	Recent renal function decline , and lung mass being evaluated for possible CA . Treatment History IVA OU - 8 / 31 / 18 ( today ) IVA OU - 7 / 22 / 18 IVA OU - 6 / 15 / 18 IVA OU - 5 / 11 / 18 IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 , A1C 6.9 ] Moderate NPDR with [s2] ciCSME [e2] OU OD - ciCSME has responded to IVA but now plateau / stable OS - ciCSME has responded to IVA , but now plateau / stable Plateau response to IVA , would like to switch to Lucentis but not covered by FAP , will continue IVA . 2 ) NSC OU - 20 / 50 and 20 / 40 .	severity	lesion	T2	T7	note_1135
NonRel	Type 2 diabetes mellitus with both eyes affected by [s1] moderate [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3313 250.50 OCT , Retina - OU - Both Eyes Z79.4 362.05 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent V58.67 Hx of ciCSME OU being treated with IVA OU with good response and now stability .	Recent renal function decline , and lung mass being evaluated for possible CA . Treatment History IVA OU - 8 / 31 / 18 ( today ) IVA OU - 7 / 22 / 18 IVA OU - 6 / 15 / 18 IVA OU - 5 / 11 / 18 IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 , A1C 6.9 ] Moderate NPDR with ciCSME OU OD - [s2] ciCSME [e2] has responded to IVA but now plateau / stable OS - ciCSME has responded to IVA , but now plateau / stable Plateau response to IVA , would like to switch to Lucentis but not covered by FAP , will continue IVA . 2 ) NSC OU - 20 / 50 and 20 / 40 .	severity	lesion	T2	T10	note_1135
NonRel	Type 2 diabetes mellitus with both eyes affected by [s1] moderate [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3313 250.50 OCT , Retina - OU - Both Eyes Z79.4 362.05 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent V58.67 Hx of ciCSME OU being treated with IVA OU with good response and now stability .	Recent renal function decline , and lung mass being evaluated for possible CA . Treatment History IVA OU - 8 / 31 / 18 ( today ) IVA OU - 7 / 22 / 18 IVA OU - 6 / 15 / 18 IVA OU - 5 / 11 / 18 IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 , A1C 6.9 ] Moderate NPDR with ciCSME OU OD - ciCSME has responded to IVA but now plateau / stable OS - [s2] ciCSME [e2] has responded to IVA , but now plateau / stable Plateau response to IVA , would like to switch to Lucentis but not covered by FAP , will continue IVA . 2 ) NSC OU - 20 / 50 and 20 / 40 .	severity	lesion	T2	T12	note_1135
NonRel	Recent renal function decline , and lung mass being evaluated for possible CA . Treatment History IVA OU - 8 / 31 / 18 ( today ) IVA OU - 7 / 22 / 18 IVA OU - 6 / 15 / 18 IVA OU - 5 / 11 / 18 IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 , A1C 6.9 ] [s1] Moderate [e1] NPDR with ciCSME OU OD - ciCSME has responded to IVA but now plateau / stable OS - ciCSME has responded to IVA , but now plateau / stable Plateau response to IVA , would like to switch to Lucentis but not covered by FAP , will continue IVA . 2 ) NSC OU - 20 / 50 and 20 / 40 .	Type 2 diabetes mellitus with both eyes affected by moderate [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3313 250.50 OCT , Retina - OU - Both Eyes Z79.4 362.05 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent V58.67 Hx of ciCSME OU being treated with IVA OU with good response and now stability .	severity	lesion	T5	T3	note_1135
NonRel	Recent renal function decline , and lung mass being evaluated for possible CA . Treatment History IVA OU - 8 / 31 / 18 ( today ) IVA OU - 7 / 22 / 18 IVA OU - 6 / 15 / 18 IVA OU - 5 / 11 / 18 IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 , A1C 6.9 ] [s1] Moderate [e1] NPDR with ciCSME OU OD - ciCSME has responded to IVA but now plateau / stable OS - ciCSME has responded to IVA , but now plateau / stable Plateau response to IVA , would like to switch to Lucentis but not covered by FAP , will continue IVA . 2 ) NSC OU - 20 / 50 and 20 / 40 .	Type 2 diabetes mellitus with both eyes affected by moderate nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3313 250.50 OCT , Retina - OU - Both Eyes Z79.4 362.05 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent V58.67 Hx of ciCSME OU being treated with IVA OU with good response and now stability .	severity	lesion	T5	T4	note_1135
NonRel	Recent renal function decline , and lung mass being evaluated for possible CA . Treatment History IVA OU - 8 / 31 / 18 ( today ) IVA OU - 7 / 22 / 18 IVA OU - 6 / 15 / 18 IVA OU - 5 / 11 / 18 IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 , A1C 6.9 ] Moderate NPDR with ciCSME [s1] OU [e1] OD - ciCSME has responded to IVA but now plateau / stable OS - ciCSME has responded to IVA , but now plateau / stable Plateau response to IVA , would like to switch to Lucentis but not covered by FAP , will continue IVA . 2 ) NSC OU - 20 / 50 and 20 / 40 .	Type 2 diabetes mellitus with both eyes affected by moderate [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3313 250.50 OCT , Retina - OU - Both Eyes Z79.4 362.05 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent V58.67 Hx of ciCSME OU being treated with IVA OU with good response and now stability .	laterality	lesion	T8	T3	note_1135
NonRel	Recent renal function decline , and lung mass being evaluated for possible CA . Treatment History IVA OU - 8 / 31 / 18 ( today ) IVA OU - 7 / 22 / 18 IVA OU - 6 / 15 / 18 IVA OU - 5 / 11 / 18 IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 , A1C 6.9 ] Moderate NPDR with ciCSME [s1] OU [e1] OD - ciCSME has responded to IVA but now plateau / stable OS - ciCSME has responded to IVA , but now plateau / stable Plateau response to IVA , would like to switch to Lucentis but not covered by FAP , will continue IVA . 2 ) NSC OU - 20 / 50 and 20 / 40 .	Type 2 diabetes mellitus with both eyes affected by moderate nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3313 250.50 OCT , Retina - OU - Both Eyes Z79.4 362.05 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent V58.67 Hx of ciCSME OU being treated with IVA OU with good response and now stability .	laterality	lesion	T8	T4	note_1135
NonRel	Recent renal function decline , and lung mass being evaluated for possible CA . Treatment History IVA OU - 8 / 31 / 18 ( today ) IVA OU - 7 / 22 / 18 IVA OU - 6 / 15 / 18 IVA OU - 5 / 11 / 18 IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 , A1C 6.9 ] Moderate NPDR with ciCSME OU [s1] OD [e1] - ciCSME has responded to IVA but now plateau / stable OS - ciCSME has responded to IVA , but now plateau / stable Plateau response to IVA , would like to switch to Lucentis but not covered by FAP , will continue IVA . 2 ) NSC OU - 20 / 50 and 20 / 40 .	Type 2 diabetes mellitus with both eyes affected by moderate [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3313 250.50 OCT , Retina - OU - Both Eyes Z79.4 362.05 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent V58.67 Hx of ciCSME OU being treated with IVA OU with good response and now stability .	laterality	lesion	T9	T3	note_1135
NonRel	Recent renal function decline , and lung mass being evaluated for possible CA . Treatment History IVA OU - 8 / 31 / 18 ( today ) IVA OU - 7 / 22 / 18 IVA OU - 6 / 15 / 18 IVA OU - 5 / 11 / 18 IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 , A1C 6.9 ] Moderate NPDR with ciCSME OU [s1] OD [e1] - ciCSME has responded to IVA but now plateau / stable OS - ciCSME has responded to IVA , but now plateau / stable Plateau response to IVA , would like to switch to Lucentis but not covered by FAP , will continue IVA . 2 ) NSC OU - 20 / 50 and 20 / 40 .	Type 2 diabetes mellitus with both eyes affected by moderate nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3313 250.50 OCT , Retina - OU - Both Eyes Z79.4 362.05 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent V58.67 Hx of ciCSME OU being treated with IVA OU with good response and now stability .	laterality	lesion	T9	T4	note_1135
NonRel	Recent renal function decline , and lung mass being evaluated for possible CA . Treatment History IVA OU - 8 / 31 / 18 ( today ) IVA OU - 7 / 22 / 18 IVA OU - 6 / 15 / 18 IVA OU - 5 / 11 / 18 IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 , A1C 6.9 ] Moderate NPDR with ciCSME OU OD - ciCSME has responded to IVA but now plateau / stable [s1] OS [e1] - ciCSME has responded to IVA , but now plateau / stable Plateau response to IVA , would like to switch to Lucentis but not covered by FAP , will continue IVA . 2 ) NSC OU - 20 / 50 and 20 / 40 .	Type 2 diabetes mellitus with both eyes affected by moderate [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3313 250.50 OCT , Retina - OU - Both Eyes Z79.4 362.05 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent V58.67 Hx of ciCSME OU being treated with IVA OU with good response and now stability .	laterality	lesion	T11	T3	note_1135
NonRel	Recent renal function decline , and lung mass being evaluated for possible CA . Treatment History IVA OU - 8 / 31 / 18 ( today ) IVA OU - 7 / 22 / 18 IVA OU - 6 / 15 / 18 IVA OU - 5 / 11 / 18 IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 , A1C 6.9 ] Moderate NPDR with ciCSME OU OD - ciCSME has responded to IVA but now plateau / stable [s1] OS [e1] - ciCSME has responded to IVA , but now plateau / stable Plateau response to IVA , would like to switch to Lucentis but not covered by FAP , will continue IVA . 2 ) NSC OU - 20 / 50 and 20 / 40 .	Type 2 diabetes mellitus with both eyes affected by moderate nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3313 250.50 OCT , Retina - OU - Both Eyes Z79.4 362.05 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent V58.67 Hx of ciCSME OU being treated with IVA OU with good response and now stability .	laterality	lesion	T11	T4	note_1135
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) IVFA - 4 / 20 / 17 : [s1] Active [e1] PDR OU OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No [s2] NVI [e2] or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T6	T12	note_171
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) IVFA - 4 / 20 / 17 : [s1] Active [e1] PDR OU OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or [s2] NVD [e2] or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T6	T13	note_171
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) IVFA - 4 / 20 / 17 : [s1] Active [e1] PDR OU OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or [s2] NVA [e2] Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T6	T14	note_171
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) IVFA - 4 / 20 / 17 : [s1] Active [e1] PDR OU OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without [s2] Edema [e2] , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T6	T15	note_171
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) IVFA - 4 / 20 / 17 : [s1] Active [e1] PDR OU OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms [s2] NVE [e2] temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T6	T17	note_171
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) IVFA - 4 / 20 / 17 : [s1] Active [e1] PDR OU OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No [s2] Neovascularization [e2] .	severity	lesion	T6	T19	note_171
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) IVFA - 4 / 20 / 17 : Active PDR [s1] OU [e1] OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No [s2] NVI [e2] or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T8	T12	note_171
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) IVFA - 4 / 20 / 17 : Active PDR [s1] OU [e1] OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or [s2] NVD [e2] or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T8	T13	note_171
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) IVFA - 4 / 20 / 17 : Active PDR [s1] OU [e1] OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or [s2] NVA [e2] Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T8	T14	note_171
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) IVFA - 4 / 20 / 17 : Active PDR [s1] OU [e1] OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without [s2] Edema [e2] , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T8	T15	note_171
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) IVFA - 4 / 20 / 17 : Active PDR [s1] OU [e1] OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms [s2] NVE [e2] temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T8	T17	note_171
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) IVFA - 4 / 20 / 17 : Active PDR [s1] OU [e1] OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No [s2] Neovascularization [e2] .	laterality	lesion	T8	T19	note_171
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	[s2] Proliferative diabetic retinopathy [e2] associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) IVFA - 4 / 20 / 17 : Active PDR OU OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	severity	lesion	T18	T5	note_171
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) IVFA - 4 / 20 / 17 : Active [s2] PDR [e2] OU OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	severity	lesion	T18	T7	note_171
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) IVFA - 4 / 20 / 17 : Active PDR OU OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New [s2] NVE [e2] temporally .	severity	lesion	T18	T11	note_171
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	Mild [s2] NPDR [e2] now .	severity	lesion	T18	T21	note_171
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : [s2] PDR [e2] OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) IVFA - 4 / 20 / 17 : Active PDR OU OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	severity	lesion	T18	T9	note_171
NonRel	[s1] Mild [e1] NPDR now .	No [s2] NVI [e2] or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T20	T12	note_171
NonRel	[s1] Mild [e1] NPDR now .	No NVI or [s2] NVD [e2] or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T20	T13	note_171
NonRel	[s1] Mild [e1] NPDR now .	No NVI or NVD or [s2] NVA [e2] Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T20	T14	note_171
NonRel	[s1] Mild [e1] NPDR now .	No NVI or NVD or NVA Mac OCT without [s2] Edema [e2] , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T20	T15	note_171
NonRel	[s1] Mild [e1] NPDR now .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms [s2] NVE [e2] temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T20	T17	note_171
NonRel	[s1] Mild [e1] NPDR now .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No [s2] Neovascularization [e2] .	severity	lesion	T20	T19	note_171
NonRel	[s1] Mild [e1] NPDR now .	Mac OCT without [s2] Edema [e2] , mild ERM , no posterior hyloid IVFA with shallow ITQ tractional RD with leakage Consented for PRP left eye mid periphery x 360 Kevin Talbot , MD participated in the care of this patient .	severity	lesion	T20	T22	note_171
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - [s1] OD [e1] - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) IVFA - 4 / 20 / 17 : Active PDR OU OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No [s2] NVI [e2] or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T23	T12	note_171
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - [s1] OD [e1] - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) IVFA - 4 / 20 / 17 : Active PDR OU OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or [s2] NVD [e2] or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T23	T13	note_171
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - [s1] OD [e1] - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) IVFA - 4 / 20 / 17 : Active PDR OU OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or [s2] NVA [e2] Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T23	T14	note_171
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - [s1] OD [e1] - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) IVFA - 4 / 20 / 17 : Active PDR OU OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without [s2] Edema [e2] , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T23	T15	note_171
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - [s1] OD [e1] - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) IVFA - 4 / 20 / 17 : Active PDR OU OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms [s2] NVE [e2] temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T23	T17	note_171
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - [s1] OD [e1] - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) IVFA - 4 / 20 / 17 : Active PDR OU OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No [s2] Neovascularization [e2] .	laterality	lesion	T23	T19	note_171
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) IVFA - 4 / 20 / 17 : Active PDR OU OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No [s2] NVI [e2] or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T10	T12	note_171
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) IVFA - 4 / 20 / 17 : Active PDR OU OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or [s2] NVD [e2] or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T10	T13	note_171
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) IVFA - 4 / 20 / 17 : Active PDR OU OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or [s2] NVA [e2] Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T10	T14	note_171
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) IVFA - 4 / 20 / 17 : Active PDR OU OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without [s2] Edema [e2] , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T10	T15	note_171
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) IVFA - 4 / 20 / 17 : Active PDR OU OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms [s2] NVE [e2] temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T10	T17	note_171
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) IVFA - 4 / 20 / 17 : Active PDR OU OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No [s2] Neovascularization [e2] .	laterality	lesion	T10	T19	note_171
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - [s1] OS [e1] : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	OS - Moderate [s2] NPDR [e2] , s / p PRP and focal laser .	laterality	lesion	T7	T19	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : [s1] Moderate [e1] / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	OS - Moderate [s2] NPDR [e2] , s / p PRP and focal laser .	severity	lesion	T8	T19	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / [s1] severe NPDR [e1] OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	OS - Moderate [s2] NPDR [e2] , s / p PRP and focal laser .	severity	lesion	T9	T19	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - [s1] OD [e1] : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	OS - Moderate [s2] NPDR [e2] , s / p PRP and focal laser .	laterality	lesion	T11	T19	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : [s1] Moderate [e1] NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	OS - Moderate [s2] NPDR [e2] , s / p PRP and focal laser .	severity	lesion	T12	T19	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 [s1] OD - [e1] Moderate NPDR , s / p PRP and focal laser .	OS - Moderate [s2] NPDR [e2] , s / p PRP and focal laser .	laterality	lesion	T14	T19	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - [s1] Moderate [e1] NPDR , s / p PRP and focal laser .	OS - Moderate [s2] NPDR [e2] , s / p PRP and focal laser .	severity	lesion	T15	T19	note_1962
NonRel	[s1] OS - [e1] Moderate NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe [s2] NPDR [e2] OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	laterality	lesion	T17	T10	note_1962
NonRel	[s1] OS - [e1] Moderate NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate [s2] NPDR [e2] OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	laterality	lesion	T17	T13	note_1962
NonRel	[s1] OS - [e1] Moderate NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate [s2] NPDR [e2] , s / p PRP and focal laser .	laterality	lesion	T17	T16	note_1962
NonRel	[s1] OS - [e1] Moderate NPDR , s / p PRP and focal laser .	[s2] CSME [e2] that was refractory to IVA and IVL .	laterality	lesion	T17	T20	note_1962
NonRel	OS - [s1] Moderate [e1] NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe [s2] NPDR [e2] OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	severity	lesion	T18	T10	note_1962
NonRel	OS - [s1] Moderate [e1] NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate [s2] NPDR [e2] OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	severity	lesion	T18	T13	note_1962
NonRel	OS - [s1] Moderate [e1] NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate [s2] NPDR [e2] , s / p PRP and focal laser .	severity	lesion	T18	T16	note_1962
NonRel	OS - [s1] Moderate [e1] NPDR , s / p PRP and focal laser .	[s2] CSME [e2] that was refractory to IVA and IVL .	severity	lesion	T18	T20	note_1962
NonRel	Inferior subhyaloid hemorrhage [s1] OS [e1] .	OCT , Posterior Segment - OU - Both Eyes OD - blunted foveal contour , no [s2] macular edema [e2] OS - blunted foveal contour , no macular edema NAME .	laterality	lesion	T15	T6	1741070_note_4310
NonRel	Inferior subhyaloid hemorrhage [s1] OS [e1] .	OCT , Posterior Segment - OU - Both Eyes OD - blunted foveal contour , no macular edema OS - blunted foveal contour , no [s2] macular edema [e2] NAME .	laterality	lesion	T15	T7	1741070_note_4310
NonRel	[s1] Inferior [e1] subhyaloid hemorrhage OS .	OCT , Posterior Segment - OU - Both Eyes OD - blunted foveal contour , no [s2] macular edema [e2] OS - blunted foveal contour , no macular edema NAME .	severity	lesion	T16	T6	1741070_note_4310
NonRel	[s1] Inferior [e1] subhyaloid hemorrhage OS .	OCT , Posterior Segment - OU - Both Eyes OD - blunted foveal contour , no macular edema OS - blunted foveal contour , no [s2] macular edema [e2] NAME .	severity	lesion	T16	T7	1741070_note_4310
NonRel	OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] - blunted foveal contour , no macular edema OS - blunted foveal contour , no macular edema NAME .	Inferior [s2] subhyaloid hemorrhage [e2] OS .	laterality	lesion	T17	T9	1741070_note_4310
NonRel	OCT , Posterior Segment - OU - Both Eyes OD - blunted foveal contour , no macular edema [s1] OS [e1] - blunted foveal contour , no macular edema NAME .	Inferior [s2] subhyaloid hemorrhage [e2] OS .	laterality	lesion	T18	T9	1741070_note_4310
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 2 .	[s2] Diabetic macular edema [e2] of left eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Hx of PDR OU ( ciCSME OD , VH OS ) , previous cardiac stent placement .	laterality	lesion	T20	T5	note_7927
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 2 .	Diabetic macular edema of left eye with [s2] proliferative retinopathy [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Hx of PDR OU ( ciCSME OD , VH OS ) , previous cardiac stent placement .	laterality	lesion	T20	T6	note_7927
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 2 .	Diabetic macular edema of left eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Hx of PDR OU ( ciCSME OD , [s2] VH [e2] OS ) , previous cardiac stent placement .	laterality	lesion	T20	T7	note_7927
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 2 .	Diabetic macular edema of left eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Hx of [s2] PDR [e2] OU ( ciCSME OD , VH OS ) , previous cardiac stent placement .	laterality	lesion	T20	T22	note_7927
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 2 .	Diabetic macular edema of left eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Hx of PDR OU ( [s2] ciCSME [e2] OD , VH OS ) , previous cardiac stent placement .	laterality	lesion	T20	T24	note_7927
NonRel	Diabetic macular edema of [s1] left eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Hx of PDR OU ( ciCSME OD , VH OS ) , previous cardiac stent placement .	[s2] Diabetic macular edema [e2] of right eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 2 .	laterality	lesion	T21	T3	note_7927
NonRel	Diabetic macular edema of [s1] left eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Hx of PDR OU ( ciCSME OD , VH OS ) , previous cardiac stent placement .	Diabetic macular edema of right eye with [s2] proliferative retinopathy [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 2 .	laterality	lesion	T21	T4	note_7927
NonRel	Diabetic macular edema of left eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Hx of PDR [s1] OU [e1] ( ciCSME OD , VH OS ) , previous cardiac stent placement .	[s2] Diabetic macular edema [e2] of right eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 2 .	laterality	lesion	T23	T3	note_7927
NonRel	Diabetic macular edema of left eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Hx of PDR [s1] OU [e1] ( ciCSME OD , VH OS ) , previous cardiac stent placement .	Diabetic macular edema of right eye with [s2] proliferative retinopathy [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 2 .	laterality	lesion	T23	T4	note_7927
NonRel	Diabetic macular edema of left eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Hx of PDR OU ( ciCSME [s1] OD [e1] , VH OS ) , previous cardiac stent placement .	[s2] Diabetic macular edema [e2] of right eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 2 .	laterality	lesion	T25	T3	note_7927
NonRel	Diabetic macular edema of left eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Hx of PDR OU ( ciCSME [s1] OD [e1] , VH OS ) , previous cardiac stent placement .	Diabetic macular edema of right eye with [s2] proliferative retinopathy [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 2 .	laterality	lesion	T25	T4	note_7927
NonRel	Diabetic macular edema of left eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Hx of PDR OU ( ciCSME OD , VH [s1] OS [e1] ) , previous cardiac stent placement .	[s2] Diabetic macular edema [e2] of right eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 2 .	laterality	lesion	T26	T3	note_7927
NonRel	Diabetic macular edema of left eye with proliferative retinopathy associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Hx of PDR OU ( ciCSME OD , VH [s1] OS [e1] ) , previous cardiac stent placement .	Diabetic macular edema of right eye with [s2] proliferative retinopathy [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 2 .	laterality	lesion	T26	T4	note_7927
NonRel	Treatment Hx IVA OS - 3 / 8 / 19 IVA OS - 2 / 1 / 19 IVFA ( 11 / 8 / 2018 ) - [s1] Mild [e1] NVE ( nearly regressed ) , residual NVD OS IVA OU - 7 / 6 / 18 IVA OU - 5 / 25 / 18 IVA OU - 4 / 6 / 18 IVA OU - 2 / 22 / 18 IVA OU - 11 / 28 / 17 IVA OS - 10 / 24 / 17 PRP OS - 4 / 28 / 2017 IVA OU - 4 / 14 / 17 PRP OD - 4 / 14 / 2017 IVFA ( 4 / 6 / 2017 ) - Active PDR OU 1 .	NIDDM - [ Duration 16 yrs , Dx [s2] PDR [e2] OU here , Most recent A1c 8.1 per patient .	severity	lesion	T27	T10	note_7927
NonRel	Treatment Hx IVA OS - 3 / 8 / 19 IVA OS - 2 / 1 / 19 IVFA ( 11 / 8 / 2018 ) - Mild NVE ( nearly regressed ) , residual NVD [s1] OS IVA [e1] OU - 7 / 6 / 18 IVA OU - 5 / 25 / 18 IVA OU - 4 / 6 / 18 IVA OU - 2 / 22 / 18 IVA OU - 11 / 28 / 17 IVA OS - 10 / 24 / 17 PRP OS - 4 / 28 / 2017 IVA OU - 4 / 14 / 17 PRP OD - 4 / 14 / 2017 IVFA ( 4 / 6 / 2017 ) - Active PDR OU 1 .	NIDDM - [ Duration 16 yrs , Dx [s2] PDR [e2] OU here , Most recent A1c 8.1 per patient .	laterality	lesion	T28	T10	note_7927
NonRel	Treatment Hx IVA OS - 3 / 8 / 19 IVA OS - 2 / 1 / 19 IVFA ( 11 / 8 / 2018 ) - Mild NVE ( nearly regressed ) , [s1] residual [e1] NVD OS IVA OU - 7 / 6 / 18 IVA OU - 5 / 25 / 18 IVA OU - 4 / 6 / 18 IVA OU - 2 / 22 / 18 IVA OU - 11 / 28 / 17 IVA OS - 10 / 24 / 17 PRP OS - 4 / 28 / 2017 IVA OU - 4 / 14 / 17 PRP OD - 4 / 14 / 2017 IVFA ( 4 / 6 / 2017 ) - Active PDR OU 1 .	NIDDM - [ Duration 16 yrs , Dx [s2] PDR [e2] OU here , Most recent A1c 8.1 per patient .	severity	lesion	T29	T10	note_7927
NonRel	Treatment Hx IVA OS - 3 / 8 / 19 IVA OS - 2 / 1 / 19 IVFA ( 11 / 8 / 2018 ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - 7 / 6 / 18 IVA OU - 5 / 25 / 18 IVA OU - 4 / 6 / 18 IVA OU - 2 / 22 / 18 IVA OU - 11 / 28 / 17 IVA OS - 10 / 24 / 17 PRP OS - 4 / 28 / 2017 IVA OU - 4 / 14 / 17 PRP OD - 4 / 14 / 2017 IVFA ( 4 / 6 / 2017 ) - Active PDR [s1] OU [e1] 1 .	NIDDM - [ Duration 16 yrs , Dx [s2] PDR [e2] OU here , Most recent A1c 8.1 per patient .	laterality	lesion	T31	T10	note_7927
NonRel	NIDDM - [ Duration 16 yrs , Dx PDR [s1] OU [e1] here , Most recent A1c 8.1 per patient .	Treatment Hx IVA OS - 3 / 8 / 19 IVA OS - 2 / 1 / 19 IVFA ( 11 / 8 / 2018 ) - Mild [s2] NVE [e2] ( nearly regressed ) , residual NVD OS IVA OU - 7 / 6 / 18 IVA OU - 5 / 25 / 18 IVA OU - 4 / 6 / 18 IVA OU - 2 / 22 / 18 IVA OU - 11 / 28 / 17 IVA OS - 10 / 24 / 17 PRP OS - 4 / 28 / 2017 IVA OU - 4 / 14 / 17 PRP OD - 4 / 14 / 2017 IVFA ( 4 / 6 / 2017 ) - Active PDR OU 1 .	laterality	lesion	T32	T8	note_7927
NonRel	NIDDM - [ Duration 16 yrs , Dx PDR [s1] OU [e1] here , Most recent A1c 8.1 per patient .	Treatment Hx IVA OS - 3 / 8 / 19 IVA OS - 2 / 1 / 19 IVFA ( 11 / 8 / 2018 ) - Mild NVE ( nearly regressed ) , residual [s2] NVD [e2] OS IVA OU - 7 / 6 / 18 IVA OU - 5 / 25 / 18 IVA OU - 4 / 6 / 18 IVA OU - 2 / 22 / 18 IVA OU - 11 / 28 / 17 IVA OS - 10 / 24 / 17 PRP OS - 4 / 28 / 2017 IVA OU - 4 / 14 / 17 PRP OD - 4 / 14 / 2017 IVFA ( 4 / 6 / 2017 ) - Active PDR OU 1 .	laterality	lesion	T32	T9	note_7927
NonRel	NIDDM - [ Duration 16 yrs , Dx PDR [s1] OU [e1] here , Most recent A1c 8.1 per patient .	BS historically very poorly controlled ] OD - [s2] PDR [e2] with ciCSME , great response to IVA .	laterality	lesion	T32	T11	note_7927
NonRel	NIDDM - [ Duration 16 yrs , Dx PDR [s1] OU [e1] here , Most recent A1c 8.1 per patient .	BS historically very poorly controlled ] OD - PDR with [s2] ciCSME [e2] , great response to IVA .	laterality	lesion	T32	T12	note_7927
NonRel	NIDDM - [ Duration 16 yrs , Dx PDR [s1] OU [e1] here , Most recent A1c 8.1 per patient .	Treatment Hx IVA OS - 3 / 8 / 19 IVA OS - 2 / 1 / 19 IVFA ( 11 / 8 / 2018 ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - 7 / 6 / 18 IVA OU - 5 / 25 / 18 IVA OU - 4 / 6 / 18 IVA OU - 2 / 22 / 18 IVA OU - 11 / 28 / 17 IVA OS - 10 / 24 / 17 PRP OS - 4 / 28 / 2017 IVA OU - 4 / 14 / 17 PRP OD - 4 / 14 / 2017 IVFA ( 4 / 6 / 2017 ) - Active [s2] PDR [e2] OU 1 .	laterality	lesion	T32	T30	note_7927
NonRel	BS historically very poorly controlled ] [s1] OD [e1] - PDR with ciCSME , great response to IVA .	NIDDM - [ Duration 16 yrs , Dx [s2] PDR [e2] OU here , Most recent A1c 8.1 per patient .	laterality	lesion	T33	T10	note_7927
NonRel	BS historically very poorly controlled ] [s1] OD [e1] - PDR with ciCSME , great response to IVA .	Significant improvement from presentation with only mild nasal [s2] NVE [e2] remaining .	laterality	lesion	T33	T13	note_7927
NonRel	Significant improvement from presentation with only [s1] mild [e1] nasal NVE remaining .	BS historically very poorly controlled ] OD - [s2] PDR [e2] with ciCSME , great response to IVA .	severity	lesion	T34	T11	note_7927
NonRel	Significant improvement from presentation with only [s1] mild [e1] nasal NVE remaining .	BS historically very poorly controlled ] OD - PDR with [s2] ciCSME [e2] , great response to IVA .	severity	lesion	T34	T12	note_7927
NonRel	Treatment Hx IVA OS - 3 / 8 / 19 IVA OS - 2 / 1 / 19 IVFA ( 11 / 8 / 2018 ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - 7 / 6 / 18 IVA OU - 5 / 25 / 18 IVA OU - 4 / 6 / 18 IVA OU - 2 / 22 / 18 IVA OU - 11 / 28 / 17 IVA OS - 10 / 24 / 17 PRP OS - 4 / 28 / 2017 IVA OU - 4 / 14 / 17 PRP OD - 4 / 14 / 2017 IVFA ( 4 / 6 / 2017 ) - [s1] Active [e1] PDR OU 1 .	NIDDM - [ Duration 16 yrs , Dx [s2] PDR [e2] OU here , Most recent A1c 8.1 per patient .	severity	lesion	T37	T10	note_7927
NonRel	S / P 25 g PPV / ML / DEM / AFX / EL / SO OS 11 / 13 / 17 Z98.890 V45.69 Treatment History PPV / TRD OS - 11 / 13 / 17 IVA OS - 11 / 9 / 17 ( preop ) PRP OD - 6 / 30 / 2017 IVA OD - 6 / 15 / 17 IVFA ( 6 / 15 / 17 ) - [s1] Active [e1] PDR OU 1 , 2 , 3 ) DM - [ Dx 1990 s ] .	Active [s2] Proliferative Diabetic retinopathy [e2] OU .	severity	lesion	T4	T8	note_2214
NonRel	S / P 25 g PPV / ML / DEM / AFX / EL / SO OS 11 / 13 / 17 Z98.890 V45.69 Treatment History PPV / TRD OS - 11 / 13 / 17 IVA OS - 11 / 9 / 17 ( preop ) PRP OD - 6 / 30 / 2017 IVA OD - 6 / 15 / 17 IVFA ( 6 / 15 / 17 ) - Active PDR [s1] OU [e1] 1 , 2 , 3 ) DM - [ Dx 1990 s ] .	Active [s2] Proliferative Diabetic retinopathy [e2] OU .	laterality	lesion	T6	T8	note_2214
NonRel	[s1] Active [e1] Proliferative Diabetic retinopathy OU .	S / P 25 g PPV / ML / DEM / AFX / EL / SO OS 11 / 13 / 17 Z98.890 V45.69 Treatment History PPV / TRD OS - 11 / 13 / 17 IVA OS - 11 / 9 / 17 ( preop ) PRP OD - 6 / 30 / 2017 IVA OD - 6 / 15 / 17 IVFA ( 6 / 15 / 17 ) - Active [s2] PDR [e2] OU 1 , 2 , 3 ) DM - [ Dx 1990 s ] .	severity	lesion	T7	T5	note_2214
NonRel	Active Proliferative Diabetic retinopathy [s1] OU [e1] .	S / P 25 g PPV / ML / DEM / AFX / EL / SO OS 11 / 13 / 17 Z98.890 V45.69 Treatment History PPV / TRD OS - 11 / 13 / 17 IVA OS - 11 / 9 / 17 ( preop ) PRP OD - 6 / 30 / 2017 IVA OD - 6 / 15 / 17 IVFA ( 6 / 15 / 17 ) - Active [s2] PDR [e2] OU 1 , 2 , 3 ) DM - [ Dx 1990 s ] .	laterality	lesion	T9	T5	note_2214
NonRel	Subjective : History of Present Illness : NAME is a 47 y.o. male who is here today for IDDM x1965 with [s1] PDR [e1] OU with regressed NV and stable preretinal heme OS s / p PRP last visit DATE .	No outpatient prescriptions have been marked as taking for the DATE encounter ( Office Visit ) with NAME Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 30 - DATE Method : Snellen - Linear Correction : Glasses Tonometry Right Left Pressure 12 13 Method : Applanation Time : 1 : 57 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 1 : 57 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Blepharitis Blepharitis Conjunctiva / Sclera White and quiet White and quiet Cornea PEK PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Nuclear sclerosis , 1 + Cortical cataract , 1 + Posterior subcapsular cataract 2 + Nuclear sclerosis , 1 + Cortical cataract , 1 + Posterior subcapsular cataract Vitreous Normal , no heme Posterior vitreous detachment , no heme Fundus Exam Right Left Disc Normal Normal [s2] Macula [e2] No CSME , + ERM No CSME , + ERM Vessels Vascular attenuation , beading , narrowing Vascular attenuation , Tortuous , Arteriolar narrowing , beading Periphery extensing PRP , but has room in the far peripehry for laser .	lesion	eye_part	T1	T3	87477_note_210
NonRel	No neovascualrization extensive PRP , [s1] dbh [e1] , inferior preretinal heme extending inf - temp - there is room for more laser peripherally Neuro / Psych Oriented x3 : Yes Other testing : OCT : OD : Macular contour is normal with a normal foveal depression .	No outpatient prescriptions have been marked as taking for the DATE encounter ( Office Visit ) with NAME Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 30 - DATE Method : Snellen - Linear Correction : Glasses Tonometry Right Left Pressure 12 13 Method : Applanation Time : 1 : 57 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 1 : 57 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Blepharitis Blepharitis Conjunctiva / Sclera White and quiet White and quiet Cornea PEK PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Nuclear sclerosis , 1 + Cortical cataract , 1 + Posterior subcapsular cataract 2 + Nuclear sclerosis , 1 + Cortical cataract , 1 + Posterior subcapsular cataract Vitreous Normal , no heme Posterior vitreous detachment , no heme Fundus Exam Right Left Disc Normal Normal [s2] Macula [e2] No CSME , + ERM No CSME , + ERM Vessels Vascular attenuation , beading , narrowing Vascular attenuation , Tortuous , Arteriolar narrowing , beading Periphery extensing PRP , but has room in the far peripehry for laser .	lesion	eye_part	T6	T3	87477_note_210
NonRel	No [s1] neovascualrization [e1] extensive PRP , dbh , inferior preretinal heme extending inf - temp - there is room for more laser peripherally Neuro / Psych Oriented x3 : Yes Other testing : OCT : OD : Macular contour is normal with a normal foveal depression .	No outpatient prescriptions have been marked as taking for the DATE encounter ( Office Visit ) with NAME Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 30 - DATE Method : Snellen - Linear Correction : Glasses Tonometry Right Left Pressure 12 13 Method : Applanation Time : 1 : 57 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 1 : 57 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Blepharitis Blepharitis Conjunctiva / Sclera White and quiet White and quiet Cornea PEK PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Nuclear sclerosis , 1 + Cortical cataract , 1 + Posterior subcapsular cataract 2 + Nuclear sclerosis , 1 + Cortical cataract , 1 + Posterior subcapsular cataract Vitreous Normal , no heme Posterior vitreous detachment , no heme Fundus Exam Right Left Disc Normal Normal [s2] Macula [e2] No CSME , + ERM No CSME , + ERM Vessels Vascular attenuation , beading , narrowing Vascular attenuation , Tortuous , Arteriolar narrowing , beading Periphery extensing PRP , but has room in the far peripehry for laser .	lesion	eye_part	T7	T3	87477_note_210
NonRel	Visit Date : DATE Referring Physician : Dr. NAME Chief Complaint Patient presents with • Eye Problem IDDM x1965 with PDR [s1] OU [e1] with regressed NV and stable preretinal heme OS s / p PRP last visit DATE .	Subjective : History of Present Illness : NAME is a 47 y.o. male who is here today for IDDM x1965 with [s2] PDR [e2] OU with regressed NV and stable preretinal heme OS s / p PRP last visit DATE .	laterality	lesion	T12	T1	87477_note_210
NonRel	Subjective : History of Present Illness : NAME is a 47 y.o. male who is here today for IDDM x1965 with PDR [s1] OU [e1] with regressed NV and stable preretinal heme OS s / p PRP last visit DATE .	Visit Date : DATE Referring Physician : Dr. NAME Chief Complaint Patient presents with • Eye Problem IDDM x1965 with [s2] PDR [e2] OU with regressed NV and stable preretinal heme OS s / p PRP last visit DATE .	laterality	lesion	T13	T2	87477_note_210
NonRel	Subjective : History of Present Illness : NAME is a 47 y.o. male who is here today for IDDM x1965 with PDR [s1] OU [e1] with regressed NV and stable preretinal heme OS s / p PRP last visit DATE .	No outpatient prescriptions have been marked as taking for the DATE encounter ( Office Visit ) with NAME Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 30 - DATE Method : Snellen - Linear Correction : Glasses Tonometry Right Left Pressure 12 13 Method : Applanation Time : 1 : 57 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 1 : 57 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Blepharitis Blepharitis Conjunctiva / Sclera White and quiet White and quiet Cornea PEK PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Nuclear sclerosis , 1 + Cortical cataract , 1 + Posterior subcapsular cataract 2 + Nuclear sclerosis , 1 + Cortical cataract , 1 + Posterior subcapsular cataract Vitreous Normal , no heme Posterior vitreous detachment , no heme Fundus Exam Right Left Disc Normal Normal Macula No [s2] CSME [e2] , + ERM No CSME , + ERM Vessels Vascular attenuation , beading , narrowing Vascular attenuation , Tortuous , Arteriolar narrowing , beading Periphery extensing PRP , but has room in the far peripehry for laser .	laterality	lesion	T13	T4	87477_note_210
NonRel	Subjective : History of Present Illness : NAME is a 47 y.o. male who is here today for IDDM x1965 with PDR [s1] OU [e1] with regressed NV and stable preretinal heme OS s / p PRP last visit DATE .	No outpatient prescriptions have been marked as taking for the DATE encounter ( Office Visit ) with NAME Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 30 - DATE Method : Snellen - Linear Correction : Glasses Tonometry Right Left Pressure 12 13 Method : Applanation Time : 1 : 57 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 1 : 57 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Blepharitis Blepharitis Conjunctiva / Sclera White and quiet White and quiet Cornea PEK PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Nuclear sclerosis , 1 + Cortical cataract , 1 + Posterior subcapsular cataract 2 + Nuclear sclerosis , 1 + Cortical cataract , 1 + Posterior subcapsular cataract Vitreous Normal , no heme Posterior vitreous detachment , no heme Fundus Exam Right Left Disc Normal Normal Macula No CSME , + ERM No [s2] CSME [e2] , + ERM Vessels Vascular attenuation , beading , narrowing Vascular attenuation , Tortuous , Arteriolar narrowing , beading Periphery extensing PRP , but has room in the far peripehry for laser .	laterality	lesion	T13	T5	87477_note_210
NonRel	ERM OD ( epiretinal membrane , [s1] right eye [e1] ) ( 362.56 ) no sig ERM or DME 3 .	ERM OS ( epiretinal membrane , left eye ) ( 362.56 ) no sig ERM or [s2] DME [e2] 4 .	laterality	lesion	T15	T11	87477_note_210
NonRel	ERM OS ( epiretinal membrane , [s1] left eye [e1] ) ( 362.56 ) no sig ERM or DME 4 .	ERM OD ( epiretinal membrane , right eye ) ( 362.56 ) no sig ERM or [s2] DME [e2] 3 .	laterality	lesion	T16	T10	87477_note_210
NonRel	Nonproliferative diabetic retinopathy of [s1] right eye [e1] , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	laterality	lesion	T6	T11	note_1120
NonRel	Nonproliferative diabetic retinopathy of [s1] right eye [e1] , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	laterality	lesion	T6	T13	note_1120
NonRel	Nonproliferative diabetic retinopathy of [s1] right eye [e1] , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate [s2] NPDR [e2] with CSME OU OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	laterality	lesion	T6	T15	note_1120
NonRel	Nonproliferative diabetic retinopathy of [s1] right eye [e1] , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with [s2] CSME [e2] OU OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	laterality	lesion	T6	T16	note_1120
NonRel	Nonproliferative diabetic retinopathy of [s1] right eye [e1] , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate [s2] NPDR [e2] with CSME , stable on IVA Continue IVA OD monthly .	laterality	lesion	T6	T20	note_1120
NonRel	Nonproliferative diabetic retinopathy of [s1] right eye [e1] , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with [s2] CSME [e2] , stable on IVA Continue IVA OD monthly .	laterality	lesion	T6	T21	note_1120
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with [s1] moderate [e1] nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	severity	lesion	T9	T11	note_1120
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with [s1] moderate [e1] nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	severity	lesion	T9	T13	note_1120
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with [s1] moderate [e1] nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate [s2] NPDR [e2] with CSME OU OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	severity	lesion	T9	T15	note_1120
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with [s1] moderate [e1] nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with [s2] CSME [e2] OU OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	severity	lesion	T9	T16	note_1120
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with [s1] moderate [e1] nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate [s2] NPDR [e2] with CSME , stable on IVA Continue IVA OD monthly .	severity	lesion	T9	T20	note_1120
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with [s1] moderate [e1] nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with [s2] CSME [e2] , stable on IVA Continue IVA OD monthly .	severity	lesion	T9	T21	note_1120
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	[s2] Nonproliferative diabetic retinopathy [e2] of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T10	T5	note_1120
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	Nonproliferative diabetic retinopathy of right eye , with [s2] macular edema [e2] , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T10	T7	note_1120
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate [s2] nonproliferative retinopathy [e2] E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T10	T8	note_1120
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	OS - Moderate [s2] NPDR [e2] with CSME , stable on IVA Continue IVA OS monthly RTC 4 - 5 weeks for MAC OCT and IVA OU IRF OU , no improvement OU Philip Ames , MD participated in the care of this patient .	severity	lesion	T10	T24	note_1120
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	OS - Moderate NPDR with [s2] CSME [e2] , stable on IVA Continue IVA OS monthly RTC 4 - 5 weeks for MAC OCT and IVA OU IRF OU , no improvement OU Philip Ames , MD participated in the care of this patient .	severity	lesion	T10	T25	note_1120
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	[s2] Nonproliferative diabetic retinopathy [e2] of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T12	T5	note_1120
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	Nonproliferative diabetic retinopathy of right eye , with [s2] macular edema [e2] , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T12	T7	note_1120
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate [s2] nonproliferative retinopathy [e2] E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T12	T8	note_1120
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	OS - Moderate [s2] NPDR [e2] with CSME , stable on IVA Continue IVA OS monthly RTC 4 - 5 weeks for MAC OCT and IVA OU IRF OU , no improvement OU Philip Ames , MD participated in the care of this patient .	laterality	lesion	T12	T24	note_1120
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	OS - Moderate NPDR with [s2] CSME [e2] , stable on IVA Continue IVA OS monthly RTC 4 - 5 weeks for MAC OCT and IVA OU IRF OU , no improvement OU Philip Ames , MD participated in the care of this patient .	laterality	lesion	T12	T25	note_1120
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] [s1] Moderate [e1] NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	[s2] Nonproliferative diabetic retinopathy [e2] of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T14	T5	note_1120
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] [s1] Moderate [e1] NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	Nonproliferative diabetic retinopathy of right eye , with [s2] macular edema [e2] , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T14	T7	note_1120
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] [s1] Moderate [e1] NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate [s2] nonproliferative retinopathy [e2] E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T14	T8	note_1120
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] [s1] Moderate [e1] NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	OS - Moderate [s2] NPDR [e2] with CSME , stable on IVA Continue IVA OS monthly RTC 4 - 5 weeks for MAC OCT and IVA OU IRF OU , no improvement OU Philip Ames , MD participated in the care of this patient .	severity	lesion	T14	T24	note_1120
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] [s1] Moderate [e1] NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	OS - Moderate NPDR with [s2] CSME [e2] , stable on IVA Continue IVA OS monthly RTC 4 - 5 weeks for MAC OCT and IVA OU IRF OU , no improvement OU Philip Ames , MD participated in the care of this patient .	severity	lesion	T14	T25	note_1120
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME [s1] OU [e1] OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	[s2] Nonproliferative diabetic retinopathy [e2] of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T17	T5	note_1120
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME [s1] OU [e1] OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	Nonproliferative diabetic retinopathy of right eye , with [s2] macular edema [e2] , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T17	T7	note_1120
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME [s1] OU [e1] OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate [s2] nonproliferative retinopathy [e2] E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T17	T8	note_1120
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME [s1] OU [e1] OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	OS - Moderate [s2] NPDR [e2] with CSME , stable on IVA Continue IVA OS monthly RTC 4 - 5 weeks for MAC OCT and IVA OU IRF OU , no improvement OU Philip Ames , MD participated in the care of this patient .	laterality	lesion	T17	T24	note_1120
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME [s1] OU [e1] OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	OS - Moderate NPDR with [s2] CSME [e2] , stable on IVA Continue IVA OS monthly RTC 4 - 5 weeks for MAC OCT and IVA OU IRF OU , no improvement OU Philip Ames , MD participated in the care of this patient .	laterality	lesion	T17	T25	note_1120
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU [s1] OD [e1] - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	[s2] Nonproliferative diabetic retinopathy [e2] of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T18	T5	note_1120
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU [s1] OD [e1] - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	Nonproliferative diabetic retinopathy of right eye , with [s2] macular edema [e2] , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T18	T7	note_1120
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU [s1] OD [e1] - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate [s2] nonproliferative retinopathy [e2] E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T18	T8	note_1120
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU [s1] OD [e1] - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	OS - Moderate [s2] NPDR [e2] with CSME , stable on IVA Continue IVA OS monthly RTC 4 - 5 weeks for MAC OCT and IVA OU IRF OU , no improvement OU Philip Ames , MD participated in the care of this patient .	laterality	lesion	T18	T24	note_1120
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU [s1] OD [e1] - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	OS - Moderate NPDR with [s2] CSME [e2] , stable on IVA Continue IVA OS monthly RTC 4 - 5 weeks for MAC OCT and IVA OU IRF OU , no improvement OU Philip Ames , MD participated in the care of this patient .	laterality	lesion	T18	T25	note_1120
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - [s1] Moderate [e1] NPDR with CSME , stable on IVA Continue IVA OD monthly .	[s2] Nonproliferative diabetic retinopathy [e2] of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T19	T5	note_1120
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - [s1] Moderate [e1] NPDR with CSME , stable on IVA Continue IVA OD monthly .	Nonproliferative diabetic retinopathy of right eye , with [s2] macular edema [e2] , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T19	T7	note_1120
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - [s1] Moderate [e1] NPDR with CSME , stable on IVA Continue IVA OD monthly .	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate [s2] nonproliferative retinopathy [e2] E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T19	T8	note_1120
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - [s1] Moderate [e1] NPDR with CSME , stable on IVA Continue IVA OD monthly .	OS - Moderate [s2] NPDR [e2] with CSME , stable on IVA Continue IVA OS monthly RTC 4 - 5 weeks for MAC OCT and IVA OU IRF OU , no improvement OU Philip Ames , MD participated in the care of this patient .	severity	lesion	T19	T24	note_1120
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - [s1] Moderate [e1] NPDR with CSME , stable on IVA Continue IVA OD monthly .	OS - Moderate NPDR with [s2] CSME [e2] , stable on IVA Continue IVA OS monthly RTC 4 - 5 weeks for MAC OCT and IVA OU IRF OU , no improvement OU Philip Ames , MD participated in the care of this patient .	severity	lesion	T19	T25	note_1120
NonRel	[s1] OS [e1] - Moderate NPDR with CSME , stable on IVA Continue IVA OS monthly RTC 4 - 5 weeks for MAC OCT and IVA OU IRF OU , no improvement OU Philip Ames , MD participated in the care of this patient .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	laterality	lesion	T22	T11	note_1120
NonRel	[s1] OS [e1] - Moderate NPDR with CSME , stable on IVA Continue IVA OS monthly RTC 4 - 5 weeks for MAC OCT and IVA OU IRF OU , no improvement OU Philip Ames , MD participated in the care of this patient .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	laterality	lesion	T22	T13	note_1120
NonRel	[s1] OS [e1] - Moderate NPDR with CSME , stable on IVA Continue IVA OS monthly RTC 4 - 5 weeks for MAC OCT and IVA OU IRF OU , no improvement OU Philip Ames , MD participated in the care of this patient .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate [s2] NPDR [e2] with CSME OU OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	laterality	lesion	T22	T15	note_1120
NonRel	[s1] OS [e1] - Moderate NPDR with CSME , stable on IVA Continue IVA OS monthly RTC 4 - 5 weeks for MAC OCT and IVA OU IRF OU , no improvement OU Philip Ames , MD participated in the care of this patient .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with [s2] CSME [e2] OU OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	laterality	lesion	T22	T16	note_1120
NonRel	[s1] OS [e1] - Moderate NPDR with CSME , stable on IVA Continue IVA OS monthly RTC 4 - 5 weeks for MAC OCT and IVA OU IRF OU , no improvement OU Philip Ames , MD participated in the care of this patient .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate [s2] NPDR [e2] with CSME , stable on IVA Continue IVA OD monthly .	laterality	lesion	T22	T20	note_1120
NonRel	[s1] OS [e1] - Moderate NPDR with CSME , stable on IVA Continue IVA OS monthly RTC 4 - 5 weeks for MAC OCT and IVA OU IRF OU , no improvement OU Philip Ames , MD participated in the care of this patient .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with [s2] CSME [e2] , stable on IVA Continue IVA OD monthly .	laterality	lesion	T22	T21	note_1120
NonRel	OS - [s1] Moderate [e1] NPDR with CSME , stable on IVA Continue IVA OS monthly RTC 4 - 5 weeks for MAC OCT and IVA OU IRF OU , no improvement OU Philip Ames , MD participated in the care of this patient .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	severity	lesion	T23	T11	note_1120
NonRel	OS - [s1] Moderate [e1] NPDR with CSME , stable on IVA Continue IVA OS monthly RTC 4 - 5 weeks for MAC OCT and IVA OU IRF OU , no improvement OU Philip Ames , MD participated in the care of this patient .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	severity	lesion	T23	T13	note_1120
NonRel	OS - [s1] Moderate [e1] NPDR with CSME , stable on IVA Continue IVA OS monthly RTC 4 - 5 weeks for MAC OCT and IVA OU IRF OU , no improvement OU Philip Ames , MD participated in the care of this patient .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate [s2] NPDR [e2] with CSME OU OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	severity	lesion	T23	T15	note_1120
NonRel	OS - [s1] Moderate [e1] NPDR with CSME , stable on IVA Continue IVA OS monthly RTC 4 - 5 weeks for MAC OCT and IVA OU IRF OU , no improvement OU Philip Ames , MD participated in the care of this patient .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with [s2] CSME [e2] OU OD - Moderate NPDR with CSME , stable on IVA Continue IVA OD monthly .	severity	lesion	T23	T16	note_1120
NonRel	OS - [s1] Moderate [e1] NPDR with CSME , stable on IVA Continue IVA OS monthly RTC 4 - 5 weeks for MAC OCT and IVA OU IRF OU , no improvement OU Philip Ames , MD participated in the care of this patient .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate [s2] NPDR [e2] with CSME , stable on IVA Continue IVA OD monthly .	severity	lesion	T23	T20	note_1120
NonRel	OS - [s1] Moderate [e1] NPDR with CSME , stable on IVA Continue IVA OS monthly RTC 4 - 5 weeks for MAC OCT and IVA OU IRF OU , no improvement OU Philip Ames , MD participated in the care of this patient .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OU - 1 / 26 / 17 ( today ) IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with [s2] CSME [e2] , stable on IVA Continue IVA OD monthly .	severity	lesion	T23	T21	note_1120
NonRel	no [s1] SRF [e1] / L / H large drusen .	Allergies : No Known Allergies ROS Positive for : HENT , Eyes Negative for : Constitutional , Gastrointestinal , Neurological , Skin , Genitourinary , Musculoskeletal , Endocrine , Cardiovascular , Respiratory , Psychiatric , Allergic / Imm , Heme / Lymph Objective : Base Eye Exam Visual Acuity Right Left Dist cc 20 / 60 - 2 20 / 70 Method : Snellen - Linear Tonometry Right Left Pressure 19 19 Method : Applanation Time : 2 : 34 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full , Ortho Full , Ortho Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 35 PM Slit Lamp and Fundus Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Blepharitis Blepharitis Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Nuclear sclerosis , Posterior subcapsular cataract 2 + Nuclear sclerosis Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.3 0.3 [s2] Macula [e2] large drusen .	lesion	eye_part	T1	T5	127106_note_331
NonRel	no SRF / L / H large [s1] drusen [e1] .	Allergies : No Known Allergies ROS Positive for : HENT , Eyes Negative for : Constitutional , Gastrointestinal , Neurological , Skin , Genitourinary , Musculoskeletal , Endocrine , Cardiovascular , Respiratory , Psychiatric , Allergic / Imm , Heme / Lymph Objective : Base Eye Exam Visual Acuity Right Left Dist cc 20 / 60 - 2 20 / 70 Method : Snellen - Linear Tonometry Right Left Pressure 19 19 Method : Applanation Time : 2 : 34 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full , Ortho Full , Ortho Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 35 PM Slit Lamp and Fundus Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Blepharitis Blepharitis Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Nuclear sclerosis , Posterior subcapsular cataract 2 + Nuclear sclerosis Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.3 0.3 [s2] Macula [e2] large drusen .	lesion	eye_part	T4	T5	127106_note_331
NonRel	Allergies : No Known Allergies ROS Positive for : HENT , Eyes Negative for : Constitutional , Gastrointestinal , Neurological , Skin , Genitourinary , Musculoskeletal , Endocrine , Cardiovascular , Respiratory , Psychiatric , Allergic / Imm , Heme / Lymph Objective : Base Eye Exam Visual Acuity Right Left Dist cc 20 / 60 - 2 20 / 70 Method : Snellen - Linear Tonometry Right Left Pressure 19 19 Method : Applanation Time : 2 : 34 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full , Ortho Full , Ortho Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 35 PM Slit Lamp and Fundus Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Blepharitis Blepharitis Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Nuclear sclerosis , Posterior subcapsular cataract 2 + Nuclear sclerosis Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.3 0.3 Macula [s1] large [e1] drusen .	no [s2] SRF [e2] / L / H large drusen .	severity	lesion	T6	T1	127106_note_331
NonRel	Allergies : No Known Allergies ROS Positive for : HENT , Eyes Negative for : Constitutional , Gastrointestinal , Neurological , Skin , Genitourinary , Musculoskeletal , Endocrine , Cardiovascular , Respiratory , Psychiatric , Allergic / Imm , Heme / Lymph Objective : Base Eye Exam Visual Acuity Right Left Dist cc 20 / 60 - 2 20 / 70 Method : Snellen - Linear Tonometry Right Left Pressure 19 19 Method : Applanation Time : 2 : 34 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full , Ortho Full , Ortho Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 35 PM Slit Lamp and Fundus Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Blepharitis Blepharitis Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Nuclear sclerosis , Posterior subcapsular cataract 2 + Nuclear sclerosis Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.3 0.3 Macula [s1] large [e1] drusen .	no SRF / L / H large [s2] drusen [e2] .	severity	lesion	T6	T4	127106_note_331
NonRel	no SRF / L / H [s1] large [e1] drusen .	no [s2] SRF [e2] / L / H Vessels Normal Normal Periphery Normal Normal Refraction Wearing Rx Sphere Cylinder Axis Right - 3.00 + 2.50 170 Left - 2.50 + 2.00 180 Type : SVL Manifest Refraction Sphere Cylinder Axis Dist Right - 3.00 + 1.00 010 20 / 60 + Left - 2.25 + 2.75 005 20 / 60 + No annotated images are attached to the encounter .	severity	lesion	T7	T2	127106_note_331
NonRel	no SRF / L / H [s1] large [e1] drusen .	Allergies : No Known Allergies ROS Positive for : HENT , Eyes Negative for : Constitutional , Gastrointestinal , Neurological , Skin , Genitourinary , Musculoskeletal , Endocrine , Cardiovascular , Respiratory , Psychiatric , Allergic / Imm , Heme / Lymph Objective : Base Eye Exam Visual Acuity Right Left Dist cc 20 / 60 - 2 20 / 70 Method : Snellen - Linear Tonometry Right Left Pressure 19 19 Method : Applanation Time : 2 : 34 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full , Ortho Full , Ortho Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 35 PM Slit Lamp and Fundus Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Blepharitis Blepharitis Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Nuclear sclerosis , Posterior subcapsular cataract 2 + Nuclear sclerosis Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.3 0.3 Macula large [s2] drusen [e2] .	severity	lesion	T7	T3	127106_note_331
NonRel	Diabetic retinopathy of [s1] both eyes [e1] ( CMS - HCC code ) E11.319 250.50 362.01 2 .	[s2] Proliferative diabetic retinopathy [e2] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3519 250.50 362.07 362.02 3 .	laterality	lesion	T2	T3	note_6491
NonRel	Diabetic retinopathy of [s1] both eyes [e1] ( CMS - HCC code ) E11.319 250.50 362.01 2 .	Proliferative diabetic retinopathy with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3519 250.50 362.07 362.02 3 .	laterality	lesion	T2	T4	note_6491
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior [s1] vit heme [e1] and layered heme .	NVE along [s2] arcades [e2] , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	lesion	eye_part	T1	T19	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one [s1] MA [e1] and exudates temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	NVE along [s2] arcades [e2] , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	lesion	eye_part	T2	T19	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and [s1] exudates [e1] temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	NVE along [s2] arcades [e2] , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	lesion	eye_part	T3	T19	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates [s1] temporally [e1] one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	[s2] NVE [e2] along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	severity	lesion	T4	T16	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates [s1] temporally [e1] one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	NVE along arcades , temporal [s2] DBH [e2] , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	severity	lesion	T4	T17	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates [s1] temporally [e1] one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	NVE along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few [s2] DBH [e2] , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	severity	lesion	T4	T20	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one [s1] MA [e1] and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	NVE along [s2] arcades [e2] , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	lesion	eye_part	T5	T19	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and [s1] exudates [e1] temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	NVE along [s2] arcades [e2] , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	lesion	eye_part	T6	T19	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates [s1] temporally [e1] Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	[s2] NVE [e2] along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	severity	lesion	T7	T16	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates [s1] temporally [e1] Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	NVE along arcades , temporal [s2] DBH [e2] , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	severity	lesion	T7	T17	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates [s1] temporally [e1] Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	NVE along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few [s2] DBH [e2] , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	severity	lesion	T7	T20	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates temporally Vessels Regressed [s1] NVE [e1] along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	NVE along [s2] arcades [e2] , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	lesion	eye_part	T8	T19	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed [s1] NVE [e1] along superior arcade without TRD Periphery inferior vit heme and layered heme .	NVE along [s2] arcades [e2] , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	lesion	eye_part	T9	T19	note_4416
NonRel	Senile nuclear sclerosis ( 366.16 ) 1 ) Chronic DME [s1] OU [e1] , more focal OD , diffuse OS , refractory to avastin .	[s2] Vitreous hemorrhage [e2] ( 379.23 ) 6 .	laterality	lesion	T12	T10	note_4416
NonRel	NVE along arcades , [s1] temporal [e1] DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior [s2] vit heme [e2] and layered heme .	severity	lesion	T18	T1	note_4416
NonRel	NVE along arcades , [s1] temporal [e1] DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one [s2] MA [e2] and exudates temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T18	T2	note_4416
NonRel	NVE along arcades , [s1] temporal [e1] DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and [s2] exudates [e2] temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T18	T3	note_4416
NonRel	NVE along arcades , [s1] temporal [e1] DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one [s2] MA [e2] and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T18	T5	note_4416
NonRel	NVE along arcades , [s1] temporal [e1] DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and [s2] exudates [e2] temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T18	T6	note_4416
NonRel	NVE along arcades , [s1] temporal [e1] DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates temporally Vessels Regressed [s2] NVE [e2] along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T18	T8	note_4416
NonRel	NVE along arcades , [s1] temporal [e1] DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed [s2] NVE [e2] along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T18	T9	note_4416
NonRel	NVE along arcades , [s1] temporal [e1] DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	DM Eye Manif Type II : H / o [s2] PDR [e2] ( OU ) S / p Laser and injections both eyes ( 250.50 ) RETINA ( OCT ) , PR INJECT INTRAVITREAL PHARMCOLOGIC , bevacizumab ( AVASTIN ) 400 MG / 16 ML injection 2 .	severity	lesion	T18	T22	note_4416
NonRel	NVE along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with [s1] few [e1] DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior [s2] vit heme [e2] and layered heme .	severity	lesion	T21	T1	note_4416
NonRel	NVE along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with [s1] few [e1] DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one [s2] MA [e2] and exudates temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T21	T2	note_4416
NonRel	NVE along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with [s1] few [e1] DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and [s2] exudates [e2] temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T21	T3	note_4416
NonRel	NVE along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with [s1] few [e1] DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one [s2] MA [e2] and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T21	T5	note_4416
NonRel	NVE along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with [s1] few [e1] DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and [s2] exudates [e2] temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T21	T6	note_4416
NonRel	NVE along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with [s1] few [e1] DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates temporally Vessels Regressed [s2] NVE [e2] along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T21	T8	note_4416
NonRel	NVE along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with [s1] few [e1] DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed [s2] NVE [e2] along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T21	T9	note_4416
NonRel	NVE along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with [s1] few [e1] DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	DM Eye Manif Type II : H / o [s2] PDR [e2] ( OU ) S / p Laser and injections both eyes ( 250.50 ) RETINA ( OCT ) , PR INJECT INTRAVITREAL PHARMCOLOGIC , bevacizumab ( AVASTIN ) 400 MG / 16 ML injection 2 .	severity	lesion	T21	T22	note_4416
NonRel	DM Eye Manif Type II : H / o [s1] PDR [e1] ( OU ) S / p Laser and injections both eyes ( 250.50 ) RETINA ( OCT ) , PR INJECT INTRAVITREAL PHARMCOLOGIC , bevacizumab ( AVASTIN ) 400 MG / 16 ML injection 2 .	NVE along [s2] arcades [e2] , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	lesion	eye_part	T22	T19	note_4416
NonRel	DM Eye Manif Type II : H / o PDR ( [s1] OU [e1] ) S / p Laser and injections both eyes ( 250.50 ) RETINA ( OCT ) , PR INJECT INTRAVITREAL PHARMCOLOGIC , bevacizumab ( AVASTIN ) 400 MG / 16 ML injection 2 .	[s2] NVE [e2] along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	laterality	lesion	T23	T16	note_4416
NonRel	DM Eye Manif Type II : H / o PDR ( [s1] OU [e1] ) S / p Laser and injections both eyes ( 250.50 ) RETINA ( OCT ) , PR INJECT INTRAVITREAL PHARMCOLOGIC , bevacizumab ( AVASTIN ) 400 MG / 16 ML injection 2 .	NVE along arcades , temporal [s2] DBH [e2] , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	laterality	lesion	T23	T17	note_4416
NonRel	DM Eye Manif Type II : H / o PDR ( [s1] OU [e1] ) S / p Laser and injections both eyes ( 250.50 ) RETINA ( OCT ) , PR INJECT INTRAVITREAL PHARMCOLOGIC , bevacizumab ( AVASTIN ) 400 MG / 16 ML injection 2 .	NVE along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few [s2] DBH [e2] , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	laterality	lesion	T23	T20	note_4416
NonRel	DM Eye Manif Type II : H / o PDR ( [s1] OU [e1] ) S / p Laser and injections both eyes ( 250.50 ) RETINA ( OCT ) , PR INJECT INTRAVITREAL PHARMCOLOGIC , bevacizumab ( AVASTIN ) 400 MG / 16 ML injection 2 .	[s2] Proliferative diabetic retinopathy [e2] ( 362.02 ) RETINA ( OCT ) , PR INJECT INTRAVITREAL PHARMCOLOGIC , bevacizumab ( AVASTIN ) 400 MG / 16 ML injection 3 .	laterality	lesion	T23	T24	note_4416
NonRel	( History ) Objective : Base Eye Exam Visual Acuity ( Snellen - Linear ) Right Left Dist sc DATE - DATE - Tonometry ( icare , 8 : 44 AM ) Right Left Pressure 18 17 Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 8 : 44 AM Slit Lamp and Fundus Exam Slit Lamp Exam Right Left Lids / Lashes Dermatochalasis - upper lid , Meibomian gland dysfunction Dermatochalasis - upper lid , Meibomian gland dysfunction Conjunctiva / Sclera Injection Injection Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Nuclear sclerosis , ACC Nuclear sclerosis , ACC Fundus Exam Right Left Vitreous syneresis syneresis Disc slight congestion overlying nasal glial tissue , congestion C / D Ratio 0.1 0.1 Macula macular hole , [s1] rare [e1] MA peripapillary telangiectasia , edema , DBH , MA Vessels tortuous tortuous Periphery rare DBH , MA mid - peripheral MA / DBH Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Central retinal vein occlusion with [s2] macular edema [e2] of left eye H34.8120 362.35 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.83 2 .	severity	lesion	T14	T8	2703704_note_9128
NonRel	( History ) Objective : Base Eye Exam Visual Acuity ( Snellen - Linear ) Right Left Dist sc DATE - DATE - Tonometry ( icare , 8 : 44 AM ) Right Left Pressure 18 17 Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 8 : 44 AM Slit Lamp and Fundus Exam Slit Lamp Exam Right Left Lids / Lashes Dermatochalasis - upper lid , Meibomian gland dysfunction Dermatochalasis - upper lid , Meibomian gland dysfunction Conjunctiva / Sclera Injection Injection Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Nuclear sclerosis , ACC Nuclear sclerosis , ACC Fundus Exam Right Left Vitreous syneresis syneresis Disc slight congestion overlying nasal glial tissue , congestion C / D Ratio 0.1 0.1 Macula macular hole , rare MA peripapillary telangiectasia , edema , DBH , MA Vessels tortuous tortuous Periphery [s1] rare [e1] DBH , MA mid - peripheral MA / DBH Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Central retinal vein occlusion with [s2] macular edema [e2] of left eye H34.8120 362.35 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.83 2 .	severity	lesion	T15	T8	2703704_note_9128
NonRel	Central retinal vein occlusion with macular edema of [s1] left eye [e1] H34.8120 362.35 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.83 2 .	( History ) Objective : Base Eye Exam Visual Acuity ( Snellen - Linear ) Right Left Dist sc DATE - DATE - Tonometry ( icare , 8 : 44 AM ) Right Left Pressure 18 17 Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 8 : 44 AM Slit Lamp and Fundus Exam Slit Lamp Exam Right Left Lids / Lashes Dermatochalasis - upper lid , Meibomian gland dysfunction Dermatochalasis - upper lid , Meibomian gland dysfunction Conjunctiva / Sclera Injection Injection Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Nuclear sclerosis , ACC Nuclear sclerosis , ACC Fundus Exam Right Left Vitreous syneresis syneresis Disc slight congestion overlying nasal glial tissue , congestion C / D Ratio 0.1 0.1 Macula macular hole , rare MA peripapillary telangiectasia , edema , DBH , MA Vessels tortuous tortuous Periphery rare DBH , [s2] MA [e2] mid - peripheral MA / DBH Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T16	T1	2703704_note_9128
NonRel	Central retinal vein occlusion with macular edema of [s1] left eye [e1] H34.8120 362.35 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.83 2 .	( History ) Objective : Base Eye Exam Visual Acuity ( Snellen - Linear ) Right Left Dist sc DATE - DATE - Tonometry ( icare , 8 : 44 AM ) Right Left Pressure 18 17 Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 8 : 44 AM Slit Lamp and Fundus Exam Slit Lamp Exam Right Left Lids / Lashes Dermatochalasis - upper lid , Meibomian gland dysfunction Dermatochalasis - upper lid , Meibomian gland dysfunction Conjunctiva / Sclera Injection Injection Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Nuclear sclerosis , ACC Nuclear sclerosis , ACC Fundus Exam Right Left Vitreous syneresis syneresis Disc slight congestion overlying nasal glial tissue , congestion C / D Ratio 0.1 0.1 Macula macular hole , rare MA peripapillary telangiectasia , [s2] edema [e2] , DBH , MA Vessels tortuous tortuous Periphery rare DBH , MA mid - peripheral MA / DBH Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T16	T2	2703704_note_9128
NonRel	Central retinal vein occlusion with macular edema of [s1] left eye [e1] H34.8120 362.35 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.83 2 .	( History ) Objective : Base Eye Exam Visual Acuity ( Snellen - Linear ) Right Left Dist sc DATE - DATE - Tonometry ( icare , 8 : 44 AM ) Right Left Pressure 18 17 Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 8 : 44 AM Slit Lamp and Fundus Exam Slit Lamp Exam Right Left Lids / Lashes Dermatochalasis - upper lid , Meibomian gland dysfunction Dermatochalasis - upper lid , Meibomian gland dysfunction Conjunctiva / Sclera Injection Injection Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Nuclear sclerosis , ACC Nuclear sclerosis , ACC Fundus Exam Right Left Vitreous syneresis syneresis Disc slight congestion overlying nasal glial tissue , congestion C / D Ratio 0.1 0.1 Macula macular hole , rare MA peripapillary telangiectasia , edema , [s2] DBH [e2] , MA Vessels tortuous tortuous Periphery rare DBH , MA mid - peripheral MA / DBH Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T16	T3	2703704_note_9128
NonRel	Central retinal vein occlusion with macular edema of [s1] left eye [e1] H34.8120 362.35 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.83 2 .	( History ) Objective : Base Eye Exam Visual Acuity ( Snellen - Linear ) Right Left Dist sc DATE - DATE - Tonometry ( icare , 8 : 44 AM ) Right Left Pressure 18 17 Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 8 : 44 AM Slit Lamp and Fundus Exam Slit Lamp Exam Right Left Lids / Lashes Dermatochalasis - upper lid , Meibomian gland dysfunction Dermatochalasis - upper lid , Meibomian gland dysfunction Conjunctiva / Sclera Injection Injection Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Nuclear sclerosis , ACC Nuclear sclerosis , ACC Fundus Exam Right Left Vitreous syneresis syneresis Disc slight congestion overlying nasal glial tissue , congestion C / D Ratio 0.1 0.1 Macula macular hole , rare MA peripapillary telangiectasia , edema , DBH , [s2] MA [e2] Vessels tortuous tortuous Periphery rare DBH , MA mid - peripheral MA / DBH Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T16	T4	2703704_note_9128
NonRel	Central retinal vein occlusion with macular edema of [s1] left eye [e1] H34.8120 362.35 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.83 2 .	( History ) Objective : Base Eye Exam Visual Acuity ( Snellen - Linear ) Right Left Dist sc DATE - DATE - Tonometry ( icare , 8 : 44 AM ) Right Left Pressure 18 17 Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 8 : 44 AM Slit Lamp and Fundus Exam Slit Lamp Exam Right Left Lids / Lashes Dermatochalasis - upper lid , Meibomian gland dysfunction Dermatochalasis - upper lid , Meibomian gland dysfunction Conjunctiva / Sclera Injection Injection Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Nuclear sclerosis , ACC Nuclear sclerosis , ACC Fundus Exam Right Left Vitreous syneresis syneresis Disc slight congestion overlying nasal glial tissue , congestion C / D Ratio 0.1 0.1 Macula macular hole , rare MA peripapillary telangiectasia , edema , DBH , MA Vessels tortuous tortuous Periphery rare [s2] DBH [e2] , MA mid - peripheral MA / DBH Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T16	T5	2703704_note_9128
NonRel	Central retinal vein occlusion with macular edema of [s1] left eye [e1] H34.8120 362.35 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.83 2 .	( History ) Objective : Base Eye Exam Visual Acuity ( Snellen - Linear ) Right Left Dist sc DATE - DATE - Tonometry ( icare , 8 : 44 AM ) Right Left Pressure 18 17 Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 8 : 44 AM Slit Lamp and Fundus Exam Slit Lamp Exam Right Left Lids / Lashes Dermatochalasis - upper lid , Meibomian gland dysfunction Dermatochalasis - upper lid , Meibomian gland dysfunction Conjunctiva / Sclera Injection Injection Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Nuclear sclerosis , ACC Nuclear sclerosis , ACC Fundus Exam Right Left Vitreous syneresis syneresis Disc slight congestion overlying nasal glial tissue , congestion C / D Ratio 0.1 0.1 Macula macular hole , rare MA peripapillary telangiectasia , edema , DBH , MA Vessels tortuous tortuous Periphery rare DBH , MA mid - peripheral [s2] MA [e2] / DBH Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T16	T6	2703704_note_9128
NonRel	Central retinal vein occlusion with macular edema of [s1] left eye [e1] H34.8120 362.35 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.83 2 .	( History ) Objective : Base Eye Exam Visual Acuity ( Snellen - Linear ) Right Left Dist sc DATE - DATE - Tonometry ( icare , 8 : 44 AM ) Right Left Pressure 18 17 Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 8 : 44 AM Slit Lamp and Fundus Exam Slit Lamp Exam Right Left Lids / Lashes Dermatochalasis - upper lid , Meibomian gland dysfunction Dermatochalasis - upper lid , Meibomian gland dysfunction Conjunctiva / Sclera Injection Injection Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Nuclear sclerosis , ACC Nuclear sclerosis , ACC Fundus Exam Right Left Vitreous syneresis syneresis Disc slight congestion overlying nasal glial tissue , congestion C / D Ratio 0.1 0.1 Macula macular hole , rare MA peripapillary telangiectasia , edema , DBH , MA Vessels tortuous tortuous Periphery rare DBH , MA mid - peripheral MA / [s2] DBH [e2] Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T16	T7	2703704_note_9128
NonRel	Central retinal vein occlusion with macular edema of [s1] left eye [e1] H34.8120 362.35 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.83 2 .	Cystoid [s2] macular edema [e2] , bilateral H35.353 362.53 OCT , Posterior Segment - OU - Both Eyes 3 .	laterality	lesion	T16	T9	2703704_note_9128
NonRel	Central retinal vein occlusion with macular edema of [s1] left eye [e1] H34.8120 362.35 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.83 2 .	( History ) Objective : Base Eye Exam Visual Acuity ( Snellen - Linear ) Right Left Dist sc DATE - DATE - Tonometry ( icare , 8 : 44 AM ) Right Left Pressure 18 17 Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 8 : 44 AM Slit Lamp and Fundus Exam Slit Lamp Exam Right Left Lids / Lashes Dermatochalasis - upper lid , Meibomian gland dysfunction Dermatochalasis - upper lid , Meibomian gland dysfunction Conjunctiva / Sclera Injection Injection Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Nuclear sclerosis , ACC Nuclear sclerosis , ACC Fundus Exam Right Left Vitreous syneresis syneresis Disc slight congestion overlying nasal glial tissue , congestion C / D Ratio 0.1 0.1 Macula macular hole , rare [s2] MA [e2] peripapillary telangiectasia , edema , DBH , MA Vessels tortuous tortuous Periphery rare DBH , MA mid - peripheral MA / DBH Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T16	T13	2703704_note_9128
NonRel	Cystoid macular edema , [s1] bilateral [e1] H35.353 362.53 OCT , Posterior Segment - OU - Both Eyes 3 .	Central retinal vein occlusion with [s2] macular edema [e2] of left eye H34.8120 362.35 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.83 2 .	laterality	lesion	T17	T8	2703704_note_9128
NonRel	Cystoid macular edema , [s1] bilateral [e1] H35.353 362.53 OCT , Posterior Segment - OU - Both Eyes 3 .	Retinal hemorrhage noted on examination of left eye H35.62 362.81 OCT , Posterior Segment - OU - Both Eyes New retina patient referred for [s2] CME [e2] OU .	laterality	lesion	T17	T10	2703704_note_9128
NonRel	Retinal hemorrhage noted on examination of left eye H35.62 362.81 OCT , Posterior Segment - OU - Both Eyes New retina patient referred for CME [s1] OU [e1] .	Cystoid [s2] macular edema [e2] , bilateral H35.353 362.53 OCT , Posterior Segment - OU - Both Eyes 3 .	laterality	lesion	T18	T9	2703704_note_9128
NonRel	Retinal hemorrhage noted on examination of left eye H35.62 362.81 OCT , Posterior Segment - OU - Both Eyes New retina patient referred for CME [s1] OU [e1] .	Complains of aniseikonia x ~ 9 months Tx hx : IVA OS - DATE ( today ) IVFA - DATE Suspected nonischemic CRVO with [s2] CME [e2] OS - A1C 3 weeks ago 5.8 - CBC wnl - VA in March this year DATE OS - Phakic OU with NSC / ACC - IVFA confirms leakage and peripheral nonperfusion OS - Mac OCT OS with slight and large CME that increased over the past 2 weeks - Due to peripheral location of DBH OIS is in DDx however no cell / flare or significant eye pain present - Recommend PCP eval of carotied duplex to rule - out carotid stenosis .	laterality	lesion	T18	T11	2703704_note_9128
NonRel	Retinal hemorrhage noted on examination of left eye H35.62 362.81 OCT , Posterior Segment - OU - Both Eyes New retina patient referred for CME [s1] OU [e1] .	Complains of aniseikonia x ~ 9 months Tx hx : IVA OS - DATE ( today ) IVFA - DATE Suspected nonischemic CRVO with CME OS - A1C 3 weeks ago 5.8 - CBC wnl - VA in March this year DATE OS - Phakic OU with NSC / ACC - IVFA confirms leakage and peripheral nonperfusion OS - Mac OCT OS with slight and large [s2] CME [e2] that increased over the past 2 weeks - Due to peripheral location of DBH OIS is in DDx however no cell / flare or significant eye pain present - Recommend PCP eval of carotied duplex to rule - out carotid stenosis .	laterality	lesion	T18	T12	2703704_note_9128
NonRel	Complains of aniseikonia x ~ 9 months Tx hx : IVA OS - DATE ( today ) IVFA - DATE Suspected nonischemic CRVO with CME [s1] OS [e1] - A1C 3 weeks ago 5.8 - CBC wnl - VA in March this year DATE OS - Phakic OU with NSC / ACC - IVFA confirms leakage and peripheral nonperfusion OS - Mac OCT OS with slight and large CME that increased over the past 2 weeks - Due to peripheral location of DBH OIS is in DDx however no cell / flare or significant eye pain present - Recommend PCP eval of carotied duplex to rule - out carotid stenosis .	Retinal hemorrhage noted on examination of left eye H35.62 362.81 OCT , Posterior Segment - OU - Both Eyes New retina patient referred for [s2] CME [e2] OU .	laterality	lesion	T19	T10	2703704_note_9128
NonRel	Complains of aniseikonia x ~ 9 months Tx hx : IVA OS - DATE ( today ) IVFA - DATE Suspected nonischemic CRVO with CME OS - A1C 3 weeks ago 5.8 - CBC wnl - VA in March this year DATE OS - Phakic OU with NSC / ACC - IVFA confirms leakage and peripheral nonperfusion OS - Mac OCT OS with slight and [s1] large [e1] CME that increased over the past 2 weeks - Due to peripheral location of DBH OIS is in DDx however no cell / flare or significant eye pain present - Recommend PCP eval of carotied duplex to rule - out carotid stenosis .	Retinal hemorrhage noted on examination of left eye H35.62 362.81 OCT , Posterior Segment - OU - Both Eyes New retina patient referred for [s2] CME [e2] OU .	severity	lesion	T20	T10	2703704_note_9128
NonRel	OCT , Retina - OU - Both Eyes OD trace EMM , good foveal contour , no fluid [s1] OS [e1] : stable nasal retinal thickening , no IRF or SRF Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	[s2] Cystoid macular edema [e2] of left eye H35.352 362.53 OCT , Retina - OU - Both Eyes Treatment Hx : IVA OS - 9 / 13 / 18 IVA OS - 7 / 22 / 18 IVA OS - 6 / 15 / 18 IVA OS - 5 / 11 / 18 IVFA ( 5 / 4 / 18 ) - vessel tortuosity with temporal scarring , perioheral nasal and inferior nonperfusion , no NVE , no NVD IVA OS - 4 / 17 / 18 IVT OS - 3 / 9 / 18 CE / IOL + PPV / SO removal - 2 / 18 / 2018 PPV / Total Funnel RD / SO OS - 10 / 2 / 17 1 ) Rubeosis Iridies OS - florid 4 + NVI noted at 4 / 17 / 18 appointment with ectropion uveae which was not seen previously .	laterality	lesion	T1	T4	note_8700
NonRel	OCT , Retina - OU - Both Eyes OD trace EMM , good foveal contour , no fluid [s1] OS [e1] : stable nasal retinal thickening , no IRF or SRF Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Cystoid macular edema of left eye H35.352 362.53 OCT , Retina - OU - Both Eyes Treatment Hx : IVA OS - 9 / 13 / 18 IVA OS - 7 / 22 / 18 IVA OS - 6 / 15 / 18 IVA OS - 5 / 11 / 18 IVFA ( 5 / 4 / 18 ) - vessel tortuosity with temporal scarring , perioheral nasal and inferior nonperfusion , no [s2] NVE [e2] , no NVD IVA OS - 4 / 17 / 18 IVT OS - 3 / 9 / 18 CE / IOL + PPV / SO removal - 2 / 18 / 2018 PPV / Total Funnel RD / SO OS - 10 / 2 / 17 1 ) Rubeosis Iridies OS - florid 4 + NVI noted at 4 / 17 / 18 appointment with ectropion uveae which was not seen previously .	laterality	lesion	T1	T6	note_8700
NonRel	OCT , Retina - OU - Both Eyes OD trace EMM , good foveal contour , no fluid [s1] OS [e1] : stable nasal retinal thickening , no IRF or SRF Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Cystoid macular edema of left eye H35.352 362.53 OCT , Retina - OU - Both Eyes Treatment Hx : IVA OS - 9 / 13 / 18 IVA OS - 7 / 22 / 18 IVA OS - 6 / 15 / 18 IVA OS - 5 / 11 / 18 IVFA ( 5 / 4 / 18 ) - vessel tortuosity with temporal scarring , perioheral nasal and inferior nonperfusion , no NVE , no [s2] NVD [e2] IVA OS - 4 / 17 / 18 IVT OS - 3 / 9 / 18 CE / IOL + PPV / SO removal - 2 / 18 / 2018 PPV / Total Funnel RD / SO OS - 10 / 2 / 17 1 ) Rubeosis Iridies OS - florid 4 + NVI noted at 4 / 17 / 18 appointment with ectropion uveae which was not seen previously .	laterality	lesion	T1	T7	note_8700
NonRel	OCT , Retina - OU - Both Eyes OD trace EMM , good foveal contour , no fluid [s1] OS [e1] : stable nasal retinal thickening , no IRF or SRF Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Cystoid macular edema of left eye H35.352 362.53 OCT , Retina - OU - Both Eyes Treatment Hx : IVA OS - 9 / 13 / 18 IVA OS - 7 / 22 / 18 IVA OS - 6 / 15 / 18 IVA OS - 5 / 11 / 18 IVFA ( 5 / 4 / 18 ) - vessel tortuosity with temporal scarring , perioheral nasal and inferior nonperfusion , no NVE , no NVD IVA OS - 4 / 17 / 18 IVT OS - 3 / 9 / 18 CE / IOL + PPV / SO removal - 2 / 18 / 2018 PPV / Total Funnel RD / SO OS - 10 / 2 / 17 1 ) Rubeosis Iridies OS - florid 4 + [s2] NVI [e2] noted at 4 / 17 / 18 appointment with ectropion uveae which was not seen previously .	laterality	lesion	T1	T11	note_8700
NonRel	Cystoid macular edema of [s1] left eye [e1] H35.352 362.53 OCT , Retina - OU - Both Eyes Treatment Hx : IVA OS - 9 / 13 / 18 IVA OS - 7 / 22 / 18 IVA OS - 6 / 15 / 18 IVA OS - 5 / 11 / 18 IVFA ( 5 / 4 / 18 ) - vessel tortuosity with temporal scarring , perioheral nasal and inferior nonperfusion , no NVE , no NVD IVA OS - 4 / 17 / 18 IVT OS - 3 / 9 / 18 CE / IOL + PPV / SO removal - 2 / 18 / 2018 PPV / Total Funnel RD / SO OS - 10 / 2 / 17 1 ) Rubeosis Iridies OS - florid 4 + NVI noted at 4 / 17 / 18 appointment with ectropion uveae which was not seen previously .	OCT , Retina - OU - Both Eyes OD trace EMM , good foveal contour , no fluid OS : stable nasal retinal thickening , no [s2] IRF [e2] or SRF Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T5	T2	note_8700
NonRel	Cystoid macular edema of [s1] left eye [e1] H35.352 362.53 OCT , Retina - OU - Both Eyes Treatment Hx : IVA OS - 9 / 13 / 18 IVA OS - 7 / 22 / 18 IVA OS - 6 / 15 / 18 IVA OS - 5 / 11 / 18 IVFA ( 5 / 4 / 18 ) - vessel tortuosity with temporal scarring , perioheral nasal and inferior nonperfusion , no NVE , no NVD IVA OS - 4 / 17 / 18 IVT OS - 3 / 9 / 18 CE / IOL + PPV / SO removal - 2 / 18 / 2018 PPV / Total Funnel RD / SO OS - 10 / 2 / 17 1 ) Rubeosis Iridies OS - florid 4 + NVI noted at 4 / 17 / 18 appointment with ectropion uveae which was not seen previously .	OCT , Retina - OU - Both Eyes OD trace EMM , good foveal contour , no fluid OS : stable nasal retinal thickening , no IRF or [s2] SRF [e2] Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T5	T3	note_8700
NonRel	Cystoid macular edema of left eye H35.352 362.53 OCT , Retina - OU - Both Eyes Treatment Hx : IVA OS - 9 / 13 / 18 IVA OS - 7 / 22 / 18 IVA OS - 6 / 15 / 18 IVA OS - 5 / 11 / 18 IVFA ( 5 / 4 / 18 ) - vessel tortuosity with temporal scarring , perioheral nasal and inferior nonperfusion , no NVE , no NVD IVA [s1] OS [e1] - 4 / 17 / 18 IVT OS - 3 / 9 / 18 CE / IOL + PPV / SO removal - 2 / 18 / 2018 PPV / Total Funnel RD / SO OS - 10 / 2 / 17 1 ) Rubeosis Iridies OS - florid 4 + NVI noted at 4 / 17 / 18 appointment with ectropion uveae which was not seen previously .	OCT , Retina - OU - Both Eyes OD trace EMM , good foveal contour , no fluid OS : stable nasal retinal thickening , no [s2] IRF [e2] or SRF Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T8	T2	note_8700
NonRel	Cystoid macular edema of left eye H35.352 362.53 OCT , Retina - OU - Both Eyes Treatment Hx : IVA OS - 9 / 13 / 18 IVA OS - 7 / 22 / 18 IVA OS - 6 / 15 / 18 IVA OS - 5 / 11 / 18 IVFA ( 5 / 4 / 18 ) - vessel tortuosity with temporal scarring , perioheral nasal and inferior nonperfusion , no NVE , no NVD IVA [s1] OS [e1] - 4 / 17 / 18 IVT OS - 3 / 9 / 18 CE / IOL + PPV / SO removal - 2 / 18 / 2018 PPV / Total Funnel RD / SO OS - 10 / 2 / 17 1 ) Rubeosis Iridies OS - florid 4 + NVI noted at 4 / 17 / 18 appointment with ectropion uveae which was not seen previously .	OCT , Retina - OU - Both Eyes OD trace EMM , good foveal contour , no fluid OS : stable nasal retinal thickening , no IRF or [s2] SRF [e2] Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T8	T3	note_8700
NonRel	Cystoid macular edema of left eye H35.352 362.53 OCT , Retina - OU - Both Eyes Treatment Hx : IVA OS - 9 / 13 / 18 IVA OS - 7 / 22 / 18 IVA OS - 6 / 15 / 18 IVA OS - 5 / 11 / 18 IVFA ( 5 / 4 / 18 ) - vessel tortuosity with temporal scarring , perioheral nasal and inferior nonperfusion , no NVE , no NVD IVA OS - 4 / 17 / 18 IVT [s1] OS [e1] - 3 / 9 / 18 CE / IOL + PPV / SO removal - 2 / 18 / 2018 PPV / Total Funnel RD / SO OS - 10 / 2 / 17 1 ) Rubeosis Iridies OS - florid 4 + NVI noted at 4 / 17 / 18 appointment with ectropion uveae which was not seen previously .	OCT , Retina - OU - Both Eyes OD trace EMM , good foveal contour , no fluid OS : stable nasal retinal thickening , no [s2] IRF [e2] or SRF Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T9	T2	note_8700
NonRel	Cystoid macular edema of left eye H35.352 362.53 OCT , Retina - OU - Both Eyes Treatment Hx : IVA OS - 9 / 13 / 18 IVA OS - 7 / 22 / 18 IVA OS - 6 / 15 / 18 IVA OS - 5 / 11 / 18 IVFA ( 5 / 4 / 18 ) - vessel tortuosity with temporal scarring , perioheral nasal and inferior nonperfusion , no NVE , no NVD IVA OS - 4 / 17 / 18 IVT [s1] OS [e1] - 3 / 9 / 18 CE / IOL + PPV / SO removal - 2 / 18 / 2018 PPV / Total Funnel RD / SO OS - 10 / 2 / 17 1 ) Rubeosis Iridies OS - florid 4 + NVI noted at 4 / 17 / 18 appointment with ectropion uveae which was not seen previously .	OCT , Retina - OU - Both Eyes OD trace EMM , good foveal contour , no fluid OS : stable nasal retinal thickening , no IRF or [s2] SRF [e2] Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T9	T3	note_8700
NonRel	Cystoid macular edema of left eye H35.352 362.53 OCT , Retina - OU - Both Eyes Treatment Hx : IVA OS - 9 / 13 / 18 IVA OS - 7 / 22 / 18 IVA OS - 6 / 15 / 18 IVA OS - 5 / 11 / 18 IVFA ( 5 / 4 / 18 ) - vessel tortuosity with temporal scarring , perioheral nasal and inferior nonperfusion , no NVE , no NVD IVA OS - 4 / 17 / 18 IVT OS - 3 / 9 / 18 CE / IOL + PPV / SO removal - 2 / 18 / 2018 PPV / Total Funnel RD / SO OS - 10 / 2 / 17 1 ) Rubeosis Iridies [s1] OS [e1] - florid 4 + NVI noted at 4 / 17 / 18 appointment with ectropion uveae which was not seen previously .	OCT , Retina - OU - Both Eyes OD trace EMM , good foveal contour , no fluid OS : stable nasal retinal thickening , no [s2] IRF [e2] or SRF Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T10	T2	note_8700
NonRel	Cystoid macular edema of left eye H35.352 362.53 OCT , Retina - OU - Both Eyes Treatment Hx : IVA OS - 9 / 13 / 18 IVA OS - 7 / 22 / 18 IVA OS - 6 / 15 / 18 IVA OS - 5 / 11 / 18 IVFA ( 5 / 4 / 18 ) - vessel tortuosity with temporal scarring , perioheral nasal and inferior nonperfusion , no NVE , no NVD IVA OS - 4 / 17 / 18 IVT OS - 3 / 9 / 18 CE / IOL + PPV / SO removal - 2 / 18 / 2018 PPV / Total Funnel RD / SO OS - 10 / 2 / 17 1 ) Rubeosis Iridies [s1] OS [e1] - florid 4 + NVI noted at 4 / 17 / 18 appointment with ectropion uveae which was not seen previously .	OCT , Retina - OU - Both Eyes OD trace EMM , good foveal contour , no fluid OS : stable nasal retinal thickening , no IRF or [s2] SRF [e2] Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T10	T3	note_8700
NonRel	OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : Drusen , no SRF OS : Geo atrophy , Drusen .	No [s2] SRF [e2] Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T3	T1	508972_note_1141
NonRel	Suspicious area ITQ [s1] OD [e1] on exam and OCT of ? early NVE - IVFA obtained today - Discussed need for strict glucose control - Discussed systemic and ocular effects of diabetes mellitus 2 .	NIDDM , Severe - Diagnosed 20 years ago but reports is Type 1 - VA 20 / 25 and 20 / 20 - OCT with scattered IRF and [s2] exudates [e2] .	laterality	lesion	T7	T5	note_2911
NonRel	Suspicious area ITQ OD on exam and OCT of ? [s1] early [e1] NVE - IVFA obtained today - Discussed need for strict glucose control - Discussed systemic and ocular effects of diabetes mellitus 2 .	NIDDM , Severe - Diagnosed 20 years ago but reports is Type 1 - VA 20 / 25 and 20 / 20 - OCT with scattered IRF and [s2] exudates [e2] .	severity	lesion	T8	T5	note_2911
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 362.07 362.05 3 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 No glaucoma Much npdr Much csme os Likely cause of field noise Not glaucoma Retina for possible prp 1 month On brimondine Stop for now If iop above 21 start in retina clinic No resident or fellow participated in the care of this patient .	laterality	lesion	T8	T4	note_3789
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 362.07 362.05 3 .	Moderate nonproliferative diabetic retinopathy of right eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3391 250.50 362.05 No glaucoma Much npdr Much csme os Likely cause of field noise Not glaucoma Retina for possible prp 1 month On brimondine Stop for now If iop above 21 start in retina clinic No resident or fellow participated in the care of this patient .	laterality	lesion	T8	T5	note_3789
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 362.07 362.05 3 .	Moderate nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 No glaucoma Much [s2] npdr [e2] Much csme os Likely cause of field noise Not glaucoma Retina for possible prp 1 month On brimondine Stop for now If iop above 21 start in retina clinic No resident or fellow participated in the care of this patient .	laterality	lesion	T8	T6	note_3789
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 362.07 362.05 3 .	Moderate nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 No glaucoma Much npdr Much [s2] csme [e2] os Likely cause of field noise Not glaucoma Retina for possible prp 1 month On brimondine Stop for now If iop above 21 start in retina clinic No resident or fellow participated in the care of this patient .	laterality	lesion	T8	T7	note_3789
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 No glaucoma Much npdr Much csme os Likely cause of field noise Not glaucoma Retina for possible prp 1 month On brimondine Stop for now If iop above 21 start in retina clinic No resident or fellow participated in the care of this patient .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 362.07 362.05 3 .	laterality	lesion	T9	T2	note_3789
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 No glaucoma Much npdr Much csme os Likely cause of field noise Not glaucoma Retina for possible prp 1 month On brimondine Stop for now If iop above 21 start in retina clinic No resident or fellow participated in the care of this patient .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 362.07 362.05 3 .	laterality	lesion	T9	T3	note_3789
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 362.07 362.05 3 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 No glaucoma Much npdr Much csme os Likely cause of field noise Not glaucoma Retina for possible prp 1 month On brimondine Stop for now If iop above 21 start in retina clinic No resident or fellow participated in the care of this patient .	severity	lesion	T10	T4	note_3789
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 362.07 362.05 3 .	Moderate nonproliferative diabetic retinopathy of right eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3391 250.50 362.05 No glaucoma Much npdr Much csme os Likely cause of field noise Not glaucoma Retina for possible prp 1 month On brimondine Stop for now If iop above 21 start in retina clinic No resident or fellow participated in the care of this patient .	severity	lesion	T10	T5	note_3789
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 362.07 362.05 3 .	Moderate nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 No glaucoma Much [s2] npdr [e2] Much csme os Likely cause of field noise Not glaucoma Retina for possible prp 1 month On brimondine Stop for now If iop above 21 start in retina clinic No resident or fellow participated in the care of this patient .	severity	lesion	T10	T6	note_3789
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 362.07 362.05 3 .	Moderate nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 No glaucoma Much npdr Much [s2] csme [e2] os Likely cause of field noise Not glaucoma Retina for possible prp 1 month On brimondine Stop for now If iop above 21 start in retina clinic No resident or fellow participated in the care of this patient .	severity	lesion	T10	T7	note_3789
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 No glaucoma Much npdr Much csme os Likely cause of field noise Not glaucoma Retina for possible prp 1 month On brimondine Stop for now If iop above 21 start in retina clinic No resident or fellow participated in the care of this patient .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 362.07 362.05 3 .	severity	lesion	T11	T2	note_3789
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 No glaucoma Much npdr Much csme os Likely cause of field noise Not glaucoma Retina for possible prp 1 month On brimondine Stop for now If iop above 21 start in retina clinic No resident or fellow participated in the care of this patient .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 362.07 362.05 3 .	severity	lesion	T11	T3	note_3789
NonRel	Moderate nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 No glaucoma [s1] Much [e1] npdr Much csme os Likely cause of field noise Not glaucoma Retina for possible prp 1 month On brimondine Stop for now If iop above 21 start in retina clinic No resident or fellow participated in the care of this patient .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 362.07 362.05 3 .	severity	lesion	T14	T2	note_3789
NonRel	Moderate nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 No glaucoma [s1] Much [e1] npdr Much csme os Likely cause of field noise Not glaucoma Retina for possible prp 1 month On brimondine Stop for now If iop above 21 start in retina clinic No resident or fellow participated in the care of this patient .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 362.07 362.05 3 .	severity	lesion	T14	T3	note_3789
NonRel	Moderate nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 No glaucoma Much npdr [s1] Much [e1] csme os Likely cause of field noise Not glaucoma Retina for possible prp 1 month On brimondine Stop for now If iop above 21 start in retina clinic No resident or fellow participated in the care of this patient .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 362.07 362.05 3 .	severity	lesion	T15	T2	note_3789
NonRel	Moderate nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 No glaucoma Much npdr [s1] Much [e1] csme os Likely cause of field noise Not glaucoma Retina for possible prp 1 month On brimondine Stop for now If iop above 21 start in retina clinic No resident or fellow participated in the care of this patient .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 362.07 362.05 3 .	severity	lesion	T15	T3	note_3789
NonRel	Moderate nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 No glaucoma Much npdr Much csme [s1] os [e1] Likely cause of field noise Not glaucoma Retina for possible prp 1 month On brimondine Stop for now If iop above 21 start in retina clinic No resident or fellow participated in the care of this patient .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 362.07 362.05 3 .	laterality	lesion	T16	T2	note_3789
NonRel	Moderate nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 No glaucoma Much npdr Much csme [s1] os [e1] Likely cause of field noise Not glaucoma Retina for possible prp 1 month On brimondine Stop for now If iop above 21 start in retina clinic No resident or fellow participated in the care of this patient .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 362.07 362.05 3 .	laterality	lesion	T16	T3	note_3789
NonRel	Still with no CNVM FAF ( today ) : PM HyperAF OD , PPA , mild peripheral degenerative changes but without interval changes Color Fundus Photos ( today ) : macular drusen with some pigment changes , no heme , mild peripheral degenerative changes without interval changes 1 ) ARMD ( nonexudative [s1] OU [e1] ) - early signs with drusen , large without IRF / SRF and pigment changes .	Nuclear cataract of both eyes - Both Eyes H25.13 366.16 Attending Note : OCT ( today ) : drusen without [s2] IRF [e2] / SRF , mild interval change at BM from last visit .	laterality	lesion	T3	T1	note_2449
NonRel	Still with no CNVM FAF ( today ) : PM HyperAF OD , PPA , mild peripheral degenerative changes but without interval changes Color Fundus Photos ( today ) : macular drusen with some pigment changes , no heme , mild peripheral degenerative changes without interval changes 1 ) ARMD ( nonexudative [s1] OU [e1] ) - early signs with drusen , large without IRF / SRF and pigment changes .	Nuclear cataract of both eyes - Both Eyes H25.13 366.16 Attending Note : OCT ( today ) : drusen without IRF / [s2] SRF [e2] , mild interval change at BM from last visit .	laterality	lesion	T3	T2	note_2449
NonRel	[s1] Right eye [e1] affected by proliferative diabetic retinopathy with traction retinal detachment involving macula , associated with type 2 diabetes mellitus E11.3521 250.50 362.02 361.81 4 .	Left eye affected by [s2] proliferative diabetic retinopathy [e2] with traction retinal detachment not involving macula , associated with type 2 diabetes mellitus E11.3532 250.50 362.02 361.81 Patient reports worsening vision OU since last visit .	laterality	lesion	T1	T4	note_8840
NonRel	[s1] Left eye [e1] affected by proliferative diabetic retinopathy with traction retinal detachment not involving macula , associated with type 2 diabetes mellitus E11.3532 250.50 362.02 361.81 Patient reports worsening vision OU since last visit .	Right eye affected by [s2] proliferative diabetic retinopathy [e2] with traction retinal detachment involving macula , associated with type 2 diabetes mellitus E11.3521 250.50 362.02 361.81 4 .	laterality	lesion	T3	T2	note_8840
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] without macular edema associated with type 2 diabetes mellitus - Left Eye E11.3592 250.50 Pan Retinal Photocoagulation - OS - Left Eye ( w / 79 modifier ) 362.02 Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with cystic DME in fovea .	Observe in the setting of good vision , recent improved BS and mild [s2] edema [e2] .	laterality	lesion	T2	T16	note_8605
NonRel	Proliferative diabetic retinopathy of left eye without macular edema associated with type 2 diabetes mellitus - Left Eye E11.3592 250.50 Pan Retinal Photocoagulation - OS - Left Eye ( w / 79 modifier ) 362.02 Here today for IVFA for better characterization of possible NVD [s1] OS [e1] , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with cystic DME in fovea .	Observe in the setting of good vision , recent improved BS and mild [s2] edema [e2] .	laterality	lesion	T5	T16	note_8605
NonRel	Proliferative diabetic retinopathy of left eye without macular edema associated with type 2 diabetes mellitus - Left Eye E11.3592 250.50 Pan Retinal Photocoagulation - OS - Left Eye ( w / 79 modifier ) 362.02 Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : [s1] mild [e1] IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with cystic DME in fovea .	Observe in the setting of good vision , recent improved BS and mild [s2] edema [e2] .	severity	lesion	T6	T16	note_8605
NonRel	Proliferative diabetic retinopathy of left eye without macular edema associated with type 2 diabetes mellitus - Left Eye E11.3592 250.50 Pan Retinal Photocoagulation - OS - Left Eye ( w / 79 modifier ) 362.02 Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF [s1] OU [e1] 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with cystic DME in fovea .	Observe in the setting of good vision , recent improved BS and mild [s2] edema [e2] .	laterality	lesion	T8	T16	note_8605
NonRel	Proliferative diabetic retinopathy of left eye without macular edema associated with type 2 diabetes mellitus - Left Eye E11.3592 250.50 Pan Retinal Photocoagulation - OS - Left Eye ( w / 79 modifier ) 362.02 Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] [s1] OD [e1] - Mild NPDR with cystic DME in fovea .	Observe in the setting of good vision , recent improved BS and mild [s2] edema [e2] .	laterality	lesion	T9	T16	note_8605
NonRel	Proliferative diabetic retinopathy of left eye without macular edema associated with type 2 diabetes mellitus - Left Eye E11.3592 250.50 Pan Retinal Photocoagulation - OS - Left Eye ( w / 79 modifier ) 362.02 Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - [s1] Mild [e1] NPDR with cystic DME in fovea .	Observe in the setting of good vision , recent improved BS and mild [s2] edema [e2] .	severity	lesion	T10	T16	note_8605
NonRel	Observe in the setting of good vision , recent improved BS and [s1] mild [e1] edema .	[s2] Proliferative diabetic retinopathy [e2] of left eye without macular edema associated with type 2 diabetes mellitus - Left Eye E11.3592 250.50 Pan Retinal Photocoagulation - OS - Left Eye ( w / 79 modifier ) 362.02 Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with cystic DME in fovea .	severity	lesion	T13	T1	note_8605
NonRel	Observe in the setting of good vision , recent improved BS and [s1] mild [e1] edema .	Proliferative diabetic retinopathy of left eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus - Left Eye E11.3592 250.50 Pan Retinal Photocoagulation - OS - Left Eye ( w / 79 modifier ) 362.02 Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with cystic DME in fovea .	severity	lesion	T13	T3	note_8605
NonRel	Observe in the setting of good vision , recent improved BS and [s1] mild [e1] edema .	Proliferative diabetic retinopathy of left eye without macular edema associated with type 2 diabetes mellitus - Left Eye E11.3592 250.50 Pan Retinal Photocoagulation - OS - Left Eye ( w / 79 modifier ) 362.02 Here today for IVFA for better characterization of possible [s2] NVD [e2] OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with cystic DME in fovea .	severity	lesion	T13	T4	note_8605
NonRel	Observe in the setting of good vision , recent improved BS and [s1] mild [e1] edema .	Proliferative diabetic retinopathy of left eye without macular edema associated with type 2 diabetes mellitus - Left Eye E11.3592 250.50 Pan Retinal Photocoagulation - OS - Left Eye ( w / 79 modifier ) 362.02 Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild [s2] IRF [e2] OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with cystic DME in fovea .	severity	lesion	T13	T7	note_8605
NonRel	Observe in the setting of good vision , recent improved BS and [s1] mild [e1] edema .	Proliferative diabetic retinopathy of left eye without macular edema associated with type 2 diabetes mellitus - Left Eye E11.3592 250.50 Pan Retinal Photocoagulation - OS - Left Eye ( w / 79 modifier ) 362.02 Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild [s2] NPDR [e2] with cystic DME in fovea .	severity	lesion	T13	T11	note_8605
NonRel	Observe in the setting of good vision , recent improved BS and [s1] mild [e1] edema .	Proliferative diabetic retinopathy of left eye without macular edema associated with type 2 diabetes mellitus - Left Eye E11.3592 250.50 Pan Retinal Photocoagulation - OS - Left Eye ( w / 79 modifier ) 362.02 Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with cystic [s2] DME [e2] in fovea .	severity	lesion	T13	T12	note_8605
NonRel	Proliferative diabetic retinopathy with macular edema associated with type 2 diabetes mellitus E11.351 250.50 Color Fundus Photography - [s1] OU [e1] - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes OD TRD OS PDR OCT , Retina - OU - Both Eyes OD vitreous debris , retina flat without edema OS normal foveal contour , hard exudates .	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active [s2] NVE [e2] OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	laterality	lesion	T8	T3	2447977_note_6711
NonRel	Proliferative diabetic retinopathy with macular edema associated with type 2 diabetes mellitus E11.351 250.50 Color Fundus Photography - [s1] OU [e1] - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes OD TRD OS PDR OCT , Retina - OU - Both Eyes OD vitreous debris , retina flat without edema OS normal foveal contour , hard exudates .	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and [s2] NVE [e2] , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	laterality	lesion	T8	T4	2447977_note_6711
NonRel	Proliferative diabetic retinopathy with macular edema associated with type 2 diabetes mellitus E11.351 250.50 Color Fundus Photography - [s1] OU [e1] - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes OD TRD OS PDR OCT , Retina - OU - Both Eyes OD vitreous debris , retina flat without edema OS normal foveal contour , hard exudates .	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex [s2] TRD [e2] OD and NVE , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	laterality	lesion	T8	T5	2447977_note_6711
NonRel	Proliferative diabetic retinopathy with macular edema associated with type 2 diabetes mellitus E11.351 250.50 Color Fundus Photography - [s1] OU [e1] - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes OD TRD OS PDR OCT , Retina - OU - Both Eyes OD vitreous debris , retina flat without edema OS normal foveal contour , hard exudates .	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached OS 1 ) DM - IDDM - Active [s2] PDR [e2] OU OD - VH + extensive TRD encircling macula .	laterality	lesion	T8	T6	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE [s1] OS [e1] Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	[s2] Proliferative diabetic retinopathy [e2] with macular edema associated with type 2 diabetes mellitus E11.351 250.50 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes OD TRD OS PDR OCT , Retina - OU - Both Eyes OD vitreous debris , retina flat without edema OS normal foveal contour , hard exudates .	laterality	lesion	T9	T1	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE [s1] OS [e1] Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	Proliferative diabetic retinopathy with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.351 250.50 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes OD TRD OS PDR OCT , Retina - OU - Both Eyes OD vitreous debris , retina flat without edema OS normal foveal contour , hard exudates .	laterality	lesion	T9	T2	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD [s1] OD [e1] and NVE , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	[s2] Proliferative diabetic retinopathy [e2] with macular edema associated with type 2 diabetes mellitus E11.351 250.50 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes OD TRD OS PDR OCT , Retina - OU - Both Eyes OD vitreous debris , retina flat without edema OS normal foveal contour , hard exudates .	laterality	lesion	T10	T1	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD [s1] OD [e1] and NVE , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	Proliferative diabetic retinopathy with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.351 250.50 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes OD TRD OS PDR OCT , Retina - OU - Both Eyes OD vitreous debris , retina flat without edema OS normal foveal contour , hard exudates .	laterality	lesion	T10	T2	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached [s1] OS [e1] 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	[s2] Proliferative diabetic retinopathy [e2] with macular edema associated with type 2 diabetes mellitus E11.351 250.50 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes OD TRD OS PDR OCT , Retina - OU - Both Eyes OD vitreous debris , retina flat without edema OS normal foveal contour , hard exudates .	laterality	lesion	T11	T1	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached [s1] OS [e1] 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	Proliferative diabetic retinopathy with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.351 250.50 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes OD TRD OS PDR OCT , Retina - OU - Both Eyes OD vitreous debris , retina flat without edema OS normal foveal contour , hard exudates .	laterality	lesion	T11	T2	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached OS 1 ) DM - IDDM - Active PDR [s1] OU [e1] OD - VH + extensive TRD encircling macula .	[s2] Proliferative diabetic retinopathy [e2] with macular edema associated with type 2 diabetes mellitus E11.351 250.50 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes OD TRD OS PDR OCT , Retina - OU - Both Eyes OD vitreous debris , retina flat without edema OS normal foveal contour , hard exudates .	laterality	lesion	T12	T1	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached OS 1 ) DM - IDDM - Active PDR [s1] OU [e1] OD - VH + extensive TRD encircling macula .	Proliferative diabetic retinopathy with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.351 250.50 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes OD TRD OS PDR OCT , Retina - OU - Both Eyes OD vitreous debris , retina flat without edema OS normal foveal contour , hard exudates .	laterality	lesion	T12	T2	2447977_note_6711
NonRel	Subjective : History of Present Illness : Anthony Demott is a 47 y.o. male who is here today for PDR with ERM [s1] OU [e1] , Cataract OU .	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem [s2] PDR [e2] with ERM OU , Cataract OU .	laterality	lesion	T4	T5	note_224
NonRel	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem PDR with ERM [s1] OU [e1] , Cataract OU .	Subjective : History of Present Illness : Anthony Demott is a 47 y.o. male who is here today for [s2] PDR [e2] with ERM OU , Cataract OU .	laterality	lesion	T6	T3	note_224
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 3 .	laterality	lesion	T11	T3	1699146_note_3999
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 2 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 3 .	laterality	lesion	T11	T4	1699146_note_3999
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 3 .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 2 .	laterality	lesion	T12	T1	1699146_note_3999
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 3 .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 2 .	laterality	lesion	T12	T2	1699146_note_3999
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 3 .	Vitreous hemorrhage , right eye H43.11 379.23 Attending Note : Treatment Hx : IVA OD - DATE ( today ) PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) 1 ) DM [ NIDDM , Hx of PDR OS ] OD - PDR with active [s2] VH [e2] , without view to the posterior segment .	laterality	lesion	T12	T6	1699146_note_3999
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 3 .	[s2] Vitreous hemorrhage [e2] , right eye H43.11 379.23 Attending Note : Treatment Hx : IVA OD - DATE ( today ) PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) 1 ) DM [ NIDDM , Hx of PDR OS ] OD - PDR with active VH , without view to the posterior segment .	laterality	lesion	T12	T9	1699146_note_3999
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 3 .	Vitreous hemorrhage , right eye H43.11 379.23 Attending Note : Treatment Hx : IVA OD - DATE ( today ) PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) 1 ) DM [ NIDDM , Hx of PDR OS ] OD - [s2] PDR [e2] with active VH , without view to the posterior segment .	laterality	lesion	T12	T17	1699146_note_3999
NonRel	Vitreous hemorrhage , [s1] right eye [e1] H43.11 379.23 Attending Note : Treatment Hx : IVA OD - DATE ( today ) PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) 1 ) DM [ NIDDM , Hx of PDR OS ] OD - PDR with active VH , without view to the posterior segment .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 3 .	laterality	lesion	T13	T3	1699146_note_3999
NonRel	Vitreous hemorrhage , [s1] right eye [e1] H43.11 379.23 Attending Note : Treatment Hx : IVA OD - DATE ( today ) PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) 1 ) DM [ NIDDM , Hx of PDR OS ] OD - PDR with active VH , without view to the posterior segment .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 3 .	laterality	lesion	T13	T4	1699146_note_3999
NonRel	Vitreous hemorrhage , [s1] right eye [e1] H43.11 379.23 Attending Note : Treatment Hx : IVA OD - DATE ( today ) PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) 1 ) DM [ NIDDM , Hx of PDR OS ] OD - PDR with active VH , without view to the posterior segment .	B scan shows hyaloidal lift with [s2] VH [e2] .	laterality	lesion	T13	T7	1699146_note_3999
NonRel	Vitreous hemorrhage , right eye H43.11 379.23 Attending Note : Treatment Hx : IVA OD - DATE ( today ) PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) 1 ) DM [ NIDDM , Hx of PDR OS ] [s1] OD [e1] - PDR with active VH , without view to the posterior segment .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 3 .	laterality	lesion	T14	T3	1699146_note_3999
NonRel	Vitreous hemorrhage , right eye H43.11 379.23 Attending Note : Treatment Hx : IVA OD - DATE ( today ) PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) 1 ) DM [ NIDDM , Hx of PDR OS ] [s1] OD [e1] - PDR with active VH , without view to the posterior segment .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 3 .	laterality	lesion	T14	T4	1699146_note_3999
NonRel	Vitreous hemorrhage , right eye H43.11 379.23 Attending Note : Treatment Hx : IVA OD - DATE ( today ) PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) 1 ) DM [ NIDDM , Hx of PDR OS ] [s1] OD [e1] - PDR with active VH , without view to the posterior segment .	B scan shows hyaloidal lift with [s2] VH [e2] .	laterality	lesion	T14	T7	1699146_note_3999
NonRel	Vitreous hemorrhage , right eye H43.11 379.23 Attending Note : Treatment Hx : IVA OD - DATE ( today ) PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) 1 ) DM [ NIDDM , Hx of PDR OS ] OD - PDR with [s1] active [e1] VH , without view to the posterior segment .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 3 .	severity	lesion	T15	T3	1699146_note_3999
NonRel	Vitreous hemorrhage , right eye H43.11 379.23 Attending Note : Treatment Hx : IVA OD - DATE ( today ) PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) 1 ) DM [ NIDDM , Hx of PDR OS ] OD - PDR with [s1] active [e1] VH , without view to the posterior segment .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 3 .	severity	lesion	T15	T4	1699146_note_3999
NonRel	Vitreous hemorrhage , right eye H43.11 379.23 Attending Note : Treatment Hx : IVA OD - DATE ( today ) PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) 1 ) DM [ NIDDM , Hx of PDR OS ] OD - PDR with [s1] active [e1] VH , without view to the posterior segment .	B scan shows hyaloidal lift with [s2] VH [e2] .	severity	lesion	T15	T7	1699146_note_3999
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 1 diabetes mellitus E10.3511 250.51 Focal Laser - OD - Right Eye 362.07 362.02 H / o PDR with DME OU s / p PRP / focal laser and multiple anti - VEGF OU in the past Treatment Hx : Focal laser OD IVA OD - 10 / 17 / 17 ( today ) IVFA ( 6 / 16 / 17 ) : No obvious NVD or NVE OD accounting for VH , quiescent PDR OS Previous PRP OU 1 ) DM - Hx of PDR OU OD - VH now significantly settled inferiorly .	Chronic [s2] CSME [e2] , patient A1C good .	laterality	lesion	T2	T18	note_4489
NonRel	Proliferative diabetic retinopathy of right eye with macular edema associated with type 1 diabetes mellitus E10.3511 250.51 Focal Laser - [s1] OD [e1] - Right Eye 362.07 362.02 H / o PDR with DME OU s / p PRP / focal laser and multiple anti - VEGF OU in the past Treatment Hx : Focal laser OD IVA OD - 10 / 17 / 17 ( today ) IVFA ( 6 / 16 / 17 ) : No obvious NVD or NVE OD accounting for VH , quiescent PDR OS Previous PRP OU 1 ) DM - Hx of PDR OU OD - VH now significantly settled inferiorly .	Chronic [s2] CSME [e2] , patient A1C good .	laterality	lesion	T4	T18	note_4489
NonRel	Proliferative diabetic retinopathy of right eye with macular edema associated with type 1 diabetes mellitus E10.3511 250.51 Focal Laser - OD - Right Eye 362.07 362.02 H / o PDR with DME [s1] OU [e1] s / p PRP / focal laser and multiple anti - VEGF OU in the past Treatment Hx : Focal laser OD IVA OD - 10 / 17 / 17 ( today ) IVFA ( 6 / 16 / 17 ) : No obvious NVD or NVE OD accounting for VH , quiescent PDR OS Previous PRP OU 1 ) DM - Hx of PDR OU OD - VH now significantly settled inferiorly .	Chronic [s2] CSME [e2] , patient A1C good .	laterality	lesion	T7	T18	note_4489
NonRel	Proliferative diabetic retinopathy of right eye with macular edema associated with type 1 diabetes mellitus E10.3511 250.51 Focal Laser - OD - Right Eye 362.07 362.02 H / o PDR with DME OU s / p PRP / focal laser and multiple anti - VEGF OU in the past Treatment Hx : Focal laser OD IVA OD - 10 / 17 / 17 ( today ) IVFA ( 6 / 16 / 17 ) : No obvious NVD or NVE [s1] OD [e1] accounting for VH , quiescent PDR OS Previous PRP OU 1 ) DM - Hx of PDR OU OD - VH now significantly settled inferiorly .	Chronic [s2] CSME [e2] , patient A1C good .	laterality	lesion	T11	T18	note_4489
NonRel	Proliferative diabetic retinopathy of right eye with macular edema associated with type 1 diabetes mellitus E10.3511 250.51 Focal Laser - OD - Right Eye 362.07 362.02 H / o PDR with DME OU s / p PRP / focal laser and multiple anti - VEGF OU in the past Treatment Hx : Focal laser OD IVA OD - 10 / 17 / 17 ( today ) IVFA ( 6 / 16 / 17 ) : No obvious NVD or NVE OD accounting for VH , quiescent PDR OS Previous PRP OU 1 ) DM - Hx of PDR [s1] OU [e1] OD - VH now significantly settled inferiorly .	Chronic [s2] CSME [e2] , patient A1C good .	laterality	lesion	T15	T18	note_4489
NonRel	Proliferative diabetic retinopathy of right eye with macular edema associated with type 1 diabetes mellitus E10.3511 250.51 Focal Laser - OD - Right Eye 362.07 362.02 H / o PDR with DME OU s / p PRP / focal laser and multiple anti - VEGF OU in the past Treatment Hx : Focal laser OD IVA OD - 10 / 17 / 17 ( today ) IVFA ( 6 / 16 / 17 ) : No obvious NVD or NVE OD accounting for VH , quiescent PDR OS Previous PRP OU 1 ) DM - Hx of PDR OU [s1] OD [e1] - VH now significantly settled inferiorly .	Chronic [s2] CSME [e2] , patient A1C good .	laterality	lesion	T16	T18	note_4489
NonRel	Proliferative diabetic retinopathy of right eye with macular edema associated with type 1 diabetes mellitus E10.3511 250.51 Focal Laser - OD - Right Eye 362.07 362.02 H / o PDR with DME OU s / p PRP / focal laser and multiple anti - VEGF OU in the past Treatment Hx : Focal laser OD IVA OD - 10 / 17 / 17 ( today ) IVFA ( 6 / 16 / 17 ) : No obvious NVD or NVE OD accounting for VH , quiescent PDR OS Previous PRP OU 1 ) DM - Hx of PDR OU OD - VH now [s1] significantly [e1] settled inferiorly .	Chronic [s2] CSME [e2] , patient A1C good .	severity	lesion	T23	T18	note_4489
NonRel	Pt CF with chronic CME and loss if IS / [s1] OS [e1] junction and NVD .	Refer to Dr. Khurshid for FA and probable targets retinal photocoagulation to resolved [s2] NVD [e2] .	laterality	lesion	T1	T3	note_5935
NonRel	[s1] Proliferative diabetic retinopathy [e1] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3513 250.50 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.07 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye 362.02 OCT , Posterior Segment - OU - Both Eyes 2 .	[s2] Central retinal vein [e2] occlusion with macular edema of right eye H34.8110 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes 3 .	lesion	eye_part	T1	T3	1156111_note_2376
NonRel	Proliferative diabetic retinopathy of both eyes with [s1] macular edema [e1] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3513 250.50 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.07 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye 362.02 OCT , Posterior Segment - OU - Both Eyes 2 .	[s2] Central retinal vein [e2] occlusion with macular edema of right eye H34.8110 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes 3 .	lesion	eye_part	T2	T3	1156111_note_2376
NonRel	Central retinal vein occlusion with [s1] macular edema [e1] of right eye H34.8110 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes 3 .	[s2] Central retinal vein [e2] occlusion with macular edema of left eye H34.8120 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes Treatment History IVL OU - DATE ( today ) IVL OU - DATE IVL OU - DATE switched to IVL for refractory CME IVA OU - DATE IVA OU - DATE IVA OU - DATE Missed appointments IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVFA - DATE - diffuse vascular leakage , mas , NVE nasally OS Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( DATE ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with Macular Edema OU Lack of regular treatments due to patient visit ( 3 month gap ) .	lesion	eye_part	T5	T6	1156111_note_2376
NonRel	Central retinal vein occlusion with [s1] macular edema [e1] of left eye H34.8120 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes Treatment History IVL OU - DATE ( today ) IVL OU - DATE IVL OU - DATE switched to IVL for refractory CME IVA OU - DATE IVA OU - DATE IVA OU - DATE Missed appointments IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVFA - DATE - diffuse vascular leakage , mas , NVE nasally OS Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( DATE ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with Macular Edema OU Lack of regular treatments due to patient visit ( 3 month gap ) .	[s2] Central retinal vein [e2] occlusion with macular edema of right eye H34.8110 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes 3 .	lesion	eye_part	T8	T3	1156111_note_2376
NonRel	Central retinal vein occlusion with macular edema of left eye H34.8120 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes Treatment History IVL OU - DATE ( today ) IVL OU - DATE IVL OU - DATE switched to IVL for refractory CME IVA OU - DATE IVA OU - DATE IVA OU - DATE Missed appointments IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVFA - DATE - diffuse vascular leakage , mas , [s1] NVE [e1] nasally OS Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( DATE ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with Macular Edema OU Lack of regular treatments due to patient visit ( 3 month gap ) .	[s2] Central retinal vein [e2] occlusion with macular edema of right eye H34.8110 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes 3 .	lesion	eye_part	T9	T3	1156111_note_2376
NonRel	Central retinal vein occlusion with macular edema of left eye H34.8120 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes Treatment History IVL OU - DATE ( today ) IVL OU - DATE IVL OU - DATE switched to IVL for refractory CME IVA OU - DATE IVA OU - DATE IVA OU - DATE Missed appointments IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVFA - DATE - diffuse vascular leakage , mas , NVE nasally OS Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( DATE ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with [s1] Macular Edema [e1] OU Lack of regular treatments due to patient visit ( 3 month gap ) .	[s2] Central retinal vein [e2] occlusion with macular edema of right eye H34.8110 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes 3 .	lesion	eye_part	T10	T3	1156111_note_2376
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3513 250.50 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.07 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye 362.02 OCT , Posterior Segment - OU - Both Eyes 2 .	Central retinal vein occlusion with [s2] macular edema [e2] of right eye H34.8110 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes 3 .	laterality	lesion	T4	T5	1156111_note_2376
NonRel	Central retinal vein occlusion with macular edema of [s1] right eye [e1] H34.8110 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes 3 .	[s2] Proliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3513 250.50 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.07 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye 362.02 OCT , Posterior Segment - OU - Both Eyes 2 .	laterality	lesion	T7	T1	1156111_note_2376
NonRel	Central retinal vein occlusion with macular edema of [s1] right eye [e1] H34.8110 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes 3 .	Proliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3513 250.50 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.07 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye 362.02 OCT , Posterior Segment - OU - Both Eyes 2 .	laterality	lesion	T7	T2	1156111_note_2376
NonRel	Central retinal vein occlusion with macular edema of [s1] right eye [e1] H34.8110 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes 3 .	Central retinal vein occlusion with [s2] macular edema [e2] of left eye H34.8120 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes Treatment History IVL OU - DATE ( today ) IVL OU - DATE IVL OU - DATE switched to IVL for refractory CME IVA OU - DATE IVA OU - DATE IVA OU - DATE Missed appointments IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVFA - DATE - diffuse vascular leakage , mas , NVE nasally OS Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( DATE ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with Macular Edema OU Lack of regular treatments due to patient visit ( 3 month gap ) .	laterality	lesion	T7	T8	1156111_note_2376
NonRel	Central retinal vein occlusion with macular edema of [s1] right eye [e1] H34.8110 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes 3 .	Central retinal vein occlusion with macular edema of left eye H34.8120 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes Treatment History IVL OU - DATE ( today ) IVL OU - DATE IVL OU - DATE switched to IVL for refractory CME IVA OU - DATE IVA OU - DATE IVA OU - DATE Missed appointments IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVFA - DATE - diffuse vascular leakage , mas , [s2] NVE [e2] nasally OS Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( DATE ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with Macular Edema OU Lack of regular treatments due to patient visit ( 3 month gap ) .	laterality	lesion	T7	T9	1156111_note_2376
NonRel	Central retinal vein occlusion with macular edema of [s1] right eye [e1] H34.8110 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes 3 .	Central retinal vein occlusion with macular edema of left eye H34.8120 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes Treatment History IVL OU - DATE ( today ) IVL OU - DATE IVL OU - DATE switched to IVL for refractory CME IVA OU - DATE IVA OU - DATE IVA OU - DATE Missed appointments IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVFA - DATE - diffuse vascular leakage , mas , NVE nasally OS Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( DATE ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with [s2] Macular Edema [e2] OU Lack of regular treatments due to patient visit ( 3 month gap ) .	laterality	lesion	T7	T10	1156111_note_2376
NonRel	Central retinal vein occlusion with macular edema of [s1] right eye [e1] H34.8110 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes 3 .	Central retinal vein occlusion with macular edema of left eye H34.8120 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes Treatment History IVL OU - DATE ( today ) IVL OU - DATE IVL OU - DATE switched to IVL for refractory CME IVA OU - DATE IVA OU - DATE IVA OU - DATE Missed appointments IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVFA - DATE - diffuse vascular leakage , [s2] mas [e2] , NVE nasally OS Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( DATE ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with Macular Edema OU Lack of regular treatments due to patient visit ( 3 month gap ) .	laterality	lesion	T7	T21	1156111_note_2376
NonRel	Central retinal vein occlusion with macular edema of [s1] left eye [e1] H34.8120 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes Treatment History IVL OU - DATE ( today ) IVL OU - DATE IVL OU - DATE switched to IVL for refractory CME IVA OU - DATE IVA OU - DATE IVA OU - DATE Missed appointments IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVFA - DATE - diffuse vascular leakage , mas , NVE nasally OS Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( DATE ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with Macular Edema OU Lack of regular treatments due to patient visit ( 3 month gap ) .	Central retinal vein occlusion with [s2] macular edema [e2] of right eye H34.8110 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes 3 .	laterality	lesion	T14	T5	1156111_note_2376
NonRel	Central retinal vein occlusion with macular edema of [s1] left eye [e1] H34.8120 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes Treatment History IVL OU - DATE ( today ) IVL OU - DATE IVL OU - DATE switched to IVL for refractory CME IVA OU - DATE IVA OU - DATE IVA OU - DATE Missed appointments IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVFA - DATE - diffuse vascular leakage , mas , NVE nasally OS Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( DATE ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with Macular Edema OU Lack of regular treatments due to patient visit ( 3 month gap ) .	Persistent [s2] ME [e2] OU .	laterality	lesion	T14	T22	1156111_note_2376
NonRel	Central retinal vein occlusion with macular edema of left eye H34.8120 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes Treatment History IVL OU - DATE ( today ) IVL OU - DATE IVL OU - DATE switched to IVL for refractory CME IVA OU - DATE IVA OU - DATE IVA OU - DATE Missed appointments IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVFA - DATE - diffuse vascular leakage , mas , NVE nasally [s1] OS [e1] Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( DATE ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with Macular Edema OU Lack of regular treatments due to patient visit ( 3 month gap ) .	Central retinal vein occlusion with [s2] macular edema [e2] of right eye H34.8110 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes 3 .	laterality	lesion	T15	T5	1156111_note_2376
NonRel	Central retinal vein occlusion with macular edema of left eye H34.8120 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes Treatment History IVL OU - DATE ( today ) IVL OU - DATE IVL OU - DATE switched to IVL for refractory CME IVA OU - DATE IVA OU - DATE IVA OU - DATE Missed appointments IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVFA - DATE - diffuse vascular leakage , mas , NVE nasally [s1] OS [e1] Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( DATE ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with Macular Edema OU Lack of regular treatments due to patient visit ( 3 month gap ) .	Persistent [s2] ME [e2] OU .	laterality	lesion	T15	T22	1156111_note_2376
NonRel	Central retinal vein occlusion with macular edema of left eye H34.8120 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes Treatment History IVL OU - DATE ( today ) IVL OU - DATE IVL OU - DATE switched to IVL for refractory CME IVA OU - DATE IVA OU - DATE IVA OU - DATE Missed appointments IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVFA - DATE - diffuse vascular leakage , mas , NVE nasally OS Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( DATE ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with Macular Edema [s1] OU [e1] Lack of regular treatments due to patient visit ( 3 month gap ) .	Central retinal vein occlusion with [s2] macular edema [e2] of right eye H34.8110 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes 3 .	laterality	lesion	T16	T5	1156111_note_2376
NonRel	Central retinal vein occlusion with macular edema of left eye H34.8120 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes Treatment History IVL OU - DATE ( today ) IVL OU - DATE IVL OU - DATE switched to IVL for refractory CME IVA OU - DATE IVA OU - DATE IVA OU - DATE Missed appointments IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVFA - DATE - diffuse vascular leakage , mas , NVE nasally OS Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( DATE ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with Macular Edema [s1] OU [e1] Lack of regular treatments due to patient visit ( 3 month gap ) .	Persistent [s2] ME [e2] OU .	laterality	lesion	T16	T22	1156111_note_2376
NonRel	Central retinal vein occlusion with macular edema of left eye H34.8120 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes Treatment History IVL OU - DATE ( today ) IVL OU - DATE IVL OU - DATE switched to IVL for refractory CME IVA OU - DATE IVA OU - DATE IVA OU - DATE Missed appointments IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVFA - DATE - diffuse vascular leakage , [s1] mas [e1] , NVE nasally OS Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( DATE ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with Macular Edema OU Lack of regular treatments due to patient visit ( 3 month gap ) .	[s2] Central retinal vein [e2] occlusion with macular edema of right eye H34.8110 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes 3 .	lesion	eye_part	T21	T3	1156111_note_2376
NonRel	Persistent [s1] ME [e1] OU .	[s2] Central retinal vein [e2] occlusion with macular edema of left eye H34.8120 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes Treatment History IVL OU - DATE ( today ) IVL OU - DATE IVL OU - DATE switched to IVL for refractory CME IVA OU - DATE IVA OU - DATE IVA OU - DATE Missed appointments IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVFA - DATE - diffuse vascular leakage , mas , NVE nasally OS Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( DATE ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with Macular Edema OU Lack of regular treatments due to patient visit ( 3 month gap ) .	lesion	eye_part	T22	T6	1156111_note_2376
NonRel	[s1] Persistent [e1] ME OU .	Central retinal vein occlusion with [s2] macular edema [e2] of left eye H34.8120 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes Treatment History IVL OU - DATE ( today ) IVL OU - DATE IVL OU - DATE switched to IVL for refractory CME IVA OU - DATE IVA OU - DATE IVA OU - DATE Missed appointments IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVFA - DATE - diffuse vascular leakage , mas , NVE nasally OS Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( DATE ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with Macular Edema OU Lack of regular treatments due to patient visit ( 3 month gap ) .	severity	lesion	T23	T8	1156111_note_2376
NonRel	[s1] Persistent [e1] ME OU .	Central retinal vein occlusion with macular edema of left eye H34.8120 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes Treatment History IVL OU - DATE ( today ) IVL OU - DATE IVL OU - DATE switched to IVL for refractory CME IVA OU - DATE IVA OU - DATE IVA OU - DATE Missed appointments IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVFA - DATE - diffuse vascular leakage , mas , [s2] NVE [e2] nasally OS Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( DATE ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with Macular Edema OU Lack of regular treatments due to patient visit ( 3 month gap ) .	severity	lesion	T23	T9	1156111_note_2376
NonRel	[s1] Persistent [e1] ME OU .	Central retinal vein occlusion with macular edema of left eye H34.8120 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes Treatment History IVL OU - DATE ( today ) IVL OU - DATE IVL OU - DATE switched to IVL for refractory CME IVA OU - DATE IVA OU - DATE IVA OU - DATE Missed appointments IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVFA - DATE - diffuse vascular leakage , mas , NVE nasally OS Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( DATE ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with [s2] Macular Edema [e2] OU Lack of regular treatments due to patient visit ( 3 month gap ) .	severity	lesion	T23	T10	1156111_note_2376
NonRel	[s1] Persistent [e1] ME OU .	Central retinal vein occlusion with macular edema of left eye H34.8120 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes Treatment History IVL OU - DATE ( today ) IVL OU - DATE IVL OU - DATE switched to IVL for refractory CME IVA OU - DATE IVA OU - DATE IVA OU - DATE Missed appointments IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVFA - DATE - diffuse vascular leakage , [s2] mas [e2] , NVE nasally OS Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( DATE ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with Macular Edema OU Lack of regular treatments due to patient visit ( 3 month gap ) .	severity	lesion	T23	T21	1156111_note_2376
NonRel	Persistent ME [s1] OU [e1] .	Central retinal vein occlusion with [s2] macular edema [e2] of left eye H34.8120 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes Treatment History IVL OU - DATE ( today ) IVL OU - DATE IVL OU - DATE switched to IVL for refractory CME IVA OU - DATE IVA OU - DATE IVA OU - DATE Missed appointments IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVFA - DATE - diffuse vascular leakage , mas , NVE nasally OS Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( DATE ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with Macular Edema OU Lack of regular treatments due to patient visit ( 3 month gap ) .	laterality	lesion	T24	T8	1156111_note_2376
NonRel	Persistent ME [s1] OU [e1] .	Central retinal vein occlusion with macular edema of left eye H34.8120 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes Treatment History IVL OU - DATE ( today ) IVL OU - DATE IVL OU - DATE switched to IVL for refractory CME IVA OU - DATE IVA OU - DATE IVA OU - DATE Missed appointments IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVFA - DATE - diffuse vascular leakage , mas , [s2] NVE [e2] nasally OS Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( DATE ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with Macular Edema OU Lack of regular treatments due to patient visit ( 3 month gap ) .	laterality	lesion	T24	T9	1156111_note_2376
NonRel	Persistent ME [s1] OU [e1] .	Central retinal vein occlusion with macular edema of left eye H34.8120 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes Treatment History IVL OU - DATE ( today ) IVL OU - DATE IVL OU - DATE switched to IVL for refractory CME IVA OU - DATE IVA OU - DATE IVA OU - DATE Missed appointments IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVFA - DATE - diffuse vascular leakage , mas , NVE nasally OS Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( DATE ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with [s2] Macular Edema [e2] OU Lack of regular treatments due to patient visit ( 3 month gap ) .	laterality	lesion	T24	T10	1156111_note_2376
NonRel	Persistent ME [s1] OU [e1] .	Central retinal vein occlusion with macular edema of left eye H34.8120 362.35 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.83 Intravitreal Injection , Pharmacologic Agent - OS - Left Eye OCT , Posterior Segment - OU - Both Eyes Treatment History IVL OU - DATE ( today ) IVL OU - DATE IVL OU - DATE switched to IVL for refractory CME IVA OU - DATE IVA OU - DATE IVA OU - DATE Missed appointments IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE ( missed appointments 3 months ) IVA OU - DATE IVA OU - DATE IVA OU - DATE IVA OU - DATE IVFA - DATE - diffuse vascular leakage , [s2] mas [e2] , NVE nasally OS Workup ( rule out RVO masquaraders given acute bilateral presentation ) Factor V Leiden - Normal Protein C - Not drawn Protein S - Not drawn PT / INR - Normal Anti - Phospholipid - Negative Lipid Panel - Trigylcerides 542 HLA - B27 - Not ordered RPR - Non - reactive FTA - abs - Not drawn Ace - Negative Lysozyme - Not drawn A1c - ~ 14 ( DATE ) Carotid duplex ( For OIS ) - < 50 % stenosis OU 1 ) CRVO OU with Macular Edema OU Lack of regular treatments due to patient visit ( 3 month gap ) .	laterality	lesion	T24	T21	1156111_note_2376
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes , with macular edema , associated with type 2 diabetes mellitus E11.3413 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.06 2 .	[s2] Macular edema [e2] , cystoid , bilateral H35.353 362.53 Fluorescein Angiography - OU - Both Eyes Dx pancreatic cancer May 2017 with subsequent diabetes .	severity	lesion	T8	T3	note_8392
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] , with macular edema , associated with type 2 diabetes mellitus E11.3413 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.06 2 .	[s2] Macular edema [e2] , cystoid , bilateral H35.353 362.53 Fluorescein Angiography - OU - Both Eyes Dx pancreatic cancer May 2017 with subsequent diabetes .	laterality	lesion	T9	T3	note_8392
NonRel	Macular edema , cystoid , [s1] bilateral [e1] H35.353 362.53 Fluorescein Angiography - OU - Both Eyes Dx pancreatic cancer May 2017 with subsequent diabetes .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes , with macular edema , associated with type 2 diabetes mellitus E11.3413 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.06 2 .	laterality	lesion	T10	T1	note_8392
NonRel	Macular edema , cystoid , [s1] bilateral [e1] H35.353 362.53 Fluorescein Angiography - OU - Both Eyes Dx pancreatic cancer May 2017 with subsequent diabetes .	Severe nonproliferative diabetic retinopathy of both eyes , with [s2] macular edema [e2] , associated with type 2 diabetes mellitus E11.3413 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.06 2 .	laterality	lesion	T10	T2	note_8392
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema - Both Eyes E10.3511 250.51 OCT , Posterior Segment - OU - Both Eyes 362.02 362.07 2 .	[s2] Diabetic retinopathy [e2] of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T2	T5	note_2271
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema - Both Eyes E10.3511 250.51 OCT , Posterior Segment - OU - Both Eyes 362.02 362.07 2 .	Diabetic retinopathy of left eye , with [s2] macular edema [e2] , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T2	T7	note_2271
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema - Both Eyes E10.3511 250.51 OCT , Posterior Segment - OU - Both Eyes 362.02 362.07 2 .	Diabetic retinopathy of left eye , with macular edema , with severe [s2] nonproliferative retinopathy [e2] , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T2	T9	note_2271
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema - [s1] Both Eyes [e1] E10.3511 250.51 OCT , Posterior Segment - OU - Both Eyes 362.02 362.07 2 .	[s2] Diabetic retinopathy [e2] of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T4	T5	note_2271
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema - [s1] Both Eyes [e1] E10.3511 250.51 OCT , Posterior Segment - OU - Both Eyes 362.02 362.07 2 .	Diabetic retinopathy of left eye , with [s2] macular edema [e2] , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T4	T7	note_2271
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema - [s1] Both Eyes [e1] E10.3511 250.51 OCT , Posterior Segment - OU - Both Eyes 362.02 362.07 2 .	Diabetic retinopathy of left eye , with macular edema , with severe [s2] nonproliferative retinopathy [e2] , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T4	T9	note_2271
NonRel	Diabetic retinopathy of [s1] left eye [e1] , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	Type 1 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema - Both Eyes E10.3511 250.51 OCT , Posterior Segment - OU - Both Eyes 362.02 362.07 2 .	laterality	lesion	T6	T1	note_2271
NonRel	Diabetic retinopathy of [s1] left eye [e1] , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] - Both Eyes E10.3511 250.51 OCT , Posterior Segment - OU - Both Eyes 362.02 362.07 2 .	laterality	lesion	T6	T3	note_2271
NonRel	Diabetic retinopathy of [s1] left eye [e1] , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	[s2] Vitreous hemorrhage [e2] of right eye H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : Severe NPDR with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T6	T10	note_2271
NonRel	Diabetic retinopathy of [s1] left eye [e1] , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : Severe [s2] NPDR [e2] with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T6	T13	note_2271
NonRel	Diabetic retinopathy of [s1] left eye [e1] , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : Severe NPDR with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T6	T15	note_2271
NonRel	Diabetic retinopathy of [s1] left eye [e1] , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : Severe NPDR with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	laterality	lesion	T6	T18	note_2271
NonRel	Diabetic retinopathy of left eye , with macular edema , with [s1] severe [e1] nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	Type 1 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema - Both Eyes E10.3511 250.51 OCT , Posterior Segment - OU - Both Eyes 362.02 362.07 2 .	severity	lesion	T8	T1	note_2271
NonRel	Diabetic retinopathy of left eye , with macular edema , with [s1] severe [e1] nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] - Both Eyes E10.3511 250.51 OCT , Posterior Segment - OU - Both Eyes 362.02 362.07 2 .	severity	lesion	T8	T3	note_2271
NonRel	Diabetic retinopathy of left eye , with macular edema , with [s1] severe [e1] nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	[s2] Vitreous hemorrhage [e2] of right eye H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : Severe NPDR with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T8	T10	note_2271
NonRel	Diabetic retinopathy of left eye , with macular edema , with [s1] severe [e1] nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : Severe [s2] NPDR [e2] with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T8	T13	note_2271
NonRel	Diabetic retinopathy of left eye , with macular edema , with [s1] severe [e1] nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : Severe NPDR with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T8	T15	note_2271
NonRel	Diabetic retinopathy of left eye , with macular edema , with [s1] severe [e1] nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : Severe NPDR with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	severity	lesion	T8	T18	note_2271
NonRel	Vitreous hemorrhage of [s1] right eye [e1] H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : Severe NPDR with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	[s2] Diabetic retinopathy [e2] of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T11	T5	note_2271
NonRel	Vitreous hemorrhage of [s1] right eye [e1] H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : Severe NPDR with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with [s2] macular edema [e2] , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T11	T7	note_2271
NonRel	Vitreous hemorrhage of [s1] right eye [e1] H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : Severe NPDR with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with macular edema , with severe [s2] nonproliferative retinopathy [e2] , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T11	T9	note_2271
NonRel	Vitreous hemorrhage of [s1] right eye [e1] H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : Severe NPDR with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe [s2] NPDR [e2] OS .	laterality	lesion	T11	T20	note_2271
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : [s1] Severe [e1] NPDR with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	[s2] Diabetic retinopathy [e2] of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	severity	lesion	T12	T5	note_2271
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : [s1] Severe [e1] NPDR with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with [s2] macular edema [e2] , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	severity	lesion	T12	T7	note_2271
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : [s1] Severe [e1] NPDR with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with macular edema , with severe [s2] nonproliferative retinopathy [e2] , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	severity	lesion	T12	T9	note_2271
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : [s1] Severe [e1] NPDR with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe [s2] NPDR [e2] OS .	severity	lesion	T12	T20	note_2271
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : Severe NPDR with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : [s1] Suspected [e1] PDR OD with single pinpoint NVE superonasally to the optic nerve .	[s2] Diabetic retinopathy [e2] of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	severity	lesion	T14	T5	note_2271
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : Severe NPDR with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : [s1] Suspected [e1] PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with [s2] macular edema [e2] , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	severity	lesion	T14	T7	note_2271
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : Severe NPDR with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : [s1] Suspected [e1] PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with macular edema , with severe [s2] nonproliferative retinopathy [e2] , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	severity	lesion	T14	T9	note_2271
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : Severe NPDR with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : [s1] Suspected [e1] PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe [s2] NPDR [e2] OS .	severity	lesion	T14	T20	note_2271
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : Severe NPDR with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	[s2] Diabetic retinopathy [e2] of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T16	T5	note_2271
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : Severe NPDR with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with [s2] macular edema [e2] , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T16	T7	note_2271
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : Severe NPDR with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with macular edema , with severe [s2] nonproliferative retinopathy [e2] , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T16	T9	note_2271
NonRel	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : Severe NPDR with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Severe [s2] NPDR [e2] OS .	laterality	lesion	T16	T20	note_2271
NonRel	[s1] Severe [e1] NPDR OS .	[s2] Vitreous hemorrhage [e2] of right eye H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : Severe NPDR with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T19	T10	note_2271
NonRel	[s1] Severe [e1] NPDR OS .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : Severe [s2] NPDR [e2] with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T19	T13	note_2271
NonRel	[s1] Severe [e1] NPDR OS .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : Severe NPDR with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T19	T15	note_2271
NonRel	[s1] Severe [e1] NPDR OS .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : Severe NPDR with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	severity	lesion	T19	T18	note_2271
NonRel	[s1] Severe [e1] NPDR OS .	IVFA - 9 / 13 / 16 : Severe [s2] NPDR [e2] OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS , CSME OU ) OD - VA CF @ 5 FT ( PH 20 / 300 ) today from LP LV .	severity	lesion	T19	T23	note_2271
NonRel	[s1] Severe [e1] NPDR OS .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe [s2] NPDR [e2] OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS , CSME OU ) OD - VA CF @ 5 FT ( PH 20 / 300 ) today from LP LV .	severity	lesion	T19	T26	note_2271
NonRel	[s1] Severe [e1] NPDR OS .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS , CSME OU ) OD - VA CF @ 5 FT ( PH 20 / 300 ) today from LP LV .	severity	lesion	T19	T28	note_2271
NonRel	[s1] Severe [e1] NPDR OS .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS , CSME OU ) OD - VA CF @ 5 FT ( PH 20 / 300 ) today from LP LV .	severity	lesion	T19	T31	note_2271
NonRel	[s1] Severe [e1] NPDR OS .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS , [s2] CSME [e2] OU ) OD - VA CF @ 5 FT ( PH 20 / 300 ) today from LP LV .	severity	lesion	T19	T33	note_2271
NonRel	Severe NPDR [s1] OS [e1] .	[s2] Vitreous hemorrhage [e2] of right eye H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : Severe NPDR with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T21	T10	note_2271
NonRel	Severe NPDR [s1] OS [e1] .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : Severe [s2] NPDR [e2] with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T21	T13	note_2271
NonRel	Severe NPDR [s1] OS [e1] .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : Severe NPDR with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T21	T15	note_2271
NonRel	Severe NPDR [s1] OS [e1] .	Vitreous hemorrhage of right eye H43.11 379.23 Treatment History IVA OD - 3 / 29 / 2018 IVFA - 3 / 29 / 18 : Severe NPDR with midperiphery nasally Focal Laser OD - 7 / 14 / 17 IVA OD - 5 / 26 / 2017 Focal Laser OD - 4 / 21 / 17 IVA OU - 4 / 21 / 2017 IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	laterality	lesion	T21	T18	note_2271
NonRel	Severe NPDR [s1] OS [e1] .	IVFA - 9 / 13 / 16 : Severe [s2] NPDR [e2] OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS , CSME OU ) OD - VA CF @ 5 FT ( PH 20 / 300 ) today from LP LV .	laterality	lesion	T21	T23	note_2271
NonRel	Severe NPDR [s1] OS [e1] .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe [s2] NPDR [e2] OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS , CSME OU ) OD - VA CF @ 5 FT ( PH 20 / 300 ) today from LP LV .	laterality	lesion	T21	T26	note_2271
NonRel	Severe NPDR [s1] OS [e1] .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS , CSME OU ) OD - VA CF @ 5 FT ( PH 20 / 300 ) today from LP LV .	laterality	lesion	T21	T28	note_2271
NonRel	Severe NPDR [s1] OS [e1] .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS , CSME OU ) OD - VA CF @ 5 FT ( PH 20 / 300 ) today from LP LV .	laterality	lesion	T21	T31	note_2271
NonRel	Severe NPDR [s1] OS [e1] .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS , [s2] CSME [e2] OU ) OD - VA CF @ 5 FT ( PH 20 / 300 ) today from LP LV .	laterality	lesion	T21	T33	note_2271
NonRel	IVFA - 9 / 13 / 16 : [s1] Severe [e1] NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS , CSME OU ) OD - VA CF @ 5 FT ( PH 20 / 300 ) today from LP LV .	Severe [s2] NPDR [e2] OS .	severity	lesion	T22	T20	note_2271
NonRel	IVFA - 9 / 13 / 16 : [s1] Severe [e1] NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS , CSME OU ) OD - VA CF @ 5 FT ( PH 20 / 300 ) today from LP LV .	Was 20 / 40 visit before last and worsened due to new [s2] vitreous hemorrhage [e2] noted LV .	severity	lesion	T22	T35	note_2271
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR [s1] OU [e1] IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS , CSME OU ) OD - VA CF @ 5 FT ( PH 20 / 300 ) today from LP LV .	Severe [s2] NPDR [e2] OS .	laterality	lesion	T24	T20	note_2271
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR [s1] OU [e1] IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS , CSME OU ) OD - VA CF @ 5 FT ( PH 20 / 300 ) today from LP LV .	Was 20 / 40 visit before last and worsened due to new [s2] vitreous hemorrhage [e2] noted LV .	laterality	lesion	T24	T35	note_2271
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : [s1] Severe [e1] NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS , CSME OU ) OD - VA CF @ 5 FT ( PH 20 / 300 ) today from LP LV .	Severe [s2] NPDR [e2] OS .	severity	lesion	T25	T20	note_2271
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : [s1] Severe [e1] NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS , CSME OU ) OD - VA CF @ 5 FT ( PH 20 / 300 ) today from LP LV .	Was 20 / 40 visit before last and worsened due to new [s2] vitreous hemorrhage [e2] noted LV .	severity	lesion	T25	T35	note_2271
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR [s1] OS [e1] 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS , CSME OU ) OD - VA CF @ 5 FT ( PH 20 / 300 ) today from LP LV .	Severe [s2] NPDR [e2] OS .	laterality	lesion	T27	T20	note_2271
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR [s1] OS [e1] 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS , CSME OU ) OD - VA CF @ 5 FT ( PH 20 / 300 ) today from LP LV .	Was 20 / 40 visit before last and worsened due to new [s2] vitreous hemorrhage [e2] noted LV .	laterality	lesion	T27	T35	note_2271
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS , CSME OU ) OD - VA CF @ 5 FT ( PH 20 / 300 ) today from LP LV .	Severe [s2] NPDR [e2] OS .	laterality	lesion	T29	T20	note_2271
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS , CSME OU ) OD - VA CF @ 5 FT ( PH 20 / 300 ) today from LP LV .	Was 20 / 40 visit before last and worsened due to new [s2] vitreous hemorrhage [e2] noted LV .	laterality	lesion	T29	T35	note_2271
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS , CSME OU ) OD - VA CF @ 5 FT ( PH 20 / 300 ) today from LP LV .	Severe [s2] NPDR [e2] OS .	severity	lesion	T30	T20	note_2271
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS , CSME OU ) OD - VA CF @ 5 FT ( PH 20 / 300 ) today from LP LV .	Was 20 / 40 visit before last and worsened due to new [s2] vitreous hemorrhage [e2] noted LV .	severity	lesion	T30	T35	note_2271
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] , CSME OU ) OD - VA CF @ 5 FT ( PH 20 / 300 ) today from LP LV .	Severe [s2] NPDR [e2] OS .	laterality	lesion	T32	T20	note_2271
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] , CSME OU ) OD - VA CF @ 5 FT ( PH 20 / 300 ) today from LP LV .	Was 20 / 40 visit before last and worsened due to new [s2] vitreous hemorrhage [e2] noted LV .	laterality	lesion	T32	T35	note_2271
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS , CSME [s1] OU [e1] ) OD - VA CF @ 5 FT ( PH 20 / 300 ) today from LP LV .	Severe [s2] NPDR [e2] OS .	laterality	lesion	T34	T20	note_2271
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS , CSME [s1] OU [e1] ) OD - VA CF @ 5 FT ( PH 20 / 300 ) today from LP LV .	Was 20 / 40 visit before last and worsened due to new [s2] vitreous hemorrhage [e2] noted LV .	laterality	lesion	T34	T35	note_2271
NonRel	Non - proliferative diabetic retinopathy , [s1] mild [e1] , both eyes E11.329 250.50 362.04 The patient has mild , moderate diabetic retinopathy .	However , there is no [s2] neovascularization [e2] and no clinically significant macular edema .	severity	lesion	T1	T4	note_2809
NonRel	Non - proliferative diabetic retinopathy , [s1] mild [e1] , both eyes E11.329 250.50 362.04 The patient has mild , moderate diabetic retinopathy .	However , there is no neovascularization and no clinically significant [s2] macular edema [e2] .	severity	lesion	T1	T5	note_2809
NonRel	Non - proliferative diabetic retinopathy , mild , [s1] both eyes [e1] E11.329 250.50 362.04 The patient has mild , moderate diabetic retinopathy .	However , there is no [s2] neovascularization [e2] and no clinically significant macular edema .	laterality	lesion	T6	T4	note_2809
NonRel	Non - proliferative diabetic retinopathy , mild , [s1] both eyes [e1] E11.329 250.50 362.04 The patient has mild , moderate diabetic retinopathy .	However , there is no neovascularization and no clinically significant [s2] macular edema [e2] .	laterality	lesion	T6	T5	note_2809
NonRel	Non - proliferative diabetic retinopathy , mild , both eyes E11.329 250.50 362.04 The patient has mild , [s1] moderate [e1] diabetic retinopathy .	However , there is no [s2] neovascularization [e2] and no clinically significant macular edema .	severity	lesion	T7	T4	note_2809
NonRel	Non - proliferative diabetic retinopathy , mild , both eyes E11.329 250.50 362.04 The patient has mild , [s1] moderate [e1] diabetic retinopathy .	However , there is no neovascularization and no clinically significant [s2] macular edema [e2] .	severity	lesion	T7	T5	note_2809
NonRel	Non - proliferative diabetic retinopathy , mild , both eyes E11.329 250.50 362.04 The patient has [s1] mild [e1] , moderate diabetic retinopathy .	However , there is no [s2] neovascularization [e2] and no clinically significant macular edema .	severity	lesion	T8	T4	note_2809
NonRel	Non - proliferative diabetic retinopathy , mild , both eyes E11.329 250.50 362.04 The patient has [s1] mild [e1] , moderate diabetic retinopathy .	However , there is no neovascularization and no clinically significant [s2] macular edema [e2] .	severity	lesion	T8	T5	note_2809
NonRel	However , there is no neovascularization and [s1] no clinically significant [e1] macular edema .	[s2] Non - proliferative diabetic retinopathy [e2] , mild , both eyes E11.329 250.50 362.04 The patient has mild , moderate diabetic retinopathy .	severity	lesion	T9	T2	note_2809
NonRel	However , there is no neovascularization and [s1] no clinically significant [e1] macular edema .	Non - proliferative diabetic retinopathy , mild , both eyes E11.329 250.50 362.04 The patient has mild , moderate [s2] diabetic retinopathy [e2] .	severity	lesion	T9	T3	note_2809
NonRel	[s1] Both eyes [e1] affected by proliferative diabetic retinopathy with traction retinal detachments involving maculae , associated with type 2 diabetes mellitus E11.3523 250.50 362.02 361.81 3 .	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - Active [s2] PDR [e2] .	laterality	lesion	T6	T2	note_8730
NonRel	[s1] Both eyes [e1] affected by proliferative diabetic retinopathy with traction retinal detachments involving maculae , associated with type 2 diabetes mellitus E11.3523 250.50 362.02 361.81 3 .	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of [s2] PDR [e2] OU OD - Active PDR .	laterality	lesion	T6	T8	note_8730
NonRel	[s1] Both eyes [e1] affected by proliferative diabetic retinopathy with traction retinal detachments involving maculae , associated with type 2 diabetes mellitus E11.3523 250.50 362.02 361.81 3 .	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - [s2] PDR [e2] OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - Active PDR .	laterality	lesion	T6	T13	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU [s1] OD [e1] - Active PDR .	Both eyes affected by [s2] proliferative diabetic retinopathy [e2] with traction retinal detachments involving maculae , associated with type 2 diabetes mellitus E11.3523 250.50 362.02 361.81 3 .	laterality	lesion	T7	T1	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU [s1] OD [e1] - Active PDR .	[s2] VH [e2] with SHH for duration of one month .	laterality	lesion	T7	T3	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU [s1] OD [e1] - Active PDR .	VH with [s2] SHH [e2] for duration of one month .	laterality	lesion	T7	T4	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR [s1] OU [e1] OD - Active PDR .	Both eyes affected by [s2] proliferative diabetic retinopathy [e2] with traction retinal detachments involving maculae , associated with type 2 diabetes mellitus E11.3523 250.50 362.02 361.81 3 .	laterality	lesion	T9	T1	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR [s1] OU [e1] OD - Active PDR .	[s2] VH [e2] with SHH for duration of one month .	laterality	lesion	T9	T3	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR [s1] OU [e1] OD - Active PDR .	VH with [s2] SHH [e2] for duration of one month .	laterality	lesion	T9	T4	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - [s1] Active [e1] PDR .	Both eyes affected by [s2] proliferative diabetic retinopathy [e2] with traction retinal detachments involving maculae , associated with type 2 diabetes mellitus E11.3523 250.50 362.02 361.81 3 .	severity	lesion	T12	T1	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - [s1] Active [e1] PDR .	[s2] VH [e2] with SHH for duration of one month .	severity	lesion	T12	T3	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - [s1] Active [e1] PDR .	VH with [s2] SHH [e2] for duration of one month .	severity	lesion	T12	T4	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR [s1] OU [e1] , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - Active PDR .	Both eyes affected by [s2] proliferative diabetic retinopathy [e2] with traction retinal detachments involving maculae , associated with type 2 diabetes mellitus E11.3523 250.50 362.02 361.81 3 .	laterality	lesion	T14	T1	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR [s1] OU [e1] , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - Active PDR .	[s2] VH [e2] with SHH for duration of one month .	laterality	lesion	T14	T3	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR [s1] OU [e1] , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - Active PDR .	VH with [s2] SHH [e2] for duration of one month .	laterality	lesion	T14	T4	note_8730
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	laterality	lesion	T1	T7	note_2442
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	laterality	lesion	T1	T8	note_2442
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with [s2] ciCSME [e2] being treated with IVA OS .	laterality	lesion	T1	T9	note_2442
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	severity	lesion	T2	T7	note_2442
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	severity	lesion	T2	T8	note_2442
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with [s2] ciCSME [e2] being treated with IVA OS .	severity	lesion	T2	T9	note_2442
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	laterality	lesion	T5	T3	note_2442
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	laterality	lesion	T5	T4	note_2442
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	severity	lesion	T6	T3	note_2442
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	severity	lesion	T6	T4	note_2442
NonRel	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA [s1] OS [e1] .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	laterality	lesion	T10	T3	note_2442
NonRel	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA [s1] OS [e1] .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	laterality	lesion	T10	T4	note_2442
NonRel	Treatment Hx IVA OS - 2 / 1 / 19 IVFA ( 11 / 8 / 2018 ) - [s1] Mild [e1] NVE ( nearly regressed ) , residual NVD OS IVA OU - 7 / 6 / 18 IVA OU - 5 / 25 / 18 IVA OU - 4 / 6 / 18 IVA OU - 2 / 22 / 18 IVA OU - 11 / 28 / 17 IVA OS - 10 / 24 / 17 PRP OS - 4 / 28 / 2017 IVA OU - 4 / 14 / 17 PRP OD - 4 / 14 / 2017 IVFA ( 4 / 6 / 2017 ) - Active PDR OU 1 .	NIDDM - [ Duration 16 yrs , Dx [s2] PDR [e2] OU here , Most recent A1c 8.1 per patient .	severity	lesion	T9	T17	note_7926
NonRel	Treatment Hx IVA OS - 2 / 1 / 19 IVFA ( 11 / 8 / 2018 ) - Mild NVE ( nearly regressed ) , [s1] residual [e1] NVD OS IVA OU - 7 / 6 / 18 IVA OU - 5 / 25 / 18 IVA OU - 4 / 6 / 18 IVA OU - 2 / 22 / 18 IVA OU - 11 / 28 / 17 IVA OS - 10 / 24 / 17 PRP OS - 4 / 28 / 2017 IVA OU - 4 / 14 / 17 PRP OD - 4 / 14 / 2017 IVFA ( 4 / 6 / 2017 ) - Active PDR OU 1 .	NIDDM - [ Duration 16 yrs , Dx [s2] PDR [e2] OU here , Most recent A1c 8.1 per patient .	severity	lesion	T11	T17	note_7926
NonRel	Treatment Hx IVA OS - 2 / 1 / 19 IVFA ( 11 / 8 / 2018 ) - Mild NVE ( nearly regressed ) , residual NVD [s1] OS [e1] IVA OU - 7 / 6 / 18 IVA OU - 5 / 25 / 18 IVA OU - 4 / 6 / 18 IVA OU - 2 / 22 / 18 IVA OU - 11 / 28 / 17 IVA OS - 10 / 24 / 17 PRP OS - 4 / 28 / 2017 IVA OU - 4 / 14 / 17 PRP OD - 4 / 14 / 2017 IVFA ( 4 / 6 / 2017 ) - Active PDR OU 1 .	NIDDM - [ Duration 16 yrs , Dx [s2] PDR [e2] OU here , Most recent A1c 8.1 per patient .	laterality	lesion	T13	T17	note_7926
NonRel	Treatment Hx IVA OS - 2 / 1 / 19 IVFA ( 11 / 8 / 2018 ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - 7 / 6 / 18 IVA OU - 5 / 25 / 18 IVA OU - 4 / 6 / 18 IVA OU - 2 / 22 / 18 IVA OU - 11 / 28 / 17 IVA OS - 10 / 24 / 17 PRP OS - 4 / 28 / 2017 IVA OU - 4 / 14 / 17 PRP OD - 4 / 14 / 2017 IVFA ( 4 / 6 / 2017 ) - [s1] Active [e1] PDR OU 1 .	NIDDM - [ Duration 16 yrs , Dx [s2] PDR [e2] OU here , Most recent A1c 8.1 per patient .	severity	lesion	T14	T17	note_7926
NonRel	Treatment Hx IVA OS - 2 / 1 / 19 IVFA ( 11 / 8 / 2018 ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - 7 / 6 / 18 IVA OU - 5 / 25 / 18 IVA OU - 4 / 6 / 18 IVA OU - 2 / 22 / 18 IVA OU - 11 / 28 / 17 IVA OS - 10 / 24 / 17 PRP OS - 4 / 28 / 2017 IVA OU - 4 / 14 / 17 PRP OD - 4 / 14 / 2017 IVFA ( 4 / 6 / 2017 ) - Active PDR [s1] OU [e1] 1 .	NIDDM - [ Duration 16 yrs , Dx [s2] PDR [e2] OU here , Most recent A1c 8.1 per patient .	laterality	lesion	T16	T17	note_7926
NonRel	NIDDM - [ Duration 16 yrs , Dx PDR [s1] OU [e1] here , Most recent A1c 8.1 per patient .	Treatment Hx IVA OS - 2 / 1 / 19 IVFA ( 11 / 8 / 2018 ) - Mild [s2] NVE [e2] ( nearly regressed ) , residual NVD OS IVA OU - 7 / 6 / 18 IVA OU - 5 / 25 / 18 IVA OU - 4 / 6 / 18 IVA OU - 2 / 22 / 18 IVA OU - 11 / 28 / 17 IVA OS - 10 / 24 / 17 PRP OS - 4 / 28 / 2017 IVA OU - 4 / 14 / 17 PRP OD - 4 / 14 / 2017 IVFA ( 4 / 6 / 2017 ) - Active PDR OU 1 .	laterality	lesion	T18	T10	note_7926
NonRel	NIDDM - [ Duration 16 yrs , Dx PDR [s1] OU [e1] here , Most recent A1c 8.1 per patient .	Treatment Hx IVA OS - 2 / 1 / 19 IVFA ( 11 / 8 / 2018 ) - Mild NVE ( nearly regressed ) , residual [s2] NVD [e2] OS IVA OU - 7 / 6 / 18 IVA OU - 5 / 25 / 18 IVA OU - 4 / 6 / 18 IVA OU - 2 / 22 / 18 IVA OU - 11 / 28 / 17 IVA OS - 10 / 24 / 17 PRP OS - 4 / 28 / 2017 IVA OU - 4 / 14 / 17 PRP OD - 4 / 14 / 2017 IVFA ( 4 / 6 / 2017 ) - Active PDR OU 1 .	laterality	lesion	T18	T12	note_7926
NonRel	NIDDM - [ Duration 16 yrs , Dx PDR [s1] OU [e1] here , Most recent A1c 8.1 per patient .	Treatment Hx IVA OS - 2 / 1 / 19 IVFA ( 11 / 8 / 2018 ) - Mild NVE ( nearly regressed ) , residual NVD OS IVA OU - 7 / 6 / 18 IVA OU - 5 / 25 / 18 IVA OU - 4 / 6 / 18 IVA OU - 2 / 22 / 18 IVA OU - 11 / 28 / 17 IVA OS - 10 / 24 / 17 PRP OS - 4 / 28 / 2017 IVA OU - 4 / 14 / 17 PRP OD - 4 / 14 / 2017 IVFA ( 4 / 6 / 2017 ) - Active [s2] PDR [e2] OU 1 .	laterality	lesion	T18	T15	note_7926
NonRel	NIDDM - [ Duration 16 yrs , Dx PDR [s1] OU [e1] here , Most recent A1c 8.1 per patient .	BS historically very poorly controlled ] OD - [s2] PDR [e2] with ciCSME now s / p PRP and IVA .	laterality	lesion	T18	T20	note_7926
NonRel	NIDDM - [ Duration 16 yrs , Dx PDR [s1] OU [e1] here , Most recent A1c 8.1 per patient .	BS historically very poorly controlled ] OD - PDR with [s2] ciCSME [e2] now s / p PRP and IVA .	laterality	lesion	T18	T21	note_7926
NonRel	BS historically very poorly controlled ] [s1] OD [e1] - PDR with ciCSME now s / p PRP and IVA .	NIDDM - [ Duration 16 yrs , Dx [s2] PDR [e2] OU here , Most recent A1c 8.1 per patient .	laterality	lesion	T19	T17	note_7926
NonRel	BS historically very poorly controlled ] [s1] OD [e1] - PDR with ciCSME now s / p PRP and IVA .	Significant improvement from presentation with only mild nasal [s2] NVE [e2] remaining .	laterality	lesion	T19	T23	note_7926
NonRel	Significant improvement from presentation with only [s1] mild [e1] nasal NVE remaining .	BS historically very poorly controlled ] OD - [s2] PDR [e2] with ciCSME now s / p PRP and IVA .	severity	lesion	T22	T20	note_7926
NonRel	Significant improvement from presentation with only [s1] mild [e1] nasal NVE remaining .	BS historically very poorly controlled ] OD - PDR with [s2] ciCSME [e2] now s / p PRP and IVA .	severity	lesion	T22	T21	note_7926
NonRel	[s1] Proliferative diabetic retinopathy [e1] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Retina - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 2 .	OCT , Retina - OU - Both Eyes OD : stable mild IRF OS : stable thickening , good contour , temporal ischemic thinning Fluorescein Angiography - OU - Both Eyes OD : peripheral ischemia , no NV OS : peripheral ischemia with temporal [s2] macular [e2] NVE , and well defined NVD Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T1	T3	2644164_note_8603
NonRel	[s1] Proliferative diabetic retinopathy [e1] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Retina - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 2 .	Mild nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Retina - OU - Both Eyes 362.04 Fluorescein Angiography - OU - Both Eyes Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with cystic DME in [s2] fovea [e2] .	lesion	eye_part	T1	T10	2644164_note_8603
NonRel	Proliferative diabetic retinopathy of left eye with [s1] macular edema [e1] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Retina - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 2 .	OCT , Retina - OU - Both Eyes OD : stable mild IRF OS : stable thickening , good contour , temporal ischemic thinning Fluorescein Angiography - OU - Both Eyes OD : peripheral ischemia , no NV OS : peripheral ischemia with temporal [s2] macular [e2] NVE , and well defined NVD Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T2	T3	2644164_note_8603
NonRel	Proliferative diabetic retinopathy of left eye with [s1] macular edema [e1] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Retina - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 2 .	Mild nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Retina - OU - Both Eyes 362.04 Fluorescein Angiography - OU - Both Eyes Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with cystic DME in [s2] fovea [e2] .	lesion	eye_part	T2	T10	2644164_note_8603
NonRel	OCT , Retina - OU - Both Eyes OD : stable mild IRF OS : stable thickening , good contour , temporal ischemic thinning Fluorescein Angiography - OU - Both Eyes OD : peripheral ischemia , no NV [s1] OS [e1] : peripheral ischemia with temporal macular NVE , and well defined NVD Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Retina - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 2 .	laterality	lesion	T13	T1	2644164_note_8603
NonRel	OCT , Retina - OU - Both Eyes OD : stable mild IRF OS : stable thickening , good contour , temporal ischemic thinning Fluorescein Angiography - OU - Both Eyes OD : peripheral ischemia , no NV [s1] OS [e1] : peripheral ischemia with temporal macular NVE , and well defined NVD Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Retina - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 2 .	laterality	lesion	T13	T2	2644164_note_8603
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Retina - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 2 .	OCT , Retina - OU - Both Eyes OD : stable mild IRF OS : stable thickening , good contour , temporal ischemic thinning Fluorescein Angiography - OU - Both Eyes OD : peripheral ischemia , no NV OS : peripheral ischemia with temporal macular [s2] NVE [e2] , and well defined NVD Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T14	T4	2644164_note_8603
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Retina - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 2 .	OCT , Retina - OU - Both Eyes OD : stable mild IRF OS : stable thickening , good contour , temporal ischemic thinning Fluorescein Angiography - OU - Both Eyes OD : peripheral ischemia , no NV OS : peripheral ischemia with temporal macular NVE , and well defined [s2] NVD [e2] Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T14	T5	2644164_note_8603
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Retina - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 2 .	Mild [s2] nonproliferative diabetic retinopathy [e2] of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Retina - OU - Both Eyes 362.04 Fluorescein Angiography - OU - Both Eyes Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with cystic DME in fovea .	laterality	lesion	T14	T6	2644164_note_8603
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Retina - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 2 .	Mild nonproliferative diabetic retinopathy of right eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Retina - OU - Both Eyes 362.04 Fluorescein Angiography - OU - Both Eyes Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with cystic DME in fovea .	laterality	lesion	T14	T7	2644164_note_8603
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Retina - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 2 .	Mild nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Retina - OU - Both Eyes 362.04 Fluorescein Angiography - OU - Both Eyes Here today for IVFA for better characterization of possible [s2] NVD [e2] OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with cystic DME in fovea .	laterality	lesion	T14	T8	2644164_note_8603
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Retina - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 2 .	Mild nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Retina - OU - Both Eyes 362.04 Fluorescein Angiography - OU - Both Eyes Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild [s2] NPDR [e2] with cystic DME in fovea .	laterality	lesion	T14	T9	2644164_note_8603
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Retina - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 2 .	Mild nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Retina - OU - Both Eyes 362.04 Fluorescein Angiography - OU - Both Eyes Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with cystic [s2] DME [e2] in fovea .	laterality	lesion	T14	T11	2644164_note_8603
NonRel	[s1] Mild [e1] nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Retina - OU - Both Eyes 362.04 Fluorescein Angiography - OU - Both Eyes Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with cystic DME in fovea .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Retina - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 2 .	severity	lesion	T15	T1	2644164_note_8603
NonRel	[s1] Mild [e1] nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Retina - OU - Both Eyes 362.04 Fluorescein Angiography - OU - Both Eyes Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with cystic DME in fovea .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Retina - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 2 .	severity	lesion	T15	T2	2644164_note_8603
NonRel	[s1] Mild [e1] nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Retina - OU - Both Eyes 362.04 Fluorescein Angiography - OU - Both Eyes Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with cystic DME in fovea .	Observe in the setting of good vision , recent improved BS and mild [s2] edema [e2] .	severity	lesion	T15	T22	2644164_note_8603
NonRel	Mild nonproliferative diabetic retinopathy of [s1] right eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Retina - OU - Both Eyes 362.04 Fluorescein Angiography - OU - Both Eyes Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with cystic DME in fovea .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Retina - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 2 .	laterality	lesion	T16	T1	2644164_note_8603
NonRel	Mild nonproliferative diabetic retinopathy of [s1] right eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Retina - OU - Both Eyes 362.04 Fluorescein Angiography - OU - Both Eyes Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with cystic DME in fovea .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Retina - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 2 .	laterality	lesion	T16	T2	2644164_note_8603
NonRel	Mild nonproliferative diabetic retinopathy of [s1] right eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Retina - OU - Both Eyes 362.04 Fluorescein Angiography - OU - Both Eyes Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with cystic DME in fovea .	Observe in the setting of good vision , recent improved BS and mild [s2] edema [e2] .	laterality	lesion	T16	T22	2644164_note_8603
NonRel	Mild nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Retina - OU - Both Eyes 362.04 Fluorescein Angiography - OU - Both Eyes Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] [s1] OD [e1] - Mild NPDR with cystic DME in fovea .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Retina - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 2 .	laterality	lesion	T17	T1	2644164_note_8603
NonRel	Mild nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Retina - OU - Both Eyes 362.04 Fluorescein Angiography - OU - Both Eyes Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] [s1] OD [e1] - Mild NPDR with cystic DME in fovea .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Retina - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 2 .	laterality	lesion	T17	T2	2644164_note_8603
NonRel	Mild nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Retina - OU - Both Eyes 362.04 Fluorescein Angiography - OU - Both Eyes Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] [s1] OD [e1] - Mild NPDR with cystic DME in fovea .	Observe in the setting of good vision , recent improved BS and mild [s2] edema [e2] .	laterality	lesion	T17	T22	2644164_note_8603
NonRel	Mild nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Retina - OU - Both Eyes 362.04 Fluorescein Angiography - OU - Both Eyes Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - [s1] Mild [e1] NPDR with cystic DME in fovea .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Retina - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 2 .	severity	lesion	T18	T1	2644164_note_8603
NonRel	Mild nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Retina - OU - Both Eyes 362.04 Fluorescein Angiography - OU - Both Eyes Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - [s1] Mild [e1] NPDR with cystic DME in fovea .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Retina - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 2 .	severity	lesion	T18	T2	2644164_note_8603
NonRel	Mild nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Retina - OU - Both Eyes 362.04 Fluorescein Angiography - OU - Both Eyes Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - [s1] Mild [e1] NPDR with cystic DME in fovea .	Observe in the setting of good vision , recent improved BS and mild [s2] edema [e2] .	severity	lesion	T18	T22	2644164_note_8603
NonRel	Mild nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Retina - OU - Both Eyes 362.04 Fluorescein Angiography - OU - Both Eyes Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with [s1] cystic [e1] DME in fovea .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Retina - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 2 .	severity	lesion	T19	T1	2644164_note_8603
NonRel	Mild nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Retina - OU - Both Eyes 362.04 Fluorescein Angiography - OU - Both Eyes Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with [s1] cystic [e1] DME in fovea .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Retina - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 2 .	severity	lesion	T19	T2	2644164_note_8603
NonRel	Mild nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Retina - OU - Both Eyes 362.04 Fluorescein Angiography - OU - Both Eyes Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with [s1] cystic [e1] DME in fovea .	Observe in the setting of good vision , recent improved BS and mild [s2] edema [e2] .	severity	lesion	T19	T22	2644164_note_8603
NonRel	Mild nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Retina - OU - Both Eyes 362.04 Fluorescein Angiography - OU - Both Eyes Here today for IVFA for better characterization of possible NVD [s1] OS [e1] , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with cystic DME in fovea .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Retina - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 2 .	laterality	lesion	T21	T1	2644164_note_8603
NonRel	Mild nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Retina - OU - Both Eyes 362.04 Fluorescein Angiography - OU - Both Eyes Here today for IVFA for better characterization of possible NVD [s1] OS [e1] , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with cystic DME in fovea .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Retina - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 2 .	laterality	lesion	T21	T2	2644164_note_8603
NonRel	Mild nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Retina - OU - Both Eyes 362.04 Fluorescein Angiography - OU - Both Eyes Here today for IVFA for better characterization of possible NVD [s1] OS [e1] , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with cystic DME in fovea .	Observe in the setting of good vision , recent improved BS and mild [s2] edema [e2] .	laterality	lesion	T21	T22	2644164_note_8603
NonRel	Observe in the setting of good vision , recent improved BS and mild [s1] edema [e1] .	Mild nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Retina - OU - Both Eyes 362.04 Fluorescein Angiography - OU - Both Eyes Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with cystic DME in [s2] fovea [e2] .	lesion	eye_part	T22	T10	2644164_note_8603
NonRel	Observe in the setting of good vision , recent improved BS and [s1] mild [e1] edema .	Mild [s2] nonproliferative diabetic retinopathy [e2] of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Retina - OU - Both Eyes 362.04 Fluorescein Angiography - OU - Both Eyes Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with cystic DME in fovea .	laterality	lesion	T23	T6	2644164_note_8603
NonRel	Observe in the setting of good vision , recent improved BS and [s1] mild [e1] edema .	Mild nonproliferative diabetic retinopathy of right eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Retina - OU - Both Eyes 362.04 Fluorescein Angiography - OU - Both Eyes Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with cystic DME in fovea .	laterality	lesion	T23	T7	2644164_note_8603
NonRel	Observe in the setting of good vision , recent improved BS and [s1] mild [e1] edema .	Mild nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Retina - OU - Both Eyes 362.04 Fluorescein Angiography - OU - Both Eyes Here today for IVFA for better characterization of possible [s2] NVD [e2] OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with cystic DME in fovea .	laterality	lesion	T23	T8	2644164_note_8603
NonRel	Observe in the setting of good vision , recent improved BS and [s1] mild [e1] edema .	Mild nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Retina - OU - Both Eyes 362.04 Fluorescein Angiography - OU - Both Eyes Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild [s2] NPDR [e2] with cystic DME in fovea .	laterality	lesion	T23	T9	2644164_note_8603
NonRel	Observe in the setting of good vision , recent improved BS and [s1] mild [e1] edema .	Mild nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Retina - OU - Both Eyes 362.04 Fluorescein Angiography - OU - Both Eyes Here today for IVFA for better characterization of possible NVD OS , and temporal ischemic OCT ( today ) : mild IRF OU 1 ) IDDM - [ Dx 20 years ago , A1c 9 ] OD - Mild NPDR with cystic [s2] DME [e2] in fovea .	laterality	lesion	T23	T11	2644164_note_8603
NonRel	Treatment Hx : IVFA ( 2 / 14 / 19 ) : [s1] Quiescent [e1] PDR OD , Active PDR OS PRP OU - 4 / 21 / 17 IVFA ( 4 / 20 / 17 ) : Active PDR OU 1 ) IDDM [ Hx of IDDM [ ( Type 1 since age 18 ) .	Last HgA 1 C 6.7 12 / 2018 ] - Hx of [s2] PDR [e2] OU without CSME OD - Hx of PDR s / p PRP last in 2017 .	severity	lesion	T3	T12	note_178
NonRel	Treatment Hx : IVFA ( 2 / 14 / 19 ) : [s1] Quiescent [e1] PDR OD , Active PDR OS PRP OU - 4 / 21 / 17 IVFA ( 4 / 20 / 17 ) : Active PDR OU 1 ) IDDM [ Hx of IDDM [ ( Type 1 since age 18 ) .	Last HgA 1 C 6.7 12 / 2018 ] - Hx of PDR OU without [s2] CSME OD [e2] - Hx of PDR s / p PRP last in 2017 .	severity	lesion	T3	T14	note_178
NonRel	Treatment Hx : IVFA ( 2 / 14 / 19 ) : [s1] Quiescent [e1] PDR OD , Active PDR OS PRP OU - 4 / 21 / 17 IVFA ( 4 / 20 / 17 ) : Active PDR OU 1 ) IDDM [ Hx of IDDM [ ( Type 1 since age 18 ) .	Last HgA 1 C 6.7 12 / 2018 ] - Hx of PDR OU without CSME OD - Hx of [s2] PDR [e2] s / p PRP last in 2017 .	severity	lesion	T3	T16	note_178
NonRel	Treatment Hx : IVFA ( 2 / 14 / 19 ) : Quiescent PDR [s1] OD [e1] , Active PDR OS PRP OU - 4 / 21 / 17 IVFA ( 4 / 20 / 17 ) : Active PDR OU 1 ) IDDM [ Hx of IDDM [ ( Type 1 since age 18 ) .	Last HgA 1 C 6.7 12 / 2018 ] - Hx of [s2] PDR [e2] OU without CSME OD - Hx of PDR s / p PRP last in 2017 .	laterality	lesion	T5	T12	note_178
NonRel	Treatment Hx : IVFA ( 2 / 14 / 19 ) : Quiescent PDR [s1] OD [e1] , Active PDR OS PRP OU - 4 / 21 / 17 IVFA ( 4 / 20 / 17 ) : Active PDR OU 1 ) IDDM [ Hx of IDDM [ ( Type 1 since age 18 ) .	Last HgA 1 C 6.7 12 / 2018 ] - Hx of PDR OU without [s2] CSME OD [e2] - Hx of PDR s / p PRP last in 2017 .	laterality	lesion	T5	T14	note_178
NonRel	Treatment Hx : IVFA ( 2 / 14 / 19 ) : Quiescent PDR [s1] OD [e1] , Active PDR OS PRP OU - 4 / 21 / 17 IVFA ( 4 / 20 / 17 ) : Active PDR OU 1 ) IDDM [ Hx of IDDM [ ( Type 1 since age 18 ) .	Last HgA 1 C 6.7 12 / 2018 ] - Hx of PDR OU without CSME OD - Hx of [s2] PDR [e2] s / p PRP last in 2017 .	laterality	lesion	T5	T16	note_178
NonRel	Treatment Hx : IVFA ( 2 / 14 / 19 ) : Quiescent PDR OD , [s1] Active [e1] PDR OS PRP OU - 4 / 21 / 17 IVFA ( 4 / 20 / 17 ) : Active PDR OU 1 ) IDDM [ Hx of IDDM [ ( Type 1 since age 18 ) .	Last HgA 1 C 6.7 12 / 2018 ] - Hx of [s2] PDR [e2] OU without CSME OD - Hx of PDR s / p PRP last in 2017 .	severity	lesion	T6	T12	note_178
NonRel	Treatment Hx : IVFA ( 2 / 14 / 19 ) : Quiescent PDR OD , [s1] Active [e1] PDR OS PRP OU - 4 / 21 / 17 IVFA ( 4 / 20 / 17 ) : Active PDR OU 1 ) IDDM [ Hx of IDDM [ ( Type 1 since age 18 ) .	Last HgA 1 C 6.7 12 / 2018 ] - Hx of PDR OU without [s2] CSME OD [e2] - Hx of PDR s / p PRP last in 2017 .	severity	lesion	T6	T14	note_178
NonRel	Treatment Hx : IVFA ( 2 / 14 / 19 ) : Quiescent PDR OD , [s1] Active [e1] PDR OS PRP OU - 4 / 21 / 17 IVFA ( 4 / 20 / 17 ) : Active PDR OU 1 ) IDDM [ Hx of IDDM [ ( Type 1 since age 18 ) .	Last HgA 1 C 6.7 12 / 2018 ] - Hx of PDR OU without CSME OD - Hx of [s2] PDR [e2] s / p PRP last in 2017 .	severity	lesion	T6	T16	note_178
NonRel	Treatment Hx : IVFA ( 2 / 14 / 19 ) : Quiescent PDR OD , Active PDR [s1] OS [e1] PRP OU - 4 / 21 / 17 IVFA ( 4 / 20 / 17 ) : Active PDR OU 1 ) IDDM [ Hx of IDDM [ ( Type 1 since age 18 ) .	Last HgA 1 C 6.7 12 / 2018 ] - Hx of [s2] PDR [e2] OU without CSME OD - Hx of PDR s / p PRP last in 2017 .	laterality	lesion	T8	T12	note_178
NonRel	Treatment Hx : IVFA ( 2 / 14 / 19 ) : Quiescent PDR OD , Active PDR [s1] OS [e1] PRP OU - 4 / 21 / 17 IVFA ( 4 / 20 / 17 ) : Active PDR OU 1 ) IDDM [ Hx of IDDM [ ( Type 1 since age 18 ) .	Last HgA 1 C 6.7 12 / 2018 ] - Hx of PDR OU without [s2] CSME OD [e2] - Hx of PDR s / p PRP last in 2017 .	laterality	lesion	T8	T14	note_178
NonRel	Treatment Hx : IVFA ( 2 / 14 / 19 ) : Quiescent PDR OD , Active PDR [s1] OS [e1] PRP OU - 4 / 21 / 17 IVFA ( 4 / 20 / 17 ) : Active PDR OU 1 ) IDDM [ Hx of IDDM [ ( Type 1 since age 18 ) .	Last HgA 1 C 6.7 12 / 2018 ] - Hx of PDR OU without CSME OD - Hx of [s2] PDR [e2] s / p PRP last in 2017 .	laterality	lesion	T8	T16	note_178
NonRel	Treatment Hx : IVFA ( 2 / 14 / 19 ) : Quiescent PDR OD , Active PDR OS PRP OU - 4 / 21 / 17 IVFA ( 4 / 20 / 17 ) : [s1] Active [e1] PDR OU 1 ) IDDM [ Hx of IDDM [ ( Type 1 since age 18 ) .	Last HgA 1 C 6.7 12 / 2018 ] - Hx of [s2] PDR [e2] OU without CSME OD - Hx of PDR s / p PRP last in 2017 .	severity	lesion	T9	T12	note_178
NonRel	Treatment Hx : IVFA ( 2 / 14 / 19 ) : Quiescent PDR OD , Active PDR OS PRP OU - 4 / 21 / 17 IVFA ( 4 / 20 / 17 ) : [s1] Active [e1] PDR OU 1 ) IDDM [ Hx of IDDM [ ( Type 1 since age 18 ) .	Last HgA 1 C 6.7 12 / 2018 ] - Hx of PDR OU without [s2] CSME OD [e2] - Hx of PDR s / p PRP last in 2017 .	severity	lesion	T9	T14	note_178
NonRel	Treatment Hx : IVFA ( 2 / 14 / 19 ) : Quiescent PDR OD , Active PDR OS PRP OU - 4 / 21 / 17 IVFA ( 4 / 20 / 17 ) : [s1] Active [e1] PDR OU 1 ) IDDM [ Hx of IDDM [ ( Type 1 since age 18 ) .	Last HgA 1 C 6.7 12 / 2018 ] - Hx of PDR OU without CSME OD - Hx of [s2] PDR [e2] s / p PRP last in 2017 .	severity	lesion	T9	T16	note_178
NonRel	Treatment Hx : IVFA ( 2 / 14 / 19 ) : Quiescent PDR OD , Active PDR OS PRP OU - 4 / 21 / 17 IVFA ( 4 / 20 / 17 ) : Active PDR [s1] OU [e1] 1 ) IDDM [ Hx of IDDM [ ( Type 1 since age 18 ) .	Last HgA 1 C 6.7 12 / 2018 ] - Hx of [s2] PDR [e2] OU without CSME OD - Hx of PDR s / p PRP last in 2017 .	laterality	lesion	T11	T12	note_178
NonRel	Treatment Hx : IVFA ( 2 / 14 / 19 ) : Quiescent PDR OD , Active PDR OS PRP OU - 4 / 21 / 17 IVFA ( 4 / 20 / 17 ) : Active PDR [s1] OU [e1] 1 ) IDDM [ Hx of IDDM [ ( Type 1 since age 18 ) .	Last HgA 1 C 6.7 12 / 2018 ] - Hx of PDR OU without [s2] CSME OD [e2] - Hx of PDR s / p PRP last in 2017 .	laterality	lesion	T11	T14	note_178
NonRel	Treatment Hx : IVFA ( 2 / 14 / 19 ) : Quiescent PDR OD , Active PDR OS PRP OU - 4 / 21 / 17 IVFA ( 4 / 20 / 17 ) : Active PDR [s1] OU [e1] 1 ) IDDM [ Hx of IDDM [ ( Type 1 since age 18 ) .	Last HgA 1 C 6.7 12 / 2018 ] - Hx of PDR OU without CSME OD - Hx of [s2] PDR [e2] s / p PRP last in 2017 .	laterality	lesion	T11	T16	note_178
NonRel	Last HgA 1 C 6.7 12 / 2018 ] - Hx of PDR [s1] OU [e1] without CSME OD - Hx of PDR s / p PRP last in 2017 .	Treatment Hx : IVFA ( 2 / 14 / 19 ) : Quiescent [s2] PDR [e2] OD , Active PDR OS PRP OU - 4 / 21 / 17 IVFA ( 4 / 20 / 17 ) : Active PDR OU 1 ) IDDM [ Hx of IDDM [ ( Type 1 since age 18 ) .	laterality	lesion	T13	T4	note_178
NonRel	Last HgA 1 C 6.7 12 / 2018 ] - Hx of PDR [s1] OU [e1] without CSME OD - Hx of PDR s / p PRP last in 2017 .	Treatment Hx : IVFA ( 2 / 14 / 19 ) : Quiescent PDR OD , Active [s2] PDR [e2] OS PRP OU - 4 / 21 / 17 IVFA ( 4 / 20 / 17 ) : Active PDR OU 1 ) IDDM [ Hx of IDDM [ ( Type 1 since age 18 ) .	laterality	lesion	T13	T7	note_178
NonRel	Last HgA 1 C 6.7 12 / 2018 ] - Hx of PDR [s1] OU [e1] without CSME OD - Hx of PDR s / p PRP last in 2017 .	Treatment Hx : IVFA ( 2 / 14 / 19 ) : Quiescent PDR OD , Active PDR OS PRP OU - 4 / 21 / 17 IVFA ( 4 / 20 / 17 ) : Active [s2] PDR [e2] OU 1 ) IDDM [ Hx of IDDM [ ( Type 1 since age 18 ) .	laterality	lesion	T13	T10	note_178
NonRel	Last HgA 1 C 6.7 12 / 2018 ] - Hx of PDR OU without CSME [s1] OD [e1] - Hx of PDR s / p PRP last in 2017 .	Treatment Hx : IVFA ( 2 / 14 / 19 ) : Quiescent [s2] PDR [e2] OD , Active PDR OS PRP OU - 4 / 21 / 17 IVFA ( 4 / 20 / 17 ) : Active PDR OU 1 ) IDDM [ Hx of IDDM [ ( Type 1 since age 18 ) .	laterality	lesion	T15	T4	note_178
NonRel	Last HgA 1 C 6.7 12 / 2018 ] - Hx of PDR OU without CSME [s1] OD [e1] - Hx of PDR s / p PRP last in 2017 .	Treatment Hx : IVFA ( 2 / 14 / 19 ) : Quiescent PDR OD , Active [s2] PDR [e2] OS PRP OU - 4 / 21 / 17 IVFA ( 4 / 20 / 17 ) : Active PDR OU 1 ) IDDM [ Hx of IDDM [ ( Type 1 since age 18 ) .	laterality	lesion	T15	T7	note_178
NonRel	Last HgA 1 C 6.7 12 / 2018 ] - Hx of PDR OU without CSME [s1] OD [e1] - Hx of PDR s / p PRP last in 2017 .	Treatment Hx : IVFA ( 2 / 14 / 19 ) : Quiescent PDR OD , Active PDR OS PRP OU - 4 / 21 / 17 IVFA ( 4 / 20 / 17 ) : Active [s2] PDR [e2] OU 1 ) IDDM [ Hx of IDDM [ ( Type 1 since age 18 ) .	laterality	lesion	T15	T10	note_178
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] without macular edema associated with type 2 diabetes mellitus E11.3593 250.50 OCT , Retina - OU - Both Eyes 362.02 2 .	Diabetes mellitus type 2 , insulin dependent E11.9 250.00 Z79.4 V58.67 Hx of [s2] PDR [e2] OU with CSME OU ( s / p PRP with Focal OU ) , management of both eyes in St Petersberg 1 ) IDDM - Hx PDR OU s / p PRP OU ( extensive laser OD > OS ) .	laterality	lesion	T2	T4	note_6094
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] without macular edema associated with type 2 diabetes mellitus E11.3593 250.50 OCT , Retina - OU - Both Eyes 362.02 2 .	Diabetes mellitus type 2 , insulin dependent E11.9 250.00 Z79.4 V58.67 Hx of PDR OU with [s2] CSME [e2] OU ( s / p PRP with Focal OU ) , management of both eyes in St Petersberg 1 ) IDDM - Hx PDR OU s / p PRP OU ( extensive laser OD > OS ) .	laterality	lesion	T2	T5	note_6094
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] without macular edema associated with type 2 diabetes mellitus E11.3593 250.50 OCT , Retina - OU - Both Eyes 362.02 2 .	Diabetes mellitus type 2 , insulin dependent E11.9 250.00 Z79.4 V58.67 Hx of PDR OU with CSME OU ( s / p PRP with Focal OU ) , management of both eyes in St Petersberg 1 ) IDDM - Hx [s2] PDR [e2] OU s / p PRP OU ( extensive laser OD > OS ) .	laterality	lesion	T2	T8	note_6094
NonRel	Diabetes mellitus type 2 , insulin dependent E11.9 250.00 Z79.4 V58.67 Hx of PDR [s1] OU [e1] with CSME OU ( s / p PRP with Focal OU ) , management of both eyes in St Petersberg 1 ) IDDM - Hx PDR OU s / p PRP OU ( extensive laser OD > OS ) .	[s2] Proliferative diabetic retinopathy [e2] of both eyes without macular edema associated with type 2 diabetes mellitus E11.3593 250.50 OCT , Retina - OU - Both Eyes 362.02 2 .	laterality	lesion	T6	T1	note_6094
NonRel	Diabetes mellitus type 2 , insulin dependent E11.9 250.00 Z79.4 V58.67 Hx of PDR [s1] OU [e1] with CSME OU ( s / p PRP with Focal OU ) , management of both eyes in St Petersberg 1 ) IDDM - Hx PDR OU s / p PRP OU ( extensive laser OD > OS ) .	Proliferative diabetic retinopathy of both eyes without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3593 250.50 OCT , Retina - OU - Both Eyes 362.02 2 .	laterality	lesion	T6	T3	note_6094
NonRel	Diabetes mellitus type 2 , insulin dependent E11.9 250.00 Z79.4 V58.67 Hx of PDR [s1] OU [e1] with CSME OU ( s / p PRP with Focal OU ) , management of both eyes in St Petersberg 1 ) IDDM - Hx PDR OU s / p PRP OU ( extensive laser OD > OS ) .	Quiescent [s2] PDR [e2] OU Heavy posterior laser with outer retinal atrophy OD influencing measured vision .	laterality	lesion	T6	T10	note_6094
NonRel	Diabetes mellitus type 2 , insulin dependent E11.9 250.00 Z79.4 V58.67 Hx of PDR OU with CSME [s1] OU [e1] ( s / p PRP with Focal OU ) , management of both eyes in St Petersberg 1 ) IDDM - Hx PDR OU s / p PRP OU ( extensive laser OD > OS ) .	[s2] Proliferative diabetic retinopathy [e2] of both eyes without macular edema associated with type 2 diabetes mellitus E11.3593 250.50 OCT , Retina - OU - Both Eyes 362.02 2 .	laterality	lesion	T7	T1	note_6094
NonRel	Diabetes mellitus type 2 , insulin dependent E11.9 250.00 Z79.4 V58.67 Hx of PDR OU with CSME [s1] OU [e1] ( s / p PRP with Focal OU ) , management of both eyes in St Petersberg 1 ) IDDM - Hx PDR OU s / p PRP OU ( extensive laser OD > OS ) .	Proliferative diabetic retinopathy of both eyes without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3593 250.50 OCT , Retina - OU - Both Eyes 362.02 2 .	laterality	lesion	T7	T3	note_6094
NonRel	Diabetes mellitus type 2 , insulin dependent E11.9 250.00 Z79.4 V58.67 Hx of PDR OU with CSME [s1] OU [e1] ( s / p PRP with Focal OU ) , management of both eyes in St Petersberg 1 ) IDDM - Hx PDR OU s / p PRP OU ( extensive laser OD > OS ) .	Quiescent [s2] PDR [e2] OU Heavy posterior laser with outer retinal atrophy OD influencing measured vision .	laterality	lesion	T7	T10	note_6094
NonRel	Diabetes mellitus type 2 , insulin dependent E11.9 250.00 Z79.4 V58.67 Hx of PDR OU with CSME OU ( s / p PRP with Focal OU ) , management of both eyes in St Petersberg 1 ) IDDM - Hx PDR [s1] OU [e1] s / p PRP OU ( extensive laser OD > OS ) .	[s2] Proliferative diabetic retinopathy [e2] of both eyes without macular edema associated with type 2 diabetes mellitus E11.3593 250.50 OCT , Retina - OU - Both Eyes 362.02 2 .	laterality	lesion	T9	T1	note_6094
NonRel	Diabetes mellitus type 2 , insulin dependent E11.9 250.00 Z79.4 V58.67 Hx of PDR OU with CSME OU ( s / p PRP with Focal OU ) , management of both eyes in St Petersberg 1 ) IDDM - Hx PDR [s1] OU [e1] s / p PRP OU ( extensive laser OD > OS ) .	Proliferative diabetic retinopathy of both eyes without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3593 250.50 OCT , Retina - OU - Both Eyes 362.02 2 .	laterality	lesion	T9	T3	note_6094
NonRel	Diabetes mellitus type 2 , insulin dependent E11.9 250.00 Z79.4 V58.67 Hx of PDR OU with CSME OU ( s / p PRP with Focal OU ) , management of both eyes in St Petersberg 1 ) IDDM - Hx PDR [s1] OU [e1] s / p PRP OU ( extensive laser OD > OS ) .	Quiescent [s2] PDR [e2] OU Heavy posterior laser with outer retinal atrophy OD influencing measured vision .	laterality	lesion	T9	T10	note_6094
NonRel	Quiescent PDR [s1] OU [e1] Heavy posterior laser with outer retinal atrophy OD influencing measured vision .	Diabetes mellitus type 2 , insulin dependent E11.9 250.00 Z79.4 V58.67 Hx of [s2] PDR [e2] OU with CSME OU ( s / p PRP with Focal OU ) , management of both eyes in St Petersberg 1 ) IDDM - Hx PDR OU s / p PRP OU ( extensive laser OD > OS ) .	laterality	lesion	T11	T4	note_6094
NonRel	Quiescent PDR [s1] OU [e1] Heavy posterior laser with outer retinal atrophy OD influencing measured vision .	Diabetes mellitus type 2 , insulin dependent E11.9 250.00 Z79.4 V58.67 Hx of PDR OU with [s2] CSME [e2] OU ( s / p PRP with Focal OU ) , management of both eyes in St Petersberg 1 ) IDDM - Hx PDR OU s / p PRP OU ( extensive laser OD > OS ) .	laterality	lesion	T11	T5	note_6094
NonRel	Quiescent PDR [s1] OU [e1] Heavy posterior laser with outer retinal atrophy OD influencing measured vision .	Diabetes mellitus type 2 , insulin dependent E11.9 250.00 Z79.4 V58.67 Hx of PDR OU with CSME OU ( s / p PRP with Focal OU ) , management of both eyes in St Petersberg 1 ) IDDM - Hx [s2] PDR [e2] OU s / p PRP OU ( extensive laser OD > OS ) .	laterality	lesion	T11	T8	note_6094
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Severe [s2] nonproliferative diabetic retinopathy [e2] of left eye , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	severity	lesion	T1	T6	note_7100
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Severe nonproliferative diabetic retinopathy of left eye , with [s2] macular edema [e2] , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	severity	lesion	T1	T8	note_7100
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Severe [s2] nonproliferative diabetic retinopathy [e2] of left eye , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T3	T6	note_7100
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Severe nonproliferative diabetic retinopathy of left eye , with [s2] macular edema [e2] , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T3	T8	note_7100
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of left eye , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	severity	lesion	T5	T2	note_7100
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of left eye , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	severity	lesion	T5	T4	note_7100
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of left eye , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Posterior Segment - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / [s2] VH [e2] OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe NPDR OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	severity	lesion	T5	T10	note_7100
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of left eye , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Posterior Segment - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe [s2] NPDR [e2] OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	severity	lesion	T5	T13	note_7100
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of left eye , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Posterior Segment - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe NPDR OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of [s2] NPDR [e2] , CSME OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	severity	lesion	T5	T16	note_7100
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of left eye , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Posterior Segment - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe NPDR OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , [s2] CSME [e2] OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	severity	lesion	T5	T17	note_7100
NonRel	Severe nonproliferative diabetic retinopathy of [s1] left eye [e1] , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	laterality	lesion	T7	T2	note_7100
NonRel	Severe nonproliferative diabetic retinopathy of [s1] left eye [e1] , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	laterality	lesion	T7	T4	note_7100
NonRel	Severe nonproliferative diabetic retinopathy of [s1] left eye [e1] , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Posterior Segment - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / [s2] VH [e2] OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe NPDR OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	laterality	lesion	T7	T10	note_7100
NonRel	Severe nonproliferative diabetic retinopathy of [s1] left eye [e1] , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Posterior Segment - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe [s2] NPDR [e2] OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	laterality	lesion	T7	T13	note_7100
NonRel	Severe nonproliferative diabetic retinopathy of [s1] left eye [e1] , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Posterior Segment - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe NPDR OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of [s2] NPDR [e2] , CSME OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	laterality	lesion	T7	T16	note_7100
NonRel	Severe nonproliferative diabetic retinopathy of [s1] left eye [e1] , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Posterior Segment - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe NPDR OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , [s2] CSME [e2] OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	laterality	lesion	T7	T17	note_7100
NonRel	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Posterior Segment - OU - Both Eyes Treatment History Ozurdex [s1] OU [e1] - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe NPDR OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	Severe [s2] nonproliferative diabetic retinopathy [e2] of left eye , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T9	T6	note_7100
NonRel	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Posterior Segment - OU - Both Eyes Treatment History Ozurdex [s1] OU [e1] - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe NPDR OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	Severe nonproliferative diabetic retinopathy of left eye , with [s2] macular edema [e2] , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T9	T8	note_7100
NonRel	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Posterior Segment - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view [s1] OD [e1] , Severe NPDR OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	Severe [s2] nonproliferative diabetic retinopathy [e2] of left eye , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T11	T6	note_7100
NonRel	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Posterior Segment - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view [s1] OD [e1] , Severe NPDR OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	Severe nonproliferative diabetic retinopathy of left eye , with [s2] macular edema [e2] , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T11	T8	note_7100
NonRel	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Posterior Segment - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , [s1] Severe [e1] NPDR OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	Severe [s2] nonproliferative diabetic retinopathy [e2] of left eye , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	severity	lesion	T12	T6	note_7100
NonRel	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Posterior Segment - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , [s1] Severe [e1] NPDR OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	Severe nonproliferative diabetic retinopathy of left eye , with [s2] macular edema [e2] , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	severity	lesion	T12	T8	note_7100
NonRel	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Posterior Segment - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe NPDR [s1] OS [e1] Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	Severe [s2] nonproliferative diabetic retinopathy [e2] of left eye , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T14	T6	note_7100
NonRel	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Posterior Segment - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe NPDR [s1] OS [e1] Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	Severe nonproliferative diabetic retinopathy of left eye , with [s2] macular edema [e2] , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T14	T8	note_7100
NonRel	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Posterior Segment - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe NPDR OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME [s1] OU [e1] ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	Severe [s2] nonproliferative diabetic retinopathy [e2] of left eye , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T18	T6	note_7100
NonRel	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Posterior Segment - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe NPDR OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME [s1] OU [e1] ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	Severe nonproliferative diabetic retinopathy of left eye , with [s2] macular edema [e2] , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T18	T8	note_7100
NonRel	OCT with [s1] significant [e1] ME .	OS - Severe [s2] NPDR [e2] with CSME now s / p Ozurdex .	severity	lesion	T20	T24	note_7100
NonRel	OCT with [s1] significant [e1] ME .	OS - Severe NPDR with [s2] CSME [e2] now s / p Ozurdex .	severity	lesion	T20	T25	note_7100
NonRel	[s1] OS [e1] - Severe NPDR with CSME now s / p Ozurdex .	OCT with significant [s2] ME [e2] .	laterality	lesion	T22	T21	note_7100
NonRel	OS - [s1] Severe [e1] NPDR with CSME now s / p Ozurdex .	OCT with significant [s2] ME [e2] .	severity	lesion	T23	T21	note_7100
NonRel	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Posterior Segment - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / VH [s1] OD [e1] - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe NPDR OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	Severe [s2] nonproliferative diabetic retinopathy [e2] of left eye , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T31	T6	note_7100
NonRel	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Posterior Segment - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / VH [s1] OD [e1] - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe NPDR OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	Severe nonproliferative diabetic retinopathy of left eye , with [s2] macular edema [e2] , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T31	T8	note_7100
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 2 .	[s2] Vitreous hemorrhage [e2] of right eye ( CMS - HCC code ) H43.11 379.23 OCT , Posterior Segment - OU - Both Eyes 3 .	laterality	lesion	T3	T5	note_2150
NonRel	Vitreous hemorrhage of [s1] right eye [e1] ( CMS - HCC code ) H43.11 379.23 OCT , Posterior Segment - OU - Both Eyes 3 .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 2 .	laterality	lesion	T6	T2	note_2150
NonRel	Vitreous hemorrhage of [s1] right eye [e1] ( CMS - HCC code ) H43.11 379.23 OCT , Posterior Segment - OU - Both Eyes 3 .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 2 .	laterality	lesion	T6	T4	note_2150
NonRel	Vitreous hemorrhage of [s1] right eye [e1] ( CMS - HCC code ) H43.11 379.23 OCT , Posterior Segment - OU - Both Eyes 3 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus - Left Eye E11.3512 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.02 Hx OF PDR OU , here for new floaters OD since 9 / 21 with new vit heme noted last visit .	laterality	lesion	T6	T7	note_2150
NonRel	Vitreous hemorrhage of [s1] right eye [e1] ( CMS - HCC code ) H43.11 379.23 OCT , Posterior Segment - OU - Both Eyes 3 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus - Left Eye E11.3512 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.02 Hx OF PDR OU , here for new floaters OD since 9 / 21 with new vit heme noted last visit .	laterality	lesion	T6	T9	note_2150
NonRel	Vitreous hemorrhage of [s1] right eye [e1] ( CMS - HCC code ) H43.11 379.23 OCT , Posterior Segment - OU - Both Eyes 3 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus - Left Eye E11.3512 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.02 Hx OF PDR OU , here for new floaters OD since 9 / 21 with new [s2] vit heme [e2] noted last visit .	laterality	lesion	T6	T26	note_2150
NonRel	Vitreous hemorrhage of [s1] right eye [e1] ( CMS - HCC code ) H43.11 379.23 OCT , Posterior Segment - OU - Both Eyes 3 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus - Left Eye E11.3512 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.02 Hx OF [s2] PDR [e2] OU , here for new floaters OD since 9 / 21 with new vit heme noted last visit .	laterality	lesion	T6	T28	note_2150
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus - Left Eye E11.3512 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.02 Hx OF PDR OU , here for new floaters OD since 9 / 21 with new vit heme noted last visit .	[s2] Vitreous hemorrhage [e2] of right eye ( CMS - HCC code ) H43.11 379.23 OCT , Posterior Segment - OU - Both Eyes 3 .	laterality	lesion	T8	T5	note_2150
NonRel	Treatment Hx : IVA OS - 1 / 4 / 19 ( today ) IVA OD - 11 / 30 / 18 IVA OD - 10 / 25 / 18 IVA OD - 9 / 27 / 18 Focal + PRP ( IVFA guided ) OS - 9 / 7 / 18 IVFA ( 8 / 10 / 18 ) - [s1] Active [e1] PDR OS ( residual NVE ) IVA OD - 12 / 29 / 17 IVA OD - 11 / 28 / 17 PRP OU - 5 / 19 / 2017 IVFA ( 5 / 4 / 17 ) : No demonstrable NVE OD ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	IVA OD - 3 / 24 / 2017 IVA OD - 2 / 10 / 17 PRP OS - 2 / 10 / 17 IVFA ( 2 / 10 / 2017 ) - Only limited peripheral view OD , but [s2] NVE [e2] with peripheral dropout .	severity	lesion	T10	T18	note_2150
NonRel	Treatment Hx : IVA OS - 1 / 4 / 19 ( today ) IVA OD - 11 / 30 / 18 IVA OD - 10 / 25 / 18 IVA OD - 9 / 27 / 18 Focal + PRP ( IVFA guided ) OS - 9 / 7 / 18 IVFA ( 8 / 10 / 18 ) - Active PDR [s1] OS [e1] ( residual NVE ) IVA OD - 12 / 29 / 17 IVA OD - 11 / 28 / 17 PRP OU - 5 / 19 / 2017 IVFA ( 5 / 4 / 17 ) : No demonstrable NVE OD ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	IVA OD - 3 / 24 / 2017 IVA OD - 2 / 10 / 17 PRP OS - 2 / 10 / 17 IVFA ( 2 / 10 / 2017 ) - Only limited peripheral view OD , but [s2] NVE [e2] with peripheral dropout .	laterality	lesion	T12	T18	note_2150
NonRel	Treatment Hx : IVA OS - 1 / 4 / 19 ( today ) IVA OD - 11 / 30 / 18 IVA OD - 10 / 25 / 18 IVA OD - 9 / 27 / 18 Focal + PRP ( IVFA guided ) OS - 9 / 7 / 18 IVFA ( 8 / 10 / 18 ) - Active PDR OS ( residual NVE ) IVA OD - 12 / 29 / 17 IVA OD - 11 / 28 / 17 PRP OU - 5 / 19 / 2017 IVFA ( 5 / 4 / 17 ) : No demonstrable NVE [s1] OD [e1] ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	IVA OD - 3 / 24 / 2017 IVA OD - 2 / 10 / 17 PRP OS - 2 / 10 / 17 IVFA ( 2 / 10 / 2017 ) - Only limited peripheral view OD , but [s2] NVE [e2] with peripheral dropout .	laterality	lesion	T15	T18	note_2150
NonRel	Treatment Hx : IVA OS - 1 / 4 / 19 ( today ) IVA OD - 11 / 30 / 18 IVA OD - 10 / 25 / 18 IVA OD - 9 / 27 / 18 Focal + PRP ( IVFA guided ) OS - 9 / 7 / 18 IVFA ( 8 / 10 / 18 ) - Active PDR OS ( residual NVE ) IVA OD - 12 / 29 / 17 IVA OD - 11 / 28 / 17 PRP OU - 5 / 19 / 2017 IVFA ( 5 / 4 / 17 ) : No demonstrable NVE OD ( IVA masking possible ) , [s1] OS [e1] with still active areas of NVE but with great improvement since prior to first laser .	IVA OD - 3 / 24 / 2017 IVA OD - 2 / 10 / 17 PRP OS - 2 / 10 / 17 IVFA ( 2 / 10 / 2017 ) - Only limited peripheral view OD , but [s2] NVE [e2] with peripheral dropout .	laterality	lesion	T17	T18	note_2150
NonRel	[s1] OS [e1] with active NVE and peripheral non - perfusion inferonasally .	IVA OD - 3 / 24 / 2017 IVA OD - 2 / 10 / 17 PRP OS - 2 / 10 / 17 IVFA ( 2 / 10 / 2017 ) - Only limited peripheral view OD , but [s2] NVE [e2] with peripheral dropout .	laterality	lesion	T19	T18	note_2150
NonRel	OS with [s1] active [e1] NVE and peripheral non - perfusion inferonasally .	IVA OD - 3 / 24 / 2017 IVA OD - 2 / 10 / 17 PRP OS - 2 / 10 / 17 IVFA ( 2 / 10 / 2017 ) - Only limited peripheral view OD , but [s2] NVE [e2] with peripheral dropout .	severity	lesion	T20	T18	note_2150
NonRel	IVA OD - 3 / 24 / 2017 IVA OD - 2 / 10 / 17 PRP OS - 2 / 10 / 17 IVFA ( 2 / 10 / 2017 ) - Only limited peripheral view [s1] OD [e1] , but NVE with peripheral dropout .	Treatment Hx : IVA OS - 1 / 4 / 19 ( today ) IVA OD - 11 / 30 / 18 IVA OD - 10 / 25 / 18 IVA OD - 9 / 27 / 18 Focal + PRP ( IVFA guided ) OS - 9 / 7 / 18 IVFA ( 8 / 10 / 18 ) - Active [s2] PDR [e2] OS ( residual NVE ) IVA OD - 12 / 29 / 17 IVA OD - 11 / 28 / 17 PRP OU - 5 / 19 / 2017 IVFA ( 5 / 4 / 17 ) : No demonstrable NVE OD ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	laterality	lesion	T24	T11	note_2150
NonRel	IVA OD - 3 / 24 / 2017 IVA OD - 2 / 10 / 17 PRP OS - 2 / 10 / 17 IVFA ( 2 / 10 / 2017 ) - Only limited peripheral view [s1] OD [e1] , but NVE with peripheral dropout .	Treatment Hx : IVA OS - 1 / 4 / 19 ( today ) IVA OD - 11 / 30 / 18 IVA OD - 10 / 25 / 18 IVA OD - 9 / 27 / 18 Focal + PRP ( IVFA guided ) OS - 9 / 7 / 18 IVFA ( 8 / 10 / 18 ) - Active PDR OS ( residual [s2] NVE [e2] ) IVA OD - 12 / 29 / 17 IVA OD - 11 / 28 / 17 PRP OU - 5 / 19 / 2017 IVFA ( 5 / 4 / 17 ) : No demonstrable NVE OD ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	laterality	lesion	T24	T13	note_2150
NonRel	IVA OD - 3 / 24 / 2017 IVA OD - 2 / 10 / 17 PRP OS - 2 / 10 / 17 IVFA ( 2 / 10 / 2017 ) - Only limited peripheral view [s1] OD [e1] , but NVE with peripheral dropout .	Treatment Hx : IVA OS - 1 / 4 / 19 ( today ) IVA OD - 11 / 30 / 18 IVA OD - 10 / 25 / 18 IVA OD - 9 / 27 / 18 Focal + PRP ( IVFA guided ) OS - 9 / 7 / 18 IVFA ( 8 / 10 / 18 ) - Active PDR OS ( residual NVE ) IVA OD - 12 / 29 / 17 IVA OD - 11 / 28 / 17 PRP OU - 5 / 19 / 2017 IVFA ( 5 / 4 / 17 ) : No demonstrable [s2] NVE [e2] OD ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	laterality	lesion	T24	T14	note_2150
NonRel	IVA OD - 3 / 24 / 2017 IVA OD - 2 / 10 / 17 PRP OS - 2 / 10 / 17 IVFA ( 2 / 10 / 2017 ) - Only limited peripheral view [s1] OD [e1] , but NVE with peripheral dropout .	Treatment Hx : IVA OS - 1 / 4 / 19 ( today ) IVA OD - 11 / 30 / 18 IVA OD - 10 / 25 / 18 IVA OD - 9 / 27 / 18 Focal + PRP ( IVFA guided ) OS - 9 / 7 / 18 IVFA ( 8 / 10 / 18 ) - Active PDR OS ( residual NVE ) IVA OD - 12 / 29 / 17 IVA OD - 11 / 28 / 17 PRP OU - 5 / 19 / 2017 IVFA ( 5 / 4 / 17 ) : No demonstrable NVE OD ( IVA masking possible ) , OS with still active areas of [s2] NVE [e2] but with great improvement since prior to first laser .	laterality	lesion	T24	T16	note_2150
NonRel	IVA OD - 3 / 24 / 2017 IVA OD - 2 / 10 / 17 PRP OS - 2 / 10 / 17 IVFA ( 2 / 10 / 2017 ) - Only limited peripheral view [s1] OD [e1] , but NVE with peripheral dropout .	OS with active [s2] NVE [e2] and peripheral non - perfusion inferonasally .	laterality	lesion	T24	T21	note_2150
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus - Left Eye E11.3512 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.02 Hx OF PDR OU , here for new floaters [s1] OD [e1] since 9 / 21 with new vit heme noted last visit .	[s2] Vitreous hemorrhage [e2] of right eye ( CMS - HCC code ) H43.11 379.23 OCT , Posterior Segment - OU - Both Eyes 3 .	laterality	lesion	T27	T5	note_2150
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus - Left Eye E11.3512 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 362.02 Hx OF PDR [s1] OU [e1] , here for new floaters OD since 9 / 21 with new vit heme noted last visit .	[s2] Vitreous hemorrhage [e2] of right eye ( CMS - HCC code ) H43.11 379.23 OCT , Posterior Segment - OU - Both Eyes 3 .	laterality	lesion	T29	T5	note_2150
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	[s2] Proliferative diabetic retinopathy [e2] associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	severity	lesion	T9	T1	note_170
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New [s2] NVE [e2] temporally .	severity	lesion	T9	T2	note_170
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	Mild [s2] NPDR [e2] now .	severity	lesion	T9	T12	note_170
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : [s2] PDR [e2] OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	severity	lesion	T9	T16	note_170
NonRel	[s1] Mild [e1] NPDR now .	No [s2] NVI [e2] or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T11	T3	note_170
NonRel	[s1] Mild [e1] NPDR now .	No NVI or [s2] NVD [e2] or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T11	T4	note_170
NonRel	[s1] Mild [e1] NPDR now .	No NVI or NVD or [s2] NVA [e2] Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T11	T5	note_170
NonRel	[s1] Mild [e1] NPDR now .	No NVI or NVD or NVA Mac OCT without [s2] Edema [e2] , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T11	T6	note_170
NonRel	[s1] Mild [e1] NPDR now .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms [s2] NVE [e2] temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T11	T8	note_170
NonRel	[s1] Mild [e1] NPDR now .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No [s2] Neovascularization [e2] .	severity	lesion	T11	T10	note_170
NonRel	[s1] Mild [e1] NPDR now .	Mac OCT without [s2] Edema [e2] , mild ERM , no posterior hyloid IVFA with shallow ITQ tractional RD with leakage Consented for PRP left eye mid periphery x 360 Kevin Talbot , MD participated in the care of this patient .	severity	lesion	T11	T13	note_170
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - [s1] OD [e1] - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No [s2] NVI [e2] or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T7	T3	note_170
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - [s1] OD [e1] - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or [s2] NVD [e2] or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T7	T4	note_170
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - [s1] OD [e1] - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or [s2] NVA [e2] Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T7	T5	note_170
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - [s1] OD [e1] - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without [s2] Edema [e2] , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T7	T6	note_170
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - [s1] OD [e1] - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms [s2] NVE [e2] temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T7	T8	note_170
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - [s1] OD [e1] - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No [s2] Neovascularization [e2] .	laterality	lesion	T7	T10	note_170
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) [s1] OD [e1] : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No [s2] NVI [e2] or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T14	T3	note_170
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) [s1] OD [e1] : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or [s2] NVD [e2] or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T14	T4	note_170
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) [s1] OD [e1] : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or [s2] NVA [e2] Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T14	T5	note_170
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) [s1] OD [e1] : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without [s2] Edema [e2] , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T14	T6	note_170
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) [s1] OD [e1] : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms [s2] NVE [e2] temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T14	T8	note_170
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) [s1] OD [e1] : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No [s2] Neovascularization [e2] .	laterality	lesion	T14	T10	note_170
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	No [s2] NVI [e2] or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T15	T3	note_170
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	No NVI or [s2] NVD [e2] or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T15	T4	note_170
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	No NVI or NVD or [s2] NVA [e2] Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T15	T5	note_170
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	No NVI or NVD or NVA Mac OCT without [s2] Edema [e2] , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T15	T6	note_170
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms [s2] NVE [e2] temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T15	T8	note_170
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No [s2] Neovascularization [e2] .	severity	lesion	T15	T10	note_170
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No [s2] NVI [e2] or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T17	T3	note_170
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or [s2] NVD [e2] or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T17	T4	note_170
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or [s2] NVA [e2] Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T17	T5	note_170
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without [s2] Edema [e2] , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T17	T6	note_170
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms [s2] NVE [e2] temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T17	T8	note_170
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No [s2] Neovascularization [e2] .	laterality	lesion	T17	T10	note_170
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 1 diabetes mellitus E10.3513 250.51 362.07 362.02 Hx of PDR OU , TRD OS now s / p PPV .	Now interested in options for OD . Treatment Hx : PPV / TRD OS - 12 / 27 / 17 IVA OS - 12 / 22 / 17 ( preop ) IVFA ( 9 / 26 / 17 ) - Active [s2] PDR [e2] OS PPV x 2 / SO OD - 2015 / 2016 ( Outside UF ) IVA OD x 3 1 ) IDDM - Hx of PDR OU OD - s / p PPV x 2 and now with dense cataract with no view to the posterior segment .	laterality	lesion	T2	T5	note_1854
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 1 diabetes mellitus E10.3513 250.51 362.07 362.02 Hx of PDR OU , TRD OS now s / p PPV .	Now interested in options for OD . Treatment Hx : PPV / TRD OS - 12 / 27 / 17 IVA OS - 12 / 22 / 17 ( preop ) IVFA ( 9 / 26 / 17 ) - Active PDR OS PPV x 2 / SO OD - 2015 / 2016 ( Outside UF ) IVA OD x 3 1 ) IDDM - Hx of [s2] PDR [e2] OU OD - s / p PPV x 2 and now with dense cataract with no view to the posterior segment .	laterality	lesion	T2	T8	note_1854
NonRel	Now interested in options for OD . Treatment Hx : PPV / TRD OS - 12 / 27 / 17 IVA OS - 12 / 22 / 17 ( preop ) IVFA ( 9 / 26 / 17 ) - [s1] Active [e1] PDR OS PPV x 2 / SO OD - 2015 / 2016 ( Outside UF ) IVA OD x 3 1 ) IDDM - Hx of PDR OU OD - s / p PPV x 2 and now with dense cataract with no view to the posterior segment .	[s2] Proliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 1 diabetes mellitus E10.3513 250.51 362.07 362.02 Hx of PDR OU , TRD OS now s / p PPV .	severity	lesion	T4	T1	note_1854
NonRel	Now interested in options for OD . Treatment Hx : PPV / TRD OS - 12 / 27 / 17 IVA OS - 12 / 22 / 17 ( preop ) IVFA ( 9 / 26 / 17 ) - [s1] Active [e1] PDR OS PPV x 2 / SO OD - 2015 / 2016 ( Outside UF ) IVA OD x 3 1 ) IDDM - Hx of PDR OU OD - s / p PPV x 2 and now with dense cataract with no view to the posterior segment .	Proliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 1 diabetes mellitus E10.3513 250.51 362.07 362.02 Hx of PDR OU , TRD OS now s / p PPV .	severity	lesion	T4	T3	note_1854
NonRel	Now interested in options for OD . Treatment Hx : PPV / TRD OS - 12 / 27 / 17 IVA OS - 12 / 22 / 17 ( preop ) IVFA ( 9 / 26 / 17 ) - [s1] Active [e1] PDR OS PPV x 2 / SO OD - 2015 / 2016 ( Outside UF ) IVA OD x 3 1 ) IDDM - Hx of PDR OU OD - s / p PPV x 2 and now with dense cataract with no view to the posterior segment .	AC shallow , no [s2] NVI [e2] today but there is heme on the corneal endothelium .	severity	lesion	T4	T7	note_1854
NonRel	Now interested in options for OD . Treatment Hx : PPV / TRD OS - 12 / 27 / 17 IVA OS - 12 / 22 / 17 ( preop ) IVFA ( 9 / 26 / 17 ) - Active PDR [s1] OS [e1] PPV x 2 / SO OD - 2015 / 2016 ( Outside UF ) IVA OD x 3 1 ) IDDM - Hx of PDR OU OD - s / p PPV x 2 and now with dense cataract with no view to the posterior segment .	[s2] Proliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 1 diabetes mellitus E10.3513 250.51 362.07 362.02 Hx of PDR OU , TRD OS now s / p PPV .	laterality	lesion	T6	T1	note_1854
NonRel	Now interested in options for OD . Treatment Hx : PPV / TRD OS - 12 / 27 / 17 IVA OS - 12 / 22 / 17 ( preop ) IVFA ( 9 / 26 / 17 ) - Active PDR [s1] OS [e1] PPV x 2 / SO OD - 2015 / 2016 ( Outside UF ) IVA OD x 3 1 ) IDDM - Hx of PDR OU OD - s / p PPV x 2 and now with dense cataract with no view to the posterior segment .	Proliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 1 diabetes mellitus E10.3513 250.51 362.07 362.02 Hx of PDR OU , TRD OS now s / p PPV .	laterality	lesion	T6	T3	note_1854
NonRel	Now interested in options for OD . Treatment Hx : PPV / TRD OS - 12 / 27 / 17 IVA OS - 12 / 22 / 17 ( preop ) IVFA ( 9 / 26 / 17 ) - Active PDR [s1] OS [e1] PPV x 2 / SO OD - 2015 / 2016 ( Outside UF ) IVA OD x 3 1 ) IDDM - Hx of PDR OU OD - s / p PPV x 2 and now with dense cataract with no view to the posterior segment .	AC shallow , no [s2] NVI [e2] today but there is heme on the corneal endothelium .	laterality	lesion	T6	T7	note_1854
NonRel	Now interested in options for OD . Treatment Hx : PPV / TRD OS - 12 / 27 / 17 IVA OS - 12 / 22 / 17 ( preop ) IVFA ( 9 / 26 / 17 ) - Active PDR OS PPV x 2 / SO OD - 2015 / 2016 ( Outside UF ) IVA OD x 3 1 ) IDDM - Hx of PDR [s1] OU [e1] OD - s / p PPV x 2 and now with dense cataract with no view to the posterior segment .	[s2] Proliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 1 diabetes mellitus E10.3513 250.51 362.07 362.02 Hx of PDR OU , TRD OS now s / p PPV .	laterality	lesion	T9	T1	note_1854
NonRel	Now interested in options for OD . Treatment Hx : PPV / TRD OS - 12 / 27 / 17 IVA OS - 12 / 22 / 17 ( preop ) IVFA ( 9 / 26 / 17 ) - Active PDR OS PPV x 2 / SO OD - 2015 / 2016 ( Outside UF ) IVA OD x 3 1 ) IDDM - Hx of PDR [s1] OU [e1] OD - s / p PPV x 2 and now with dense cataract with no view to the posterior segment .	Proliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 1 diabetes mellitus E10.3513 250.51 362.07 362.02 Hx of PDR OU , TRD OS now s / p PPV .	laterality	lesion	T9	T3	note_1854
NonRel	Now interested in options for OD . Treatment Hx : PPV / TRD OS - 12 / 27 / 17 IVA OS - 12 / 22 / 17 ( preop ) IVFA ( 9 / 26 / 17 ) - Active PDR OS PPV x 2 / SO OD - 2015 / 2016 ( Outside UF ) IVA OD x 3 1 ) IDDM - Hx of PDR [s1] OU [e1] OD - s / p PPV x 2 and now with dense cataract with no view to the posterior segment .	AC shallow , no [s2] NVI [e2] today but there is heme on the corneal endothelium .	laterality	lesion	T9	T7	note_1854
NonRel	Nonproliferative diabetic retinopathy of [s1] right eye [e1] , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T4	T8	note_5745
NonRel	Nonproliferative diabetic retinopathy of [s1] right eye [e1] , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T4	T9	note_5745
NonRel	Nonproliferative diabetic retinopathy of [s1] right eye [e1] , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with [s2] ciCSME [e2] .	laterality	lesion	T4	T15	note_5745
NonRel	Nonproliferative diabetic retinopathy of [s1] right eye [e1] , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate [s2] NPDR [e2] with ciCSME .	laterality	lesion	T4	T16	note_5745
NonRel	Nonproliferative diabetic retinopathy of [s1] right eye [e1] , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate [s2] NPDR [e2] OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T4	T22	note_5745
NonRel	Nonproliferative diabetic retinopathy of [s1] right eye [e1] , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with [s2] CSME [e2] OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T4	T23	note_5745
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with [s1] moderate [e1] nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T7	T8	note_5745
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with [s1] moderate [e1] nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T7	T9	note_5745
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with [s1] moderate [e1] nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with [s2] ciCSME [e2] .	severity	lesion	T7	T15	note_5745
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with [s1] moderate [e1] nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate [s2] NPDR [e2] with ciCSME .	severity	lesion	T7	T16	note_5745
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with [s1] moderate [e1] nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate [s2] NPDR [e2] OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T7	T22	note_5745
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with [s1] moderate [e1] nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with [s2] CSME [e2] OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T7	T23	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	[s2] Nonproliferative diabetic retinopathy [e2] of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T10	T3	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Nonproliferative diabetic retinopathy of right eye , with [s2] macular edema [e2] , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T10	T5	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate [s2] nonproliferative retinopathy [e2] E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T10	T6	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	IRF stable , will continue with treatment OS - Moderate [s2] NPDR [e2] with ciCSME .	laterality	lesion	T10	T12	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	IRF stable , will continue with treatment OS - Moderate NPDR with [s2] ciCSME [e2] .	laterality	lesion	T10	T14	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	[s2] IRF [e2] stable , will continue with treatment OS - Moderate NPDR with ciCSME .	laterality	lesion	T10	T20	note_5745
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	[s2] Nonproliferative diabetic retinopathy [e2] of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T11	T3	note_5745
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Nonproliferative diabetic retinopathy of right eye , with [s2] macular edema [e2] , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T11	T5	note_5745
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate [s2] nonproliferative retinopathy [e2] E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T11	T6	note_5745
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	IRF stable , will continue with treatment OS - Moderate [s2] NPDR [e2] with ciCSME .	severity	lesion	T11	T12	note_5745
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	IRF stable , will continue with treatment OS - Moderate NPDR with [s2] ciCSME [e2] .	severity	lesion	T11	T14	note_5745
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	[s2] IRF [e2] stable , will continue with treatment OS - Moderate NPDR with ciCSME .	severity	lesion	T11	T20	note_5745
NonRel	IRF stable , will continue with treatment OS - [s1] Moderate [e1] NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T13	T8	note_5745
NonRel	IRF stable , will continue with treatment OS - [s1] Moderate [e1] NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T13	T9	note_5745
NonRel	IRF stable , will continue with treatment OS - [s1] Moderate [e1] NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with [s2] ciCSME [e2] .	severity	lesion	T13	T15	note_5745
NonRel	IRF stable , will continue with treatment OS - [s1] Moderate [e1] NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate [s2] NPDR [e2] with ciCSME .	severity	lesion	T13	T16	note_5745
NonRel	IRF stable , will continue with treatment OS - [s1] Moderate [e1] NPDR with ciCSME .	[s2] IRF [e2] responds to treatment with shorter interval .	severity	lesion	T13	T21	note_5745
NonRel	IRF stable , will continue with treatment OS - [s1] Moderate [e1] NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate [s2] NPDR [e2] OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T13	T22	note_5745
NonRel	IRF stable , will continue with treatment OS - [s1] Moderate [e1] NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with [s2] CSME [e2] OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T13	T23	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - [s1] Moderate [e1] NPDR with ciCSME .	[s2] Nonproliferative diabetic retinopathy [e2] of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T17	T3	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - [s1] Moderate [e1] NPDR with ciCSME .	Nonproliferative diabetic retinopathy of right eye , with [s2] macular edema [e2] , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T17	T5	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - [s1] Moderate [e1] NPDR with ciCSME .	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate [s2] nonproliferative retinopathy [e2] E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T17	T6	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - [s1] Moderate [e1] NPDR with ciCSME .	IRF stable , will continue with treatment OS - Moderate [s2] NPDR [e2] with ciCSME .	severity	lesion	T17	T12	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - [s1] Moderate [e1] NPDR with ciCSME .	IRF stable , will continue with treatment OS - Moderate NPDR with [s2] ciCSME [e2] .	severity	lesion	T17	T14	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - [s1] Moderate [e1] NPDR with ciCSME .	[s2] IRF [e2] stable , will continue with treatment OS - Moderate NPDR with ciCSME .	severity	lesion	T17	T20	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] [s1] OD [e1] - Moderate NPDR with ciCSME .	[s2] Nonproliferative diabetic retinopathy [e2] of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T18	T3	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] [s1] OD [e1] - Moderate NPDR with ciCSME .	Nonproliferative diabetic retinopathy of right eye , with [s2] macular edema [e2] , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T18	T5	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] [s1] OD [e1] - Moderate NPDR with ciCSME .	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate [s2] nonproliferative retinopathy [e2] E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T18	T6	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] [s1] OD [e1] - Moderate NPDR with ciCSME .	IRF stable , will continue with treatment OS - Moderate [s2] NPDR [e2] with ciCSME .	laterality	lesion	T18	T12	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] [s1] OD [e1] - Moderate NPDR with ciCSME .	IRF stable , will continue with treatment OS - Moderate NPDR with [s2] ciCSME [e2] .	laterality	lesion	T18	T14	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] [s1] OD [e1] - Moderate NPDR with ciCSME .	[s2] IRF [e2] stable , will continue with treatment OS - Moderate NPDR with ciCSME .	laterality	lesion	T18	T20	note_5745
NonRel	IRF stable , will continue with treatment [s1] OS [e1] - Moderate NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T19	T8	note_5745
NonRel	IRF stable , will continue with treatment [s1] OS [e1] - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T19	T9	note_5745
NonRel	IRF stable , will continue with treatment [s1] OS [e1] - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with [s2] ciCSME [e2] .	laterality	lesion	T19	T15	note_5745
NonRel	IRF stable , will continue with treatment [s1] OS [e1] - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate [s2] NPDR [e2] with ciCSME .	laterality	lesion	T19	T16	note_5745
NonRel	IRF stable , will continue with treatment [s1] OS [e1] - Moderate NPDR with ciCSME .	[s2] IRF [e2] responds to treatment with shorter interval .	laterality	lesion	T19	T21	note_5745
NonRel	IRF stable , will continue with treatment [s1] OS [e1] - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate [s2] NPDR [e2] OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T19	T22	note_5745
NonRel	IRF stable , will continue with treatment [s1] OS [e1] - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with [s2] CSME [e2] OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T19	T23	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR [s1] OU [e1] with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	[s2] Nonproliferative diabetic retinopathy [e2] of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T24	T3	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR [s1] OU [e1] with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Nonproliferative diabetic retinopathy of right eye , with [s2] macular edema [e2] , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T24	T5	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR [s1] OU [e1] with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate [s2] nonproliferative retinopathy [e2] E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T24	T6	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR [s1] OU [e1] with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	IRF stable , will continue with treatment OS - Moderate [s2] NPDR [e2] with ciCSME .	laterality	lesion	T24	T12	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR [s1] OU [e1] with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	IRF stable , will continue with treatment OS - Moderate NPDR with [s2] ciCSME [e2] .	laterality	lesion	T24	T14	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR [s1] OU [e1] with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	[s2] IRF [e2] stable , will continue with treatment OS - Moderate NPDR with ciCSME .	laterality	lesion	T24	T20	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - [s1] Moderate [e1] NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	[s2] Nonproliferative diabetic retinopathy [e2] of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T25	T3	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - [s1] Moderate [e1] NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Nonproliferative diabetic retinopathy of right eye , with [s2] macular edema [e2] , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T25	T5	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - [s1] Moderate [e1] NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate [s2] nonproliferative retinopathy [e2] E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T25	T6	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - [s1] Moderate [e1] NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	IRF stable , will continue with treatment OS - Moderate [s2] NPDR [e2] with ciCSME .	severity	lesion	T25	T12	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - [s1] Moderate [e1] NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	IRF stable , will continue with treatment OS - Moderate NPDR with [s2] ciCSME [e2] .	severity	lesion	T25	T14	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - [s1] Moderate [e1] NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	[s2] IRF [e2] stable , will continue with treatment OS - Moderate NPDR with ciCSME .	severity	lesion	T25	T20	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME [s1] OS [e1] > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	[s2] Nonproliferative diabetic retinopathy [e2] of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T26	T3	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME [s1] OS [e1] > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Nonproliferative diabetic retinopathy of right eye , with [s2] macular edema [e2] , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T26	T5	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME [s1] OS [e1] > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate [s2] nonproliferative retinopathy [e2] E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T26	T6	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME [s1] OS [e1] > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	IRF stable , will continue with treatment OS - Moderate [s2] NPDR [e2] with ciCSME .	laterality	lesion	T26	T12	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME [s1] OS [e1] > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	IRF stable , will continue with treatment OS - Moderate NPDR with [s2] ciCSME [e2] .	laterality	lesion	T26	T14	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME [s1] OS [e1] > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	[s2] IRF [e2] stable , will continue with treatment OS - Moderate NPDR with ciCSME .	laterality	lesion	T26	T20	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > [s1] OD [e1] 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	[s2] Nonproliferative diabetic retinopathy [e2] of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T27	T3	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > [s1] OD [e1] 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Nonproliferative diabetic retinopathy of right eye , with [s2] macular edema [e2] , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T27	T5	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > [s1] OD [e1] 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate [s2] nonproliferative retinopathy [e2] E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T27	T6	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > [s1] OD [e1] 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	IRF stable , will continue with treatment OS - Moderate [s2] NPDR [e2] with ciCSME .	laterality	lesion	T27	T12	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > [s1] OD [e1] 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	IRF stable , will continue with treatment OS - Moderate NPDR with [s2] ciCSME [e2] .	laterality	lesion	T27	T14	note_5745
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 8 / 31 / 18 ( today ) IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > [s1] OD [e1] 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	[s2] IRF [e2] stable , will continue with treatment OS - Moderate NPDR with ciCSME .	laterality	lesion	T27	T20	note_5745
NonRel	NVE inf [s1] OS [e1] : Diffuse NVE / NVD .	[s2] NVD [e2] .	laterality	lesion	T19	T2	note_2162
NonRel	[s1] OS [e1] + NVD / NVE / NVI / NVA .	Combined TRD / RRD with choroidal effusion shallowing peripheral AC but IOP 12 with open angles and [s2] NVA [e2] . - All of the following was discussed in lay terms .	laterality	lesion	T26	T27	note_2162
NonRel	Non - proliferative diabetic retinopathy , [s1] severe [e1] , both eyes - Both Eyes E11.3493 250.50 362.06 6 .	[s2] Diabetic macular edema [e2] of left eye - Left Eye E11.311 250.50 H35.81 362.07 362.01 7 .	severity	lesion	T11	T4	1058348_note_1910
NonRel	Non - proliferative diabetic retinopathy , severe , [s1] both eyes [e1] - Both Eyes E11.3493 250.50 362.06 6 .	[s2] Diabetic macular edema [e2] of left eye - Left Eye E11.311 250.50 H35.81 362.07 362.01 7 .	laterality	lesion	T12	T4	1058348_note_1910
NonRel	Diabetic macular edema of [s1] left eye [e1] - Left Eye E11.311 250.50 H35.81 362.07 362.01 7 .	[s2] Non - proliferative diabetic retinopathy [e2] , severe , both eyes - Both Eyes E11.3493 250.50 362.06 6 .	laterality	lesion	T13	T1	1058348_note_1910
NonRel	Other secondary cataract of left eye - Left Eye H26.492 366.50 Treatment History IVFA ( 12 / 4 / 18 ) : * * * [s1] Active [e1] PDR OD , quiescent OS Stabismus - 7 / 23 / 18 ( Beal ) CE / IOL OD - 8 / 22 / 17 ( Gray ) PPV / TRD Repair OD 4 / 10 / 2017 IVA OD - 4 / 7 / 2017 ( Pre - operative ) PPV / TRD Repair OS 2 / 6 / 2017 IVA OS - 2 / 3 / 2017 ( Pre - operative ) IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( hx PDR / TRD OU , Duration > 20 years , on lantus / metformin , last A1c > 10 per patient ) .	[s2] Proliferative diabetic retinopathy [e2] of both eyes without macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3593 250.50 362.02 2 .	severity	lesion	T7	T1	note_643
NonRel	Other secondary cataract of left eye - Left Eye H26.492 366.50 Treatment History IVFA ( 12 / 4 / 18 ) : * * * [s1] Active [e1] PDR OD , quiescent OS Stabismus - 7 / 23 / 18 ( Beal ) CE / IOL OD - 8 / 22 / 17 ( Gray ) PPV / TRD Repair OD 4 / 10 / 2017 IVA OD - 4 / 7 / 2017 ( Pre - operative ) PPV / TRD Repair OS 2 / 6 / 2017 IVA OS - 2 / 3 / 2017 ( Pre - operative ) IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( hx PDR / TRD OU , Duration > 20 years , on lantus / metformin , last A1c > 10 per patient ) .	Proliferative diabetic retinopathy of both eyes without [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3593 250.50 362.02 2 .	severity	lesion	T7	T2	note_643
NonRel	Other secondary cataract of left eye - Left Eye H26.492 366.50 Treatment History IVFA ( 12 / 4 / 18 ) : * * * [s1] Active [e1] PDR OD , quiescent OS Stabismus - 7 / 23 / 18 ( Beal ) CE / IOL OD - 8 / 22 / 17 ( Gray ) PPV / TRD Repair OD 4 / 10 / 2017 IVA OD - 4 / 7 / 2017 ( Pre - operative ) PPV / TRD Repair OS 2 / 6 / 2017 IVA OS - 2 / 3 / 2017 ( Pre - operative ) IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( hx PDR / TRD OU , Duration > 20 years , on lantus / metformin , last A1c > 10 per patient ) .	Quiescent [s2] PDR [e2] OU OD - s / p TRD Stage C4 repair .	severity	lesion	T7	T6	note_643
NonRel	Other secondary cataract of left eye - Left Eye H26.492 366.50 Treatment History IVFA ( 12 / 4 / 18 ) : * * * Active PDR [s1] OD [e1] , quiescent OS Stabismus - 7 / 23 / 18 ( Beal ) CE / IOL OD - 8 / 22 / 17 ( Gray ) PPV / TRD Repair OD 4 / 10 / 2017 IVA OD - 4 / 7 / 2017 ( Pre - operative ) PPV / TRD Repair OS 2 / 6 / 2017 IVA OS - 2 / 3 / 2017 ( Pre - operative ) IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( hx PDR / TRD OU , Duration > 20 years , on lantus / metformin , last A1c > 10 per patient ) .	[s2] Proliferative diabetic retinopathy [e2] of both eyes without macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3593 250.50 362.02 2 .	laterality	lesion	T8	T1	note_643
NonRel	Other secondary cataract of left eye - Left Eye H26.492 366.50 Treatment History IVFA ( 12 / 4 / 18 ) : * * * Active PDR [s1] OD [e1] , quiescent OS Stabismus - 7 / 23 / 18 ( Beal ) CE / IOL OD - 8 / 22 / 17 ( Gray ) PPV / TRD Repair OD 4 / 10 / 2017 IVA OD - 4 / 7 / 2017 ( Pre - operative ) PPV / TRD Repair OS 2 / 6 / 2017 IVA OS - 2 / 3 / 2017 ( Pre - operative ) IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( hx PDR / TRD OU , Duration > 20 years , on lantus / metformin , last A1c > 10 per patient ) .	Proliferative diabetic retinopathy of both eyes without [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3593 250.50 362.02 2 .	laterality	lesion	T8	T2	note_643
NonRel	Other secondary cataract of left eye - Left Eye H26.492 366.50 Treatment History IVFA ( 12 / 4 / 18 ) : * * * Active PDR [s1] OD [e1] , quiescent OS Stabismus - 7 / 23 / 18 ( Beal ) CE / IOL OD - 8 / 22 / 17 ( Gray ) PPV / TRD Repair OD 4 / 10 / 2017 IVA OD - 4 / 7 / 2017 ( Pre - operative ) PPV / TRD Repair OS 2 / 6 / 2017 IVA OS - 2 / 3 / 2017 ( Pre - operative ) IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( hx PDR / TRD OU , Duration > 20 years , on lantus / metformin , last A1c > 10 per patient ) .	Quiescent [s2] PDR [e2] OU OD - s / p TRD Stage C4 repair .	laterality	lesion	T8	T6	note_643
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] without macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3593 250.50 362.02 2 .	Other secondary cataract of left eye - Left Eye H26.492 366.50 Treatment History IVFA ( 12 / 4 / 18 ) : * * * Active [s2] PDR [e2] OD , quiescent OS Stabismus - 7 / 23 / 18 ( Beal ) CE / IOL OD - 8 / 22 / 17 ( Gray ) PPV / TRD Repair OD 4 / 10 / 2017 IVA OD - 4 / 7 / 2017 ( Pre - operative ) PPV / TRD Repair OS 2 / 6 / 2017 IVA OS - 2 / 3 / 2017 ( Pre - operative ) IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( hx PDR / TRD OU , Duration > 20 years , on lantus / metformin , last A1c > 10 per patient ) .	laterality	lesion	T9	T3	note_643
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] without macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3593 250.50 362.02 2 .	Other secondary cataract of left eye - Left Eye H26.492 366.50 Treatment History IVFA ( 12 / 4 / 18 ) : * * * Active PDR OD , quiescent OS Stabismus - 7 / 23 / 18 ( Beal ) CE / IOL OD - 8 / 22 / 17 ( Gray ) PPV / TRD Repair OD 4 / 10 / 2017 IVA OD - 4 / 7 / 2017 ( Pre - operative ) PPV / TRD Repair OS 2 / 6 / 2017 IVA OS - 2 / 3 / 2017 ( Pre - operative ) IVFA ( 1 / 26 / 2017 ) : Active [s2] PDR [e2] / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( hx PDR / TRD OU , Duration > 20 years , on lantus / metformin , last A1c > 10 per patient ) .	laterality	lesion	T9	T4	note_643
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] without macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3593 250.50 362.02 2 .	Other secondary cataract of left eye - Left Eye H26.492 366.50 Treatment History IVFA ( 12 / 4 / 18 ) : * * * Active PDR OD , quiescent OS Stabismus - 7 / 23 / 18 ( Beal ) CE / IOL OD - 8 / 22 / 17 ( Gray ) PPV / TRD Repair OD 4 / 10 / 2017 IVA OD - 4 / 7 / 2017 ( Pre - operative ) PPV / TRD Repair OS 2 / 6 / 2017 IVA OS - 2 / 3 / 2017 ( Pre - operative ) IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active [s2] PDR [e2] / TRD OU 1 ) IDDM - ( hx PDR / TRD OU , Duration > 20 years , on lantus / metformin , last A1c > 10 per patient ) .	laterality	lesion	T9	T5	note_643
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] without macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3593 250.50 362.02 2 .	Other secondary cataract of left eye - Left Eye H26.492 366.50 Treatment History IVFA ( 12 / 4 / 18 ) : * * * Active PDR OD , quiescent OS Stabismus - 7 / 23 / 18 ( Beal ) CE / IOL OD - 8 / 22 / 17 ( Gray ) PPV / TRD Repair OD 4 / 10 / 2017 IVA OD - 4 / 7 / 2017 ( Pre - operative ) PPV / TRD Repair OS 2 / 6 / 2017 IVA OS - 2 / 3 / 2017 ( Pre - operative ) IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( hx [s2] PDR [e2] / TRD OU , Duration > 20 years , on lantus / metformin , last A1c > 10 per patient ) .	laterality	lesion	T9	T14	note_643
NonRel	Other secondary cataract of left eye - Left Eye H26.492 366.50 Treatment History IVFA ( 12 / 4 / 18 ) : * * * Active PDR OD , quiescent OS Stabismus - 7 / 23 / 18 ( Beal ) CE / IOL OD - 8 / 22 / 17 ( Gray ) PPV / TRD Repair OD 4 / 10 / 2017 IVA OD - 4 / 7 / 2017 ( Pre - operative ) PPV / TRD Repair OS 2 / 6 / 2017 IVA OS - 2 / 3 / 2017 ( Pre - operative ) IVFA ( 1 / 26 / 2017 ) : [s1] Active [e1] PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( hx PDR / TRD OU , Duration > 20 years , on lantus / metformin , last A1c > 10 per patient ) .	[s2] Proliferative diabetic retinopathy [e2] of both eyes without macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3593 250.50 362.02 2 .	severity	lesion	T10	T1	note_643
NonRel	Other secondary cataract of left eye - Left Eye H26.492 366.50 Treatment History IVFA ( 12 / 4 / 18 ) : * * * Active PDR OD , quiescent OS Stabismus - 7 / 23 / 18 ( Beal ) CE / IOL OD - 8 / 22 / 17 ( Gray ) PPV / TRD Repair OD 4 / 10 / 2017 IVA OD - 4 / 7 / 2017 ( Pre - operative ) PPV / TRD Repair OS 2 / 6 / 2017 IVA OS - 2 / 3 / 2017 ( Pre - operative ) IVFA ( 1 / 26 / 2017 ) : [s1] Active [e1] PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( hx PDR / TRD OU , Duration > 20 years , on lantus / metformin , last A1c > 10 per patient ) .	Proliferative diabetic retinopathy of both eyes without [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3593 250.50 362.02 2 .	severity	lesion	T10	T2	note_643
NonRel	Other secondary cataract of left eye - Left Eye H26.492 366.50 Treatment History IVFA ( 12 / 4 / 18 ) : * * * Active PDR OD , quiescent OS Stabismus - 7 / 23 / 18 ( Beal ) CE / IOL OD - 8 / 22 / 17 ( Gray ) PPV / TRD Repair OD 4 / 10 / 2017 IVA OD - 4 / 7 / 2017 ( Pre - operative ) PPV / TRD Repair OS 2 / 6 / 2017 IVA OS - 2 / 3 / 2017 ( Pre - operative ) IVFA ( 1 / 26 / 2017 ) : [s1] Active [e1] PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( hx PDR / TRD OU , Duration > 20 years , on lantus / metformin , last A1c > 10 per patient ) .	Quiescent [s2] PDR [e2] OU OD - s / p TRD Stage C4 repair .	severity	lesion	T10	T6	note_643
NonRel	Other secondary cataract of left eye - Left Eye H26.492 366.50 Treatment History IVFA ( 12 / 4 / 18 ) : * * * Active PDR OD , quiescent OS Stabismus - 7 / 23 / 18 ( Beal ) CE / IOL OD - 8 / 22 / 17 ( Gray ) PPV / TRD Repair OD 4 / 10 / 2017 IVA OD - 4 / 7 / 2017 ( Pre - operative ) PPV / TRD Repair OS 2 / 6 / 2017 IVA OS - 2 / 3 / 2017 ( Pre - operative ) IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD [s1] OU [e1] IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( hx PDR / TRD OU , Duration > 20 years , on lantus / metformin , last A1c > 10 per patient ) .	[s2] Proliferative diabetic retinopathy [e2] of both eyes without macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3593 250.50 362.02 2 .	laterality	lesion	T11	T1	note_643
NonRel	Other secondary cataract of left eye - Left Eye H26.492 366.50 Treatment History IVFA ( 12 / 4 / 18 ) : * * * Active PDR OD , quiescent OS Stabismus - 7 / 23 / 18 ( Beal ) CE / IOL OD - 8 / 22 / 17 ( Gray ) PPV / TRD Repair OD 4 / 10 / 2017 IVA OD - 4 / 7 / 2017 ( Pre - operative ) PPV / TRD Repair OS 2 / 6 / 2017 IVA OS - 2 / 3 / 2017 ( Pre - operative ) IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD [s1] OU [e1] IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( hx PDR / TRD OU , Duration > 20 years , on lantus / metformin , last A1c > 10 per patient ) .	Proliferative diabetic retinopathy of both eyes without [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3593 250.50 362.02 2 .	laterality	lesion	T11	T2	note_643
NonRel	Other secondary cataract of left eye - Left Eye H26.492 366.50 Treatment History IVFA ( 12 / 4 / 18 ) : * * * Active PDR OD , quiescent OS Stabismus - 7 / 23 / 18 ( Beal ) CE / IOL OD - 8 / 22 / 17 ( Gray ) PPV / TRD Repair OD 4 / 10 / 2017 IVA OD - 4 / 7 / 2017 ( Pre - operative ) PPV / TRD Repair OS 2 / 6 / 2017 IVA OS - 2 / 3 / 2017 ( Pre - operative ) IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD [s1] OU [e1] IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( hx PDR / TRD OU , Duration > 20 years , on lantus / metformin , last A1c > 10 per patient ) .	Quiescent [s2] PDR [e2] OU OD - s / p TRD Stage C4 repair .	laterality	lesion	T11	T6	note_643
NonRel	Other secondary cataract of left eye - Left Eye H26.492 366.50 Treatment History IVFA ( 12 / 4 / 18 ) : * * * Active PDR OD , quiescent OS Stabismus - 7 / 23 / 18 ( Beal ) CE / IOL OD - 8 / 22 / 17 ( Gray ) PPV / TRD Repair OD 4 / 10 / 2017 IVA OD - 4 / 7 / 2017 ( Pre - operative ) PPV / TRD Repair OS 2 / 6 / 2017 IVA OS - 2 / 3 / 2017 ( Pre - operative ) IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : [s1] Active [e1] PDR / TRD OU 1 ) IDDM - ( hx PDR / TRD OU , Duration > 20 years , on lantus / metformin , last A1c > 10 per patient ) .	[s2] Proliferative diabetic retinopathy [e2] of both eyes without macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3593 250.50 362.02 2 .	severity	lesion	T12	T1	note_643
NonRel	Other secondary cataract of left eye - Left Eye H26.492 366.50 Treatment History IVFA ( 12 / 4 / 18 ) : * * * Active PDR OD , quiescent OS Stabismus - 7 / 23 / 18 ( Beal ) CE / IOL OD - 8 / 22 / 17 ( Gray ) PPV / TRD Repair OD 4 / 10 / 2017 IVA OD - 4 / 7 / 2017 ( Pre - operative ) PPV / TRD Repair OS 2 / 6 / 2017 IVA OS - 2 / 3 / 2017 ( Pre - operative ) IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : [s1] Active [e1] PDR / TRD OU 1 ) IDDM - ( hx PDR / TRD OU , Duration > 20 years , on lantus / metformin , last A1c > 10 per patient ) .	Proliferative diabetic retinopathy of both eyes without [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3593 250.50 362.02 2 .	severity	lesion	T12	T2	note_643
NonRel	Other secondary cataract of left eye - Left Eye H26.492 366.50 Treatment History IVFA ( 12 / 4 / 18 ) : * * * Active PDR OD , quiescent OS Stabismus - 7 / 23 / 18 ( Beal ) CE / IOL OD - 8 / 22 / 17 ( Gray ) PPV / TRD Repair OD 4 / 10 / 2017 IVA OD - 4 / 7 / 2017 ( Pre - operative ) PPV / TRD Repair OS 2 / 6 / 2017 IVA OS - 2 / 3 / 2017 ( Pre - operative ) IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : [s1] Active [e1] PDR / TRD OU 1 ) IDDM - ( hx PDR / TRD OU , Duration > 20 years , on lantus / metformin , last A1c > 10 per patient ) .	Quiescent [s2] PDR [e2] OU OD - s / p TRD Stage C4 repair .	severity	lesion	T12	T6	note_643
NonRel	Other secondary cataract of left eye - Left Eye H26.492 366.50 Treatment History IVFA ( 12 / 4 / 18 ) : * * * Active PDR OD , quiescent OS Stabismus - 7 / 23 / 18 ( Beal ) CE / IOL OD - 8 / 22 / 17 ( Gray ) PPV / TRD Repair OD 4 / 10 / 2017 IVA OD - 4 / 7 / 2017 ( Pre - operative ) PPV / TRD Repair OS 2 / 6 / 2017 IVA OS - 2 / 3 / 2017 ( Pre - operative ) IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD [s1] OU [e1] 1 ) IDDM - ( hx PDR / TRD OU , Duration > 20 years , on lantus / metformin , last A1c > 10 per patient ) .	[s2] Proliferative diabetic retinopathy [e2] of both eyes without macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3593 250.50 362.02 2 .	laterality	lesion	T13	T1	note_643
NonRel	Other secondary cataract of left eye - Left Eye H26.492 366.50 Treatment History IVFA ( 12 / 4 / 18 ) : * * * Active PDR OD , quiescent OS Stabismus - 7 / 23 / 18 ( Beal ) CE / IOL OD - 8 / 22 / 17 ( Gray ) PPV / TRD Repair OD 4 / 10 / 2017 IVA OD - 4 / 7 / 2017 ( Pre - operative ) PPV / TRD Repair OS 2 / 6 / 2017 IVA OS - 2 / 3 / 2017 ( Pre - operative ) IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD [s1] OU [e1] 1 ) IDDM - ( hx PDR / TRD OU , Duration > 20 years , on lantus / metformin , last A1c > 10 per patient ) .	Proliferative diabetic retinopathy of both eyes without [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3593 250.50 362.02 2 .	laterality	lesion	T13	T2	note_643
NonRel	Other secondary cataract of left eye - Left Eye H26.492 366.50 Treatment History IVFA ( 12 / 4 / 18 ) : * * * Active PDR OD , quiescent OS Stabismus - 7 / 23 / 18 ( Beal ) CE / IOL OD - 8 / 22 / 17 ( Gray ) PPV / TRD Repair OD 4 / 10 / 2017 IVA OD - 4 / 7 / 2017 ( Pre - operative ) PPV / TRD Repair OS 2 / 6 / 2017 IVA OS - 2 / 3 / 2017 ( Pre - operative ) IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD [s1] OU [e1] 1 ) IDDM - ( hx PDR / TRD OU , Duration > 20 years , on lantus / metformin , last A1c > 10 per patient ) .	Quiescent [s2] PDR [e2] OU OD - s / p TRD Stage C4 repair .	laterality	lesion	T13	T6	note_643
NonRel	Other secondary cataract of left eye - Left Eye H26.492 366.50 Treatment History IVFA ( 12 / 4 / 18 ) : * * * Active PDR OD , quiescent OS Stabismus - 7 / 23 / 18 ( Beal ) CE / IOL OD - 8 / 22 / 17 ( Gray ) PPV / TRD Repair OD 4 / 10 / 2017 IVA OD - 4 / 7 / 2017 ( Pre - operative ) PPV / TRD Repair OS 2 / 6 / 2017 IVA OS - 2 / 3 / 2017 ( Pre - operative ) IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( hx PDR / TRD [s1] OU [e1] , Duration > 20 years , on lantus / metformin , last A1c > 10 per patient ) .	[s2] Proliferative diabetic retinopathy [e2] of both eyes without macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3593 250.50 362.02 2 .	laterality	lesion	T15	T1	note_643
NonRel	Other secondary cataract of left eye - Left Eye H26.492 366.50 Treatment History IVFA ( 12 / 4 / 18 ) : * * * Active PDR OD , quiescent OS Stabismus - 7 / 23 / 18 ( Beal ) CE / IOL OD - 8 / 22 / 17 ( Gray ) PPV / TRD Repair OD 4 / 10 / 2017 IVA OD - 4 / 7 / 2017 ( Pre - operative ) PPV / TRD Repair OS 2 / 6 / 2017 IVA OS - 2 / 3 / 2017 ( Pre - operative ) IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( hx PDR / TRD [s1] OU [e1] , Duration > 20 years , on lantus / metformin , last A1c > 10 per patient ) .	Proliferative diabetic retinopathy of both eyes without [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3593 250.50 362.02 2 .	laterality	lesion	T15	T2	note_643
NonRel	Other secondary cataract of left eye - Left Eye H26.492 366.50 Treatment History IVFA ( 12 / 4 / 18 ) : * * * Active PDR OD , quiescent OS Stabismus - 7 / 23 / 18 ( Beal ) CE / IOL OD - 8 / 22 / 17 ( Gray ) PPV / TRD Repair OD 4 / 10 / 2017 IVA OD - 4 / 7 / 2017 ( Pre - operative ) PPV / TRD Repair OS 2 / 6 / 2017 IVA OS - 2 / 3 / 2017 ( Pre - operative ) IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( hx PDR / TRD [s1] OU [e1] , Duration > 20 years , on lantus / metformin , last A1c > 10 per patient ) .	Quiescent [s2] PDR [e2] OU OD - s / p TRD Stage C4 repair .	laterality	lesion	T15	T6	note_643
NonRel	Quiescent PDR [s1] OU [e1] OD - s / p TRD Stage C4 repair .	Other secondary cataract of left eye - Left Eye H26.492 366.50 Treatment History IVFA ( 12 / 4 / 18 ) : * * * Active [s2] PDR [e2] OD , quiescent OS Stabismus - 7 / 23 / 18 ( Beal ) CE / IOL OD - 8 / 22 / 17 ( Gray ) PPV / TRD Repair OD 4 / 10 / 2017 IVA OD - 4 / 7 / 2017 ( Pre - operative ) PPV / TRD Repair OS 2 / 6 / 2017 IVA OS - 2 / 3 / 2017 ( Pre - operative ) IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( hx PDR / TRD OU , Duration > 20 years , on lantus / metformin , last A1c > 10 per patient ) .	laterality	lesion	T16	T3	note_643
NonRel	Quiescent PDR [s1] OU [e1] OD - s / p TRD Stage C4 repair .	Other secondary cataract of left eye - Left Eye H26.492 366.50 Treatment History IVFA ( 12 / 4 / 18 ) : * * * Active PDR OD , quiescent OS Stabismus - 7 / 23 / 18 ( Beal ) CE / IOL OD - 8 / 22 / 17 ( Gray ) PPV / TRD Repair OD 4 / 10 / 2017 IVA OD - 4 / 7 / 2017 ( Pre - operative ) PPV / TRD Repair OS 2 / 6 / 2017 IVA OS - 2 / 3 / 2017 ( Pre - operative ) IVFA ( 1 / 26 / 2017 ) : Active [s2] PDR [e2] / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( hx PDR / TRD OU , Duration > 20 years , on lantus / metformin , last A1c > 10 per patient ) .	laterality	lesion	T16	T4	note_643
NonRel	Quiescent PDR [s1] OU [e1] OD - s / p TRD Stage C4 repair .	Other secondary cataract of left eye - Left Eye H26.492 366.50 Treatment History IVFA ( 12 / 4 / 18 ) : * * * Active PDR OD , quiescent OS Stabismus - 7 / 23 / 18 ( Beal ) CE / IOL OD - 8 / 22 / 17 ( Gray ) PPV / TRD Repair OD 4 / 10 / 2017 IVA OD - 4 / 7 / 2017 ( Pre - operative ) PPV / TRD Repair OS 2 / 6 / 2017 IVA OS - 2 / 3 / 2017 ( Pre - operative ) IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active [s2] PDR [e2] / TRD OU 1 ) IDDM - ( hx PDR / TRD OU , Duration > 20 years , on lantus / metformin , last A1c > 10 per patient ) .	laterality	lesion	T16	T5	note_643
NonRel	Quiescent PDR [s1] OU [e1] OD - s / p TRD Stage C4 repair .	Other secondary cataract of left eye - Left Eye H26.492 366.50 Treatment History IVFA ( 12 / 4 / 18 ) : * * * Active PDR OD , quiescent OS Stabismus - 7 / 23 / 18 ( Beal ) CE / IOL OD - 8 / 22 / 17 ( Gray ) PPV / TRD Repair OD 4 / 10 / 2017 IVA OD - 4 / 7 / 2017 ( Pre - operative ) PPV / TRD Repair OS 2 / 6 / 2017 IVA OS - 2 / 3 / 2017 ( Pre - operative ) IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( hx [s2] PDR [e2] / TRD OU , Duration > 20 years , on lantus / metformin , last A1c > 10 per patient ) .	laterality	lesion	T16	T14	note_643
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	laterality	lesion	T1	T7	note_2444
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	laterality	lesion	T1	T8	note_2444
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with [s2] ciCSME [e2] being treated with IVA OS .	laterality	lesion	T1	T9	note_2444
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	severity	lesion	T2	T7	note_2444
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	severity	lesion	T2	T8	note_2444
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with [s2] ciCSME [e2] being treated with IVA OS .	severity	lesion	T2	T9	note_2444
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	laterality	lesion	T5	T3	note_2444
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	laterality	lesion	T5	T4	note_2444
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	severity	lesion	T6	T3	note_2444
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	severity	lesion	T6	T4	note_2444
NonRel	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA [s1] OS [e1] .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	laterality	lesion	T10	T3	note_2444
NonRel	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA [s1] OS [e1] .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	laterality	lesion	T10	T4	note_2444
NonRel	Recently in ED for [s1] mild [e1] VH , but clearing and will await laser maturation .	Treatment History PRP OD - 6 / 30 / 2017 IVA OD - 6 / 15 / 17 IVFA ( 6 / 15 / 17 ) - Active PDR OU 1 ) DM - Active [s2] Proliferative Diabetic retinopathy [e2] OU . Diagnosed in the 90 s , A1c 10.0 OD PDR s / p PRP as above .	severity	lesion	T1	T4	note_2182
NonRel	Recently in ED for [s1] mild [e1] VH , but clearing and will await laser maturation .	Treatment History PRP OD - 6 / 30 / 2017 IVA OD - 6 / 15 / 17 IVFA ( 6 / 15 / 17 ) - Active [s2] PDR [e2] OU 1 ) DM - Active Proliferative Diabetic retinopathy OU . Diagnosed in the 90 s , A1c 10.0 OD PDR s / p PRP as above .	severity	lesion	T1	T16	note_2182
NonRel	Recently in ED for [s1] mild [e1] VH , but clearing and will await laser maturation .	Treatment History PRP OD - 6 / 30 / 2017 IVA OD - 6 / 15 / 17 IVFA ( 6 / 15 / 17 ) - Active PDR OU 1 ) DM - Active Proliferative Diabetic retinopathy OU . Diagnosed in the 90 s , A1c 10.0 OD [s2] PDR [e2] s / p PRP as above .	severity	lesion	T1	T19	note_2182
NonRel	Treatment History PRP OD - 6 / 30 / 2017 IVA OD - 6 / 15 / 17 IVFA ( 6 / 15 / 17 ) - Active PDR OU 1 ) DM - [s1] Active [e1] Proliferative Diabetic retinopathy OU . Diagnosed in the 90 s , A1c 10.0 OD PDR s / p PRP as above .	Recently in ED for mild [s2] VH [e2] , but clearing and will await laser maturation .	severity	lesion	T3	T2	note_2182
NonRel	Treatment History PRP OD - 6 / 30 / 2017 IVA OD - 6 / 15 / 17 IVFA ( 6 / 15 / 17 ) - Active PDR OU 1 ) DM - Active Proliferative Diabetic retinopathy [s1] OU [e1] . Diagnosed in the 90 s , A1c 10.0 OD PDR s / p PRP as above .	Recently in ED for mild [s2] VH [e2] , but clearing and will await laser maturation .	laterality	lesion	T5	T2	note_2182
NonRel	[s1] Left eye [e1] affected by proliferative diabetic retinopathy with traction retinal detachment involving macula , associated with type 2 diabetes mellitus E11.3522 250.50 362.02 361.81 Seen by endocrine today who recommended increasing metformin .	[s2] Proliferative diabetic retinopathy [e2] of right eye associated with type 2 diabetes mellitus , macular edema presence unspecified E11.3591 250.50 362.02 2 .	laterality	lesion	T6	T8	note_2182
NonRel	[s1] Left eye [e1] affected by proliferative diabetic retinopathy with traction retinal detachment involving macula , associated with type 2 diabetes mellitus E11.3522 250.50 362.02 361.81 Seen by endocrine today who recommended increasing metformin .	Proliferative diabetic retinopathy of right eye associated with type 2 diabetes mellitus , [s2] macular edema [e2] presence unspecified E11.3591 250.50 362.02 2 .	laterality	lesion	T6	T10	note_2182
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] associated with type 2 diabetes mellitus , macular edema presence unspecified E11.3591 250.50 362.02 2 .	Left eye affected by [s2] proliferative diabetic retinopathy [e2] with traction retinal detachment involving macula , associated with type 2 diabetes mellitus E11.3522 250.50 362.02 361.81 Seen by endocrine today who recommended increasing metformin .	laterality	lesion	T9	T7	note_2182
NonRel	Treatment History PRP OD - 6 / 30 / 2017 IVA OD - 6 / 15 / 17 IVFA ( 6 / 15 / 17 ) - [s1] Active [e1] PDR OU 1 ) DM - Active Proliferative Diabetic retinopathy OU . Diagnosed in the 90 s , A1c 10.0 OD PDR s / p PRP as above .	Recently in ED for mild [s2] VH [e2] , but clearing and will await laser maturation .	severity	lesion	T17	T2	note_2182
NonRel	Treatment History PRP OD - 6 / 30 / 2017 IVA OD - 6 / 15 / 17 IVFA ( 6 / 15 / 17 ) - Active PDR [s1] OU [e1] 1 ) DM - Active Proliferative Diabetic retinopathy OU . Diagnosed in the 90 s , A1c 10.0 OD PDR s / p PRP as above .	Recently in ED for mild [s2] VH [e2] , but clearing and will await laser maturation .	laterality	lesion	T18	T2	note_2182
NonRel	Treatment History PRP OD - 6 / 30 / 2017 IVA OD - 6 / 15 / 17 IVFA ( 6 / 15 / 17 ) - Active PDR OU 1 ) DM - Active Proliferative Diabetic retinopathy OU . Diagnosed in the 90 s , A1c 10.0 [s1] OD [e1] PDR s / p PRP as above .	Recently in ED for mild [s2] VH [e2] , but clearing and will await laser maturation .	laterality	lesion	T20	T2	note_2182
NonRel	Mac OCT [s1] OS [e1] shows laser scarring with no IRF .	Mac OCT OD shows atrophy and [s2] IRF [e2] .	laterality	lesion	T7	T5	note_3956
NonRel	Mac OCT [s1] OD [e1] shows atrophy and IRF .	Mac OCT OS shows laser scarring with no [s2] IRF [e2] .	laterality	lesion	T8	T6	note_3956
NonRel	OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : Normal foveal contour without IRF / SRF .	No loss of IS / SO junction OS : Normeal foveal contour without [s2] IRF [e2] / SRF .	laterality	lesion	T6	T3	note_1498
NonRel	OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : Normal foveal contour without IRF / SRF .	No loss of IS / SO junction OS : Normeal foveal contour without IRF / [s2] SRF [e2] .	laterality	lesion	T6	T4	note_1498
NonRel	No loss of IS / SO junction [s1] OS [e1] : Normeal foveal contour without IRF / SRF .	OCT , Posterior Segment - OU - Both Eyes OD : Normal foveal contour without [s2] IRF [e2] / SRF .	laterality	lesion	T7	T1	note_1498
NonRel	No loss of IS / SO junction [s1] OS [e1] : Normeal foveal contour without IRF / SRF .	OCT , Posterior Segment - OU - Both Eyes OD : Normal foveal contour without IRF / [s2] SRF [e2] .	laterality	lesion	T7	T2	note_1498
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Severe [s2] nonproliferative diabetic retinopathy [e2] of left eye , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 3 .	severity	lesion	T9	T14	note_7087
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Severe nonproliferative diabetic retinopathy of left eye , with [s2] macular edema [e2] , associated with type 2 diabetes mellitus E11.3412 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 3 .	severity	lesion	T9	T16	note_7087
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Severe [s2] nonproliferative diabetic retinopathy [e2] of left eye , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 3 .	laterality	lesion	T11	T14	note_7087
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Severe nonproliferative diabetic retinopathy of left eye , with [s2] macular edema [e2] , associated with type 2 diabetes mellitus E11.3412 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 3 .	laterality	lesion	T11	T16	note_7087
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of left eye , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 3 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T13	T10	note_7087
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of left eye , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 3 .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3311 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T13	T12	note_7087
NonRel	Severe nonproliferative diabetic retinopathy of [s1] left eye [e1] , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 3 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T15	T10	note_7087
NonRel	Severe nonproliferative diabetic retinopathy of [s1] left eye [e1] , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 3 .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3311 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T15	T12	note_7087
NonRel	[s1] OS [e1] - Severe NPDR with + + + CSME .	Lengthy hx of treatment with chronic [s2] ME [e2] with anti - VEGF every agent ( IVA , IVL , IVE multiple ) .	laterality	lesion	T27	T31	note_7087
NonRel	OS - [s1] Severe [e1] NPDR with + + + CSME .	Lengthy hx of treatment with chronic [s2] ME [e2] with anti - VEGF every agent ( IVA , IVL , IVE multiple ) .	severity	lesion	T28	T31	note_7087
NonRel	NVE inf [s1] OS [e1] : Diffuse NVE / NVD .	[s2] NVD [e2] .	laterality	lesion	T19	T2	1140836_note_2161
NonRel	OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : Drusen , no SRF OS : Geo atrophy , Drusen .	No [s2] SRF [e2] Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T4	T2	note_1142
NonRel	S / P 25 g PPV / ML / SDEM / EL / AFx OD 4 / 3 / 17 Z98.890 V45.69 OCT , Posterior Segment - OU - Both Eyes Color Fundus Photography - OD - Right Eye Attending Note : Treatment Hx : PPV / TRD / AFx OD - 4 / 3 / 17 PRP OS ( IVFA guided ) - 3 / 31 / 17 IVA OD ( preop ) - 3 / 31 / 17 IVFA ( 3 / 28 / 2017 ) - [s1] Active [e1] PDR OU 1 .	DMII - Active [s2] PDR [e2] OU .	severity	lesion	T1	T5	note_1190
NonRel	S / P 25 g PPV / ML / SDEM / EL / AFx OD 4 / 3 / 17 Z98.890 V45.69 OCT , Posterior Segment - OU - Both Eyes Color Fundus Photography - OD - Right Eye Attending Note : Treatment Hx : PPV / TRD / AFx OD - 4 / 3 / 17 PRP OS ( IVFA guided ) - 3 / 31 / 17 IVA OD ( preop ) - 3 / 31 / 17 IVFA ( 3 / 28 / 2017 ) - Active PDR [s1] OU [e1] 1 .	DMII - Active [s2] PDR [e2] OU .	laterality	lesion	T3	T5	note_1190
NonRel	DMII - [s1] Active [e1] PDR OU .	S / P 25 g PPV / ML / SDEM / EL / AFx OD 4 / 3 / 17 Z98.890 V45.69 OCT , Posterior Segment - OU - Both Eyes Color Fundus Photography - OD - Right Eye Attending Note : Treatment Hx : PPV / TRD / AFx OD - 4 / 3 / 17 PRP OS ( IVFA guided ) - 3 / 31 / 17 IVA OD ( preop ) - 3 / 31 / 17 IVFA ( 3 / 28 / 2017 ) - Active [s2] PDR [e2] OU 1 .	severity	lesion	T4	T2	note_1190
NonRel	DMII - Active PDR [s1] OU [e1] .	S / P 25 g PPV / ML / SDEM / EL / AFx OD 4 / 3 / 17 Z98.890 V45.69 OCT , Posterior Segment - OU - Both Eyes Color Fundus Photography - OD - Right Eye Attending Note : Treatment Hx : PPV / TRD / AFx OD - 4 / 3 / 17 PRP OS ( IVFA guided ) - 3 / 31 / 17 IVA OD ( preop ) - 3 / 31 / 17 IVFA ( 3 / 28 / 2017 ) - Active [s2] PDR [e2] OU 1 .	laterality	lesion	T6	T2	note_1190
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Focal Laser - OS - Left Eye Treatment History IVL OD , IVE OS - 1 / 18 / 19 Focal Laser OS - 1 / 18 / 19 IVL OD , IVE OS - 12 / 14 / 18 IVL OD , IVE OS - 11 / 9 / 2018 IVL OU - 10 / 5 / 2018 IVL OU - 8 / 31 / 18 IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T5	T10	note_5755
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Focal Laser - OS - Left Eye Treatment History IVL OD , IVE OS - 1 / 18 / 19 Focal Laser OS - 1 / 18 / 19 IVL OD , IVE OS - 12 / 14 / 18 IVL OD , IVE OS - 11 / 9 / 2018 IVL OU - 10 / 5 / 2018 IVL OU - 8 / 31 / 18 IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T5	T12	note_5755
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Focal Laser - OS - Left Eye Treatment History IVL OD , IVE OS - 1 / 18 / 19 Focal Laser OS - 1 / 18 / 19 IVL OD , IVE OS - 12 / 14 / 18 IVL OD , IVE OS - 11 / 9 / 2018 IVL OU - 10 / 5 / 2018 IVL OU - 8 / 31 / 18 IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate [s2] NPDR [e2] OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T5	T15	note_5755
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Focal Laser - OS - Left Eye Treatment History IVL OD , IVE OS - 1 / 18 / 19 Focal Laser OS - 1 / 18 / 19 IVL OD , IVE OS - 12 / 14 / 18 IVL OD , IVE OS - 11 / 9 / 2018 IVL OU - 10 / 5 / 2018 IVL OU - 8 / 31 / 18 IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with [s2] CSME [e2] OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T5	T17	note_5755
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Focal Laser - OS - Left Eye Treatment History IVL OD , IVE OS - 1 / 18 / 19 Focal Laser OS - 1 / 18 / 19 IVL OD , IVE OS - 12 / 14 / 18 IVL OD , IVE OS - 11 / 9 / 2018 IVL OU - 10 / 5 / 2018 IVL OU - 8 / 31 / 18 IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate [s2] NPDR [e2] with ciCSME .	severity	lesion	T5	T21	note_5755
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Focal Laser - OS - Left Eye Treatment History IVL OD , IVE OS - 1 / 18 / 19 Focal Laser OS - 1 / 18 / 19 IVL OD , IVE OS - 12 / 14 / 18 IVL OD , IVE OS - 11 / 9 / 2018 IVL OU - 10 / 5 / 2018 IVL OU - 8 / 31 / 18 IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with [s2] ciCSME [e2] .	severity	lesion	T5	T22	note_5755
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Focal Laser - OS - Left Eye Treatment History IVL OD , IVE OS - 1 / 18 / 19 Focal Laser OS - 1 / 18 / 19 IVL OD , IVE OS - 12 / 14 / 18 IVL OD , IVE OS - 11 / 9 / 2018 IVL OU - 10 / 5 / 2018 IVL OU - 8 / 31 / 18 IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T7	T10	note_5755
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Focal Laser - OS - Left Eye Treatment History IVL OD , IVE OS - 1 / 18 / 19 Focal Laser OS - 1 / 18 / 19 IVL OD , IVE OS - 12 / 14 / 18 IVL OD , IVE OS - 11 / 9 / 2018 IVL OU - 10 / 5 / 2018 IVL OU - 8 / 31 / 18 IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T7	T12	note_5755
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Focal Laser - OS - Left Eye Treatment History IVL OD , IVE OS - 1 / 18 / 19 Focal Laser OS - 1 / 18 / 19 IVL OD , IVE OS - 12 / 14 / 18 IVL OD , IVE OS - 11 / 9 / 2018 IVL OU - 10 / 5 / 2018 IVL OU - 8 / 31 / 18 IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate [s2] NPDR [e2] OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T7	T15	note_5755
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Focal Laser - OS - Left Eye Treatment History IVL OD , IVE OS - 1 / 18 / 19 Focal Laser OS - 1 / 18 / 19 IVL OD , IVE OS - 12 / 14 / 18 IVL OD , IVE OS - 11 / 9 / 2018 IVL OU - 10 / 5 / 2018 IVL OU - 8 / 31 / 18 IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with [s2] CSME [e2] OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T7	T17	note_5755
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Focal Laser - OS - Left Eye Treatment History IVL OD , IVE OS - 1 / 18 / 19 Focal Laser OS - 1 / 18 / 19 IVL OD , IVE OS - 12 / 14 / 18 IVL OD , IVE OS - 11 / 9 / 2018 IVL OU - 10 / 5 / 2018 IVL OU - 8 / 31 / 18 IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate [s2] NPDR [e2] with ciCSME .	laterality	lesion	T7	T21	note_5755
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Focal Laser - OS - Left Eye Treatment History IVL OD , IVE OS - 1 / 18 / 19 Focal Laser OS - 1 / 18 / 19 IVL OD , IVE OS - 12 / 14 / 18 IVL OD , IVE OS - 11 / 9 / 2018 IVL OU - 10 / 5 / 2018 IVL OU - 8 / 31 / 18 IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with [s2] ciCSME [e2] .	laterality	lesion	T7	T22	note_5755
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Focal Laser - OS - Left Eye Treatment History IVL OD , IVE OS - 1 / 18 / 19 Focal Laser OS - 1 / 18 / 19 IVL OD , IVE OS - 12 / 14 / 18 IVL OD , IVE OS - 11 / 9 / 2018 IVL OU - 10 / 5 / 2018 IVL OU - 8 / 31 / 18 IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T9	T6	note_5755
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Focal Laser - OS - Left Eye Treatment History IVL OD , IVE OS - 1 / 18 / 19 Focal Laser OS - 1 / 18 / 19 IVL OD , IVE OS - 12 / 14 / 18 IVL OD , IVE OS - 11 / 9 / 2018 IVL OU - 10 / 5 / 2018 IVL OU - 8 / 31 / 18 IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T9	T8	note_5755
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Focal Laser - OS - Left Eye Treatment History IVL OD , IVE OS - 1 / 18 / 19 Focal Laser OS - 1 / 18 / 19 IVL OD , IVE OS - 12 / 14 / 18 IVL OD , IVE OS - 11 / 9 / 2018 IVL OU - 10 / 5 / 2018 IVL OU - 8 / 31 / 18 IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T11	T6	note_5755
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Focal Laser - OS - Left Eye Treatment History IVL OD , IVE OS - 1 / 18 / 19 Focal Laser OS - 1 / 18 / 19 IVL OD , IVE OS - 12 / 14 / 18 IVL OD , IVE OS - 11 / 9 / 2018 IVL OU - 10 / 5 / 2018 IVL OU - 8 / 31 / 18 IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T11	T8	note_5755
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Focal Laser - OS - Left Eye Treatment History IVL OD , IVE OS - 1 / 18 / 19 Focal Laser OS - 1 / 18 / 19 IVL OD , IVE OS - 12 / 14 / 18 IVL OD , IVE OS - 11 / 9 / 2018 IVL OU - 10 / 5 / 2018 IVL OU - 8 / 31 / 18 IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - [s1] Moderate [e1] NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T14	T6	note_5755
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Focal Laser - OS - Left Eye Treatment History IVL OD , IVE OS - 1 / 18 / 19 Focal Laser OS - 1 / 18 / 19 IVL OD , IVE OS - 12 / 14 / 18 IVL OD , IVE OS - 11 / 9 / 2018 IVL OU - 10 / 5 / 2018 IVL OU - 8 / 31 / 18 IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - [s1] Moderate [e1] NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T14	T8	note_5755
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Focal Laser - OS - Left Eye Treatment History IVL OD , IVE OS - 1 / 18 / 19 Focal Laser OS - 1 / 18 / 19 IVL OD , IVE OS - 12 / 14 / 18 IVL OD , IVE OS - 11 / 9 / 2018 IVL OU - 10 / 5 / 2018 IVL OU - 8 / 31 / 18 IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR [s1] OU [e1] with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T16	T6	note_5755
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Focal Laser - OS - Left Eye Treatment History IVL OD , IVE OS - 1 / 18 / 19 Focal Laser OS - 1 / 18 / 19 IVL OD , IVE OS - 12 / 14 / 18 IVL OD , IVE OS - 11 / 9 / 2018 IVL OU - 10 / 5 / 2018 IVL OU - 8 / 31 / 18 IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR [s1] OU [e1] with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T16	T8	note_5755
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Focal Laser - OS - Left Eye Treatment History IVL OD , IVE OS - 1 / 18 / 19 Focal Laser OS - 1 / 18 / 19 IVL OD , IVE OS - 12 / 14 / 18 IVL OD , IVE OS - 11 / 9 / 2018 IVL OU - 10 / 5 / 2018 IVL OU - 8 / 31 / 18 IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME [s1] OS [e1] > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T18	T6	note_5755
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Focal Laser - OS - Left Eye Treatment History IVL OD , IVE OS - 1 / 18 / 19 Focal Laser OS - 1 / 18 / 19 IVL OD , IVE OS - 12 / 14 / 18 IVL OD , IVE OS - 11 / 9 / 2018 IVL OU - 10 / 5 / 2018 IVL OU - 8 / 31 / 18 IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME [s1] OS [e1] > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T18	T8	note_5755
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Focal Laser - OS - Left Eye Treatment History IVL OD , IVE OS - 1 / 18 / 19 Focal Laser OS - 1 / 18 / 19 IVL OD , IVE OS - 12 / 14 / 18 IVL OD , IVE OS - 11 / 9 / 2018 IVL OU - 10 / 5 / 2018 IVL OU - 8 / 31 / 18 IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] [s1] OD [e1] - Moderate NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T19	T6	note_5755
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Focal Laser - OS - Left Eye Treatment History IVL OD , IVE OS - 1 / 18 / 19 Focal Laser OS - 1 / 18 / 19 IVL OD , IVE OS - 12 / 14 / 18 IVL OD , IVE OS - 11 / 9 / 2018 IVL OU - 10 / 5 / 2018 IVL OU - 8 / 31 / 18 IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] [s1] OD [e1] - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T19	T8	note_5755
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Focal Laser - OS - Left Eye Treatment History IVL OD , IVE OS - 1 / 18 / 19 Focal Laser OS - 1 / 18 / 19 IVL OD , IVE OS - 12 / 14 / 18 IVL OD , IVE OS - 11 / 9 / 2018 IVL OU - 10 / 5 / 2018 IVL OU - 8 / 31 / 18 IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - [s1] Moderate [e1] NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T20	T6	note_5755
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Focal Laser - OS - Left Eye Treatment History IVL OD , IVE OS - 1 / 18 / 19 Focal Laser OS - 1 / 18 / 19 IVL OD , IVE OS - 12 / 14 / 18 IVL OD , IVE OS - 11 / 9 / 2018 IVL OU - 10 / 5 / 2018 IVL OU - 8 / 31 / 18 IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - [s1] Moderate [e1] NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T20	T8	note_5755
NonRel	[s1] OS [e1] - Moderate NPDR with ciCSME .	[s2] IRF [e2] responds to treatment with shorter intervals but still with persistent IRF emanating from superior macula .	laterality	lesion	T23	T27	note_5755
NonRel	[s1] OS [e1] - Moderate NPDR with ciCSME .	IRF responds to treatment with shorter intervals but still with persistent [s2] IRF [e2] emanating from superior macula .	laterality	lesion	T23	T29	note_5755
NonRel	OS - [s1] Moderate [e1] NPDR with ciCSME .	[s2] IRF [e2] responds to treatment with shorter intervals but still with persistent IRF emanating from superior macula .	severity	lesion	T24	T27	note_5755
NonRel	OS - [s1] Moderate [e1] NPDR with ciCSME .	IRF responds to treatment with shorter intervals but still with persistent [s2] IRF [e2] emanating from superior macula .	severity	lesion	T24	T29	note_5755
NonRel	IRF responds to treatment with shorter intervals but still with [s1] persistent [e1] IRF emanating from superior macula .	OS - Moderate [s2] NPDR [e2] with ciCSME .	severity	lesion	T28	T25	note_5755
NonRel	IRF responds to treatment with shorter intervals but still with [s1] persistent [e1] IRF emanating from superior macula .	OS - Moderate NPDR with [s2] ciCSME [e2] .	severity	lesion	T28	T26	note_5755
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Focal Laser - OS - Left Eye Treatment History IVL OD , IVE OS - 1 / 18 / 19 Focal Laser OS - 1 / 18 / 19 IVL OD , IVE OS - 12 / 14 / 18 IVL OD , IVE OS - 11 / 9 / 2018 IVL OU - 10 / 5 / 2018 IVL OU - 8 / 31 / 18 IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > [s1] OD [e1] 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T30	T6	note_5755
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Focal Laser - OS - Left Eye Treatment History IVL OD , IVE OS - 1 / 18 / 19 Focal Laser OS - 1 / 18 / 19 IVL OD , IVE OS - 12 / 14 / 18 IVL OD , IVE OS - 11 / 9 / 2018 IVL OU - 10 / 5 / 2018 IVL OU - 8 / 31 / 18 IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > [s1] OD [e1] 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T30	T8	note_5755
NonRel	IRF inf to fovea ( - ) ERM or SRF [s1] OS [e1] : thickness : 224 .	Good foveal contour with [s2] VMA [e2] ( - ) IRF or SRF ( - ) ERM Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T3	T4	note_481
NonRel	IRF inf to fovea ( - ) ERM or SRF [s1] OS [e1] : thickness : 224 .	Good foveal contour with VMA ( - ) [s2] IRF [e2] or SRF ( - ) ERM Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T3	T5	note_481
NonRel	IRF inf to fovea ( - ) ERM or SRF [s1] OS [e1] : thickness : 224 .	Good foveal contour with VMA ( - ) IRF or [s2] SRF [e2] ( - ) ERM Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T3	T6	note_481
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , [s1] MAs [e1] , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to [s2] fovea [e2] ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T7	T30	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , [s1] MAs [e1] , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo [s2] Macula [e2] few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T7	T33	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , [s1] exudate [e1] OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to [s2] fovea [e2] ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T8	T30	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , [s1] exudate [e1] OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo [s2] Macula [e2] few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T8	T33	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , [s1] dbh [e1] , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to [s2] fovea [e2] ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T9	T30	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , [s1] dbh [e1] , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo [s2] Macula [e2] few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T9	T33	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : [s1] MAs [e1] , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to [s2] fovea [e2] ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T10	T30	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : [s1] MAs [e1] , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo [s2] Macula [e2] few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T10	T33	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , [s1] dbh [e1] , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to [s2] fovea [e2] ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T11	T30	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , [s1] dbh [e1] , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo [s2] Macula [e2] few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T11	T33	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , [s1] exudate [e1] IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to [s2] fovea [e2] ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T12	T30	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , [s1] exudate [e1] IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo [s2] Macula [e2] few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T12	T33	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered [s1] MA ' s [e1] , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to [s2] fovea [e2] ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T13	T30	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered [s1] MA ' s [e1] , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo [s2] Macula [e2] few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T13	T33	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no [s1] NV [e1] OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to [s2] fovea [e2] ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T14	T30	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no [s1] NV [e1] OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo [s2] Macula [e2] few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T14	T33	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered [s1] MA ' s [e1] , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to [s2] fovea [e2] ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T15	T30	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered [s1] MA ' s [e1] , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo [s2] Macula [e2] few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T15	T33	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of [s1] NVE [e1] Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to [s2] fovea [e2] ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T16	T30	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of [s1] NVE [e1] Assessment Assessment and Plan : 1 .	no neo [s2] Macula [e2] few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T16	T33	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate [s1] OS [e1] : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard [s2] exudates [e2] scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T19	T5	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate [s1] OS [e1] : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard [s2] exudates [e2] Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T19	T6	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate [s1] OS [e1] : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe [s2] NDPR [e2] OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	laterality	lesion	T19	T18	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate [s1] OS [e1] : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea [s2] ma ' s [e2] with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T19	T29	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate [s1] OS [e1] : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few [s2] ma ' s [e2] , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T19	T31	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos [s1] OD [e1] , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard [s2] exudates [e2] scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T20	T5	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos [s1] OD [e1] , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard [s2] exudates [e2] Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T20	T6	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos [s1] OD [e1] , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe [s2] NDPR [e2] OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	laterality	lesion	T20	T18	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos [s1] OD [e1] , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea [s2] ma ' s [e2] with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T20	T29	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos [s1] OD [e1] , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few [s2] ma ' s [e2] , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T20	T31	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : [s1] OD [e1] : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard [s2] exudates [e2] scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T21	T5	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : [s1] OD [e1] : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard [s2] exudates [e2] Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T21	T6	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : [s1] OD [e1] : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe [s2] NDPR [e2] OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	laterality	lesion	T21	T18	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : [s1] OD [e1] : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea [s2] ma ' s [e2] with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T21	T29	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : [s1] OD [e1] : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few [s2] ma ' s [e2] , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T21	T31	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : [s1] scattered [e1] MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard [s2] exudates [e2] scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	severity	lesion	T22	T5	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : [s1] scattered [e1] MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard [s2] exudates [e2] Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	severity	lesion	T22	T6	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : [s1] scattered [e1] MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe [s2] NDPR [e2] OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	severity	lesion	T22	T18	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : [s1] scattered [e1] MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea [s2] ma ' s [e2] with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	severity	lesion	T22	T29	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : [s1] scattered [e1] MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few [s2] ma ' s [e2] , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	severity	lesion	T22	T31	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV [s1] OS [e1] : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard [s2] exudates [e2] scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T23	T5	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV [s1] OS [e1] : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard [s2] exudates [e2] Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T23	T6	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV [s1] OS [e1] : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe [s2] NDPR [e2] OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	laterality	lesion	T23	T18	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV [s1] OS [e1] : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea [s2] ma ' s [e2] with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T23	T29	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV [s1] OS [e1] : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few [s2] ma ' s [e2] , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T23	T31	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : [s1] scattered [e1] MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard [s2] exudates [e2] scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	severity	lesion	T24	T5	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : [s1] scattered [e1] MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard [s2] exudates [e2] Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	severity	lesion	T24	T6	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : [s1] scattered [e1] MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe [s2] NDPR [e2] OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	severity	lesion	T24	T18	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : [s1] scattered [e1] MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea [s2] ma ' s [e2] with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	severity	lesion	T24	T29	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : [s1] scattered [e1] MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few [s2] ma ' s [e2] , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	severity	lesion	T24	T31	257077_note_501
NonRel	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of [s1] hard [e1] exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , [s2] MAs [e2] , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T25	T7	257077_note_501
NonRel	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of [s1] hard [e1] exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , [s2] exudate [e2] OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T25	T8	257077_note_501
NonRel	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of [s1] hard [e1] exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , [s2] dbh [e2] , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T25	T9	257077_note_501
NonRel	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of [s1] hard [e1] exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : [s2] MAs [e2] , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T25	T10	257077_note_501
NonRel	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of [s1] hard [e1] exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , [s2] dbh [e2] , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T25	T11	257077_note_501
NonRel	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of [s1] hard [e1] exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , [s2] exudate [e2] IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T25	T12	257077_note_501
NonRel	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of [s1] hard [e1] exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered [s2] MA ' s [e2] , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T25	T13	257077_note_501
NonRel	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of [s1] hard [e1] exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no [s2] NV [e2] OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T25	T14	257077_note_501
NonRel	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of [s1] hard [e1] exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered [s2] MA ' s [e2] , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T25	T15	257077_note_501
NonRel	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of [s1] hard [e1] exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of [s2] NVE [e2] Assessment Assessment and Plan : 1 .	severity	lesion	T25	T16	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / [s1] severe [e1] NDPR OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , [s2] MAs [e2] , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T27	T7	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / [s1] severe [e1] NDPR OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , [s2] exudate [e2] OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T27	T8	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / [s1] severe [e1] NDPR OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , [s2] dbh [e2] , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T27	T9	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / [s1] severe [e1] NDPR OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : [s2] MAs [e2] , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T27	T10	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / [s1] severe [e1] NDPR OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , [s2] dbh [e2] , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T27	T11	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / [s1] severe [e1] NDPR OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , [s2] exudate [e2] IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T27	T12	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / [s1] severe [e1] NDPR OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered [s2] MA ' s [e2] , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T27	T13	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / [s1] severe [e1] NDPR OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no [s2] NV [e2] OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T27	T14	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / [s1] severe [e1] NDPR OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered [s2] MA ' s [e2] , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T27	T15	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / [s1] severe [e1] NDPR OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of [s2] NVE [e2] Assessment Assessment and Plan : 1 .	severity	lesion	T27	T16	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe NDPR [s1] OD [e1] Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , [s2] MAs [e2] , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T28	T7	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe NDPR [s1] OD [e1] Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , [s2] exudate [e2] OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T28	T8	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe NDPR [s1] OD [e1] Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , [s2] dbh [e2] , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T28	T9	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe NDPR [s1] OD [e1] Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : [s2] MAs [e2] , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T28	T10	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe NDPR [s1] OD [e1] Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , [s2] dbh [e2] , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T28	T11	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe NDPR [s1] OD [e1] Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , [s2] exudate [e2] IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T28	T12	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe NDPR [s1] OD [e1] Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered [s2] MA ' s [e2] , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T28	T13	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe NDPR [s1] OD [e1] Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no [s2] NV [e2] OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T28	T14	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe NDPR [s1] OD [e1] Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered [s2] MA ' s [e2] , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T28	T15	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe NDPR [s1] OD [e1] Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of [s2] NVE [e2] Assessment Assessment and Plan : 1 .	laterality	lesion	T28	T16	257077_note_501
NonRel	no neo Macula [s1] few [e1] ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , [s2] MAs [e2] , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T32	T7	257077_note_501
NonRel	no neo Macula [s1] few [e1] ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , [s2] exudate [e2] OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T32	T8	257077_note_501
NonRel	no neo Macula [s1] few [e1] ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , [s2] dbh [e2] , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T32	T9	257077_note_501
NonRel	no neo Macula [s1] few [e1] ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : [s2] MAs [e2] , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T32	T10	257077_note_501
NonRel	no neo Macula [s1] few [e1] ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , [s2] dbh [e2] , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T32	T11	257077_note_501
NonRel	no neo Macula [s1] few [e1] ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , [s2] exudate [e2] IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T32	T12	257077_note_501
NonRel	no neo Macula [s1] few [e1] ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered [s2] MA ' s [e2] , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T32	T13	257077_note_501
NonRel	no neo Macula [s1] few [e1] ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no [s2] NV [e2] OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T32	T14	257077_note_501
NonRel	no neo Macula [s1] few [e1] ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered [s2] MA ' s [e2] , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T32	T15	257077_note_501
NonRel	no neo Macula [s1] few [e1] ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of [s2] NVE [e2] Assessment Assessment and Plan : 1 .	severity	lesion	T32	T16	257077_note_501
NonRel	Proliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] Right Eye [e1] E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 OCT , Posterior Segment - OU - Both Eyes 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 OCT , Posterior Segment - OU - Both Eyes Treatment History IVFA ( 3 / 17 / 2017 ) - 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( 1 / 2016 ) down from 11 ( 2014 / 15 ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	laterality	lesion	T3	T5	note_2397
NonRel	Proliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] Right Eye [e1] E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 OCT , Posterior Segment - OU - Both Eyes 2 .	Moderate nonproliferative diabetic retinopathy without [s2] macular edema [e2] associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 OCT , Posterior Segment - OU - Both Eyes Treatment History IVFA ( 3 / 17 / 2017 ) - 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( 1 / 2016 ) down from 11 ( 2014 / 15 ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	laterality	lesion	T3	T6	note_2397
NonRel	Proliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] Right Eye [e1] E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 OCT , Posterior Segment - OU - Both Eyes 2 .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 OCT , Posterior Segment - OU - Both Eyes Treatment History IVFA ( 3 / 17 / 2017 ) - 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( 1 / 2016 ) down from 11 ( 2014 / 15 ) 75 lb weight loss ] OD - Clinical [s2] PDR [e2] without CSME ( + NVE , - NVI ) .	laterality	lesion	T3	T9	note_2397
NonRel	Proliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] Right Eye [e1] E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 OCT , Posterior Segment - OU - Both Eyes 2 .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 OCT , Posterior Segment - OU - Both Eyes Treatment History IVFA ( 3 / 17 / 2017 ) - 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( 1 / 2016 ) down from 11 ( 2014 / 15 ) 75 lb weight loss ] OD - Clinical PDR without [s2] CSME [e2] ( + NVE , - NVI ) .	laterality	lesion	T3	T10	note_2397
NonRel	Proliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] Right Eye [e1] E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 OCT , Posterior Segment - OU - Both Eyes 2 .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 OCT , Posterior Segment - OU - Both Eyes Treatment History IVFA ( 3 / 17 / 2017 ) - 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( 1 / 2016 ) down from 11 ( 2014 / 15 ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + [s2] NVE [e2] , - NVI ) .	laterality	lesion	T3	T11	note_2397
NonRel	Proliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] Right Eye [e1] E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 OCT , Posterior Segment - OU - Both Eyes 2 .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 OCT , Posterior Segment - OU - Both Eyes Treatment History IVFA ( 3 / 17 / 2017 ) - 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( 1 / 2016 ) down from 11 ( 2014 / 15 ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - [s2] NVI [e2] ) .	laterality	lesion	T3	T12	note_2397
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 OCT , Posterior Segment - OU - Both Eyes Treatment History IVFA ( 3 / 17 / 2017 ) - 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( 1 / 2016 ) down from 11 ( 2014 / 15 ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	[s2] Proliferative diabetic retinopathy [e2] without macular edema associated with type 2 diabetes mellitus - Right Eye E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 OCT , Posterior Segment - OU - Both Eyes 2 .	severity	lesion	T4	T1	note_2397
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 OCT , Posterior Segment - OU - Both Eyes Treatment History IVFA ( 3 / 17 / 2017 ) - 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( 1 / 2016 ) down from 11 ( 2014 / 15 ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Proliferative diabetic retinopathy without [s2] macular edema [e2] associated with type 2 diabetes mellitus - Right Eye E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 OCT , Posterior Segment - OU - Both Eyes 2 .	severity	lesion	T4	T2	note_2397
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 OCT , Posterior Segment - OU - Both Eyes Treatment History IVFA ( 3 / 17 / 2017 ) - 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( 1 / 2016 ) down from 11 ( 2014 / 15 ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	OS - Moderate [s2] NPDR [e2] without CSME .	severity	lesion	T4	T15	note_2397
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 OCT , Posterior Segment - OU - Both Eyes Treatment History IVFA ( 3 / 17 / 2017 ) - 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( 1 / 2016 ) down from 11 ( 2014 / 15 ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	OS - Moderate NPDR without [s2] CSME [e2] .	severity	lesion	T4	T16	note_2397
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] left eye [e1] E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 OCT , Posterior Segment - OU - Both Eyes Treatment History IVFA ( 3 / 17 / 2017 ) - 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( 1 / 2016 ) down from 11 ( 2014 / 15 ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	[s2] Proliferative diabetic retinopathy [e2] without macular edema associated with type 2 diabetes mellitus - Right Eye E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 OCT , Posterior Segment - OU - Both Eyes 2 .	laterality	lesion	T7	T1	note_2397
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] left eye [e1] E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 OCT , Posterior Segment - OU - Both Eyes Treatment History IVFA ( 3 / 17 / 2017 ) - 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( 1 / 2016 ) down from 11 ( 2014 / 15 ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Proliferative diabetic retinopathy without [s2] macular edema [e2] associated with type 2 diabetes mellitus - Right Eye E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 OCT , Posterior Segment - OU - Both Eyes 2 .	laterality	lesion	T7	T2	note_2397
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] left eye [e1] E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 OCT , Posterior Segment - OU - Both Eyes Treatment History IVFA ( 3 / 17 / 2017 ) - 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( 1 / 2016 ) down from 11 ( 2014 / 15 ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	OS - Moderate [s2] NPDR [e2] without CSME .	laterality	lesion	T7	T15	note_2397
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] left eye [e1] E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 OCT , Posterior Segment - OU - Both Eyes Treatment History IVFA ( 3 / 17 / 2017 ) - 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( 1 / 2016 ) down from 11 ( 2014 / 15 ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	OS - Moderate NPDR without [s2] CSME [e2] .	laterality	lesion	T7	T16	note_2397
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 OCT , Posterior Segment - OU - Both Eyes Treatment History IVFA ( 3 / 17 / 2017 ) - 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( 1 / 2016 ) down from 11 ( 2014 / 15 ) 75 lb weight loss ] [s1] OD [e1] - Clinical PDR without CSME ( + NVE , - NVI ) .	[s2] Proliferative diabetic retinopathy [e2] without macular edema associated with type 2 diabetes mellitus - Right Eye E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 OCT , Posterior Segment - OU - Both Eyes 2 .	laterality	lesion	T8	T1	note_2397
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 OCT , Posterior Segment - OU - Both Eyes Treatment History IVFA ( 3 / 17 / 2017 ) - 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( 1 / 2016 ) down from 11 ( 2014 / 15 ) 75 lb weight loss ] [s1] OD [e1] - Clinical PDR without CSME ( + NVE , - NVI ) .	Proliferative diabetic retinopathy without [s2] macular edema [e2] associated with type 2 diabetes mellitus - Right Eye E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 OCT , Posterior Segment - OU - Both Eyes 2 .	laterality	lesion	T8	T2	note_2397
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 OCT , Posterior Segment - OU - Both Eyes Treatment History IVFA ( 3 / 17 / 2017 ) - 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( 1 / 2016 ) down from 11 ( 2014 / 15 ) 75 lb weight loss ] [s1] OD [e1] - Clinical PDR without CSME ( + NVE , - NVI ) .	OS - Moderate [s2] NPDR [e2] without CSME .	laterality	lesion	T8	T15	note_2397
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 OCT , Posterior Segment - OU - Both Eyes Treatment History IVFA ( 3 / 17 / 2017 ) - 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( 1 / 2016 ) down from 11 ( 2014 / 15 ) 75 lb weight loss ] [s1] OD [e1] - Clinical PDR without CSME ( + NVE , - NVI ) .	OS - Moderate NPDR without [s2] CSME [e2] .	laterality	lesion	T8	T16	note_2397
NonRel	[s1] OS [e1] - Moderate NPDR without CSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 OCT , Posterior Segment - OU - Both Eyes Treatment History IVFA ( 3 / 17 / 2017 ) - 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( 1 / 2016 ) down from 11 ( 2014 / 15 ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	laterality	lesion	T13	T5	note_2397
NonRel	[s1] OS [e1] - Moderate NPDR without CSME .	Moderate nonproliferative diabetic retinopathy without [s2] macular edema [e2] associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 OCT , Posterior Segment - OU - Both Eyes Treatment History IVFA ( 3 / 17 / 2017 ) - 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( 1 / 2016 ) down from 11 ( 2014 / 15 ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	laterality	lesion	T13	T6	note_2397
NonRel	[s1] OS [e1] - Moderate NPDR without CSME .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 OCT , Posterior Segment - OU - Both Eyes Treatment History IVFA ( 3 / 17 / 2017 ) - 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( 1 / 2016 ) down from 11 ( 2014 / 15 ) 75 lb weight loss ] OD - Clinical [s2] PDR [e2] without CSME ( + NVE , - NVI ) .	laterality	lesion	T13	T9	note_2397
NonRel	[s1] OS [e1] - Moderate NPDR without CSME .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 OCT , Posterior Segment - OU - Both Eyes Treatment History IVFA ( 3 / 17 / 2017 ) - 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( 1 / 2016 ) down from 11 ( 2014 / 15 ) 75 lb weight loss ] OD - Clinical PDR without [s2] CSME [e2] ( + NVE , - NVI ) .	laterality	lesion	T13	T10	note_2397
NonRel	[s1] OS [e1] - Moderate NPDR without CSME .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 OCT , Posterior Segment - OU - Both Eyes Treatment History IVFA ( 3 / 17 / 2017 ) - 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( 1 / 2016 ) down from 11 ( 2014 / 15 ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + [s2] NVE [e2] , - NVI ) .	laterality	lesion	T13	T11	note_2397
NonRel	[s1] OS [e1] - Moderate NPDR without CSME .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 OCT , Posterior Segment - OU - Both Eyes Treatment History IVFA ( 3 / 17 / 2017 ) - 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( 1 / 2016 ) down from 11 ( 2014 / 15 ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - [s2] NVI [e2] ) .	laterality	lesion	T13	T12	note_2397
NonRel	OS - [s1] Moderate [e1] NPDR without CSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 OCT , Posterior Segment - OU - Both Eyes Treatment History IVFA ( 3 / 17 / 2017 ) - 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( 1 / 2016 ) down from 11 ( 2014 / 15 ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	severity	lesion	T14	T5	note_2397
NonRel	OS - [s1] Moderate [e1] NPDR without CSME .	Moderate nonproliferative diabetic retinopathy without [s2] macular edema [e2] associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 OCT , Posterior Segment - OU - Both Eyes Treatment History IVFA ( 3 / 17 / 2017 ) - 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( 1 / 2016 ) down from 11 ( 2014 / 15 ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	severity	lesion	T14	T6	note_2397
NonRel	OS - [s1] Moderate [e1] NPDR without CSME .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 OCT , Posterior Segment - OU - Both Eyes Treatment History IVFA ( 3 / 17 / 2017 ) - 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( 1 / 2016 ) down from 11 ( 2014 / 15 ) 75 lb weight loss ] OD - Clinical [s2] PDR [e2] without CSME ( + NVE , - NVI ) .	severity	lesion	T14	T9	note_2397
NonRel	OS - [s1] Moderate [e1] NPDR without CSME .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 OCT , Posterior Segment - OU - Both Eyes Treatment History IVFA ( 3 / 17 / 2017 ) - 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( 1 / 2016 ) down from 11 ( 2014 / 15 ) 75 lb weight loss ] OD - Clinical PDR without [s2] CSME [e2] ( + NVE , - NVI ) .	severity	lesion	T14	T10	note_2397
NonRel	OS - [s1] Moderate [e1] NPDR without CSME .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 OCT , Posterior Segment - OU - Both Eyes Treatment History IVFA ( 3 / 17 / 2017 ) - 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( 1 / 2016 ) down from 11 ( 2014 / 15 ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + [s2] NVE [e2] , - NVI ) .	severity	lesion	T14	T11	note_2397
NonRel	OS - [s1] Moderate [e1] NPDR without CSME .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 OCT , Posterior Segment - OU - Both Eyes Treatment History IVFA ( 3 / 17 / 2017 ) - 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( 1 / 2016 ) down from 11 ( 2014 / 15 ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - [s2] NVI [e2] ) .	severity	lesion	T14	T12	note_2397
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view [s1] OD [e1] due to vit heme .	PDR OS with nasal [s2] NVE [e2] and peripheral non - perfusion . 1 ) IDDM [ Dx 2002 , HgA 1 C > 14 5 / 2018 ] .	laterality	lesion	T5	T3	note_3720
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view [s1] OD [e1] due to vit heme .	Type 2 diabetes mellitus with right eye affected by [s2] proliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.02 362.07 V58.67 2 .	laterality	lesion	T5	T10	note_3720
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view [s1] OD [e1] due to vit heme .	Type 2 diabetes mellitus with right eye affected by proliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.02 362.07 V58.67 2 .	laterality	lesion	T5	T11	note_3720
NonRel	PDR [s1] OS [e1] with nasal NVE and peripheral non - perfusion . 1 ) IDDM [ Dx 2002 , HgA 1 C > 14 5 / 2018 ] .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view OD due to [s2] vit heme [e2] .	laterality	lesion	T6	T4	note_3720
NonRel	PDR [s1] OS [e1] with nasal NVE and peripheral non - perfusion . 1 ) IDDM [ Dx 2002 , HgA 1 C > 14 5 / 2018 ] .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view OD due to vit heme .	laterality	lesion	T6	T7	note_3720
NonRel	PDR [s1] OS [e1] with nasal NVE and peripheral non - perfusion . 1 ) IDDM [ Dx 2002 , HgA 1 C > 14 5 / 2018 ] .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view OD due to vit heme .	laterality	lesion	T6	T9	note_3720
NonRel	PDR [s1] OS [e1] with nasal NVE and peripheral non - perfusion . 1 ) IDDM [ Dx 2002 , HgA 1 C > 14 5 / 2018 ] .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : Quiescent PDR OD ( mild [s2] NVD [e2] ) , Active PDR OS PPV / VH / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view OD due to vit heme .	laterality	lesion	T6	T13	note_3720
NonRel	PDR [s1] OS [e1] with nasal NVE and peripheral non - perfusion . 1 ) IDDM [ Dx 2002 , HgA 1 C > 14 5 / 2018 ] .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : Quiescent PDR OD ( mild NVD ) , Active [s2] PDR [e2] OS PPV / VH / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view OD due to vit heme .	laterality	lesion	T6	T14	note_3720
NonRel	PDR [s1] OS [e1] with nasal NVE and peripheral non - perfusion . 1 ) IDDM [ Dx 2002 , HgA 1 C > 14 5 / 2018 ] .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / [s2] VH [e2] / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view OD due to vit heme .	laterality	lesion	T6	T17	note_3720
NonRel	PDR [s1] OS [e1] with nasal NVE and peripheral non - perfusion . 1 ) IDDM [ Dx 2002 , HgA 1 C > 14 5 / 2018 ] .	Hx of [s2] PDR [e2] OU without CSME OD - s / p PPV .	laterality	lesion	T6	T19	note_3720
NonRel	PDR [s1] OS [e1] with nasal NVE and peripheral non - perfusion . 1 ) IDDM [ Dx 2002 , HgA 1 C > 14 5 / 2018 ] .	Hx of PDR OU without [s2] CSME [e2] OD - s / p PPV .	laterality	lesion	T6	T20	note_3720
NonRel	PDR [s1] OS [e1] with nasal NVE and peripheral non - perfusion . 1 ) IDDM [ Dx 2002 , HgA 1 C > 14 5 / 2018 ] .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : Quiescent [s2] PDR [e2] OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view OD due to vit heme .	laterality	lesion	T6	T26	note_3720
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view OD due to vit heme .	PDR OS with nasal [s2] NVE [e2] and peripheral non - perfusion . 1 ) IDDM [ Dx 2002 , HgA 1 C > 14 5 / 2018 ] .	laterality	lesion	T8	T3	note_3720
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view OD due to vit heme .	Type 2 diabetes mellitus with right eye affected by [s2] proliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.02 362.07 V58.67 2 .	laterality	lesion	T8	T10	note_3720
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view OD due to vit heme .	Type 2 diabetes mellitus with right eye affected by proliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.02 362.07 V58.67 2 .	laterality	lesion	T8	T11	note_3720
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by proliferative retinopathy and macular edema , with long - term current use of insulin E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.02 362.07 V58.67 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view OD due to [s2] vit heme [e2] .	laterality	lesion	T12	T4	note_3720
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by proliferative retinopathy and macular edema , with long - term current use of insulin E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.02 362.07 V58.67 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view OD due to vit heme .	laterality	lesion	T12	T7	note_3720
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by proliferative retinopathy and macular edema , with long - term current use of insulin E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.02 362.07 V58.67 2 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view OD due to vit heme .	laterality	lesion	T12	T9	note_3720
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by proliferative retinopathy and macular edema , with long - term current use of insulin E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.02 362.07 V58.67 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : Quiescent PDR OD ( mild [s2] NVD [e2] ) , Active PDR OS PPV / VH / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view OD due to vit heme .	laterality	lesion	T12	T13	note_3720
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by proliferative retinopathy and macular edema , with long - term current use of insulin E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.02 362.07 V58.67 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : Quiescent PDR OD ( mild NVD ) , Active [s2] PDR [e2] OS PPV / VH / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view OD due to vit heme .	laterality	lesion	T12	T14	note_3720
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by proliferative retinopathy and macular edema , with long - term current use of insulin E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.02 362.07 V58.67 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / [s2] VH [e2] / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view OD due to vit heme .	laterality	lesion	T12	T17	note_3720
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by proliferative retinopathy and macular edema , with long - term current use of insulin E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.02 362.07 V58.67 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : Quiescent [s2] PDR [e2] OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view OD due to vit heme .	laterality	lesion	T12	T26	note_3720
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : Quiescent PDR [s1] OD [e1] ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view OD due to vit heme .	PDR OS with nasal [s2] NVE [e2] and peripheral non - perfusion . 1 ) IDDM [ Dx 2002 , HgA 1 C > 14 5 / 2018 ] .	laterality	lesion	T15	T3	note_3720
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : Quiescent PDR [s1] OD [e1] ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view OD due to vit heme .	Type 2 diabetes mellitus with right eye affected by [s2] proliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.02 362.07 V58.67 2 .	laterality	lesion	T15	T10	note_3720
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : Quiescent PDR [s1] OD [e1] ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view OD due to vit heme .	Type 2 diabetes mellitus with right eye affected by proliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.02 362.07 V58.67 2 .	laterality	lesion	T15	T11	note_3720
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : Quiescent PDR OD ( [s1] mild [e1] NVD ) , Active PDR OS PPV / VH / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view OD due to vit heme .	PDR OS with nasal [s2] NVE [e2] and peripheral non - perfusion . 1 ) IDDM [ Dx 2002 , HgA 1 C > 14 5 / 2018 ] .	severity	lesion	T16	T3	note_3720
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : Quiescent PDR OD ( [s1] mild [e1] NVD ) , Active PDR OS PPV / VH / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view OD due to vit heme .	Type 2 diabetes mellitus with right eye affected by [s2] proliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.02 362.07 V58.67 2 .	severity	lesion	T16	T10	note_3720
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : Quiescent PDR OD ( [s1] mild [e1] NVD ) , Active PDR OS PPV / VH / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view OD due to vit heme .	Type 2 diabetes mellitus with right eye affected by proliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.02 362.07 V58.67 2 .	severity	lesion	T16	T11	note_3720
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : Quiescent PDR OD ( mild NVD ) , Active PDR [s1] OS [e1] PPV / VH / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view OD due to vit heme .	PDR OS with nasal [s2] NVE [e2] and peripheral non - perfusion . 1 ) IDDM [ Dx 2002 , HgA 1 C > 14 5 / 2018 ] .	laterality	lesion	T18	T3	note_3720
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : Quiescent PDR OD ( mild NVD ) , Active PDR [s1] OS [e1] PPV / VH / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view OD due to vit heme .	Type 2 diabetes mellitus with right eye affected by [s2] proliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.02 362.07 V58.67 2 .	laterality	lesion	T18	T10	note_3720
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : Quiescent PDR OD ( mild NVD ) , Active PDR [s1] OS [e1] PPV / VH / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view OD due to vit heme .	Type 2 diabetes mellitus with right eye affected by proliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.02 362.07 V58.67 2 .	laterality	lesion	T18	T11	note_3720
NonRel	Hx of PDR [s1] OU [e1] without CSME OD - s / p PPV .	PDR OS with nasal [s2] NVE [e2] and peripheral non - perfusion . 1 ) IDDM [ Dx 2002 , HgA 1 C > 14 5 / 2018 ] .	laterality	lesion	T21	T3	note_3720
NonRel	Hx of PDR OU without CSME [s1] OD [e1] - s / p PPV .	PDR OS with nasal [s2] NVE [e2] and peripheral non - perfusion . 1 ) IDDM [ Dx 2002 , HgA 1 C > 14 5 / 2018 ] .	laterality	lesion	T22	T3	note_3720
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : [s1] Quiescent [e1] PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view OD due to vit heme .	PDR OS with nasal [s2] NVE [e2] and peripheral non - perfusion . 1 ) IDDM [ Dx 2002 , HgA 1 C > 14 5 / 2018 ] .	severity	lesion	T27	T3	note_3720
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : [s1] Quiescent [e1] PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view OD due to vit heme .	Type 2 diabetes mellitus with right eye affected by [s2] proliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.02 362.07 V58.67 2 .	severity	lesion	T27	T10	note_3720
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Treatment History IVA OS - 1 / 19 / 18 IVA OS - 12 / 14 / 17 IVA OS - 11 / 3 / 17 IVA OS - 9 / 28 / 17 IVA OS - 8 / 3 / 17 IVA OS - 5 / 19 / 17 IVFA ( 5 / 2 / 17 ) : [s1] Quiescent [e1] PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - 2 / 21 / 2017 PRP OS - ( 2 / 3 / 2017 ) - IVFA - Guided to Nasal Retina OS IVFA ( 1 / 27 / 2017 ) - No view OD due to vit heme .	Type 2 diabetes mellitus with right eye affected by proliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.02 362.07 V58.67 2 .	severity	lesion	T27	T11	note_3720
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T1	T14	note_7747
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with [s2] nci [e2] DME OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T1	T16	note_7747
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T1	T17	note_7747
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	severity	lesion	T1	T19	note_7747
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	severity	lesion	T1	T23	note_7747
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	severity	lesion	T1	T24	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T3	T14	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with [s2] nci [e2] DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T3	T16	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T3	T17	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	laterality	lesion	T3	T19	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	laterality	lesion	T3	T23	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	laterality	lesion	T3	T24	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T5	T14	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with [s2] nci [e2] DME OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T5	T16	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T5	T17	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	severity	lesion	T5	T19	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	severity	lesion	T5	T23	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	severity	lesion	T5	T24	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T7	T14	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with [s2] nci [e2] DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T7	T16	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T7	T17	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	laterality	lesion	T7	T19	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	laterality	lesion	T7	T23	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	laterality	lesion	T7	T24	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T9	T14	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with [s2] nci [e2] DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T9	T16	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T9	T17	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	laterality	lesion	T9	T19	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	laterality	lesion	T9	T23	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	laterality	lesion	T9	T24	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T10	T14	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with [s2] nci [e2] DME OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T10	T16	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T10	T17	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	severity	lesion	T10	T19	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	severity	lesion	T10	T23	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	severity	lesion	T10	T24	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T12	T14	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with [s2] nci [e2] DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T12	T16	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T12	T17	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	laterality	lesion	T12	T19	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	laterality	lesion	T12	T23	note_7747
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	laterality	lesion	T12	T24	note_7747
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T13	T2	note_7747
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T13	T4	note_7747
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T13	T6	note_7747
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T13	T8	note_7747
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T13	T11	note_7747
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T15	T2	note_7747
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T15	T4	note_7747
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T15	T6	note_7747
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T15	T8	note_7747
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T15	T11	note_7747
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T18	T2	note_7747
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T18	T4	note_7747
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T18	T6	note_7747
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T18	T8	note_7747
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T18	T11	note_7747
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T20	T2	note_7747
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T20	T4	note_7747
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T20	T6	note_7747
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T20	T8	note_7747
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T20	T11	note_7747
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T21	T2	note_7747
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T21	T4	note_7747
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T21	T6	note_7747
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T21	T8	note_7747
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T21	T11	note_7747
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T22	T2	note_7747
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T22	T4	note_7747
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T22	T6	note_7747
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T22	T8	note_7747
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T22	T11	note_7747
NonRel	IDDM , + 81 mg ASA Treatment Hx : IVFA ( DATE ) : [s1] Active [e1] PDR OD , Global Ischemia OS Focal / PRP OU previously 1 ) DM - Active PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	+ [s2] NVI [e2] .	severity	lesion	T11	T16	2491473_note_7653
NonRel	IDDM , + 81 mg ASA Treatment Hx : IVFA ( DATE ) : Active PDR [s1] OD [e1] , Global Ischemia OS Focal / PRP OU previously 1 ) DM - Active PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	+ [s2] NVI [e2] .	laterality	lesion	T12	T16	2491473_note_7653
NonRel	IDDM , + 81 mg ASA Treatment Hx : IVFA ( DATE ) : Active PDR OD , Global Ischemia OS Focal / PRP OU previously 1 ) DM - [s1] Active [e1] PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	+ [s2] NVI [e2] .	severity	lesion	T13	T16	2491473_note_7653
NonRel	IDDM , + 81 mg ASA Treatment Hx : IVFA ( DATE ) : Active PDR OD , Global Ischemia OS Focal / PRP OU previously 1 ) DM - Active PDR [s1] OU [e1] ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	+ [s2] NVI [e2] .	laterality	lesion	T14	T16	2491473_note_7653
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with VH that has responded to treatment with IVA .	laterality	lesion	T2	T4	note_4009
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with VH that has responded to treatment with IVA .	laterality	lesion	T2	T6	note_4009
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - [s2] PDR [e2] with VH that has responded to treatment with IVA .	laterality	lesion	T2	T8	note_4009
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with [s2] VH [e2] that has responded to treatment with IVA .	laterality	lesion	T2	T9	note_4009
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with VH that has responded to treatment with IVA .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	laterality	lesion	T5	T1	note_4009
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with VH that has responded to treatment with IVA .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	laterality	lesion	T5	T3	note_4009
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] [s1] OD [e1] - PDR with VH that has responded to treatment with IVA .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	laterality	lesion	T7	T1	note_4009
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] [s1] OD [e1] - PDR with VH that has responded to treatment with IVA .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	laterality	lesion	T7	T3	note_4009
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 2 .	Severe [s2] nonproliferative diabetic retinopathy [e2] of left eye , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 3 .	severity	lesion	T14	T3	note_7090
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 2 .	Severe nonproliferative diabetic retinopathy of left eye , with [s2] macular edema [e2] , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 3 .	severity	lesion	T14	T4	note_7090
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 2 .	Severe [s2] nonproliferative diabetic retinopathy [e2] of left eye , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T15	T3	note_7090
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 2 .	Severe nonproliferative diabetic retinopathy of left eye , with [s2] macular edema [e2] , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T15	T4	note_7090
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of left eye , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 3 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 2 .	severity	lesion	T16	T1	note_7090
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of left eye , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 3 .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 2 .	severity	lesion	T16	T2	note_7090
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of left eye , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 3 .	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Retina - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / [s2] VH [e2] OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe NPDR OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	severity	lesion	T16	T6	note_7090
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of left eye , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 3 .	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Retina - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe [s2] NPDR [e2] OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	severity	lesion	T16	T7	note_7090
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of left eye , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 3 .	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Retina - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe NPDR OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of [s2] NPDR [e2] , CSME OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	severity	lesion	T16	T8	note_7090
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of left eye , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 3 .	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Retina - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe NPDR OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , [s2] CSME [e2] OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	severity	lesion	T16	T9	note_7090
NonRel	Severe nonproliferative diabetic retinopathy of [s1] left eye [e1] , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 3 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 2 .	laterality	lesion	T17	T1	note_7090
NonRel	Severe nonproliferative diabetic retinopathy of [s1] left eye [e1] , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 3 .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 2 .	laterality	lesion	T17	T2	note_7090
NonRel	Severe nonproliferative diabetic retinopathy of [s1] left eye [e1] , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 3 .	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Retina - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / [s2] VH [e2] OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe NPDR OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	laterality	lesion	T17	T6	note_7090
NonRel	Severe nonproliferative diabetic retinopathy of [s1] left eye [e1] , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 3 .	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Retina - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe [s2] NPDR [e2] OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	laterality	lesion	T17	T7	note_7090
NonRel	Severe nonproliferative diabetic retinopathy of [s1] left eye [e1] , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 3 .	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Retina - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe NPDR OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of [s2] NPDR [e2] , CSME OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	laterality	lesion	T17	T8	note_7090
NonRel	Severe nonproliferative diabetic retinopathy of [s1] left eye [e1] , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 3 .	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Retina - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe NPDR OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , [s2] CSME [e2] OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	laterality	lesion	T17	T9	note_7090
NonRel	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Retina - OU - Both Eyes Treatment History Ozurdex [s1] OU [e1] - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe NPDR OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	Severe [s2] nonproliferative diabetic retinopathy [e2] of left eye , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T5	T3	note_7090
NonRel	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Retina - OU - Both Eyes Treatment History Ozurdex [s1] OU [e1] - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe NPDR OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	Severe nonproliferative diabetic retinopathy of left eye , with [s2] macular edema [e2] , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T5	T4	note_7090
NonRel	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Retina - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , [s1] Severe [e1] NPDR OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	Severe [s2] nonproliferative diabetic retinopathy [e2] of left eye , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 3 .	severity	lesion	T18	T3	note_7090
NonRel	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Retina - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , [s1] Severe [e1] NPDR OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	Severe nonproliferative diabetic retinopathy of left eye , with [s2] macular edema [e2] , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 3 .	severity	lesion	T18	T4	note_7090
NonRel	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Retina - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe NPDR [s1] OS [e1] Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	Severe [s2] nonproliferative diabetic retinopathy [e2] of left eye , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T19	T3	note_7090
NonRel	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Retina - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe NPDR [s1] OS [e1] Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	Severe nonproliferative diabetic retinopathy of left eye , with [s2] macular edema [e2] , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T19	T4	note_7090
NonRel	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Retina - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe NPDR OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME [s1] OU [e1] ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	Severe [s2] nonproliferative diabetic retinopathy [e2] of left eye , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T20	T3	note_7090
NonRel	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Retina - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe NPDR OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME [s1] OU [e1] ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	Severe nonproliferative diabetic retinopathy of left eye , with [s2] macular edema [e2] , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T20	T4	note_7090
NonRel	[s1] OS [e1] - Severe NPDR with CSME now s / p Ozurdex .	Significant cataract , consider referral for Phaco when [s2] diabetic retinopathy [e2] stable .	laterality	lesion	T21	T11	note_7090
NonRel	OS - [s1] Severe [e1] NPDR with CSME now s / p Ozurdex .	Significant cataract , consider referral for Phaco when [s2] diabetic retinopathy [e2] stable .	severity	lesion	T22	T11	note_7090
NonRel	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Retina - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe NPDR OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser [s1] OU [e1] No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	Severe [s2] nonproliferative diabetic retinopathy [e2] of left eye , with macular edema , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T23	T3	note_7090
NonRel	Hypertensive retinopathy of both eyes H35.033 362.11 OCT , Retina - OU - Both Eyes Treatment History Ozurdex OU - 5 / 19 / 2017 PPV / VH OD - 10 / 24 / 16 IVFA ( 9 / 29 / 16 ) : No view OD , Severe NPDR OS Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser [s1] OU [e1] No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last per patient to around 7 HgA 1 C ) OD - s / p PPV .	Severe nonproliferative diabetic retinopathy of left eye , with [s2] macular edema [e2] , associated with type 2 diabetes mellitus E11.3412 250.50 OCT , Retina - OU - Both Eyes 362.07 362.06 3 .	laterality	lesion	T23	T4	note_7090
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus - Right Eye E11.3513 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Pt missed last appt due to transportation issues ( transport never showed up ) Treatment Hx : IVA OD - 11 / 30 / 18 IVA OD - 9 / 14 / 18 IVA OD - 8 / 10 / 18 IVA OD - 6 / 1 / 18 IVA OD - 4 / 27 / 18 IVA OD - 3 / 16 / 18 PPV / SDEM / Retinectomy / SO ( OS ) - 1 / 22 / 18 IVA OD - 12 / 28 / 17 PPV / ML / SDEM / AFX / EPC / C3F8 ( OS ) 11 / 6 / 17 IVA OS - 11 / 2 / 17 IVA OD - 10 / 12 / 17 IVA OD - 8 / 4 / 17 PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active PDR OU 1 ) IDDM [ Type II , Dx 2002 ] .	Active [s2] PDR [e2] OU , TRD OS .	laterality	lesion	T2	T9	note_8524
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus - Right Eye E11.3513 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Pt missed last appt due to transportation issues ( transport never showed up ) Treatment Hx : IVA OD - 11 / 30 / 18 IVA OD - 9 / 14 / 18 IVA OD - 8 / 10 / 18 IVA OD - 6 / 1 / 18 IVA OD - 4 / 27 / 18 IVA OD - 3 / 16 / 18 PPV / SDEM / Retinectomy / SO ( OS ) - 1 / 22 / 18 IVA OD - 12 / 28 / 17 PPV / ML / SDEM / AFX / EPC / C3F8 ( OS ) 11 / 6 / 17 IVA OS - 11 / 2 / 17 IVA OD - 10 / 12 / 17 IVA OD - 8 / 4 / 17 PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - [s1] Active [e1] PDR OU 1 ) IDDM [ Type II , Dx 2002 ] .	Active [s2] PDR [e2] OU , TRD OS .	severity	lesion	T5	T9	note_8524
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus - Right Eye E11.3513 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Pt missed last appt due to transportation issues ( transport never showed up ) Treatment Hx : IVA OD - 11 / 30 / 18 IVA OD - 9 / 14 / 18 IVA OD - 8 / 10 / 18 IVA OD - 6 / 1 / 18 IVA OD - 4 / 27 / 18 IVA OD - 3 / 16 / 18 PPV / SDEM / Retinectomy / SO ( OS ) - 1 / 22 / 18 IVA OD - 12 / 28 / 17 PPV / ML / SDEM / AFX / EPC / C3F8 ( OS ) 11 / 6 / 17 IVA OS - 11 / 2 / 17 IVA OD - 10 / 12 / 17 IVA OD - 8 / 4 / 17 PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active PDR [s1] OU [e1] 1 ) IDDM [ Type II , Dx 2002 ] .	Active [s2] PDR [e2] OU , TRD OS .	laterality	lesion	T7	T9	note_8524
NonRel	[s1] Active [e1] PDR OU , TRD OS .	[s2] Proliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus - Right Eye E11.3513 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Pt missed last appt due to transportation issues ( transport never showed up ) Treatment Hx : IVA OD - 11 / 30 / 18 IVA OD - 9 / 14 / 18 IVA OD - 8 / 10 / 18 IVA OD - 6 / 1 / 18 IVA OD - 4 / 27 / 18 IVA OD - 3 / 16 / 18 PPV / SDEM / Retinectomy / SO ( OS ) - 1 / 22 / 18 IVA OD - 12 / 28 / 17 PPV / ML / SDEM / AFX / EPC / C3F8 ( OS ) 11 / 6 / 17 IVA OS - 11 / 2 / 17 IVA OD - 10 / 12 / 17 IVA OD - 8 / 4 / 17 PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active PDR OU 1 ) IDDM [ Type II , Dx 2002 ] .	severity	lesion	T8	T1	note_8524
NonRel	[s1] Active [e1] PDR OU , TRD OS .	Proliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus - Right Eye E11.3513 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Pt missed last appt due to transportation issues ( transport never showed up ) Treatment Hx : IVA OD - 11 / 30 / 18 IVA OD - 9 / 14 / 18 IVA OD - 8 / 10 / 18 IVA OD - 6 / 1 / 18 IVA OD - 4 / 27 / 18 IVA OD - 3 / 16 / 18 PPV / SDEM / Retinectomy / SO ( OS ) - 1 / 22 / 18 IVA OD - 12 / 28 / 17 PPV / ML / SDEM / AFX / EPC / C3F8 ( OS ) 11 / 6 / 17 IVA OS - 11 / 2 / 17 IVA OD - 10 / 12 / 17 IVA OD - 8 / 4 / 17 PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active PDR OU 1 ) IDDM [ Type II , Dx 2002 ] .	severity	lesion	T8	T3	note_8524
NonRel	[s1] Active [e1] PDR OU , TRD OS .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus - Right Eye E11.3513 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Pt missed last appt due to transportation issues ( transport never showed up ) Treatment Hx : IVA OD - 11 / 30 / 18 IVA OD - 9 / 14 / 18 IVA OD - 8 / 10 / 18 IVA OD - 6 / 1 / 18 IVA OD - 4 / 27 / 18 IVA OD - 3 / 16 / 18 PPV / SDEM / Retinectomy / SO ( OS ) - 1 / 22 / 18 IVA OD - 12 / 28 / 17 PPV / ML / SDEM / AFX / EPC / C3F8 ( OS ) 11 / 6 / 17 IVA OS - 11 / 2 / 17 IVA OD - 10 / 12 / 17 IVA OD - 8 / 4 / 17 PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active [s2] PDR [e2] OU 1 ) IDDM [ Type II , Dx 2002 ] .	severity	lesion	T8	T6	note_8524
NonRel	Active PDR [s1] OU [e1] , TRD OS .	[s2] Proliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus - Right Eye E11.3513 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Pt missed last appt due to transportation issues ( transport never showed up ) Treatment Hx : IVA OD - 11 / 30 / 18 IVA OD - 9 / 14 / 18 IVA OD - 8 / 10 / 18 IVA OD - 6 / 1 / 18 IVA OD - 4 / 27 / 18 IVA OD - 3 / 16 / 18 PPV / SDEM / Retinectomy / SO ( OS ) - 1 / 22 / 18 IVA OD - 12 / 28 / 17 PPV / ML / SDEM / AFX / EPC / C3F8 ( OS ) 11 / 6 / 17 IVA OS - 11 / 2 / 17 IVA OD - 10 / 12 / 17 IVA OD - 8 / 4 / 17 PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active PDR OU 1 ) IDDM [ Type II , Dx 2002 ] .	laterality	lesion	T10	T1	note_8524
NonRel	Active PDR [s1] OU [e1] , TRD OS .	Proliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus - Right Eye E11.3513 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Pt missed last appt due to transportation issues ( transport never showed up ) Treatment Hx : IVA OD - 11 / 30 / 18 IVA OD - 9 / 14 / 18 IVA OD - 8 / 10 / 18 IVA OD - 6 / 1 / 18 IVA OD - 4 / 27 / 18 IVA OD - 3 / 16 / 18 PPV / SDEM / Retinectomy / SO ( OS ) - 1 / 22 / 18 IVA OD - 12 / 28 / 17 PPV / ML / SDEM / AFX / EPC / C3F8 ( OS ) 11 / 6 / 17 IVA OS - 11 / 2 / 17 IVA OD - 10 / 12 / 17 IVA OD - 8 / 4 / 17 PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active PDR OU 1 ) IDDM [ Type II , Dx 2002 ] .	laterality	lesion	T10	T3	note_8524
NonRel	Active PDR [s1] OU [e1] , TRD OS .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus - Right Eye E11.3513 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Pt missed last appt due to transportation issues ( transport never showed up ) Treatment Hx : IVA OD - 11 / 30 / 18 IVA OD - 9 / 14 / 18 IVA OD - 8 / 10 / 18 IVA OD - 6 / 1 / 18 IVA OD - 4 / 27 / 18 IVA OD - 3 / 16 / 18 PPV / SDEM / Retinectomy / SO ( OS ) - 1 / 22 / 18 IVA OD - 12 / 28 / 17 PPV / ML / SDEM / AFX / EPC / C3F8 ( OS ) 11 / 6 / 17 IVA OS - 11 / 2 / 17 IVA OD - 10 / 12 / 17 IVA OD - 8 / 4 / 17 PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active [s2] PDR [e2] OU 1 ) IDDM [ Type II , Dx 2002 ] .	laterality	lesion	T10	T6	note_8524
NonRel	VA down 20 / 70 - vs 20 / 60 LV No NVA on gonio today [s1] OU [e1] History of newly diagnosed APL currently on treatment .	OCT [s2] ME [e2] worse today than priors .	laterality	lesion	T1	T2	note_3194
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) - Left Eye E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye without macular edema associated with type 2 diabetes mellitus - Right Eye E11.3391 250.50 OCT , Posterior Segment - OU - Both Eyes 362.05 OPH - OS Intravitreal Injection , Pharmacologic Agent Hx of IDDM .	laterality	lesion	T10	T13	note_8629
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) - Left Eye E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 2 .	Moderate nonproliferative diabetic retinopathy of right eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus - Right Eye E11.3391 250.50 OCT , Posterior Segment - OU - Both Eyes 362.05 OPH - OS Intravitreal Injection , Pharmacologic Agent Hx of IDDM .	laterality	lesion	T10	T15	note_8629
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus - Right Eye E11.3391 250.50 OCT , Posterior Segment - OU - Both Eyes 362.05 OPH - OS Intravitreal Injection , Pharmacologic Agent Hx of IDDM .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) - Left Eye E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 2 .	severity	lesion	T12	T9	note_8629
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus - Right Eye E11.3391 250.50 OCT , Posterior Segment - OU - Both Eyes 362.05 OPH - OS Intravitreal Injection , Pharmacologic Agent Hx of IDDM .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) - Left Eye E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 2 .	severity	lesion	T12	T11	note_8629
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus - Right Eye E11.3391 250.50 OCT , Posterior Segment - OU - Both Eyes 362.05 OPH - OS Intravitreal Injection , Pharmacologic Agent Hx of IDDM .	[s2] PDR [e2] OS .	severity	lesion	T12	T16	note_8629
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] without macular edema associated with type 2 diabetes mellitus - Right Eye E11.3391 250.50 OCT , Posterior Segment - OU - Both Eyes 362.05 OPH - OS Intravitreal Injection , Pharmacologic Agent Hx of IDDM .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) - Left Eye E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 2 .	laterality	lesion	T14	T9	note_8629
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] without macular edema associated with type 2 diabetes mellitus - Right Eye E11.3391 250.50 OCT , Posterior Segment - OU - Both Eyes 362.05 OPH - OS Intravitreal Injection , Pharmacologic Agent Hx of IDDM .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) - Left Eye E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 2 .	laterality	lesion	T14	T11	note_8629
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] without macular edema associated with type 2 diabetes mellitus - Right Eye E11.3391 250.50 OCT , Posterior Segment - OU - Both Eyes 362.05 OPH - OS Intravitreal Injection , Pharmacologic Agent Hx of IDDM .	[s2] PDR [e2] OS .	laterality	lesion	T14	T16	note_8629
NonRel	PDR [s1] OS [e1] .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye without macular edema associated with type 2 diabetes mellitus - Right Eye E11.3391 250.50 OCT , Posterior Segment - OU - Both Eyes 362.05 OPH - OS Intravitreal Injection , Pharmacologic Agent Hx of IDDM .	laterality	lesion	T17	T13	note_8629
NonRel	PDR [s1] OS [e1] .	Moderate nonproliferative diabetic retinopathy of right eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus - Right Eye E11.3391 250.50 OCT , Posterior Segment - OU - Both Eyes 362.05 OPH - OS Intravitreal Injection , Pharmacologic Agent Hx of IDDM .	laterality	lesion	T17	T15	note_8629
NonRel	PDR [s1] OS [e1] .	Previously seen here 12 / 2017 , treated with PRP OS for active [s2] PDR [e2] .	laterality	lesion	T17	T20	note_8629
NonRel	Previously seen here 12 / 2017 , treated with PRP [s1] OS [e1] for active PDR .	[s2] PDR [e2] OS .	laterality	lesion	T18	T16	note_8629
NonRel	Previously seen here 12 / 2017 , treated with PRP OS for [s1] active [e1] PDR .	[s2] PDR [e2] OS .	severity	lesion	T19	T16	note_8629
NonRel	Proliferative diabetic retinopathy with macular edema associated with type 2 diabetes mellitus E11.3519 250.50 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.07 362.02 2 .	[s2] Subhyaloid hemorrhage [e2] of right eye H35.61 362.81 3 .	laterality	lesion	T5	T3	note_3664
NonRel	Subhyaloid hemorrhage of [s1] right eye [e1] H35.61 362.81 3 .	[s2] Proliferative diabetic retinopathy [e2] with macular edema associated with type 2 diabetes mellitus E11.3519 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 2 .	laterality	lesion	T6	T1	note_3664
NonRel	Subhyaloid hemorrhage of [s1] right eye [e1] H35.61 362.81 3 .	Proliferative diabetic retinopathy with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3519 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 2 .	laterality	lesion	T6	T2	note_3664
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 4 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Pt with hx of insulin dependent DM , most recent HgA 1 c is 10 % ( per pt ) last Wednesday .	laterality	lesion	T20	T4	837304_note_1177
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 4 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Pt with hx of insulin dependent DM , most recent HgA 1 c is 10 % ( per pt ) last Wednesday .	laterality	lesion	T20	T5	837304_note_1177
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Pt with hx of insulin dependent DM , most recent HgA 1 c is 10 % ( per pt ) last Wednesday .	[s2] Diabetic macular edema [e2] of right eye with proliferative retinopathy associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 4 .	laterality	lesion	T21	T2	837304_note_1177
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Pt with hx of insulin dependent DM , most recent HgA 1 c is 10 % ( per pt ) last Wednesday .	Diabetic macular edema of right eye with [s2] proliferative retinopathy [e2] associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 4 .	laterality	lesion	T21	T3	837304_note_1177
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Pt with hx of insulin dependent DM , most recent HgA 1 c is 10 % ( per pt ) last Wednesday .	Previously notes HgA 1 c was 14 % Vitreous hemorrhage , OD - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense vitreous heme obscurring posterior exam - B scan consistent with vit heme w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely [s2] PDR [e2] for non - clearing vit heme PDR - pt w / insulin DM with HgA 1 c 10 % last week per pt .	laterality	lesion	T21	T6	837304_note_1177
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Pt with hx of insulin dependent DM , most recent HgA 1 c is 10 % ( per pt ) last Wednesday .	Previously notes HgA 1 c was 14 % Vitreous hemorrhage , OD - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense vitreous heme obscurring posterior exam - B scan consistent with vit heme w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely PDR for non - clearing vit heme [s2] PDR [e2] - pt w / insulin DM with HgA 1 c 10 % last week per pt .	laterality	lesion	T21	T7	837304_note_1177
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Pt with hx of insulin dependent DM , most recent HgA 1 c is 10 % ( per pt ) last Wednesday .	Previously notes HgA 1 c was 14 % [s2] Vitreous hemorrhage [e2] , OD - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense vitreous heme obscurring posterior exam - B scan consistent with vit heme w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely PDR for non - clearing vit heme PDR - pt w / insulin DM with HgA 1 c 10 % last week per pt .	laterality	lesion	T21	T22	837304_note_1177
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Pt with hx of insulin dependent DM , most recent HgA 1 c is 10 % ( per pt ) last Wednesday .	Previously notes HgA 1 c was 14 % Vitreous hemorrhage , OD - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense [s2] vitreous heme [e2] obscurring posterior exam - B scan consistent with vit heme w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely PDR for non - clearing vit heme PDR - pt w / insulin DM with HgA 1 c 10 % last week per pt .	laterality	lesion	T21	T24	837304_note_1177
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Pt with hx of insulin dependent DM , most recent HgA 1 c is 10 % ( per pt ) last Wednesday .	Previously notes HgA 1 c was 14 % Vitreous hemorrhage , OD - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense vitreous heme obscurring posterior exam - B scan consistent with [s2] vit heme [e2] w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely PDR for non - clearing vit heme PDR - pt w / insulin DM with HgA 1 c 10 % last week per pt .	laterality	lesion	T21	T25	837304_note_1177
NonRel	Previously notes HgA 1 c was 14 % Vitreous hemorrhage , [s1] OD [e1] - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense vitreous heme obscurring posterior exam - B scan consistent with vit heme w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely PDR for non - clearing vit heme PDR - pt w / insulin DM with HgA 1 c 10 % last week per pt .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Pt with hx of insulin dependent DM , most recent HgA 1 c is 10 % ( per pt ) last Wednesday .	laterality	lesion	T23	T4	837304_note_1177
NonRel	Previously notes HgA 1 c was 14 % Vitreous hemorrhage , [s1] OD [e1] - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense vitreous heme obscurring posterior exam - B scan consistent with vit heme w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely PDR for non - clearing vit heme PDR - pt w / insulin DM with HgA 1 c 10 % last week per pt .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Pt with hx of insulin dependent DM , most recent HgA 1 c is 10 % ( per pt ) last Wednesday .	laterality	lesion	T23	T5	837304_note_1177
NonRel	Previously notes HgA 1 c was 14 % Vitreous hemorrhage , [s1] OD [e1] - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense vitreous heme obscurring posterior exam - B scan consistent with vit heme w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely PDR for non - clearing vit heme PDR - pt w / insulin DM with HgA 1 c 10 % last week per pt .	Hx of peripheral neuropathy and toe amputation in the past - dense vit heme OD , likely related to [s2] PDR [e2] - exam OS with NVD w / fibrosis around disc , macular MA / DBH / exudates and peripheral NVE appearing ITQ w / scattered MA / DBH - IVFA confirms NVD and NVE , significant 360 non perfusion approaching macula - OCT w / ERM , exudates and mild parafoveal IRF - plan on PRP friday NAME , MD participated in the care of this patient .	laterality	lesion	T23	T8	837304_note_1177
NonRel	Previously notes HgA 1 c was 14 % Vitreous hemorrhage , [s1] OD [e1] - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense vitreous heme obscurring posterior exam - B scan consistent with vit heme w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely PDR for non - clearing vit heme PDR - pt w / insulin DM with HgA 1 c 10 % last week per pt .	Hx of peripheral neuropathy and toe amputation in the past - dense vit heme OD , likely related to PDR - exam OS with [s2] NVD [e2] w / fibrosis around disc , macular MA / DBH / exudates and peripheral NVE appearing ITQ w / scattered MA / DBH - IVFA confirms NVD and NVE , significant 360 non perfusion approaching macula - OCT w / ERM , exudates and mild parafoveal IRF - plan on PRP friday NAME , MD participated in the care of this patient .	laterality	lesion	T23	T9	837304_note_1177
NonRel	Previously notes HgA 1 c was 14 % Vitreous hemorrhage , [s1] OD [e1] - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense vitreous heme obscurring posterior exam - B scan consistent with vit heme w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely PDR for non - clearing vit heme PDR - pt w / insulin DM with HgA 1 c 10 % last week per pt .	Hx of peripheral neuropathy and toe amputation in the past - dense vit heme OD , likely related to PDR - exam OS with NVD w / fibrosis around disc , macular [s2] MA [e2] / DBH / exudates and peripheral NVE appearing ITQ w / scattered MA / DBH - IVFA confirms NVD and NVE , significant 360 non perfusion approaching macula - OCT w / ERM , exudates and mild parafoveal IRF - plan on PRP friday NAME , MD participated in the care of this patient .	laterality	lesion	T23	T10	837304_note_1177
NonRel	Previously notes HgA 1 c was 14 % Vitreous hemorrhage , [s1] OD [e1] - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense vitreous heme obscurring posterior exam - B scan consistent with vit heme w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely PDR for non - clearing vit heme PDR - pt w / insulin DM with HgA 1 c 10 % last week per pt .	Hx of peripheral neuropathy and toe amputation in the past - dense vit heme OD , likely related to PDR - exam OS with NVD w / fibrosis around disc , macular MA / [s2] DBH [e2] / exudates and peripheral NVE appearing ITQ w / scattered MA / DBH - IVFA confirms NVD and NVE , significant 360 non perfusion approaching macula - OCT w / ERM , exudates and mild parafoveal IRF - plan on PRP friday NAME , MD participated in the care of this patient .	laterality	lesion	T23	T11	837304_note_1177
NonRel	Previously notes HgA 1 c was 14 % Vitreous hemorrhage , [s1] OD [e1] - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense vitreous heme obscurring posterior exam - B scan consistent with vit heme w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely PDR for non - clearing vit heme PDR - pt w / insulin DM with HgA 1 c 10 % last week per pt .	Hx of peripheral neuropathy and toe amputation in the past - dense vit heme OD , likely related to PDR - exam OS with NVD w / fibrosis around disc , macular MA / DBH / [s2] exudates [e2] and peripheral NVE appearing ITQ w / scattered MA / DBH - IVFA confirms NVD and NVE , significant 360 non perfusion approaching macula - OCT w / ERM , exudates and mild parafoveal IRF - plan on PRP friday NAME , MD participated in the care of this patient .	laterality	lesion	T23	T12	837304_note_1177
NonRel	Previously notes HgA 1 c was 14 % Vitreous hemorrhage , [s1] OD [e1] - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense vitreous heme obscurring posterior exam - B scan consistent with vit heme w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely PDR for non - clearing vit heme PDR - pt w / insulin DM with HgA 1 c 10 % last week per pt .	Hx of peripheral neuropathy and toe amputation in the past - dense vit heme OD , likely related to PDR - exam OS with NVD w / fibrosis around disc , macular MA / DBH / exudates and peripheral [s2] NVE [e2] appearing ITQ w / scattered MA / DBH - IVFA confirms NVD and NVE , significant 360 non perfusion approaching macula - OCT w / ERM , exudates and mild parafoveal IRF - plan on PRP friday NAME , MD participated in the care of this patient .	laterality	lesion	T23	T13	837304_note_1177
NonRel	Previously notes HgA 1 c was 14 % Vitreous hemorrhage , [s1] OD [e1] - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense vitreous heme obscurring posterior exam - B scan consistent with vit heme w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely PDR for non - clearing vit heme PDR - pt w / insulin DM with HgA 1 c 10 % last week per pt .	Hx of peripheral neuropathy and toe amputation in the past - dense vit heme OD , likely related to PDR - exam OS with NVD w / fibrosis around disc , macular MA / DBH / exudates and peripheral NVE appearing ITQ w / scattered [s2] MA [e2] / DBH - IVFA confirms NVD and NVE , significant 360 non perfusion approaching macula - OCT w / ERM , exudates and mild parafoveal IRF - plan on PRP friday NAME , MD participated in the care of this patient .	laterality	lesion	T23	T14	837304_note_1177
NonRel	Previously notes HgA 1 c was 14 % Vitreous hemorrhage , [s1] OD [e1] - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense vitreous heme obscurring posterior exam - B scan consistent with vit heme w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely PDR for non - clearing vit heme PDR - pt w / insulin DM with HgA 1 c 10 % last week per pt .	Hx of peripheral neuropathy and toe amputation in the past - dense vit heme OD , likely related to PDR - exam OS with NVD w / fibrosis around disc , macular MA / DBH / exudates and peripheral NVE appearing ITQ w / scattered MA / [s2] DBH [e2] - IVFA confirms NVD and NVE , significant 360 non perfusion approaching macula - OCT w / ERM , exudates and mild parafoveal IRF - plan on PRP friday NAME , MD participated in the care of this patient .	laterality	lesion	T23	T15	837304_note_1177
NonRel	Previously notes HgA 1 c was 14 % Vitreous hemorrhage , [s1] OD [e1] - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense vitreous heme obscurring posterior exam - B scan consistent with vit heme w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely PDR for non - clearing vit heme PDR - pt w / insulin DM with HgA 1 c 10 % last week per pt .	Hx of peripheral neuropathy and toe amputation in the past - dense vit heme OD , likely related to PDR - exam OS with NVD w / fibrosis around disc , macular MA / DBH / exudates and peripheral NVE appearing ITQ w / scattered MA / DBH - IVFA confirms [s2] NVD [e2] and NVE , significant 360 non perfusion approaching macula - OCT w / ERM , exudates and mild parafoveal IRF - plan on PRP friday NAME , MD participated in the care of this patient .	laterality	lesion	T23	T16	837304_note_1177
NonRel	Previously notes HgA 1 c was 14 % Vitreous hemorrhage , [s1] OD [e1] - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense vitreous heme obscurring posterior exam - B scan consistent with vit heme w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely PDR for non - clearing vit heme PDR - pt w / insulin DM with HgA 1 c 10 % last week per pt .	Hx of peripheral neuropathy and toe amputation in the past - dense vit heme OD , likely related to PDR - exam OS with NVD w / fibrosis around disc , macular MA / DBH / exudates and peripheral NVE appearing ITQ w / scattered MA / DBH - IVFA confirms NVD and [s2] NVE [e2] , significant 360 non perfusion approaching macula - OCT w / ERM , exudates and mild parafoveal IRF - plan on PRP friday NAME , MD participated in the care of this patient .	laterality	lesion	T23	T17	837304_note_1177
NonRel	Previously notes HgA 1 c was 14 % Vitreous hemorrhage , [s1] OD [e1] - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense vitreous heme obscurring posterior exam - B scan consistent with vit heme w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely PDR for non - clearing vit heme PDR - pt w / insulin DM with HgA 1 c 10 % last week per pt .	Hx of peripheral neuropathy and toe amputation in the past - dense vit heme OD , likely related to PDR - exam OS with NVD w / fibrosis around disc , macular MA / DBH / exudates and peripheral NVE appearing ITQ w / scattered MA / DBH - IVFA confirms NVD and NVE , significant 360 non perfusion approaching macula - OCT w / ERM , [s2] exudates [e2] and mild parafoveal IRF - plan on PRP friday NAME , MD participated in the care of this patient .	laterality	lesion	T23	T18	837304_note_1177
NonRel	Previously notes HgA 1 c was 14 % Vitreous hemorrhage , [s1] OD [e1] - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense vitreous heme obscurring posterior exam - B scan consistent with vit heme w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely PDR for non - clearing vit heme PDR - pt w / insulin DM with HgA 1 c 10 % last week per pt .	Hx of peripheral neuropathy and toe amputation in the past - dense vit heme OD , likely related to PDR - exam OS with NVD w / fibrosis around disc , macular MA / DBH / exudates and peripheral NVE appearing ITQ w / scattered MA / DBH - IVFA confirms NVD and NVE , significant 360 non perfusion approaching macula - OCT w / ERM , exudates and mild parafoveal [s2] IRF [e2] - plan on PRP friday NAME , MD participated in the care of this patient .	laterality	lesion	T23	T19	837304_note_1177
NonRel	Previously notes HgA 1 c was 14 % Vitreous hemorrhage , [s1] OD [e1] - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense vitreous heme obscurring posterior exam - B scan consistent with vit heme w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely PDR for non - clearing vit heme PDR - pt w / insulin DM with HgA 1 c 10 % last week per pt .	Hx of peripheral neuropathy and toe amputation in the past - dense [s2] vit heme [e2] OD , likely related to PDR - exam OS with NVD w / fibrosis around disc , macular MA / DBH / exudates and peripheral NVE appearing ITQ w / scattered MA / DBH - IVFA confirms NVD and NVE , significant 360 non perfusion approaching macula - OCT w / ERM , exudates and mild parafoveal IRF - plan on PRP friday NAME , MD participated in the care of this patient .	laterality	lesion	T23	T26	837304_note_1177
NonRel	Hx of peripheral neuropathy and toe amputation in the past - [s1] dense [e1] vit heme OD , likely related to PDR - exam OS with NVD w / fibrosis around disc , macular MA / DBH / exudates and peripheral NVE appearing ITQ w / scattered MA / DBH - IVFA confirms NVD and NVE , significant 360 non perfusion approaching macula - OCT w / ERM , exudates and mild parafoveal IRF - plan on PRP friday NAME , MD participated in the care of this patient .	Previously notes HgA 1 c was 14 % Vitreous hemorrhage , OD - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense vitreous heme obscurring posterior exam - B scan consistent with vit heme w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely [s2] PDR [e2] for non - clearing vit heme PDR - pt w / insulin DM with HgA 1 c 10 % last week per pt .	severity	lesion	T27	T6	837304_note_1177
NonRel	Hx of peripheral neuropathy and toe amputation in the past - [s1] dense [e1] vit heme OD , likely related to PDR - exam OS with NVD w / fibrosis around disc , macular MA / DBH / exudates and peripheral NVE appearing ITQ w / scattered MA / DBH - IVFA confirms NVD and NVE , significant 360 non perfusion approaching macula - OCT w / ERM , exudates and mild parafoveal IRF - plan on PRP friday NAME , MD participated in the care of this patient .	Previously notes HgA 1 c was 14 % Vitreous hemorrhage , OD - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense vitreous heme obscurring posterior exam - B scan consistent with vit heme w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely PDR for non - clearing vit heme [s2] PDR [e2] - pt w / insulin DM with HgA 1 c 10 % last week per pt .	severity	lesion	T27	T7	837304_note_1177
NonRel	Hx of peripheral neuropathy and toe amputation in the past - [s1] dense [e1] vit heme OD , likely related to PDR - exam OS with NVD w / fibrosis around disc , macular MA / DBH / exudates and peripheral NVE appearing ITQ w / scattered MA / DBH - IVFA confirms NVD and NVE , significant 360 non perfusion approaching macula - OCT w / ERM , exudates and mild parafoveal IRF - plan on PRP friday NAME , MD participated in the care of this patient .	Previously notes HgA 1 c was 14 % [s2] Vitreous hemorrhage [e2] , OD - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense vitreous heme obscurring posterior exam - B scan consistent with vit heme w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely PDR for non - clearing vit heme PDR - pt w / insulin DM with HgA 1 c 10 % last week per pt .	severity	lesion	T27	T22	837304_note_1177
NonRel	Hx of peripheral neuropathy and toe amputation in the past - [s1] dense [e1] vit heme OD , likely related to PDR - exam OS with NVD w / fibrosis around disc , macular MA / DBH / exudates and peripheral NVE appearing ITQ w / scattered MA / DBH - IVFA confirms NVD and NVE , significant 360 non perfusion approaching macula - OCT w / ERM , exudates and mild parafoveal IRF - plan on PRP friday NAME , MD participated in the care of this patient .	Previously notes HgA 1 c was 14 % Vitreous hemorrhage , OD - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense [s2] vitreous heme [e2] obscurring posterior exam - B scan consistent with vit heme w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely PDR for non - clearing vit heme PDR - pt w / insulin DM with HgA 1 c 10 % last week per pt .	severity	lesion	T27	T24	837304_note_1177
NonRel	Hx of peripheral neuropathy and toe amputation in the past - [s1] dense [e1] vit heme OD , likely related to PDR - exam OS with NVD w / fibrosis around disc , macular MA / DBH / exudates and peripheral NVE appearing ITQ w / scattered MA / DBH - IVFA confirms NVD and NVE , significant 360 non perfusion approaching macula - OCT w / ERM , exudates and mild parafoveal IRF - plan on PRP friday NAME , MD participated in the care of this patient .	Previously notes HgA 1 c was 14 % Vitreous hemorrhage , OD - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense vitreous heme obscurring posterior exam - B scan consistent with [s2] vit heme [e2] w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely PDR for non - clearing vit heme PDR - pt w / insulin DM with HgA 1 c 10 % last week per pt .	severity	lesion	T27	T25	837304_note_1177
NonRel	Hx of peripheral neuropathy and toe amputation in the past - dense vit heme [s1] OD [e1] , likely related to PDR - exam OS with NVD w / fibrosis around disc , macular MA / DBH / exudates and peripheral NVE appearing ITQ w / scattered MA / DBH - IVFA confirms NVD and NVE , significant 360 non perfusion approaching macula - OCT w / ERM , exudates and mild parafoveal IRF - plan on PRP friday NAME , MD participated in the care of this patient .	Previously notes HgA 1 c was 14 % Vitreous hemorrhage , OD - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense vitreous heme obscurring posterior exam - B scan consistent with vit heme w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely [s2] PDR [e2] for non - clearing vit heme PDR - pt w / insulin DM with HgA 1 c 10 % last week per pt .	laterality	lesion	T28	T6	837304_note_1177
NonRel	Hx of peripheral neuropathy and toe amputation in the past - dense vit heme [s1] OD [e1] , likely related to PDR - exam OS with NVD w / fibrosis around disc , macular MA / DBH / exudates and peripheral NVE appearing ITQ w / scattered MA / DBH - IVFA confirms NVD and NVE , significant 360 non perfusion approaching macula - OCT w / ERM , exudates and mild parafoveal IRF - plan on PRP friday NAME , MD participated in the care of this patient .	Previously notes HgA 1 c was 14 % Vitreous hemorrhage , OD - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense vitreous heme obscurring posterior exam - B scan consistent with vit heme w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely PDR for non - clearing vit heme [s2] PDR [e2] - pt w / insulin DM with HgA 1 c 10 % last week per pt .	laterality	lesion	T28	T7	837304_note_1177
NonRel	Hx of peripheral neuropathy and toe amputation in the past - dense vit heme [s1] OD [e1] , likely related to PDR - exam OS with NVD w / fibrosis around disc , macular MA / DBH / exudates and peripheral NVE appearing ITQ w / scattered MA / DBH - IVFA confirms NVD and NVE , significant 360 non perfusion approaching macula - OCT w / ERM , exudates and mild parafoveal IRF - plan on PRP friday NAME , MD participated in the care of this patient .	Previously notes HgA 1 c was 14 % [s2] Vitreous hemorrhage [e2] , OD - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense vitreous heme obscurring posterior exam - B scan consistent with vit heme w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely PDR for non - clearing vit heme PDR - pt w / insulin DM with HgA 1 c 10 % last week per pt .	laterality	lesion	T28	T22	837304_note_1177
NonRel	Hx of peripheral neuropathy and toe amputation in the past - dense vit heme [s1] OD [e1] , likely related to PDR - exam OS with NVD w / fibrosis around disc , macular MA / DBH / exudates and peripheral NVE appearing ITQ w / scattered MA / DBH - IVFA confirms NVD and NVE , significant 360 non perfusion approaching macula - OCT w / ERM , exudates and mild parafoveal IRF - plan on PRP friday NAME , MD participated in the care of this patient .	Previously notes HgA 1 c was 14 % Vitreous hemorrhage , OD - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense [s2] vitreous heme [e2] obscurring posterior exam - B scan consistent with vit heme w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely PDR for non - clearing vit heme PDR - pt w / insulin DM with HgA 1 c 10 % last week per pt .	laterality	lesion	T28	T24	837304_note_1177
NonRel	Hx of peripheral neuropathy and toe amputation in the past - dense vit heme [s1] OD [e1] , likely related to PDR - exam OS with NVD w / fibrosis around disc , macular MA / DBH / exudates and peripheral NVE appearing ITQ w / scattered MA / DBH - IVFA confirms NVD and NVE , significant 360 non perfusion approaching macula - OCT w / ERM , exudates and mild parafoveal IRF - plan on PRP friday NAME , MD participated in the care of this patient .	Previously notes HgA 1 c was 14 % Vitreous hemorrhage , OD - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense vitreous heme obscurring posterior exam - B scan consistent with [s2] vit heme [e2] w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely PDR for non - clearing vit heme PDR - pt w / insulin DM with HgA 1 c 10 % last week per pt .	laterality	lesion	T28	T25	837304_note_1177
NonRel	Hx of peripheral neuropathy and toe amputation in the past - dense vit heme OD , likely related to PDR - exam [s1] OS [e1] with NVD w / fibrosis around disc , macular MA / DBH / exudates and peripheral NVE appearing ITQ w / scattered MA / DBH - IVFA confirms NVD and NVE , significant 360 non perfusion approaching macula - OCT w / ERM , exudates and mild parafoveal IRF - plan on PRP friday NAME , MD participated in the care of this patient .	Previously notes HgA 1 c was 14 % Vitreous hemorrhage , OD - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense vitreous heme obscurring posterior exam - B scan consistent with vit heme w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely [s2] PDR [e2] for non - clearing vit heme PDR - pt w / insulin DM with HgA 1 c 10 % last week per pt .	laterality	lesion	T29	T6	837304_note_1177
NonRel	Hx of peripheral neuropathy and toe amputation in the past - dense vit heme OD , likely related to PDR - exam [s1] OS [e1] with NVD w / fibrosis around disc , macular MA / DBH / exudates and peripheral NVE appearing ITQ w / scattered MA / DBH - IVFA confirms NVD and NVE , significant 360 non perfusion approaching macula - OCT w / ERM , exudates and mild parafoveal IRF - plan on PRP friday NAME , MD participated in the care of this patient .	Previously notes HgA 1 c was 14 % Vitreous hemorrhage , OD - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense vitreous heme obscurring posterior exam - B scan consistent with vit heme w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely PDR for non - clearing vit heme [s2] PDR [e2] - pt w / insulin DM with HgA 1 c 10 % last week per pt .	laterality	lesion	T29	T7	837304_note_1177
NonRel	Hx of peripheral neuropathy and toe amputation in the past - dense vit heme OD , likely related to PDR - exam [s1] OS [e1] with NVD w / fibrosis around disc , macular MA / DBH / exudates and peripheral NVE appearing ITQ w / scattered MA / DBH - IVFA confirms NVD and NVE , significant 360 non perfusion approaching macula - OCT w / ERM , exudates and mild parafoveal IRF - plan on PRP friday NAME , MD participated in the care of this patient .	Previously notes HgA 1 c was 14 % [s2] Vitreous hemorrhage [e2] , OD - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense vitreous heme obscurring posterior exam - B scan consistent with vit heme w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely PDR for non - clearing vit heme PDR - pt w / insulin DM with HgA 1 c 10 % last week per pt .	laterality	lesion	T29	T22	837304_note_1177
NonRel	Hx of peripheral neuropathy and toe amputation in the past - dense vit heme OD , likely related to PDR - exam [s1] OS [e1] with NVD w / fibrosis around disc , macular MA / DBH / exudates and peripheral NVE appearing ITQ w / scattered MA / DBH - IVFA confirms NVD and NVE , significant 360 non perfusion approaching macula - OCT w / ERM , exudates and mild parafoveal IRF - plan on PRP friday NAME , MD participated in the care of this patient .	Previously notes HgA 1 c was 14 % Vitreous hemorrhage , OD - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense [s2] vitreous heme [e2] obscurring posterior exam - B scan consistent with vit heme w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely PDR for non - clearing vit heme PDR - pt w / insulin DM with HgA 1 c 10 % last week per pt .	laterality	lesion	T29	T24	837304_note_1177
NonRel	Hx of peripheral neuropathy and toe amputation in the past - dense vit heme OD , likely related to PDR - exam [s1] OS [e1] with NVD w / fibrosis around disc , macular MA / DBH / exudates and peripheral NVE appearing ITQ w / scattered MA / DBH - IVFA confirms NVD and NVE , significant 360 non perfusion approaching macula - OCT w / ERM , exudates and mild parafoveal IRF - plan on PRP friday NAME , MD participated in the care of this patient .	Previously notes HgA 1 c was 14 % Vitreous hemorrhage , OD - reports 1 mo hx of extremely poor vision - VA remains CF face , IOP 11 - exam w / continued dense vitreous heme obscurring posterior exam - B scan consistent with [s2] vit heme [e2] w / separation of posterior hyaloid - will need exploratory PPV / endolaser for likely PDR for non - clearing vit heme PDR - pt w / insulin DM with HgA 1 c 10 % last week per pt .	laterality	lesion	T29	T25	837304_note_1177
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.02 2 .	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active [s2] PDR [e2] OU 1 .	laterality	lesion	T4	T7	note_8432
NonRel	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - [s1] Active [e1] PDR OU 1 .	[s2] Proliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.02 2 .	severity	lesion	T6	T3	note_8432
NonRel	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - [s1] Active [e1] PDR OU 1 .	Proliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3513 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.02 2 .	severity	lesion	T6	T5	note_8432
NonRel	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - [s1] Active [e1] PDR OU 1 .	DM type II with [s2] PDR [e2] OU and tractional RD OS OD : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	severity	lesion	T6	T9	note_8432
NonRel	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - [s1] Active [e1] PDR OU 1 .	DM type II with PDR OU and tractional RD OS OD : [s2] PDR [e2] with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	severity	lesion	T6	T13	note_8432
NonRel	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - [s1] Active [e1] PDR OU 1 .	DM type II with PDR OU and tractional RD OS OD : PDR with [s2] NVD [e2] , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	severity	lesion	T6	T14	note_8432
NonRel	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - [s1] Active [e1] PDR OU 1 .	DM type II with PDR OU and tractional RD OS OD : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of [s2] intraretinal hemorrhages [e2] , NVE .	severity	lesion	T6	T15	note_8432
NonRel	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - [s1] Active [e1] PDR OU 1 .	DM type II with PDR OU and tractional RD OS OD : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , [s2] NVE [e2] .	severity	lesion	T6	T16	note_8432
NonRel	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active PDR [s1] OU [e1] 1 .	[s2] Proliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.02 2 .	laterality	lesion	T8	T3	note_8432
NonRel	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active PDR [s1] OU [e1] 1 .	Proliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3513 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.02 2 .	laterality	lesion	T8	T5	note_8432
NonRel	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active PDR [s1] OU [e1] 1 .	DM type II with [s2] PDR [e2] OU and tractional RD OS OD : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	laterality	lesion	T8	T9	note_8432
NonRel	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active PDR [s1] OU [e1] 1 .	DM type II with PDR OU and tractional RD OS OD : [s2] PDR [e2] with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	laterality	lesion	T8	T13	note_8432
NonRel	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active PDR [s1] OU [e1] 1 .	DM type II with PDR OU and tractional RD OS OD : PDR with [s2] NVD [e2] , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	laterality	lesion	T8	T14	note_8432
NonRel	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active PDR [s1] OU [e1] 1 .	DM type II with PDR OU and tractional RD OS OD : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of [s2] intraretinal hemorrhages [e2] , NVE .	laterality	lesion	T8	T15	note_8432
NonRel	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active PDR [s1] OU [e1] 1 .	DM type II with PDR OU and tractional RD OS OD : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , [s2] NVE [e2] .	laterality	lesion	T8	T16	note_8432
NonRel	DM type II with PDR [s1] OU [e1] and tractional RD OS OD : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active [s2] PDR [e2] OU 1 .	laterality	lesion	T10	T7	note_8432
NonRel	DM type II with PDR [s1] OU [e1] and tractional RD OS OD : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	No [s2] NVI [e2] .	laterality	lesion	T10	T17	note_8432
NonRel	DM type II with PDR OU and tractional RD OS [s1] OD [e1] : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active [s2] PDR [e2] OU 1 .	laterality	lesion	T12	T7	note_8432
NonRel	DM type II with PDR OU and tractional RD OS [s1] OD [e1] : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	No [s2] NVI [e2] .	laterality	lesion	T12	T17	note_8432
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 1 diabetes mellitus E10.3513 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Mr. Colonair is referred from Dr. Cameron for evaluation of PDR OU . 1 .	OCT , Posterior Segment - OU - Both Eyes OD : No significant edema OS : temporal [s2] cystic edema [e2] Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T4	T1	note_7933
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus E10.3513 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Mr. Colonair is referred from Dr. Cameron for evaluation of PDR [s1] OU [e1] . 1 .	OCT , Posterior Segment - OU - Both Eyes OD : No significant edema OS : temporal [s2] cystic edema [e2] Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T7	T1	note_7933
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy [s1] OD [e1] - Active PDR without CSME ( + DME ) on exam .	OS - Active [s2] PDR [e2] with sub - hyaloid hemorrhage .	laterality	lesion	T8	T15	note_7933
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy [s1] OD [e1] - Active PDR without CSME ( + DME ) on exam .	OS - Active PDR with sub - hyaloid [s2] hemorrhage [e2] .	laterality	lesion	T8	T16	note_7933
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy OD - [s1] Active [e1] PDR without CSME ( + DME ) on exam .	OS - Active [s2] PDR [e2] with sub - hyaloid hemorrhage .	severity	lesion	T9	T15	note_7933
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy OD - [s1] Active [e1] PDR without CSME ( + DME ) on exam .	OS - Active PDR with sub - hyaloid [s2] hemorrhage [e2] .	severity	lesion	T9	T16	note_7933
NonRel	[s1] OS [e1] - Active PDR with sub - hyaloid hemorrhage .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy OD - Active [s2] PDR [e2] without CSME ( + DME ) on exam .	laterality	lesion	T13	T10	note_7933
NonRel	[s1] OS [e1] - Active PDR with sub - hyaloid hemorrhage .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy OD - Active PDR without [s2] CSME [e2] ( + DME ) on exam .	laterality	lesion	T13	T11	note_7933
NonRel	[s1] OS [e1] - Active PDR with sub - hyaloid hemorrhage .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy OD - Active PDR without CSME ( + [s2] DME [e2] ) on exam .	laterality	lesion	T13	T12	note_7933
NonRel	[s1] OS [e1] - Active PDR with sub - hyaloid hemorrhage .	Mild temporal [s2] macular edema [e2] Plan IVFA - Guided PRP OU with IVA pre - treatment OS .	laterality	lesion	T13	T19	note_7933
NonRel	OS - [s1] Active [e1] PDR with sub - hyaloid hemorrhage .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy OD - Active [s2] PDR [e2] without CSME ( + DME ) on exam .	severity	lesion	T14	T10	note_7933
NonRel	OS - [s1] Active [e1] PDR with sub - hyaloid hemorrhage .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy OD - Active PDR without [s2] CSME [e2] ( + DME ) on exam .	severity	lesion	T14	T11	note_7933
NonRel	OS - [s1] Active [e1] PDR with sub - hyaloid hemorrhage .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy OD - Active PDR without CSME ( + [s2] DME [e2] ) on exam .	severity	lesion	T14	T12	note_7933
NonRel	OS - [s1] Active [e1] PDR with sub - hyaloid hemorrhage .	Mild temporal [s2] macular edema [e2] Plan IVFA - Guided PRP OU with IVA pre - treatment OS .	severity	lesion	T14	T19	note_7933
NonRel	[s1] Mild [e1] temporal macular edema Plan IVFA - Guided PRP OU with IVA pre - treatment OS .	OS - Active [s2] PDR [e2] with sub - hyaloid hemorrhage .	severity	lesion	T17	T15	note_7933
NonRel	[s1] Mild [e1] temporal macular edema Plan IVFA - Guided PRP OU with IVA pre - treatment OS .	OS - Active PDR with sub - hyaloid [s2] hemorrhage [e2] .	severity	lesion	T17	T16	note_7933
NonRel	Mild [s1] temporal [e1] macular edema Plan IVFA - Guided PRP OU with IVA pre - treatment OS .	OS - Active [s2] PDR [e2] with sub - hyaloid hemorrhage .	severity	lesion	T18	T15	note_7933
NonRel	Mild [s1] temporal [e1] macular edema Plan IVFA - Guided PRP OU with IVA pre - treatment OS .	OS - Active PDR with sub - hyaloid [s2] hemorrhage [e2] .	severity	lesion	T18	T16	note_7933
NonRel	Mild temporal macular edema Plan IVFA - Guided PRP [s1] OU [e1] with IVA pre - treatment OS .	OS - Active [s2] PDR [e2] with sub - hyaloid hemorrhage .	laterality	lesion	T20	T15	note_7933
NonRel	Mild temporal macular edema Plan IVFA - Guided PRP [s1] OU [e1] with IVA pre - treatment OS .	OS - Active PDR with sub - hyaloid [s2] hemorrhage [e2] .	laterality	lesion	T20	T16	note_7933
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : No significant edema OS : [s1] temporal [e1] cystic edema Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	[s2] Proliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 1 diabetes mellitus E10.3513 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Mr. Colonair is referred from Dr. Cameron for evaluation of PDR OU . 1 .	severity	lesion	T2	T3	note_7933
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : No significant edema OS : [s1] temporal [e1] cystic edema Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Proliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 1 diabetes mellitus E10.3513 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Mr. Colonair is referred from Dr. Cameron for evaluation of PDR OU . 1 .	severity	lesion	T2	T5	note_7933
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : No significant edema OS : [s1] temporal [e1] cystic edema Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus E10.3513 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Mr. Colonair is referred from Dr. Cameron for evaluation of [s2] PDR [e2] OU . 1 .	severity	lesion	T2	T6	note_7933
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : No significant edema [s1] OS [e1] : temporal cystic edema Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	[s2] Proliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 1 diabetes mellitus E10.3513 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Mr. Colonair is referred from Dr. Cameron for evaluation of PDR OU . 1 .	laterality	lesion	T21	T3	note_7933
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : No significant edema [s1] OS [e1] : temporal cystic edema Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Proliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 1 diabetes mellitus E10.3513 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Mr. Colonair is referred from Dr. Cameron for evaluation of PDR OU . 1 .	laterality	lesion	T21	T5	note_7933
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : No significant edema [s1] OS [e1] : temporal cystic edema Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus E10.3513 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Mr. Colonair is referred from Dr. Cameron for evaluation of [s2] PDR [e2] OU . 1 .	laterality	lesion	T21	T6	note_7933
NonRel	[s1] Mild [e1] nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 2 .	Mild [s2] nonproliferative diabetic retinopathy [e2] of left eye without macular edema associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	severity	lesion	T1	T6	note_8083
NonRel	[s1] Mild [e1] nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 2 .	Mild nonproliferative diabetic retinopathy of left eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	severity	lesion	T1	T8	note_8083
NonRel	Mild nonproliferative diabetic retinopathy of [s1] right eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 2 .	Mild [s2] nonproliferative diabetic retinopathy [e2] of left eye without macular edema associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	laterality	lesion	T3	T6	note_8083
NonRel	Mild nonproliferative diabetic retinopathy of [s1] right eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 2 .	Mild nonproliferative diabetic retinopathy of left eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	laterality	lesion	T3	T8	note_8083
NonRel	[s1] Mild [e1] nonproliferative diabetic retinopathy of left eye without macular edema associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	Mild [s2] nonproliferative diabetic retinopathy [e2] of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 2 .	severity	lesion	T5	T2	note_8083
NonRel	[s1] Mild [e1] nonproliferative diabetic retinopathy of left eye without macular edema associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	Mild nonproliferative diabetic retinopathy of right eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 2 .	severity	lesion	T5	T4	note_8083
NonRel	Mild nonproliferative diabetic retinopathy of [s1] left eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	Mild [s2] nonproliferative diabetic retinopathy [e2] of right eye without macular edema associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 2 .	laterality	lesion	T7	T2	note_8083
NonRel	Mild nonproliferative diabetic retinopathy of [s1] left eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	Mild nonproliferative diabetic retinopathy of right eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3291 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 2 .	laterality	lesion	T7	T4	note_8083
NonRel	BRVO with macular edema [s1] OS [e1] - Previously treated at UFH , saw retina MD in LOCATION _ CITY , FL and was receiving IVA injections OS q6 - 8 weeks , last ~ DATE .	- Recurrence of [s2] ME [e2] last visit and treatment re - initiated with great response .	laterality	lesion	T10	T2	1936668_note_5255
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) - Left Eye E11.3512 250.50 362.07 362.02 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye without macular edema associated with type 2 diabetes mellitus - Right Eye E11.3391 250.50 362.05 Gonioscopy by Dr. Sherwood : D40r with trace to 1 + Pig PTM OU and no PAS .	laterality	lesion	T6	T3	note_8618
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) - Left Eye E11.3512 250.50 362.07 362.02 2 .	Moderate nonproliferative diabetic retinopathy of right eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus - Right Eye E11.3391 250.50 362.05 Gonioscopy by Dr. Sherwood : D40r with trace to 1 + Pig PTM OU and no PAS .	laterality	lesion	T6	T4	note_8618
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus - Right Eye E11.3391 250.50 362.05 Gonioscopy by Dr. Sherwood : D40r with trace to 1 + Pig PTM OU and no PAS .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) - Left Eye E11.3512 250.50 362.07 362.02 2 .	severity	lesion	T7	T1	note_8618
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus - Right Eye E11.3391 250.50 362.05 Gonioscopy by Dr. Sherwood : D40r with trace to 1 + Pig PTM OU and no PAS .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) - Left Eye E11.3512 250.50 362.07 362.02 2 .	severity	lesion	T7	T2	note_8618
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus - Right Eye E11.3391 250.50 362.05 Gonioscopy by Dr. Sherwood : D40r with trace to 1 + Pig PTM OU and no PAS .	No NV in angle OU [s2] NVI [e2] noted OU today Plan IVA OU today Aaron Noll , MD participated in the care of this patient .	severity	lesion	T7	T5	note_8618
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] without macular edema associated with type 2 diabetes mellitus - Right Eye E11.3391 250.50 362.05 Gonioscopy by Dr. Sherwood : D40r with trace to 1 + Pig PTM OU and no PAS .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) - Left Eye E11.3512 250.50 362.07 362.02 2 .	laterality	lesion	T8	T1	note_8618
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] without macular edema associated with type 2 diabetes mellitus - Right Eye E11.3391 250.50 362.05 Gonioscopy by Dr. Sherwood : D40r with trace to 1 + Pig PTM OU and no PAS .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) - Left Eye E11.3512 250.50 362.07 362.02 2 .	laterality	lesion	T8	T2	note_8618
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] without macular edema associated with type 2 diabetes mellitus - Right Eye E11.3391 250.50 362.05 Gonioscopy by Dr. Sherwood : D40r with trace to 1 + Pig PTM OU and no PAS .	No NV in angle OU [s2] NVI [e2] noted OU today Plan IVA OU today Aaron Noll , MD participated in the care of this patient .	laterality	lesion	T8	T5	note_8618
NonRel	No NV in angle [s1] OU NVI [e1] noted OU today Plan IVA OU today Aaron Noll , MD participated in the care of this patient .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye without macular edema associated with type 2 diabetes mellitus - Right Eye E11.3391 250.50 362.05 Gonioscopy by Dr. Sherwood : D40r with trace to 1 + Pig PTM OU and no PAS .	laterality	lesion	T9	T3	note_8618
NonRel	No NV in angle [s1] OU NVI [e1] noted OU today Plan IVA OU today Aaron Noll , MD participated in the care of this patient .	Moderate nonproliferative diabetic retinopathy of right eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus - Right Eye E11.3391 250.50 362.05 Gonioscopy by Dr. Sherwood : D40r with trace to 1 + Pig PTM OU and no PAS .	laterality	lesion	T9	T4	note_8618
NonRel	[s1] Mild [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3211 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.04 2 .	Mild [s2] nonproliferative diabetic retinopathy [e2] of left eye without macular edema associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	severity	lesion	T1	T6	note_83
NonRel	[s1] Mild [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3211 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.04 2 .	Mild nonproliferative diabetic retinopathy of left eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	severity	lesion	T1	T8	note_83
NonRel	Mild nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3211 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.04 2 .	Mild [s2] nonproliferative diabetic retinopathy [e2] of left eye without macular edema associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	laterality	lesion	T3	T6	note_83
NonRel	Mild nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3211 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.04 2 .	Mild nonproliferative diabetic retinopathy of left eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	laterality	lesion	T3	T8	note_83
NonRel	[s1] Mild [e1] nonproliferative diabetic retinopathy of left eye without macular edema associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	Mild [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3211 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.04 2 .	severity	lesion	T5	T2	note_83
NonRel	[s1] Mild [e1] nonproliferative diabetic retinopathy of left eye without macular edema associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	Mild nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3211 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.04 2 .	severity	lesion	T5	T4	note_83
NonRel	[s1] Mild [e1] nonproliferative diabetic retinopathy of left eye without macular edema associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	Choroidal nevus , left D31.32 224.6 1 ) IDDM [ Dx mid 80 ' s . most recent a1c was 7.6 ( 2 / 2018 ) ] OD - mild [s2] CSME [e2] that is stable .	severity	lesion	T5	T11	note_83
NonRel	Mild nonproliferative diabetic retinopathy of [s1] left eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	Mild [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3211 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.04 2 .	laterality	lesion	T7	T2	note_83
NonRel	Mild nonproliferative diabetic retinopathy of [s1] left eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	Mild nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3211 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.04 2 .	laterality	lesion	T7	T4	note_83
NonRel	Mild nonproliferative diabetic retinopathy of [s1] left eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	Choroidal nevus , left D31.32 224.6 1 ) IDDM [ Dx mid 80 ' s . most recent a1c was 7.6 ( 2 / 2018 ) ] OD - mild [s2] CSME [e2] that is stable .	laterality	lesion	T7	T11	note_83
NonRel	Choroidal nevus , left D31.32 224.6 1 ) IDDM [ Dx mid 80 ' s . most recent a1c was 7.6 ( 2 / 2018 ) ] [s1] OD [e1] - mild CSME that is stable .	Mild [s2] nonproliferative diabetic retinopathy [e2] of left eye without macular edema associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	laterality	lesion	T9	T6	note_83
NonRel	Choroidal nevus , left D31.32 224.6 1 ) IDDM [ Dx mid 80 ' s . most recent a1c was 7.6 ( 2 / 2018 ) ] [s1] OD [e1] - mild CSME that is stable .	Mild nonproliferative diabetic retinopathy of left eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	laterality	lesion	T9	T8	note_83
NonRel	Choroidal nevus , left D31.32 224.6 1 ) IDDM [ Dx mid 80 ' s . most recent a1c was 7.6 ( 2 / 2018 ) ] OD - [s1] mild [e1] CSME that is stable .	Mild [s2] nonproliferative diabetic retinopathy [e2] of left eye without macular edema associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	severity	lesion	T10	T6	note_83
NonRel	Choroidal nevus , left D31.32 224.6 1 ) IDDM [ Dx mid 80 ' s . most recent a1c was 7.6 ( 2 / 2018 ) ] OD - [s1] mild [e1] CSME that is stable .	Mild nonproliferative diabetic retinopathy of left eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	severity	lesion	T10	T8	note_83
NonRel	Choroidal nevus , left D31.32 224.6 1 ) IDDM [ Dx mid 80 ' s . most recent a1c was 7.6 ( 2 / 2018 ) ] OD - mild CSME that is [s1] stable [e1] .	Mild [s2] nonproliferative diabetic retinopathy [e2] of left eye without macular edema associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	severity	lesion	T24	T6	note_83
NonRel	Choroidal nevus , left D31.32 224.6 1 ) IDDM [ Dx mid 80 ' s . most recent a1c was 7.6 ( 2 / 2018 ) ] OD - mild CSME that is [s1] stable [e1] .	Mild nonproliferative diabetic retinopathy of left eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 3 .	severity	lesion	T24	T8	note_83
NonRel	1 . DM type II with PDR [s1] OU [e1] and tractional RD OS OD : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	No [s2] NVI [e2] .	laterality	lesion	T12	T8	2595274_note_8416
NonRel	1 . DM type II with PDR OU and tractional RD OS [s1] OD [e1] : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	No [s2] NVI [e2] .	laterality	lesion	T13	T8	2595274_note_8416
NonRel	Cataract , left eye H26.9 366.9 1 - [s1] Mild [e1] NPDR with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered [s2] exudates [e2] , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T17	T5	20773_note_35
NonRel	Cataract , left eye H26.9 366.9 1 - [s1] Mild [e1] NPDR with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	Has new labs ordered next month - MAC OCT OD with scattered [s2] exudates [e2] w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T17	T6	20773_note_35
NonRel	Cataract , left eye H26.9 366.9 1 - [s1] Mild [e1] NPDR with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild [s2] IRF [e2] just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T17	T7	20773_note_35
NonRel	Cataract , left eye H26.9 366.9 1 - [s1] Mild [e1] NPDR with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no [s2] IRF [e2] / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T17	T8	20773_note_35
NonRel	Cataract , left eye H26.9 366.9 1 - [s1] Mild [e1] NPDR with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / [s2] SRF [e2] - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T17	T9	20773_note_35
NonRel	Cataract , left eye H26.9 366.9 1 - [s1] Mild [e1] NPDR with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered [s2] exudates [e2] , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T17	T10	20773_note_35
NonRel	Cataract , left eye H26.9 366.9 1 - [s1] Mild [e1] NPDR with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild [s2] IRF [e2] superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T17	T11	20773_note_35
NonRel	Cataract , left eye H26.9 366.9 1 - [s1] Mild [e1] NPDR with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered [s2] exudates [e2] , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T17	T12	20773_note_35
NonRel	Cataract , left eye H26.9 366.9 1 - [s1] Mild [e1] NPDR with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no [s2] IRF [e2] / SRF NAME , MD participated in the care of this patient .	severity	lesion	T17	T13	20773_note_35
NonRel	Cataract , left eye H26.9 366.9 1 - [s1] Mild [e1] NPDR with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / [s2] SRF [e2] NAME , MD participated in the care of this patient .	severity	lesion	T17	T14	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT [s1] OD [e1] with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild [s2] NPDR [e2] with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	laterality	lesion	T18	T3	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT [s1] OD [e1] with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild NPDR with [s2] macular edema [e2] - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	laterality	lesion	T18	T4	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / [s1] mild [e1] IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild [s2] NPDR [e2] with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	severity	lesion	T19	T3	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / [s1] mild [e1] IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild NPDR with [s2] macular edema [e2] - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	severity	lesion	T19	T4	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT [s1] OS [e1] w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild [s2] NPDR [e2] with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	laterality	lesion	T20	T3	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT [s1] OS [e1] w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild NPDR with [s2] macular edema [e2] - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	laterality	lesion	T20	T4	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes [s1] OD [e1] : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild [s2] NPDR [e2] with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	laterality	lesion	T21	T3	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes [s1] OD [e1] : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild NPDR with [s2] macular edema [e2] - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	laterality	lesion	T21	T4	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : [s1] scattered [e1] exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild [s2] NPDR [e2] with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	severity	lesion	T22	T3	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : [s1] scattered [e1] exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild NPDR with [s2] macular edema [e2] - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	severity	lesion	T22	T4	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / [s1] mild [e1] IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild [s2] NPDR [e2] with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	severity	lesion	T23	T3	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / [s1] mild [e1] IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild NPDR with [s2] macular edema [e2] - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	severity	lesion	T23	T4	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea [s1] OS [e1] : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild [s2] NPDR [e2] with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	laterality	lesion	T24	T3	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea [s1] OS [e1] : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild NPDR with [s2] macular edema [e2] - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	laterality	lesion	T24	T4	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : [s1] scattered [e1] exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild [s2] NPDR [e2] with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	severity	lesion	T25	T3	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : [s1] scattered [e1] exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild NPDR with [s2] macular edema [e2] - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	severity	lesion	T25	T4	20773_note_35
NonRel	Peripheral vision loss , bilateral - Both Eyes H53.453 368.44 OCT , Retina - OU - Both Eyes [s1] OD [e1] : few vitreous debris , blunted foveal contour , scattered exudates , VMA , few scattered RPE breaks .	No [s2] SRF [e2] / IRF OS : blunted foveal contour , VMA with traction temporally with resulting pseudohole inferotemporally .	laterality	lesion	T3	T8	note_436
NonRel	Peripheral vision loss , bilateral - Both Eyes H53.453 368.44 OCT , Retina - OU - Both Eyes [s1] OD [e1] : few vitreous debris , blunted foveal contour , scattered exudates , VMA , few scattered RPE breaks .	No SRF / [s2] IRF [e2] OS : blunted foveal contour , VMA with traction temporally with resulting pseudohole inferotemporally .	laterality	lesion	T3	T9	note_436
NonRel	Peripheral vision loss , bilateral - Both Eyes H53.453 368.44 OCT , Retina - OU - Both Eyes [s1] OD [e1] : few vitreous debris , blunted foveal contour , scattered exudates , VMA , few scattered RPE breaks .	No SRF / IRF OS : blunted foveal contour , [s2] VMA [e2] with traction temporally with resulting pseudohole inferotemporally .	laterality	lesion	T3	T11	note_436
NonRel	Peripheral vision loss , bilateral - Both Eyes H53.453 368.44 OCT , Retina - OU - Both Eyes OD : few vitreous debris , blunted foveal contour , [s1] scattered [e1] exudates , VMA , few scattered RPE breaks .	No [s2] SRF [e2] / IRF OS : blunted foveal contour , VMA with traction temporally with resulting pseudohole inferotemporally .	severity	lesion	T5	T8	note_436
NonRel	Peripheral vision loss , bilateral - Both Eyes H53.453 368.44 OCT , Retina - OU - Both Eyes OD : few vitreous debris , blunted foveal contour , [s1] scattered [e1] exudates , VMA , few scattered RPE breaks .	No SRF / [s2] IRF [e2] OS : blunted foveal contour , VMA with traction temporally with resulting pseudohole inferotemporally .	severity	lesion	T5	T9	note_436
NonRel	Peripheral vision loss , bilateral - Both Eyes H53.453 368.44 OCT , Retina - OU - Both Eyes OD : few vitreous debris , blunted foveal contour , [s1] scattered [e1] exudates , VMA , few scattered RPE breaks .	No SRF / IRF OS : blunted foveal contour , [s2] VMA [e2] with traction temporally with resulting pseudohole inferotemporally .	severity	lesion	T5	T11	note_436
NonRel	No SRF / IRF [s1] OS [e1] : blunted foveal contour , VMA with traction temporally with resulting pseudohole inferotemporally .	Peripheral vision loss , bilateral - Both Eyes H53.453 368.44 OCT , Retina - OU - Both Eyes OD : few vitreous debris , blunted foveal contour , scattered [s2] exudates [e2] , VMA , few scattered RPE breaks .	laterality	lesion	T10	T6	note_436
NonRel	No SRF / IRF [s1] OS [e1] : blunted foveal contour , VMA with traction temporally with resulting pseudohole inferotemporally .	Peripheral vision loss , bilateral - Both Eyes H53.453 368.44 OCT , Retina - OU - Both Eyes OD : few vitreous debris , blunted foveal contour , scattered exudates , [s2] VMA [e2] , few scattered RPE breaks .	laterality	lesion	T10	T7	note_436
NonRel	No SRF / IRF [s1] OS [e1] : blunted foveal contour , VMA with traction temporally with resulting pseudohole inferotemporally .	No [s2] SRF [e2] / IRF 1 .	laterality	lesion	T10	T12	note_436
NonRel	No SRF / IRF [s1] OS [e1] : blunted foveal contour , VMA with traction temporally with resulting pseudohole inferotemporally .	No SRF / [s2] IRF [e2] 1 .	laterality	lesion	T10	T13	note_436
NonRel	PROLIFERATIVE DIABETIC RETINOPATHY - HbA 1 c 10.4 10 / 2016 - IRMA vs NVE present on exam today [s1] OD [e1] - Will refer to Retina for consideration of further PRP / focal - Tight glucose and Blood pressure control .	No [s2] SRF [e2] / IRF 1 .	laterality	lesion	T4	T12	note_436
NonRel	PROLIFERATIVE DIABETIC RETINOPATHY - HbA 1 c 10.4 10 / 2016 - IRMA vs NVE present on exam today [s1] OD [e1] - Will refer to Retina for consideration of further PRP / focal - Tight glucose and Blood pressure control .	No SRF / [s2] IRF [e2] 1 .	laterality	lesion	T4	T13	note_436
NonRel	OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : good foveal contour , no IRF / SRF OS : extensive IRF , significantly worse than study on DATE Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	[s2] CME [e2] ( cystoid macular edema ) , left H35.352 362.53 2 .	laterality	lesion	T5	T4	1306375_note_2993
NonRel	OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : good foveal contour , no IRF / SRF OS : extensive IRF , significantly worse than study on DATE Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	CME ( [s2] cystoid macular edema [e2] ) , left H35.352 362.53 2 .	laterality	lesion	T5	T8	1306375_note_2993
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : good foveal contour , no IRF / SRF [s1] OS [e1] : extensive IRF , significantly worse than study on DATE Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	[s2] CME [e2] ( cystoid macular edema ) , left H35.352 362.53 2 .	laterality	lesion	T6	T4	1306375_note_2993
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : good foveal contour , no IRF / SRF [s1] OS [e1] : extensive IRF , significantly worse than study on DATE Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	CME ( [s2] cystoid macular edema [e2] ) , left H35.352 362.53 2 .	laterality	lesion	T6	T8	1306375_note_2993
NonRel	CME ( cystoid macular edema ) , [s1] left [e1] H35.352 362.53 2 .	OCT , Posterior Segment - OU - Both Eyes OD : good foveal contour , no [s2] IRF [e2] / SRF OS : extensive IRF , significantly worse than study on DATE Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T7	T1	1306375_note_2993
NonRel	CME ( cystoid macular edema ) , [s1] left [e1] H35.352 362.53 2 .	OCT , Posterior Segment - OU - Both Eyes OD : good foveal contour , no IRF / [s2] SRF [e2] OS : extensive IRF , significantly worse than study on DATE Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T7	T2	1306375_note_2993
NonRel	CME ( cystoid macular edema ) , [s1] left [e1] H35.352 362.53 2 .	OCT , Posterior Segment - OU - Both Eyes OD : good foveal contour , no IRF / SRF OS : extensive [s2] IRF [e2] , significantly worse than study on DATE Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T7	T3	1306375_note_2993
NonRel	NAME , MD Allergies : Allergies Allergen Reactions • Codeine Other ( See Comments ) Memory loss disoriented ROS Negative for : Constitutional , Skin Objective : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 30 + 1 20 / 70 - 1 Dist ph sc 20 / 25 - Method : Snellen - Linear Tonometry Right Left Pressure 12 12 Method : Applanation Time : 11 : 06 AM Manifest Refraction Sphere Cylinder Axis Dist Add Right - 0.50 + 0.50 175 20 / 25 + 2.50 Left - 1.25 + 0.50 5 20 / 25 + 2.50 Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 11 : 03 AM Pupils Pupils Right PERRL Left PERRL Final Rx Sphere Cylinder Axis Add Right - 0.50 + 0.50 175 + 2.50 Left - 1.25 + 0.50 5 + 2.50 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Centered posterior chamber intraocular lens , Posterior capsular opacification Centered posterior chamber intraocular lens , Posterior capsular opacification Vitreous Normal Normal Fundus Exam Right Left Disc Normal Normal Macula few [s1] ma ' s [e1] , temporal HE multiple dbh / ma ' s with circinate HE and edema in papillomacular bundle , temp HE and edema Vessels Normal Normal Periphery Ma ' s , tr edema Normal Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT - Macula : OD : DME [s2] nasal to fovea [e2] improved , exudates OS : DME temporal to fovea , slightly worse , exudates No outpatient prescriptions have been marked as taking for the DATE encounter ( Office Visit ) with NAME , MD .	lesion	eye_part	T1	T9	2045823_note_5689
NonRel	NAME , MD Allergies : Allergies Allergen Reactions • Codeine Other ( See Comments ) Memory loss disoriented ROS Negative for : Constitutional , Skin Objective : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 30 + 1 20 / 70 - 1 Dist ph sc 20 / 25 - Method : Snellen - Linear Tonometry Right Left Pressure 12 12 Method : Applanation Time : 11 : 06 AM Manifest Refraction Sphere Cylinder Axis Dist Add Right - 0.50 + 0.50 175 20 / 25 + 2.50 Left - 1.25 + 0.50 5 20 / 25 + 2.50 Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 11 : 03 AM Pupils Pupils Right PERRL Left PERRL Final Rx Sphere Cylinder Axis Add Right - 0.50 + 0.50 175 + 2.50 Left - 1.25 + 0.50 5 + 2.50 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Centered posterior chamber intraocular lens , Posterior capsular opacification Centered posterior chamber intraocular lens , Posterior capsular opacification Vitreous Normal Normal Fundus Exam Right Left Disc Normal Normal Macula few [s1] ma ' s [e1] , temporal HE multiple dbh / ma ' s with circinate HE and edema in papillomacular bundle , temp HE and edema Vessels Normal Normal Periphery Ma ' s , tr edema Normal Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT - Macula : OD : DME nasal to fovea improved , exudates OS : DME temporal to [s2] fovea [e2] , slightly worse , exudates No outpatient prescriptions have been marked as taking for the DATE encounter ( Office Visit ) with NAME , MD .	lesion	eye_part	T1	T10	2045823_note_5689
NonRel	NAME , MD Allergies : Allergies Allergen Reactions • Codeine Other ( See Comments ) Memory loss disoriented ROS Negative for : Constitutional , Skin Objective : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 30 + 1 20 / 70 - 1 Dist ph sc 20 / 25 - Method : Snellen - Linear Tonometry Right Left Pressure 12 12 Method : Applanation Time : 11 : 06 AM Manifest Refraction Sphere Cylinder Axis Dist Add Right - 0.50 + 0.50 175 20 / 25 + 2.50 Left - 1.25 + 0.50 5 20 / 25 + 2.50 Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 11 : 03 AM Pupils Pupils Right PERRL Left PERRL Final Rx Sphere Cylinder Axis Add Right - 0.50 + 0.50 175 + 2.50 Left - 1.25 + 0.50 5 + 2.50 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Centered posterior chamber intraocular lens , Posterior capsular opacification Centered posterior chamber intraocular lens , Posterior capsular opacification Vitreous Normal Normal Fundus Exam Right Left Disc Normal Normal Macula few ma ' s , temporal HE multiple dbh / [s1] ma ' s [e1] with circinate HE and edema in papillomacular bundle , temp HE and edema Vessels Normal Normal Periphery Ma ' s , tr edema Normal Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT - Macula : OD : DME [s2] nasal to fovea [e2] improved , exudates OS : DME temporal to fovea , slightly worse , exudates No outpatient prescriptions have been marked as taking for the DATE encounter ( Office Visit ) with NAME , MD .	lesion	eye_part	T2	T9	2045823_note_5689
NonRel	NAME , MD Allergies : Allergies Allergen Reactions • Codeine Other ( See Comments ) Memory loss disoriented ROS Negative for : Constitutional , Skin Objective : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 30 + 1 20 / 70 - 1 Dist ph sc 20 / 25 - Method : Snellen - Linear Tonometry Right Left Pressure 12 12 Method : Applanation Time : 11 : 06 AM Manifest Refraction Sphere Cylinder Axis Dist Add Right - 0.50 + 0.50 175 20 / 25 + 2.50 Left - 1.25 + 0.50 5 20 / 25 + 2.50 Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 11 : 03 AM Pupils Pupils Right PERRL Left PERRL Final Rx Sphere Cylinder Axis Add Right - 0.50 + 0.50 175 + 2.50 Left - 1.25 + 0.50 5 + 2.50 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Centered posterior chamber intraocular lens , Posterior capsular opacification Centered posterior chamber intraocular lens , Posterior capsular opacification Vitreous Normal Normal Fundus Exam Right Left Disc Normal Normal Macula few ma ' s , temporal HE multiple dbh / [s1] ma ' s [e1] with circinate HE and edema in papillomacular bundle , temp HE and edema Vessels Normal Normal Periphery Ma ' s , tr edema Normal Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT - Macula : OD : DME nasal to fovea improved , exudates OS : DME temporal to [s2] fovea [e2] , slightly worse , exudates No outpatient prescriptions have been marked as taking for the DATE encounter ( Office Visit ) with NAME , MD .	lesion	eye_part	T2	T10	2045823_note_5689
NonRel	NAME , MD Allergies : Allergies Allergen Reactions • Codeine Other ( See Comments ) Memory loss disoriented ROS Negative for : Constitutional , Skin Objective : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 30 + 1 20 / 70 - 1 Dist ph sc 20 / 25 - Method : Snellen - Linear Tonometry Right Left Pressure 12 12 Method : Applanation Time : 11 : 06 AM Manifest Refraction Sphere Cylinder Axis Dist Add Right - 0.50 + 0.50 175 20 / 25 + 2.50 Left - 1.25 + 0.50 5 20 / 25 + 2.50 Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 11 : 03 AM Pupils Pupils Right PERRL Left PERRL Final Rx Sphere Cylinder Axis Add Right - 0.50 + 0.50 175 + 2.50 Left - 1.25 + 0.50 5 + 2.50 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Centered posterior chamber intraocular lens , Posterior capsular opacification Centered posterior chamber intraocular lens , Posterior capsular opacification Vitreous Normal Normal Fundus Exam Right Left Disc Normal Normal Macula few ma ' s , temporal HE multiple dbh / ma ' s with circinate HE and edema in papillomacular bundle , temp HE and edema Vessels Normal Normal Periphery [s1] Ma ' s [e1] , tr edema Normal Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT - Macula : OD : DME [s2] nasal to fovea [e2] improved , exudates OS : DME temporal to fovea , slightly worse , exudates No outpatient prescriptions have been marked as taking for the DATE encounter ( Office Visit ) with NAME , MD .	lesion	eye_part	T3	T9	2045823_note_5689
NonRel	NAME , MD Allergies : Allergies Allergen Reactions • Codeine Other ( See Comments ) Memory loss disoriented ROS Negative for : Constitutional , Skin Objective : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 30 + 1 20 / 70 - 1 Dist ph sc 20 / 25 - Method : Snellen - Linear Tonometry Right Left Pressure 12 12 Method : Applanation Time : 11 : 06 AM Manifest Refraction Sphere Cylinder Axis Dist Add Right - 0.50 + 0.50 175 20 / 25 + 2.50 Left - 1.25 + 0.50 5 20 / 25 + 2.50 Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 11 : 03 AM Pupils Pupils Right PERRL Left PERRL Final Rx Sphere Cylinder Axis Add Right - 0.50 + 0.50 175 + 2.50 Left - 1.25 + 0.50 5 + 2.50 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Centered posterior chamber intraocular lens , Posterior capsular opacification Centered posterior chamber intraocular lens , Posterior capsular opacification Vitreous Normal Normal Fundus Exam Right Left Disc Normal Normal Macula few ma ' s , temporal HE multiple dbh / ma ' s with circinate HE and edema in papillomacular bundle , temp HE and edema Vessels Normal Normal Periphery [s1] Ma ' s [e1] , tr edema Normal Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT - Macula : OD : DME nasal to fovea improved , exudates OS : DME temporal to [s2] fovea [e2] , slightly worse , exudates No outpatient prescriptions have been marked as taking for the DATE encounter ( Office Visit ) with NAME , MD .	lesion	eye_part	T3	T10	2045823_note_5689
NonRel	NAME , MD Allergies : Allergies Allergen Reactions • Codeine Other ( See Comments ) Memory loss disoriented ROS Negative for : Constitutional , Skin Objective : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 30 + 1 20 / 70 - 1 Dist ph sc 20 / 25 - Method : Snellen - Linear Tonometry Right Left Pressure 12 12 Method : Applanation Time : 11 : 06 AM Manifest Refraction Sphere Cylinder Axis Dist Add Right - 0.50 + 0.50 175 20 / 25 + 2.50 Left - 1.25 + 0.50 5 20 / 25 + 2.50 Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 11 : 03 AM Pupils Pupils Right PERRL Left PERRL Final Rx Sphere Cylinder Axis Add Right - 0.50 + 0.50 175 + 2.50 Left - 1.25 + 0.50 5 + 2.50 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Centered posterior chamber intraocular lens , Posterior capsular opacification Centered posterior chamber intraocular lens , Posterior capsular opacification Vitreous Normal Normal Fundus Exam Right Left Disc Normal Normal Macula few ma ' s , temporal HE multiple [s1] dbh [e1] / ma ' s with circinate HE and edema in papillomacular bundle , temp HE and edema Vessels Normal Normal Periphery Ma ' s , tr edema Normal Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT - Macula : OD : DME [s2] nasal to fovea [e2] improved , exudates OS : DME temporal to fovea , slightly worse , exudates No outpatient prescriptions have been marked as taking for the DATE encounter ( Office Visit ) with NAME , MD .	lesion	eye_part	T6	T9	2045823_note_5689
NonRel	NAME , MD Allergies : Allergies Allergen Reactions • Codeine Other ( See Comments ) Memory loss disoriented ROS Negative for : Constitutional , Skin Objective : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 30 + 1 20 / 70 - 1 Dist ph sc 20 / 25 - Method : Snellen - Linear Tonometry Right Left Pressure 12 12 Method : Applanation Time : 11 : 06 AM Manifest Refraction Sphere Cylinder Axis Dist Add Right - 0.50 + 0.50 175 20 / 25 + 2.50 Left - 1.25 + 0.50 5 20 / 25 + 2.50 Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 11 : 03 AM Pupils Pupils Right PERRL Left PERRL Final Rx Sphere Cylinder Axis Add Right - 0.50 + 0.50 175 + 2.50 Left - 1.25 + 0.50 5 + 2.50 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Centered posterior chamber intraocular lens , Posterior capsular opacification Centered posterior chamber intraocular lens , Posterior capsular opacification Vitreous Normal Normal Fundus Exam Right Left Disc Normal Normal Macula few ma ' s , temporal HE multiple [s1] dbh [e1] / ma ' s with circinate HE and edema in papillomacular bundle , temp HE and edema Vessels Normal Normal Periphery Ma ' s , tr edema Normal Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT - Macula : OD : DME nasal to fovea improved , exudates OS : DME temporal to [s2] fovea [e2] , slightly worse , exudates No outpatient prescriptions have been marked as taking for the DATE encounter ( Office Visit ) with NAME , MD .	lesion	eye_part	T6	T10	2045823_note_5689
NonRel	Other testing : OCT - Macula : OD : DME nasal to fovea improved , [s1] exudates [e1] OS : DME temporal to fovea , slightly worse , exudates No outpatient prescriptions have been marked as taking for the DATE encounter ( Office Visit ) with NAME , MD .	NAME , MD Allergies : Allergies Allergen Reactions • Codeine Other ( See Comments ) Memory loss disoriented ROS Negative for : Constitutional , Skin Objective : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 30 + 1 20 / 70 - 1 Dist ph sc 20 / 25 - Method : Snellen - Linear Tonometry Right Left Pressure 12 12 Method : Applanation Time : 11 : 06 AM Manifest Refraction Sphere Cylinder Axis Dist Add Right - 0.50 + 0.50 175 20 / 25 + 2.50 Left - 1.25 + 0.50 5 20 / 25 + 2.50 Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 11 : 03 AM Pupils Pupils Right PERRL Left PERRL Final Rx Sphere Cylinder Axis Add Right - 0.50 + 0.50 175 + 2.50 Left - 1.25 + 0.50 5 + 2.50 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Centered posterior chamber intraocular lens , Posterior capsular opacification Centered posterior chamber intraocular lens , Posterior capsular opacification Vitreous Normal Normal Fundus Exam Right Left Disc Normal Normal [s2] Macula [e2] few ma ' s , temporal HE multiple dbh / ma ' s with circinate HE and edema in papillomacular bundle , temp HE and edema Vessels Normal Normal Periphery Ma ' s , tr edema Normal Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T7	T4	2045823_note_5689
NonRel	Other testing : OCT - Macula : OD : DME nasal to fovea improved , [s1] exudates [e1] OS : DME temporal to fovea , slightly worse , exudates No outpatient prescriptions have been marked as taking for the DATE encounter ( Office Visit ) with NAME , MD .	NAME , MD Allergies : Allergies Allergen Reactions • Codeine Other ( See Comments ) Memory loss disoriented ROS Negative for : Constitutional , Skin Objective : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 30 + 1 20 / 70 - 1 Dist ph sc 20 / 25 - Method : Snellen - Linear Tonometry Right Left Pressure 12 12 Method : Applanation Time : 11 : 06 AM Manifest Refraction Sphere Cylinder Axis Dist Add Right - 0.50 + 0.50 175 20 / 25 + 2.50 Left - 1.25 + 0.50 5 20 / 25 + 2.50 Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 11 : 03 AM Pupils Pupils Right PERRL Left PERRL Final Rx Sphere Cylinder Axis Add Right - 0.50 + 0.50 175 + 2.50 Left - 1.25 + 0.50 5 + 2.50 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Centered posterior chamber intraocular lens , Posterior capsular opacification Centered posterior chamber intraocular lens , Posterior capsular opacification Vitreous Normal Normal Fundus Exam Right Left Disc Normal Normal Macula few ma ' s , temporal HE multiple dbh / ma ' s with circinate HE and edema in papillomacular bundle , temp HE and edema Vessels Normal Normal [s2] Periphery [e2] Ma ' s , tr edema Normal Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T7	T5	2045823_note_5689
NonRel	Other testing : OCT - Macula : OD : [s1] DME [e1] nasal to fovea improved , exudates OS : DME temporal to fovea , slightly worse , exudates No outpatient prescriptions have been marked as taking for the DATE encounter ( Office Visit ) with NAME , MD .	NAME , MD Allergies : Allergies Allergen Reactions • Codeine Other ( See Comments ) Memory loss disoriented ROS Negative for : Constitutional , Skin Objective : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 30 + 1 20 / 70 - 1 Dist ph sc 20 / 25 - Method : Snellen - Linear Tonometry Right Left Pressure 12 12 Method : Applanation Time : 11 : 06 AM Manifest Refraction Sphere Cylinder Axis Dist Add Right - 0.50 + 0.50 175 20 / 25 + 2.50 Left - 1.25 + 0.50 5 20 / 25 + 2.50 Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 11 : 03 AM Pupils Pupils Right PERRL Left PERRL Final Rx Sphere Cylinder Axis Add Right - 0.50 + 0.50 175 + 2.50 Left - 1.25 + 0.50 5 + 2.50 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Centered posterior chamber intraocular lens , Posterior capsular opacification Centered posterior chamber intraocular lens , Posterior capsular opacification Vitreous Normal Normal Fundus Exam Right Left Disc Normal Normal [s2] Macula [e2] few ma ' s , temporal HE multiple dbh / ma ' s with circinate HE and edema in papillomacular bundle , temp HE and edema Vessels Normal Normal Periphery Ma ' s , tr edema Normal Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T8	T4	2045823_note_5689
NonRel	Other testing : OCT - Macula : OD : [s1] DME [e1] nasal to fovea improved , exudates OS : DME temporal to fovea , slightly worse , exudates No outpatient prescriptions have been marked as taking for the DATE encounter ( Office Visit ) with NAME , MD .	NAME , MD Allergies : Allergies Allergen Reactions • Codeine Other ( See Comments ) Memory loss disoriented ROS Negative for : Constitutional , Skin Objective : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 30 + 1 20 / 70 - 1 Dist ph sc 20 / 25 - Method : Snellen - Linear Tonometry Right Left Pressure 12 12 Method : Applanation Time : 11 : 06 AM Manifest Refraction Sphere Cylinder Axis Dist Add Right - 0.50 + 0.50 175 20 / 25 + 2.50 Left - 1.25 + 0.50 5 20 / 25 + 2.50 Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 11 : 03 AM Pupils Pupils Right PERRL Left PERRL Final Rx Sphere Cylinder Axis Add Right - 0.50 + 0.50 175 + 2.50 Left - 1.25 + 0.50 5 + 2.50 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Centered posterior chamber intraocular lens , Posterior capsular opacification Centered posterior chamber intraocular lens , Posterior capsular opacification Vitreous Normal Normal Fundus Exam Right Left Disc Normal Normal Macula few ma ' s , temporal HE multiple dbh / ma ' s with circinate HE and edema in papillomacular bundle , temp HE and edema Vessels Normal Normal [s2] Periphery [e2] Ma ' s , tr edema Normal Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T8	T5	2045823_note_5689
NonRel	Other testing : OCT - Macula : OD : DME nasal to fovea improved , exudates OS : [s1] DME [e1] temporal to fovea , slightly worse , exudates No outpatient prescriptions have been marked as taking for the DATE encounter ( Office Visit ) with NAME , MD .	NAME , MD Allergies : Allergies Allergen Reactions • Codeine Other ( See Comments ) Memory loss disoriented ROS Negative for : Constitutional , Skin Objective : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 30 + 1 20 / 70 - 1 Dist ph sc 20 / 25 - Method : Snellen - Linear Tonometry Right Left Pressure 12 12 Method : Applanation Time : 11 : 06 AM Manifest Refraction Sphere Cylinder Axis Dist Add Right - 0.50 + 0.50 175 20 / 25 + 2.50 Left - 1.25 + 0.50 5 20 / 25 + 2.50 Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 11 : 03 AM Pupils Pupils Right PERRL Left PERRL Final Rx Sphere Cylinder Axis Add Right - 0.50 + 0.50 175 + 2.50 Left - 1.25 + 0.50 5 + 2.50 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Centered posterior chamber intraocular lens , Posterior capsular opacification Centered posterior chamber intraocular lens , Posterior capsular opacification Vitreous Normal Normal Fundus Exam Right Left Disc Normal Normal [s2] Macula [e2] few ma ' s , temporal HE multiple dbh / ma ' s with circinate HE and edema in papillomacular bundle , temp HE and edema Vessels Normal Normal Periphery Ma ' s , tr edema Normal Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T11	T4	2045823_note_5689
NonRel	Other testing : OCT - Macula : OD : DME nasal to fovea improved , exudates OS : [s1] DME [e1] temporal to fovea , slightly worse , exudates No outpatient prescriptions have been marked as taking for the DATE encounter ( Office Visit ) with NAME , MD .	NAME , MD Allergies : Allergies Allergen Reactions • Codeine Other ( See Comments ) Memory loss disoriented ROS Negative for : Constitutional , Skin Objective : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 30 + 1 20 / 70 - 1 Dist ph sc 20 / 25 - Method : Snellen - Linear Tonometry Right Left Pressure 12 12 Method : Applanation Time : 11 : 06 AM Manifest Refraction Sphere Cylinder Axis Dist Add Right - 0.50 + 0.50 175 20 / 25 + 2.50 Left - 1.25 + 0.50 5 20 / 25 + 2.50 Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 11 : 03 AM Pupils Pupils Right PERRL Left PERRL Final Rx Sphere Cylinder Axis Add Right - 0.50 + 0.50 175 + 2.50 Left - 1.25 + 0.50 5 + 2.50 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Centered posterior chamber intraocular lens , Posterior capsular opacification Centered posterior chamber intraocular lens , Posterior capsular opacification Vitreous Normal Normal Fundus Exam Right Left Disc Normal Normal Macula few ma ' s , temporal HE multiple dbh / ma ' s with circinate HE and edema in papillomacular bundle , temp HE and edema Vessels Normal Normal [s2] Periphery [e2] Ma ' s , tr edema Normal Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T11	T5	2045823_note_5689
NonRel	Other testing : OCT - Macula : OD : DME nasal to fovea improved , exudates OS : DME temporal to fovea , slightly worse , [s1] exudates [e1] No outpatient prescriptions have been marked as taking for the DATE encounter ( Office Visit ) with NAME , MD .	NAME , MD Allergies : Allergies Allergen Reactions • Codeine Other ( See Comments ) Memory loss disoriented ROS Negative for : Constitutional , Skin Objective : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 30 + 1 20 / 70 - 1 Dist ph sc 20 / 25 - Method : Snellen - Linear Tonometry Right Left Pressure 12 12 Method : Applanation Time : 11 : 06 AM Manifest Refraction Sphere Cylinder Axis Dist Add Right - 0.50 + 0.50 175 20 / 25 + 2.50 Left - 1.25 + 0.50 5 20 / 25 + 2.50 Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 11 : 03 AM Pupils Pupils Right PERRL Left PERRL Final Rx Sphere Cylinder Axis Add Right - 0.50 + 0.50 175 + 2.50 Left - 1.25 + 0.50 5 + 2.50 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Centered posterior chamber intraocular lens , Posterior capsular opacification Centered posterior chamber intraocular lens , Posterior capsular opacification Vitreous Normal Normal Fundus Exam Right Left Disc Normal Normal [s2] Macula [e2] few ma ' s , temporal HE multiple dbh / ma ' s with circinate HE and edema in papillomacular bundle , temp HE and edema Vessels Normal Normal Periphery Ma ' s , tr edema Normal Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T12	T4	2045823_note_5689
NonRel	Other testing : OCT - Macula : OD : DME nasal to fovea improved , exudates OS : DME temporal to fovea , slightly worse , [s1] exudates [e1] No outpatient prescriptions have been marked as taking for the DATE encounter ( Office Visit ) with NAME , MD .	NAME , MD Allergies : Allergies Allergen Reactions • Codeine Other ( See Comments ) Memory loss disoriented ROS Negative for : Constitutional , Skin Objective : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 30 + 1 20 / 70 - 1 Dist ph sc 20 / 25 - Method : Snellen - Linear Tonometry Right Left Pressure 12 12 Method : Applanation Time : 11 : 06 AM Manifest Refraction Sphere Cylinder Axis Dist Add Right - 0.50 + 0.50 175 20 / 25 + 2.50 Left - 1.25 + 0.50 5 20 / 25 + 2.50 Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 11 : 03 AM Pupils Pupils Right PERRL Left PERRL Final Rx Sphere Cylinder Axis Add Right - 0.50 + 0.50 175 + 2.50 Left - 1.25 + 0.50 5 + 2.50 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Centered posterior chamber intraocular lens , Posterior capsular opacification Centered posterior chamber intraocular lens , Posterior capsular opacification Vitreous Normal Normal Fundus Exam Right Left Disc Normal Normal Macula few ma ' s , temporal HE multiple dbh / ma ' s with circinate HE and edema in papillomacular bundle , temp HE and edema Vessels Normal Normal [s2] Periphery [e2] Ma ' s , tr edema Normal Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T12	T5	2045823_note_5689
NonRel	DME - improved with less edema [s1] OS [e1] since focal .	[s2] Diabetic macular edema [e2] ( 362.07 ) RETINA ( OCT ) 1 .	laterality	lesion	T16	T15	2045823_note_5689
NonRel	DME - [s1] improved [e1] with less edema OS since focal .	[s2] Diabetic macular edema [e2] ( 362.07 ) RETINA ( OCT ) 1 .	severity	lesion	T17	T15	2045823_note_5689
NonRel	Other testing : OCT - Macula : [s1] OD [e1] : DME nasal to fovea improved , exudates OS : DME temporal to fovea , slightly worse , exudates No outpatient prescriptions have been marked as taking for the DATE encounter ( Office Visit ) with NAME , MD .	NAME , MD Allergies : Allergies Allergen Reactions • Codeine Other ( See Comments ) Memory loss disoriented ROS Negative for : Constitutional , Skin Objective : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 30 + 1 20 / 70 - 1 Dist ph sc 20 / 25 - Method : Snellen - Linear Tonometry Right Left Pressure 12 12 Method : Applanation Time : 11 : 06 AM Manifest Refraction Sphere Cylinder Axis Dist Add Right - 0.50 + 0.50 175 20 / 25 + 2.50 Left - 1.25 + 0.50 5 20 / 25 + 2.50 Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 11 : 03 AM Pupils Pupils Right PERRL Left PERRL Final Rx Sphere Cylinder Axis Add Right - 0.50 + 0.50 175 + 2.50 Left - 1.25 + 0.50 5 + 2.50 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Centered posterior chamber intraocular lens , Posterior capsular opacification Centered posterior chamber intraocular lens , Posterior capsular opacification Vitreous Normal Normal Fundus Exam Right Left Disc Normal Normal Macula few [s2] ma ' s [e2] , temporal HE multiple dbh / ma ' s with circinate HE and edema in papillomacular bundle , temp HE and edema Vessels Normal Normal Periphery Ma ' s , tr edema Normal Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T18	T1	2045823_note_5689
NonRel	Other testing : OCT - Macula : [s1] OD [e1] : DME nasal to fovea improved , exudates OS : DME temporal to fovea , slightly worse , exudates No outpatient prescriptions have been marked as taking for the DATE encounter ( Office Visit ) with NAME , MD .	NAME , MD Allergies : Allergies Allergen Reactions • Codeine Other ( See Comments ) Memory loss disoriented ROS Negative for : Constitutional , Skin Objective : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 30 + 1 20 / 70 - 1 Dist ph sc 20 / 25 - Method : Snellen - Linear Tonometry Right Left Pressure 12 12 Method : Applanation Time : 11 : 06 AM Manifest Refraction Sphere Cylinder Axis Dist Add Right - 0.50 + 0.50 175 20 / 25 + 2.50 Left - 1.25 + 0.50 5 20 / 25 + 2.50 Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 11 : 03 AM Pupils Pupils Right PERRL Left PERRL Final Rx Sphere Cylinder Axis Add Right - 0.50 + 0.50 175 + 2.50 Left - 1.25 + 0.50 5 + 2.50 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Centered posterior chamber intraocular lens , Posterior capsular opacification Centered posterior chamber intraocular lens , Posterior capsular opacification Vitreous Normal Normal Fundus Exam Right Left Disc Normal Normal Macula few ma ' s , temporal HE multiple dbh / [s2] ma ' s [e2] with circinate HE and edema in papillomacular bundle , temp HE and edema Vessels Normal Normal Periphery Ma ' s , tr edema Normal Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T18	T2	2045823_note_5689
NonRel	Other testing : OCT - Macula : [s1] OD [e1] : DME nasal to fovea improved , exudates OS : DME temporal to fovea , slightly worse , exudates No outpatient prescriptions have been marked as taking for the DATE encounter ( Office Visit ) with NAME , MD .	NAME , MD Allergies : Allergies Allergen Reactions • Codeine Other ( See Comments ) Memory loss disoriented ROS Negative for : Constitutional , Skin Objective : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 30 + 1 20 / 70 - 1 Dist ph sc 20 / 25 - Method : Snellen - Linear Tonometry Right Left Pressure 12 12 Method : Applanation Time : 11 : 06 AM Manifest Refraction Sphere Cylinder Axis Dist Add Right - 0.50 + 0.50 175 20 / 25 + 2.50 Left - 1.25 + 0.50 5 20 / 25 + 2.50 Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 11 : 03 AM Pupils Pupils Right PERRL Left PERRL Final Rx Sphere Cylinder Axis Add Right - 0.50 + 0.50 175 + 2.50 Left - 1.25 + 0.50 5 + 2.50 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Centered posterior chamber intraocular lens , Posterior capsular opacification Centered posterior chamber intraocular lens , Posterior capsular opacification Vitreous Normal Normal Fundus Exam Right Left Disc Normal Normal Macula few ma ' s , temporal HE multiple dbh / ma ' s with circinate HE and edema in papillomacular bundle , temp HE and edema Vessels Normal Normal Periphery [s2] Ma ' s [e2] , tr edema Normal Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T18	T3	2045823_note_5689
NonRel	Other testing : OCT - Macula : [s1] OD [e1] : DME nasal to fovea improved , exudates OS : DME temporal to fovea , slightly worse , exudates No outpatient prescriptions have been marked as taking for the DATE encounter ( Office Visit ) with NAME , MD .	NAME , MD Allergies : Allergies Allergen Reactions • Codeine Other ( See Comments ) Memory loss disoriented ROS Negative for : Constitutional , Skin Objective : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 30 + 1 20 / 70 - 1 Dist ph sc 20 / 25 - Method : Snellen - Linear Tonometry Right Left Pressure 12 12 Method : Applanation Time : 11 : 06 AM Manifest Refraction Sphere Cylinder Axis Dist Add Right - 0.50 + 0.50 175 20 / 25 + 2.50 Left - 1.25 + 0.50 5 20 / 25 + 2.50 Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 11 : 03 AM Pupils Pupils Right PERRL Left PERRL Final Rx Sphere Cylinder Axis Add Right - 0.50 + 0.50 175 + 2.50 Left - 1.25 + 0.50 5 + 2.50 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Centered posterior chamber intraocular lens , Posterior capsular opacification Centered posterior chamber intraocular lens , Posterior capsular opacification Vitreous Normal Normal Fundus Exam Right Left Disc Normal Normal Macula few ma ' s , temporal HE multiple [s2] dbh [e2] / ma ' s with circinate HE and edema in papillomacular bundle , temp HE and edema Vessels Normal Normal Periphery Ma ' s , tr edema Normal Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T18	T6	2045823_note_5689
NonRel	IRMA temporal along inferotemporal arcade Periphery Normal , WWP inf / temp [s1] MA [e1] nasally , DBH ' s super to superior arcade , cobblestone inferior Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : MAC OCT OD : foveal contour intact OS : foveal contour intact , ERM HGBA 1 C : Lab Results Component Value Date / Time HGBA 1 C 11.6 DATE 3 : 29 PM Assessment and Plan : 1 .	NAME , MD Allergies : No Known Allergies Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 25 20 / 40 - Method : Snellen - Linear Tonometry Right Left Pressure 17 16 Method : Applanation Time : 2 : 48 PM Wearing Rx Sphere Cylinder Axis Right - 7.50 + 0.50 90 Left - 7.50 + 0.25 140 Manifest Refraction Sphere Cylinder Axis Dist Right - 7.50 + 0.50 90 20 / 20 Left - 8.00 + 0.25 140 20 / 25 + Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 04 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Final Rx Sphere Cylinder Axis Add Right - 7.50 + 0.50 90 + 1.25 Left - 8.00 + 0.25 140 + 1.25 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea ETBUT , PEK ETBUT , PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive , No NVI Seen Round and reactive , No NVI Seen Lens Trace nuclear sclerosis , Early Cortical cataract Trace nuclear sclerosis , Early Cortical cataract Vitreous Normal Normal Fundus Exam Right Left Disc Mylination , extensive PPA , no NVD , superonasal DBH ' s Normal , NVD Macula rare DBH , rare MAs , few temp exudates Few MAs nasal to [s2] fovea [e2] Vessels arteriolar narrowing , few small CWSsuperiorly arteriolar narrowing .	lesion	eye_part	T13	T12	893554_note_1323
NonRel	IRMA temporal along inferotemporal arcade Periphery Normal , WWP inf / temp [s1] MA [e1] nasally , DBH ' s super to superior arcade , cobblestone inferior Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : MAC OCT OD : foveal contour intact OS : foveal contour intact , ERM HGBA 1 C : Lab Results Component Value Date / Time HGBA 1 C 11.6 DATE 3 : 29 PM Assessment and Plan : 1 .	NAME , MD Allergies : No Known Allergies Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 25 20 / 40 - Method : Snellen - Linear Tonometry Right Left Pressure 17 16 Method : Applanation Time : 2 : 48 PM Wearing Rx Sphere Cylinder Axis Right - 7.50 + 0.50 90 Left - 7.50 + 0.25 140 Manifest Refraction Sphere Cylinder Axis Dist Right - 7.50 + 0.50 90 20 / 20 Left - 8.00 + 0.25 140 20 / 25 + Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 04 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Final Rx Sphere Cylinder Axis Add Right - 7.50 + 0.50 90 + 1.25 Left - 8.00 + 0.25 140 + 1.25 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea ETBUT , PEK ETBUT , PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive , No NVI Seen Round and reactive , No NVI Seen Lens Trace nuclear sclerosis , Early Cortical cataract Trace nuclear sclerosis , Early Cortical cataract Vitreous Normal Normal Fundus Exam Right Left Disc Mylination , extensive PPA , no NVD , superonasal DBH ' s Normal , NVD [s2] Macula [e2] rare DBH , rare MAs , few temp exudates Few MAs nasal to fovea Vessels arteriolar narrowing , few small CWSsuperiorly arteriolar narrowing .	lesion	eye_part	T13	T27	893554_note_1323
NonRel	IRMA temporal along inferotemporal arcade Periphery Normal , WWP inf / temp MA nasally , [s1] DBH ' s [e1] super to superior arcade , cobblestone inferior Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : MAC OCT OD : foveal contour intact OS : foveal contour intact , ERM HGBA 1 C : Lab Results Component Value Date / Time HGBA 1 C 11.6 DATE 3 : 29 PM Assessment and Plan : 1 .	NAME , MD Allergies : No Known Allergies Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 25 20 / 40 - Method : Snellen - Linear Tonometry Right Left Pressure 17 16 Method : Applanation Time : 2 : 48 PM Wearing Rx Sphere Cylinder Axis Right - 7.50 + 0.50 90 Left - 7.50 + 0.25 140 Manifest Refraction Sphere Cylinder Axis Dist Right - 7.50 + 0.50 90 20 / 20 Left - 8.00 + 0.25 140 20 / 25 + Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 04 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Final Rx Sphere Cylinder Axis Add Right - 7.50 + 0.50 90 + 1.25 Left - 8.00 + 0.25 140 + 1.25 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea ETBUT , PEK ETBUT , PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive , No NVI Seen Round and reactive , No NVI Seen Lens Trace nuclear sclerosis , Early Cortical cataract Trace nuclear sclerosis , Early Cortical cataract Vitreous Normal Normal Fundus Exam Right Left Disc Mylination , extensive PPA , no NVD , superonasal DBH ' s Normal , NVD Macula rare DBH , rare MAs , few temp exudates Few MAs nasal to [s2] fovea [e2] Vessels arteriolar narrowing , few small CWSsuperiorly arteriolar narrowing .	lesion	eye_part	T14	T12	893554_note_1323
NonRel	IRMA temporal along inferotemporal arcade Periphery Normal , WWP inf / temp MA nasally , [s1] DBH ' s [e1] super to superior arcade , cobblestone inferior Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : MAC OCT OD : foveal contour intact OS : foveal contour intact , ERM HGBA 1 C : Lab Results Component Value Date / Time HGBA 1 C 11.6 DATE 3 : 29 PM Assessment and Plan : 1 .	NAME , MD Allergies : No Known Allergies Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 25 20 / 40 - Method : Snellen - Linear Tonometry Right Left Pressure 17 16 Method : Applanation Time : 2 : 48 PM Wearing Rx Sphere Cylinder Axis Right - 7.50 + 0.50 90 Left - 7.50 + 0.25 140 Manifest Refraction Sphere Cylinder Axis Dist Right - 7.50 + 0.50 90 20 / 20 Left - 8.00 + 0.25 140 20 / 25 + Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 04 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Final Rx Sphere Cylinder Axis Add Right - 7.50 + 0.50 90 + 1.25 Left - 8.00 + 0.25 140 + 1.25 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea ETBUT , PEK ETBUT , PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive , No NVI Seen Round and reactive , No NVI Seen Lens Trace nuclear sclerosis , Early Cortical cataract Trace nuclear sclerosis , Early Cortical cataract Vitreous Normal Normal Fundus Exam Right Left Disc Mylination , extensive PPA , no NVD , superonasal DBH ' s Normal , NVD [s2] Macula [e2] rare DBH , rare MAs , few temp exudates Few MAs nasal to fovea Vessels arteriolar narrowing , few small CWSsuperiorly arteriolar narrowing .	lesion	eye_part	T14	T27	893554_note_1323
NonRel	Visit Date : DATE Chief Complaint : Chief Complaint Patient presents with • Eye Problem [s1] moderate [e1] NPDR , HTN Retinopathy , POHS , High Myopia .	Subjective : History of Present Illness : NAME is a 47 y.o. female who is here today for moderate [s2] NPDR [e2] , HTN Retinopathy , POHS , High Myopia .	severity	lesion	T18	T2	893554_note_1323
NonRel	Subjective : History of Present Illness : NAME is a 47 y.o. female who is here today for [s1] moderate [e1] NPDR , HTN Retinopathy , POHS , High Myopia .	Visit Date : DATE Chief Complaint : Chief Complaint Patient presents with • Eye Problem moderate [s2] NPDR [e2] , HTN Retinopathy , POHS , High Myopia .	severity	lesion	T19	T1	893554_note_1323
NonRel	[s1] IRMA [e1] temporal along inferotemporal arcade Periphery Normal , WWP inf / temp MA nasally , DBH ' s super to superior arcade , cobblestone inferior Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : MAC OCT OD : foveal contour intact OS : foveal contour intact , ERM HGBA 1 C : Lab Results Component Value Date / Time HGBA 1 C 11.6 DATE 3 : 29 PM Assessment and Plan : 1 .	NAME , MD Allergies : No Known Allergies Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 25 20 / 40 - Method : Snellen - Linear Tonometry Right Left Pressure 17 16 Method : Applanation Time : 2 : 48 PM Wearing Rx Sphere Cylinder Axis Right - 7.50 + 0.50 90 Left - 7.50 + 0.25 140 Manifest Refraction Sphere Cylinder Axis Dist Right - 7.50 + 0.50 90 20 / 20 Left - 8.00 + 0.25 140 20 / 25 + Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 04 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Final Rx Sphere Cylinder Axis Add Right - 7.50 + 0.50 90 + 1.25 Left - 8.00 + 0.25 140 + 1.25 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea ETBUT , PEK ETBUT , PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive , No NVI Seen Round and reactive , No NVI Seen Lens Trace nuclear sclerosis , Early Cortical cataract Trace nuclear sclerosis , Early Cortical cataract Vitreous Normal Normal Fundus Exam Right Left Disc Mylination , extensive PPA , no NVD , superonasal DBH ' s Normal , NVD Macula rare DBH , rare MAs , few temp exudates Few MAs nasal to [s2] fovea [e2] Vessels arteriolar narrowing , few small CWSsuperiorly arteriolar narrowing .	lesion	eye_part	T25	T12	893554_note_1323
NonRel	[s1] IRMA [e1] temporal along inferotemporal arcade Periphery Normal , WWP inf / temp MA nasally , DBH ' s super to superior arcade , cobblestone inferior Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : MAC OCT OD : foveal contour intact OS : foveal contour intact , ERM HGBA 1 C : Lab Results Component Value Date / Time HGBA 1 C 11.6 DATE 3 : 29 PM Assessment and Plan : 1 .	NAME , MD Allergies : No Known Allergies Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 25 20 / 40 - Method : Snellen - Linear Tonometry Right Left Pressure 17 16 Method : Applanation Time : 2 : 48 PM Wearing Rx Sphere Cylinder Axis Right - 7.50 + 0.50 90 Left - 7.50 + 0.25 140 Manifest Refraction Sphere Cylinder Axis Dist Right - 7.50 + 0.50 90 20 / 20 Left - 8.00 + 0.25 140 20 / 25 + Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 04 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Final Rx Sphere Cylinder Axis Add Right - 7.50 + 0.50 90 + 1.25 Left - 8.00 + 0.25 140 + 1.25 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea ETBUT , PEK ETBUT , PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive , No NVI Seen Round and reactive , No NVI Seen Lens Trace nuclear sclerosis , Early Cortical cataract Trace nuclear sclerosis , Early Cortical cataract Vitreous Normal Normal Fundus Exam Right Left Disc Mylination , extensive PPA , no NVD , superonasal DBH ' s Normal , NVD [s2] Macula [e2] rare DBH , rare MAs , few temp exudates Few MAs nasal to fovea Vessels arteriolar narrowing , few small CWSsuperiorly arteriolar narrowing .	lesion	eye_part	T25	T27	893554_note_1323
NonRel	NAME , MD Allergies : No Known Allergies Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 25 20 / 40 - Method : Snellen - Linear Tonometry Right Left Pressure 17 16 Method : Applanation Time : 2 : 48 PM Wearing Rx Sphere Cylinder Axis Right - 7.50 + 0.50 90 Left - 7.50 + 0.25 140 Manifest Refraction Sphere Cylinder Axis Dist Right - 7.50 + 0.50 90 20 / 20 Left - 8.00 + 0.25 140 20 / 25 + Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 04 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Final Rx Sphere Cylinder Axis Add Right - 7.50 + 0.50 90 + 1.25 Left - 8.00 + 0.25 140 + 1.25 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea ETBUT , PEK ETBUT , PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive , No NVI Seen Round and reactive , No NVI Seen Lens Trace nuclear sclerosis , Early Cortical cataract Trace nuclear sclerosis , Early Cortical cataract Vitreous Normal Normal Fundus Exam Right Left Disc Mylination , extensive PPA , no NVD , superonasal DBH ' s Normal , NVD Macula [s1] rare [e1] DBH , rare MAs , few temp exudates Few MAs nasal to fovea Vessels arteriolar narrowing , few small CWSsuperiorly arteriolar narrowing .	IRMA temporal along inferotemporal arcade Periphery Normal , WWP inf / temp [s2] MA [e2] nasally , DBH ' s super to superior arcade , cobblestone inferior Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : MAC OCT OD : foveal contour intact OS : foveal contour intact , ERM HGBA 1 C : Lab Results Component Value Date / Time HGBA 1 C 11.6 DATE 3 : 29 PM Assessment and Plan : 1 .	severity	lesion	T26	T13	893554_note_1323
NonRel	NAME , MD Allergies : No Known Allergies Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 25 20 / 40 - Method : Snellen - Linear Tonometry Right Left Pressure 17 16 Method : Applanation Time : 2 : 48 PM Wearing Rx Sphere Cylinder Axis Right - 7.50 + 0.50 90 Left - 7.50 + 0.25 140 Manifest Refraction Sphere Cylinder Axis Dist Right - 7.50 + 0.50 90 20 / 20 Left - 8.00 + 0.25 140 20 / 25 + Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 04 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Final Rx Sphere Cylinder Axis Add Right - 7.50 + 0.50 90 + 1.25 Left - 8.00 + 0.25 140 + 1.25 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea ETBUT , PEK ETBUT , PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive , No NVI Seen Round and reactive , No NVI Seen Lens Trace nuclear sclerosis , Early Cortical cataract Trace nuclear sclerosis , Early Cortical cataract Vitreous Normal Normal Fundus Exam Right Left Disc Mylination , extensive PPA , no NVD , superonasal DBH ' s Normal , NVD Macula [s1] rare [e1] DBH , rare MAs , few temp exudates Few MAs nasal to fovea Vessels arteriolar narrowing , few small CWSsuperiorly arteriolar narrowing .	IRMA temporal along inferotemporal arcade Periphery Normal , WWP inf / temp MA nasally , [s2] DBH ' s [e2] super to superior arcade , cobblestone inferior Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : MAC OCT OD : foveal contour intact OS : foveal contour intact , ERM HGBA 1 C : Lab Results Component Value Date / Time HGBA 1 C 11.6 DATE 3 : 29 PM Assessment and Plan : 1 .	severity	lesion	T26	T14	893554_note_1323
NonRel	NAME , MD Allergies : No Known Allergies Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 25 20 / 40 - Method : Snellen - Linear Tonometry Right Left Pressure 17 16 Method : Applanation Time : 2 : 48 PM Wearing Rx Sphere Cylinder Axis Right - 7.50 + 0.50 90 Left - 7.50 + 0.25 140 Manifest Refraction Sphere Cylinder Axis Dist Right - 7.50 + 0.50 90 20 / 20 Left - 8.00 + 0.25 140 20 / 25 + Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 04 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Final Rx Sphere Cylinder Axis Add Right - 7.50 + 0.50 90 + 1.25 Left - 8.00 + 0.25 140 + 1.25 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea ETBUT , PEK ETBUT , PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive , No NVI Seen Round and reactive , No NVI Seen Lens Trace nuclear sclerosis , Early Cortical cataract Trace nuclear sclerosis , Early Cortical cataract Vitreous Normal Normal Fundus Exam Right Left Disc Mylination , extensive PPA , no NVD , superonasal DBH ' s Normal , NVD Macula [s1] rare [e1] DBH , rare MAs , few temp exudates Few MAs nasal to fovea Vessels arteriolar narrowing , few small CWSsuperiorly arteriolar narrowing .	[s2] IRMA [e2] temporal along inferotemporal arcade Periphery Normal , WWP inf / temp MA nasally , DBH ' s super to superior arcade , cobblestone inferior Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : MAC OCT OD : foveal contour intact OS : foveal contour intact , ERM HGBA 1 C : Lab Results Component Value Date / Time HGBA 1 C 11.6 DATE 3 : 29 PM Assessment and Plan : 1 .	severity	lesion	T26	T25	893554_note_1323
NonRel	NAME , MD Allergies : No Known Allergies Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 25 20 / 40 - Method : Snellen - Linear Tonometry Right Left Pressure 17 16 Method : Applanation Time : 2 : 48 PM Wearing Rx Sphere Cylinder Axis Right - 7.50 + 0.50 90 Left - 7.50 + 0.25 140 Manifest Refraction Sphere Cylinder Axis Dist Right - 7.50 + 0.50 90 20 / 20 Left - 8.00 + 0.25 140 20 / 25 + Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 04 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Final Rx Sphere Cylinder Axis Add Right - 7.50 + 0.50 90 + 1.25 Left - 8.00 + 0.25 140 + 1.25 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea ETBUT , PEK ETBUT , PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive , No NVI Seen Round and reactive , No NVI Seen Lens Trace nuclear sclerosis , Early Cortical cataract Trace nuclear sclerosis , Early Cortical cataract Vitreous Normal Normal Fundus Exam Right Left Disc Mylination , extensive PPA , no NVD , superonasal DBH ' s Normal , NVD Macula rare DBH , [s1] rare [e1] MAs , few temp exudates Few MAs nasal to fovea Vessels arteriolar narrowing , few small CWSsuperiorly arteriolar narrowing .	IRMA temporal along inferotemporal arcade Periphery Normal , WWP inf / temp [s2] MA [e2] nasally , DBH ' s super to superior arcade , cobblestone inferior Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : MAC OCT OD : foveal contour intact OS : foveal contour intact , ERM HGBA 1 C : Lab Results Component Value Date / Time HGBA 1 C 11.6 DATE 3 : 29 PM Assessment and Plan : 1 .	severity	lesion	T28	T13	893554_note_1323
NonRel	NAME , MD Allergies : No Known Allergies Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 25 20 / 40 - Method : Snellen - Linear Tonometry Right Left Pressure 17 16 Method : Applanation Time : 2 : 48 PM Wearing Rx Sphere Cylinder Axis Right - 7.50 + 0.50 90 Left - 7.50 + 0.25 140 Manifest Refraction Sphere Cylinder Axis Dist Right - 7.50 + 0.50 90 20 / 20 Left - 8.00 + 0.25 140 20 / 25 + Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 04 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Final Rx Sphere Cylinder Axis Add Right - 7.50 + 0.50 90 + 1.25 Left - 8.00 + 0.25 140 + 1.25 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea ETBUT , PEK ETBUT , PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive , No NVI Seen Round and reactive , No NVI Seen Lens Trace nuclear sclerosis , Early Cortical cataract Trace nuclear sclerosis , Early Cortical cataract Vitreous Normal Normal Fundus Exam Right Left Disc Mylination , extensive PPA , no NVD , superonasal DBH ' s Normal , NVD Macula rare DBH , [s1] rare [e1] MAs , few temp exudates Few MAs nasal to fovea Vessels arteriolar narrowing , few small CWSsuperiorly arteriolar narrowing .	IRMA temporal along inferotemporal arcade Periphery Normal , WWP inf / temp MA nasally , [s2] DBH ' s [e2] super to superior arcade , cobblestone inferior Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : MAC OCT OD : foveal contour intact OS : foveal contour intact , ERM HGBA 1 C : Lab Results Component Value Date / Time HGBA 1 C 11.6 DATE 3 : 29 PM Assessment and Plan : 1 .	severity	lesion	T28	T14	893554_note_1323
NonRel	NAME , MD Allergies : No Known Allergies Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 25 20 / 40 - Method : Snellen - Linear Tonometry Right Left Pressure 17 16 Method : Applanation Time : 2 : 48 PM Wearing Rx Sphere Cylinder Axis Right - 7.50 + 0.50 90 Left - 7.50 + 0.25 140 Manifest Refraction Sphere Cylinder Axis Dist Right - 7.50 + 0.50 90 20 / 20 Left - 8.00 + 0.25 140 20 / 25 + Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 04 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Final Rx Sphere Cylinder Axis Add Right - 7.50 + 0.50 90 + 1.25 Left - 8.00 + 0.25 140 + 1.25 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea ETBUT , PEK ETBUT , PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive , No NVI Seen Round and reactive , No NVI Seen Lens Trace nuclear sclerosis , Early Cortical cataract Trace nuclear sclerosis , Early Cortical cataract Vitreous Normal Normal Fundus Exam Right Left Disc Mylination , extensive PPA , no NVD , superonasal DBH ' s Normal , NVD Macula rare DBH , [s1] rare [e1] MAs , few temp exudates Few MAs nasal to fovea Vessels arteriolar narrowing , few small CWSsuperiorly arteriolar narrowing .	[s2] IRMA [e2] temporal along inferotemporal arcade Periphery Normal , WWP inf / temp MA nasally , DBH ' s super to superior arcade , cobblestone inferior Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : MAC OCT OD : foveal contour intact OS : foveal contour intact , ERM HGBA 1 C : Lab Results Component Value Date / Time HGBA 1 C 11.6 DATE 3 : 29 PM Assessment and Plan : 1 .	severity	lesion	T28	T25	893554_note_1323
NonRel	NAME , MD Allergies : No Known Allergies Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 25 20 / 40 - Method : Snellen - Linear Tonometry Right Left Pressure 17 16 Method : Applanation Time : 2 : 48 PM Wearing Rx Sphere Cylinder Axis Right - 7.50 + 0.50 90 Left - 7.50 + 0.25 140 Manifest Refraction Sphere Cylinder Axis Dist Right - 7.50 + 0.50 90 20 / 20 Left - 8.00 + 0.25 140 20 / 25 + Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 04 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Final Rx Sphere Cylinder Axis Add Right - 7.50 + 0.50 90 + 1.25 Left - 8.00 + 0.25 140 + 1.25 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea ETBUT , PEK ETBUT , PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive , No NVI Seen Round and reactive , No NVI Seen Lens Trace nuclear sclerosis , Early Cortical cataract Trace nuclear sclerosis , Early Cortical cataract Vitreous Normal Normal Fundus Exam Right Left Disc Mylination , extensive PPA , no NVD , superonasal DBH ' s Normal , NVD Macula rare DBH , rare MAs , few [s1] temp [e1] exudates Few MAs nasal to fovea Vessels arteriolar narrowing , few small CWSsuperiorly arteriolar narrowing .	IRMA temporal along inferotemporal arcade Periphery Normal , WWP inf / temp [s2] MA [e2] nasally , DBH ' s super to superior arcade , cobblestone inferior Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : MAC OCT OD : foveal contour intact OS : foveal contour intact , ERM HGBA 1 C : Lab Results Component Value Date / Time HGBA 1 C 11.6 DATE 3 : 29 PM Assessment and Plan : 1 .	severity	lesion	T29	T13	893554_note_1323
NonRel	NAME , MD Allergies : No Known Allergies Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 25 20 / 40 - Method : Snellen - Linear Tonometry Right Left Pressure 17 16 Method : Applanation Time : 2 : 48 PM Wearing Rx Sphere Cylinder Axis Right - 7.50 + 0.50 90 Left - 7.50 + 0.25 140 Manifest Refraction Sphere Cylinder Axis Dist Right - 7.50 + 0.50 90 20 / 20 Left - 8.00 + 0.25 140 20 / 25 + Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 04 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Final Rx Sphere Cylinder Axis Add Right - 7.50 + 0.50 90 + 1.25 Left - 8.00 + 0.25 140 + 1.25 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea ETBUT , PEK ETBUT , PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive , No NVI Seen Round and reactive , No NVI Seen Lens Trace nuclear sclerosis , Early Cortical cataract Trace nuclear sclerosis , Early Cortical cataract Vitreous Normal Normal Fundus Exam Right Left Disc Mylination , extensive PPA , no NVD , superonasal DBH ' s Normal , NVD Macula rare DBH , rare MAs , few [s1] temp [e1] exudates Few MAs nasal to fovea Vessels arteriolar narrowing , few small CWSsuperiorly arteriolar narrowing .	IRMA temporal along inferotemporal arcade Periphery Normal , WWP inf / temp MA nasally , [s2] DBH ' s [e2] super to superior arcade , cobblestone inferior Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : MAC OCT OD : foveal contour intact OS : foveal contour intact , ERM HGBA 1 C : Lab Results Component Value Date / Time HGBA 1 C 11.6 DATE 3 : 29 PM Assessment and Plan : 1 .	severity	lesion	T29	T14	893554_note_1323
NonRel	NAME , MD Allergies : No Known Allergies Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 25 20 / 40 - Method : Snellen - Linear Tonometry Right Left Pressure 17 16 Method : Applanation Time : 2 : 48 PM Wearing Rx Sphere Cylinder Axis Right - 7.50 + 0.50 90 Left - 7.50 + 0.25 140 Manifest Refraction Sphere Cylinder Axis Dist Right - 7.50 + 0.50 90 20 / 20 Left - 8.00 + 0.25 140 20 / 25 + Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 04 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Final Rx Sphere Cylinder Axis Add Right - 7.50 + 0.50 90 + 1.25 Left - 8.00 + 0.25 140 + 1.25 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea ETBUT , PEK ETBUT , PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive , No NVI Seen Round and reactive , No NVI Seen Lens Trace nuclear sclerosis , Early Cortical cataract Trace nuclear sclerosis , Early Cortical cataract Vitreous Normal Normal Fundus Exam Right Left Disc Mylination , extensive PPA , no NVD , superonasal DBH ' s Normal , NVD Macula rare DBH , rare MAs , few [s1] temp [e1] exudates Few MAs nasal to fovea Vessels arteriolar narrowing , few small CWSsuperiorly arteriolar narrowing .	[s2] IRMA [e2] temporal along inferotemporal arcade Periphery Normal , WWP inf / temp MA nasally , DBH ' s super to superior arcade , cobblestone inferior Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : MAC OCT OD : foveal contour intact OS : foveal contour intact , ERM HGBA 1 C : Lab Results Component Value Date / Time HGBA 1 C 11.6 DATE 3 : 29 PM Assessment and Plan : 1 .	severity	lesion	T29	T25	893554_note_1323
NonRel	NAME , MD Allergies : No Known Allergies Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 25 20 / 40 - Method : Snellen - Linear Tonometry Right Left Pressure 17 16 Method : Applanation Time : 2 : 48 PM Wearing Rx Sphere Cylinder Axis Right - 7.50 + 0.50 90 Left - 7.50 + 0.25 140 Manifest Refraction Sphere Cylinder Axis Dist Right - 7.50 + 0.50 90 20 / 20 Left - 8.00 + 0.25 140 20 / 25 + Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 04 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Final Rx Sphere Cylinder Axis Add Right - 7.50 + 0.50 90 + 1.25 Left - 8.00 + 0.25 140 + 1.25 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea ETBUT , PEK ETBUT , PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive , No NVI Seen Round and reactive , No NVI Seen Lens Trace nuclear sclerosis , Early Cortical cataract Trace nuclear sclerosis , Early Cortical cataract Vitreous Normal Normal Fundus Exam Right Left Disc Mylination , extensive PPA , no NVD , superonasal DBH ' s Normal , NVD Macula rare DBH , rare MAs , [s1] few [e1] temp exudates Few MAs nasal to fovea Vessels arteriolar narrowing , few small CWSsuperiorly arteriolar narrowing .	IRMA temporal along inferotemporal arcade Periphery Normal , WWP inf / temp [s2] MA [e2] nasally , DBH ' s super to superior arcade , cobblestone inferior Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : MAC OCT OD : foveal contour intact OS : foveal contour intact , ERM HGBA 1 C : Lab Results Component Value Date / Time HGBA 1 C 11.6 DATE 3 : 29 PM Assessment and Plan : 1 .	severity	lesion	T30	T13	893554_note_1323
NonRel	NAME , MD Allergies : No Known Allergies Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 25 20 / 40 - Method : Snellen - Linear Tonometry Right Left Pressure 17 16 Method : Applanation Time : 2 : 48 PM Wearing Rx Sphere Cylinder Axis Right - 7.50 + 0.50 90 Left - 7.50 + 0.25 140 Manifest Refraction Sphere Cylinder Axis Dist Right - 7.50 + 0.50 90 20 / 20 Left - 8.00 + 0.25 140 20 / 25 + Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 04 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Final Rx Sphere Cylinder Axis Add Right - 7.50 + 0.50 90 + 1.25 Left - 8.00 + 0.25 140 + 1.25 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea ETBUT , PEK ETBUT , PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive , No NVI Seen Round and reactive , No NVI Seen Lens Trace nuclear sclerosis , Early Cortical cataract Trace nuclear sclerosis , Early Cortical cataract Vitreous Normal Normal Fundus Exam Right Left Disc Mylination , extensive PPA , no NVD , superonasal DBH ' s Normal , NVD Macula rare DBH , rare MAs , [s1] few [e1] temp exudates Few MAs nasal to fovea Vessels arteriolar narrowing , few small CWSsuperiorly arteriolar narrowing .	IRMA temporal along inferotemporal arcade Periphery Normal , WWP inf / temp MA nasally , [s2] DBH ' s [e2] super to superior arcade , cobblestone inferior Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : MAC OCT OD : foveal contour intact OS : foveal contour intact , ERM HGBA 1 C : Lab Results Component Value Date / Time HGBA 1 C 11.6 DATE 3 : 29 PM Assessment and Plan : 1 .	severity	lesion	T30	T14	893554_note_1323
NonRel	NAME , MD Allergies : No Known Allergies Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 25 20 / 40 - Method : Snellen - Linear Tonometry Right Left Pressure 17 16 Method : Applanation Time : 2 : 48 PM Wearing Rx Sphere Cylinder Axis Right - 7.50 + 0.50 90 Left - 7.50 + 0.25 140 Manifest Refraction Sphere Cylinder Axis Dist Right - 7.50 + 0.50 90 20 / 20 Left - 8.00 + 0.25 140 20 / 25 + Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 04 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Final Rx Sphere Cylinder Axis Add Right - 7.50 + 0.50 90 + 1.25 Left - 8.00 + 0.25 140 + 1.25 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea ETBUT , PEK ETBUT , PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive , No NVI Seen Round and reactive , No NVI Seen Lens Trace nuclear sclerosis , Early Cortical cataract Trace nuclear sclerosis , Early Cortical cataract Vitreous Normal Normal Fundus Exam Right Left Disc Mylination , extensive PPA , no NVD , superonasal DBH ' s Normal , NVD Macula rare DBH , rare MAs , [s1] few [e1] temp exudates Few MAs nasal to fovea Vessels arteriolar narrowing , few small CWSsuperiorly arteriolar narrowing .	[s2] IRMA [e2] temporal along inferotemporal arcade Periphery Normal , WWP inf / temp MA nasally , DBH ' s super to superior arcade , cobblestone inferior Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : MAC OCT OD : foveal contour intact OS : foveal contour intact , ERM HGBA 1 C : Lab Results Component Value Date / Time HGBA 1 C 11.6 DATE 3 : 29 PM Assessment and Plan : 1 .	severity	lesion	T30	T25	893554_note_1323
NonRel	NAME , MD Allergies : No Known Allergies Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 25 20 / 40 - Method : Snellen - Linear Tonometry Right Left Pressure 17 16 Method : Applanation Time : 2 : 48 PM Wearing Rx Sphere Cylinder Axis Right - 7.50 + 0.50 90 Left - 7.50 + 0.25 140 Manifest Refraction Sphere Cylinder Axis Dist Right - 7.50 + 0.50 90 20 / 20 Left - 8.00 + 0.25 140 20 / 25 + Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 04 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Final Rx Sphere Cylinder Axis Add Right - 7.50 + 0.50 90 + 1.25 Left - 8.00 + 0.25 140 + 1.25 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea ETBUT , PEK ETBUT , PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive , No NVI Seen Round and reactive , No NVI Seen Lens Trace nuclear sclerosis , Early Cortical cataract Trace nuclear sclerosis , Early Cortical cataract Vitreous Normal Normal Fundus Exam Right Left Disc Mylination , extensive PPA , no NVD , superonasal DBH ' s Normal , NVD Macula rare DBH , rare MAs , few temp exudates [s1] Few [e1] MAs nasal to fovea Vessels arteriolar narrowing , few small CWSsuperiorly arteriolar narrowing .	IRMA temporal along inferotemporal arcade Periphery Normal , WWP inf / temp [s2] MA [e2] nasally , DBH ' s super to superior arcade , cobblestone inferior Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : MAC OCT OD : foveal contour intact OS : foveal contour intact , ERM HGBA 1 C : Lab Results Component Value Date / Time HGBA 1 C 11.6 DATE 3 : 29 PM Assessment and Plan : 1 .	severity	lesion	T31	T13	893554_note_1323
NonRel	NAME , MD Allergies : No Known Allergies Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 25 20 / 40 - Method : Snellen - Linear Tonometry Right Left Pressure 17 16 Method : Applanation Time : 2 : 48 PM Wearing Rx Sphere Cylinder Axis Right - 7.50 + 0.50 90 Left - 7.50 + 0.25 140 Manifest Refraction Sphere Cylinder Axis Dist Right - 7.50 + 0.50 90 20 / 20 Left - 8.00 + 0.25 140 20 / 25 + Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 04 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Final Rx Sphere Cylinder Axis Add Right - 7.50 + 0.50 90 + 1.25 Left - 8.00 + 0.25 140 + 1.25 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea ETBUT , PEK ETBUT , PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive , No NVI Seen Round and reactive , No NVI Seen Lens Trace nuclear sclerosis , Early Cortical cataract Trace nuclear sclerosis , Early Cortical cataract Vitreous Normal Normal Fundus Exam Right Left Disc Mylination , extensive PPA , no NVD , superonasal DBH ' s Normal , NVD Macula rare DBH , rare MAs , few temp exudates [s1] Few [e1] MAs nasal to fovea Vessels arteriolar narrowing , few small CWSsuperiorly arteriolar narrowing .	IRMA temporal along inferotemporal arcade Periphery Normal , WWP inf / temp MA nasally , [s2] DBH ' s [e2] super to superior arcade , cobblestone inferior Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : MAC OCT OD : foveal contour intact OS : foveal contour intact , ERM HGBA 1 C : Lab Results Component Value Date / Time HGBA 1 C 11.6 DATE 3 : 29 PM Assessment and Plan : 1 .	severity	lesion	T31	T14	893554_note_1323
NonRel	NAME , MD Allergies : No Known Allergies Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 25 20 / 40 - Method : Snellen - Linear Tonometry Right Left Pressure 17 16 Method : Applanation Time : 2 : 48 PM Wearing Rx Sphere Cylinder Axis Right - 7.50 + 0.50 90 Left - 7.50 + 0.25 140 Manifest Refraction Sphere Cylinder Axis Dist Right - 7.50 + 0.50 90 20 / 20 Left - 8.00 + 0.25 140 20 / 25 + Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 04 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Final Rx Sphere Cylinder Axis Add Right - 7.50 + 0.50 90 + 1.25 Left - 8.00 + 0.25 140 + 1.25 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea ETBUT , PEK ETBUT , PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive , No NVI Seen Round and reactive , No NVI Seen Lens Trace nuclear sclerosis , Early Cortical cataract Trace nuclear sclerosis , Early Cortical cataract Vitreous Normal Normal Fundus Exam Right Left Disc Mylination , extensive PPA , no NVD , superonasal DBH ' s Normal , NVD Macula rare DBH , rare MAs , few temp exudates [s1] Few [e1] MAs nasal to fovea Vessels arteriolar narrowing , few small CWSsuperiorly arteriolar narrowing .	[s2] IRMA [e2] temporal along inferotemporal arcade Periphery Normal , WWP inf / temp MA nasally , DBH ' s super to superior arcade , cobblestone inferior Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : MAC OCT OD : foveal contour intact OS : foveal contour intact , ERM HGBA 1 C : Lab Results Component Value Date / Time HGBA 1 C 11.6 DATE 3 : 29 PM Assessment and Plan : 1 .	severity	lesion	T31	T25	893554_note_1323
NonRel	IRMA [s1] temporal [e1] along inferotemporal arcade Periphery Normal , WWP inf / temp MA nasally , DBH ' s super to superior arcade , cobblestone inferior Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : MAC OCT OD : foveal contour intact OS : foveal contour intact , ERM HGBA 1 C : Lab Results Component Value Date / Time HGBA 1 C 11.6 DATE 3 : 29 PM Assessment and Plan : 1 .	NAME , MD Allergies : No Known Allergies Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 25 20 / 40 - Method : Snellen - Linear Tonometry Right Left Pressure 17 16 Method : Applanation Time : 2 : 48 PM Wearing Rx Sphere Cylinder Axis Right - 7.50 + 0.50 90 Left - 7.50 + 0.25 140 Manifest Refraction Sphere Cylinder Axis Dist Right - 7.50 + 0.50 90 20 / 20 Left - 8.00 + 0.25 140 20 / 25 + Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 04 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Final Rx Sphere Cylinder Axis Add Right - 7.50 + 0.50 90 + 1.25 Left - 8.00 + 0.25 140 + 1.25 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea ETBUT , PEK ETBUT , PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive , No [s2] NVI [e2] Seen Round and reactive , No NVI Seen Lens Trace nuclear sclerosis , Early Cortical cataract Trace nuclear sclerosis , Early Cortical cataract Vitreous Normal Normal Fundus Exam Right Left Disc Mylination , extensive PPA , no NVD , superonasal DBH ' s Normal , NVD Macula rare DBH , rare MAs , few temp exudates Few MAs nasal to fovea Vessels arteriolar narrowing , few small CWSsuperiorly arteriolar narrowing .	severity	lesion	T32	T3	893554_note_1323
NonRel	IRMA [s1] temporal [e1] along inferotemporal arcade Periphery Normal , WWP inf / temp MA nasally , DBH ' s super to superior arcade , cobblestone inferior Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : MAC OCT OD : foveal contour intact OS : foveal contour intact , ERM HGBA 1 C : Lab Results Component Value Date / Time HGBA 1 C 11.6 DATE 3 : 29 PM Assessment and Plan : 1 .	NAME , MD Allergies : No Known Allergies Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 25 20 / 40 - Method : Snellen - Linear Tonometry Right Left Pressure 17 16 Method : Applanation Time : 2 : 48 PM Wearing Rx Sphere Cylinder Axis Right - 7.50 + 0.50 90 Left - 7.50 + 0.25 140 Manifest Refraction Sphere Cylinder Axis Dist Right - 7.50 + 0.50 90 20 / 20 Left - 8.00 + 0.25 140 20 / 25 + Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 04 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Final Rx Sphere Cylinder Axis Add Right - 7.50 + 0.50 90 + 1.25 Left - 8.00 + 0.25 140 + 1.25 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea ETBUT , PEK ETBUT , PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive , No NVI Seen Round and reactive , No [s2] NVI [e2] Seen Lens Trace nuclear sclerosis , Early Cortical cataract Trace nuclear sclerosis , Early Cortical cataract Vitreous Normal Normal Fundus Exam Right Left Disc Mylination , extensive PPA , no NVD , superonasal DBH ' s Normal , NVD Macula rare DBH , rare MAs , few temp exudates Few MAs nasal to fovea Vessels arteriolar narrowing , few small CWSsuperiorly arteriolar narrowing .	severity	lesion	T32	T4	893554_note_1323
NonRel	IRMA [s1] temporal [e1] along inferotemporal arcade Periphery Normal , WWP inf / temp MA nasally , DBH ' s super to superior arcade , cobblestone inferior Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : MAC OCT OD : foveal contour intact OS : foveal contour intact , ERM HGBA 1 C : Lab Results Component Value Date / Time HGBA 1 C 11.6 DATE 3 : 29 PM Assessment and Plan : 1 .	NAME , MD Allergies : No Known Allergies Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 25 20 / 40 - Method : Snellen - Linear Tonometry Right Left Pressure 17 16 Method : Applanation Time : 2 : 48 PM Wearing Rx Sphere Cylinder Axis Right - 7.50 + 0.50 90 Left - 7.50 + 0.25 140 Manifest Refraction Sphere Cylinder Axis Dist Right - 7.50 + 0.50 90 20 / 20 Left - 8.00 + 0.25 140 20 / 25 + Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 04 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Final Rx Sphere Cylinder Axis Add Right - 7.50 + 0.50 90 + 1.25 Left - 8.00 + 0.25 140 + 1.25 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea ETBUT , PEK ETBUT , PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive , No NVI Seen Round and reactive , No NVI Seen Lens Trace nuclear sclerosis , Early Cortical cataract Trace nuclear sclerosis , Early Cortical cataract Vitreous Normal Normal Fundus Exam Right Left Disc Mylination , extensive PPA , no [s2] NVD [e2] , superonasal DBH ' s Normal , NVD Macula rare DBH , rare MAs , few temp exudates Few MAs nasal to fovea Vessels arteriolar narrowing , few small CWSsuperiorly arteriolar narrowing .	severity	lesion	T32	T5	893554_note_1323
NonRel	IRMA [s1] temporal [e1] along inferotemporal arcade Periphery Normal , WWP inf / temp MA nasally , DBH ' s super to superior arcade , cobblestone inferior Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : MAC OCT OD : foveal contour intact OS : foveal contour intact , ERM HGBA 1 C : Lab Results Component Value Date / Time HGBA 1 C 11.6 DATE 3 : 29 PM Assessment and Plan : 1 .	NAME , MD Allergies : No Known Allergies Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 25 20 / 40 - Method : Snellen - Linear Tonometry Right Left Pressure 17 16 Method : Applanation Time : 2 : 48 PM Wearing Rx Sphere Cylinder Axis Right - 7.50 + 0.50 90 Left - 7.50 + 0.25 140 Manifest Refraction Sphere Cylinder Axis Dist Right - 7.50 + 0.50 90 20 / 20 Left - 8.00 + 0.25 140 20 / 25 + Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 04 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Final Rx Sphere Cylinder Axis Add Right - 7.50 + 0.50 90 + 1.25 Left - 8.00 + 0.25 140 + 1.25 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea ETBUT , PEK ETBUT , PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive , No NVI Seen Round and reactive , No NVI Seen Lens Trace nuclear sclerosis , Early Cortical cataract Trace nuclear sclerosis , Early Cortical cataract Vitreous Normal Normal Fundus Exam Right Left Disc Mylination , extensive PPA , no NVD , superonasal [s2] DBH ' s [e2] Normal , NVD Macula rare DBH , rare MAs , few temp exudates Few MAs nasal to fovea Vessels arteriolar narrowing , few small CWSsuperiorly arteriolar narrowing .	severity	lesion	T32	T6	893554_note_1323
NonRel	IRMA [s1] temporal [e1] along inferotemporal arcade Periphery Normal , WWP inf / temp MA nasally , DBH ' s super to superior arcade , cobblestone inferior Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : MAC OCT OD : foveal contour intact OS : foveal contour intact , ERM HGBA 1 C : Lab Results Component Value Date / Time HGBA 1 C 11.6 DATE 3 : 29 PM Assessment and Plan : 1 .	NAME , MD Allergies : No Known Allergies Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 25 20 / 40 - Method : Snellen - Linear Tonometry Right Left Pressure 17 16 Method : Applanation Time : 2 : 48 PM Wearing Rx Sphere Cylinder Axis Right - 7.50 + 0.50 90 Left - 7.50 + 0.25 140 Manifest Refraction Sphere Cylinder Axis Dist Right - 7.50 + 0.50 90 20 / 20 Left - 8.00 + 0.25 140 20 / 25 + Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 04 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Final Rx Sphere Cylinder Axis Add Right - 7.50 + 0.50 90 + 1.25 Left - 8.00 + 0.25 140 + 1.25 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea ETBUT , PEK ETBUT , PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive , No NVI Seen Round and reactive , No NVI Seen Lens Trace nuclear sclerosis , Early Cortical cataract Trace nuclear sclerosis , Early Cortical cataract Vitreous Normal Normal Fundus Exam Right Left Disc Mylination , extensive PPA , no NVD , superonasal DBH ' s Normal , [s2] NVD [e2] Macula rare DBH , rare MAs , few temp exudates Few MAs nasal to fovea Vessels arteriolar narrowing , few small CWSsuperiorly arteriolar narrowing .	severity	lesion	T32	T7	893554_note_1323
NonRel	IRMA [s1] temporal [e1] along inferotemporal arcade Periphery Normal , WWP inf / temp MA nasally , DBH ' s super to superior arcade , cobblestone inferior Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : MAC OCT OD : foveal contour intact OS : foveal contour intact , ERM HGBA 1 C : Lab Results Component Value Date / Time HGBA 1 C 11.6 DATE 3 : 29 PM Assessment and Plan : 1 .	NAME , MD Allergies : No Known Allergies Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 25 20 / 40 - Method : Snellen - Linear Tonometry Right Left Pressure 17 16 Method : Applanation Time : 2 : 48 PM Wearing Rx Sphere Cylinder Axis Right - 7.50 + 0.50 90 Left - 7.50 + 0.25 140 Manifest Refraction Sphere Cylinder Axis Dist Right - 7.50 + 0.50 90 20 / 20 Left - 8.00 + 0.25 140 20 / 25 + Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 04 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Final Rx Sphere Cylinder Axis Add Right - 7.50 + 0.50 90 + 1.25 Left - 8.00 + 0.25 140 + 1.25 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea ETBUT , PEK ETBUT , PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive , No NVI Seen Round and reactive , No NVI Seen Lens Trace nuclear sclerosis , Early Cortical cataract Trace nuclear sclerosis , Early Cortical cataract Vitreous Normal Normal Fundus Exam Right Left Disc Mylination , extensive PPA , no NVD , superonasal DBH ' s Normal , NVD Macula rare [s2] DBH [e2] , rare MAs , few temp exudates Few MAs nasal to fovea Vessels arteriolar narrowing , few small CWSsuperiorly arteriolar narrowing .	severity	lesion	T32	T8	893554_note_1323
NonRel	IRMA [s1] temporal [e1] along inferotemporal arcade Periphery Normal , WWP inf / temp MA nasally , DBH ' s super to superior arcade , cobblestone inferior Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : MAC OCT OD : foveal contour intact OS : foveal contour intact , ERM HGBA 1 C : Lab Results Component Value Date / Time HGBA 1 C 11.6 DATE 3 : 29 PM Assessment and Plan : 1 .	NAME , MD Allergies : No Known Allergies Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 25 20 / 40 - Method : Snellen - Linear Tonometry Right Left Pressure 17 16 Method : Applanation Time : 2 : 48 PM Wearing Rx Sphere Cylinder Axis Right - 7.50 + 0.50 90 Left - 7.50 + 0.25 140 Manifest Refraction Sphere Cylinder Axis Dist Right - 7.50 + 0.50 90 20 / 20 Left - 8.00 + 0.25 140 20 / 25 + Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 04 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Final Rx Sphere Cylinder Axis Add Right - 7.50 + 0.50 90 + 1.25 Left - 8.00 + 0.25 140 + 1.25 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea ETBUT , PEK ETBUT , PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive , No NVI Seen Round and reactive , No NVI Seen Lens Trace nuclear sclerosis , Early Cortical cataract Trace nuclear sclerosis , Early Cortical cataract Vitreous Normal Normal Fundus Exam Right Left Disc Mylination , extensive PPA , no NVD , superonasal DBH ' s Normal , NVD Macula rare DBH , rare [s2] MAs [e2] , few temp exudates Few MAs nasal to fovea Vessels arteriolar narrowing , few small CWSsuperiorly arteriolar narrowing .	severity	lesion	T32	T9	893554_note_1323
NonRel	IRMA [s1] temporal [e1] along inferotemporal arcade Periphery Normal , WWP inf / temp MA nasally , DBH ' s super to superior arcade , cobblestone inferior Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : MAC OCT OD : foveal contour intact OS : foveal contour intact , ERM HGBA 1 C : Lab Results Component Value Date / Time HGBA 1 C 11.6 DATE 3 : 29 PM Assessment and Plan : 1 .	NAME , MD Allergies : No Known Allergies Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 25 20 / 40 - Method : Snellen - Linear Tonometry Right Left Pressure 17 16 Method : Applanation Time : 2 : 48 PM Wearing Rx Sphere Cylinder Axis Right - 7.50 + 0.50 90 Left - 7.50 + 0.25 140 Manifest Refraction Sphere Cylinder Axis Dist Right - 7.50 + 0.50 90 20 / 20 Left - 8.00 + 0.25 140 20 / 25 + Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 04 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Final Rx Sphere Cylinder Axis Add Right - 7.50 + 0.50 90 + 1.25 Left - 8.00 + 0.25 140 + 1.25 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea ETBUT , PEK ETBUT , PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive , No NVI Seen Round and reactive , No NVI Seen Lens Trace nuclear sclerosis , Early Cortical cataract Trace nuclear sclerosis , Early Cortical cataract Vitreous Normal Normal Fundus Exam Right Left Disc Mylination , extensive PPA , no NVD , superonasal DBH ' s Normal , NVD Macula rare DBH , rare MAs , few temp [s2] exudates [e2] Few MAs nasal to fovea Vessels arteriolar narrowing , few small CWSsuperiorly arteriolar narrowing .	severity	lesion	T32	T10	893554_note_1323
NonRel	IRMA [s1] temporal [e1] along inferotemporal arcade Periphery Normal , WWP inf / temp MA nasally , DBH ' s super to superior arcade , cobblestone inferior Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : MAC OCT OD : foveal contour intact OS : foveal contour intact , ERM HGBA 1 C : Lab Results Component Value Date / Time HGBA 1 C 11.6 DATE 3 : 29 PM Assessment and Plan : 1 .	NAME , MD Allergies : No Known Allergies Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Neurologic problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 25 20 / 40 - Method : Snellen - Linear Tonometry Right Left Pressure 17 16 Method : Applanation Time : 2 : 48 PM Wearing Rx Sphere Cylinder Axis Right - 7.50 + 0.50 90 Left - 7.50 + 0.25 140 Manifest Refraction Sphere Cylinder Axis Dist Right - 7.50 + 0.50 90 20 / 20 Left - 8.00 + 0.25 140 20 / 25 + Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 04 PM Pupils Pupils Right PERRL Left PERRL Visual Fields Right Left Result Full Full Extraocular Movement Right Left Result Full Full Final Rx Sphere Cylinder Axis Add Right - 7.50 + 0.50 90 + 1.25 Left - 8.00 + 0.25 140 + 1.25 Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Meibomian gland dysfunction Meibomian gland dysfunction Conjunctiva / Sclera White and quiet White and quiet Cornea ETBUT , PEK ETBUT , PEK Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive , No NVI Seen Round and reactive , No NVI Seen Lens Trace nuclear sclerosis , Early Cortical cataract Trace nuclear sclerosis , Early Cortical cataract Vitreous Normal Normal Fundus Exam Right Left Disc Mylination , extensive PPA , no NVD , superonasal DBH ' s Normal , NVD Macula rare DBH , rare MAs , few temp exudates Few [s2] MAs [e2] nasal to fovea Vessels arteriolar narrowing , few small CWSsuperiorly arteriolar narrowing .	severity	lesion	T32	T11	893554_note_1323
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye E11.3391 250.50 362.05 4 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye E11.3392 250.50 362.05 Mr. Bigbie is referred from the GVAMC for evaluation of ARMD PMHx of DM , HTN , HTD POHx of Phaco OU 4 - 5 years ago 1 .	severity	lesion	T10	T4	note_8074
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] E11.3391 250.50 362.05 4 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye E11.3392 250.50 362.05 Mr. Bigbie is referred from the GVAMC for evaluation of ARMD PMHx of DM , HTN , HTD POHx of Phaco OU 4 - 5 years ago 1 .	laterality	lesion	T11	T4	note_8074
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] E11.3392 250.50 362.05 Mr. Bigbie is referred from the GVAMC for evaluation of ARMD PMHx of DM , HTN , HTD POHx of Phaco OU 4 - 5 years ago 1 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye E11.3391 250.50 362.05 4 .	laterality	lesion	T12	T3	note_8074
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye E11.3392 250.50 362.05 Mr. Bigbie is referred from the GVAMC for evaluation of ARMD PMHx of DM , HTN , HTD POHx of Phaco OU 4 - 5 years ago 1 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye E11.3391 250.50 362.05 4 .	severity	lesion	T13	T3	note_8074
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus E11.3511 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 362.02 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 1 .	laterality	lesion	T3	T5	note_1341
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus E11.3511 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 362.02 2 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 1 .	laterality	lesion	T3	T7	note_1341
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 1 .	[s2] Diabetic macular edema [e2] of right eye with proliferative retinopathy associated with type 2 diabetes mellitus E11.3511 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 362.02 2 .	laterality	lesion	T6	T2	note_1341
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 1 .	Diabetic macular edema of right eye with [s2] proliferative retinopathy [e2] associated with type 2 diabetes mellitus E11.3511 250.50 Pan Retinal Photocoagulation - OD - Right Eye 362.07 362.02 2 .	laterality	lesion	T6	T4	note_1341
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 1 .	DMII - Duration 15 years , on insulin , last A1c 11.6 OD : [s2] PDR [e2] with anterior peripheral non - perfusion , no CSME .	laterality	lesion	T6	T9	note_1341
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 1 .	DMII - Duration 15 years , on insulin , last A1c 11.6 OD : PDR with anterior peripheral non - perfusion , no [s2] CSME [e2] .	laterality	lesion	T6	T10	note_1341
NonRel	DMII - Duration 15 years , on insulin , last A1c 11.6 [s1] OD [e1] : PDR with anterior peripheral non - perfusion , no CSME .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 1 .	laterality	lesion	T8	T5	note_1341
NonRel	DMII - Duration 15 years , on insulin , last A1c 11.6 [s1] OD [e1] : PDR with anterior peripheral non - perfusion , no CSME .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 1 .	laterality	lesion	T8	T7	note_1341
NonRel	Severe nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus E11.349 250.50 362.06 Ultrasound Biometry - OD - Right Eye Retina attached , VH [s1] OD [e1] OCT , Posterior Segment - OU - Both Eyes + ME OS Attending Note : Treatment hx : IVFA ( today ) : No view OD , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants Color Fundus Photos ( today ) : VH OD , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants OCT ( today ) : + ME OS B scan ( today ) : VH OD , retina attached Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last month HgA 1 C ) OD - Active VH , for atleast 6 months per patient .	[s2] Proliferative diabetic retinopathy [e2] with macular edema associated with type 2 diabetes mellitus E11.351 250.50 362.07 362.02 3 .	laterality	lesion	T10	T1	2476381_note_7065
NonRel	Severe nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus E11.349 250.50 362.06 Ultrasound Biometry - OD - Right Eye Retina attached , VH [s1] OD [e1] OCT , Posterior Segment - OU - Both Eyes + ME OS Attending Note : Treatment hx : IVFA ( today ) : No view OD , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants Color Fundus Photos ( today ) : VH OD , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants OCT ( today ) : + ME OS B scan ( today ) : VH OD , retina attached Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last month HgA 1 C ) OD - Active VH , for atleast 6 months per patient .	Proliferative diabetic retinopathy with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.351 250.50 362.07 362.02 3 .	laterality	lesion	T10	T16	2476381_note_7065
NonRel	Severe nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus E11.349 250.50 362.06 Ultrasound Biometry - OD - Right Eye Retina attached , VH OD OCT , Posterior Segment - OU - Both Eyes + ME OS Attending Note : Treatment hx : IVFA ( today ) : No view OD , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants Color Fundus Photos ( today ) : VH [s1] OD [e1] , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants OCT ( today ) : + ME OS B scan ( today ) : VH OD , retina attached Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last month HgA 1 C ) OD - Active VH , for atleast 6 months per patient .	[s2] Proliferative diabetic retinopathy [e2] with macular edema associated with type 2 diabetes mellitus E11.351 250.50 362.07 362.02 3 .	laterality	lesion	T11	T1	2476381_note_7065
NonRel	Severe nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus E11.349 250.50 362.06 Ultrasound Biometry - OD - Right Eye Retina attached , VH OD OCT , Posterior Segment - OU - Both Eyes + ME OS Attending Note : Treatment hx : IVFA ( today ) : No view OD , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants Color Fundus Photos ( today ) : VH [s1] OD [e1] , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants OCT ( today ) : + ME OS B scan ( today ) : VH OD , retina attached Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last month HgA 1 C ) OD - Active VH , for atleast 6 months per patient .	Proliferative diabetic retinopathy with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.351 250.50 362.07 362.02 3 .	laterality	lesion	T11	T16	2476381_note_7065
NonRel	Severe nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus E11.349 250.50 362.06 Ultrasound Biometry - OD - Right Eye Retina attached , VH OD OCT , Posterior Segment - OU - Both Eyes + ME OS Attending Note : Treatment hx : IVFA ( today ) : No view OD , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants Color Fundus Photos ( today ) : VH OD , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants OCT ( today ) : + ME OS B scan ( today ) : VH OD , retina attached Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME [s1] OU [e1] ( Previous HgA 1 C 13 improved to last month HgA 1 C ) OD - Active VH , for atleast 6 months per patient .	[s2] Proliferative diabetic retinopathy [e2] with macular edema associated with type 2 diabetes mellitus E11.351 250.50 362.07 362.02 3 .	laterality	lesion	T12	T1	2476381_note_7065
NonRel	Severe nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus E11.349 250.50 362.06 Ultrasound Biometry - OD - Right Eye Retina attached , VH OD OCT , Posterior Segment - OU - Both Eyes + ME OS Attending Note : Treatment hx : IVFA ( today ) : No view OD , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants Color Fundus Photos ( today ) : VH OD , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants OCT ( today ) : + ME OS B scan ( today ) : VH OD , retina attached Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME [s1] OU [e1] ( Previous HgA 1 C 13 improved to last month HgA 1 C ) OD - Active VH , for atleast 6 months per patient .	Proliferative diabetic retinopathy with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.351 250.50 362.07 362.02 3 .	laterality	lesion	T12	T16	2476381_note_7065
NonRel	Severe nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus E11.349 250.50 362.06 Ultrasound Biometry - OD - Right Eye Retina attached , VH OD OCT , Posterior Segment - OU - Both Eyes + ME OS Attending Note : Treatment hx : IVFA ( today ) : No view OD , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants Color Fundus Photos ( today ) : VH OD , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants OCT ( today ) : + ME OS B scan ( today ) : VH OD , retina attached Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last month HgA 1 C ) [s1] OD [e1] - Active VH , for atleast 6 months per patient .	[s2] Proliferative diabetic retinopathy [e2] with macular edema associated with type 2 diabetes mellitus E11.351 250.50 362.07 362.02 3 .	laterality	lesion	T13	T1	2476381_note_7065
NonRel	Severe nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus E11.349 250.50 362.06 Ultrasound Biometry - OD - Right Eye Retina attached , VH OD OCT , Posterior Segment - OU - Both Eyes + ME OS Attending Note : Treatment hx : IVFA ( today ) : No view OD , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants Color Fundus Photos ( today ) : VH OD , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants OCT ( today ) : + ME OS B scan ( today ) : VH OD , retina attached Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last month HgA 1 C ) [s1] OD [e1] - Active VH , for atleast 6 months per patient .	Proliferative diabetic retinopathy with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.351 250.50 362.07 362.02 3 .	laterality	lesion	T13	T16	2476381_note_7065
NonRel	Vitreous hemorrhage , [s1] right [e1] H43.11 379.23 Ultrasound Biometry - OD - Right Eye OCT , Posterior Segment - OU - Both Eyes 2 .	[s2] Proliferative diabetic retinopathy [e2] with macular edema associated with type 2 diabetes mellitus E11.351 250.50 362.07 362.02 3 .	laterality	lesion	T15	T1	2476381_note_7065
NonRel	Vitreous hemorrhage , [s1] right [e1] H43.11 379.23 Ultrasound Biometry - OD - Right Eye OCT , Posterior Segment - OU - Both Eyes 2 .	Proliferative diabetic retinopathy with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.351 250.50 362.07 362.02 3 .	laterality	lesion	T15	T16	2476381_note_7065
NonRel	Severe nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus E11.349 250.50 362.06 Ultrasound Biometry - OD - Right Eye Retina attached , VH OD OCT , Posterior Segment - OU - Both Eyes + ME OS Attending Note : Treatment hx : IVFA ( today ) : No view OD , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants Color Fundus Photos ( today ) : VH OD , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants OCT ( today ) : + ME OS B scan ( today ) : VH OD , retina attached Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last month HgA 1 C ) OD - [s1] Active [e1] VH , for atleast 6 months per patient .	[s2] Proliferative diabetic retinopathy [e2] with macular edema associated with type 2 diabetes mellitus E11.351 250.50 362.07 362.02 3 .	severity	lesion	T17	T1	2476381_note_7065
NonRel	Severe nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus E11.349 250.50 362.06 Ultrasound Biometry - OD - Right Eye Retina attached , VH OD OCT , Posterior Segment - OU - Both Eyes + ME OS Attending Note : Treatment hx : IVFA ( today ) : No view OD , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants Color Fundus Photos ( today ) : VH OD , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants OCT ( today ) : + ME OS B scan ( today ) : VH OD , retina attached Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last month HgA 1 C ) OD - [s1] Active [e1] VH , for atleast 6 months per patient .	Proliferative diabetic retinopathy with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.351 250.50 362.07 362.02 3 .	severity	lesion	T17	T16	2476381_note_7065
NonRel	Severe nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus E11.349 250.50 362.06 Ultrasound Biometry - OD - Right Eye Retina attached , VH OD OCT , Posterior Segment - OU - Both Eyes + ME OS Attending Note : Treatment hx : IVFA ( today ) : No view OD , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants Color Fundus Photos ( today ) : VH OD , [s1] Severe [e1] NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants OCT ( today ) : + ME OS B scan ( today ) : VH OD , retina attached Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last month HgA 1 C ) OD - Active VH , for atleast 6 months per patient .	[s2] Proliferative diabetic retinopathy [e2] with macular edema associated with type 2 diabetes mellitus E11.351 250.50 362.07 362.02 3 .	severity	lesion	T18	T1	2476381_note_7065
NonRel	Severe nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus E11.349 250.50 362.06 Ultrasound Biometry - OD - Right Eye Retina attached , VH OD OCT , Posterior Segment - OU - Both Eyes + ME OS Attending Note : Treatment hx : IVFA ( today ) : No view OD , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants Color Fundus Photos ( today ) : VH OD , [s1] Severe [e1] NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants OCT ( today ) : + ME OS B scan ( today ) : VH OD , retina attached Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last month HgA 1 C ) OD - Active VH , for atleast 6 months per patient .	Proliferative diabetic retinopathy with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.351 250.50 362.07 362.02 3 .	severity	lesion	T18	T16	2476381_note_7065
NonRel	Severe nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus E11.349 250.50 362.06 Ultrasound Biometry - OD - Right Eye Retina attached , VH OD OCT , Posterior Segment - OU - Both Eyes + ME OS Attending Note : Treatment hx : IVFA ( today ) : No view OD , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants Color Fundus Photos ( today ) : VH OD , Severe NPDR [s1] OS [e1] , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants OCT ( today ) : + ME OS B scan ( today ) : VH OD , retina attached Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last month HgA 1 C ) OD - Active VH , for atleast 6 months per patient .	[s2] Proliferative diabetic retinopathy [e2] with macular edema associated with type 2 diabetes mellitus E11.351 250.50 362.07 362.02 3 .	laterality	lesion	T20	T1	2476381_note_7065
NonRel	Severe nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus E11.349 250.50 362.06 Ultrasound Biometry - OD - Right Eye Retina attached , VH OD OCT , Posterior Segment - OU - Both Eyes + ME OS Attending Note : Treatment hx : IVFA ( today ) : No view OD , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants Color Fundus Photos ( today ) : VH OD , Severe NPDR [s1] OS [e1] , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants OCT ( today ) : + ME OS B scan ( today ) : VH OD , retina attached Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last month HgA 1 C ) OD - Active VH , for atleast 6 months per patient .	Proliferative diabetic retinopathy with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.351 250.50 362.07 362.02 3 .	laterality	lesion	T20	T16	2476381_note_7065
NonRel	Severe nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus E11.349 250.50 362.06 Ultrasound Biometry - OD - Right Eye Retina attached , VH OD OCT , Posterior Segment - OU - Both Eyes + ME [s1] OS [e1] Attending Note : Treatment hx : IVFA ( today ) : No view OD , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants Color Fundus Photos ( today ) : VH OD , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants OCT ( today ) : + ME OS B scan ( today ) : VH OD , retina attached Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last month HgA 1 C ) OD - Active VH , for atleast 6 months per patient .	[s2] Proliferative diabetic retinopathy [e2] with macular edema associated with type 2 diabetes mellitus E11.351 250.50 362.07 362.02 3 .	laterality	lesion	T22	T1	2476381_note_7065
NonRel	Severe nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus E11.349 250.50 362.06 Ultrasound Biometry - OD - Right Eye Retina attached , VH OD OCT , Posterior Segment - OU - Both Eyes + ME [s1] OS [e1] Attending Note : Treatment hx : IVFA ( today ) : No view OD , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants Color Fundus Photos ( today ) : VH OD , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants OCT ( today ) : + ME OS B scan ( today ) : VH OD , retina attached Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last month HgA 1 C ) OD - Active VH , for atleast 6 months per patient .	Proliferative diabetic retinopathy with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.351 250.50 362.07 362.02 3 .	laterality	lesion	T22	T16	2476381_note_7065
NonRel	Severe nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus E11.349 250.50 362.06 Ultrasound Biometry - OD - Right Eye Retina attached , VH OD OCT , Posterior Segment - OU - Both Eyes + ME OS Attending Note : Treatment hx : IVFA ( today ) : No view OD , [s1] Severe [e1] NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants Color Fundus Photos ( today ) : VH OD , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants OCT ( today ) : + ME OS B scan ( today ) : VH OD , retina attached Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last month HgA 1 C ) OD - Active VH , for atleast 6 months per patient .	[s2] Proliferative diabetic retinopathy [e2] with macular edema associated with type 2 diabetes mellitus E11.351 250.50 362.07 362.02 3 .	severity	lesion	T23	T1	2476381_note_7065
NonRel	Severe nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus E11.349 250.50 362.06 Ultrasound Biometry - OD - Right Eye Retina attached , VH OD OCT , Posterior Segment - OU - Both Eyes + ME OS Attending Note : Treatment hx : IVFA ( today ) : No view OD , [s1] Severe [e1] NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants Color Fundus Photos ( today ) : VH OD , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants OCT ( today ) : + ME OS B scan ( today ) : VH OD , retina attached Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last month HgA 1 C ) OD - Active VH , for atleast 6 months per patient .	Proliferative diabetic retinopathy with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.351 250.50 362.07 362.02 3 .	severity	lesion	T23	T16	2476381_note_7065
NonRel	Severe nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus E11.349 250.50 362.06 Ultrasound Biometry - OD - Right Eye Retina attached , VH OD OCT , Posterior Segment - OU - Both Eyes + ME OS Attending Note : Treatment hx : IVFA ( today ) : No view OD , Severe NPDR [s1] OS [e1] , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants Color Fundus Photos ( today ) : VH OD , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants OCT ( today ) : + ME OS B scan ( today ) : VH OD , retina attached Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last month HgA 1 C ) OD - Active VH , for atleast 6 months per patient .	[s2] Proliferative diabetic retinopathy [e2] with macular edema associated with type 2 diabetes mellitus E11.351 250.50 362.07 362.02 3 .	laterality	lesion	T25	T1	2476381_note_7065
NonRel	Severe nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus E11.349 250.50 362.06 Ultrasound Biometry - OD - Right Eye Retina attached , VH OD OCT , Posterior Segment - OU - Both Eyes + ME OS Attending Note : Treatment hx : IVFA ( today ) : No view OD , Severe NPDR [s1] OS [e1] , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants Color Fundus Photos ( today ) : VH OD , Severe NPDR OS , midperipheral capillary dropout , focal laser scars , dispersed MAs all four quadrants OCT ( today ) : + ME OS B scan ( today ) : VH OD , retina attached Previous anti - VEGF ( per patient 50 injections total OU ) Previous focal laser OU No hx of PRP 1 ) DM - hx of NPDR , CSME OU ( Previous HgA 1 C 13 improved to last month HgA 1 C ) OD - Active VH , for atleast 6 months per patient .	Proliferative diabetic retinopathy with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.351 250.50 362.07 362.02 3 .	laterality	lesion	T25	T16	2476381_note_7065
NonRel	OS - [s1] Severe [e1] NPDR with CSME .	Presumed etiology is [s2] PDR [e2] given history .	severity	lesion	T29	T26	2476381_note_7065
NonRel	OS - [s1] Severe [e1] NPDR with CSME .	Lengthy hx of treatment with chronic [s2] ME [e2] with anti - VEGF every agent ( IVA , IVL , IVE multiple ) .	severity	lesion	T29	T31	2476381_note_7065
NonRel	[s1] OS [e1] - Severe NPDR with CSME .	Presumed etiology is [s2] PDR [e2] given history .	laterality	lesion	T30	T26	2476381_note_7065
NonRel	[s1] OS [e1] - Severe NPDR with CSME .	Lengthy hx of treatment with chronic [s2] ME [e2] with anti - VEGF every agent ( IVA , IVL , IVE multiple ) .	laterality	lesion	T30	T31	2476381_note_7065
NonRel	Lengthy hx of treatment with [s1] chronic [e1] ME with anti - VEGF every agent ( IVA , IVL , IVE multiple ) .	OS - Severe [s2] NPDR [e2] with CSME .	severity	lesion	T32	T27	2476381_note_7065
NonRel	Lengthy hx of treatment with [s1] chronic [e1] ME with anti - VEGF every agent ( IVA , IVL , IVE multiple ) .	OS - Severe NPDR with [s2] CSME [e2] .	severity	lesion	T32	T28	2476381_note_7065
NonRel	Previous dx included glaucoma and ARMD . Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - [s1] Moderate [e1] NPDR OU .	Mild [s2] DME [e2] that has improved with better BS and observation .	severity	lesion	T2	T4	note_3797
NonRel	Previous dx included glaucoma and ARMD . Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - [s1] Moderate [e1] NPDR OU .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 1 diabetes mellitus E10.3313 250.51 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	severity	lesion	T2	T6	note_3797
NonRel	Previous dx included glaucoma and ARMD . Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - [s1] Moderate [e1] NPDR OU .	Moderate nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 1 diabetes mellitus E10.3313 250.51 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	severity	lesion	T2	T7	note_3797
NonRel	Previous dx included glaucoma and ARMD . Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR [s1] OU [e1] .	Mild [s2] DME [e2] that has improved with better BS and observation .	laterality	lesion	T3	T4	note_3797
NonRel	Previous dx included glaucoma and ARMD . Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR [s1] OU [e1] .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 1 diabetes mellitus E10.3313 250.51 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	laterality	lesion	T3	T6	note_3797
NonRel	Previous dx included glaucoma and ARMD . Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR [s1] OU [e1] .	Moderate nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 1 diabetes mellitus E10.3313 250.51 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	laterality	lesion	T3	T7	note_3797
NonRel	[s1] Mild [e1] DME that has improved with better BS and observation .	Previous dx included glaucoma and ARMD . Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate [s2] NPDR [e2] OU .	severity	lesion	T5	T1	note_3797
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 1 diabetes mellitus E10.3313 250.51 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	Previous dx included glaucoma and ARMD . Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate [s2] NPDR [e2] OU .	laterality	lesion	T8	T1	note_3797
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus E10.3313 250.51 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	Previous dx included glaucoma and ARMD . Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate [s2] NPDR [e2] OU .	severity	lesion	T9	T1	note_3797
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus - Right Eye E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 3 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus - Left Eye E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 4 .	laterality	lesion	T17	T5	1125619_note_2145
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus - Right Eye E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 3 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus - Left Eye E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 4 .	laterality	lesion	T17	T6	1125619_note_2145
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus - Right Eye E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 3 .	[s2] Vitreous hemorrhage [e2] , right - Right Eye H43.11 379.23 OCT , Posterior Segment - OU - Both Eyes OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T17	T29	1125619_note_2145
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus - Left Eye E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 4 .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus - Right Eye E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 3 .	laterality	lesion	T18	T3	1125619_note_2145
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus - Left Eye E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 4 .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus - Right Eye E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 3 .	laterality	lesion	T18	T4	1125619_note_2145
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus - Left Eye E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 4 .	Type 2 diabetes mellitus with other ophthalmic complication , with long - term current use of insulin ( CMS - HCC code ) E11.39 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 V58.67 Hx OF [s2] PDR [e2] OU , here for new floaters OD since DATE with new vit heme noted last visit .	laterality	lesion	T18	T31	1125619_note_2145
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus - Left Eye E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 4 .	Type 2 diabetes mellitus with other ophthalmic complication , with long - term current use of insulin ( CMS - HCC code ) E11.39 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 V58.67 Hx OF PDR OU , here for new floaters OD since DATE with new [s2] vit heme [e2] noted last visit .	laterality	lesion	T18	T33	1125619_note_2145
NonRel	Treatment Hx : IVA OD - DATE ( today ) IVA OD - DATE Focal + PRP ( IVFA guided ) OS - DATE IVFA ( DATE ) - Active PDR [s1] OS [e1] ( residual NVE ) IVA OD - DATE IVA OD - DATE PRP OU - DATE IVFA ( DATE ) : No demonstrable NVE OD ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	IVA OD - DATE IVA OD - DATE PRP OS - DATE IVFA ( DATE ) - Only limited peripheral view OD , but [s2] NVE [e2] with peripheral dropout .	laterality	lesion	T19	T11	1125619_note_2145
NonRel	Treatment Hx : IVA OD - DATE ( today ) IVA OD - DATE Focal + PRP ( IVFA guided ) OS - DATE IVFA ( DATE ) - Active PDR OS ( residual NVE ) IVA OD - DATE IVA OD - DATE PRP OU - DATE IVFA ( DATE ) : No demonstrable NVE [s1] OD [e1] ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	IVA OD - DATE IVA OD - DATE PRP OS - DATE IVFA ( DATE ) - Only limited peripheral view OD , but [s2] NVE [e2] with peripheral dropout .	laterality	lesion	T20	T11	1125619_note_2145
NonRel	Treatment Hx : IVA OD - DATE ( today ) IVA OD - DATE Focal + PRP ( IVFA guided ) OS - DATE IVFA ( DATE ) - Active PDR OS ( residual NVE ) IVA OD - DATE IVA OD - DATE PRP OU - DATE IVFA ( DATE ) : No demonstrable NVE OD ( IVA masking possible ) , [s1] OS [e1] with still active areas of NVE but with great improvement since prior to first laser .	IVA OD - DATE IVA OD - DATE PRP OS - DATE IVFA ( DATE ) - Only limited peripheral view OD , but [s2] NVE [e2] with peripheral dropout .	laterality	lesion	T21	T11	1125619_note_2145
NonRel	IVA OD - DATE IVA OD - DATE PRP OS - DATE IVFA ( DATE ) - Only limited peripheral view [s1] OD [e1] , but NVE with peripheral dropout .	Treatment Hx : IVA OD - DATE ( today ) IVA OD - DATE Focal + PRP ( IVFA guided ) OS - DATE IVFA ( DATE ) - Active [s2] PDR [e2] OS ( residual NVE ) IVA OD - DATE IVA OD - DATE PRP OU - DATE IVFA ( DATE ) : No demonstrable NVE OD ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	laterality	lesion	T22	T7	1125619_note_2145
NonRel	IVA OD - DATE IVA OD - DATE PRP OS - DATE IVFA ( DATE ) - Only limited peripheral view [s1] OD [e1] , but NVE with peripheral dropout .	Treatment Hx : IVA OD - DATE ( today ) IVA OD - DATE Focal + PRP ( IVFA guided ) OS - DATE IVFA ( DATE ) - Active PDR OS ( residual [s2] NVE [e2] ) IVA OD - DATE IVA OD - DATE PRP OU - DATE IVFA ( DATE ) : No demonstrable NVE OD ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	laterality	lesion	T22	T8	1125619_note_2145
NonRel	IVA OD - DATE IVA OD - DATE PRP OS - DATE IVFA ( DATE ) - Only limited peripheral view [s1] OD [e1] , but NVE with peripheral dropout .	Treatment Hx : IVA OD - DATE ( today ) IVA OD - DATE Focal + PRP ( IVFA guided ) OS - DATE IVFA ( DATE ) - Active PDR OS ( residual NVE ) IVA OD - DATE IVA OD - DATE PRP OU - DATE IVFA ( DATE ) : No demonstrable [s2] NVE [e2] OD ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	laterality	lesion	T22	T9	1125619_note_2145
NonRel	IVA OD - DATE IVA OD - DATE PRP OS - DATE IVFA ( DATE ) - Only limited peripheral view [s1] OD [e1] , but NVE with peripheral dropout .	Treatment Hx : IVA OD - DATE ( today ) IVA OD - DATE Focal + PRP ( IVFA guided ) OS - DATE IVFA ( DATE ) - Active PDR OS ( residual NVE ) IVA OD - DATE IVA OD - DATE PRP OU - DATE IVFA ( DATE ) : No demonstrable NVE OD ( IVA masking possible ) , OS with still active areas of [s2] NVE [e2] but with great improvement since prior to first laser .	laterality	lesion	T22	T10	1125619_note_2145
NonRel	IVA OD - DATE IVA OD - DATE PRP OS - DATE IVFA ( DATE ) - Only limited peripheral view [s1] OD [e1] , but NVE with peripheral dropout .	OS with active [s2] NVE [e2] and peripheral non - perfusion inferonasally .	laterality	lesion	T22	T12	1125619_note_2145
NonRel	[s1] OS [e1] with active NVE and peripheral non - perfusion inferonasally .	IVA OD - DATE IVA OD - DATE PRP OS - DATE IVFA ( DATE ) - Only limited peripheral view OD , but [s2] NVE [e2] with peripheral dropout .	laterality	lesion	T23	T11	1125619_note_2145
NonRel	[s1] OS [e1] with active NVE and peripheral non - perfusion inferonasally .	1 ) NIDDM ( Type 2 , Duration > 15 years ; Last A1c 6.4 8 / 2018 OD - New [s2] VH [e2] today .	laterality	lesion	T23	T13	1125619_note_2145
NonRel	1 ) NIDDM ( Type 2 , Duration > 15 years ; Last A1c 6.4 8 / 2018 [s1] OD [e1] - New VH today .	OS with active [s2] NVE [e2] and peripheral non - perfusion inferonasally .	laterality	lesion	T24	T12	1125619_note_2145
NonRel	1 ) NIDDM ( Type 2 , Duration > 15 years ; Last A1c 6.4 8 / 2018 [s1] OD [e1] - New VH today .	IN vessel extending into vitreous prior visit , new [s2] vit heme [e2] last visit , now improved with IVA .	laterality	lesion	T24	T36	1125619_note_2145
NonRel	Vitreous hemorrhage , [s1] right [e1] - Right Eye H43.11 379.23 OCT , Posterior Segment - OU - Both Eyes OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus - Right Eye E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 3 .	laterality	lesion	T30	T3	1125619_note_2145
NonRel	Vitreous hemorrhage , [s1] right [e1] - Right Eye H43.11 379.23 OCT , Posterior Segment - OU - Both Eyes OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus - Right Eye E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 3 .	laterality	lesion	T30	T4	1125619_note_2145
NonRel	Type 2 diabetes mellitus with other ophthalmic complication , with long - term current use of insulin ( CMS - HCC code ) E11.39 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 V58.67 Hx OF PDR [s1] OU [e1] , here for new floaters OD since DATE with new vit heme noted last visit .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus - Left Eye E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 4 .	laterality	lesion	T32	T5	1125619_note_2145
NonRel	Type 2 diabetes mellitus with other ophthalmic complication , with long - term current use of insulin ( CMS - HCC code ) E11.39 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 V58.67 Hx OF PDR [s1] OU [e1] , here for new floaters OD since DATE with new vit heme noted last visit .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus - Left Eye E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 4 .	laterality	lesion	T32	T6	1125619_note_2145
NonRel	Type 2 diabetes mellitus with other ophthalmic complication , with long - term current use of insulin ( CMS - HCC code ) E11.39 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 V58.67 Hx OF PDR OU , here for new floaters [s1] OD [e1] since DATE with new vit heme noted last visit .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus - Left Eye E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 4 .	laterality	lesion	T34	T5	1125619_note_2145
NonRel	Type 2 diabetes mellitus with other ophthalmic complication , with long - term current use of insulin ( CMS - HCC code ) E11.39 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 V58.67 Hx OF PDR OU , here for new floaters [s1] OD [e1] since DATE with new vit heme noted last visit .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus - Left Eye E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 4 .	laterality	lesion	T34	T6	1125619_note_2145
NonRel	Treatment Hx : IVA OD - DATE ( today ) IVA OD - DATE Focal + PRP ( IVFA guided ) OS - DATE IVFA ( DATE ) - [s1] Active [e1] PDR OS ( residual NVE ) IVA OD - DATE IVA OD - DATE PRP OU - DATE IVFA ( DATE ) : No demonstrable NVE OD ( IVA masking possible ) , OS with still active areas of NVE but with great improvement since prior to first laser .	IVA OD - DATE IVA OD - DATE PRP OS - DATE IVFA ( DATE ) - Only limited peripheral view OD , but [s2] NVE [e2] with peripheral dropout .	severity	lesion	T35	T11	1125619_note_2145
NonRel	OS with [s1] active [e1] NVE and peripheral non - perfusion inferonasally .	IVA OD - DATE IVA OD - DATE PRP OS - DATE IVFA ( DATE ) - Only limited peripheral view OD , but [s2] NVE [e2] with peripheral dropout .	severity	lesion	T39	T11	1125619_note_2145
NonRel	OS with [s1] active [e1] NVE and peripheral non - perfusion inferonasally .	1 ) NIDDM ( Type 2 , Duration > 15 years ; Last A1c 6.4 8 / 2018 OD - New [s2] VH [e2] today .	severity	lesion	T39	T13	1125619_note_2145
NonRel	OS - IVFA showing PED [s1] OS [e1] with no changes since the last visit and no IRF / SRF on OCT .	Nuclear sclerotic cataract of both eyes H25.13 366.16 Attending Note : 1 ) ARMD OU [ Nonexudative OD ( high risk features ) , Nonexudative with Quiescent CNVM OS ] OD - plaqueoid moderate to large soft drusen / RPED with high risk features but without changes since last visit or [s2] IRF [e2] / SRF on OCT .	laterality	lesion	T7	T1	1342474_note_3109
NonRel	OS - IVFA showing PED [s1] OS [e1] with no changes since the last visit and no IRF / SRF on OCT .	Nuclear sclerotic cataract of both eyes H25.13 366.16 Attending Note : 1 ) ARMD OU [ Nonexudative OD ( high risk features ) , Nonexudative with Quiescent CNVM OS ] OD - plaqueoid moderate to large soft drusen / RPED with high risk features but without changes since last visit or IRF / [s2] SRF [e2] on OCT .	laterality	lesion	T7	T2	1342474_note_3109
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 1 diabetes mellitus E10.3511 250.51 362.07 362.02 2 .	[s2] Diabetic macular edema [e2] of left eye with proliferative retinopathy associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 Pan Retinal Photocoagulation - OS - Left Eye 362.07 362.02 Treatment History PRP OS ( IVFA - Guided ) - 6 / 30 / 2017 ( today ) PRP OD [ IVFA - guided ] - 6 / 16 / 17 IVA OS - 6 / 16 / 17 1 .	laterality	lesion	T13	T4	note_7940
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 1 diabetes mellitus E10.3511 250.51 362.07 362.02 2 .	Diabetic macular edema of left eye with [s2] proliferative retinopathy [e2] associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 Pan Retinal Photocoagulation - OS - Left Eye 362.07 362.02 Treatment History PRP OS ( IVFA - Guided ) - 6 / 30 / 2017 ( today ) PRP OD [ IVFA - guided ] - 6 / 16 / 17 IVA OS - 6 / 16 / 17 1 .	laterality	lesion	T13	T5	note_7940
NonRel	Diabetic macular edema of [s1] left eye [e1] with proliferative retinopathy associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 Pan Retinal Photocoagulation - OS - Left Eye 362.07 362.02 Treatment History PRP OS ( IVFA - Guided ) - 6 / 30 / 2017 ( today ) PRP OD [ IVFA - guided ] - 6 / 16 / 17 IVA OS - 6 / 16 / 17 1 .	[s2] Diabetic macular edema [e2] of right eye with proliferative retinopathy associated with type 1 diabetes mellitus E10.3511 250.51 362.07 362.02 2 .	laterality	lesion	T14	T2	note_7940
NonRel	Diabetic macular edema of [s1] left eye [e1] with proliferative retinopathy associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 Pan Retinal Photocoagulation - OS - Left Eye 362.07 362.02 Treatment History PRP OS ( IVFA - Guided ) - 6 / 30 / 2017 ( today ) PRP OD [ IVFA - guided ] - 6 / 16 / 17 IVA OS - 6 / 16 / 17 1 .	Diabetic macular edema of right eye with [s2] proliferative retinopathy [e2] associated with type 1 diabetes mellitus E10.3511 250.51 362.07 362.02 2 .	laterality	lesion	T14	T3	note_7940
NonRel	Diabetic macular edema of [s1] left eye [e1] with proliferative retinopathy associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 Pan Retinal Photocoagulation - OS - Left Eye 362.07 362.02 Treatment History PRP OS ( IVFA - Guided ) - 6 / 30 / 2017 ( today ) PRP OD [ IVFA - guided ] - 6 / 16 / 17 IVA OS - 6 / 16 / 17 1 .	IDDM ( Type I ) - Active [s2] PDR [e2] OU . ( DM duration 30 years .	laterality	lesion	T14	T6	note_7940
NonRel	IDDM ( Type I ) - Active PDR [s1] OU [e1] . ( DM duration 30 years .	[s2] Diabetic macular edema [e2] of left eye with proliferative retinopathy associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 Pan Retinal Photocoagulation - OS - Left Eye 362.07 362.02 Treatment History PRP OS ( IVFA - Guided ) - 6 / 30 / 2017 ( today ) PRP OD [ IVFA - guided ] - 6 / 16 / 17 IVA OS - 6 / 16 / 17 1 .	laterality	lesion	T15	T4	note_7940
NonRel	IDDM ( Type I ) - Active PDR [s1] OU [e1] . ( DM duration 30 years .	Diabetic macular edema of left eye with [s2] proliferative retinopathy [e2] associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 Pan Retinal Photocoagulation - OS - Left Eye 362.07 362.02 Treatment History PRP OS ( IVFA - Guided ) - 6 / 30 / 2017 ( today ) PRP OD [ IVFA - guided ] - 6 / 16 / 17 IVA OS - 6 / 16 / 17 1 .	laterality	lesion	T15	T5	note_7940
NonRel	IDDM ( Type I ) - Active PDR [s1] OU [e1] . ( DM duration 30 years .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active [s2] PDR [e2] without CSME ( + DME ) on exam .	laterality	lesion	T15	T7	note_7940
NonRel	IDDM ( Type I ) - Active PDR [s1] OU [e1] . ( DM duration 30 years .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active PDR without [s2] CSME [e2] ( + DME ) on exam .	laterality	lesion	T15	T8	note_7940
NonRel	IDDM ( Type I ) - Active PDR [s1] OU [e1] . ( DM duration 30 years .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active PDR without CSME ( + [s2] DME [e2] ) on exam .	laterality	lesion	T15	T9	note_7940
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) [s1] OD [e1] - Active PDR without CSME ( + DME ) on exam .	IDDM ( Type I ) - Active [s2] PDR [e2] OU . ( DM duration 30 years .	laterality	lesion	T16	T6	note_7940
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) [s1] OD [e1] - Active PDR without CSME ( + DME ) on exam .	S / P IVFA - Guided PRP 6 / 16 / 2017 OS - Active [s2] PDR [e2] with sub - hyaloid hemorrhage .	laterality	lesion	T16	T10	note_7940
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) [s1] OD [e1] - Active PDR without CSME ( + DME ) on exam .	S / P IVFA - Guided PRP 6 / 16 / 2017 OS - Active PDR with [s2] sub - hyaloid hemorrhage [e2] .	laterality	lesion	T16	T11	note_7940
NonRel	[s1] Mild [e1] temporal macular edema . S / P IVA 6 / 16 / 2017 .	S / P IVFA - Guided PRP 6 / 16 / 2017 OS - Active [s2] PDR [e2] with sub - hyaloid hemorrhage .	severity	lesion	T17	T10	note_7940
NonRel	[s1] Mild [e1] temporal macular edema . S / P IVA 6 / 16 / 2017 .	S / P IVFA - Guided PRP 6 / 16 / 2017 OS - Active PDR with [s2] sub - hyaloid hemorrhage [e2] .	severity	lesion	T17	T11	note_7940
NonRel	S / P IVFA - Guided PRP 6 / 16 / 2017 [s1] OS [e1] - Active PDR with sub - hyaloid hemorrhage .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active [s2] PDR [e2] without CSME ( + DME ) on exam .	laterality	lesion	T19	T7	note_7940
NonRel	S / P IVFA - Guided PRP 6 / 16 / 2017 [s1] OS [e1] - Active PDR with sub - hyaloid hemorrhage .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active PDR without [s2] CSME [e2] ( + DME ) on exam .	laterality	lesion	T19	T8	note_7940
NonRel	S / P IVFA - Guided PRP 6 / 16 / 2017 [s1] OS [e1] - Active PDR with sub - hyaloid hemorrhage .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active PDR without CSME ( + [s2] DME [e2] ) on exam .	laterality	lesion	T19	T9	note_7940
NonRel	S / P IVFA - Guided PRP 6 / 16 / 2017 [s1] OS [e1] - Active PDR with sub - hyaloid hemorrhage .	Mild temporal [s2] macular edema [e2] . S / P IVA 6 / 16 / 2017 .	laterality	lesion	T19	T12	note_7940
NonRel	IDDM ( Type I ) - [s1] Active [e1] PDR OU . ( DM duration 30 years .	[s2] Diabetic macular edema [e2] of left eye with proliferative retinopathy associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 Pan Retinal Photocoagulation - OS - Left Eye 362.07 362.02 Treatment History PRP OS ( IVFA - Guided ) - 6 / 30 / 2017 ( today ) PRP OD [ IVFA - guided ] - 6 / 16 / 17 IVA OS - 6 / 16 / 17 1 .	severity	lesion	T20	T4	note_7940
NonRel	IDDM ( Type I ) - [s1] Active [e1] PDR OU . ( DM duration 30 years .	Diabetic macular edema of left eye with [s2] proliferative retinopathy [e2] associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 Pan Retinal Photocoagulation - OS - Left Eye 362.07 362.02 Treatment History PRP OS ( IVFA - Guided ) - 6 / 30 / 2017 ( today ) PRP OD [ IVFA - guided ] - 6 / 16 / 17 IVA OS - 6 / 16 / 17 1 .	severity	lesion	T20	T5	note_7940
NonRel	IDDM ( Type I ) - [s1] Active [e1] PDR OU . ( DM duration 30 years .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active [s2] PDR [e2] without CSME ( + DME ) on exam .	severity	lesion	T20	T7	note_7940
NonRel	IDDM ( Type I ) - [s1] Active [e1] PDR OU . ( DM duration 30 years .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active PDR without [s2] CSME [e2] ( + DME ) on exam .	severity	lesion	T20	T8	note_7940
NonRel	IDDM ( Type I ) - [s1] Active [e1] PDR OU . ( DM duration 30 years .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active PDR without CSME ( + [s2] DME [e2] ) on exam .	severity	lesion	T20	T9	note_7940
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - [s1] Active PDR [e1] without CSME ( + DME ) on exam .	IDDM ( Type I ) - Active [s2] PDR [e2] OU . ( DM duration 30 years .	severity	lesion	T21	T6	note_7940
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - [s1] Active PDR [e1] without CSME ( + DME ) on exam .	S / P IVFA - Guided PRP 6 / 16 / 2017 OS - Active [s2] PDR [e2] with sub - hyaloid hemorrhage .	severity	lesion	T21	T10	note_7940
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - [s1] Active PDR [e1] without CSME ( + DME ) on exam .	S / P IVFA - Guided PRP 6 / 16 / 2017 OS - Active PDR with [s2] sub - hyaloid hemorrhage [e2] .	severity	lesion	T21	T11	note_7940
NonRel	S / P IVFA - Guided PRP 6 / 16 / 2017 OS - [s1] Active [e1] PDR with sub - hyaloid hemorrhage .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active [s2] PDR [e2] without CSME ( + DME ) on exam .	severity	lesion	T22	T7	note_7940
NonRel	S / P IVFA - Guided PRP 6 / 16 / 2017 OS - [s1] Active [e1] PDR with sub - hyaloid hemorrhage .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active PDR without [s2] CSME [e2] ( + DME ) on exam .	severity	lesion	T22	T8	note_7940
NonRel	S / P IVFA - Guided PRP 6 / 16 / 2017 OS - [s1] Active [e1] PDR with sub - hyaloid hemorrhage .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active PDR without CSME ( + [s2] DME [e2] ) on exam .	severity	lesion	T22	T9	note_7940
NonRel	S / P IVFA - Guided PRP 6 / 16 / 2017 OS - [s1] Active [e1] PDR with sub - hyaloid hemorrhage .	Mild temporal [s2] macular edema [e2] . S / P IVA 6 / 16 / 2017 .	severity	lesion	T22	T12	note_7940
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T7	T12	note_5742
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T7	T14	note_5742
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate [s2] NPDR [e2] OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T7	T16	note_5742
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with [s2] CSME [e2] OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T7	T18	note_5742
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate [s2] NPDR [e2] with ciCSME .	severity	lesion	T7	T23	note_5742
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with [s2] ciCSME [e2] .	severity	lesion	T7	T24	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T9	T12	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T9	T14	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate [s2] NPDR [e2] OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T9	T16	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with [s2] CSME [e2] OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T9	T18	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate [s2] NPDR [e2] with ciCSME .	laterality	lesion	T9	T23	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with [s2] ciCSME [e2] .	laterality	lesion	T9	T24	note_5742
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T11	T8	note_5742
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T11	T10	note_5742
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	[s2] IRF [e2] seems slightly improved on OCT .	severity	lesion	T11	T25	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T13	T8	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T13	T10	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	[s2] IRF [e2] seems slightly improved on OCT .	laterality	lesion	T13	T25	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - [s1] Moderate [e1] NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T15	T8	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - [s1] Moderate [e1] NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T15	T10	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - [s1] Moderate [e1] NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	[s2] IRF [e2] seems slightly improved on OCT .	severity	lesion	T15	T25	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR [s1] OU [e1] with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T17	T8	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR [s1] OU [e1] with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T17	T10	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR [s1] OU [e1] with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	[s2] IRF [e2] seems slightly improved on OCT .	laterality	lesion	T17	T25	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME [s1] OS [e1] > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T19	T8	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME [s1] OS [e1] > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T19	T10	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME [s1] OS [e1] > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	[s2] IRF [e2] seems slightly improved on OCT .	laterality	lesion	T19	T25	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > [s1] OD [e1] 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T20	T8	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > [s1] OD [e1] 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T20	T10	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > [s1] OD [e1] 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	[s2] IRF [e2] seems slightly improved on OCT .	laterality	lesion	T20	T25	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] [s1] OD [e1] - Moderate NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T21	T8	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] [s1] OD [e1] - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T21	T10	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] [s1] OD [e1] - Moderate NPDR with ciCSME .	[s2] IRF [e2] seems slightly improved on OCT .	laterality	lesion	T21	T25	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - [s1] Moderate [e1] NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T22	T8	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - [s1] Moderate [e1] NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T22	T10	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - [s1] Moderate [e1] NPDR with ciCSME .	[s2] IRF [e2] seems slightly improved on OCT .	severity	lesion	T22	T25	note_5742
NonRel	[s1] OS [e1] - Moderate NPDR with ciCSME .	[s2] IRF [e2] seems slightly improved on OCT .	laterality	lesion	T26	T25	note_5742
NonRel	[s1] OS [e1] - Moderate NPDR with ciCSME .	[s2] IRF [e2] significantly improved OS since the last visit when brought back at shorter interval .	laterality	lesion	T26	T30	note_5742
NonRel	OS - [s1] Moderate [e1] NPDR with ciCSME .	[s2] IRF [e2] seems slightly improved on OCT .	severity	lesion	T27	T25	note_5742
NonRel	OS - [s1] Moderate [e1] NPDR with ciCSME .	[s2] IRF [e2] significantly improved OS since the last visit when brought back at shorter interval .	severity	lesion	T27	T30	note_5742
NonRel	IRF significantly improved [s1] OS [e1] since the last visit when brought back at shorter interval .	OS - Moderate [s2] NPDR [e2] with ciCSME .	laterality	lesion	T31	T28	note_5742
NonRel	IRF significantly improved [s1] OS [e1] since the last visit when brought back at shorter interval .	OS - Moderate NPDR with [s2] ciCSME [e2] .	laterality	lesion	T31	T29	note_5742
NonRel	IRF [s1] significantly improved [e1] OS since the last visit when brought back at shorter interval .	OS - Moderate [s2] NPDR [e2] with ciCSME .	severity	lesion	T32	T28	note_5742
NonRel	IRF [s1] significantly improved [e1] OS since the last visit when brought back at shorter interval .	OS - Moderate NPDR with [s2] ciCSME [e2] .	severity	lesion	T32	T29	note_5742
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Severe [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	laterality	lesion	T17	T4	2710850_note_9151
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Severe nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	laterality	lesion	T17	T5	2710850_note_9151
NonRel	Severe nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T18	T2	2710850_note_9151
NonRel	Severe nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T18	T3	2710850_note_9151
NonRel	Severe nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	[s2] Vitreous hemorrhage [e2] of right eye H43.11 379.23 OPH - OD Intravitreal Injection , Pharmacologic Agent On Saturday morning he had a hazey view in a small spot that enlarged to cover his entire vision .	laterality	lesion	T18	T6	2710850_note_9151
NonRel	Vitreous hemorrhage of [s1] right eye [e1] H43.11 379.23 OPH - OD Intravitreal Injection , Pharmacologic Agent On Saturday morning he had a hazey view in a small spot that enlarged to cover his entire vision .	Severe [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	laterality	lesion	T19	T4	2710850_note_9151
NonRel	Vitreous hemorrhage of [s1] right eye [e1] H43.11 379.23 OPH - OD Intravitreal Injection , Pharmacologic Agent On Saturday morning he had a hazey view in a small spot that enlarged to cover his entire vision .	Severe nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	laterality	lesion	T19	T5	2710850_note_9151
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] mild [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3211 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.04 Color Fundus Photography - OU - Both Eyes 362.07 V58.67 2 .	Mild [s2] nonproliferative diabetic retinopathy [e2] of left eye associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 Color Fundus Photography - OU - Both Eyes 3 .	severity	lesion	T1	T6	note_50
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by mild nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3211 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.04 Color Fundus Photography - OU - Both Eyes 362.07 V58.67 2 .	Mild [s2] nonproliferative diabetic retinopathy [e2] of left eye associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 Color Fundus Photography - OU - Both Eyes 3 .	laterality	lesion	T4	T6	note_50
NonRel	[s1] Mild [e1] nonproliferative diabetic retinopathy of left eye associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 Color Fundus Photography - OU - Both Eyes 3 .	Type 2 diabetes mellitus with right eye affected by mild [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3211 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.04 Color Fundus Photography - OU - Both Eyes 362.07 V58.67 2 .	severity	lesion	T5	T2	note_50
NonRel	[s1] Mild [e1] nonproliferative diabetic retinopathy of left eye associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 Color Fundus Photography - OU - Both Eyes 3 .	Type 2 diabetes mellitus with right eye affected by mild nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3211 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.04 Color Fundus Photography - OU - Both Eyes 362.07 V58.67 2 .	severity	lesion	T5	T3	note_50
NonRel	Mild nonproliferative diabetic retinopathy of [s1] left eye [e1] associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 Color Fundus Photography - OU - Both Eyes 3 .	Type 2 diabetes mellitus with right eye affected by mild [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3211 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.04 Color Fundus Photography - OU - Both Eyes 362.07 V58.67 2 .	laterality	lesion	T7	T2	note_50
NonRel	Mild nonproliferative diabetic retinopathy of [s1] left eye [e1] associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 Color Fundus Photography - OU - Both Eyes 3 .	Type 2 diabetes mellitus with right eye affected by mild nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3211 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.04 Color Fundus Photography - OU - Both Eyes 362.07 V58.67 2 .	laterality	lesion	T7	T3	note_50
NonRel	Dry ARMD H35.3190 362.51 1 ) ARMD OU ( Advanced Nonexudtative OU - High Risk Features ) - VAcc excellent and stable OU - DFE with heavy large drusen throughout OU , [s1] small [e1] intraretinal hemorrhage noted OD lv but not present on exam today .	No CNVM , no [s2] IRF [e2] / SRF ; although there are high risk features .	laterality	lesion	T1	T3	342322_note_924
NonRel	Dry ARMD H35.3190 362.51 1 ) ARMD OU ( Advanced Nonexudtative OU - High Risk Features ) - VAcc excellent and stable OU - DFE with heavy large drusen throughout OU , [s1] small [e1] intraretinal hemorrhage noted OD lv but not present on exam today .	No CNVM , no IRF / [s2] SRF [e2] ; although there are high risk features .	laterality	lesion	T1	T4	342322_note_924
NonRel	Dry ARMD H35.3190 362.51 1 ) ARMD OU ( Advanced Nonexudtative OU - High Risk Features ) - VAcc excellent and stable OU - DFE with heavy large drusen throughout OU , small intraretinal hemorrhage noted [s1] OD [e1] lv but not present on exam today .	No CNVM , no [s2] IRF [e2] / SRF ; although there are high risk features .	laterality	lesion	T7	T3	342322_note_924
NonRel	Dry ARMD H35.3190 362.51 1 ) ARMD OU ( Advanced Nonexudtative OU - High Risk Features ) - VAcc excellent and stable OU - DFE with heavy large drusen throughout OU , small intraretinal hemorrhage noted [s1] OD [e1] lv but not present on exam today .	No CNVM , no IRF / [s2] SRF [e2] ; although there are high risk features .	laterality	lesion	T7	T4	342322_note_924
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 3 .	laterality	lesion	T7	T3	note_4013
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 3 .	laterality	lesion	T7	T4	note_4013
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 3 .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	laterality	lesion	T8	T1	note_4013
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 3 .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	laterality	lesion	T8	T2	note_4013
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 3 .	[s2] Vitreous hemorrhage [e2] , right eye H43.11 379.23 Treatment Hx : IVA OD - 12 / 1 / 17 IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with VH that has responded to treatment with IVA .	laterality	lesion	T8	T5	note_4013
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 3 .	Vitreous hemorrhage , right eye H43.11 379.23 Treatment Hx : IVA OD - 12 / 1 / 17 IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with [s2] VH [e2] that has responded to treatment with IVA .	laterality	lesion	T8	T6	note_4013
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 3 .	Vitreous hemorrhage , right eye H43.11 379.23 Treatment Hx : IVA OD - 12 / 1 / 17 IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - [s2] PDR [e2] with VH that has responded to treatment with IVA .	laterality	lesion	T8	T10	note_4013
NonRel	Vitreous hemorrhage , [s1] right eye [e1] H43.11 379.23 Treatment Hx : IVA OD - 12 / 1 / 17 IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with VH that has responded to treatment with IVA .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 3 .	laterality	lesion	T9	T3	note_4013
NonRel	Vitreous hemorrhage , [s1] right eye [e1] H43.11 379.23 Treatment Hx : IVA OD - 12 / 1 / 17 IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with VH that has responded to treatment with IVA .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 3 .	laterality	lesion	T9	T4	note_4013
NonRel	Vitreous hemorrhage , right eye H43.11 379.23 Treatment Hx : IVA OD - 12 / 1 / 17 IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] [s1] OD [e1] - PDR with VH that has responded to treatment with IVA .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 3 .	laterality	lesion	T11	T3	note_4013
NonRel	Vitreous hemorrhage , right eye H43.11 379.23 Treatment Hx : IVA OD - 12 / 1 / 17 IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] [s1] OD [e1] - PDR with VH that has responded to treatment with IVA .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 3 .	laterality	lesion	T11	T4	note_4013
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 OCT , Retina - OU - Both Eyes 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	laterality	lesion	T6	T4	1590841_note_3799
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 OCT , Retina - OU - Both Eyes 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	laterality	lesion	T6	T5	1590841_note_3799
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate [s2] NPDR [e2] OU OD - nciDME , stable .	laterality	lesion	T7	T1	1590841_note_3799
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 OCT , Retina - OU - Both Eyes 362.05 2 .	laterality	lesion	T7	T2	1590841_note_3799
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	Moderate nonproliferative diabetic retinopathy of right eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3391 250.50 OCT , Retina - OU - Both Eyes 362.05 2 .	laterality	lesion	T7	T3	1590841_note_3799
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate NPDR OU OD - [s2] nciDME [e2] , stable .	laterality	lesion	T7	T13	1590841_note_3799
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 OCT , Retina - OU - Both Eyes 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	severity	lesion	T8	T4	1590841_note_3799
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 OCT , Retina - OU - Both Eyes 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	severity	lesion	T8	T5	1590841_note_3799
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate [s2] NPDR [e2] OU OD - nciDME , stable .	severity	lesion	T9	T1	1590841_note_3799
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 OCT , Retina - OU - Both Eyes 362.05 2 .	severity	lesion	T9	T2	1590841_note_3799
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	Moderate nonproliferative diabetic retinopathy of right eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3391 250.50 OCT , Retina - OU - Both Eyes 362.05 2 .	severity	lesion	T9	T3	1590841_note_3799
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate NPDR OU OD - [s2] nciDME [e2] , stable .	severity	lesion	T9	T13	1590841_note_3799
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - [s1] Moderate [e1] NPDR OU OD - nciDME , stable .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	severity	lesion	T10	T4	1590841_note_3799
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - [s1] Moderate [e1] NPDR OU OD - nciDME , stable .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	severity	lesion	T10	T5	1590841_note_3799
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate NPDR [s1] OU [e1] OD - nciDME , stable .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	laterality	lesion	T11	T4	1590841_note_3799
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate NPDR [s1] OU [e1] OD - nciDME , stable .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	laterality	lesion	T11	T5	1590841_note_3799
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate NPDR OU [s1] OD [e1] - nciDME , stable .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	laterality	lesion	T12	T4	1590841_note_3799
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate NPDR OU [s1] OD [e1] - nciDME , stable .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	laterality	lesion	T12	T5	1590841_note_3799
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate NPDR OU OD - nciDME , [s1] stable [e1] .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	severity	lesion	T14	T4	1590841_note_3799
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate NPDR OU OD - nciDME , [s1] stable [e1] .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	severity	lesion	T14	T5	1590841_note_3799
NonRel	NIDDM , Severe - Diagnosed 20 years ago but reports is Type 1 - VA 20 / 25 and 20 / 20 - OCT with [s1] scattered [e1] IRF and exudates .	Suspicious area ITQ OD on exam and OCT of ? early [s2] NVE [e2] - IVFA obtained today - Discussed need for strict glucose control - Discussed systemic and ocular effects of diabetes mellitus 2 .	severity	lesion	T8	T5	note_2913
NonRel	Suspicious area ITQ OD on exam and OCT of ? [s1] early [e1] NVE - IVFA obtained today - Discussed need for strict glucose control - Discussed systemic and ocular effects of diabetes mellitus 2 .	NIDDM , Severe - Diagnosed 20 years ago but reports is Type 1 - VA 20 / 25 and 20 / 20 - OCT with scattered [s2] IRF [e2] and exudates .	severity	lesion	T9	T3	note_2913
NonRel	Suspicious area ITQ OD on exam and OCT of ? [s1] early [e1] NVE - IVFA obtained today - Discussed need for strict glucose control - Discussed systemic and ocular effects of diabetes mellitus 2 .	NIDDM , Severe - Diagnosed 20 years ago but reports is Type 1 - VA 20 / 25 and 20 / 20 - OCT with scattered IRF and [s2] exudates [e2] .	severity	lesion	T9	T4	note_2913
NonRel	Suspicious area ITQ [s1] OD [e1] on exam and OCT of ? early NVE - IVFA obtained today - Discussed need for strict glucose control - Discussed systemic and ocular effects of diabetes mellitus 2 .	NIDDM , Severe - Diagnosed 20 years ago but reports is Type 1 - VA 20 / 25 and 20 / 20 - OCT with scattered [s2] IRF [e2] and exudates .	laterality	lesion	T10	T3	note_2913
NonRel	Suspicious area ITQ [s1] OD [e1] on exam and OCT of ? early NVE - IVFA obtained today - Discussed need for strict glucose control - Discussed systemic and ocular effects of diabetes mellitus 2 .	NIDDM , Severe - Diagnosed 20 years ago but reports is Type 1 - VA 20 / 25 and 20 / 20 - OCT with scattered IRF and [s2] exudates [e2] .	laterality	lesion	T10	T4	note_2913
NonRel	Today without [s1] SRF [e1] .	1 ) [s2] Maculopathy [e2] ( w / RPE loss ) - evidence of prior SRF , mild RPE attenuation .	lesion	eye_part	T3	T2	1896876_note_5099
NonRel	1 ) ARMD OU ( Nonexudative OD , Exudative [s1] OS [e1] s / p PPV for SMH ) OD - stable on exam .	Without heme or [s2] IRF [e2] / SRF .	laterality	lesion	T6	T3	note_7183
NonRel	1 ) ARMD OU ( Nonexudative OD , Exudative [s1] OS [e1] s / p PPV for SMH ) OD - stable on exam .	Without heme or IRF / [s2] SRF [e2] .	laterality	lesion	T6	T4	note_7183
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Severe [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	laterality	lesion	T5	T8	note_9150
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Severe nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	laterality	lesion	T5	T10	note_9150
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	severity	lesion	T7	T4	note_9150
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	severity	lesion	T7	T6	note_9150
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	[s2] Vitreous hemorrhage [e2] of right eye H43.11 379.23 OPH - OD Intravitreal Injection , Pharmacologic Agent T2DM x 30 years became insulin dependent 6 - 8 years ago Has had laser in right eye .	severity	lesion	T7	T11	note_9150
NonRel	Severe nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T9	T4	note_9150
NonRel	Severe nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T9	T6	note_9150
NonRel	Severe nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	[s2] Vitreous hemorrhage [e2] of right eye H43.11 379.23 OPH - OD Intravitreal Injection , Pharmacologic Agent T2DM x 30 years became insulin dependent 6 - 8 years ago Has had laser in right eye .	laterality	lesion	T9	T11	note_9150
NonRel	Vitreous hemorrhage of [s1] right eye [e1] H43.11 379.23 OPH - OD Intravitreal Injection , Pharmacologic Agent T2DM x 30 years became insulin dependent 6 - 8 years ago Has had laser in right eye .	Severe [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	laterality	lesion	T12	T8	note_9150
NonRel	Vitreous hemorrhage of [s1] right eye [e1] H43.11 379.23 OPH - OD Intravitreal Injection , Pharmacologic Agent T2DM x 30 years became insulin dependent 6 - 8 years ago Has had laser in right eye .	Severe nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	laterality	lesion	T12	T10	note_9150
NonRel	1 . Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD 2 .	Severe [s2] NPDR [e2] with macular edema OD - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	laterality	lesion	T14	T16	note_9150
NonRel	1 . Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD 2 .	Severe NPDR with [s2] macular edema [e2] OD - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	laterality	lesion	T14	T17	note_9150
NonRel	1 . Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD 2 .	Severe NPDR with macular edema OD - [s2] DBH [e2] and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	laterality	lesion	T14	T19	note_9150
NonRel	1 . Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD 2 .	Severe NPDR with macular edema OD - DBH and [s2] MAs [e2] in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	laterality	lesion	T14	T20	note_9150
NonRel	1 . Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD 2 .	Severe NPDR with macular edema OD - DBH and MAs in posterior pole - Small [s2] IRF [e2] adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	laterality	lesion	T14	T22	note_9150
NonRel	1 . Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD 2 .	Severe NPDR with macular edema OD - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , [s2] IRMA [e2] , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	laterality	lesion	T14	T23	note_9150
NonRel	1 . Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD 2 .	Severe NPDR with macular edema OD - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of [s2] MAs [e2] temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	laterality	lesion	T14	T24	note_9150
NonRel	[s1] Severe [e1] NPDR with macular edema OD - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	1 . [s2] Vitreous hemorrhage [e2] OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD 2 .	severity	lesion	T15	T13	note_9150
NonRel	Severe NPDR with macular edema [s1] OD [e1] - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	1 . [s2] Vitreous hemorrhage [e2] OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD 2 .	laterality	lesion	T18	T13	note_9150
NonRel	Severe NPDR with macular edema OD - DBH and MAs in posterior pole - [s1] Small [e1] IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	1 . [s2] Vitreous hemorrhage [e2] OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD 2 .	severity	lesion	T21	T13	note_9150
NonRel	BRVO ( branch retinal vein occlusion ) - Left Eye H34.8392 362.36 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes Here for evaluation of retinal hemorrhages [s1] OS [e1] by Dr Cameron Patient with CKD stage 3 , unsure what caused it but patient reports a ) diabetes and b ) urinary retention from prostate issues as is now on Flomax ( had 2 episoded of sepsis last year , likely secondary to urosepsis ) 1 ) Branch retinal vein occlusion OS - Patient asymptomatic .	Seen by Dr Cameron for glasses Rx . - VA 20 / 20 OS - Exam with a branch retinal vein occlusion inferotemporally , questionable [s2] NVE [e2] in area but unable to confirm with IVFA given his kidney disease .	laterality	lesion	T8	T2	note_702
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	severity	lesion	T1	T6	note_3801
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Moderate nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	severity	lesion	T1	T8	note_3801
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Moderate nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic [s2] retinopathy [e2] .	severity	lesion	T1	T9	note_3801
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	laterality	lesion	T3	T6	note_3801
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Moderate nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	laterality	lesion	T3	T8	note_3801
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Moderate nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic [s2] retinopathy [e2] .	laterality	lesion	T3	T9	note_3801
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	severity	lesion	T5	T2	note_3801
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	severity	lesion	T5	T4	note_3801
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate [s2] NPDR [e2] OU OD - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	severity	lesion	T5	T11	note_3801
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU OD - trace [s2] DME [e2] with trace increase since lv OS - ciCSME with trace interval increase .	severity	lesion	T5	T14	note_3801
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU OD - trace DME with trace increase since lv OS - [s2] ciCSME [e2] with trace interval increase .	severity	lesion	T5	T16	note_3801
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	laterality	lesion	T7	T2	note_3801
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	laterality	lesion	T7	T4	note_3801
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate [s2] NPDR [e2] OU OD - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	laterality	lesion	T7	T11	note_3801
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU OD - trace [s2] DME [e2] with trace increase since lv OS - ciCSME with trace interval increase .	laterality	lesion	T7	T14	note_3801
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU OD - trace DME with trace increase since lv OS - [s2] ciCSME [e2] with trace interval increase .	laterality	lesion	T7	T16	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - [s1] Moderate [e1] NPDR OU OD - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	severity	lesion	T10	T6	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - [s1] Moderate [e1] NPDR OU OD - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	Moderate nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	severity	lesion	T10	T8	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - [s1] Moderate [e1] NPDR OU OD - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	Moderate nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic [s2] retinopathy [e2] .	severity	lesion	T10	T9	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR [s1] OU [e1] OD - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	laterality	lesion	T12	T6	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR [s1] OU [e1] OD - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	Moderate nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	laterality	lesion	T12	T8	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR [s1] OU [e1] OD - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	Moderate nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic [s2] retinopathy [e2] .	laterality	lesion	T12	T9	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU [s1] OD [e1] - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	laterality	lesion	T13	T6	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU [s1] OD [e1] - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	Moderate nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	laterality	lesion	T13	T8	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU [s1] OD [e1] - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	Moderate nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic [s2] retinopathy [e2] .	laterality	lesion	T13	T9	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU OD - trace DME with trace increase since lv [s1] OS [e1] - ciCSME with trace interval increase .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	laterality	lesion	T15	T6	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU OD - trace DME with trace increase since lv [s1] OS [e1] - ciCSME with trace interval increase .	Moderate nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	laterality	lesion	T15	T8	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU OD - trace DME with trace increase since lv [s1] OS [e1] - ciCSME with trace interval increase .	Moderate nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic [s2] retinopathy [e2] .	laterality	lesion	T15	T9	note_3801
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T1	T5	note_7572
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T1	T7	note_7572
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T1	T9	note_7572
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T1	T12	note_7572
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	severity	lesion	T1	T16	note_7572
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	severity	lesion	T1	T17	note_7572
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T3	T5	note_7572
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T3	T7	note_7572
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T3	T9	note_7572
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T3	T12	note_7572
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	laterality	lesion	T3	T16	note_7572
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	laterality	lesion	T3	T17	note_7572
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T6	T2	note_7572
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T6	T4	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - [s1] Severe [e1] NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	severity	lesion	T8	T2	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - [s1] Severe [e1] NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	severity	lesion	T8	T4	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR [s1] OD [e1] , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T10	T2	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR [s1] OD [e1] , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T10	T4	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , [s1] Active [e1] PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	severity	lesion	T11	T2	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , [s1] Active [e1] PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	severity	lesion	T11	T4	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR [s1] OS [e1] Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T13	T2	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR [s1] OS [e1] Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T13	T4	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] [s1] OD [e1] - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T14	T2	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] [s1] OD [e1] - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T14	T4	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - [s1] Severe [e1] NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	severity	lesion	T15	T2	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - [s1] Severe [e1] NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	severity	lesion	T15	T4	note_7572
NonRel	[s1] OS [e1] - PDR now s / p PRP .	Atrophic appearance of macula on mac OCT with interval decrease in [s2] CME [e2] .	laterality	lesion	T19	T25	note_7572
NonRel	NVE along superior arcade demonstrated on IVFA from 12 / 16 then s / p PRP . 2 ) Macular Atrophy OS - + subjective APD , OCT confirms atrophic macula with [s1] mild [e1] CME decreased today on Mac OCT as above .	Atrophic appearance of macula on mac OCT with interval decrease in [s2] CME [e2] .	severity	lesion	T22	T25	note_7572
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] associated with type 2 diabetes mellitus E11.3591 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye associated with type 2 diabetes mellitus E11.3592 250.50 Pan Retinal Photocoagulation - OS - Left Eye 362.02 OPH - OS Intravitreal Injection , Pharmacologic Agent 3 .	laterality	lesion	T8	T9	note_7659
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] associated with type 2 diabetes mellitus E11.3592 250.50 Pan Retinal Photocoagulation - OS - Left Eye 362.02 OPH - OS Intravitreal Injection , Pharmacologic Agent 3 .	[s2] Proliferative diabetic retinopathy [e2] of right eye associated with type 2 diabetes mellitus E11.3591 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 2 .	laterality	lesion	T10	T7	note_7659
NonRel	IDDM , + 81 mg ASA Treatment Hx : IVA OU - 6 / 30 / 17 ( today ) PRP OS - 6 / 30 / 17 ( today ) IVFA ( 6 / 15 / 17 ) : [s1] Active [e1] PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	+ [s2] NVI [e2] .	severity	lesion	T13	T19	note_7659
NonRel	IDDM , + 81 mg ASA Treatment Hx : IVA OU - 6 / 30 / 17 ( today ) PRP OS - 6 / 30 / 17 ( today ) IVFA ( 6 / 15 / 17 ) : Active PDR [s1] OD [e1] , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	+ [s2] NVI [e2] .	laterality	lesion	T15	T19	note_7659
NonRel	IDDM , + 81 mg ASA Treatment Hx : IVA OU - 6 / 30 / 17 ( today ) PRP OS - 6 / 30 / 17 ( today ) IVFA ( 6 / 15 / 17 ) : Active PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - [s1] Active [e1] PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	+ [s2] NVI [e2] .	severity	lesion	T16	T19	note_7659
NonRel	IDDM , + 81 mg ASA Treatment Hx : IVA OU - 6 / 30 / 17 ( today ) PRP OS - 6 / 30 / 17 ( today ) IVFA ( 6 / 15 / 17 ) : Active PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR [s1] OU [e1] ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	+ [s2] NVI [e2] .	laterality	lesion	T18	T19	note_7659
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	severity	lesion	T14	T4	2487564_note_7561
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	severity	lesion	T14	T5	2487564_note_7561
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T14	T8	2487564_note_7561
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T14	T9	2487564_note_7561
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T14	T28	2487564_note_7561
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T14	T30	2487564_note_7561
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	laterality	lesion	T15	T4	2487564_note_7561
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	laterality	lesion	T15	T5	2487564_note_7561
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T15	T8	2487564_note_7561
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T15	T9	2487564_note_7561
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T15	T28	2487564_note_7561
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T15	T30	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - [s1] Severe [e1] NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	severity	lesion	T16	T1	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - [s1] Severe [e1] NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	severity	lesion	T16	T2	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR [s1] OD [e1] , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	laterality	lesion	T17	T1	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR [s1] OD [e1] , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	laterality	lesion	T17	T2	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , [s1] Active [e1] PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	severity	lesion	T18	T1	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , [s1] Active [e1] PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	severity	lesion	T18	T2	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR [s1] OS [e1] Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	laterality	lesion	T19	T1	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR [s1] OS [e1] Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	laterality	lesion	T19	T2	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - [s1] Severe [e1] NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	severity	lesion	T20	T1	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - [s1] Severe [e1] NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	severity	lesion	T20	T2	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] [s1] OD [e1] - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	laterality	lesion	T21	T1	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] [s1] OD [e1] - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	laterality	lesion	T21	T2	2487564_note_7561
NonRel	[s1] OS [e1] - PDR now s / p PRP .	Mild increase in [s2] ME [e2] , but given atrophic appearance will observe .	laterality	lesion	T23	T6	2487564_note_7561
NonRel	[s1] Mild [e1] increase in ME , but given atrophic appearance will observe .	OS - [s2] PDR [e2] now s / p PRP .	severity	lesion	T24	T7	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	laterality	lesion	T29	T1	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	laterality	lesion	T29	T2	2487564_note_7561
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 1 diabetes mellitus - Right Eye E10.3511 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Pan Retinal Photocoagulation - OD - Right Eye OPH - OS Intravitreal Injection , Pharmacologic Agent 2 .	[s2] Diabetic macular edema [e2] of left eye with proliferative retinopathy associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment history : PRP OD [ IVFA - guided ] - DATE ( today ) IVA OS - DATE ( today ) 1 .	laterality	lesion	T15	T6	2542462_note_7938
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 1 diabetes mellitus - Right Eye E10.3511 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Pan Retinal Photocoagulation - OD - Right Eye OPH - OS Intravitreal Injection , Pharmacologic Agent 2 .	Diabetic macular edema of left eye with [s2] proliferative retinopathy [e2] associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment history : PRP OD [ IVFA - guided ] - DATE ( today ) IVA OS - DATE ( today ) 1 .	laterality	lesion	T15	T7	2542462_note_7938
NonRel	Diabetic macular edema of [s1] left eye [e1] with proliferative retinopathy associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment history : PRP OD [ IVFA - guided ] - DATE ( today ) IVA OS - DATE ( today ) 1 .	[s2] Diabetic macular edema [e2] of right eye with proliferative retinopathy associated with type 1 diabetes mellitus - Right Eye E10.3511 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Pan Retinal Photocoagulation - OD - Right Eye OPH - OS Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T16	T4	2542462_note_7938
NonRel	Diabetic macular edema of [s1] left eye [e1] with proliferative retinopathy associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment history : PRP OD [ IVFA - guided ] - DATE ( today ) IVA OS - DATE ( today ) 1 .	Diabetic macular edema of right eye with [s2] proliferative retinopathy [e2] associated with type 1 diabetes mellitus - Right Eye E10.3511 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Pan Retinal Photocoagulation - OD - Right Eye OPH - OS Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T16	T5	2542462_note_7938
NonRel	Diabetic macular edema of [s1] left eye [e1] with proliferative retinopathy associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment history : PRP OD [ IVFA - guided ] - DATE ( today ) IVA OS - DATE ( today ) 1 .	IDDM ( Type I ) - Active [s2] PDR [e2] OU . ( DM duration 30 years .	laterality	lesion	T16	T8	2542462_note_7938
NonRel	IDDM ( Type I ) - [s1] Active [e1] PDR OU . ( DM duration 30 years .	[s2] Diabetic macular edema [e2] of left eye with proliferative retinopathy associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment history : PRP OD [ IVFA - guided ] - DATE ( today ) IVA OS - DATE ( today ) 1 .	severity	lesion	T17	T6	2542462_note_7938
NonRel	IDDM ( Type I ) - [s1] Active [e1] PDR OU . ( DM duration 30 years .	Diabetic macular edema of left eye with [s2] proliferative retinopathy [e2] associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment history : PRP OD [ IVFA - guided ] - DATE ( today ) IVA OS - DATE ( today ) 1 .	severity	lesion	T17	T7	2542462_note_7938
NonRel	IDDM ( Type I ) - [s1] Active [e1] PDR OU . ( DM duration 30 years .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active [s2] PDR [e2] without CSME ( + DME ) on exam .	severity	lesion	T17	T9	2542462_note_7938
NonRel	IDDM ( Type I ) - [s1] Active [e1] PDR OU . ( DM duration 30 years .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active PDR without [s2] CSME [e2] ( + DME ) on exam .	severity	lesion	T17	T10	2542462_note_7938
NonRel	IDDM ( Type I ) - [s1] Active [e1] PDR OU . ( DM duration 30 years .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active PDR without CSME ( + [s2] DME [e2] ) on exam .	severity	lesion	T17	T11	2542462_note_7938
NonRel	IDDM ( Type I ) - Active PDR [s1] OU [e1] . ( DM duration 30 years .	[s2] Diabetic macular edema [e2] of left eye with proliferative retinopathy associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment history : PRP OD [ IVFA - guided ] - DATE ( today ) IVA OS - DATE ( today ) 1 .	laterality	lesion	T18	T6	2542462_note_7938
NonRel	IDDM ( Type I ) - Active PDR [s1] OU [e1] . ( DM duration 30 years .	Diabetic macular edema of left eye with [s2] proliferative retinopathy [e2] associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment history : PRP OD [ IVFA - guided ] - DATE ( today ) IVA OS - DATE ( today ) 1 .	laterality	lesion	T18	T7	2542462_note_7938
NonRel	IDDM ( Type I ) - Active PDR [s1] OU [e1] . ( DM duration 30 years .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active [s2] PDR [e2] without CSME ( + DME ) on exam .	laterality	lesion	T18	T9	2542462_note_7938
NonRel	IDDM ( Type I ) - Active PDR [s1] OU [e1] . ( DM duration 30 years .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active PDR without [s2] CSME [e2] ( + DME ) on exam .	laterality	lesion	T18	T10	2542462_note_7938
NonRel	IDDM ( Type I ) - Active PDR [s1] OU [e1] . ( DM duration 30 years .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active PDR without CSME ( + [s2] DME [e2] ) on exam .	laterality	lesion	T18	T11	2542462_note_7938
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) [s1] OD [e1] - Active PDR without CSME ( + DME ) on exam .	IDDM ( Type I ) - Active [s2] PDR [e2] OU . ( DM duration 30 years .	laterality	lesion	T19	T8	2542462_note_7938
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) [s1] OD [e1] - Active PDR without CSME ( + DME ) on exam .	OS - Active [s2] PDR [e2] with sub - hyaloid hemorrhage .	laterality	lesion	T19	T12	2542462_note_7938
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) [s1] OD [e1] - Active PDR without CSME ( + DME ) on exam .	OS - Active PDR with [s2] sub - hyaloid hemorrhage [e2] .	laterality	lesion	T19	T33	2542462_note_7938
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - [s1] Active [e1] PDR without CSME ( + DME ) on exam .	IDDM ( Type I ) - Active [s2] PDR [e2] OU . ( DM duration 30 years .	severity	lesion	T20	T8	2542462_note_7938
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - [s1] Active [e1] PDR without CSME ( + DME ) on exam .	OS - Active [s2] PDR [e2] with sub - hyaloid hemorrhage .	severity	lesion	T20	T12	2542462_note_7938
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - [s1] Active [e1] PDR without CSME ( + DME ) on exam .	OS - Active PDR with [s2] sub - hyaloid hemorrhage [e2] .	severity	lesion	T20	T33	2542462_note_7938
NonRel	OS - [s1] Active [e1] PDR with sub - hyaloid hemorrhage .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active [s2] PDR [e2] without CSME ( + DME ) on exam .	severity	lesion	T21	T9	2542462_note_7938
NonRel	OS - [s1] Active [e1] PDR with sub - hyaloid hemorrhage .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active PDR without [s2] CSME [e2] ( + DME ) on exam .	severity	lesion	T21	T10	2542462_note_7938
NonRel	OS - [s1] Active [e1] PDR with sub - hyaloid hemorrhage .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active PDR without CSME ( + [s2] DME [e2] ) on exam .	severity	lesion	T21	T11	2542462_note_7938
NonRel	OS - [s1] Active [e1] PDR with sub - hyaloid hemorrhage .	Mild temporal [s2] macular edema [e2] . Treat with IVA concurrently today .	severity	lesion	T21	T13	2542462_note_7938
NonRel	[s1] OS [e1] - Active PDR with sub - hyaloid hemorrhage .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active [s2] PDR [e2] without CSME ( + DME ) on exam .	laterality	lesion	T22	T9	2542462_note_7938
NonRel	[s1] OS [e1] - Active PDR with sub - hyaloid hemorrhage .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active PDR without [s2] CSME [e2] ( + DME ) on exam .	laterality	lesion	T22	T10	2542462_note_7938
NonRel	[s1] OS [e1] - Active PDR with sub - hyaloid hemorrhage .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active PDR without CSME ( + [s2] DME [e2] ) on exam .	laterality	lesion	T22	T11	2542462_note_7938
NonRel	[s1] OS [e1] - Active PDR with sub - hyaloid hemorrhage .	Mild temporal [s2] macular edema [e2] . Treat with IVA concurrently today .	laterality	lesion	T22	T13	2542462_note_7938
NonRel	[s1] Mild [e1] temporal macular edema . Treat with IVA concurrently today .	OS - Active [s2] PDR [e2] with sub - hyaloid hemorrhage .	severity	lesion	T23	T12	2542462_note_7938
NonRel	[s1] Mild [e1] temporal macular edema . Treat with IVA concurrently today .	OS - Active PDR with [s2] sub - hyaloid hemorrhage [e2] .	severity	lesion	T23	T33	2542462_note_7938
NonRel	Mild [s1] temporal [e1] macular edema . Treat with IVA concurrently today .	OS - Active [s2] PDR [e2] with sub - hyaloid hemorrhage .	severity	lesion	T24	T12	2542462_note_7938
NonRel	Mild [s1] temporal [e1] macular edema . Treat with IVA concurrently today .	OS - Active PDR with [s2] sub - hyaloid hemorrhage [e2] .	severity	lesion	T24	T33	2542462_note_7938
NonRel	S / P 25 g PPV / ML / SDEM / EL / AFx OD 4 / 3 / 17 Z98.890 V45.69 OCT , Posterior Segment - OU - Both Eyes Treatment History PPV / TRD / AFx OD - 4 / 3 / 17 IVA OD ( preop ) - 3 / 31 / 17 PRP OS ( IVFA guided ) - 3 / 31 / 17 IVFA ( 3 / 28 / 2017 ) - [s1] Active [e1] PDR OU 1 .	DMII - Active [s2] PDR [e2] OU .	severity	lesion	T1	T5	note_1196
NonRel	S / P 25 g PPV / ML / SDEM / EL / AFx OD 4 / 3 / 17 Z98.890 V45.69 OCT , Posterior Segment - OU - Both Eyes Treatment History PPV / TRD / AFx OD - 4 / 3 / 17 IVA OD ( preop ) - 3 / 31 / 17 PRP OS ( IVFA guided ) - 3 / 31 / 17 IVFA ( 3 / 28 / 2017 ) - Active PDR [s1] OU [e1] 1 .	DMII - Active [s2] PDR [e2] OU .	laterality	lesion	T3	T5	note_1196
NonRel	DMII - [s1] Active [e1] PDR OU .	S / P 25 g PPV / ML / SDEM / EL / AFx OD 4 / 3 / 17 Z98.890 V45.69 OCT , Posterior Segment - OU - Both Eyes Treatment History PPV / TRD / AFx OD - 4 / 3 / 17 IVA OD ( preop ) - 3 / 31 / 17 PRP OS ( IVFA guided ) - 3 / 31 / 17 IVFA ( 3 / 28 / 2017 ) - Active [s2] PDR [e2] OU 1 .	severity	lesion	T4	T2	note_1196
NonRel	DMII - Active PDR [s1] OU [e1] .	S / P 25 g PPV / ML / SDEM / EL / AFx OD 4 / 3 / 17 Z98.890 V45.69 OCT , Posterior Segment - OU - Both Eyes Treatment History PPV / TRD / AFx OD - 4 / 3 / 17 IVA OD ( preop ) - 3 / 31 / 17 PRP OS ( IVFA guided ) - 3 / 31 / 17 IVFA ( 3 / 28 / 2017 ) - Active [s2] PDR [e2] OU 1 .	laterality	lesion	T6	T2	note_1196
NonRel	She has proliferative diabetic retinopathy s / p panretinal photocoagulation ( PRP ) [s1] OU [e1] ( x 1 ; x 2 ) , both eyes ( Bangladesh ) , and s / p IVL OS ( 4 months ago in Bangladesh ) .	The [s2] neovascularization [e2] ( 2 ) is persistent , increasing , or a new area is now present on the retina or iris requiring further PRP treatments OS .	laterality	lesion	T6	T3	2555907_note_7978
NonRel	The neovascularization ( 2 ) is persistent , increasing , or a new area is now present on the retina or iris requiring further PRP treatments [s1] OS [e1] .	She has [s2] proliferative diabetic retinopathy [e2] s / p panretinal photocoagulation ( PRP ) OU ( x 1 ; x 2 ) , both eyes ( Bangladesh ) , and s / p IVL OS ( 4 months ago in Bangladesh ) .	laterality	lesion	T7	T2	2555907_note_7978
NonRel	OCT , Posterior Segment - OU - Both Eyes SD - OCT macula : chronic TRD with MH OD ; juxtafoveal mild DME [s1] OS [e1] Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	[s2] Proliferative diabetic retinopathy [e2] of both eyes - Both Eyes E11.3593 250.50 Appt req Opthalmology 362.02 2 .	laterality	lesion	T11	T13	2555907_note_7978
NonRel	OCT , Posterior Segment - OU - Both Eyes SD - OCT macula : chronic TRD with MH OD ; juxtafoveal [s1] mild [e1] DME OS Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	[s2] Proliferative diabetic retinopathy [e2] of both eyes - Both Eyes E11.3593 250.50 Appt req Opthalmology 362.02 2 .	severity	lesion	T12	T13	2555907_note_7978
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] - Both Eyes E11.3593 250.50 Appt req Opthalmology 362.02 2 .	OCT , Posterior Segment - OU - Both Eyes SD - OCT macula : chronic TRD with MH OD ; juxtafoveal mild [s2] DME [e2] OS Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T14	T10	2555907_note_7978
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 New retina patient here today for evaluation .	severity	lesion	T1	T6	note_3786
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.05 2 .	Moderate nonproliferative diabetic retinopathy of right eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3391 250.50 362.05 New retina patient here today for evaluation .	severity	lesion	T1	T8	note_3786
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 New retina patient here today for evaluation .	laterality	lesion	T3	T6	note_3786
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.05 2 .	Moderate nonproliferative diabetic retinopathy of right eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3391 250.50 362.05 New retina patient here today for evaluation .	laterality	lesion	T3	T8	note_3786
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 New retina patient here today for evaluation .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.05 2 .	severity	lesion	T5	T2	note_3786
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 New retina patient here today for evaluation .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.05 2 .	severity	lesion	T5	T4	note_3786
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 New retina patient here today for evaluation .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.05 2 .	laterality	lesion	T7	T2	note_3786
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 New retina patient here today for evaluation .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.05 2 .	laterality	lesion	T7	T4	note_3786
NonRel	Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - [s1] Moderate [e1] NPDR OU .	Mild [s2] DME [e2] .	severity	lesion	T10	T14	note_3786
NonRel	Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR [s1] OU [e1] .	Mild [s2] DME [e2] .	laterality	lesion	T12	T14	note_3786
NonRel	[s1] Mild [e1] DME .	Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate [s2] NPDR [e2] OU .	severity	lesion	T13	T11	note_3786
NonRel	Moderate [s1] nonproliferative diabetic retinopathy [e1] without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	OCT , Posterior Segment - OU - Both Eyes OD : CSME , exudates OS : IRF with extension into [s2] fovea [e2] , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T5	T8	1036182_note_1786
NonRel	Moderate nonproliferative diabetic retinopathy without [s1] macular edema [e1] associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	OCT , Posterior Segment - OU - Both Eyes OD : CSME , exudates OS : IRF with extension into [s2] fovea [e2] , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T6	T8	1036182_note_1786
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	OCT , Posterior Segment - OU - Both Eyes OD : [s2] CSME [e2] , exudates OS : IRF with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	severity	lesion	T17	T1	1036182_note_1786
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	OCT , Posterior Segment - OU - Both Eyes OD : CSME , [s2] exudates [e2] OS : IRF with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	severity	lesion	T17	T2	1036182_note_1786
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	OCT , Posterior Segment - OU - Both Eyes OD : CSME , exudates OS : [s2] IRF [e2] with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	severity	lesion	T17	T3	1036182_note_1786
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	OCT , Posterior Segment - OU - Both Eyes OD : CSME , exudates OS : IRF with extension into fovea , [s2] exudates [e2] Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	severity	lesion	T17	T4	1036182_note_1786
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	[s2] Diabetic macular edema [e2] not clinically significant - Both Eyes E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 3 .	severity	lesion	T17	T7	1036182_note_1786
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - [s1] Both Eyes [e1] E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	OCT , Posterior Segment - OU - Both Eyes OD : [s2] CSME [e2] , exudates OS : IRF with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T18	T1	1036182_note_1786
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - [s1] Both Eyes [e1] E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	OCT , Posterior Segment - OU - Both Eyes OD : CSME , [s2] exudates [e2] OS : IRF with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T18	T2	1036182_note_1786
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - [s1] Both Eyes [e1] E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	OCT , Posterior Segment - OU - Both Eyes OD : CSME , exudates OS : [s2] IRF [e2] with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T18	T3	1036182_note_1786
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - [s1] Both Eyes [e1] E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	OCT , Posterior Segment - OU - Both Eyes OD : CSME , exudates OS : IRF with extension into fovea , [s2] exudates [e2] Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T18	T4	1036182_note_1786
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - [s1] Both Eyes [e1] E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	[s2] Diabetic macular edema [e2] not clinically significant - Both Eyes E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 3 .	laterality	lesion	T18	T7	1036182_note_1786
NonRel	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR OU OD - [s1] Severe [e1] NPDR with ciCSME .	Mild / stable [s2] IRF [e2] with 20 / 80 vision , although some of decreased vision likely from cataract .	severity	lesion	T19	T13	1036182_note_1786
NonRel	OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : CSME , exudates OS : IRF with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	laterality	lesion	T20	T5	1036182_note_1786
NonRel	OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : CSME , exudates OS : IRF with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Moderate nonproliferative diabetic retinopathy without [s2] macular edema [e2] associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	laterality	lesion	T20	T6	1036182_note_1786
NonRel	Diabetic macular edema [s1] not clinically significant [e1] - Both Eyes E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 3 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	severity	lesion	T21	T5	1036182_note_1786
NonRel	Diabetic macular edema [s1] not clinically significant [e1] - Both Eyes E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 3 .	Moderate nonproliferative diabetic retinopathy without [s2] macular edema [e2] associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	severity	lesion	T21	T6	1036182_note_1786
NonRel	Diabetic macular edema not clinically significant - [s1] Both Eyes [e1] E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 3 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	laterality	lesion	T22	T5	1036182_note_1786
NonRel	Diabetic macular edema not clinically significant - [s1] Both Eyes [e1] E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 3 .	Moderate nonproliferative diabetic retinopathy without [s2] macular edema [e2] associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	laterality	lesion	T22	T6	1036182_note_1786
NonRel	Treatment Hx : IVFA ( DATE ) - [s1] Severe [e1] NPDR OU 1 ) NPDR OU OD - Severe NPDR with ciCSME .	Mild / stable [s2] IRF [e2] with 20 / 80 vision , although some of decreased vision likely from cataract .	severity	lesion	T23	T13	1036182_note_1786
NonRel	Treatment Hx : IVFA ( DATE ) - Severe NPDR [s1] OU [e1] 1 ) NPDR OU OD - Severe NPDR with ciCSME .	Mild / stable [s2] IRF [e2] with 20 / 80 vision , although some of decreased vision likely from cataract .	laterality	lesion	T24	T13	1036182_note_1786
NonRel	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR [s1] OU [e1] OD - Severe NPDR with ciCSME .	Mild / stable [s2] IRF [e2] with 20 / 80 vision , although some of decreased vision likely from cataract .	laterality	lesion	T25	T13	1036182_note_1786
NonRel	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR OU [s1] OD [e1] - Severe NPDR with ciCSME .	Mild / stable [s2] IRF [e2] with 20 / 80 vision , although some of decreased vision likely from cataract .	laterality	lesion	T26	T13	1036182_note_1786
NonRel	[s1] Mild / stable [e1] IRF with 20 / 80 vision , although some of decreased vision likely from cataract .	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) [s2] NPDR [e2] OU OD - Severe NPDR with ciCSME .	severity	lesion	T27	T9	1036182_note_1786
NonRel	[s1] Mild / stable [e1] IRF with 20 / 80 vision , although some of decreased vision likely from cataract .	Treatment Hx : IVFA ( DATE ) - Severe [s2] NPDR [e2] OU 1 ) NPDR OU OD - Severe NPDR with ciCSME .	severity	lesion	T27	T10	1036182_note_1786
NonRel	[s1] Mild / stable [e1] IRF with 20 / 80 vision , although some of decreased vision likely from cataract .	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR OU OD - Severe [s2] NPDR [e2] with ciCSME .	severity	lesion	T27	T11	1036182_note_1786
NonRel	[s1] Mild / stable [e1] IRF with 20 / 80 vision , although some of decreased vision likely from cataract .	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR OU OD - Severe NPDR with [s2] ciCSME [e2] .	severity	lesion	T27	T12	1036182_note_1786
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : CSME , exudates [s1] OS [e1] : IRF with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	laterality	lesion	T30	T5	1036182_note_1786
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : CSME , exudates [s1] OS [e1] : IRF with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Moderate nonproliferative diabetic retinopathy without [s2] macular edema [e2] associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	laterality	lesion	T30	T6	1036182_note_1786
NonRel	[s1] Proliferative diabetic retinopathy [e1] associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in [s2] posterior pole [e2] , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T10	T2	2482683_note_7206
NonRel	[s1] Proliferative diabetic retinopathy [e1] associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , [s2] preretinal [e2] hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T10	T4	2482683_note_7206
NonRel	[s1] Proliferative diabetic retinopathy [e1] associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in [s2] posterior pole [e2] , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T10	T7	2482683_note_7206
NonRel	[s1] Proliferative diabetic retinopathy [e1] associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , [s2] preretinal [e2] hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T10	T8	2482683_note_7206
NonRel	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , [s1] macular edema presence [e1] unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in [s2] posterior pole [e2] , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T11	T2	2482683_note_7206
NonRel	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , [s1] macular edema presence [e1] unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , [s2] preretinal [e2] hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T11	T4	2482683_note_7206
NonRel	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , [s1] macular edema presence [e1] unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in [s2] posterior pole [e2] , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T11	T7	2482683_note_7206
NonRel	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , [s1] macular edema presence [e1] unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , [s2] preretinal [e2] hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T11	T8	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA [s1] OD [e1] : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	[s2] Proliferative diabetic retinopathy [e2] associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	laterality	lesion	T13	T10	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA [s1] OD [e1] : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , [s2] macular edema presence [e2] unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	laterality	lesion	T13	T11	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , [s1] extensive [e1] neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	[s2] Proliferative diabetic retinopathy [e2] associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	severity	lesion	T14	T10	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , [s1] extensive [e1] neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , [s2] macular edema presence [e2] unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	severity	lesion	T14	T11	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit [s1] OS [e1] : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	[s2] Proliferative diabetic retinopathy [e2] associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	laterality	lesion	T15	T10	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit [s1] OS [e1] : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , [s2] macular edema presence [e2] unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	laterality	lesion	T15	T11	2482683_note_7206
NonRel	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive [s2] neovascularization [e2] and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T16	T1	2482683_note_7206
NonRel	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive [s2] neovascularization [e2] in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T16	T3	2482683_note_7206
NonRel	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal [s2] hemorrhage [e2] Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T16	T5	2482683_note_7206
NonRel	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive [s2] neovascularization [e2] in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T16	T6	2482683_note_7206
NonRel	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal [s2] hemorrhage [e2] BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T16	T9	2482683_note_7206
NonRel	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	TRD ( traction retinal detachment ) , bilateral H33.43 361.81 OCT , Posterior Segment - OU - Both Eyes Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye Severe [s2] proliferative diabetic retinopathy [e2] with bilateral tabletop tractional retinal detachments OU - Pt with rapid progression of TRD and vision loss over last few months - Recent diagnosis with diabetes with recent A1c reported 12 ( glucose meter 254 in ED last night ) and BUN / Cr 14 / 0.84 - Pt is a minister that travels frequently for work ; discussed that he will not be able to travel by air during the course of treatment and that he will need to reschedule work arrangements Counseling : Discussed extensive , severe disease OD > OS with extremely guarded visual prognosis .	laterality	lesion	T16	T12	2482683_note_7206
NonRel	TRD ( traction retinal detachment ) , bilateral H33.43 361.81 OCT , Posterior Segment - OU - Both Eyes Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye [s1] Severe [e1] proliferative diabetic retinopathy with bilateral tabletop tractional retinal detachments OU - Pt with rapid progression of TRD and vision loss over last few months - Recent diagnosis with diabetes with recent A1c reported 12 ( glucose meter 254 in ED last night ) and BUN / Cr 14 / 0.84 - Pt is a minister that travels frequently for work ; discussed that he will not be able to travel by air during the course of treatment and that he will need to reschedule work arrangements Counseling : Discussed extensive , severe disease OD > OS with extremely guarded visual prognosis .	[s2] Proliferative diabetic retinopathy [e2] associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	severity	lesion	T17	T10	2482683_note_7206
NonRel	TRD ( traction retinal detachment ) , bilateral H33.43 361.81 OCT , Posterior Segment - OU - Both Eyes Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye [s1] Severe [e1] proliferative diabetic retinopathy with bilateral tabletop tractional retinal detachments OU - Pt with rapid progression of TRD and vision loss over last few months - Recent diagnosis with diabetes with recent A1c reported 12 ( glucose meter 254 in ED last night ) and BUN / Cr 14 / 0.84 - Pt is a minister that travels frequently for work ; discussed that he will not be able to travel by air during the course of treatment and that he will need to reschedule work arrangements Counseling : Discussed extensive , severe disease OD > OS with extremely guarded visual prognosis .	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , [s2] macular edema presence [e2] unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	severity	lesion	T17	T11	2482683_note_7206
NonRel	TRD ( traction retinal detachment ) , bilateral H33.43 361.81 OCT , Posterior Segment - OU - Both Eyes Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - [s1] Left Eye [e1] Severe proliferative diabetic retinopathy with bilateral tabletop tractional retinal detachments OU - Pt with rapid progression of TRD and vision loss over last few months - Recent diagnosis with diabetes with recent A1c reported 12 ( glucose meter 254 in ED last night ) and BUN / Cr 14 / 0.84 - Pt is a minister that travels frequently for work ; discussed that he will not be able to travel by air during the course of treatment and that he will need to reschedule work arrangements Counseling : Discussed extensive , severe disease OD > OS with extremely guarded visual prognosis .	[s2] Proliferative diabetic retinopathy [e2] associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	laterality	lesion	T18	T10	2482683_note_7206
NonRel	TRD ( traction retinal detachment ) , bilateral H33.43 361.81 OCT , Posterior Segment - OU - Both Eyes Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - [s1] Left Eye [e1] Severe proliferative diabetic retinopathy with bilateral tabletop tractional retinal detachments OU - Pt with rapid progression of TRD and vision loss over last few months - Recent diagnosis with diabetes with recent A1c reported 12 ( glucose meter 254 in ED last night ) and BUN / Cr 14 / 0.84 - Pt is a minister that travels frequently for work ; discussed that he will not be able to travel by air during the course of treatment and that he will need to reschedule work arrangements Counseling : Discussed extensive , severe disease OD > OS with extremely guarded visual prognosis .	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , [s2] macular edema presence [e2] unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	laterality	lesion	T18	T11	2482683_note_7206
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T13	T5	2512733_note_7749
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T13	T6	2512733_note_7749
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	severity	lesion	T13	T7	2512733_note_7749
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	severity	lesion	T13	T8	2512733_note_7749
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	severity	lesion	T13	T9	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T14	T5	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T14	T6	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	laterality	lesion	T14	T7	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	laterality	lesion	T14	T8	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	laterality	lesion	T14	T9	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T15	T5	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T15	T6	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	severity	lesion	T15	T7	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	severity	lesion	T15	T8	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	severity	lesion	T15	T9	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T16	T5	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T16	T6	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	laterality	lesion	T16	T7	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	laterality	lesion	T16	T8	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	laterality	lesion	T16	T9	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T17	T5	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T17	T6	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	laterality	lesion	T17	T7	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	laterality	lesion	T17	T8	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	laterality	lesion	T17	T9	2512733_note_7749
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T18	T1	2512733_note_7749
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T18	T2	2512733_note_7749
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T18	T3	2512733_note_7749
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T18	T4	2512733_note_7749
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T18	T27	2512733_note_7749
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T19	T1	2512733_note_7749
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T19	T2	2512733_note_7749
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T19	T3	2512733_note_7749
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T19	T4	2512733_note_7749
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T19	T27	2512733_note_7749
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T20	T1	2512733_note_7749
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T20	T2	2512733_note_7749
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T20	T3	2512733_note_7749
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T20	T4	2512733_note_7749
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T20	T27	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T21	T1	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T21	T2	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T21	T3	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T21	T4	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T21	T27	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T22	T1	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T22	T2	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T22	T3	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T22	T4	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T22	T27	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T23	T1	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T23	T2	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T23	T3	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T23	T4	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T23	T27	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T28	T5	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T28	T6	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	severity	lesion	T28	T7	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	severity	lesion	T28	T8	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	severity	lesion	T28	T9	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T29	T5	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T29	T6	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	laterality	lesion	T29	T7	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	laterality	lesion	T29	T8	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	laterality	lesion	T29	T9	2512733_note_7749
NonRel	2 ) LD OS - temporally with PVD present but given the hx of HST + SRF [s1] OD [e1] will likely consider laser prophylaxis OS at later date .	Today will enhance ( still with [s2] VH [e2] ) and recheck in 6 weeks .	laterality	lesion	T1	T5	note_1744
NonRel	Review of Systems : Heart problems : no complaints Respiratory problems : no complaints General problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 40 + 2 20 / 70 + 2 Method : Snellen - Linear Tonometry Right Left Pressure 15 16 Method : Tonopen Time : 3 : 37 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 38 PM Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Posterior subcapsular cataract Posterior subcapsular cataract Other testing : Macular OCT [s1] OD [e1] : dme OS : dme Assessment and Plan : 1 .	DM Eye Manif Type II : H / o [s2] PDR [e2] ( OU ) S / p Laser and injections both eyes ( 250.50 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 2 .	laterality	lesion	T9	T13	note_4421
NonRel	Review of Systems : Heart problems : no complaints Respiratory problems : no complaints General problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 40 + 2 20 / 70 + 2 Method : Snellen - Linear Tonometry Right Left Pressure 15 16 Method : Tonopen Time : 3 : 37 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 38 PM Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Posterior subcapsular cataract Posterior subcapsular cataract Other testing : Macular OCT OD : dme [s1] OS [e1] : dme Assessment and Plan : 1 .	DM Eye Manif Type II : H / o [s2] PDR [e2] ( OU ) S / p Laser and injections both eyes ( 250.50 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 2 .	laterality	lesion	T11	T13	note_4421
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy ( 362.05 ) PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 3 .	DM Eye Manif Type II : H / o [s2] PDR [e2] ( OU ) S / p Laser and injections both eyes ( 250.50 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 2 .	severity	lesion	T14	T13	note_4421
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy ( 362.05 ) PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 3 .	[s2] Diabetic macular edema [e2] ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic DME OU , more focal OD , diffuse OS , refractory to avastin .	severity	lesion	T14	T16	note_4421
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy ( 362.05 ) PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 3 .	Diabetic macular edema ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic [s2] DME [e2] OU , more focal OD , diffuse OS , refractory to avastin .	severity	lesion	T14	T17	note_4421
NonRel	Diabetic macular edema ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic DME [s1] OU [e1] , more focal OD , diffuse OS , refractory to avastin .	Moderate [s2] nonproliferative diabetic retinopathy [e2] ( 362.05 ) PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 3 .	laterality	lesion	T18	T15	note_4421
NonRel	Diabetic macular edema ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic DME [s1] OU [e1] , more focal OD , diffuse OS , refractory to avastin .	2 ) [s2] PDR [e2] - inactive , good prp Repeat IVA OU done today .	laterality	lesion	T18	T21	note_4421
NonRel	Diabetic macular edema ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic DME OU , more focal [s1] OD [e1] , diffuse OS , refractory to avastin .	Moderate [s2] nonproliferative diabetic retinopathy [e2] ( 362.05 ) PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 3 .	laterality	lesion	T19	T15	note_4421
NonRel	Diabetic macular edema ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic DME OU , more focal [s1] OD [e1] , diffuse OS , refractory to avastin .	2 ) [s2] PDR [e2] - inactive , good prp Repeat IVA OU done today .	laterality	lesion	T19	T21	note_4421
NonRel	Diabetic macular edema ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic DME OU , more focal OD , diffuse [s1] OS [e1] , refractory to avastin .	Moderate [s2] nonproliferative diabetic retinopathy [e2] ( 362.05 ) PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 3 .	laterality	lesion	T20	T15	note_4421
NonRel	Diabetic macular edema ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic DME OU , more focal OD , diffuse [s1] OS [e1] , refractory to avastin .	2 ) [s2] PDR [e2] - inactive , good prp Repeat IVA OU done today .	laterality	lesion	T20	T21	note_4421
NonRel	2 ) PDR - inactive , good prp Repeat IVA [s1] OU [e1] done today .	[s2] Diabetic macular edema [e2] ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic DME OU , more focal OD , diffuse OS , refractory to avastin .	laterality	lesion	T26	T16	note_4421
NonRel	2 ) PDR - inactive , good prp Repeat IVA [s1] OU [e1] done today .	Diabetic macular edema ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic [s2] DME [e2] OU , more focal OD , diffuse OS , refractory to avastin .	laterality	lesion	T26	T17	note_4421
NonRel	Treatment Hx IVFA - PRP and focal laser scars with [s1] active [e1] NVE OU .	Diabetes mellitus due to underlying condition with chronic kidney disease on chronic dialysis , with long - term current use of insulin E08 . 22 249.40 N18.6 585.9 Z79.4 V45.11 Z99.2 V58.67 Mr. Caine is a 72 year old male with a h / o PDR OU s / p PRP OU Referred from Dr. Grieser for evaluation of possible [s2] NVE [e2] seen clinically .	severity	lesion	T9	T3	note_439
NonRel	Treatment Hx IVFA - PRP and focal laser scars with [s1] active [e1] NVE OU .	Diabetes mellitus due to underlying condition with chronic kidney disease on chronic dialysis , with long - term current use of insulin E08 . 22 249.40 N18.6 585.9 Z79.4 V45.11 Z99.2 V58.67 Mr. Caine is a 72 year old male with a h / o [s2] PDR [e2] OU s / p PRP OU Referred from Dr. Grieser for evaluation of possible NVE seen clinically .	severity	lesion	T9	T18	note_439
NonRel	Treatment Hx IVFA - PRP and focal laser scars with active NVE [s1] OU [e1] .	Diabetes mellitus due to underlying condition with chronic kidney disease on chronic dialysis , with long - term current use of insulin E08 . 22 249.40 N18.6 585.9 Z79.4 V45.11 Z99.2 V58.67 Mr. Caine is a 72 year old male with a h / o PDR OU s / p PRP OU Referred from Dr. Grieser for evaluation of possible [s2] NVE [e2] seen clinically .	laterality	lesion	T10	T3	note_439
NonRel	Treatment Hx IVFA - PRP and focal laser scars with active NVE [s1] OU [e1] .	Diabetes mellitus due to underlying condition with chronic kidney disease on chronic dialysis , with long - term current use of insulin E08 . 22 249.40 N18.6 585.9 Z79.4 V45.11 Z99.2 V58.67 Mr. Caine is a 72 year old male with a h / o [s2] PDR [e2] OU s / p PRP OU Referred from Dr. Grieser for evaluation of possible NVE seen clinically .	laterality	lesion	T10	T18	note_439
NonRel	Diabetes mellitus due to underlying condition with chronic kidney disease on chronic dialysis , with long - term current use of insulin E08 . 22 249.40 N18.6 585.9 Z79.4 V45.11 Z99.2 V58.67 Mr. Caine is a 72 year old male with a h / o PDR OU s / p PRP OU Referred from Dr. Grieser for evaluation of [s1] possible [e1] NVE seen clinically .	Treatment Hx IVFA - PRP and focal laser scars with active [s2] NVE [e2] OU .	severity	lesion	T11	T4	note_439
NonRel	Today with active + NVE [s1] OU [e1] demonstrated on IVFA .	OD - Mild [s2] NVE [e2] in mid - periphery , but well - lasered .	laterality	lesion	T12	T6	note_439
NonRel	Today with [s1] active [e1] + NVE OU demonstrated on IVFA .	OD - Mild [s2] NVE [e2] in mid - periphery , but well - lasered .	severity	lesion	T13	T6	note_439
NonRel	OD - [s1] Mild [e1] NVE in mid - periphery , but well - lasered .	Today with active + [s2] NVE [e2] OU demonstrated on IVFA .	severity	lesion	T14	T5	note_439
NonRel	OD - [s1] Mild [e1] NVE in mid - periphery , but well - lasered .	S / P Focal OS - Mild [s2] NVE [e2] in mid periphery .	severity	lesion	T14	T7	note_439
NonRel	[s1] OD [e1] - Mild NVE in mid - periphery , but well - lasered .	Today with active + [s2] NVE [e2] OU demonstrated on IVFA .	laterality	lesion	T15	T5	note_439
NonRel	[s1] OD [e1] - Mild NVE in mid - periphery , but well - lasered .	S / P Focal OS - Mild [s2] NVE [e2] in mid periphery .	laterality	lesion	T15	T7	note_439
NonRel	S / P Focal OS - [s1] Mild [e1] NVE in mid periphery .	OD - Mild [s2] NVE [e2] in mid - periphery , but well - lasered .	severity	lesion	T16	T6	note_439
NonRel	S / P Focal [s1] OS [e1] - Mild NVE in mid periphery .	OD - Mild [s2] NVE [e2] in mid - periphery , but well - lasered .	laterality	lesion	T17	T6	note_439
NonRel	Diabetes mellitus due to underlying condition with chronic kidney disease on chronic dialysis , with long - term current use of insulin E08 . 22 249.40 N18.6 585.9 Z79.4 V45.11 Z99.2 V58.67 Mr. Caine is a 72 year old male with a h / o PDR [s1] OU [e1] s / p PRP OU Referred from Dr. Grieser for evaluation of possible NVE seen clinically .	Treatment Hx IVFA - PRP and focal laser scars with active [s2] NVE [e2] OU .	laterality	lesion	T19	T4	note_439
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - [s1] OD [e1] - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No [s2] NVI [e2] or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T15	T5	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - [s1] OD [e1] - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or [s2] NVD [e2] or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T15	T6	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - [s1] OD [e1] - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or [s2] NVA [e2] Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T15	T7	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - [s1] OD [e1] - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without [s2] Edema [e2] , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T15	T8	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - [s1] OD [e1] - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms [s2] NVE [e2] temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T15	T9	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - [s1] OD [e1] - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No [s2] Neovascularization [e2] .	laterality	lesion	T15	T10	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	No [s2] NVI [e2] or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T16	T5	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	No NVI or [s2] NVD [e2] or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T16	T6	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	No NVI or NVD or [s2] NVA [e2] Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T16	T7	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	No NVI or NVD or NVA Mac OCT without [s2] Edema [e2] , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T16	T8	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms [s2] NVE [e2] temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T16	T9	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No [s2] Neovascularization [e2] .	severity	lesion	T16	T10	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) [s1] OD [e1] : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No [s2] NVI [e2] or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T17	T5	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) [s1] OD [e1] : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or [s2] NVD [e2] or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T17	T6	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) [s1] OD [e1] : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or [s2] NVA [e2] Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T17	T7	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) [s1] OD [e1] : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without [s2] Edema [e2] , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T17	T8	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) [s1] OD [e1] : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms [s2] NVE [e2] temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T17	T9	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) [s1] OD [e1] : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No [s2] Neovascularization [e2] .	laterality	lesion	T17	T10	note_169
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	[s2] Proliferative diabetic retinopathy [e2] associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	severity	lesion	T18	T3	note_169
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New [s2] NVE [e2] temporally .	severity	lesion	T18	T4	note_169
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	Mild [s2] NPDR [e2] now .	severity	lesion	T18	T11	note_169
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : [s2] PDR [e2] OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	severity	lesion	T18	T20	note_169
NonRel	[s1] Mild [e1] NPDR now .	No [s2] NVI [e2] or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T19	T5	note_169
NonRel	[s1] Mild [e1] NPDR now .	No NVI or [s2] NVD [e2] or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T19	T6	note_169
NonRel	[s1] Mild [e1] NPDR now .	No NVI or NVD or [s2] NVA [e2] Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T19	T7	note_169
NonRel	[s1] Mild [e1] NPDR now .	No NVI or NVD or NVA Mac OCT without [s2] Edema [e2] , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T19	T8	note_169
NonRel	[s1] Mild [e1] NPDR now .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms [s2] NVE [e2] temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T19	T9	note_169
NonRel	[s1] Mild [e1] NPDR now .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No [s2] Neovascularization [e2] .	severity	lesion	T19	T10	note_169
NonRel	[s1] Mild [e1] NPDR now .	Mac OCT without [s2] Edema [e2] , mild ERM , no posterior hyloid IVFA with shallow ITQ tractional RD with leakage Consented for PRP left eye mid periphery x 360 Kevin Talbot , MD participated in the care of this patient .	severity	lesion	T19	T12	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No [s2] NVI [e2] or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T21	T5	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or [s2] NVD [e2] or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T21	T6	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or [s2] NVA [e2] Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T21	T7	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without [s2] Edema [e2] , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T21	T8	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms [s2] NVE [e2] temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T21	T9	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No [s2] Neovascularization [e2] .	laterality	lesion	T21	T10	note_169
